RESULT_COUNT: 2832,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
AGN,AGN:US,BBG000FH8PX5,Allergan Stock: Performance in 3Q17,2017-10-20 20:36:06 +0000,http://finance.yahoo.com/r/a49ccbb7-9a42-320b-b3b2-558d3c2ede3e/allergan-stock-performance-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan stock has fallen ~15.4% in 3Q17. It has fallen 9.8% year-to-date as of October 20, 2017."
,,,Allergan Stock: Performance in 3Q17,2017-10-20 20:36:06 +0000,http://finance.yahoo.com/r/a49ccbb7-9a42-320b-b3b2-558d3c2ede3e/allergan-stock-performance-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan stock has fallen ~15.4% in 3Q17. It has fallen 9.8% year-to-date as of October 20, 2017."
,,,Allergan: A Splitting Headache?,2017-10-20 18:19:00 +0000,http://finance.yahoo.com/r/6b6827ea-2f0d-3e7f-8762-237865ca2466/allergan-a-splitting-headache-1508523587?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Another analyst is weighing in on the growing guesswork regarding the likelihood that Allergan (AGN) could be heading for a break up.  Allergan is appealing the decision, though the outcome of such a move is far from certain.  Meanwhile, several analysts warn that a cheaper-priced generic version of Restasis could hit the U.S. market next year, eroding sales of Allergan’s second-biggest selling drug and creating a $1.5 billion revenue hole."
AGN,AGN:US,BBG000FH8PX5,Allergan: A Splitting Headache?,2017-10-20 18:19:00 +0000,http://finance.yahoo.com/r/6b6827ea-2f0d-3e7f-8762-237865ca2466/allergan-a-splitting-headache-1508523587?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Another analyst is weighing in on the growing guesswork regarding the likelihood that Allergan (AGN) could be heading for a break up.  Allergan is appealing the decision, though the outcome of such a move is far from certain.  Meanwhile, several analysts warn that a cheaper-priced generic version of Restasis could hit the U.S. market next year, eroding sales of Allergan’s second-biggest selling drug and creating a $1.5 billion revenue hole."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling",2017-10-20 15:14:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-gagVZGWJ0M/pharma-stock-roundup-beat-raise-quarter-from-jj-allergan-hit-by-restasis-ruling-cm862525,Johnson amp Johnson JNJ kicked off third quarter earnings season for the pharmaceutical sector on a strong note with the company beating on both earnings and revenues While focus remained on J amp J s strong earnings results companies like Allergan AGN were also in the news regarding
,,,"Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling",2017-10-20 15:14:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-gagVZGWJ0M/pharma-stock-roundup-beat-raise-quarter-from-jj-allergan-hit-by-restasis-ruling-cm862525,Johnson amp Johnson JNJ kicked off third quarter earnings season for the pharmaceutical sector on a strong note with the company beating on both earnings and revenues While focus remained on J amp J s strong earnings results companies like Allergan AGN were also in the news regarding
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling",2017-10-20 12:47:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-beat-raise-124712930.html?.tsrc=rss,Johnson & Johnson&apos;s (JNJ) Q3 earnings results were the key highlight this week with the company reporting strong results and raising its outlook.
,,,"Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling",2017-10-20 12:47:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-beat-raise-124712930.html?.tsrc=rss,Johnson & Johnson&apos;s (JNJ) Q3 earnings results were the key highlight this week with the company reporting strong results and raising its outlook.
,,,Imprimis Pharma to take on Allergan's Restasis with cheaper product,2017-10-20 03:29:19 +0000,https://finance.yahoo.com/news/imprimis-pharma-allergans-restasis-cheaper-032919709.html?.tsrc=rss,"San Diego-based Imprimis' therapy will cost 99 cents for a month's supply, with refills starting at $79 a month and the company will start selling prescriptions on Nov. 1, Imprimis' Chief Executive Mark Baum told Reuters.  Allergan recently stirred controversy after striking a deal with the Native American Saint Regis Mohawk tribe that would shield certain patents on Restasis."
AGN,AGN:US,BBG000FH8PX5,Imprimis Pharma to take on Allergan's Restasis with cheaper product,2017-10-20 03:29:19 +0000,https://finance.yahoo.com/news/imprimis-pharma-allergans-restasis-cheaper-032919709.html?.tsrc=rss,"San Diego-based Imprimis' therapy will cost 99 cents for a month's supply, with refills starting at $79 a month and the company will start selling prescriptions on Nov. 1, Imprimis' Chief Executive Mark Baum told Reuters.  Allergan recently stirred controversy after striking a deal with the Native American Saint Regis Mohawk tribe that would shield certain patents on Restasis."
,,,"Health Care Sector Update for 10/19/2017: IMMY,ADHD,JNJ,IMNP",2017-10-19 20:03:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/39wng5y4Hfg/health-care-sector-update-for-10192017-immyadhdjnjimnp-cm862244,Top Health Care StocksTop Health Care Stocks JNJ 1 0 JNJ 1 0 PFE 1 4 PFE 1 4 ABT 0 2 ABT 0 2 MRK 0 50 MRK 0 50 AMGN 1 2 AMGN 1 2 Health care stocks trended higher today with the NYSE Health Care Index NYP advancing almost 0 6 while shares of health care companies in the S amp
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 10/19/2017: IMMY,ADHD,JNJ,IMNP",2017-10-19 20:03:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/39wng5y4Hfg/health-care-sector-update-for-10192017-immyadhdjnjimnp-cm862244,Top Health Care StocksTop Health Care Stocks JNJ 1 0 JNJ 1 0 PFE 1 4 PFE 1 4 ABT 0 2 ABT 0 2 MRK 0 50 MRK 0 50 AMGN 1 2 AMGN 1 2 Health care stocks trended higher today with the NYSE Health Care Index NYP advancing almost 0 6 while shares of health care companies in the S amp
,,,Mid-Afternoon Market Update: Crude Oil Down 1.25%; Alcobra Shares Spike Higher,2017-10-19 19:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VAFsFCrPTkg/mid-afternoon-market-update-crude-oil-down-125-alcobra-shares-spike-higher-cm862235,Toward the end of trading Thursday the Dow traded down 0 10 percent to 23 134 42 while the NASDAQ declined 0 51 percent to 6 590 67 The S amp P also fell dropping 0 09 percent to 2 558 84 Leading and Lagging Sectors Thursday afternoon the utilities shares surged 0 49
AGN,AGN:US,BBG000FH8PX5,Mid-Afternoon Market Update: Crude Oil Down 1.25%; Alcobra Shares Spike Higher,2017-10-19 19:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VAFsFCrPTkg/mid-afternoon-market-update-crude-oil-down-125-alcobra-shares-spike-higher-cm862235,Toward the end of trading Thursday the Dow traded down 0 10 percent to 23 134 42 while the NASDAQ declined 0 51 percent to 6 590 67 The S amp P also fell dropping 0 09 percent to 2 558 84 Leading and Lagging Sectors Thursday afternoon the utilities shares surged 0 49
AGN,AGN:US,BBG000FH8PX5,"Verde Servicos Internacionais S.A. Buys iShares MSCI Brazil Capped Index Fund, Citigroup Inc, ...",2017-10-19 17:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9PEg79aIc9g/verde-servicos-internacionais-sa-buys-ishares-msci-brazil-capped-index-fund-citigroup-inc-cm862134,Verde Servicos Internacionais S A New Purchases EWZ C BACPRL GD ILMN GDDY CHTR CTXS BHP TISI Added Positions BAC CMCSA FB VEON UTX MOH RYAMPRA NOW XRAY UNVR Reduced Positions ORCL GOOG SYF ARMK JCI CONE TAP NKE MSFT VALE
,,,"Verde Servicos Internacionais S.A. Buys iShares MSCI Brazil Capped Index Fund, Citigroup Inc, ...",2017-10-19 17:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9PEg79aIc9g/verde-servicos-internacionais-sa-buys-ishares-msci-brazil-capped-index-fund-citigroup-inc-cm862134,Verde Servicos Internacionais S A New Purchases EWZ C BACPRL GD ILMN GDDY CHTR CTXS BHP TISI Added Positions BAC CMCSA FB VEON UTX MOH RYAMPRA NOW XRAY UNVR Reduced Positions ORCL GOOG SYF ARMK JCI CONE TAP NKE MSFT VALE
,,,Allergan's Hard Fall Is Not Enough of a Reason to Buy,2017-10-19 15:24:00 +0000,http://finance.yahoo.com/r/c6cd7648-9ef6-3411-91ec-2322f8d0ca79/allergans-hard-fall-not-enough-reason-buy?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,AGN could make a capitulation low but it is a long way from making a bottom formation.
AGN,AGN:US,BBG000FH8PX5,Allergan's Hard Fall Is Not Enough of a Reason to Buy,2017-10-19 15:24:00 +0000,http://finance.yahoo.com/r/c6cd7648-9ef6-3411-91ec-2322f8d0ca79/allergans-hard-fall-not-enough-reason-buy?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,AGN could make a capitulation low but it is a long way from making a bottom formation.
,,,Mid-Morning Market Update: Markets Open Lower; Verizon Sales Beat Estimates,2017-10-19 15:13:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/juEcyMfdX78/mid-morning-market-update-markets-open-lower-verizon-sales-beat-estimates-cm861998,Following the market opening Thursday the Dow traded down 0 42 percent to 23 059 85 while the NASDAQ declined 0 93 percent to 6 562 66 The S amp P also fell dropping 0 48 percent to 2 549 03 Leading and Lagging Sectors Thursday morning the telecommunications services
AGN,AGN:US,BBG000FH8PX5,Mid-Morning Market Update: Markets Open Lower; Verizon Sales Beat Estimates,2017-10-19 15:13:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/juEcyMfdX78/mid-morning-market-update-markets-open-lower-verizon-sales-beat-estimates-cm861998,Following the market opening Thursday the Dow traded down 0 42 percent to 23 059 85 while the NASDAQ declined 0 93 percent to 6 562 66 The S amp P also fell dropping 0 48 percent to 2 549 03 Leading and Lagging Sectors Thursday morning the telecommunications services
AGN,AGN:US,BBG000FH8PX5,Allergan: All In or Fall Out?,2017-10-19 15:03:00 +0000,http://finance.yahoo.com/r/d846834a-621b-344c-affe-8dd581ab2fa6/allergan-all-in-or-fall-out-1508425433?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Is Allergan (AGN) worth the risk? That’s the question analysts and investors are tackling this week after the drug maker got rocked by a federal court ruling that invalidated some of the patents protecting ...
,,,Allergan: All In or Fall Out?,2017-10-19 15:03:00 +0000,http://finance.yahoo.com/r/d846834a-621b-344c-affe-8dd581ab2fa6/allergan-all-in-or-fall-out-1508425433?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Is Allergan (AGN) worth the risk? That’s the question analysts and investors are tackling this week after the drug maker got rocked by a federal court ruling that invalidated some of the patents protecting ...
AGN,AGN:US,BBG000FH8PX5,"Company News For Oct 19, 2017",2017-10-19 14:04:02 +0000,https://finance.yahoo.com/news/company-news-oct-19-2017-140402755.html?.tsrc=rss,"Companies in the News are: FOGO,ABT,AGN,EA"
,,,"Company News For Oct 19, 2017",2017-10-19 14:04:02 +0000,https://finance.yahoo.com/news/company-news-oct-19-2017-140402755.html?.tsrc=rss,"Companies in the News are: FOGO,ABT,AGN,EA"
,,,"Morning Movers: Gilead Gains, Nike Drops, Philip Morris Tumbles",2017-10-19 13:43:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y7NLF6-6xUQ/morning-movers-gilead-gains-nike-drops-philip-morris-tumbles-cm861860,The Dow looks set to drop around 100 points as U S markets look to follow international stocks lower this morning The Dow looks set to drop around 100 points as U S markets look to followinternational stocks lower this morning Agence France Presse Getty Images
AGN,AGN:US,BBG000FH8PX5,"Morning Movers: Gilead Gains, Nike Drops, Philip Morris Tumbles",2017-10-19 13:43:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y7NLF6-6xUQ/morning-movers-gilead-gains-nike-drops-philip-morris-tumbles-cm861860,The Dow looks set to drop around 100 points as U S markets look to follow international stocks lower this morning The Dow looks set to drop around 100 points as U S markets look to followinternational stocks lower this morning Agence France Presse Getty Images
AGN,AGN:US,BBG000FH8PX5,Conatus Entrusts Keith W. Marshall With Key Management Roles,2017-10-19 13:36:01 +0000,https://finance.yahoo.com/news/conatus-entrusts-keith-w-marshall-133601849.html?.tsrc=rss,"Conatus Pharmaceuticals (CNAT) announced the appointment of Keith W. Marshall as executive vice president, chief operating officer and chief financial officer."
,,,Conatus Entrusts Keith W. Marshall With Key Management Roles,2017-10-19 13:36:01 +0000,https://finance.yahoo.com/news/conatus-entrusts-keith-w-marshall-133601849.html?.tsrc=rss,"Conatus Pharmaceuticals (CNAT) announced the appointment of Keith W. Marshall as executive vice president, chief operating officer and chief financial officer."
,,,Allergan Issues Investor FAQ on Federal District Court RESTASIS® Patent Decision,2017-10-18 22:45:00 +0000,https://finance.yahoo.com/news/allergan-issues-investor-faq-federal-224500885.html?.tsrc=rss,"Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.  Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care.  With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry with 65+ mid-to-late stage pipeline programs currently in development."
AGN,AGN:US,BBG000FH8PX5,Allergan Issues Investor FAQ on Federal District Court RESTASIS® Patent Decision,2017-10-18 22:45:00 +0000,https://finance.yahoo.com/news/allergan-issues-investor-faq-federal-224500885.html?.tsrc=rss,"Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.  Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care.  With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry with 65+ mid-to-late stage pipeline programs currently in development."
,,,The Biggest Loser: Allergan's Patent Troubles,2017-10-18 21:55:00 +0000,http://finance.yahoo.com/r/f1c42140-70d8-38e5-851b-8dae961c4469/the-biggest-loser-allergans-patent-troubles-1508363734?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Allergan (AGN) fell to the bottom of the S&P 500 today as analysts predicted that the drug maker’s blockbuster eye drug Restasis could see a generic rival as soon as next year.  Shares of Allergan fell more than 5.3% to close at $187.15 a share, on a day when the index edged 0.7% lower.  On Monday, Allergan got rocked when a federal judge invalidated some of the patents protecting Restasis, opening the door for generic rivals that could push Allergan’s second-biggest selling drug off a cliff."
AGN,AGN:US,BBG000FH8PX5,The Biggest Loser: Allergan's Patent Troubles,2017-10-18 21:55:00 +0000,http://finance.yahoo.com/r/f1c42140-70d8-38e5-851b-8dae961c4469/the-biggest-loser-allergans-patent-troubles-1508363734?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Allergan (AGN) fell to the bottom of the S&P 500 today as analysts predicted that the drug maker’s blockbuster eye drug Restasis could see a generic rival as soon as next year.  Shares of Allergan fell more than 5.3% to close at $187.15 a share, on a day when the index edged 0.7% lower.  On Monday, Allergan got rocked when a federal judge invalidated some of the patents protecting Restasis, opening the door for generic rivals that could push Allergan’s second-biggest selling drug off a cliff."
,,,"Why SUPERVALU, Synchronoss Technologies, and Allergan Slumped Today",2017-10-18 20:30:00 +0000,https://finance.yahoo.com/news/why-supervalu-synchronoss-technologies-allergan-203000996.html?.tsrc=rss,"Even as the market climbed, these stocks lagged behind. Find out why."
AGN,AGN:US,BBG000FH8PX5,"Why SUPERVALU, Synchronoss Technologies, and Allergan Slumped Today",2017-10-18 20:30:00 +0000,https://finance.yahoo.com/news/why-supervalu-synchronoss-technologies-allergan-203000996.html?.tsrc=rss,"Even as the market climbed, these stocks lagged behind. Find out why."
AGN,AGN:US,BBG000FH8PX5,"Notable Wednesday Option Activity: AGN, REGN, ABBV",2017-10-18 19:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ilrEAV82u8A/notable-wednesday-option-activity-agn-regn-abbv-cm861538,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Allergan PLC Symbol AGN where a total of 46 585 contracts have traded so far representing approximately 4 7 million underlying shares That amounts to about 149 of AGN s average
,,,"Notable Wednesday Option Activity: AGN, REGN, ABBV",2017-10-18 19:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ilrEAV82u8A/notable-wednesday-option-activity-agn-regn-abbv-cm861538,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Allergan PLC Symbol AGN where a total of 46 585 contracts have traded so far representing approximately 4 7 million underlying shares That amounts to about 149 of AGN s average
,,,"Mohawk Tribe sues Microsoft, Amazon for patent infringeme...",2017-10-18 19:23:00 +0000,https://finance.yahoo.com/video/mohawk-tribe-sues-microsoft-amazon-192300355.html?.tsrc=rss,CNBC's Meg Tirrell reports on the latest patent lawsuits from the Saint Regis Mohawk Tribe.
AGN,AGN:US,BBG000FH8PX5,"Mohawk Tribe sues Microsoft, Amazon for patent infringeme...",2017-10-18 19:23:00 +0000,https://finance.yahoo.com/video/mohawk-tribe-sues-microsoft-amazon-192300355.html?.tsrc=rss,CNBC's Meg Tirrell reports on the latest patent lawsuits from the Saint Regis Mohawk Tribe.
,,,4 health stocks and a gamer in the Blitz,2017-10-18 18:33:00 +0000,https://finance.yahoo.com/video/4-health-stocks-gamer-blitz-183300619.html?.tsrc=rss,Big movers in today's blitz
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Are Ready for a 30% Bounce Within Days,2017-10-18 18:33:00 +0000,http://finance.yahoo.com/r/79e0ffa4-d197-3c15-bdcf-a12bcb5f9ee2/allergan-shares-ready-for-big-bounce.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Last October Allergan stock bounced off this support level; it could do it again.
,,,Allergan Shares Are Ready for a 30% Bounce Within Days,2017-10-18 18:33:00 +0000,http://finance.yahoo.com/r/79e0ffa4-d197-3c15-bdcf-a12bcb5f9ee2/allergan-shares-ready-for-big-bounce.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Last October Allergan stock bounced off this support level; it could do it again.
AGN,AGN:US,BBG000FH8PX5,4 health stocks and a gamer in the Blitz,2017-10-18 18:33:00 +0000,https://finance.yahoo.com/video/4-health-stocks-gamer-blitz-183300619.html?.tsrc=rss,Big movers in today's blitz
AGN,AGN:US,BBG000FH8PX5,Native American tribe holding patents sues Amazon and Microsoft,2017-10-18 18:09:32 +0000,https://finance.yahoo.com/news/native-american-tribe-holding-patents-180932153.html?.tsrc=rss,"A Native American tribe sued Amazon.com Inc and Microsoft Corp in federal court in Virginia on Wednesday for infringing supercomputer patents it is holding for a technology firm.  The Saint Regis Mohawk Tribe was assigned the patents by SRC Labs LLC in August, in a deal intended to use the tribe's sovereign status to shield them from administrative review.  Microsoft and Amazon did not immediately return requests for comment."
,,,Native American tribe holding patents sues Amazon and Microsoft,2017-10-18 18:09:32 +0000,https://finance.yahoo.com/news/native-american-tribe-holding-patents-180932153.html?.tsrc=rss,"A Native American tribe sued Amazon.com Inc and Microsoft Corp in federal court in Virginia on Wednesday for infringing supercomputer patents it is holding for a technology firm.  The Saint Regis Mohawk Tribe was assigned the patents by SRC Labs LLC in August, in a deal intended to use the tribe's sovereign status to shield them from administrative review.  Microsoft and Amazon did not immediately return requests for comment."
AGN,AGN:US,BBG000FH8PX5,Allergan Becomes Oversold (AGN),2017-10-18 17:51:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hlS01WLO-pQ/allergan-becomes-oversold-agn-cm861452,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
,,,Allergan Becomes Oversold (AGN),2017-10-18 17:51:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hlS01WLO-pQ/allergan-becomes-oversold-agn-cm861452,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
AGN,AGN:US,BBG000FH8PX5,Native American tribe holding patents sues Amazon and Microsoft,2017-10-18 17:38:43 +0000,https://finance.yahoo.com/news/native-american-tribe-holding-patents-173843535.html?.tsrc=rss,"A Native American tribe sued Amazon.com  Inc and Microsoft Corp in federal court in  Virginia on Wednesday for infringing supercomputer patents it is  holding for a technology firm.  The Saint Regis Mohawk Tribe was assigned the patents by SRC  Labs LLC in August, in a deal intended to use the tribe's  sovereign status to shield them from administrative review."
AGN,AGN:US,BBG000FH8PX5,Is a Breakup Allergan's Best Bet?,2017-10-18 15:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dgktcuPYXFs/is-a-breakup-allergans-best-bet-cm861285,Is it too soon to talk about breaking up Allergan AGN Is it too soon to talk about breaking upAllerganAllergan AGN Bloomberg News Bloomberg News Bernstein analyst Aaron Gal met with Allergan CEO Brent Saunders yesterday following Monday s ruling by a federal
,,,Is a Breakup Allergan's Best Bet?,2017-10-18 15:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dgktcuPYXFs/is-a-breakup-allergans-best-bet-cm861285,Is it too soon to talk about breaking up Allergan AGN Is it too soon to talk about breaking upAllerganAllergan AGN Bloomberg News Bloomberg News Bernstein analyst Aaron Gal met with Allergan CEO Brent Saunders yesterday following Monday s ruling by a federal
,,,"Mohawk tribe sues Microsoft, Amazon for patent infringement",2017-10-18 15:26:46 +0000,http://finance.yahoo.com/r/5564cb88-4036-3a9c-9bb6-321949dfb0a8/104780578?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104780578&yptr=yahoo&.tsrc=rss,"The tribe is a co-plaintiff with SRC Labs, which claims its data processing technology patents have been infringed for years."
AGN,AGN:US,BBG000FH8PX5,"Mohawk tribe sues Microsoft, Amazon for patent infringement",2017-10-18 15:26:46 +0000,http://finance.yahoo.com/r/5564cb88-4036-3a9c-9bb6-321949dfb0a8/104780578?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104780578&yptr=yahoo&.tsrc=rss,"The tribe is a co-plaintiff with SRC Labs, which claims its data processing technology patents have been infringed for years."
AGN,AGN:US,BBG000FH8PX5,Allergan ruling casts doubt on tribal patent strategy,2017-10-18 14:43:25 +0000,https://finance.yahoo.com/news/allergan-ruling-casts-doubt-tribal-143334847.html?.tsrc=rss,"In a deal announced last month, Allergan transferred the Restasis patents to New York state's Saint Regis Mohawk Tribe,  claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office.  Allergan said the move was justified because the same patents were already being reviewed in federal court, but critics said it was a cynical attempt to prolong the company's monopoly on Restasis."
,,,Allergan ruling casts doubt on tribal patent strategy,2017-10-18 14:43:25 +0000,https://finance.yahoo.com/news/allergan-ruling-casts-doubt-tribal-143334847.html?.tsrc=rss,"In a deal announced last month, Allergan transferred the Restasis patents to New York state's Saint Regis Mohawk Tribe,  claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office.  Allergan said the move was justified because the same patents were already being reviewed in federal court, but critics said it was a cynical attempt to prolong the company's monopoly on Restasis."
AGN,AGN:US,BBG000FH8PX5,Is a Breakup Allergan's Best Bet?,2017-10-18 14:10:00 +0000,http://finance.yahoo.com/r/e8fa1fba-0a10-3710-9ebd-d75d8a661222/is-a-breakup-allergans-best-bet-1508335847?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Is it too soon to talk about breaking up Allergan (AGN)?  Bernstein analyst Aaron Gal met with Allergan CEO Brent Saunders yesterday following Monday’s ruling by a federal judge invalidating patents protecting the drug maker’s blockbuster dry-eye therapy Restasis.  To be clear upfront, when asked, CEO Saunders noted that this is a ""premature discussion"" and it is his job to ""think of everything,"" so him willing to comment does not suggest they are taking active steps in this direction."
,,,Is a Breakup Allergan's Best Bet?,2017-10-18 14:10:00 +0000,http://finance.yahoo.com/r/e8fa1fba-0a10-3710-9ebd-d75d8a661222/is-a-breakup-allergans-best-bet-1508335847?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Is it too soon to talk about breaking up Allergan (AGN)?  Bernstein analyst Aaron Gal met with Allergan CEO Brent Saunders yesterday following Monday’s ruling by a federal judge invalidating patents protecting the drug maker’s blockbuster dry-eye therapy Restasis.  To be clear upfront, when asked, CEO Saunders noted that this is a ""premature discussion"" and it is his job to ""think of everything,"" so him willing to comment does not suggest they are taking active steps in this direction."
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall",2017-10-17 23:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aE36nyCQKmQ/allergan-agn-loses-restasis-patent-lawsuit-shares-fall-cm861054,Allergan plc AGN announced that a Texas federal district court invalidated four of the six patents covering Restasis Allergan s second bestselling drug This potentially opens the doors for early generic competition Shares of the company fell almost 3 5 in response on Monday The company
,,,"Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall",2017-10-17 23:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aE36nyCQKmQ/allergan-agn-loses-restasis-patent-lawsuit-shares-fall-cm861054,Allergan plc AGN announced that a Texas federal district court invalidated four of the six patents covering Restasis Allergan s second bestselling drug This potentially opens the doors for early generic competition Shares of the company fell almost 3 5 in response on Monday The company
AGN,AGN:US,BBG000FH8PX5,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 23:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fp2mfwN6_Eg/aerie-aeri-up-on-fda-review-committee-result-for-rhopressa-cm861041,Shares of Aerie Pharmaceuticals Inc AERI have moved up 15 8 in the last one week on positive news for its lead drug Rhopressa In fact Aerie s stock has surged 71 4 year to date compared with the industry s gain of 3 4 On Oct 13 the Dermatologic and Ophthalmic
,,,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 23:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fp2mfwN6_Eg/aerie-aeri-up-on-fda-review-committee-result-for-rhopressa-cm861041,Shares of Aerie Pharmaceuticals Inc AERI have moved up 15 8 in the last one week on positive news for its lead drug Rhopressa In fact Aerie s stock has surged 71 4 year to date compared with the industry s gain of 3 4 On Oct 13 the Dermatologic and Ophthalmic
AGN,AGN:US,BBG000FH8PX5,Cramer: Getting Out the Bad News Gives a Post-Earnings Boost,2017-10-17 23:01:00 +0000,http://finance.yahoo.com/r/b58f894f-5d3e-3217-8be8-f19719704c8c/cramer-getting-out-bad-news-gives-post-earnings-boost?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"When management gets ahead of bad news, it allows a stock to prosper when the company reports earnings."
,,,Cramer: Getting Out the Bad News Gives a Post-Earnings Boost,2017-10-17 23:01:00 +0000,http://finance.yahoo.com/r/b58f894f-5d3e-3217-8be8-f19719704c8c/cramer-getting-out-bad-news-gives-post-earnings-boost?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"When management gets ahead of bad news, it allows a stock to prosper when the company reports earnings."
AGN,AGN:US,BBG000FH8PX5,Allergan ruling casts doubt on tribal patent strategy,2017-10-17 22:17:15 +0000,https://finance.yahoo.com/news/allergan-ruling-casts-doubt-tribal-221715099.html?.tsrc=rss,"In a deal announced last month, Allergan transferred the Restasis patents to New York state's Saint Regis Mohawk Tribe,  claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office.  Allergan said the move was justified because the same patents were already being reviewed in federal court, but critics said it was a cynical attempt to prolong the company's monopoly on Restasis."
,,,Allergan ruling casts doubt on tribal patent strategy,2017-10-17 22:17:15 +0000,https://finance.yahoo.com/news/allergan-ruling-casts-doubt-tribal-221715099.html?.tsrc=rss,"In a deal announced last month, Allergan transferred the Restasis patents to New York state's Saint Regis Mohawk Tribe,  claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office.  Allergan said the move was justified because the same patents were already being reviewed in federal court, but critics said it was a cynical attempt to prolong the company's monopoly on Restasis."
,,,Allergan ruling casts doubt on tribal patent strategy,2017-10-17 22:02:34 +0000,https://finance.yahoo.com/news/allergan-ruling-casts-doubt-tribal-220234276.html?.tsrc=rss,"In a deal announced last month, Allergan transferred the Restasis patents to New York state's Saint Regis Mohawk Tribe,  claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office.  Allergan said the move was justified because the same patents were already being reviewed in federal court, but critics said it was a cynical attempt to prolong the company's monopoly on Restasis."
AGN,AGN:US,BBG000FH8PX5,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 21:59:09 +0000,https://finance.yahoo.com/news/aerie-aeri-fda-review-committee-215909645.html?.tsrc=rss,"Shares of Aerie Pharmaceuticals, Inc. (AERI) have moved up 15.8% in the last week on positive news for its lead drug, Rhopressa."
,,,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 21:59:09 +0000,https://finance.yahoo.com/news/aerie-aeri-fda-review-committee-215909645.html?.tsrc=rss,"Shares of Aerie Pharmaceuticals, Inc. (AERI) have moved up 15.8% in the last week on positive news for its lead drug, Rhopressa."
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall",2017-10-17 21:44:09 +0000,https://finance.yahoo.com/news/allergan-agn-loses-restasis-patent-214409500.html?.tsrc=rss,"Allergan (AGN) lost a patent infringement lawsuit filed against companies trying to develop a generic version of its eye drug, Restasis, which is also its second bestselling drug."
,,,"Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall",2017-10-17 21:44:09 +0000,https://finance.yahoo.com/news/allergan-agn-loses-restasis-patent-214409500.html?.tsrc=rss,"Allergan (AGN) lost a patent infringement lawsuit filed against companies trying to develop a generic version of its eye drug, Restasis, which is also its second bestselling drug."
AGN,AGN:US,BBG000FH8PX5,How Allergan's 'Public Relations Backlash' Deepened This Week,2017-10-17 20:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MS0e4TAnYTc/how-allergans-public-relations-backlash-deepened-this-week-cm860847,Allergan AGN was already facing a public relations backlash after transferring patent rights for its Restasis eye medication to a Native American tribe when a judge on Monday then invalidated four of those patents ibd display video id 2326965 width 50 float
,,,How Allergan's 'Public Relations Backlash' Deepened This Week,2017-10-17 20:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MS0e4TAnYTc/how-allergans-public-relations-backlash-deepened-this-week-cm860847,Allergan AGN was already facing a public relations backlash after transferring patent rights for its Restasis eye medication to a Native American tribe when a judge on Monday then invalidated four of those patents ibd display video id 2326965 width 50 float
AGN,AGN:US,BBG000FH8PX5,How Allergan&apos;s &apos;Public Relations Backlash&apos; Deepened This Week,2017-10-17 20:29:24 +0000,http://finance.yahoo.com/r/0cc641fe-e264-3906-bcf5-979c9c2efe5f/how-allergans-public-relations-backlash-deepened-this-week?src=A00220&yptr=yahoo&.tsrc=rss,Allergan already faced a &quot;public relations backlash&quot; after transferring the rights to its Restasis patents to a Native American tribe.
,,,How Allergan&apos;s &apos;Public Relations Backlash&apos; Deepened This Week,2017-10-17 20:29:24 +0000,http://finance.yahoo.com/r/0cc641fe-e264-3906-bcf5-979c9c2efe5f/how-allergans-public-relations-backlash-deepened-this-week?src=A00220&yptr=yahoo&.tsrc=rss,Allergan already faced a &quot;public relations backlash&quot; after transferring the rights to its Restasis patents to a Native American tribe.
AGN,AGN:US,BBG000FH8PX5,And For Allergen's Next Trick..Filling a $1.5 Billion Hole?,2017-10-17 19:59:00 +0000,http://finance.yahoo.com/r/69fa5845-b9cb-39ba-8680-d9cb266ef072/and-for-allergens-next-trick-filling-a-1-5-billion-hole-1508270353?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Not even Botox can wipe away the worry lines that followed Allergan’s (AGN) recent patent loss.  Yesterday, a federal district court judge invalidated some of the patents protecting blockbuster dry-eye treatment Restasis, opening the door for generic rivals that could shove sales of Allergan’s second-biggest selling drug righ off a cliff.  Many argue that the event is already baked into Allergan’s stock price, as is the public relations backlash from the controversial deal the drug maker struck last month with the Saint Regis Mohawk Tribe of upstate New York to block its Restasis patents from scrutiny by the U.S. Patent and Trade Office."
,,,And For Allergen's Next Trick..Filling a $1.5 Billion Hole?,2017-10-17 19:59:00 +0000,http://finance.yahoo.com/r/69fa5845-b9cb-39ba-8680-d9cb266ef072/and-for-allergens-next-trick-filling-a-1-5-billion-hole-1508270353?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Not even Botox can wipe away the worry lines that followed Allergan’s (AGN) recent patent loss.  Yesterday, a federal district court judge invalidated some of the patents protecting blockbuster dry-eye treatment Restasis, opening the door for generic rivals that could shove sales of Allergan’s second-biggest selling drug righ off a cliff.  Many argue that the event is already baked into Allergan’s stock price, as is the public relations backlash from the controversial deal the drug maker struck last month with the Saint Regis Mohawk Tribe of upstate New York to block its Restasis patents from scrutiny by the U.S. Patent and Trade Office."
,,,Here's How Drug Companies Game the Patent System,2017-10-17 16:39:44 +0000,http://finance.yahoo.com/r/16907bc1-a486-3418-8ffe-8d50ca63f3b0/here-s-how-drug-companies-game-the-patent-system?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Only Congress can rewrite the laws that keep prices high. Ask the judge.
AGN,AGN:US,BBG000FH8PX5,Here's How Drug Companies Game the Patent System,2017-10-17 16:39:44 +0000,http://finance.yahoo.com/r/16907bc1-a486-3418-8ffe-8d50ca63f3b0/here-s-how-drug-companies-game-the-patent-system?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Only Congress can rewrite the laws that keep prices high. Ask the judge.
AGN,AGN:US,BBG000FH8PX5,3 Dividend Healthcare Stocks,2017-10-17 15:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVL2vNb4zjM/3-dividend-healthcare-stocks-cm860621,Healthcare stocks have been extremely fertile ground for dividend investors over the last few years thanks in large part to the aging global population that s presently driving a surge in demand for medical products and healthcare services Best of all this rising tide is showing
,,,3 Dividend Healthcare Stocks,2017-10-17 15:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVL2vNb4zjM/3-dividend-healthcare-stocks-cm860621,Healthcare stocks have been extremely fertile ground for dividend investors over the last few years thanks in large part to the aging global population that s presently driving a surge in demand for medical products and healthcare services Best of all this rising tide is showing
AGN,AGN:US,BBG000FH8PX5,Allergan Is the Cheapest Big-Cap Drug Stock in the Universe: Jim Cramer,2017-10-17 14:07:00 +0000,http://finance.yahoo.com/r/bc48d0b1-2a97-346a-8584-3c0ad7f32b50/allergan-is-the-cheapest-big-cap-drug-stock-jim-cramer-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Cramer says he'll buy more shares of the lackluster drugmaker for his charitable trust if the price drops below $200.
,,,Allergan Is the Cheapest Big-Cap Drug Stock in the Universe: Jim Cramer,2017-10-17 14:07:00 +0000,http://finance.yahoo.com/r/bc48d0b1-2a97-346a-8584-3c0ad7f32b50/allergan-is-the-cheapest-big-cap-drug-stock-jim-cramer-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Cramer says he'll buy more shares of the lackluster drugmaker for his charitable trust if the price drops below $200.
AGN,AGN:US,BBG000FH8PX5,3 Dividend Healthcare Stocks,2017-10-17 14:00:00 +0000,https://finance.yahoo.com/news/3-dividend-healthcare-stocks-140000927.html?.tsrc=rss,"If you&apos;re on the hunt for outstanding healthcare dividend stocks, Allergan, Bristol-Myers Squibb, and McKesson need to be on your radar."
,,,3 Dividend Healthcare Stocks,2017-10-17 14:00:00 +0000,https://finance.yahoo.com/news/3-dividend-healthcare-stocks-140000927.html?.tsrc=rss,"If you&apos;re on the hunt for outstanding healthcare dividend stocks, Allergan, Bristol-Myers Squibb, and McKesson need to be on your radar."
AGN,AGN:US,BBG000FH8PX5,Today's Research Reports on Stocks to Watch: Allergan and Gilead Sciences,2017-10-17 12:40:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-124000289.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 17, 2017 / Shares of Allergan closed lower after a federal judge invalidated four of the company's patents for its eye-drug Restasis. Shares of Gilead also went lower ..."
,,,Today's Research Reports on Stocks to Watch: Allergan and Gilead Sciences,2017-10-17 12:40:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-124000289.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 17, 2017 / Shares of Allergan closed lower after a federal judge invalidated four of the company's patents for its eye-drug Restasis. Shares of Gilead also went lower ..."
AGN,AGN:US,BBG000FH8PX5,Allergan patent suit loss sends stock down 4%,2017-10-17 11:10:17 +0000,http://finance.yahoo.com/r/6a5d2bd0-a786-3208-89e5-0275b2709cee/Story.aspx?guid=F20F3F3E-B299-11E7-B158-683ECF325DAA&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot.
,,,Allergan patent suit loss sends stock down 4%,2017-10-17 11:10:17 +0000,http://finance.yahoo.com/r/6a5d2bd0-a786-3208-89e5-0275b2709cee/Story.aspx?guid=F20F3F3E-B299-11E7-B158-683ECF325DAA&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot.
,,,[$$] Allergan Loses Patent Fight in Federal Court,2017-10-16 23:59:00 +0000,http://finance.yahoo.com/r/32a5a260-31ed-38f1-92cb-5c0d264c74ad/allergan-loses-patent-fight-in-federal-court-1508184673?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"A U.S. District Court ruled patents for one of Allergan’s best-selling drugs are invalid, potentially opening the door for generic competition."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan Loses Patent Fight in Federal Court,2017-10-16 23:59:00 +0000,http://finance.yahoo.com/r/32a5a260-31ed-38f1-92cb-5c0d264c74ad/allergan-loses-patent-fight-in-federal-court-1508184673?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"A U.S. District Court ruled patents for one of Allergan’s best-selling drugs are invalid, potentially opening the door for generic competition."
,,,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 21:17:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byGTOw3jPuk/allergan-tanks-after-judge-invalidates-restasis-patents-cm860268,Allergan AGN stock tanked Monday after a federal judge invalidated patents covering eye drug Restasis in a dispute pitting Allergan against a group of generic drugmakers led by Teva Pharmaceutical TEVA and Mylan MYL ibd display video id
AGN,AGN:US,BBG000FH8PX5,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 21:17:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byGTOw3jPuk/allergan-tanks-after-judge-invalidates-restasis-patents-cm860268,Allergan AGN stock tanked Monday after a federal judge invalidated patents covering eye drug Restasis in a dispute pitting Allergan against a group of generic drugmakers led by Teva Pharmaceutical TEVA and Mylan MYL ibd display video id
,,,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 20:42:31 +0000,http://finance.yahoo.com/r/6c6efe6a-0b42-36c5-89c9-988233aabccd/allergan-tanks-after-judge-reportedly-invalidates-restasis-patents?src=A00220&yptr=yahoo&.tsrc=rss,Allergan tanked Monday after a federal judge invalidated patents covering eye-drug Restasis.
AGN,AGN:US,BBG000FH8PX5,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 20:42:31 +0000,http://finance.yahoo.com/r/6c6efe6a-0b42-36c5-89c9-988233aabccd/allergan-tanks-after-judge-reportedly-invalidates-restasis-patents?src=A00220&yptr=yahoo&.tsrc=rss,Allergan tanked Monday after a federal judge invalidated patents covering eye-drug Restasis.
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan Loses Patent Fight in Federal Court,2017-10-16 20:11:16 +0000,http://finance.yahoo.com/r/32a5a260-31ed-38f1-92cb-5c0d264c74ad/allergan-loses-patent-fight-in-federal-court-1508184673?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"A U.S. District Court ruled patents for one of Allergan’s best-selling drugs are invalid, potentially opening the door for generic competition."
,,,[$$] Allergan Loses Patent Fight in Federal Court,2017-10-16 20:11:16 +0000,http://finance.yahoo.com/r/32a5a260-31ed-38f1-92cb-5c0d264c74ad/allergan-loses-patent-fight-in-federal-court-1508184673?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"A U.S. District Court ruled patents for one of Allergan’s best-selling drugs are invalid, potentially opening the door for generic competition."
AGN,AGN:US,BBG000FH8PX5,Allergan will repeal Restasis patent decision,2017-10-16 19:45:00 +0000,https://finance.yahoo.com/video/allergan-repeal-restasis-patent-decision-194500831.html?.tsrc=rss,CNBC's Meg Tirrell reports on the latest developments on a federal court invalidating Allergan's eye drug patents.
,,,Allergan will repeal Restasis patent decision,2017-10-16 19:45:00 +0000,https://finance.yahoo.com/video/allergan-repeal-restasis-patent-decision-194500831.html?.tsrc=rss,CNBC's Meg Tirrell reports on the latest developments on a federal court invalidating Allergan's eye drug patents.
AGN,AGN:US,BBG000FH8PX5,Allergan Loses a Patent Battle…Has It Lost the War?,2017-10-16 19:35:00 +0000,http://finance.yahoo.com/r/581cdd06-ce45-3531-a138-4fbb9174ff0e/allergan-loses-a-patent-battlehas-it-lost-the-war-1508182546?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"With its stock price in a free fall after a federal judge invalidated patents covering the dry eye drug Restasis, what’s next for Allergan (AGN).  ... a generic version of Restasis has not yet been approved and even if a generic were approved within that time frame, a launch prior to the conclusion of that appeal would be considered ''at-risk''.  Today’s court ruling is the latest development in the legal dispute pitting Allergan against a group of generic drug makers led by Teva Pharmaceutical Industries (TEVA) and Mylan (MYL)."
,,,Allergan Loses a Patent Battle…Has It Lost the War?,2017-10-16 19:35:00 +0000,http://finance.yahoo.com/r/581cdd06-ce45-3531-a138-4fbb9174ff0e/allergan-loses-a-patent-battlehas-it-lost-the-war-1508182546?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"With its stock price in a free fall after a federal judge invalidated patents covering the dry eye drug Restasis, what’s next for Allergan (AGN).  ... a generic version of Restasis has not yet been approved and even if a generic were approved within that time frame, a launch prior to the conclusion of that appeal would be considered ''at-risk''.  Today’s court ruling is the latest development in the legal dispute pitting Allergan against a group of generic drug makers led by Teva Pharmaceutical Industries (TEVA) and Mylan (MYL)."
AGN,AGN:US,BBG000FH8PX5,Allergan patent suit loss sends stock down 5%,2017-10-16 18:33:13 +0000,https://finance.yahoo.com/news/allergan-patent-suit-loss-sends-183313538.html?.tsrc=rss,Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot.
,,,Allergan patent suit loss sends stock down 5%,2017-10-16 18:33:13 +0000,https://finance.yahoo.com/news/allergan-patent-suit-loss-sends-183313538.html?.tsrc=rss,Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot.
AGN,AGN:US,BBG000FH8PX5,U.S. judge in Texas invalidates Allergan patents on Restasis,2017-10-16 17:45:51 +0000,https://finance.yahoo.com/news/u-judge-texas-invalidates-allergan-174551505.html?.tsrc=rss,"Shares of pharmaceutical company Allergan  Plc dropped on Monday after a ruling by a U.S. judge  invalidated patents on its dry eye medicine Restasis on the  grounds that the patents cover obvious ideas.  Judge William Bryson issued the ruling in federal court in  Marshall, Texas, in a longstanding dispute between Allergan and  generic drugmakers led by Mylan NV and Teva  Pharmaceutical Industries Ltd.  The ruling could enable the generic drug companies to sell  their own versions of Restasis, which generated around $1.5  billion in sales for Allergan last year and accounted for more  than 10 percent of the company's revenue."
,,,U.S. judge in Texas invalidates Allergan patents on Restasis,2017-10-16 17:45:51 +0000,https://finance.yahoo.com/news/u-judge-texas-invalidates-allergan-174551505.html?.tsrc=rss,"Shares of pharmaceutical company Allergan  Plc dropped on Monday after a ruling by a U.S. judge  invalidated patents on its dry eye medicine Restasis on the  grounds that the patents cover obvious ideas.  Judge William Bryson issued the ruling in federal court in  Marshall, Texas, in a longstanding dispute between Allergan and  generic drugmakers led by Mylan NV and Teva  Pharmaceutical Industries Ltd.  The ruling could enable the generic drug companies to sell  their own versions of Restasis, which generated around $1.5  billion in sales for Allergan last year and accounted for more  than 10 percent of the company's revenue."
AGN,AGN:US,BBG000FH8PX5,U.S. District Court for the Eastern District of Texas Issues Adverse Trial Decision Concerning RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patents,2017-10-16 17:45:00 +0000,https://finance.yahoo.com/news/u-district-court-eastern-district-174500864.html?.tsrc=rss,"DUBLIN, Oct. 16, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today acknowledged that the U.S. District Court for the Eastern District of Texas has issued an adverse trial decision finding that the four asserted patents covering RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% are invalid.  ""We are disappointed by the Federal District Court's decision on the RESTASIS® patents.  To date, none of the proposed generic versions of RESTASIS® have received approval and none of these products would be able to launch in the market."
,,,U.S. District Court for the Eastern District of Texas Issues Adverse Trial Decision Concerning RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patents,2017-10-16 17:45:00 +0000,https://finance.yahoo.com/news/u-district-court-eastern-district-174500864.html?.tsrc=rss,"DUBLIN, Oct. 16, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today acknowledged that the U.S. District Court for the Eastern District of Texas has issued an adverse trial decision finding that the four asserted patents covering RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% are invalid.  ""We are disappointed by the Federal District Court's decision on the RESTASIS® patents.  To date, none of the proposed generic versions of RESTASIS® have received approval and none of these products would be able to launch in the market."
AGN,AGN:US,BBG000FH8PX5,Allergan stock drops 5% after judge decides against company on key dry eye product,2017-10-16 17:42:40 +0000,http://finance.yahoo.com/r/a22eec67-52f5-3c89-b715-1293d8c1d7de/Story.aspx?guid=AA7E0AF9-7A1D-4429-BBE8-78757C9F8610&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan PLC shares dropped 5% in extremely heavy afternoon trade Monday after a Texas district court judge ruled against the company in a patent lawsuit regarding the company's key billion-dollar dry ...
,,,Allergan stock drops 5% after judge decides against company on key dry eye product,2017-10-16 17:42:40 +0000,http://finance.yahoo.com/r/a22eec67-52f5-3c89-b715-1293d8c1d7de/Story.aspx?guid=AA7E0AF9-7A1D-4429-BBE8-78757C9F8610&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan PLC shares dropped 5% in extremely heavy afternoon trade Monday after a Texas district court judge ruled against the company in a patent lawsuit regarding the company's key billion-dollar dry ...
,,,Allergan's Restasis patents invalidated by federal judge,2017-10-16 17:21:00 +0000,https://finance.yahoo.com/video/allergans-restasis-patents-invalidated-federal-172100773.html?.tsrc=rss,CNBC's Meg Tirrell reports on Allergan sinking after a federal judge invalidates patents on their drug Restasis.
AGN,AGN:US,BBG000FH8PX5,Allergan's Restasis patents invalidated by federal judge,2017-10-16 17:21:00 +0000,https://finance.yahoo.com/video/allergans-restasis-patents-invalidated-federal-172100773.html?.tsrc=rss,CNBC's Meg Tirrell reports on Allergan sinking after a federal judge invalidates patents on their drug Restasis.
,,,Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017,2017-10-16 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-world-congress-120100638.html?.tsrc=rss,"DUBLIN, Oct. 16, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that new data from its gastroenterology portfolio will be featured at the World Congress of Gastroenterology (WCOG), American College of Gastroenterology (ACG), from October 13–18, 2017 in Orlando, Florida.  ""Through our innovation and Open Science research and development model, our dedication to collaborations allows Allergan to continue to be on the cutting-edge in the field of gastroenterology,"" said David Nicholson, Ph.D., Chief Research and Development Officer, Allergan.  A key presentation will include the radar plots used to display disparate global effects of eluxadoline in a large group of patients who typically experience a broad range of symptoms associated with Irritable Bowel Syndrome with Diarrhea (IBS-D) (Poster #P2029)."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017,2017-10-16 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-world-congress-120100638.html?.tsrc=rss,"DUBLIN, Oct. 16, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that new data from its gastroenterology portfolio will be featured at the World Congress of Gastroenterology (WCOG), American College of Gastroenterology (ACG), from October 13–18, 2017 in Orlando, Florida.  ""Through our innovation and Open Science research and development model, our dedication to collaborations allows Allergan to continue to be on the cutting-edge in the field of gastroenterology,"" said David Nicholson, Ph.D., Chief Research and Development Officer, Allergan.  A key presentation will include the radar plots used to display disparate global effects of eluxadoline in a large group of patients who typically experience a broad range of symptoms associated with Irritable Bowel Syndrome with Diarrhea (IBS-D) (Poster #P2029)."
,,,Allergan Update; Fixed Income: Doug Kass' Views,2017-10-16 05:00:00 +0000,http://finance.yahoo.com/r/d7c2ef63-a79b-3772-a172-fbab3758dd48/allergan-update-disney-and-priceline-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Allergan and fixed income.
AGN,AGN:US,BBG000FH8PX5,Allergan Update; Fixed Income: Doug Kass' Views,2017-10-16 05:00:00 +0000,http://finance.yahoo.com/r/d7c2ef63-a79b-3772-a172-fbab3758dd48/allergan-update-disney-and-priceline-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Allergan and fixed income.
AGN,AGN:US,BBG000FH8PX5,[$$] Mylan Calls Allergan’s Patent Sale to Indian Tribe a ‘Sham’,2017-10-16 04:17:21 +0000,http://finance.yahoo.com/r/cce7bb6c-115d-30d2-8a59-1f753ffa0ad8/mylan-calls-allergans-patent-sale-to-indian-tribe-a-sham-1507996687?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Generic-drug company Mylan has fired back at rival Allergan’s attempt to shield its top-selling eye medication from competition by transferring the patents to an Indian tribe.
,,,[$$] Mylan Calls Allergan’s Patent Sale to Indian Tribe a ‘Sham’,2017-10-16 04:17:21 +0000,http://finance.yahoo.com/r/cce7bb6c-115d-30d2-8a59-1f753ffa0ad8/mylan-calls-allergans-patent-sale-to-indian-tribe-a-sham-1507996687?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Generic-drug company Mylan has fired back at rival Allergan’s attempt to shield its top-selling eye medication from competition by transferring the patents to an Indian tribe.
AGN,AGN:US,BBG000FH8PX5,3 Biotech Stocks That Soared This Week: Are They Buys?,2017-10-14 16:16:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2MduHMOBq0I/3-biotech-stocks-that-soared-this-week-are-they-buys-cm859833,For some stocks racking up gains of 28 or more can take a couple of years or more For others it takes only a few days That s the case for three of the biggest biotech stocks this week AnaptysBio NASDAQ ANAB Sorrento Therapeutics NASDAQ SRNE and
,,,3 Biotech Stocks That Soared This Week: Are They Buys?,2017-10-14 16:16:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2MduHMOBq0I/3-biotech-stocks-that-soared-this-week-are-they-buys-cm859833,For some stocks racking up gains of 28 or more can take a couple of years or more For others it takes only a few days That s the case for three of the biggest biotech stocks this week AnaptysBio NASDAQ ANAB Sorrento Therapeutics NASDAQ SRNE and
AGN,AGN:US,BBG000FH8PX5,[$$] Mylan Calls Allergan's Patent Sale to Tribe a 'Sham',2017-10-14 15:58:11 +0000,http://finance.yahoo.com/r/cce7bb6c-115d-30d2-8a59-1f753ffa0ad8/mylan-calls-allergans-patent-sale-to-indian-tribe-a-sham-1507996687?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Generic-drug company Mylan NV has fired back at rival Allergan PLC’s attempt to shield its top-selling eye drug from competition by transferring the patents to an Indian tribe.
,,,[$$] Mylan Calls Allergan's Patent Sale to Tribe a 'Sham',2017-10-14 15:58:11 +0000,http://finance.yahoo.com/r/cce7bb6c-115d-30d2-8a59-1f753ffa0ad8/mylan-calls-allergans-patent-sale-to-indian-tribe-a-sham-1507996687?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Generic-drug company Mylan NV has fired back at rival Allergan PLC’s attempt to shield its top-selling eye drug from competition by transferring the patents to an Indian tribe.
AGN,AGN:US,BBG000FH8PX5,Trump to scrap a crucial part of Obamacare,2017-10-13 14:38:00 +0000,https://finance.yahoo.com/video/trump-amputates-crucial-part-obamacare-143845976.html?.tsrc=rss,The White House is eliminating a crucial part of the Affordable Care Act. President Donald Trump wants to immediately stop payments to insurers. The administration said the government cannot legally continue to make payments. Yahoo Finance’s Alexis Christoforous and Rick Newman figure out how this will impact the insurance industry and patients.
,,,Trump to scrap a crucial part of Obamacare,2017-10-13 14:38:00 +0000,https://finance.yahoo.com/video/trump-amputates-crucial-part-obamacare-143845976.html?.tsrc=rss,The White House is eliminating a crucial part of the Affordable Care Act. President Donald Trump wants to immediately stop payments to insurers. The administration said the government cannot legally continue to make payments. Yahoo Finance’s Alexis Christoforous and Rick Newman figure out how this will impact the insurance industry and patients.
,,,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback",2017-10-13 14:20:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o-6IHur8DDQ/pharma-stock-roundup-pfizer-mulls-options-for-consumer-healthcare-llys-pipeline-setback-cm859307,Companies like Pfizer PFE Merck MRK and Eli Lilly LLY were in the news this week while Pfizer is mulling strategic options for its Consumer Healthcare business Merck said that it will not file its CETP inhibitor Recap of the Week s Most Important Stories Pfizer to
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback",2017-10-13 14:20:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o-6IHur8DDQ/pharma-stock-roundup-pfizer-mulls-options-for-consumer-healthcare-llys-pipeline-setback-cm859307,Companies like Pfizer PFE Merck MRK and Eli Lilly LLY were in the news this week while Pfizer is mulling strategic options for its Consumer Healthcare business Merck said that it will not file its CETP inhibitor Recap of the Week s Most Important Stories Pfizer to
,,,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY&apos;s Pipeline Setback",2017-10-13 12:06:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-mulls-120612619.html?.tsrc=rss,Pfizer (PFE) is looking at strategic options for its Consumer Healthcare business while Merck announced that it won&apos;t be seeking approval for its CETP inhibitor.
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY&apos;s Pipeline Setback",2017-10-13 12:06:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-mulls-120612619.html?.tsrc=rss,Pfizer (PFE) is looking at strategic options for its Consumer Healthcare business while Merck announced that it won&apos;t be seeking approval for its CETP inhibitor.
,,,3 Healthcare Value Stocks,2017-10-13 11:13:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2mLgu7TVTls/3-healthcare-value-stocks-cm859201,When value 160 investors search through 10 Ks and valuation ratios for stocks selling on the cheap healthcare isn t typically a sector full of stocks selling at a deep discount When those stocks go on sale though it can be a great opportunity to pounce So we asked three of
AGN,AGN:US,BBG000FH8PX5,3 Healthcare Value Stocks,2017-10-13 11:13:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2mLgu7TVTls/3-healthcare-value-stocks-cm859201,When value 160 investors search through 10 Ks and valuation ratios for stocks selling on the cheap healthcare isn t typically a sector full of stocks selling at a deep discount When those stocks go on sale though it can be a great opportunity to pounce So we asked three of
,,,3 Healthcare Value Stocks,2017-10-13 10:05:00 +0000,https://finance.yahoo.com/news/3-healthcare-value-stocks-100500001.html?.tsrc=rss,"Looking for some investments in the healthcare sector that aren&apos;t priced at a high premium? Allergan, Gilead Sciences, and DaVita are an excellent place to start."
AGN,AGN:US,BBG000FH8PX5,3 Healthcare Value Stocks,2017-10-13 10:05:00 +0000,https://finance.yahoo.com/news/3-healthcare-value-stocks-100500001.html?.tsrc=rss,"Looking for some investments in the healthcare sector that aren&apos;t priced at a high premium? Allergan, Gilead Sciences, and DaVita are an excellent place to start."
AGN,AGN:US,BBG000FH8PX5,Non-Alcoholic Steatohepatitis 2017 Progress Update,2017-10-13 01:12:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ib7V2EqL_pM/non-alcoholic-steatohepatitis-2017-progress-update-cm859149,Big time investors of late have been investing a substantial portion of their R amp D sources for the treatment of Non Alcoholic Steatohepatitis NASH The market for NASH is poised to witness rapid growth unlike other lucrative but saturated markets like cancer A chronic liver disease NASH
,,,Non-Alcoholic Steatohepatitis 2017 Progress Update,2017-10-13 01:12:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ib7V2EqL_pM/non-alcoholic-steatohepatitis-2017-progress-update-cm859149,Big time investors of late have been investing a substantial portion of their R amp D sources for the treatment of Non Alcoholic Steatohepatitis NASH The market for NASH is poised to witness rapid growth unlike other lucrative but saturated markets like cancer A chronic liver disease NASH
,,,Allergan Reports Settlement On RESTASIS 0.05% Patent Litigation With InnoPharma,2017-10-12 23:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dkc3yNX2Pxg/allergan-reports-settlement-on-restasis-005-patent-litigation-with-innopharma-20171012-01468,Allergan Reports Settlement On RESTASIS 0.05% Patent Litigation With InnoPharma
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Settlement On RESTASIS 0.05% Patent Litigation With InnoPharma,2017-10-12 23:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dkc3yNX2Pxg/allergan-reports-settlement-on-restasis-005-patent-litigation-with-innopharma-20171012-01468,Allergan Reports Settlement On RESTASIS 0.05% Patent Litigation With InnoPharma
AGN,AGN:US,BBG000FH8PX5,Non-Alcoholic Steatohepatitis 2017 Progress Update,2017-10-12 22:45:10 +0000,https://finance.yahoo.com/news/non-alcoholic-steatohepatitis-2017-progress-224510567.html?.tsrc=rss,Bigwigs of late have been investing a substantial portion of their R&D sources for the treatment of Non-Alcoholic Steatohepatitis (NASH).
,,,Non-Alcoholic Steatohepatitis 2017 Progress Update,2017-10-12 22:45:10 +0000,https://finance.yahoo.com/news/non-alcoholic-steatohepatitis-2017-progress-224510567.html?.tsrc=rss,Bigwigs of late have been investing a substantial portion of their R&D sources for the treatment of Non-Alcoholic Steatohepatitis (NASH).
,,,Allergan settles with one of four companies contesting Restasis patent,2017-10-12 21:41:19 +0000,https://finance.yahoo.com/news/allergan-settles-one-four-companies-214119116.html?.tsrc=rss,"Allergan Plc said on Thursday it  reached a settlement with InnoPharma Inc, one of the four  generic drugmakers challenging the patents for its dry eye  medication Restasis in federal court.  Mylan NV, Teva Pharmaceutical Industries Ltd  and Akorn Inc are still contesting those  patents in U.S. District Court in Marshall, Texas."
AGN,AGN:US,BBG000FH8PX5,Allergan settles with one of four companies contesting Restasis patent,2017-10-12 21:41:19 +0000,https://finance.yahoo.com/news/allergan-settles-one-four-companies-214119116.html?.tsrc=rss,"Allergan Plc said on Thursday it  reached a settlement with InnoPharma Inc, one of the four  generic drugmakers challenging the patents for its dry eye  medication Restasis in federal court.  Mylan NV, Teva Pharmaceutical Industries Ltd  and Akorn Inc are still contesting those  patents in U.S. District Court in Marshall, Texas."
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces Settlement on RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with InnoPharma, Inc.",2017-10-12 20:15:00 +0000,https://finance.yahoo.com/news/allergan-announces-settlement-restasis-cyclosporine-201500252.html?.tsrc=rss,"DUBLIN , Oct. 12, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and its subsidiaries today announced that the Company has reached an agreement with InnoPharma ..."
,,,"Allergan Announces Settlement on RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with InnoPharma, Inc.",2017-10-12 20:15:00 +0000,https://finance.yahoo.com/news/allergan-announces-settlement-restasis-cyclosporine-201500252.html?.tsrc=rss,"DUBLIN , Oct. 12, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and its subsidiaries today announced that the Company has reached an agreement with InnoPharma ..."
,,,"Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up",2017-10-12 16:17:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqXzKaEnAqg/ardelyx-ibs-c-candidate-succeeds-in-pivotal-study-stock-up-cm858783,Ardelyx Inc ARDX announced meeting the primary endpoint in a second phase III study T3MPO 2 evaluating tenapanor in patients with irritable bowel syndrome with constipation IBS C Based on the positive top line data from this study as well as previously completed T3MPO 1 study
AGN,AGN:US,BBG000FH8PX5,"Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up",2017-10-12 16:17:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqXzKaEnAqg/ardelyx-ibs-c-candidate-succeeds-in-pivotal-study-stock-up-cm858783,Ardelyx Inc ARDX announced meeting the primary endpoint in a second phase III study T3MPO 2 evaluating tenapanor in patients with irritable bowel syndrome with constipation IBS C Based on the positive top line data from this study as well as previously completed T3MPO 1 study
AGN,AGN:US,BBG000FH8PX5,December 1st Options Now Available For Allergan (AGN),2017-10-12 16:14:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dpI_KXxBZzs/december-1st-options-now-available-for-allergan-agn-cm858792,Investors in Allergan PLC Symbol AGN saw new options become available today for the December 1st expiration At Stock Options Channel our YieldBoost formula has looked up and down the AGN options chain for the new December 1st contracts and identified one put and one call contract
,,,December 1st Options Now Available For Allergan (AGN),2017-10-12 16:14:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dpI_KXxBZzs/december-1st-options-now-available-for-allergan-agn-cm858792,Investors in Allergan PLC Symbol AGN saw new options become available today for the December 1st expiration At Stock Options Channel our YieldBoost formula has looked up and down the AGN options chain for the new December 1st contracts and identified one put and one call contract
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Outflows: PFF, AGN, HSBC, DB",2017-10-12 16:10:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caEEMnvmnqs/noteworthy-etf-outflows-pff-agn-hsbc-db-cm858767,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 215 2 million dollar outflow that s a 1 2 decrease week over week
,,,"Noteworthy ETF Outflows: PFF, AGN, HSBC, DB",2017-10-12 16:10:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caEEMnvmnqs/noteworthy-etf-outflows-pff-agn-hsbc-db-cm858767,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 215 2 million dollar outflow that s a 1 2 decrease week over week
AGN,AGN:US,BBG000FH8PX5,"Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up",2017-10-12 14:30:02 +0000,https://finance.yahoo.com/news/ardelyx-ibs-c-candidate-succeeds-143002361.html?.tsrc=rss,Ardelyx&apos;s (ARDX) tenapanor reduces abdominal pain and improves bowel movements in a phase III study evaluating the drug in irritable bowel syndrome with constipation.
,,,"Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up",2017-10-12 14:30:02 +0000,https://finance.yahoo.com/news/ardelyx-ibs-c-candidate-succeeds-143002361.html?.tsrc=rss,Ardelyx&apos;s (ARDX) tenapanor reduces abdominal pain and improves bowel movements in a phase III study evaluating the drug in irritable bowel syndrome with constipation.
,,,Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA,2017-10-11 21:12:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gjcCToBRmUk/allergans-uterine-fibroids-candidates-nda-accepted-by-fda-cm858431,Allergan plc AGN announced that the FDA has accepted the new drug application NDA for its pipeline candidate ulipristal acetate Allergan is looking to get ulipristal acetate approved for the treatment of abnormal uterine bleeding from fibroids in that organ The company expects the FDA
AGN,AGN:US,BBG000FH8PX5,Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA,2017-10-11 21:12:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gjcCToBRmUk/allergans-uterine-fibroids-candidates-nda-accepted-by-fda-cm858431,Allergan plc AGN announced that the FDA has accepted the new drug application NDA for its pipeline candidate ulipristal acetate Allergan is looking to get ulipristal acetate approved for the treatment of abnormal uterine bleeding from fibroids in that organ The company expects the FDA
,,,Allergan&apos;s Uterine Fibroids Candidate&apos;s NDA Accepted by FDA,2017-10-11 19:34:07 +0000,https://finance.yahoo.com/news/allergan-apos-uterine-fibroids-candidate-193407903.html?.tsrc=rss,"Allergan plc (AGN) announced that the FDA has accepted the new drug application (NDA) for ulipristal acetate, for the treatment of abnormal uterine bleeding in women with uterine fibroids."
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s Uterine Fibroids Candidate&apos;s NDA Accepted by FDA,2017-10-11 19:34:07 +0000,https://finance.yahoo.com/news/allergan-apos-uterine-fibroids-candidate-193407903.html?.tsrc=rss,"Allergan plc (AGN) announced that the FDA has accepted the new drug application (NDA) for ulipristal acetate, for the treatment of abnormal uterine bleeding in women with uterine fibroids."
AGN,AGN:US,BBG000FH8PX5,"Notable Wednesday Option Activity: ABBV, AGN, REGN",2017-10-11 19:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ATIHWNN1G7E/notable-wednesday-option-activity-abbv-agn-regn-cm858361,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in AbbVie Inc Symbol ABBV where a total volume of 68 948 contracts has been traded thus far today a contract volume which is representative of approximately 6 9
,,,"Notable Wednesday Option Activity: ABBV, AGN, REGN",2017-10-11 19:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ATIHWNN1G7E/notable-wednesday-option-activity-abbv-agn-regn-cm858361,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in AbbVie Inc Symbol ABBV where a total volume of 68 948 contracts has been traded thus far today a contract volume which is representative of approximately 6 9
,,,"Examining Consolidated Results on Allergan, Starbucks, Equifax, Walgreens, Texas Instruments, and Kraft Heinz – Fundamental Analysis and Changes in Performance Indicators",2017-10-11 13:45:00 +0000,https://finance.yahoo.com/news/examining-consolidated-results-allergan-starbucks-134500992.html?.tsrc=rss,"NEW YORK, Oct. 11, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allergan ..."
AGN,AGN:US,BBG000FH8PX5,"Examining Consolidated Results on Allergan, Starbucks, Equifax, Walgreens, Texas Instruments, and Kraft Heinz – Fundamental Analysis and Changes in Performance Indicators",2017-10-11 13:45:00 +0000,https://finance.yahoo.com/news/examining-consolidated-results-allergan-starbucks-134500992.html?.tsrc=rss,"NEW YORK, Oct. 11, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allergan ..."
,,,Mylan Deals a Blow to Teva Pharmaceutical,2017-10-11 13:15:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YdBrYm_IM_U/mylan-deals-a-blow-to-teva-pharmaceutical-cm857951,Generic drugmakers Mylan NASDAQ MYL and Teva Pharmaceutical NYSE TEVA 160 usually deal blows to brand name drug manufacturers not each other but that changed last week when the Food and Drug Administration approved Mylan s generic version of Teva Pharmaceutical
AGN,AGN:US,BBG000FH8PX5,Mylan Deals a Blow to Teva Pharmaceutical,2017-10-11 13:15:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YdBrYm_IM_U/mylan-deals-a-blow-to-teva-pharmaceutical-cm857951,Generic drugmakers Mylan NASDAQ MYL and Teva Pharmaceutical NYSE TEVA 160 usually deal blows to brand name drug manufacturers not each other but that changed last week when the Food and Drug Administration approved Mylan s generic version of Teva Pharmaceutical
AGN,AGN:US,BBG000FH8PX5,Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference,2017-10-11 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-more-20-120100928.html?.tsrc=rss,"DUBLIN , Oct. 11, 2017 /PRNewswire/ -- Allergan (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 22 abstracts at the 2017 Fall Clinical Dermatology Conference ..."
,,,Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference,2017-10-11 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-more-20-120100928.html?.tsrc=rss,"DUBLIN , Oct. 11, 2017 /PRNewswire/ -- Allergan (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 22 abstracts at the 2017 Fall Clinical Dermatology Conference ..."
AGN,AGN:US,BBG000FH8PX5,"CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4",2017-10-11 01:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EzjObddRtQY/cry-opens-wallet-llys-juniper-flops-mdxg-catches-eyes-rnn-awaits-data-in-q4-20171011-00020,"CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4"
,,,"CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4",2017-10-11 01:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EzjObddRtQY/cry-opens-wallet-llys-juniper-flops-mdxg-catches-eyes-rnn-awaits-data-in-q4-20171011-00020,"CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4"
,,,"Health insurers, hospitals and generic-drug makers ask Congress to examine Allergan patent deal",2017-10-10 22:41:04 +0000,http://finance.yahoo.com/r/442a2f87-0f36-3bdf-b516-4c0f94390a13/104764018?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104764018&yptr=yahoo&.tsrc=rss,The group is the latest to call on lawmakers to examine Allergan's controversial patent deal with a Native American tribe.
AGN,AGN:US,BBG000FH8PX5,"Health insurers, hospitals and generic-drug makers ask Congress to examine Allergan patent deal",2017-10-10 22:41:04 +0000,http://finance.yahoo.com/r/442a2f87-0f36-3bdf-b516-4c0f94390a13/104764018?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104764018&yptr=yahoo&.tsrc=rss,The group is the latest to call on lawmakers to examine Allergan's controversial patent deal with a Native American tribe.
AGN,AGN:US,BBG000FH8PX5,Favorite stock picks from one of Wall Street's top biotech analysts,2017-10-10 21:22:46 +0000,http://finance.yahoo.com/r/ecd3942d-ea67-3060-b92b-e09e6f5984be/104764328?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104764328&yptr=yahoo&.tsrc=rss,Umer Raffat of Evercore ISI has two names at the top of his buy list — Allergan and Dermira.
,,,Favorite stock picks from one of Wall Street&apos;s top biotech analysts,2017-10-10 21:22:46 +0000,https://finance.yahoo.com/news/favorite-stock-picks-one-wall-212246598.html?.tsrc=rss,Umer Raffat of Evercore ISI has two names at the top of his buy list — Allergan and Dermira.
,,,Favorite stock picks from one of Wall Street's top biotech analysts,2017-10-10 21:22:46 +0000,http://finance.yahoo.com/r/ecd3942d-ea67-3060-b92b-e09e6f5984be/104764328?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104764328&yptr=yahoo&.tsrc=rss,Umer Raffat of Evercore ISI has two names at the top of his buy list — Allergan and Dermira.
AGN,AGN:US,BBG000FH8PX5,Favorite stock picks from one of Wall Street&apos;s top biotech analysts,2017-10-10 21:22:46 +0000,https://finance.yahoo.com/news/favorite-stock-picks-one-wall-212246598.html?.tsrc=rss,Umer Raffat of Evercore ISI has two names at the top of his buy list — Allergan and Dermira.
,,,Allergan trading at a zero pipeline valuation: Evercore's...,2017-10-10 19:18:00 +0000,https://finance.yahoo.com/video/allergan-trading-zero-pipeline-valuation-191800143.html?.tsrc=rss,"After being named Institutional Investor's 2017 number-one biotech analyst, Umer Raffat of Evercore ISI discusses his picks for the biotech and specialty pharma sector."
AGN,AGN:US,BBG000FH8PX5,Allergan trading at a zero pipeline valuation: Evercore's...,2017-10-10 19:18:00 +0000,https://finance.yahoo.com/video/allergan-trading-zero-pipeline-valuation-191800143.html?.tsrc=rss,"After being named Institutional Investor's 2017 number-one biotech analyst, Umer Raffat of Evercore ISI discusses his picks for the biotech and specialty pharma sector."
AGN,AGN:US,BBG000FH8PX5,[$$] CVC Picks Former Allergan Executive to Run Women's Drug Portfolio,2017-10-10 17:00:30 +0000,http://finance.yahoo.com/r/0906733e-8484-34a5-8c01-64439d2622be/cvc-picks-former-allergan-executive-to-run-womens-drug-portfolio-1507654827?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Anish Mehta oversaw the $40.5 billion sale of Allergan’s generics business in 2016.
,,,[$$] CVC Picks Former Allergan Executive to Run Women's Drug Portfolio,2017-10-10 17:00:30 +0000,http://finance.yahoo.com/r/0906733e-8484-34a5-8c01-64439d2622be/cvc-picks-former-allergan-executive-to-run-womens-drug-portfolio-1507654827?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Anish Mehta oversaw the $40.5 billion sale of Allergan’s generics business in 2016.
AGN,AGN:US,BBG000FH8PX5,"Morning Movers: Tesla Rises, United Continental Flies, Wal-Mart Gains",2017-10-10 14:10:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mAKVNmbg79I/morning-movers-tesla-rises-united-continental-flies-wal-mart-gains-cm857378,Stocks look set for a higher open this morning as the dollar weakened Stocks look set for a higher open this morning asthe dollar weakened Agence France Presse Getty Images Agence France Presse Getty Images S amp P 500 futures have advanced 0 2 while Dow Jones
,,,"Morning Movers: Tesla Rises, United Continental Flies, Wal-Mart Gains",2017-10-10 14:10:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mAKVNmbg79I/morning-movers-tesla-rises-united-continental-flies-wal-mart-gains-cm857378,Stocks look set for a higher open this morning as the dollar weakened Stocks look set for a higher open this morning asthe dollar weakened Agence France Presse Getty Images Agence France Presse Getty Images S amp P 500 futures have advanced 0 2 while Dow Jones
AGN,AGN:US,BBG000FH8PX5,Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids,2017-10-10 12:01:00 +0000,https://finance.yahoo.com/news/allergan-announces-fda-accepts-drug-120100273.html?.tsrc=rss,"DUBLIN, Oct. 10, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ulipristal acetate, an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids.  ""Women with symptomatic uterine fibroids may suffer from physical and emotional distress2,3 without realizing their symptoms are caused by a treatable medical condition,"" said David Nicholson, Ph.D., Chief Research and Development Officer, Allergan."
,,,Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids,2017-10-10 12:01:00 +0000,https://finance.yahoo.com/news/allergan-announces-fda-accepts-drug-120100273.html?.tsrc=rss,"DUBLIN, Oct. 10, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ulipristal acetate, an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids.  ""Women with symptomatic uterine fibroids may suffer from physical and emotional distress2,3 without realizing their symptoms are caused by a treatable medical condition,"" said David Nicholson, Ph.D., Chief Research and Development Officer, Allergan."
,,,Allergan: FDA Accepts NDA For Ulipristal Acetate For Uterine Fibroids,2017-10-10 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwzk1TswD5k/allergan-fda-accepts-nda-for-ulipristal-acetate-for-uterine-fibroids-20171010-00515,Allergan: FDA Accepts NDA For Ulipristal Acetate For Uterine Fibroids
AGN,AGN:US,BBG000FH8PX5,Allergan: FDA Accepts NDA For Ulipristal Acetate For Uterine Fibroids,2017-10-10 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwzk1TswD5k/allergan-fda-accepts-nda-for-ulipristal-acetate-for-uterine-fibroids-20171010-00515,Allergan: FDA Accepts NDA For Ulipristal Acetate For Uterine Fibroids
,,,'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe,2017-10-10 07:19:00 +0000,https://finance.yahoo.com/news/illegal-lawmakers-taking-aim-pharma-071900300.html?.tsrc=rss,"In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer..."
AGN,AGN:US,BBG000FH8PX5,'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe,2017-10-10 07:19:00 +0000,https://finance.yahoo.com/news/illegal-lawmakers-taking-aim-pharma-071900300.html?.tsrc=rss,"In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer..."
,,,United Natural (UNFI) Approves New $200M Share Buyback Plan,2017-10-09 20:51:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BYjHEQirY98/united-natural-unfi-approves-new-200m-share-buyback-plan-cm857193,United Natural Foods Inc UNFI has recently approved the authorization of a new 200 million share buyback plan in a bid to boost shareholder value However the number and value of shares along with time to repurchase them will be decided by the company alongside depending on various
AGN,AGN:US,BBG000FH8PX5,United Natural (UNFI) Approves New $200M Share Buyback Plan,2017-10-09 20:51:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BYjHEQirY98/united-natural-unfi-approves-new-200m-share-buyback-plan-cm857193,United Natural Foods Inc UNFI has recently approved the authorization of a new 200 million share buyback plan in a bid to boost shareholder value However the number and value of shares along with time to repurchase them will be decided by the company alongside depending on various
AGN,AGN:US,BBG000FH8PX5,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,2017-10-09 19:56:37 +0000,https://finance.yahoo.com/news/health-care-sector-back-focus-195637436.html?.tsrc=rss,"The health care sector has been one of the better-performing sectors in 2017, bouncing back after being the only sector in the S&P 500 (SPX) to finish last year in the red. So far this year, the S&P Health ..."
,,,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,2017-10-09 19:56:37 +0000,https://finance.yahoo.com/news/health-care-sector-back-focus-195637436.html?.tsrc=rss,"The health care sector has been one of the better-performing sectors in 2017, bouncing back after being the only sector in the S&P 500 (SPX) to finish last year in the red. So far this year, the S&P Health ..."
,,,'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe,2017-10-09 18:49:54 +0000,https://finance.yahoo.com/news/illegal-lawmakers-taking-aim-pharma-184954198.html?.tsrc=rss,"In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer..."
AGN,AGN:US,BBG000FH8PX5,'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe,2017-10-09 18:49:54 +0000,https://finance.yahoo.com/news/illegal-lawmakers-taking-aim-pharma-184954198.html?.tsrc=rss,"In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer..."
,,,Valeant's Biggest Drug Gets a Shot at More Sales,2017-10-09 14:32:00 +0000,http://finance.yahoo.com/r/b1d82f8f-5ceb-3b62-bccc-1fa89cdf4274/valeants-biggest-drug-gets-a-shot-at-more-sales-1507559553?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are falling today despite a bullish analyst note that suggests the troubled drug maker’s biggest-selling drugs could grow market share in the next year.  Deutsche Bank’s Gregg Gilbert and Greg Fraser conducted a survey of 25 primary care physicians who frequently prescribe treatments for irritable bowel syndrome inorder to assess their views on Valeant’s Xifaxan and two rival drugs from Allergan (AGN).  The pair expect accelerating sales growth for Xifaxan, but flat sales for Allergan’s Viberzi and slowing growth for Linzess."
AGN,AGN:US,BBG000FH8PX5,Valeant's Biggest Drug Gets a Shot at More Sales,2017-10-09 14:32:00 +0000,http://finance.yahoo.com/r/b1d82f8f-5ceb-3b62-bccc-1fa89cdf4274/valeants-biggest-drug-gets-a-shot-at-more-sales-1507559553?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are falling today despite a bullish analyst note that suggests the troubled drug maker’s biggest-selling drugs could grow market share in the next year.  Deutsche Bank’s Gregg Gilbert and Greg Fraser conducted a survey of 25 primary care physicians who frequently prescribe treatments for irritable bowel syndrome inorder to assess their views on Valeant’s Xifaxan and two rival drugs from Allergan (AGN).  The pair expect accelerating sales growth for Xifaxan, but flat sales for Allergan’s Viberzi and slowing growth for Linzess."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Dry Eye Data at the American Academy of Optometry Meeting in Chicago,2017-10-09 12:30:00 +0000,https://finance.yahoo.com/news/allergan-present-dry-eye-data-123000945.html?.tsrc=rss,"DUBLIN , Oct. 9, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced  several Allergan-supported abstracts were selected for poster presentation at the ..."
,,,Allergan to Present New Dry Eye Data at the American Academy of Optometry Meeting in Chicago,2017-10-09 12:30:00 +0000,https://finance.yahoo.com/news/allergan-present-dry-eye-data-123000945.html?.tsrc=rss,"DUBLIN , Oct. 9, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced  several Allergan-supported abstracts were selected for poster presentation at the ..."
AGN,AGN:US,BBG000FH8PX5,This billion-dollar dry eye drug is behind Allergan’s controversial patent deal,2017-10-09 12:26:48 +0000,http://finance.yahoo.com/r/96932218-5d5a-34a4-814a-e843f7df4e2b/Story.aspx?guid=41346F58-A863-11E7-8867-1382C8BFE928&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan struck a deal with an American Indian tribe to help protect its Restasis from competition—but the agreement has attracted criticism and lawmaker scrutiny.
,,,This billion-dollar dry eye drug is behind Allergan’s controversial patent deal,2017-10-09 12:26:48 +0000,http://finance.yahoo.com/r/96932218-5d5a-34a4-814a-e843f7df4e2b/Story.aspx?guid=41346F58-A863-11E7-8867-1382C8BFE928&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan struck a deal with an American Indian tribe to help protect its Restasis from competition—but the agreement has attracted criticism and lawmaker scrutiny.
AGN,AGN:US,BBG000FH8PX5,"Rep. Peter Welch on Allergan’s ‘bold, brazen, bizarre’ patent deal with an American Indian tribe",2017-10-09 12:02:23 +0000,http://finance.yahoo.com/r/7c4cdf9a-c3d2-3c8a-aad6-a05942cddc6d/Story.aspx?guid=5191CAB0-A9FF-11E7-9346-5B61074AF419&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"“They would only do that if they felt a kind of arrogant confidence that they can continue to get away with murder,” Welch told MarketWatch."
,,,"Rep. Peter Welch on Allergan’s ‘bold, brazen, bizarre’ patent deal with an American Indian tribe",2017-10-09 12:02:23 +0000,http://finance.yahoo.com/r/7c4cdf9a-c3d2-3c8a-aad6-a05942cddc6d/Story.aspx?guid=5191CAB0-A9FF-11E7-9346-5B61074AF419&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"“They would only do that if they felt a kind of arrogant confidence that they can continue to get away with murder,” Welch told MarketWatch."
,,,[$$] Reverse Patent Trolls Are Harming Drug Innovation—and Patients,2017-10-09 04:34:51 +0000,http://finance.yahoo.com/r/18c0b4fa-6f48-31b2-8944-b03dec80bbe5/reverse-patent-trolls-are-harming-drug-innovationand-patients-1507487600?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Generic competition is good, but the law Congress passed in 2011 puts unfair burdens on innovators."
AGN,AGN:US,BBG000FH8PX5,[$$] Reverse Patent Trolls Are Harming Drug Innovation—and Patients,2017-10-09 04:34:51 +0000,http://finance.yahoo.com/r/18c0b4fa-6f48-31b2-8944-b03dec80bbe5/reverse-patent-trolls-are-harming-drug-innovationand-patients-1507487600?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Generic competition is good, but the law Congress passed in 2011 puts unfair burdens on innovators."
AGN,AGN:US,BBG000FH8PX5,[$$] Waxman hits out at Allergan patent deal with Mohawk tribe,2017-10-08 11:12:55 +0000,"http://finance.yahoo.com/r/f355fd21-3118-3bd6-826c-ac8b9cea38ca/81bd8930-abb8-11e7-aab9-abaa44b1e130,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The architect of landmark legislation that established the system for generic medicines in the US has hit out at Allergan, accusing the drugmaker of blocking competition by transferring its patents to ..."
,,,[$$] Waxman hits out at Allergan patent deal with Mohawk tribe,2017-10-08 11:12:55 +0000,"http://finance.yahoo.com/r/f355fd21-3118-3bd6-826c-ac8b9cea38ca/81bd8930-abb8-11e7-aab9-abaa44b1e130,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The architect of landmark legislation that established the system for generic medicines in the US has hit out at Allergan, accusing the drugmaker of blocking competition by transferring its patents to ..."
,,,This billion-dollar dry eye drug is behind Allergan’s controversial patent deal,2017-10-07 14:17:28 +0000,https://finance.yahoo.com/news/billion-dollar-dry-eye-drug-141728421.html?.tsrc=rss,Allergan struck a deal with an American Indian tribe to help protect its Restasis from competition—but the agreement has attracted criticism and lawmaker scrutiny.
AGN,AGN:US,BBG000FH8PX5,This billion-dollar dry eye drug is behind Allergan’s controversial patent deal,2017-10-07 14:17:28 +0000,https://finance.yahoo.com/news/billion-dollar-dry-eye-drug-141728421.html?.tsrc=rss,Allergan struck a deal with an American Indian tribe to help protect its Restasis from competition—but the agreement has attracted criticism and lawmaker scrutiny.
,,,"Rep. Peter Welch on Allergan’s ‘bold, brazen, bizarre’ patent deal with an American Indian tribe",2017-10-07 14:13:31 +0000,https://finance.yahoo.com/news/rep-peter-welch-allergan-bold-141331230.html?.tsrc=rss,"“They would only do that if they felt a kind of arrogant confidence that they can continue to get away with murder,” Welch told MarketWatch."
AGN,AGN:US,BBG000FH8PX5,"Rep. Peter Welch on Allergan’s ‘bold, brazen, bizarre’ patent deal with an American Indian tribe",2017-10-07 14:13:31 +0000,https://finance.yahoo.com/news/rep-peter-welch-allergan-bold-141331230.html?.tsrc=rss,"“They would only do that if they felt a kind of arrogant confidence that they can continue to get away with murder,” Welch told MarketWatch."
AGN,AGN:US,BBG000FH8PX5,Judge asks if Allergan's patent deal with Mohawk tribe is a 'sham',2017-10-06 21:45:22 +0000,http://finance.yahoo.com/r/faacfbdf-d47a-37a3-9c10-af99722d0186/104758180?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104758180&yptr=yahoo&.tsrc=rss,"Allergan's unusual deal to shield Restasis from certain patent challenges has drawn scrutiny from competitors, lawmakers and now a federal judge."
,,,Judge asks if Allergan's patent deal with Mohawk tribe is a 'sham',2017-10-06 21:45:22 +0000,http://finance.yahoo.com/r/faacfbdf-d47a-37a3-9c10-af99722d0186/104758180?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104758180&yptr=yahoo&.tsrc=rss,"Allergan's unusual deal to shield Restasis from certain patent challenges has drawn scrutiny from competitors, lawmakers and now a federal judge."
AGN,AGN:US,BBG000FH8PX5,Bernstein analyst breaks down his best biotech picks,2017-10-06 17:20:00 +0000,https://finance.yahoo.com/video/bernstein-analyst-breaks-down-best-172000371.html?.tsrc=rss,"Ronny Gal, Bernstein senior analyst, discusses his top biotech picks to buy ahead of earnings."
,,,Bernstein analyst breaks down his best biotech picks,2017-10-06 17:20:00 +0000,https://finance.yahoo.com/video/bernstein-analyst-breaks-down-best-172000371.html?.tsrc=rss,"Ronny Gal, Bernstein senior analyst, discusses his top biotech picks to buy ahead of earnings."
,,,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 16:45:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_-pQcEu8t4/is-allergan-plc-a-bargain-after-a-76-billion-dip-in-september-cm856329,What happened According to data from S amp P Global Market Intelligence Botox maker Allergan NYSE AGN shed 10 of its value which equates to approximately 7 6 billion of its market cap last month This sizable drop appears to be the result of two
AGN,AGN:US,BBG000FH8PX5,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 16:45:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_-pQcEu8t4/is-allergan-plc-a-bargain-after-a-76-billion-dip-in-september-cm856329,What happened According to data from S amp P Global Market Intelligence Botox maker Allergan NYSE AGN shed 10 of its value which equates to approximately 7 6 billion of its market cap last month This sizable drop appears to be the result of two
,,,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 15:00:00 +0000,http://finance.yahoo.com/r/7a43aead-17e3-3ee3-8fc4-c9d3bf8c17e5/is-allergan-plc-a-bargain-after-a-76-billion-dip-i.aspx?yptr=yahoo&.tsrc=rss,Allergan continues to be a victim of Teva&apos;s downfall.
AGN,AGN:US,BBG000FH8PX5,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 15:00:00 +0000,http://finance.yahoo.com/r/7a43aead-17e3-3ee3-8fc4-c9d3bf8c17e5/is-allergan-plc-a-bargain-after-a-76-billion-dip-i.aspx?yptr=yahoo&.tsrc=rss,Allergan continues to be a victim of Teva&apos;s downfall.
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal",2017-10-06 14:44:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7icxbt800Go/pharma-stock-roundup-mylan-up-teva-down-on-copaxone-news-lawmakers-question-allergan-deal-cm856152,This week companies like Allergan AGN Teva TEVA and Mylan MYL were in the limelight While Mylan and Teva were in the news related to the FDA approval of Mylan s generic versions of Teva s top selling branded drug Copaxone Allergan is under fire for its agreement with the Saint Regis
,,,"Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal",2017-10-06 14:44:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7icxbt800Go/pharma-stock-roundup-mylan-up-teva-down-on-copaxone-news-lawmakers-question-allergan-deal-cm856152,This week companies like Allergan AGN Teva TEVA and Mylan MYL were in the limelight While Mylan and Teva were in the news related to the FDA approval of Mylan s generic versions of Teva s top selling branded drug Copaxone Allergan is under fire for its agreement with the Saint Regis
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal",2017-10-06 13:07:01 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mylan-teva-130701395.html?.tsrc=rss,The FDA approval of Mylan&apos;s (MYL) generic version of Teva&apos;s Copaxone was the main news this week. Allergan was also in the headlines related to its deal with the Saint Regis Mohawk Tribe.
,,,"Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal",2017-10-06 13:07:01 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mylan-teva-130701395.html?.tsrc=rss,The FDA approval of Mylan&apos;s (MYL) generic version of Teva&apos;s Copaxone was the main news this week. Allergan was also in the headlines related to its deal with the Saint Regis Mohawk Tribe.
AGN,AGN:US,BBG000FH8PX5,'Nobody's talking about' 2 medical conditions that affect 8 million women in America — but that could be about to change,2017-10-06 02:54:00 +0000,https://finance.yahoo.com/news/nobodys-talking-2-medical-conditions-203558275.html?.tsrc=rss,A pair of $2 billion markets are gearing up for some new therapies over the next few...
,,,'Nobody's talking about' 2 medical conditions that affect 8 million women in America — but that could be about to change,2017-10-06 02:54:00 +0000,https://finance.yahoo.com/news/nobodys-talking-2-medical-conditions-203558275.html?.tsrc=rss,A pair of $2 billion markets are gearing up for some new therapies over the next few...
,,,Senator McCaskill drafts bill in response to Allergan patent maneuver,2017-10-05 21:22:52 +0000,https://finance.yahoo.com/news/senator-mccaskill-drafts-bill-response-181633344.html?.tsrc=rss,Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent.  Drugmaker Allergan Plc made a deal to transfer some of its patents to a Native American tribe two weeks ago in order to shield them from review.  McCaskill's response follows a bipartisan U.S. House of Representatives committee decision to investigate the deal earlier this week and previous calls by Democratic Senators for a probe.
AGN,AGN:US,BBG000FH8PX5,Senator McCaskill drafts bill in response to Allergan patent maneuver,2017-10-05 21:22:52 +0000,https://finance.yahoo.com/news/senator-mccaskill-drafts-bill-response-181633344.html?.tsrc=rss,Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent.  Drugmaker Allergan Plc made a deal to transfer some of its patents to a Native American tribe two weeks ago in order to shield them from review.  McCaskill's response follows a bipartisan U.S. House of Representatives committee decision to investigate the deal earlier this week and previous calls by Democratic Senators for a probe.
,,,Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago,2017-10-05 16:05:00 +0000,https://finance.yahoo.com/news/allergan-presents-data-seventeen-abstracts-160500776.html?.tsrc=rss,"DUBLIN , Oct. 5, 2017 /PRNewswire/ -- Allergan (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 17 Allergan-supported abstracts at the 2017 American Society for ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago,2017-10-05 16:05:00 +0000,https://finance.yahoo.com/news/allergan-presents-data-seventeen-abstracts-160500776.html?.tsrc=rss,"DUBLIN , Oct. 5, 2017 /PRNewswire/ -- Allergan (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 17 Allergan-supported abstracts at the 2017 American Society for ..."
,,,3 Biotechs to Buy Ahead of Q3 Earnings,2017-10-05 15:45:00 +0000,http://finance.yahoo.com/r/cd0a82b5-88f1-31bc-bf3e-51c9bcf75909/3-biotechs-to-buy-ahead-of-q3-earnings-1507218301?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"With third-quarter earnings season just around the corner, Bernstein's Aaron (Ronny) Gal and his team take a look at the biotech sector with an eye toward upcoming reports.  As for specific stocks, he has Outperform ratings on Biogen (BIIB), Allergan (AGN) and Mylan (MYL).  Allergan reminded us EPS should be similar to 2Q17 ($4.02) and with hurricanes probably come close (BERN: $4.04, -4c)."
AGN,AGN:US,BBG000FH8PX5,3 Biotechs to Buy Ahead of Q3 Earnings,2017-10-05 15:45:00 +0000,http://finance.yahoo.com/r/cd0a82b5-88f1-31bc-bf3e-51c9bcf75909/3-biotechs-to-buy-ahead-of-q3-earnings-1507218301?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"With third-quarter earnings season just around the corner, Bernstein's Aaron (Ronny) Gal and his team take a look at the biotech sector with an eye toward upcoming reports.  As for specific stocks, he has Outperform ratings on Biogen (BIIB), Allergan (AGN) and Mylan (MYL).  Allergan reminded us EPS should be similar to 2Q17 ($4.02) and with hurricanes probably come close (BERN: $4.04, -4c)."
,,,3 Big Pharma Stocks Set to Succeed,2017-10-05 11:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LQAhrrsmmjA/3-big-pharma-stocks-set-to-succeed-cm855528,That disclaimer that the Securities and Exchange Commission requires mutual funds to provide to investors isn t one to overlook Past performance really may not be indicative of future results This applies to mutual funds and to individual stocks For big pharma stocks though you
AGN,AGN:US,BBG000FH8PX5,3 Big Pharma Stocks Set to Succeed,2017-10-05 11:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LQAhrrsmmjA/3-big-pharma-stocks-set-to-succeed-cm855528,That disclaimer that the Securities and Exchange Commission requires mutual funds to provide to investors isn t one to overlook Past performance really may not be indicative of future results This applies to mutual funds and to individual stocks For big pharma stocks though you
AGN,AGN:US,BBG000FH8PX5,Changes in Eli Lilly’s Valuation,2017-10-05 11:37:42 +0000,http://finance.yahoo.com/r/3c55f325-212b-374e-857f-8d43170d3572/changes-in-eli-lillys-valuation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 28, 2017, Eli Lilly was trading at a forward PE multiple of ~18.7x compared to the industry average of ~16.6x."
,,,Changes in Eli Lilly’s Valuation,2017-10-05 11:37:42 +0000,http://finance.yahoo.com/r/3c55f325-212b-374e-857f-8d43170d3572/changes-in-eli-lillys-valuation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 28, 2017, Eli Lilly was trading at a forward PE multiple of ~18.7x compared to the industry average of ~16.6x."
,,,3 Big Pharma Stocks Set to Succeed,2017-10-05 10:03:00 +0000,http://finance.yahoo.com/r/95c39b07-5929-34ce-ba00-36385b5d02f4/3-big-pharma-stocks-set-to-succeed.aspx?yptr=yahoo&.tsrc=rss,Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.
AGN,AGN:US,BBG000FH8PX5,3 Big Pharma Stocks Set to Succeed,2017-10-05 10:03:00 +0000,http://finance.yahoo.com/r/95c39b07-5929-34ce-ba00-36385b5d02f4/3-big-pharma-stocks-set-to-succeed.aspx?yptr=yahoo&.tsrc=rss,Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.
AGN,AGN:US,BBG000FH8PX5,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-04 17:34:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kodlL4tWFfA/teva-shares-plummet-after-mylans-copaxone-generic-gets-fda-approval-cm855313,Shares of Teva Pharmaceuticals TEVA opened more than 13 lower on Wednesday plunging close to their 52 week low in the process The struggling Israeli pharma firm which has faced significant pressure to reduce its debt load is sliding once again this time because of a brand new
,,,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-04 17:34:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kodlL4tWFfA/teva-shares-plummet-after-mylans-copaxone-generic-gets-fda-approval-cm855313,Shares of Teva Pharmaceuticals TEVA opened more than 13 lower on Wednesday plunging close to their 52 week low in the process The struggling Israeli pharma firm which has faced significant pressure to reduce its debt load is sliding once again this time because of a brand new
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Outflow Detected - VHT, AGN, TMO, BIIB",2017-10-04 16:31:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L51yqJ1BAF8/notable-etf-outflow-detected-vht-agn-tmo-biib-cm855242,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Health Care ETF Symbol VHT where we have detected an approximate 30 8 million dollar outflow that s a 0 4 decrease week over week from 46 477 345
,,,"Notable ETF Outflow Detected - VHT, AGN, TMO, BIIB",2017-10-04 16:31:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L51yqJ1BAF8/notable-etf-outflow-detected-vht-agn-tmo-biib-cm855242,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Health Care ETF Symbol VHT where we have detected an approximate 30 8 million dollar outflow that s a 0 4 decrease week over week from 46 477 345
,,,Teva Shares Plummet After Mylan&apos;s Copaxone Generic Gets FDA Approval,2017-10-04 15:40:03 +0000,https://finance.yahoo.com/news/teva-shares-plummet-mylan-apos-154003466.html?.tsrc=rss,"Shares of Teva Pharmaceuticals (TEVA) opened more than 13% lower on Wednesday, plunging close to their 52-week low in the process. The struggling Israeli pharma firm, which has faced significant pressure to reduce its debt load, is sliding once again--this time because of a brand new competitor."
AGN,AGN:US,BBG000FH8PX5,Teva Shares Plummet After Mylan&apos;s Copaxone Generic Gets FDA Approval,2017-10-04 15:40:03 +0000,https://finance.yahoo.com/news/teva-shares-plummet-mylan-apos-154003466.html?.tsrc=rss,"Shares of Teva Pharmaceuticals (TEVA) opened more than 13% lower on Wednesday, plunging close to their 52-week low in the process. The struggling Israeli pharma firm, which has faced significant pressure to reduce its debt load, is sliding once again--this time because of a brand new competitor."
AGN,AGN:US,BBG000FH8PX5,Allergan's Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 15:36:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zEQs0CtzZpk/allergans-botox-gets-fda-nod-for-forehead-line-treatment-cm855190,Allergan plc AGN announced that the FDA has approved its Botox Cosmetic product for a third indication temporary improvement of moderate to severe forehead lines in appearance associated with frontalis muscle activity in adults So far this year Allergan s share price has slipped 0
,,,Allergan's Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 15:36:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zEQs0CtzZpk/allergans-botox-gets-fda-nod-for-forehead-line-treatment-cm855190,Allergan plc AGN announced that the FDA has approved its Botox Cosmetic product for a third indication temporary improvement of moderate to severe forehead lines in appearance associated with frontalis muscle activity in adults So far this year Allergan s share price has slipped 0
AGN,AGN:US,BBG000FH8PX5,6 Pharma Stocks to Buy Now,2017-10-04 13:45:00 +0000,http://finance.yahoo.com/r/f3cccfc1-7c9d-3715-9654-f388834d1e79/6-pharma-stocks-to-buy-now-1507124725?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Now that we’re in the home stretch of 2017, Credit Suisse’s Vamil Divan and his team take a look at the best stocks in the pharmaceutical sector.  Divan writes that he expects investors will continue to keep one eye focused on macro issues, from the potential for tax reform to drug pricing inquiries, but that news about specific products from pharma companies should be able to move the needle.  Overall, he writes that investor sentiment on the pharma industry is “robust,” and that it could get a further boost if tax reform does happen and includes policies like a cash repatriation holiday that could spur more M&A in the group."
,,,6 Pharma Stocks to Buy Now,2017-10-04 13:45:00 +0000,http://finance.yahoo.com/r/f3cccfc1-7c9d-3715-9654-f388834d1e79/6-pharma-stocks-to-buy-now-1507124725?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Now that we’re in the home stretch of 2017, Credit Suisse’s Vamil Divan and his team take a look at the best stocks in the pharmaceutical sector.  Divan writes that he expects investors will continue to keep one eye focused on macro issues, from the potential for tax reform to drug pricing inquiries, but that news about specific products from pharma companies should be able to move the needle.  Overall, he writes that investor sentiment on the pharma industry is “robust,” and that it could get a further boost if tax reform does happen and includes policies like a cash repatriation holiday that could spur more M&A in the group."
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 13:15:01 +0000,https://finance.yahoo.com/news/allergan-apos-botox-gets-fda-131501131.html?.tsrc=rss,Allergan (AGN) secures an FDA approval for Botox Cosmetic product for its third indication of forehead line development.
,,,Allergan&apos;s Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 13:15:01 +0000,https://finance.yahoo.com/news/allergan-apos-botox-gets-fda-131501131.html?.tsrc=rss,Allergan (AGN) secures an FDA approval for Botox Cosmetic product for its third indication of forehead line development.
AGN,AGN:US,BBG000FH8PX5,Allergan To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017 In San Diego,2017-10-04 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-anti-infectives-120100073.html?.tsrc=rss,"DUBLIN , Oct. 4, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company committed to improving outcomes and meeting critical needs in infectious diseases, will present new ..."
,,,Allergan To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017 In San Diego,2017-10-04 12:01:00 +0000,https://finance.yahoo.com/news/allergan-present-data-anti-infectives-120100073.html?.tsrc=rss,"DUBLIN , Oct. 4, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company committed to improving outcomes and meeting critical needs in infectious diseases, will present new ..."
AGN,AGN:US,BBG000FH8PX5,U.S. House committee launches probe of Allergan patent deal,2017-10-03 20:43:24 +0000,https://finance.yahoo.com/news/allergan-ceo-says-patent-review-170240066.html?.tsrc=rss,"A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's (AGN.N) deal to transfer some of its patents to a Native American tribe to shield them from review.  Allergan said last month that it was transferring patents on its dry eye medication Restasis to New York's Saint Regis Mohawk Tribe, which agreed to exclusively license them back to the company in exchange for ongoing payments."
,,,U.S. House committee launches probe of Allergan patent deal,2017-10-03 20:43:24 +0000,https://finance.yahoo.com/news/allergan-ceo-says-patent-review-170240066.html?.tsrc=rss,"A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's (AGN.N) deal to transfer some of its patents to a Native American tribe to shield them from review.  Allergan said last month that it was transferring patents on its dry eye medication Restasis to New York's Saint Regis Mohawk Tribe, which agreed to exclusively license them back to the company in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,Drugmaker Under Fire For Using Mohawk Tribe To Shield Patent,2017-10-03 20:27:04 +0000,http://finance.yahoo.com/r/84f0da0c-3fab-3ea4-bea5-fbdd5a025596/drugmaker-under-fire-for-using-mohawk-tribe-to-shield-patent?src=A00220&yptr=yahoo&.tsrc=rss,"What’s got a tax address in Ireland, a blockbuster drug on a Native American reservation, and new trouble in Washington?"
,,,Drugmaker Under Fire For Using Mohawk Tribe To Shield Patent,2017-10-03 20:27:04 +0000,http://finance.yahoo.com/r/84f0da0c-3fab-3ea4-bea5-fbdd5a025596/drugmaker-under-fire-for-using-mohawk-tribe-to-shield-patent?src=A00220&yptr=yahoo&.tsrc=rss,"What’s got a tax address in Ireland, a blockbuster drug on a Native American reservation, and new trouble in Washington?"
,,,Allergan's unusual patent agreement,2017-10-03 19:45:00 +0000,https://finance.yahoo.com/video/allergans-unusual-patent-agreement-194500846.html?.tsrc=rss,CNBC's Meg Tirrell reports on senators commenting on Allergan's patent agreement with the Saint Regis Mohawk Tribe.
AGN,AGN:US,BBG000FH8PX5,Allergan's unusual patent agreement,2017-10-03 19:45:00 +0000,https://finance.yahoo.com/video/allergans-unusual-patent-agreement-194500846.html?.tsrc=rss,CNBC's Meg Tirrell reports on senators commenting on Allergan's patent agreement with the Saint Regis Mohawk Tribe.
,,,"Allergan Patent Deal May Hurt Competition, Lawmakers Say",2017-10-03 17:23:57 +0000,http://finance.yahoo.com/r/86f50661-0904-3a58-9a04-c17e5201dd07/house-oversight-panel-leaders-question-allergan-on-mohawk-deal?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"What’s got a tax address in Ireland, headquarters in New Jersey, a blockbuster drug on a Native American reservation, and new trouble in Washington?"
AGN,AGN:US,BBG000FH8PX5,"Allergan Patent Deal May Hurt Competition, Lawmakers Say",2017-10-03 17:23:57 +0000,http://finance.yahoo.com/r/86f50661-0904-3a58-9a04-c17e5201dd07/house-oversight-panel-leaders-question-allergan-on-mohawk-deal?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"What’s got a tax address in Ireland, headquarters in New Jersey, a blockbuster drug on a Native American reservation, and new trouble in Washington?"
AGN,AGN:US,BBG000FH8PX5,Allergan CEO says patent review flawed in response to senators,2017-10-03 16:53:09 +0000,https://finance.yahoo.com/news/allergan-ceo-says-patent-review-165309167.html?.tsrc=rss,"Allergan Plc (AGN.N) Chief Executive Brent Saunders on Tuesday  defended his company's decision to transfer drug patents to a Native American tribe as a proper way to shield them from a flawed patent review process, in a response to congressional criticism.  Saunders sent a letter to Republican Senator Charles Grassley and Democratic Senator Dianne Feinstein, the chairman and ranking member of the Senate Judiciary Committee,  after four Democratic U.S. senators asked them to launch a committee investigation into the deal."
,,,Allergan CEO says patent review flawed in response to senators,2017-10-03 16:53:09 +0000,https://finance.yahoo.com/news/allergan-ceo-says-patent-review-165309167.html?.tsrc=rss,"Allergan Plc (AGN.N) Chief Executive Brent Saunders on Tuesday  defended his company's decision to transfer drug patents to a Native American tribe as a proper way to shield them from a flawed patent review process, in a response to congressional criticism.  Saunders sent a letter to Republican Senator Charles Grassley and Democratic Senator Dianne Feinstein, the chairman and ranking member of the Senate Judiciary Committee,  after four Democratic U.S. senators asked them to launch a committee investigation into the deal."
,,,Allergan's sNDA for Anti-Infective Avycaz Accepted by FDA,2017-10-03 14:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/duZla6ZlWGM/allergans-snda-for-anti-infective-avycaz-accepted-by-fda-cm854524,Allergan plc AGN announced that a supplemental New Drug Application sNDA for its anti infective drug Avycaz has been accepted and granted priority review by the FDA We remind investors that Avycaz is currently approved for the treatment of complicated urinary tract infections
AGN,AGN:US,BBG000FH8PX5,Allergan's sNDA for Anti-Infective Avycaz Accepted by FDA,2017-10-03 14:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/duZla6ZlWGM/allergans-snda-for-anti-infective-avycaz-accepted-by-fda-cm854524,Allergan plc AGN announced that a supplemental New Drug Application sNDA for its anti infective drug Avycaz has been accepted and granted priority review by the FDA We remind investors that Avycaz is currently approved for the treatment of complicated urinary tract infections
AGN,AGN:US,BBG000FH8PX5,[$$] Big Questions for Big Pharma,2017-10-03 14:19:00 +0000,http://finance.yahoo.com/r/e77903f7-eb88-3df7-9671-aba3546ca973/big-questions-for-big-pharma-1507040386?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We have spent much of the past several weeks on the road, attending medical conferences and meeting with various companies and investors.  Overall, sentiment on the group remains relatively robust with noise on the U.S. drug pricing side far below what it has been and investors still cautiously optimistic on the possibility of U.S. corporate tax reform coming through in 2018.  What will get Allergan (AGN) turned around?"
,,,[$$] Big Questions for Big Pharma,2017-10-03 14:19:00 +0000,http://finance.yahoo.com/r/e77903f7-eb88-3df7-9671-aba3546ca973/big-questions-for-big-pharma-1507040386?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We have spent much of the past several weeks on the road, attending medical conferences and meeting with various companies and investors.  Overall, sentiment on the group remains relatively robust with noise on the U.S. drug pricing side far below what it has been and investors still cautiously optimistic on the possibility of U.S. corporate tax reform coming through in 2018.  What will get Allergan (AGN) turned around?"
,,,Allergan&apos;s sNDA for Anti-Infective Avycaz Accepted by FDA,2017-10-03 13:50:01 +0000,https://finance.yahoo.com/news/allergan-apos-snda-anti-infective-135001236.html?.tsrc=rss,Allergan (AGN) announced that the FDA has accepted the application for the label expansion of Avycaz to include a new indication and study data.
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s sNDA for Anti-Infective Avycaz Accepted by FDA,2017-10-03 13:50:01 +0000,https://finance.yahoo.com/news/allergan-apos-snda-anti-infective-135001236.html?.tsrc=rss,Allergan (AGN) announced that the FDA has accepted the application for the label expansion of Avycaz to include a new indication and study data.
,,,Allergan responds to mounting criticism of Mohawk patent deal,2017-10-03 13:45:44 +0000,http://finance.yahoo.com/r/4a0e2dc6-28f8-3e5e-84ff-20b9dd297474/104749086?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104749086&yptr=yahoo&.tsrc=rss,Allergan is urging the Senate Judiciary Committee to review the patent challenge system it’s been accused of thwarting.
AGN,AGN:US,BBG000FH8PX5,Allergan responds to mounting criticism of Mohawk patent deal,2017-10-03 13:45:44 +0000,http://finance.yahoo.com/r/4a0e2dc6-28f8-3e5e-84ff-20b9dd297474/104749086?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104749086&yptr=yahoo&.tsrc=rss,Allergan is urging the Senate Judiciary Committee to review the patent challenge system it’s been accused of thwarting.
AGN,AGN:US,BBG000FH8PX5,European Markets Struggled To Extend Recent Gains,2017-10-03 11:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z9UW-aLRUdc/european-markets-struggled-to-extend-recent-gains-20171003-00950,European Markets Struggled To Extend Recent Gains
,,,European Markets Struggled To Extend Recent Gains,2017-10-03 11:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z9UW-aLRUdc/european-markets-struggled-to-extend-recent-gains-20171003-00950,European Markets Struggled To Extend Recent Gains
AGN,AGN:US,BBG000FH8PX5,Allergan's Botox gets FDA OK to treat forehead lines,2017-10-03 11:37:09 +0000,http://finance.yahoo.com/r/a461a63f-2bac-3ed9-ac4c-b5473fd416c7/Story.aspx?guid=CA90F6A0-56E1-49DE-B7F6-EFFE38A5F2C7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Tuesday that the Food and Drug Administration has approved Botox for the temporary improvement of moderate-to-severe forehead lines. Botox is already approved for treat ""crow's feet"" ..."
,,,Allergan's Botox gets FDA OK to treat forehead lines,2017-10-03 11:37:09 +0000,http://finance.yahoo.com/r/a461a63f-2bac-3ed9-ac4c-b5473fd416c7/Story.aspx?guid=CA90F6A0-56E1-49DE-B7F6-EFFE38A5F2C7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Tuesday that the Food and Drug Administration has approved Botox for the temporary improvement of moderate-to-severe forehead lines. Botox is already approved for treat ""crow's feet"" ..."
,,,FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults,2017-10-03 11:31:00 +0000,https://finance.yahoo.com/news/fda-approves-botox-cosmetic-onabotulinumtoxina-113100422.html?.tsrc=rss,"DUBLIN, Oct. 3, 2017 /PRNewswire/ -- Today Allergan plc (AGN) announced the FDA approval of BOTOX® Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults.  This approval makes the brand the first and only neurotoxin indicated for three facial treatment areas - forehead lines, crow's feet lines and glabellar lines."
AGN,AGN:US,BBG000FH8PX5,FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults,2017-10-03 11:31:00 +0000,https://finance.yahoo.com/news/fda-approves-botox-cosmetic-onabotulinumtoxina-113100422.html?.tsrc=rss,"DUBLIN, Oct. 3, 2017 /PRNewswire/ -- Today Allergan plc (AGN) announced the FDA approval of BOTOX® Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults.  This approval makes the brand the first and only neurotoxin indicated for three facial treatment areas - forehead lines, crow's feet lines and glabellar lines."
,,,European Shares Little Changed In Lackluster Trade,2017-10-03 05:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-D3txi8HLsI/european-shares-little-changed-in-lackluster-trade-20171003-00168,European Shares Little Changed In Lackluster Trade
AGN,AGN:US,BBG000FH8PX5,European Shares Little Changed In Lackluster Trade,2017-10-03 05:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-D3txi8HLsI/european-shares-little-changed-in-lackluster-trade-20171003-00168,European Shares Little Changed In Lackluster Trade
AGN,AGN:US,BBG000FH8PX5,FTSE 100 Little Changed In Cautious Trade,2017-10-03 05:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJUfYsQlUKM/ftse-100-little-changed-in-cautious-trade-20171003-00147,FTSE 100 Little Changed In Cautious Trade
,,,FTSE 100 Little Changed In Cautious Trade,2017-10-03 05:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJUfYsQlUKM/ftse-100-little-changed-in-cautious-trade-20171003-00147,FTSE 100 Little Changed In Cautious Trade
,,,Shire Alleges Allergan Blocked Drug From Medicare Contracts,2017-10-03 05:04:53 +0000,http://finance.yahoo.com/r/ca5d2602-65cd-3630-bb0f-f8d728003ced/shire-alleges-allergan-blocked-drug-from-medicare-contracts-1506957534?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Shire filed an antitrust suit against Allergan, alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug."
AGN,AGN:US,BBG000FH8PX5,Shire Alleges Allergan Blocked Drug From Medicare Contracts,2017-10-03 05:04:53 +0000,http://finance.yahoo.com/r/ca5d2602-65cd-3630-bb0f-f8d728003ced/shire-alleges-allergan-blocked-drug-from-medicare-contracts-1506957534?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Shire filed an antitrust suit against Allergan, alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug."
,,,"VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch",2017-10-03 01:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bw4ozm4q16o/vicl-soars-afterhours-dmtx-deems-rare-bid-superior-mdxg-on-watch-20171003-00026,"VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch"
AGN,AGN:US,BBG000FH8PX5,"VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch",2017-10-03 01:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bw4ozm4q16o/vicl-soars-afterhours-dmtx-deems-rare-bid-superior-mdxg-on-watch-20171003-00026,"VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch"
AGN,AGN:US,BBG000FH8PX5,Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI,2017-10-03 00:28:00 +0000,http://finance.yahoo.com/r/ab7a3ffc-eca2-377c-8b46-6a2c2664f9b9/markets-move-higher-inversion-rules-put-pfizer-allergan-back-in-focus-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Monday, Oct. 2."
,,,Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI,2017-10-03 00:28:00 +0000,http://finance.yahoo.com/r/ab7a3ffc-eca2-377c-8b46-6a2c2664f9b9/markets-move-higher-inversion-rules-put-pfizer-allergan-back-in-focus-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Monday, Oct. 2."
,,,4 Biotech Stocks (and 1 ETF) to Buy As They Bolt Higher,2017-10-02 23:46:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YC71v8n_SPQ/4-biotech-stocks-and-1-etf-to-buy-as-they-bolt-higher-cm854290,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are continuing their recent push higher on Monday led once again by the performance of small cap stocks in the Russell 2000 From its mid August low the index is up more than 11 in an impressive near
AGN,AGN:US,BBG000FH8PX5,4 Biotech Stocks (and 1 ETF) to Buy As They Bolt Higher,2017-10-02 23:46:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YC71v8n_SPQ/4-biotech-stocks-and-1-etf-to-buy-as-they-bolt-higher-cm854290,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are continuing their recent push higher on Monday led once again by the performance of small cap stocks in the Russell 2000 From its mid August low the index is up more than 11 in an impressive near
AGN,AGN:US,BBG000FH8PX5,More scrutiny for Allergan over Native American tribe deal,2017-10-02 22:31:44 +0000,https://finance.yahoo.com/news/more-scrutiny-allergan-over-native-223144722.html?.tsrc=rss,Senator Claire McCaskill late Monday called Allergan&apos;s deal a &quot;brazen loophole&quot; she says should be illegal.
,,,More scrutiny for Allergan over Native American tribe deal,2017-10-02 22:31:44 +0000,http://finance.yahoo.com/r/2ab93f0e-e4fb-38d1-9ce7-8d8df2742780/104747827?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104747827&yptr=yahoo&.tsrc=rss,"Senator Claire McCaskill late Monday called Allergan's deal a ""brazen loophole"" she says should be illegal."
,,,More scrutiny for Allergan over Native American tribe deal,2017-10-02 22:31:44 +0000,https://finance.yahoo.com/news/more-scrutiny-allergan-over-native-223144722.html?.tsrc=rss,Senator Claire McCaskill late Monday called Allergan&apos;s deal a &quot;brazen loophole&quot; she says should be illegal.
AGN,AGN:US,BBG000FH8PX5,More scrutiny for Allergan over Native American tribe deal,2017-10-02 22:31:44 +0000,http://finance.yahoo.com/r/2ab93f0e-e4fb-38d1-9ce7-8d8df2742780/104747827?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104747827&yptr=yahoo&.tsrc=rss,"Senator Claire McCaskill late Monday called Allergan's deal a ""brazen loophole"" she says should be illegal."
,,,Senator questions Allergan deal,2017-10-02 21:18:00 +0000,https://finance.yahoo.com/video/senator-questions-allergan-deal-211800453.html?.tsrc=rss,CNBC's Meg Tirrell reports on Sen. Claire McCaskill comments regarding Allergan's patent deal with the Saint Regis Mohawk Tribe.
AGN,AGN:US,BBG000FH8PX5,Senator questions Allergan deal,2017-10-02 21:18:00 +0000,https://finance.yahoo.com/video/senator-questions-allergan-deal-211800453.html?.tsrc=rss,CNBC's Meg Tirrell reports on Sen. Claire McCaskill comments regarding Allergan's patent deal with the Saint Regis Mohawk Tribe.
,,,[$$] Allergan leads drugmakers higher on repatriation hopes,2017-10-02 20:40:24 +0000,"http://finance.yahoo.com/r/a8b60ada-ae8a-3c11-a6a7-654d872eea42/e6156258-a786-11e7-93c5-648314d2c72c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The stocks of the largest pharmaceutical companies led Wall Street's advances on Monday as tax reform proposals offered a further lift for the healthcare sector. The sector rose nearly 1 per cent, outpacing ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan leads drugmakers higher on repatriation hopes,2017-10-02 20:40:24 +0000,"http://finance.yahoo.com/r/a8b60ada-ae8a-3c11-a6a7-654d872eea42/e6156258-a786-11e7-93c5-648314d2c72c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The stocks of the largest pharmaceutical companies led Wall Street's advances on Monday as tax reform proposals offered a further lift for the healthcare sector. The sector rose nearly 1 per cent, outpacing ..."
,,,Shire Alleges Allergan Blocked Drug From Medicare Contracts,2017-10-02 18:00:43 +0000,http://finance.yahoo.com/r/ca5d2602-65cd-3630-bb0f-f8d728003ced/shire-alleges-allergan-blocked-drug-from-medicare-contracts-1506957534?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Shire filed an antitrust suit against Allergan, alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug."
AGN,AGN:US,BBG000FH8PX5,Shire Alleges Allergan Blocked Drug From Medicare Contracts,2017-10-02 18:00:43 +0000,http://finance.yahoo.com/r/ca5d2602-65cd-3630-bb0f-f8d728003ced/shire-alleges-allergan-blocked-drug-from-medicare-contracts-1506957534?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Shire filed an antitrust suit against Allergan, alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug."
,,,Deere in high gear,2017-10-02 17:31:00 +0000,https://finance.yahoo.com/video/deere-high-gear-173100870.html?.tsrc=rss,&quot;Halftime Report&quot; trader Jon Najarian spots unusual activity in shares of Allergan and Deere.
AGN,AGN:US,BBG000FH8PX5,Deere in high gear,2017-10-02 17:31:00 +0000,https://finance.yahoo.com/video/deere-high-gear-173100870.html?.tsrc=rss,&quot;Halftime Report&quot; trader Jon Najarian spots unusual activity in shares of Allergan and Deere.
,,,Shire sues Allergan in U.S. over dry eye drug,2017-10-02 16:14:58 +0000,https://finance.yahoo.com/news/shire-sues-allergan-u-over-161458250.html?.tsrc=rss,"In a complaint filed with the federal court in Newark, New Jersey, Shire accused Allergan of violating antitrust laws to preserve its roughly 90 percent share in Medicare prescription drug plans for its older and ""clinically inferior"" dry eye drug Restasis, and block prescriptions of Shire's rival drug Xiidra.  ""Quite simply, Allergan has and will continue to use bundled discounts, exclusive dealing, coercion and interference to unlawfully 'block' Shire from competing with it, and to maintain its monopoly in the Part D market at all costs,"" Shire said, referring to the Medicare drug plans."
AGN,AGN:US,BBG000FH8PX5,Shire sues Allergan in U.S. over dry eye drug,2017-10-02 16:14:58 +0000,https://finance.yahoo.com/news/shire-sues-allergan-u-over-161458250.html?.tsrc=rss,"In a complaint filed with the federal court in Newark, New Jersey, Shire accused Allergan of violating antitrust laws to preserve its roughly 90 percent share in Medicare prescription drug plans for its older and ""clinically inferior"" dry eye drug Restasis, and block prescriptions of Shire's rival drug Xiidra.  ""Quite simply, Allergan has and will continue to use bundled discounts, exclusive dealing, coercion and interference to unlawfully 'block' Shire from competing with it, and to maintain its monopoly in the Part D market at all costs,"" Shire said, referring to the Medicare drug plans."
,,,Shire sues Allergan in U.S. over dry eye drug,2017-10-02 16:10:36 +0000,https://finance.yahoo.com/news/shire-sues-allergan-u-over-161036113.html?.tsrc=rss,"Allergan Plc was sued on Monday by  Shire Plc for allegedly scheming to block doctors from  prescribing its new treatment for dry eye disease.  In a complaint filed with the federal court in Newark, New  Jersey, Shire accused Allergan of violating antitrust laws to  preserve its roughly 90 percent share in Medicare prescription  drug plans for its older and ""clinically inferior"" dry eye drug  Restasis, and block prescriptions of Shire's rival drug Xiidra."
AGN,AGN:US,BBG000FH8PX5,FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ® (ceftazidime and avibactam),2017-10-02 12:00:00 +0000,https://finance.yahoo.com/news/fda-accepts-supplemental-drug-application-120000424.html?.tsrc=rss,- Application Seeks to Expand Label to Include an Indication and Phase 3 Data for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia (HABP/VABP) ...
,,,FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ® (ceftazidime and avibactam),2017-10-02 12:00:00 +0000,https://finance.yahoo.com/news/fda-accepts-supplemental-drug-application-120000424.html?.tsrc=rss,- Application Seeks to Expand Label to Include an Indication and Phase 3 Data for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia (HABP/VABP) ...
,,,Allergan to Report Third Quarter 2017 Earnings and Host Conference Call and Webcast,2017-10-02 11:30:00 +0000,https://finance.yahoo.com/news/allergan-report-third-quarter-2017-113000035.html?.tsrc=rss,"DUBLIN, Oct. 2, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced it intends to release third quarter 2017 financial results on Wednesday, November 1, 2017, prior to the open of the U.S. Financial Markets.  Allergan will host a conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, November 1, 2017 to discuss its financial results.  The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 65879759."
AGN,AGN:US,BBG000FH8PX5,Allergan to Report Third Quarter 2017 Earnings and Host Conference Call and Webcast,2017-10-02 11:30:00 +0000,https://finance.yahoo.com/news/allergan-report-third-quarter-2017-113000035.html?.tsrc=rss,"DUBLIN, Oct. 2, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced it intends to release third quarter 2017 financial results on Wednesday, November 1, 2017, prior to the open of the U.S. Financial Markets.  Allergan will host a conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, November 1, 2017 to discuss its financial results.  The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 65879759."
AGN,AGN:US,BBG000FH8PX5,Allergan: FDA To Review SNDA For AVYCAZ; Filing Seeks To Expand Label,2017-10-02 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uZchTJwp1UI/allergan-fda-to-review-snda-for-avycaz-filing-seeks-to-expand-label-20171002-00560,Allergan: FDA To Review SNDA For AVYCAZ; Filing Seeks To Expand Label
,,,Allergan: FDA To Review SNDA For AVYCAZ; Filing Seeks To Expand Label,2017-10-02 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uZchTJwp1UI/allergan-fda-to-review-snda-for-avycaz-filing-seeks-to-expand-label-20171002-00560,Allergan: FDA To Review SNDA For AVYCAZ; Filing Seeks To Expand Label
,,,Allergan Price Target Reduction; Lacing Up Nike: Doug Kass' Views,2017-10-02 05:00:00 +0000,http://finance.yahoo.com/r/2a76ddfa-1187-38b3-981c-c1bd58a3e97f/allergan-price-target-reduction-lacing-up-nike-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on Allergan, Nike and a few other companies."
AGN,AGN:US,BBG000FH8PX5,Allergan Price Target Reduction; Lacing Up Nike: Doug Kass' Views,2017-10-02 05:00:00 +0000,http://finance.yahoo.com/r/2a76ddfa-1187-38b3-981c-c1bd58a3e97f/allergan-price-target-reduction-lacing-up-nike-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on Allergan, Nike and a few other companies."
AGN,AGN:US,BBG000FH8PX5,U.S. court strikes down Obama-era rule on tax inversions,2017-09-30 03:10:10 +0000,https://finance.yahoo.com/news/u-court-strikes-down-obama-031010678.html?.tsrc=rss,"A federal court in Texas on Friday ruled that the Obama administration acted unlawfully last year when its Treasury Department cracked down on U.S. companies that try to reduce their U.S. taxes by rebasing abroad, in a process known as inversion.  The U.S. Chamber of Commerce and the Texas Association of Business had filed a lawsuit in Texas federal court that said a regulation from the Treasury Department in April 2016 exceeded what the law allows the department to do."
,,,U.S. court strikes down Obama-era rule on tax inversions,2017-09-30 03:10:10 +0000,https://finance.yahoo.com/news/u-court-strikes-down-obama-031010678.html?.tsrc=rss,"A federal court in Texas on Friday ruled that the Obama administration acted unlawfully last year when its Treasury Department cracked down on U.S. companies that try to reduce their U.S. taxes by rebasing abroad, in a process known as inversion.  The U.S. Chamber of Commerce and the Texas Association of Business had filed a lawsuit in Texas federal court that said a regulation from the Treasury Department in April 2016 exceeded what the law allows the department to do."
AGN,AGN:US,BBG000FH8PX5,U.S. court strikes down Obama-era rule on tax inversions,2017-09-30 03:00:11 +0000,https://finance.yahoo.com/news/u-court-strikes-down-obama-030011657.html?.tsrc=rss,"A federal court in Texas on  Friday ruled that the Obama administration acted unlawfully last  year when its Treasury Department cracked down on U.S. companies  that try to reduce their U.S. taxes by rebasing abroad, in a  process known as inversion.  The U.S. Chamber of Commerce and the Texas Association of  Business had filed a lawsuit in Texas federal court that said a  regulation from the Treasury Department in April 2016 exceeded  what the law allows the department to do."
AGN,AGN:US,BBG000FH8PX5,Why Synergy Pharmaceuticals Rallied 12% Today,2017-09-29 22:33:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kf8xD1UZt78/why-synergy-pharmaceuticals-rallied-12-today-cm853327,What happened Synergy Pharmaceuticals NASDAQ SGYP updated investors on the performance of its chronic idiopathic constipation CIC drug Trulance at the Ladenburg Thalmann Healthcare Conference on Sept 26 and the Cantor Fitzgerald global healthcare conference on Sept 27
,,,Why Synergy Pharmaceuticals Rallied 12% Today,2017-09-29 22:33:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kf8xD1UZt78/why-synergy-pharmaceuticals-rallied-12-today-cm853327,What happened Synergy Pharmaceuticals NASDAQ SGYP updated investors on the performance of its chronic idiopathic constipation CIC drug Trulance at the Ladenburg Thalmann Healthcare Conference on Sept 26 and the Cantor Fitzgerald global healthcare conference on Sept 27
,,,Allergan (AGN) Pipeline & New Drugs to Counter Generic Woes,2017-09-29 13:20:01 +0000,https://finance.yahoo.com/news/allergan-agn-pipeline-drugs-counter-132001972.html?.tsrc=rss,"Allergan&apos;s key drugs like Botox/Linzess and new drugs are supporting sales. However, Allergan faces generic threat for Namenda franchise and patent challenges for some other branded drugs."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Pipeline & New Drugs to Counter Generic Woes,2017-09-29 13:20:01 +0000,https://finance.yahoo.com/news/allergan-agn-pipeline-drugs-counter-132001972.html?.tsrc=rss,"Allergan&apos;s key drugs like Botox/Linzess and new drugs are supporting sales. However, Allergan faces generic threat for Namenda franchise and patent challenges for some other branded drugs."
,,,Tax reform could spark a wave of biopharma M&A,2017-09-28 21:27:00 +0000,https://finance.yahoo.com/video/tax-reform-could-spark-wave-212700721.html?.tsrc=rss,CNBC's Meg Tirrell discusses the failed attempts at Pfizer trying to acquire two companies in the past but how the Republican tax reform plan could change that. The “Fast Money” traders weigh in.
AGN,AGN:US,BBG000FH8PX5,Tax reform could spark a wave of biopharma M&A,2017-09-28 21:27:00 +0000,https://finance.yahoo.com/video/tax-reform-could-spark-wave-212700721.html?.tsrc=rss,CNBC's Meg Tirrell discusses the failed attempts at Pfizer trying to acquire two companies in the past but how the Republican tax reform plan could change that. The “Fast Money” traders weigh in.
AGN,AGN:US,BBG000FH8PX5,Will Conatus Liver Disease Candidate Drive Long-Term Growth?,2017-09-28 14:46:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BcfS-bmZNTM/will-conatus-liver-disease-candidate-drive-long-term-growth-cm852556,On Sep 26 2017 we issued an updated report on Conatus Pharmaceuticals Inc CNAT With no approved product in Conatus s portfolio at the moment the company is yet to generate revenues However it is focused on developing the lead candidate emricasan an orally active pan caspase
,,,Will Conatus Liver Disease Candidate Drive Long-Term Growth?,2017-09-28 14:46:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BcfS-bmZNTM/will-conatus-liver-disease-candidate-drive-long-term-growth-cm852556,On Sep 26 2017 we issued an updated report on Conatus Pharmaceuticals Inc CNAT With no approved product in Conatus s portfolio at the moment the company is yet to generate revenues However it is focused on developing the lead candidate emricasan an orally active pan caspase
AGN,AGN:US,BBG000FH8PX5,November 10th Options Now Available For Allergan (AGN),2017-09-28 14:41:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NS-en2gLcwU/november-10th-options-now-available-for-allergan-agn-cm852488,Investors in Allergan PLC Symbol AGN saw new options begin trading today for the November 10th expiration At Stock Options Channel our YieldBoost formula has looked up and down the AGN options chain for the new November 10th contracts and identified one put and one call contract
,,,November 10th Options Now Available For Allergan (AGN),2017-09-28 14:41:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NS-en2gLcwU/november-10th-options-now-available-for-allergan-agn-cm852488,Investors in Allergan PLC Symbol AGN saw new options begin trading today for the November 10th expiration At Stock Options Channel our YieldBoost formula has looked up and down the AGN options chain for the new November 10th contracts and identified one put and one call contract
AGN,AGN:US,BBG000FH8PX5,Will Conatus Liver Disease Candidate Drive Long-Term Growth?,2017-09-28 13:23:01 +0000,https://finance.yahoo.com/news/conatus-liver-disease-candidate-drive-132301545.html?.tsrc=rss,Conatus&apos; (CNAT) efforts to develop lead candidate emricasan in absence of an approved product in the company&apos;s portfolio are a positive step toward driving growth.
,,,Will Conatus Liver Disease Candidate Drive Long-Term Growth?,2017-09-28 13:23:01 +0000,https://finance.yahoo.com/news/conatus-liver-disease-candidate-drive-132301545.html?.tsrc=rss,Conatus&apos; (CNAT) efforts to develop lead candidate emricasan in absence of an approved product in the company&apos;s portfolio are a positive step toward driving growth.
AGN,AGN:US,BBG000FH8PX5,Allergan’s controversial patent agreement with an American Indian tribe is worrying investors,2017-09-28 11:48:44 +0000,http://finance.yahoo.com/r/eeae5644-b24f-3546-8058-57efeb96962d/Story.aspx?guid=0E6B3AB4-A392-11E7-BDF5-7DD5423393CF&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The criticism suggests a change in public perception of the drugmaker, which led the way in self-imposed limits on drug price increases last fall."
,,,Allergan’s controversial patent agreement with an American Indian tribe is worrying investors,2017-09-28 11:48:44 +0000,http://finance.yahoo.com/r/eeae5644-b24f-3546-8058-57efeb96962d/Story.aspx?guid=0E6B3AB4-A392-11E7-BDF5-7DD5423393CF&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The criticism suggests a change in public perception of the drugmaker, which led the way in self-imposed limits on drug price increases last fall."
AGN,AGN:US,BBG000FH8PX5,Healthcare: Stock Selection Key as Valuations Rise,2017-09-28 11:00:00 +0000,http://finance.yahoo.com/r/84b6189e-a24d-3e31-afe2-840cd6d9c9e9/article.aspx?id=825979&SR=Yahoo&yptr=yahoo&.tsrc=rss,"Valuations in the healthcare sector in aggregate look fair, increasing the importance on stock selection where innovation and redeployment of capital weigh heavily."
,,,Healthcare: Stock Selection Key as Valuations Rise,2017-09-28 11:00:00 +0000,http://finance.yahoo.com/r/84b6189e-a24d-3e31-afe2-840cd6d9c9e9/article.aspx?id=825979&SR=Yahoo&yptr=yahoo&.tsrc=rss,"Valuations in the healthcare sector in aggregate look fair, increasing the importance on stock selection where innovation and redeployment of capital weigh heavily."
AGN,AGN:US,BBG000FH8PX5,Senators want probe of Allergan transfer deal with tribe: letter,2017-09-27 22:13:20 +0000,https://finance.yahoo.com/news/exclusive-u-senators-want-probe-200530669.html?.tsrc=rss,Four U.S. senators have asked the Senate Judiciary Committee to launch an investigation into a deal drugmaker Allergan Plc struck with a Native American tribe to protect some of its patents from generic ...
,,,Senators want probe of Allergan transfer deal with tribe: letter,2017-09-27 22:13:20 +0000,https://finance.yahoo.com/news/exclusive-u-senators-want-probe-200530669.html?.tsrc=rss,Four U.S. senators have asked the Senate Judiciary Committee to launch an investigation into a deal drugmaker Allergan Plc struck with a Native American tribe to protect some of its patents from generic ...
AGN,AGN:US,BBG000FH8PX5,Axovant Rises After Tuesday's Plunge - Biotech Movers,2017-09-27 13:46:00 +0000,http://finance.yahoo.com/r/5e103c6b-bcc6-3240-9c66-7c59de1d64a4/axovant-rises-after-tuesday-s-plunge-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Axovant shares were up in premarket trading on Sept. 27 after plummeting on Tuesday on the heels of the announcement that the company's Phase 3 study of intepirdine in patients with Alzheimer's disease ...
,,,Axovant Rises After Tuesday's Plunge - Biotech Movers,2017-09-27 13:46:00 +0000,http://finance.yahoo.com/r/5e103c6b-bcc6-3240-9c66-7c59de1d64a4/axovant-rises-after-tuesday-s-plunge-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Axovant shares were up in premarket trading on Sept. 27 after plummeting on Tuesday on the heels of the announcement that the company's Phase 3 study of intepirdine in patients with Alzheimer's disease ...
,,,What Happened to Allergan’s Valuation after 2Q17?,2017-09-27 11:37:12 +0000,http://finance.yahoo.com/r/08cec61f-6888-3ef7-a419-b673d64a59e6/what-happened-to-allergans-valuation-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 21 analysts tracking Allergan stock, 14 recommend a “buy,” and seven analysts recommend a “hold.” None recommends a “sell.”"
AGN,AGN:US,BBG000FH8PX5,What Happened to Allergan’s Valuation after 2Q17?,2017-09-27 11:37:12 +0000,http://finance.yahoo.com/r/08cec61f-6888-3ef7-a419-b673d64a59e6/what-happened-to-allergans-valuation-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 21 analysts tracking Allergan stock, 14 recommend a “buy,” and seven analysts recommend a “hold.” None recommends a “sell.”"
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan deal with Mohawk tribe casts patent shadow,2017-09-27 10:01:18 +0000,"http://finance.yahoo.com/r/cfd12d4a-1125-3831-a02e-8825fb6ea817/5ec7305a-9f17-11e7-9a86-4d5a475ba4c5,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The headquarters of the Saint Regis Mohawk Tribe, an American Indian community in upstate New York, is an unlikely venue for one of the most controversial patent disputes in years. But this low-slung building, ..."
,,,[$$] Allergan deal with Mohawk tribe casts patent shadow,2017-09-27 10:01:18 +0000,"http://finance.yahoo.com/r/cfd12d4a-1125-3831-a02e-8825fb6ea817/5ec7305a-9f17-11e7-9a86-4d5a475ba4c5,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The headquarters of the Saint Regis Mohawk Tribe, an American Indian community in upstate New York, is an unlikely venue for one of the most controversial patent disputes in years. But this low-slung building, ..."
,,,"Allergan Authorizes New $2B Share Buyback Plan, Stock Up",2017-09-26 21:07:09 +0000,https://finance.yahoo.com/news/allergan-authorizes-2b-share-buyback-210709706.html?.tsrc=rss,Allergan plc (AZN) sanctions a new stock repurchase program. The company also reiterates its commitment toward annual hike of quarterly cash dividend.
AGN,AGN:US,BBG000FH8PX5,"Allergan Authorizes New $2B Share Buyback Plan, Stock Up",2017-09-26 21:07:09 +0000,https://finance.yahoo.com/news/allergan-authorizes-2b-share-buyback-210709706.html?.tsrc=rss,Allergan plc (AZN) sanctions a new stock repurchase program. The company also reiterates its commitment toward annual hike of quarterly cash dividend.
,,,"Evening Sector Snapshot: Trucking Gains, Pharmaceuticals Slip",2017-09-26 21:06:00 +0000,http://finance.yahoo.com/r/f3d00011-5e3c-330c-ad1e-98a4f3804d04/evening-sector-snapshot-trucking-gains-pharmaceuticals-slip-1506459983?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"A look at the day's biggest moving sectors. Wholesale distributors were higher, led by Fastenal (FAST). Davita's (DVA) gain helped medical and nursing services. Trucking stocks, including J.B. Hunt (JBHT), ..."
AGN,AGN:US,BBG000FH8PX5,"Evening Sector Snapshot: Trucking Gains, Pharmaceuticals Slip",2017-09-26 21:06:00 +0000,http://finance.yahoo.com/r/f3d00011-5e3c-330c-ad1e-98a4f3804d04/evening-sector-snapshot-trucking-gains-pharmaceuticals-slip-1506459983?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"A look at the day's biggest moving sectors. Wholesale distributors were higher, led by Fastenal (FAST). Davita's (DVA) gain helped medical and nursing services. Trucking stocks, including J.B. Hunt (JBHT), ..."
AGN,AGN:US,BBG000FH8PX5,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 19:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rAwfgjO4Ips/is-teva-pharmaceutical-teva-stock-worth-the-risk-cm851359,InvestorPlace Stock Market News Stock Advice amp Trading Tips Those who do not learn from history are doomed to repeat it That feels awfully applicable when talking about 160 Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA Source Open Grid
,,,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 19:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rAwfgjO4Ips/is-teva-pharmaceutical-teva-stock-worth-the-risk-cm851359,InvestorPlace Stock Market News Stock Advice amp Trading Tips Those who do not learn from history are doomed to repeat it That feels awfully applicable when talking about 160 Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA Source Open Grid
AGN,AGN:US,BBG000FH8PX5,Drug companies ask Oklahoma judge to dismiss opioid lawsuit,2017-09-26 17:39:41 +0000,https://finance.yahoo.com/news/drug-companies-ask-oklahoma-judge-173941797.html?.tsrc=rss,Drug companies have asked a judge to dismiss a lawsuit filed by Oklahoma's attorney general accusing them of fueling the state's opioid epidemic through fraudulent marketing. About a dozen pharmaceutical ...
,,,Drug companies ask Oklahoma judge to dismiss opioid lawsuit,2017-09-26 17:39:41 +0000,https://finance.yahoo.com/news/drug-companies-ask-oklahoma-judge-173941797.html?.tsrc=rss,Drug companies have asked a judge to dismiss a lawsuit filed by Oklahoma's attorney general accusing them of fueling the state's opioid epidemic through fraudulent marketing. About a dozen pharmaceutical ...
,,,Allergan: Running Afoul of the Socially Responsible?,2017-09-26 17:11:00 +0000,http://finance.yahoo.com/r/341d3cce-1ed5-3dc2-a093-180b50c05ba1/allergan-running-afoul-of-the-socially-responsible-1506445911?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Has Allergan’s (AGN) controversial deal to defend the patents protecting the dry eye treatment Restasis run afoul of socially responsible investors?  Credit Suisse’s Vamil Divan and his team lowered earnings estimates for the drug maker and cut the price target on the stock from $286 a share to $266 a share, citing the recent refusal-to-file letter from the FDA on the Vraylar label expansion, the $2 billion share buyback plan announced yesterday and other adjustments."
AGN,AGN:US,BBG000FH8PX5,Allergan: Running Afoul of the Socially Responsible?,2017-09-26 17:11:00 +0000,http://finance.yahoo.com/r/341d3cce-1ed5-3dc2-a093-180b50c05ba1/allergan-running-afoul-of-the-socially-responsible-1506445911?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Has Allergan’s (AGN) controversial deal to defend the patents protecting the dry eye treatment Restasis run afoul of socially responsible investors?  Credit Suisse’s Vamil Divan and his team lowered earnings estimates for the drug maker and cut the price target on the stock from $286 a share to $266 a share, citing the recent refusal-to-file letter from the FDA on the Vraylar label expansion, the $2 billion share buyback plan announced yesterday and other adjustments."
,,,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 15:25:20 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-teva-stock-worth-152520894.html?.tsrc=rss,"This highly levered, acquisition-focused growth story has come crashing down recently.  It is eerily similar to when the highly-levered, acquisition-focused growth story of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell apart not too long ago.  As we all know, VRX stock went bust and hasn’t recovered."
AGN,AGN:US,BBG000FH8PX5,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 15:25:20 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-teva-stock-worth-152520894.html?.tsrc=rss,"This highly levered, acquisition-focused growth story has come crashing down recently.  It is eerily similar to when the highly-levered, acquisition-focused growth story of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell apart not too long ago.  As we all know, VRX stock went bust and hasn’t recovered."
,,,A Closer Look at Allergan’s International Business,2017-09-26 14:38:09 +0000,http://finance.yahoo.com/r/e315c589-2226-3c11-bf69-27bf5ce30e36/a-closer-look-at-allergans-international-business?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's International segment reported a 13.4% YoY (year-over-year) rise in revenues to $858.5 million in 2Q17, compared with $757.0 million in 2Q16."
AGN,AGN:US,BBG000FH8PX5,A Closer Look at Allergan’s International Business,2017-09-26 14:38:09 +0000,http://finance.yahoo.com/r/e315c589-2226-3c11-bf69-27bf5ce30e36/a-closer-look-at-allergans-international-business?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's International segment reported a 13.4% YoY (year-over-year) rise in revenues to $858.5 million in 2Q17, compared with $757.0 million in 2Q16."
,,,A Closer Look at Allergan’s US General Medicines Segment,2017-09-26 13:08:52 +0000,http://finance.yahoo.com/r/44a175be-899e-35a2-8e64-ff4b9eaa1c06/a-closer-look-at-allergans-us-general-medicines-segment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's US General Medicines segment reported a 1.5% fall in revenues to $1.43 billion during 2Q17, compared to $1.45 billion in 2Q16."
AGN,AGN:US,BBG000FH8PX5,A Closer Look at Allergan’s US General Medicines Segment,2017-09-26 13:08:52 +0000,http://finance.yahoo.com/r/44a175be-899e-35a2-8e64-ff4b9eaa1c06/a-closer-look-at-allergans-us-general-medicines-segment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's US General Medicines segment reported a 1.5% fall in revenues to $1.43 billion during 2Q17, compared to $1.45 billion in 2Q16."
,,,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",2017-09-26 12:50:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IavOpd2pqmg/pharma-stock-roundup-jj-drug-gets-crl-label-expansion-for-merck-and-bmy-drugs-cm850815,Key highlights in the pharma sector include a complete response letter CRL from the FDA for Johnson amp Johnson s JNJ investigational rheumatoid arthritis RA treatment and FDA approval for Merck s MRK and Bristol Myers Squibb s BMY cancer drugs Recap of the Week s Most
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",2017-09-26 12:50:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IavOpd2pqmg/pharma-stock-roundup-jj-drug-gets-crl-label-expansion-for-merck-and-bmy-drugs-cm850815,Key highlights in the pharma sector include a complete response letter CRL from the FDA for Johnson amp Johnson s JNJ investigational rheumatoid arthritis RA treatment and FDA approval for Merck s MRK and Bristol Myers Squibb s BMY cancer drugs Recap of the Week s Most
,,,Allergan Investors Praise Buybacks; Target Vows to Raise Wages - ICYMI,2017-09-26 12:26:00 +0000,http://finance.yahoo.com/r/191818e8-aa5c-356b-9e28-fa2b0a37e854/allergan-investors-praise-buybacks-target-under-armour-give-retailing-hope-ic.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Amid the 50-point market selloff Monday, Allergan provided a bright spot Monday, Sept. 25., as did Target and Under Armour."
AGN,AGN:US,BBG000FH8PX5,Allergan Investors Praise Buybacks; Target Vows to Raise Wages - ICYMI,2017-09-26 12:26:00 +0000,http://finance.yahoo.com/r/191818e8-aa5c-356b-9e28-fa2b0a37e854/allergan-investors-praise-buybacks-target-under-armour-give-retailing-hope-ic.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Amid the 50-point market selloff Monday, Allergan provided a bright spot Monday, Sept. 25., as did Target and Under Armour."
AGN,AGN:US,BBG000FH8PX5,"ACZONE® (dapsone) Gel, 7.5% Recognized With Teen Vogue Acne Award Win",2017-09-26 12:00:00 +0000,https://finance.yahoo.com/news/aczone-dapsone-gel-7-5-120000560.html?.tsrc=rss,"DUBLIN, Sept. 26, 2017 /PRNewswire/ -- Today, Allergan plc (AGN) is pleased to announce that ACZONE® (dapsone) Gel, 7.5%, a prescription medicine used on the skin (topical) to treat acne in people 12 years and older, has received a Teen Vogue Acne Award for ""Best Prescription Product.""  This is the first year that Teen Vogue, a publication regarded as an information destination for the next generation, known for empowering young, millennial women to lead stylish, healthy and informed lives, has honored acne-fighting products on the market with its own dedicated awards.  ""We are proud to be recognized by Teen Vogue as the only prescription product within a competitive and crowded category,"" said Marc Forth, Senior Vice President, U.S. Neurosciences/Urology & Medical Dermatology at Allergan."
,,,"ACZONE® (dapsone) Gel, 7.5% Recognized With Teen Vogue Acne Award Win",2017-09-26 12:00:00 +0000,https://finance.yahoo.com/news/aczone-dapsone-gel-7-5-120000560.html?.tsrc=rss,"DUBLIN, Sept. 26, 2017 /PRNewswire/ -- Today, Allergan plc (AGN) is pleased to announce that ACZONE® (dapsone) Gel, 7.5%, a prescription medicine used on the skin (topical) to treat acne in people 12 years and older, has received a Teen Vogue Acne Award for ""Best Prescription Product.""  This is the first year that Teen Vogue, a publication regarded as an information destination for the next generation, known for empowering young, millennial women to lead stylish, healthy and informed lives, has honored acne-fighting products on the market with its own dedicated awards.  ""We are proud to be recognized by Teen Vogue as the only prescription product within a competitive and crowded category,"" said Marc Forth, Senior Vice President, U.S. Neurosciences/Urology & Medical Dermatology at Allergan."
,,,Featured Company News - Allergan Gets a Refusal to File Letter from FDA for its Vraylar(R) Supplemental New Drug Application,2017-09-26 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-allergan-gets-115000543.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / September 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Allergan PLC (NYSE: AGN ), following which we have published ..."
AGN,AGN:US,BBG000FH8PX5,Featured Company News - Allergan Gets a Refusal to File Letter from FDA for its Vraylar(R) Supplemental New Drug Application,2017-09-26 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-allergan-gets-115000543.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / September 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Allergan PLC (NYSE: AGN ), following which we have published ..."
AGN,AGN:US,BBG000FH8PX5,A Closer Look at Allergan’s US Specialized Therapeutics,2017-09-26 11:39:34 +0000,http://finance.yahoo.com/r/248b8512-e306-3c8b-a0f4-2dc12948e29c/a-closer-look-at-allergans-us-specialized-therapeutics?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan’s US Specialized Therapeutics segment includes eye care, medical aesthetics, medical dermatology, and neuroscience and urology products."
,,,A Closer Look at Allergan’s US Specialized Therapeutics,2017-09-26 11:39:34 +0000,http://finance.yahoo.com/r/248b8512-e306-3c8b-a0f4-2dc12948e29c/a-closer-look-at-allergans-us-specialized-therapeutics?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan’s US Specialized Therapeutics segment includes eye care, medical aesthetics, medical dermatology, and neuroscience and urology products."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",2017-09-26 10:52:10 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-j-j-105210392.html?.tsrc=rss,"Industry heavyweights like Johnson & Johnson (JNJ), Merck and Bristol-Myers were in the news related to regulatory updates."
,,,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",2017-09-26 10:52:10 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-j-j-105210392.html?.tsrc=rss,"Industry heavyweights like Johnson & Johnson (JNJ), Merck and Bristol-Myers were in the news related to regulatory updates."
,,,The maker of Botox has turned to the oldest trick in the book to save its cratering stock,2017-09-26 04:22:00 +0000,https://finance.yahoo.com/news/maker-botox-turned-oldest-trick-042200004.html?.tsrc=rss,"To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the..."
AGN,AGN:US,BBG000FH8PX5,The maker of Botox has turned to the oldest trick in the book to save its cratering stock,2017-09-26 04:22:00 +0000,https://finance.yahoo.com/news/maker-botox-turned-oldest-trick-042200004.html?.tsrc=rss,"To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the..."
,,,CTI BioPharma Appoints Laurent Fischer Chairman Of Board - Quick Facts,2017-09-26 01:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yPaVgjmlN7s/cti-biopharma-appoints-laurent-fischer-chairman-of-board--quick-facts-20170926-00035,CTI BioPharma Appoints Laurent Fischer Chairman Of Board - Quick Facts
AGN,AGN:US,BBG000FH8PX5,CTI BioPharma Appoints Laurent Fischer Chairman Of Board - Quick Facts,2017-09-26 01:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yPaVgjmlN7s/cti-biopharma-appoints-laurent-fischer-chairman-of-board--quick-facts-20170926-00035,CTI BioPharma Appoints Laurent Fischer Chairman Of Board - Quick Facts
,,,Tesla Inc (TSLA) Stock Has Topped Out and Needs a Recharge,2017-09-25 21:48:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4lyP5LiCe1w/tesla-inc-tsla-stock-has-topped-out-and-needs-a-recharge-cm850689,InvestorPlace Stock Market News Stock Advice amp Trading Tips After more than doubling in price since last December shares of 160 Tesla Inc NASDAQ TSLA have definitely encountered some serious difficulties recently TSLA stock broke out to new all time highs at 389 61 a
AGN,AGN:US,BBG000FH8PX5,Tesla Inc (TSLA) Stock Has Topped Out and Needs a Recharge,2017-09-25 21:48:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4lyP5LiCe1w/tesla-inc-tsla-stock-has-topped-out-and-needs-a-recharge-cm850689,InvestorPlace Stock Market News Stock Advice amp Trading Tips After more than doubling in price since last December shares of 160 Tesla Inc NASDAQ TSLA have definitely encountered some serious difficulties recently TSLA stock broke out to new all time highs at 389 61 a
AGN,AGN:US,BBG000FH8PX5,STOCKS SLIP: Here's what you need to know,2017-09-25 20:00:53 +0000,https://finance.yahoo.com/news/stocks-slip-heres-know-200053121.html?.tsrc=rss,All three major US stock indexes fell in trading on Monday as a number of geopolitical events...
,,,STOCKS SLIP: Here's what you need to know,2017-09-25 20:00:53 +0000,https://finance.yahoo.com/news/stocks-slip-heres-know-200053121.html?.tsrc=rss,All three major US stock indexes fell in trading on Monday as a number of geopolitical events...
,,,Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!,2017-09-25 19:47:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vTtSs71XLCQ/buy-allergan-plc-ordinary-shares-agn-stock-and-dont-look-back-cm850624,InvestorPlace Stock Market News Stock Advice amp Trading Tips Wall Street has been confused about the prospects of the pharmaceutical industry for almost two years The 2016 U S presidential campaign and election results wreaked havoc with their stocks First investors
AGN,AGN:US,BBG000FH8PX5,Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!,2017-09-25 19:47:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vTtSs71XLCQ/buy-allergan-plc-ordinary-shares-agn-stock-and-dont-look-back-cm850624,InvestorPlace Stock Market News Stock Advice amp Trading Tips Wall Street has been confused about the prospects of the pharmaceutical industry for almost two years The 2016 U S presidential campaign and election results wreaked havoc with their stocks First investors
AGN,AGN:US,BBG000FH8PX5,The Apple Inc. (AAPL) Stock Selloff Is Ripe for a Reversal,2017-09-25 19:47:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uhjL-bGvHEg/the-apple-inc-aapl-stock-selloff-is-ripe-for-a-reversal-cm850618,InvestorPlace Stock Market News Stock Advice amp Trading Tips The losses are mounting for Apple Inc NASDAQ AAPL shares With Friday s drop AAPL has now shed 8 this month making it one of the worst performing big cap tech stocks But with technical support levels looming
,,,The Apple Inc. (AAPL) Stock Selloff Is Ripe for a Reversal,2017-09-25 19:47:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uhjL-bGvHEg/the-apple-inc-aapl-stock-selloff-is-ripe-for-a-reversal-cm850618,InvestorPlace Stock Market News Stock Advice amp Trading Tips The losses are mounting for Apple Inc NASDAQ AAPL shares With Friday s drop AAPL has now shed 8 this month making it one of the worst performing big cap tech stocks But with technical support levels looming
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Monday Option Activity: AGN, SWKS, AVGO",2017-09-25 18:48:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6mTiNZJ-5J8/noteworthy-monday-option-activity-agn-swks-avgo-cm850558,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Allergan PLC Symbol AGN where a total of 13 410 contracts have traded so far representing approximately 1 3 million underlying shares That amounts to about 50 3 of AGN s
,,,"Noteworthy Monday Option Activity: AGN, SWKS, AVGO",2017-09-25 18:48:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6mTiNZJ-5J8/noteworthy-monday-option-activity-agn-swks-avgo-cm850558,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Allergan PLC Symbol AGN where a total of 13 410 contracts have traded so far representing approximately 1 3 million underlying shares That amounts to about 50 3 of AGN s
,,,General Motors among IQ100 leaders,2017-09-25 17:36:00 +0000,https://finance.yahoo.com/video/general-motors-among-iq100-leaders-173600806.html?.tsrc=rss,"The CNBC iq100 index, leading the broader market over one year up 22 percent. Today's leaders include Nabors industries, Allergan, General Motors, Level 3 Communications and Garmin."
AGN,AGN:US,BBG000FH8PX5,General Motors among IQ100 leaders,2017-09-25 17:36:00 +0000,https://finance.yahoo.com/video/general-motors-among-iq100-leaders-173600806.html?.tsrc=rss,"The CNBC iq100 index, leading the broader market over one year up 22 percent. Today's leaders include Nabors industries, Allergan, General Motors, Level 3 Communications and Garmin."
,,,"Allergan's (AGN) Vraylar Gets RTF From FDA, New Data for CVC",2017-09-25 16:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCqPe-4kfIo/allergans-agn-vraylar-gets-rtf-from-fda-new-data-for-cvc-cm850439,Allergan plc AGN announced that the FDA has issued a refusal to file RTF letter to its supplemental New Drug Application sNDA for Vraylar cariprazine The company is looking to get Vraylar s label expanded to include new data which supports the drug s use as a maintenance
AGN,AGN:US,BBG000FH8PX5,"Allergan's (AGN) Vraylar Gets RTF From FDA, New Data for CVC",2017-09-25 16:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCqPe-4kfIo/allergans-agn-vraylar-gets-rtf-from-fda-new-data-for-cvc-cm850439,Allergan plc AGN announced that the FDA has issued a refusal to file RTF letter to its supplemental New Drug Application sNDA for Vraylar cariprazine The company is looking to get Vraylar s label expanded to include new data which supports the drug s use as a maintenance
AGN,AGN:US,BBG000FH8PX5,"Allergan 'Very Attractive' After Buybacks, Dividend Increase -Cramer Says",2017-09-25 16:27:00 +0000,http://finance.yahoo.com/r/09981d40-9eca-3938-a85a-9122170e579e/allergan-unveils-buyback-program-as-cfo-retires.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Dublin-based drug maker said its board has authorized a $2 billion share buyback program. In a separate announcement, Allergan said CFO Tessa Hilado plans to retire from the company."
,,,"Allergan 'Very Attractive' After Buybacks, Dividend Increase -Cramer Says",2017-09-25 16:27:00 +0000,http://finance.yahoo.com/r/09981d40-9eca-3938-a85a-9122170e579e/allergan-unveils-buyback-program-as-cfo-retires.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Dublin-based drug maker said its board has authorized a $2 billion share buyback program. In a separate announcement, Allergan said CFO Tessa Hilado plans to retire from the company."
AGN,AGN:US,BBG000FH8PX5,The maker of Botox has turned to the oldest trick in the book to save its cratering stock,2017-09-25 15:53:00 +0000,https://finance.yahoo.com/news/maker-botox-turned-oldest-trick-155300583.html?.tsrc=rss,"To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the..."
,,,The maker of Botox has turned to the oldest trick in the book to save its cratering stock,2017-09-25 15:53:00 +0000,https://finance.yahoo.com/news/maker-botox-turned-oldest-trick-155300583.html?.tsrc=rss,"To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the..."
AGN,AGN:US,BBG000FH8PX5,Why Allergan is Jumping,2017-09-25 15:42:00 +0000,http://finance.yahoo.com/r/7cdc91da-aa59-384c-a75b-cb02c1cf8e01/why-allergan-is-jumping-1506354153?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Often enough, the departure of a company's chief financial officer is seen as bad news by investors.  Why is Allergan gaining when companies like Red Hat (RHT) and Shire (SHPG) have dropped after similar announcements?  Chalk it up to Allergan's announcement that it would use its free cash flow to buy back stock instead of on acquisitions, as well as pay down debt and increase the dividend."
,,,Why Allergan is Jumping,2017-09-25 15:42:00 +0000,http://finance.yahoo.com/r/7cdc91da-aa59-384c-a75b-cb02c1cf8e01/why-allergan-is-jumping-1506354153?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Often enough, the departure of a company's chief financial officer is seen as bad news by investors.  Why is Allergan gaining when companies like Red Hat (RHT) and Shire (SHPG) have dropped after similar announcements?  Chalk it up to Allergan's announcement that it would use its free cash flow to buy back stock instead of on acquisitions, as well as pay down debt and increase the dividend."
AGN,AGN:US,BBG000FH8PX5,Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!,2017-09-25 15:25:58 +0000,https://finance.yahoo.com/news/buy-allergan-plc-ordinary-shares-152558472.html?.tsrc=rss,"Wall Street has been confused about the prospects of the pharmaceutical industry for almost two years.  The 2016 U.S. presidential campaign and election results wreaked havoc with their stocks.  Allergan plc Ordinary Shares (NYSE:AGN) stock, in general, follows a trend on the industry from the stock price perspective."
,,,Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!,2017-09-25 15:25:58 +0000,https://finance.yahoo.com/news/buy-allergan-plc-ordinary-shares-152558472.html?.tsrc=rss,"Wall Street has been confused about the prospects of the pharmaceutical industry for almost two years.  The 2016 U.S. presidential campaign and election results wreaked havoc with their stocks.  Allergan plc Ordinary Shares (NYSE:AGN) stock, in general, follows a trend on the industry from the stock price perspective."
AGN,AGN:US,BBG000FH8PX5,Allergan boosts shares with $2 billion buyback,2017-09-25 15:03:13 +0000,https://finance.yahoo.com/news/allergan-boosts-shares-2-billion-125542070.html?.tsrc=rss,"Allergan shares have fallen by around a fifth in value since late July but were up nearly 4 percent in morning trading on Monday.  The company also said its Chief Financial Officer Tessa Hilado, 53, would retire.  The planned stock buyback follows Allergan's completion of a separate $15 billion repurchase, and after the company reported mixed trial data for its experimental treatment of NASH liver fibrosis."
,,,Allergan boosts shares with $2 billion buyback,2017-09-25 15:03:13 +0000,https://finance.yahoo.com/news/allergan-boosts-shares-2-billion-125542070.html?.tsrc=rss,"Allergan shares have fallen by around a fifth in value since late July but were up nearly 4 percent in morning trading on Monday.  The company also said its Chief Financial Officer Tessa Hilado, 53, would retire.  The planned stock buyback follows Allergan's completion of a separate $15 billion repurchase, and after the company reported mixed trial data for its experimental treatment of NASH liver fibrosis."
AGN,AGN:US,BBG000FH8PX5,"Allergan&apos;s (AGN) Vraylar Gets RTF From FDA, New Data for CVC",2017-09-25 14:55:02 +0000,https://finance.yahoo.com/news/allergan-apos-agn-vraylar-gets-145502816.html?.tsrc=rss,The FDA slaps a refusal-to-file letter on Allergan&apos;s (AGN) Vraylar for its supplemental New Drug Application. The company tries to expand the drug???s label for its use as a maintenance treatment.
,,,"Allergan&apos;s (AGN) Vraylar Gets RTF From FDA, New Data for CVC",2017-09-25 14:55:02 +0000,https://finance.yahoo.com/news/allergan-apos-agn-vraylar-gets-145502816.html?.tsrc=rss,The FDA slaps a refusal-to-file letter on Allergan&apos;s (AGN) Vraylar for its supplemental New Drug Application. The company tries to expand the drug???s label for its use as a maintenance treatment.
AGN,AGN:US,BBG000FH8PX5,"[$$] Allergan CFO to Retire, Drugmaker Plans $2 Billion Stock Buyback",2017-09-25 14:40:31 +0000,http://finance.yahoo.com/r/e7340943-f596-34a2-8049-c8658283c27c/allergan-cfo-to-retire-drugmaker-plans-2-billion-stock-buyback-1506346966?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Allergan said Chief Financial Officer Tessa Hilado plans to retire but will stay on the job until her replacement is hired. The company also authorized a $2 billion share repurchase and announced plans ...
,,,"[$$] Allergan CFO to Retire, Drugmaker Plans $2 Billion Stock Buyback",2017-09-25 14:40:31 +0000,http://finance.yahoo.com/r/e7340943-f596-34a2-8049-c8658283c27c/allergan-cfo-to-retire-drugmaker-plans-2-billion-stock-buyback-1506346966?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Allergan said Chief Financial Officer Tessa Hilado plans to retire but will stay on the job until her replacement is hired. The company also authorized a $2 billion share repurchase and announced plans ...
,,,Inside Allergan’s 2Q17 Performance by Business Segment,2017-09-25 14:39:41 +0000,http://finance.yahoo.com/r/24851505-e2fc-302f-a533-0d47da3c5211/inside-allergans-2q17-performance-by-business-segment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's US Specialized Therapeutics segment reported a ~15% rise in revenues to $1.7 billion in 2Q17, compared with $1.49 billion in 2Q16."
AGN,AGN:US,BBG000FH8PX5,Inside Allergan’s 2Q17 Performance by Business Segment,2017-09-25 14:39:41 +0000,http://finance.yahoo.com/r/24851505-e2fc-302f-a533-0d47da3c5211/inside-allergans-2q17-performance-by-business-segment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's US Specialized Therapeutics segment reported a ~15% rise in revenues to $1.7 billion in 2Q17, compared with $1.49 billion in 2Q16."
AGN,AGN:US,BBG000FH8PX5,Assessing Allergan’s Quarterly Revenues,2017-09-25 13:11:38 +0000,http://finance.yahoo.com/r/a6a459ae-ba0a-35b4-a13e-0fe9c376a205/assessing-allergans-quarterly-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan reported revenues of $4.01 billion for 2Q17—an 8.8% rise over 2Q16, driven by the strong performance of key brands in specialized therapeutics."
,,,Assessing Allergan’s Quarterly Revenues,2017-09-25 13:11:38 +0000,http://finance.yahoo.com/r/a6a459ae-ba0a-35b4-a13e-0fe9c376a205/assessing-allergans-quarterly-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan reported revenues of $4.01 billion for 2Q17—an 8.8% rise over 2Q16, driven by the strong performance of key brands in specialized therapeutics."
AGN,AGN:US,BBG000FH8PX5,A Narrower Win for Merkel and Ever-Present North Korea Threat Pressures Markets,2017-09-25 12:30:00 +0000,http://finance.yahoo.com/r/7d73fdef-105a-3c31-892c-27784550e3db/a-narrower-win-for-merkel-and-ever-present-north-korea-threat-pressure-markets.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stock futures are lower. Here's where stocks are trading ahead of the market open on Monday.
,,,A Narrower Win for Merkel and Ever-Present North Korea Threat Pressures Markets,2017-09-25 12:30:00 +0000,http://finance.yahoo.com/r/7d73fdef-105a-3c31-892c-27784550e3db/a-narrower-win-for-merkel-and-ever-present-north-korea-threat-pressure-markets.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stock futures are lower. Here's where stocks are trading ahead of the market open on Monday.
AGN,AGN:US,BBG000FH8PX5,Allergan CFO to retire after successor is found,2017-09-25 12:19:06 +0000,http://finance.yahoo.com/r/0a8bbe1b-f5f4-33d3-ac67-79c5b8caefa2/Story.aspx?guid=A5005025-F42C-4346-BFB6-4C5FDD1F29C5&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Monday that Chief Financial Officer Tessa Hilado will retire, effective when a successor is named. Hilado joined Allergan in December 2014. ""When I joined Allergan in December 2014, ..."
,,,Allergan CFO to retire after successor is found,2017-09-25 12:19:06 +0000,http://finance.yahoo.com/r/0a8bbe1b-f5f4-33d3-ac67-79c5b8caefa2/Story.aspx?guid=A5005025-F42C-4346-BFB6-4C5FDD1F29C5&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Monday that Chief Financial Officer Tessa Hilado will retire, effective when a successor is named. Hilado joined Allergan in December 2014. ""When I joined Allergan in December 2014, ..."
AGN,AGN:US,BBG000FH8PX5,Allergan sets new $2 billion program to buy back 'undervalued' shares,2017-09-25 11:54:33 +0000,http://finance.yahoo.com/r/eb46c916-8b7a-3b5d-8faa-04df1f210645/Story.aspx?guid=789F1E32-326D-4529-8199-79CE1CE7C019&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Monday it has authorized a new $2 billion stock repurchase program, saying it believes its shares are ""substantially undervalued."" Based on Friday's stock closing price of $204.65, ..."
,,,Allergan sets new $2 billion program to buy back 'undervalued' shares,2017-09-25 11:54:33 +0000,http://finance.yahoo.com/r/eb46c916-8b7a-3b5d-8faa-04df1f210645/Story.aspx?guid=789F1E32-326D-4529-8199-79CE1CE7C019&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said Monday it has authorized a new $2 billion stock repurchase program, saying it believes its shares are ""substantially undervalued."" Based on Friday's stock closing price of $204.65, ..."
,,,Allergan sets $2 bln share buyback; CFO to retire,2017-09-25 11:48:03 +0000,https://finance.yahoo.com/news/allergan-sets-2-bln-share-114803866.html?.tsrc=rss,U.S. drugmaker Allergan Plc on Monday authorized a $2 billion buyback of its shares and said its Chief Financial Officer Tessa Hilado would retire. Allergan said it had begun the search for a new finance ...
AGN,AGN:US,BBG000FH8PX5,Allergan sets $2 bln share buyback; CFO to retire,2017-09-25 11:48:03 +0000,https://finance.yahoo.com/news/allergan-sets-2-bln-share-114803866.html?.tsrc=rss,U.S. drugmaker Allergan Plc on Monday authorized a $2 billion buyback of its shares and said its Chief Financial Officer Tessa Hilado would retire. Allergan said it had begun the search for a new finance ...
,,,Behind Allergan’s Developments after 2Q17,2017-09-25 11:41:54 +0000,http://finance.yahoo.com/r/b5510f91-a92c-3717-a2a3-6ab77edc01f7/behind-allergans-developments-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 19, 2017, Allergan’s Allure received three 2017 Best of the Beauty Breakthrough awards."
AGN,AGN:US,BBG000FH8PX5,Behind Allergan’s Developments after 2Q17,2017-09-25 11:41:54 +0000,http://finance.yahoo.com/r/b5510f91-a92c-3717-a2a3-6ab77edc01f7/behind-allergans-developments-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 19, 2017, Allergan’s Allure received three 2017 Best of the Beauty Breakthrough awards."
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company",2017-09-25 11:35:00 +0000,https://finance.yahoo.com/news/allergan-announces-tessa-hilado-executive-113500396.html?.tsrc=rss,"DUBLIN, Ireland, Sept. 25, 2017 Allergan plc (AGN) a leading global biopharmaceutical company, today announced that Tessa Hilado, Executive Vice President and Chief Financial Officer, has decided to retire from Allergan.  ""When I joined Allergan in December 2014, I promised Brent Saunders, Chairman and CEO, that I would stay three years to help transform the finance organization, institute better systems and financial controls and improve the balance sheet,"" said Hilado.  ""I am proud of the improvements we have made in each of these areas and the talent that we have attracted to our finance organization over that time, including new leaders for Commercial Finance, Tax, Research & Development Finance and Investor Relations & Strategy."
,,,"Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company",2017-09-25 11:35:00 +0000,https://finance.yahoo.com/news/allergan-announces-tessa-hilado-executive-113500396.html?.tsrc=rss,"DUBLIN, Ireland, Sept. 25, 2017 Allergan plc (AGN) a leading global biopharmaceutical company, today announced that Tessa Hilado, Executive Vice President and Chief Financial Officer, has decided to retire from Allergan.  ""When I joined Allergan in December 2014, I promised Brent Saunders, Chairman and CEO, that I would stay three years to help transform the finance organization, institute better systems and financial controls and improve the balance sheet,"" said Hilado.  ""I am proud of the improvements we have made in each of these areas and the talent that we have attracted to our finance organization over that time, including new leaders for Commercial Finance, Tax, Research & Development Finance and Investor Relations & Strategy."
AGN,AGN:US,BBG000FH8PX5,"Allergan Board of Directors Authorizes New $2 Billion Share Repurchase Program, Affirms Commitment to Increasing Cash Dividend Annually",2017-09-25 11:30:00 +0000,https://finance.yahoo.com/news/allergan-board-directors-authorizes-2-113000497.html?.tsrc=rss,"- Company Reaffirms 2017 Full-Year Guidance, Including Affirming Third Quarter Revenue Guidance - - Affirms Commitment to Investment Grade Credit Ratings and Debt Pay Down Strategy - DUBLIN, Ireland , ..."
,,,"Allergan Board of Directors Authorizes New $2 Billion Share Repurchase Program, Affirms Commitment to Increasing Cash Dividend Annually",2017-09-25 11:30:00 +0000,https://finance.yahoo.com/news/allergan-board-directors-authorizes-2-113000497.html?.tsrc=rss,"- Company Reaffirms 2017 Full-Year Guidance, Including Affirming Third Quarter Revenue Guidance - - Affirms Commitment to Investment Grade Credit Ratings and Debt Pay Down Strategy - DUBLIN, Ireland , ..."
,,,Allergan EVP And CFO Tessa Hilado Decides To Retire - Quick Facts,2017-09-25 07:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qETc8eNtbwA/allergan-evp-and-cfo-tessa-hilado-decides-to-retire--quick-facts-20170925-00392,Allergan EVP And CFO Tessa Hilado Decides To Retire - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Allergan EVP And CFO Tessa Hilado Decides To Retire - Quick Facts,2017-09-25 07:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qETc8eNtbwA/allergan-evp-and-cfo-tessa-hilado-decides-to-retire--quick-facts-20170925-00392,Allergan EVP And CFO Tessa Hilado Decides To Retire - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Allergan Board Authorizes $2 Bln Share Buyback; Reaffirms 2017 Guidance,2017-09-25 07:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gcZrX3k1xhE/allergan-board-authorizes-2-bln-share-buyback-reaffirms-2017-guidance-20170925-00385,Allergan Board Authorizes $2 Bln Share Buyback; Reaffirms 2017 Guidance
,,,Allergan Board Authorizes $2 Bln Share Buyback; Reaffirms 2017 Guidance,2017-09-25 07:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gcZrX3k1xhE/allergan-board-authorizes-2-bln-share-buyback-reaffirms-2017-guidance-20170925-00385,Allergan Board Authorizes $2 Bln Share Buyback; Reaffirms 2017 Guidance
,,,"Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes",2017-09-24 22:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6nJFlMBC3uc/opdivo-keytruda-back-in-the-news-fda-snubs-agn-ears-catches-eyes-20170924-00100,"Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes"
AGN,AGN:US,BBG000FH8PX5,"Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes",2017-09-24 22:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6nJFlMBC3uc/opdivo-keytruda-back-in-the-news-fda-snubs-agn-ears-catches-eyes-20170924-00100,"Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes"
AGN,AGN:US,BBG000FH8PX5,Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia,2017-09-22 20:49:00 +0000,https://finance.yahoo.com/news/allergan-receives-refusal-file-letter-204900293.html?.tsrc=rss,"DUBLIN, Sept. 22, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for Vraylar (cariprazine) for treatment of negative symptoms associated with schizophrenia in adult patients.  VRAYLAR is an oral, once daily atypical antipsychotic approved in the United States for the treatment of schizophrenia and the acute treatment of adult patients with manic or mixed episodes associated with bipolar I disorder."
,,,Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia,2017-09-22 20:49:00 +0000,https://finance.yahoo.com/news/allergan-receives-refusal-file-letter-204900293.html?.tsrc=rss,"DUBLIN, Sept. 22, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for Vraylar (cariprazine) for treatment of negative symptoms associated with schizophrenia in adult patients.  VRAYLAR is an oral, once daily atypical antipsychotic approved in the United States for the treatment of schizophrenia and the acute treatment of adult patients with manic or mixed episodes associated with bipolar I disorder."
AGN,AGN:US,BBG000FH8PX5,Why Allergan&apos;s Hepatitis Drug Likely Won&apos;t Get FDA Approval,2017-09-22 20:38:48 +0000,http://finance.yahoo.com/r/02b2a6a8-7320-33cb-a930-9ae131419216/why-allergans-hepatitis-drug-likely-wont-get-fda-approval?src=A00220&yptr=yahoo&.tsrc=rss,Allergan is advancing a nonalcoholic steatohepatitis drug into Phase 3 testing that likely won&apos;t get FDA approval.
,,,Why Allergan&apos;s Hepatitis Drug Likely Won&apos;t Get FDA Approval,2017-09-22 20:38:48 +0000,http://finance.yahoo.com/r/02b2a6a8-7320-33cb-a930-9ae131419216/why-allergans-hepatitis-drug-likely-wont-get-fda-approval?src=A00220&yptr=yahoo&.tsrc=rss,Allergan is advancing a nonalcoholic steatohepatitis drug into Phase 3 testing that likely won&apos;t get FDA approval.
,,,Native American tribe moves to dismiss Allergan patent case,2017-09-22 19:04:18 +0000,https://finance.yahoo.com/news/native-american-tribe-moves-dismiss-190418757.html?.tsrc=rss,"In a filing to the U.S. Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds that the board has no jurisdiction over the tribe.  The move was expected after Allergan announced on Sept. 8 that it had transferred Restasis patents to the tribe in order to protect them from administrative challenges."
AGN,AGN:US,BBG000FH8PX5,Native American tribe moves to dismiss Allergan patent case,2017-09-22 19:04:18 +0000,https://finance.yahoo.com/news/native-american-tribe-moves-dismiss-190418757.html?.tsrc=rss,"In a filing to the U.S. Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds that the board has no jurisdiction over the tribe.  The move was expected after Allergan announced on Sept. 8 that it had transferred Restasis patents to the tribe in order to protect them from administrative challenges."
,,,Allergan Needs to Learn to Let Go,2017-09-22 16:01:18 +0000,http://finance.yahoo.com/r/37962f36-82c1-34bc-8ce2-bf92ab940182/allergan-cenicriviroc-data-time-to-let-it-go?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pressing ahead after mixed data is usually a recipe for failure.
AGN,AGN:US,BBG000FH8PX5,Allergan Needs to Learn to Let Go,2017-09-22 16:01:18 +0000,http://finance.yahoo.com/r/37962f36-82c1-34bc-8ce2-bf92ab940182/allergan-cenicriviroc-data-time-to-let-it-go?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pressing ahead after mixed data is usually a recipe for failure.
,,,New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial,2017-09-22 12:00:00 +0000,https://finance.yahoo.com/news/data-centaur-phase-2b-clinical-120000624.html?.tsrc=rss,"DUBLIN, Sept. 22, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver fibrosis in adults with NASH.  One year data from the CENTAUR trial was released in 2016."
AGN,AGN:US,BBG000FH8PX5,New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial,2017-09-22 12:00:00 +0000,https://finance.yahoo.com/news/data-centaur-phase-2b-clinical-120000624.html?.tsrc=rss,"DUBLIN, Sept. 22, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver fibrosis in adults with NASH.  One year data from the CENTAUR trial was released in 2016."
AGN,AGN:US,BBG000FH8PX5,How is the Age-Related Macular Degeneration Space Faring Now?,2017-09-21 16:40:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zTtLy-KfdzM/how-is-the-age-related-macular-degeneration-space-faring-now-cm849094,The Age Related Macular Degeneration AMD space has been in the spotlight of late due to a number of developments Earlier in the month Swiss pharma company Roche Holdings AG RHHBY suffered a setback when its ophthalmology candidate lampalizumab failed to achieve the primary endpoint
,,,How is the Age-Related Macular Degeneration Space Faring Now?,2017-09-21 16:40:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zTtLy-KfdzM/how-is-the-age-related-macular-degeneration-space-faring-now-cm849094,The Age Related Macular Degeneration AMD space has been in the spotlight of late due to a number of developments Earlier in the month Swiss pharma company Roche Holdings AG RHHBY suffered a setback when its ophthalmology candidate lampalizumab failed to achieve the primary endpoint
AGN,AGN:US,BBG000FH8PX5,"S&P 500 Movers: NVDA, APC",2017-09-21 15:38:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8Dr5WxEUxY/sp-500-movers-nvda-apc-cm849021,In early trading on Thursday shares of Anadarko Petroleum Corp APC topped the list of the day s best performing components of the S amp P 500 index trading up 6 2 Year to date Anadarko Petroleum Corp has lost about 31 8 of its value And the worst performing S amp P 500
,,,"S&P 500 Movers: NVDA, APC",2017-09-21 15:38:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8Dr5WxEUxY/sp-500-movers-nvda-apc-cm849021,In early trading on Thursday shares of Anadarko Petroleum Corp APC topped the list of the day s best performing components of the S amp P 500 index trading up 6 2 Year to date Anadarko Petroleum Corp has lost about 31 8 of its value And the worst performing S amp P 500
AGN,AGN:US,BBG000FH8PX5,How Does Allergan plc (AGN) Affect Your Portfolio Returns?,2017-09-21 15:09:16 +0000,https://finance.yahoo.com/news/does-allergan-plc-agn-affect-150916183.html?.tsrc=rss,"If you are a shareholder in Allergan plc’s (NYSE:AGN), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolioRead More..."
,,,How Does Allergan plc (AGN) Affect Your Portfolio Returns?,2017-09-21 15:09:16 +0000,https://finance.yahoo.com/news/does-allergan-plc-agn-affect-150916183.html?.tsrc=rss,"If you are a shareholder in Allergan plc’s (NYSE:AGN), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolioRead More..."
AGN,AGN:US,BBG000FH8PX5,How is the Age-Related Macular Degeneration Space Faring Now?,2017-09-21 14:15:02 +0000,https://finance.yahoo.com/news/age-related-macular-degeneration-space-141502834.html?.tsrc=rss,The Age-Related Macular Degeneration (AMD) space has been in the spotlight of late due to a number of developments.
,,,How is the Age-Related Macular Degeneration Space Faring Now?,2017-09-21 14:15:02 +0000,https://finance.yahoo.com/news/age-related-macular-degeneration-space-141502834.html?.tsrc=rss,The Age-Related Macular Degeneration (AMD) space has been in the spotlight of late due to a number of developments.
,,,"John Paulson Buys Vistra Energy Corp, Altaba Inc, T-Mobile US Inc, Sells Extended Stay America ...",2017-09-21 12:34:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gnLVTaX7AA/john-paulson-buys-vistra-energy-corp-altaba-inc-t-mobile-us-inc-sells-extended-stay-america-cm848863,John Paulson New Purchases VST AABA VWR HZNP XCRA NEWR DOVA BCR TGNA CTRP Added Positions TMUS VRX DISH MON MBBYF TEAM RAI NXPI FDX ISRG Reduced Positions STAY TEVA SHPG AGN MYL ALXN MNK AIG RLGY STE Sold Out AKRX MJN
AGN,AGN:US,BBG000FH8PX5,"John Paulson Buys Vistra Energy Corp, Altaba Inc, T-Mobile US Inc, Sells Extended Stay America ...",2017-09-21 12:34:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gnLVTaX7AA/john-paulson-buys-vistra-energy-corp-altaba-inc-t-mobile-us-inc-sells-extended-stay-america-cm848863,John Paulson New Purchases VST AABA VWR HZNP XCRA NEWR DOVA BCR TGNA CTRP Added Positions TMUS VRX DISH MON MBBYF TEAM RAI NXPI FDX ISRG Reduced Positions STAY TEVA SHPG AGN MYL ALXN MNK AIG RLGY STE Sold Out AKRX MJN
,,,Allergan: Just How Far Will Big Pharma Go To Protect Its Patents?,2017-09-20 16:33:00 +0000,http://finance.yahoo.com/r/2768cb49-9da3-3184-a3a1-9fc9cab899e1/allergan-just-how-far-will-big-pharma-go-to-protect-its-patents-1505925225?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Specialty drug maker Allergan (AGN) raised more than a few eyebrows this month when news broke of the deal it made with the Saint Regis Mohawk Tribe of upstate New York to protect patents for one of its blockbuster drugs.  In fact, one of Wall Street biggest drug analysts cited the deal as one of three reasons it has downgraded Allergan’s stock and slashed its price target.  Allergan decided earlier this month to transfer ownership of the patents protecting the dry eye treatment Restasis, Allergan’s second biggest selling drug, to the tribe to prevent the scrutiny of the U.S. Patent & Trademark Office."
AGN,AGN:US,BBG000FH8PX5,Allergan: Just How Far Will Big Pharma Go To Protect Its Patents?,2017-09-20 16:33:00 +0000,http://finance.yahoo.com/r/2768cb49-9da3-3184-a3a1-9fc9cab899e1/allergan-just-how-far-will-big-pharma-go-to-protect-its-patents-1505925225?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Specialty drug maker Allergan (AGN) raised more than a few eyebrows this month when news broke of the deal it made with the Saint Regis Mohawk Tribe of upstate New York to protect patents for one of its blockbuster drugs.  In fact, one of Wall Street biggest drug analysts cited the deal as one of three reasons it has downgraded Allergan’s stock and slashed its price target.  Allergan decided earlier this month to transfer ownership of the patents protecting the dry eye treatment Restasis, Allergan’s second biggest selling drug, to the tribe to prevent the scrutiny of the U.S. Patent & Trademark Office."
AGN,AGN:US,BBG000FH8PX5,"Morning Movers: General Mills Slumps, Johnson & Johnson Slips, American Airlines Gains",2017-09-20 13:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_HUzVV1qEYM/morning-movers-general-mills-slumps-johnson-johnson-slips-american-airlines-gains-cm848257,Stocks look set to open relatively unchanged this morning ahead of today s Fed announcement which could mark the beginning of the end of quantitative easing Stocks look set to open relatively unchanged this morning ahead oftoday s Fed announcement which could mark the beginning of the end
,,,"Morning Movers: General Mills Slumps, Johnson & Johnson Slips, American Airlines Gains",2017-09-20 13:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_HUzVV1qEYM/morning-movers-general-mills-slumps-johnson-johnson-slips-american-airlines-gains-cm848257,Stocks look set to open relatively unchanged this morning ahead of today s Fed announcement which could mark the beginning of the end of quantitative easing Stocks look set to open relatively unchanged this morning ahead oftoday s Fed announcement which could mark the beginning of the end
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-20 12:04:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120427671.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-20 12:04:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120427671.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It,2017-09-20 08:00:00 +0000,http://finance.yahoo.com/r/9a8de936-d1bc-31cc-be7a-2d0a5104155d/apple-likes-the-patent-death-squad-allergan-pays-to-avoid-it?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Allergan Plc’s decision to pay a Native American tribe $15 million a year rather than let one of its blockbuster drugs be scrutinized by the U.S. Patent & Trademark Office is part of a backlash against an ...
,,,Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It,2017-09-20 08:00:00 +0000,http://finance.yahoo.com/r/9a8de936-d1bc-31cc-be7a-2d0a5104155d/apple-likes-the-patent-death-squad-allergan-pays-to-avoid-it?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Allergan Plc’s decision to pay a Native American tribe $15 million a year rather than let one of its blockbuster drugs be scrutinized by the U.S. Patent & Trademark Office is part of a backlash against an ...
AGN,AGN:US,BBG000FH8PX5,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-20 04:24:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
,,,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-20 04:24:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
,,,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-19 22:05:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
AGN,AGN:US,BBG000FH8PX5,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-19 22:05:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
AGN,AGN:US,BBG000FH8PX5,"States expand investigation of opioid makers, distributors",2017-09-19 18:55:22 +0000,http://finance.yahoo.com/r/e6a91d61-9e5f-39bd-a2cc-570f01c10ddb/states-expand-investigation-opioid-makers-160300201.html?.tsrc=rss,Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives.
,,,"States expand investigation of opioid makers, distributors",2017-09-19 18:55:22 +0000,http://finance.yahoo.com/r/e6a91d61-9e5f-39bd-a2cc-570f01c10ddb/states-expand-investigation-opioid-makers-160300201.html?.tsrc=rss,Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives.
,,,"States expand investigation of opioid makers, distributors",2017-09-19 18:55:16 +0000,https://finance.yahoo.com/news/states-expand-investigation-opioid-makers-160300201.html?.tsrc=rss,Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives. They announced Tuesday that they had ...
AGN,AGN:US,BBG000FH8PX5,"States expand investigation of opioid makers, distributors",2017-09-19 18:55:16 +0000,https://finance.yahoo.com/news/states-expand-investigation-opioid-makers-160300201.html?.tsrc=rss,Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives. They announced Tuesday that they had ...
AGN,AGN:US,BBG000FH8PX5,State attorneys general subpoena opioid makers and dealer...,2017-09-19 16:22:00 +0000,https://finance.yahoo.com/video/state-attorneys-general-subpoena-opioid-162200859.html?.tsrc=rss,CNBC's Sue Herera reports on the companies state Attornies General are subpoenaing for the opioid investigation.
,,,State attorneys general subpoena opioid makers and dealer...,2017-09-19 16:22:00 +0000,https://finance.yahoo.com/video/state-attorneys-general-subpoena-opioid-162200859.html?.tsrc=rss,CNBC's Sue Herera reports on the companies state Attornies General are subpoenaing for the opioid investigation.
AGN,AGN:US,BBG000FH8PX5,The only thing Trump is doing to end the opioid crisis rewards the companies that started it,2017-09-19 15:58:31 +0000,https://finance.yahoo.com/news/only-thing-trump-doing-end-155831496.html?.tsrc=rss,"A month after he said he would, President Donald Trump has yet to declare the opioid epidemic a..."
,,,The only thing Trump is doing to end the opioid crisis rewards the companies that started it,2017-09-19 15:58:31 +0000,https://finance.yahoo.com/news/only-thing-trump-doing-end-155831496.html?.tsrc=rss,"A month after he said he would, President Donald Trump has yet to declare the opioid epidemic a..."
,,,Should Value Investors Consider Allergan plc (AGN) Stock Now?,2017-09-19 15:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ciL4ili8PrU/should-value-investors-consider-allergan-plc-agn-stock-now-cm847743,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
AGN,AGN:US,BBG000FH8PX5,Should Value Investors Consider Allergan plc (AGN) Stock Now?,2017-09-19 15:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ciL4ili8PrU/should-value-investors-consider-allergan-plc-agn-stock-now-cm847743,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
AGN,AGN:US,BBG000FH8PX5,Should Value Investors Consider Allergan plc (AGN) Stock Now?,2017-09-19 13:35:01 +0000,https://finance.yahoo.com/news/value-investors-consider-allergan-plc-133501127.html?.tsrc=rss,Is Allergan (AGN) a great pick from the value investor&apos;s perspective right now? Read on to know more.
,,,Should Value Investors Consider Allergan plc (AGN) Stock Now?,2017-09-19 13:35:01 +0000,https://finance.yahoo.com/news/value-investors-consider-allergan-plc-133501127.html?.tsrc=rss,Is Allergan (AGN) a great pick from the value investor&apos;s perspective right now? Read on to know more.
,,,Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards,2017-09-19 11:35:00 +0000,https://finance.yahoo.com/news/allergan-innovation-recognized-three-2017-113500567.html?.tsrc=rss,"DUBLIN, Sept. 19, 2017 /PRNewswire/ -- For over 17 years, the highly-coveted Allure Best of Beauty Breakthrough Awards have recognized hair, makeup and skin products, fragrances and devices  for their innovative formulations, performance and technologies.  Today Allergan plc (AGN) is happy to announce that Allure has awarded the 2017 Best of Beauty Breakthrough Award to three of the company's products: JUVÉDERM VOLBELLA® XC, RHOFADE® (oxymetazoline HCl) cream 1%, and SkinMedica® Lytera 2.0 Pigment Correcting Serum.  JUVÉDERM VOLBELLA® XC was honored marking the second Allure Beauty Breakthrough award for the JUVÉDERM® collection of fillers (JUVÉDERM VOLUMA® XC won in 2014)."
AGN,AGN:US,BBG000FH8PX5,Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards,2017-09-19 11:35:00 +0000,https://finance.yahoo.com/news/allergan-innovation-recognized-three-2017-113500567.html?.tsrc=rss,"DUBLIN, Sept. 19, 2017 /PRNewswire/ -- For over 17 years, the highly-coveted Allure Best of Beauty Breakthrough Awards have recognized hair, makeup and skin products, fragrances and devices  for their innovative formulations, performance and technologies.  Today Allergan plc (AGN) is happy to announce that Allure has awarded the 2017 Best of Beauty Breakthrough Award to three of the company's products: JUVÉDERM VOLBELLA® XC, RHOFADE® (oxymetazoline HCl) cream 1%, and SkinMedica® Lytera 2.0 Pigment Correcting Serum.  JUVÉDERM VOLBELLA® XC was honored marking the second Allure Beauty Breakthrough award for the JUVÉDERM® collection of fillers (JUVÉDERM VOLUMA® XC won in 2014)."
AGN,AGN:US,BBG000FH8PX5,AMD leading IQ100 top gainers,2017-09-18 17:58:00 +0000,https://finance.yahoo.com/video/amd-leading-iq100-top-gainers-175800913.html?.tsrc=rss,"The CNBC IQ100 index, beating the broader market over one year up 24 percent. Among today's top gainers AMD, Allergan, Micron, Applied Materials and Nabors Industries."
,,,AMD leading IQ100 top gainers,2017-09-18 17:58:00 +0000,https://finance.yahoo.com/video/amd-leading-iq100-top-gainers-175800913.html?.tsrc=rss,"The CNBC IQ100 index, beating the broader market over one year up 24 percent. Among today's top gainers AMD, Allergan, Micron, Applied Materials and Nabors Industries."
AGN,AGN:US,BBG000FH8PX5,Why Allergan Could Be A $300 Stock,2017-09-18 16:37:00 +0000,http://finance.yahoo.com/r/6d88979d-42fa-3467-845b-4b3058505b60/why-allergan-could-be-a-300-stock-1505752669?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Allergan (AGN) are rising today after J.P. Morgan analyst Chris Schott said the drug maker’s stock could climb more than 30% in the next year.  Allergan’s share price has fallen more than 12% since it hit a 52-week high of $256.80 in late July.  Overall, we believe several controversies (most notably the timing of generic Restasis competition) have taken focus away from a highly attractive core franchise at Allergan and as we look out to 2018, we see an increasingly compelling setup for AGN shares with both pipeline optionality and a strong SOTP valuation argument."
,,,Why Allergan Could Be A $300 Stock,2017-09-18 16:37:00 +0000,http://finance.yahoo.com/r/6d88979d-42fa-3467-845b-4b3058505b60/why-allergan-could-be-a-300-stock-1505752669?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Allergan (AGN) are rising today after J.P. Morgan analyst Chris Schott said the drug maker’s stock could climb more than 30% in the next year.  Allergan’s share price has fallen more than 12% since it hit a 52-week high of $256.80 in late July.  Overall, we believe several controversies (most notably the timing of generic Restasis competition) have taken focus away from a highly attractive core franchise at Allergan and as we look out to 2018, we see an increasingly compelling setup for AGN shares with both pipeline optionality and a strong SOTP valuation argument."
AGN,AGN:US,BBG000FH8PX5,8 Stocks Billionaires Own,2017-09-16 12:35:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lMkkO5EOHDs/8-stocks-billionaires-own-cm846683,Rummage through the holdings of billionaire investors and you re likely to find similar stocks occupying their portfolios With so much money to invest they can t take a meaningful position in a small business because they d end up owning the whole thing outright so their
,,,8 Stocks Billionaires Own,2017-09-16 12:35:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lMkkO5EOHDs/8-stocks-billionaires-own-cm846683,Rummage through the holdings of billionaire investors and you re likely to find similar stocks occupying their portfolios With so much money to invest they can t take a meaningful position in a small business because they d end up owning the whole thing outright so their
,,,Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle,2017-09-16 11:27:00 +0000,https://finance.yahoo.com/news/video-allergans-restasis-patent-transfer-112700869.html?.tsrc=rss,"Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack."
AGN,AGN:US,BBG000FH8PX5,Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle,2017-09-16 11:27:00 +0000,https://finance.yahoo.com/news/video-allergans-restasis-patent-transfer-112700869.html?.tsrc=rss,"Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack."
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Friday Option Activity: VHC, VLO, AGN",2017-09-15 20:37:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a-G7MI7aZZg/noteworthy-friday-option-activity-vhc-vlo-agn-cm846520,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in VirnetX Holding Corp Symbol VHC where a total of 1 075 contracts have traded so far representing approximately 107 500 underlying shares That amounts to about 51 4 of VHC s
,,,"Noteworthy Friday Option Activity: VHC, VLO, AGN",2017-09-15 20:37:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a-G7MI7aZZg/noteworthy-friday-option-activity-vhc-vlo-agn-cm846520,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in VirnetX Holding Corp Symbol VHC where a total of 1 075 contracts have traded so far representing approximately 107 500 underlying shares That amounts to about 51 4 of VHC s
,,,U.S. senator slams Allergan patent deal with Native-American tribe,2017-09-15 17:56:58 +0000,https://finance.yahoo.com/news/u-senator-slams-allergan-patent-162352398.html?.tsrc=rss,"Brown's staff has requested a meeting with Allergan  representatives to press them about the transaction.  Allergan said on Sept. 8 it will transfer patents relating  to its dry-eye medicine Restasis to the Saint Regis Mohawk  Tribe, which will exclusively license them back to the company  in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,U.S. senator slams Allergan patent deal with Native-American tribe,2017-09-15 17:56:58 +0000,https://finance.yahoo.com/news/u-senator-slams-allergan-patent-162352398.html?.tsrc=rss,"Brown's staff has requested a meeting with Allergan  representatives to press them about the transaction.  Allergan said on Sept. 8 it will transfer patents relating  to its dry-eye medicine Restasis to the Saint Regis Mohawk  Tribe, which will exclusively license them back to the company  in exchange for ongoing payments."
,,,Amgen/Allergan's Avastin Biosimilar Secures FDA Approval,2017-09-15 16:39:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-pZR7gePil4/amgenallergans-avastin-biosimilar-secures-fda-approval-cm846368,Amgen AMGN and partner Allergan AGN announced that the FDA approved their biosimilar version of Roche s RHHBY cancer drug Avastin bevacizumab for treatment of five types of cancers including lung cancer colorectal cancer glioblastoma renal cell carcinoma and cervix cancer The
AGN,AGN:US,BBG000FH8PX5,Amgen/Allergan's Avastin Biosimilar Secures FDA Approval,2017-09-15 16:39:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-pZR7gePil4/amgenallergans-avastin-biosimilar-secures-fda-approval-cm846368,Amgen AMGN and partner Allergan AGN announced that the FDA approved their biosimilar version of Roche s RHHBY cancer drug Avastin bevacizumab for treatment of five types of cancers including lung cancer colorectal cancer glioblastoma renal cell carcinoma and cervix cancer The
AGN,AGN:US,BBG000FH8PX5,U.S. senator slams Allergan tribal patent deal,2017-09-15 15:42:26 +0000,https://finance.yahoo.com/news/u-senator-slams-allergan-tribal-154226052.html?.tsrc=rss,"U.S. Senator Sherrod Brown said on Friday a deal Allergan Plc made with a Native American tribe to shield its patents ""rips off consumers"" and cannot ""become the new normal."" The Ohio ..."
,,,U.S. senator slams Allergan tribal patent deal,2017-09-15 15:42:26 +0000,https://finance.yahoo.com/news/u-senator-slams-allergan-tribal-154226052.html?.tsrc=rss,"U.S. Senator Sherrod Brown said on Friday a deal Allergan Plc made with a Native American tribe to shield its patents ""rips off consumers"" and cannot ""become the new normal."" The Ohio ..."
AGN,AGN:US,BBG000FH8PX5,Amgen/Allergan&apos;s Avastin Biosimilar Secures FDA Approval,2017-09-15 14:33:02 +0000,https://finance.yahoo.com/news/amgen-allergan-apos-avastin-biosimilar-143302566.html?.tsrc=rss,"The FDA approves Amgen-Allergan&apos;s biosimilar version of Roche&apos;s Avastin for treating multiple types of cancers, to be marketed by the trade name of Mvasi."
,,,Amgen/Allergan&apos;s Avastin Biosimilar Secures FDA Approval,2017-09-15 14:33:02 +0000,https://finance.yahoo.com/news/amgen-allergan-apos-avastin-biosimilar-143302566.html?.tsrc=rss,"The FDA approves Amgen-Allergan&apos;s biosimilar version of Roche&apos;s Avastin for treating multiple types of cancers, to be marketed by the trade name of Mvasi."
,,,"Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO",2017-09-15 12:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nEtZLBtU3oM/pharma-stock-roundup-achillion-slumps-on-end-of-hcv-deal-teva-gets-a-new-ceo-cm846148,Several important developments were reported this week with key highlights including the termination of a hepatitis C virus deal the approval of the first cancer biosimilar in the United States and the presentation of data by companies like Pfizer PFE and Bristol Myers Squibb BMY among
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO",2017-09-15 12:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nEtZLBtU3oM/pharma-stock-roundup-achillion-slumps-on-end-of-hcv-deal-teva-gets-a-new-ceo-cm846148,Several important developments were reported this week with key highlights including the termination of a hepatitis C virus deal the approval of the first cancer biosimilar in the United States and the presentation of data by companies like Pfizer PFE and Bristol Myers Squibb BMY among
AGN,AGN:US,BBG000FH8PX5,3 Dividend Healthcare Stocks,2017-09-15 11:37:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KORQk9TYSJY/3-dividend-healthcare-stocks-cm846127,One great reason to consider buying healthcare stocks is that demand for their products tends to remain stable in good times and bad After all no one gets to choose when they get sick That makes the healthcare sector a great place to hunt for income ideas So which
,,,3 Dividend Healthcare Stocks,2017-09-15 11:37:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KORQk9TYSJY/3-dividend-healthcare-stocks-cm846127,One great reason to consider buying healthcare stocks is that demand for their products tends to remain stable in good times and bad After all no one gets to choose when they get sick That makes the healthcare sector a great place to hunt for income ideas So which
AGN,AGN:US,BBG000FH8PX5,3 Dividend Healthcare Stocks,2017-09-15 10:00:00 +0000,http://finance.yahoo.com/r/f28366d7-8655-3016-b9c1-9433d5c91bf5/3-dividend-healthcare-stocks.aspx?yptr=yahoo&.tsrc=rss,"Looking for income from the healthcare sector? Here&apos;s why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular."
,,,3 Dividend Healthcare Stocks,2017-09-15 10:00:00 +0000,http://finance.yahoo.com/r/f28366d7-8655-3016-b9c1-9433d5c91bf5/3-dividend-healthcare-stocks.aspx?yptr=yahoo&.tsrc=rss,"Looking for income from the healthcare sector? Here&apos;s why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular."
AGN,AGN:US,BBG000FH8PX5,A Biosimilar Cure for Sky-High Cancer Drug Prices,2017-09-15 03:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNEbOQo2ZlM/a-biosimilar-cure-for-sky-high-cancer-drug-prices-cm846078,On Thursday the U S Food and Drug Administration approved Amgen Inc NASDAQ AMGN and Allergan PLC s NYSE AGN Mvasi the first biosimilar to a cancer drug to win the regulatory green light The FDA s decision will create competition for Roche Holdings
,,,A Biosimilar Cure for Sky-High Cancer Drug Prices,2017-09-15 03:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNEbOQo2ZlM/a-biosimilar-cure-for-sky-high-cancer-drug-prices-cm846078,On Thursday the U S Food and Drug Administration approved Amgen Inc NASDAQ AMGN and Allergan PLC s NYSE AGN Mvasi the first biosimilar to a cancer drug to win the regulatory green light The FDA s decision will create competition for Roche Holdings
AGN,AGN:US,BBG000FH8PX5,A Biosimilar Cure for Sky-High Cancer Drug Prices,2017-09-15 01:30:00 +0000,http://finance.yahoo.com/r/7aa0719a-aea7-3fb6-8d6b-89b2412a70e4/a-biosimilar-cure-for-sky-high-cancer-drug-prices.aspx?yptr=yahoo&.tsrc=rss,"The FDA has approved Amgen and Allergan&apos;s Mvasi, the first-ever cancer-drug biosimilar to win an OK."
,,,A Biosimilar Cure for Sky-High Cancer Drug Prices,2017-09-15 01:30:00 +0000,http://finance.yahoo.com/r/7aa0719a-aea7-3fb6-8d6b-89b2412a70e4/a-biosimilar-cure-for-sky-high-cancer-drug-prices.aspx?yptr=yahoo&.tsrc=rss,"The FDA has approved Amgen and Allergan&apos;s Mvasi, the first-ever cancer-drug biosimilar to win an OK."
,,,Biosimilar 2017 Progress Report: Stocks in Focus,2017-09-14 23:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aiqYdLEkio/biosimilar-2017-progress-report-stocks-in-focus-cm846042,The biosimilar space remains in the spotlight as a number of regulatory decisions are pending While generic drugs are follow on versions of chemically synthesized molecules biosimilars contain a version of the active substance of an already approved original biological drug Development
AGN,AGN:US,BBG000FH8PX5,Biosimilar 2017 Progress Report: Stocks in Focus,2017-09-14 23:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aiqYdLEkio/biosimilar-2017-progress-report-stocks-in-focus-cm846042,The biosimilar space remains in the spotlight as a number of regulatory decisions are pending While generic drugs are follow on versions of chemically synthesized molecules biosimilars contain a version of the active substance of an already approved original biological drug Development
AGN,AGN:US,BBG000FH8PX5,Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions,2017-09-14 23:35:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sCAdyrW2mI/allergan-plc-ordinary-shares-agn-may-have-just-saved-itself-billions-cm846052,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since 2012 as a result of the America Invents Act biopharma companies have had to deal with an incredibly unfair situation regarding patent defense in the form of the inter partes patent review process This past
,,,Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions,2017-09-14 23:35:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sCAdyrW2mI/allergan-plc-ordinary-shares-agn-may-have-just-saved-itself-billions-cm846052,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since 2012 as a result of the America Invents Act biopharma companies have had to deal with an incredibly unfair situation regarding patent defense in the form of the inter partes patent review process This past
,,,Challenge of Allergan tribal patent deal in uncharted legal territory,2017-09-14 21:23:18 +0000,https://finance.yahoo.com/news/challenge-allergan-tribal-patent-deal-210524763.html?.tsrc=rss,"(Fixes date in dateline)  By Jan  Wolfe  Sept 14 (Reuters) - As generic drug manufacturers are  gearing up to argue that a deal Allergan Plc  made with a  Native American tribe to shield patents from administrative  review is a sham, some experts say the generic companies are in  uncharted legal territory.  Last week, Allergan announced it would transfer the patent  rights to its Restasis dry-eye treatment to the Saint Regis  Mohawk Tribe, which will license them back to the company in  exchange for ongoing payments.  Allergan says the tribe's sovereign immunity puts the  patents beyond the authority of the Patent Trial and Appeal  Board, an administrative court created in 2012 that can cancel  patents."
AGN,AGN:US,BBG000FH8PX5,Challenge of Allergan tribal patent deal in uncharted legal territory,2017-09-14 21:23:18 +0000,https://finance.yahoo.com/news/challenge-allergan-tribal-patent-deal-210524763.html?.tsrc=rss,"(Fixes date in dateline)  By Jan  Wolfe  Sept 14 (Reuters) - As generic drug manufacturers are  gearing up to argue that a deal Allergan Plc  made with a  Native American tribe to shield patents from administrative  review is a sham, some experts say the generic companies are in  uncharted legal territory.  Last week, Allergan announced it would transfer the patent  rights to its Restasis dry-eye treatment to the Saint Regis  Mohawk Tribe, which will license them back to the company in  exchange for ongoing payments.  Allergan says the tribe's sovereign immunity puts the  patents beyond the authority of the Patent Trial and Appeal  Board, an administrative court created in 2012 that can cancel  patents."
AGN,AGN:US,BBG000FH8PX5,"Apple, JPMorgan Among Top Picks On New List From UBS",2017-09-14 19:28:33 +0000,https://finance.yahoo.com/news/apple-jpmorgan-among-top-picks-192833749.html?.tsrc=rss,"Analysts at UBS published a list of their highest conviction calls among all of the firm's analysts across North America. Here is a sample of some of the names that are ranked as the firm's ""highest ..."
,,,"Apple, JPMorgan Among Top Picks On New List From UBS",2017-09-14 19:28:33 +0000,https://finance.yahoo.com/news/apple-jpmorgan-among-top-picks-192833749.html?.tsrc=rss,"Analysts at UBS published a list of their highest conviction calls among all of the firm's analysts across North America. Here is a sample of some of the names that are ranked as the firm's ""highest ..."
,,,Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin,2017-09-14 19:12:44 +0000,http://finance.yahoo.com/r/cf635854-7a67-340a-83fc-8f9ace90007e/Story.aspx?guid=B819E2B7-B681-44FC-AF29-AFCB6711B7DD&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Amgen Inc. and Allergan said Thursday that the Food and Drug Administration has approved their biosimilar version of Roche's Avastin for five types of cancer. The drug, Mvasi, is the first anti-cancer ..."
AGN,AGN:US,BBG000FH8PX5,Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin,2017-09-14 19:12:44 +0000,http://finance.yahoo.com/r/cf635854-7a67-340a-83fc-8f9ace90007e/Story.aspx?guid=B819E2B7-B681-44FC-AF29-AFCB6711B7DD&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Amgen Inc. and Allergan said Thursday that the Food and Drug Administration has approved their biosimilar version of Roche's Avastin for five types of cancer. The drug, Mvasi, is the first anti-cancer ..."
AGN,AGN:US,BBG000FH8PX5,Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions,2017-09-14 18:56:19 +0000,https://finance.yahoo.com/news/allergan-plc-ordinary-shares-agn-185619390.html?.tsrc=rss,"Since 2012, as a result of the America Invents Act, biopharma companies have had to deal with an incredibly unfair situation regarding patent defense, in the form of the inter partes patent review process.  Most importantly, Allergan believes (and I agree) that this will insulate Restasis from the unfair patent challenge that the IPR process permits, while still allowing generic challenges through the tried, tested and fair Hatch-Waxman pathway.  If successful, this may lead to every other bipharma company doing the same — protecting hard-earned intellectual property while still fostering generic competition and incentivizing innovation."
,,,Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions,2017-09-14 18:56:19 +0000,https://finance.yahoo.com/news/allergan-plc-ordinary-shares-agn-185619390.html?.tsrc=rss,"Since 2012, as a result of the America Invents Act, biopharma companies have had to deal with an incredibly unfair situation regarding patent defense, in the form of the inter partes patent review process.  Most importantly, Allergan believes (and I agree) that this will insulate Restasis from the unfair patent challenge that the IPR process permits, while still allowing generic challenges through the tried, tested and fair Hatch-Waxman pathway.  If successful, this may lead to every other bipharma company doing the same — protecting hard-earned intellectual property while still fostering generic competition and incentivizing innovation."
AGN,AGN:US,BBG000FH8PX5,FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer,2017-09-14 18:54:00 +0000,https://finance.yahoo.com/news/fda-approves-amgen-allergans-mvasi-185400720.html?.tsrc=rss,"THOUSAND OAKS, Calif., Sept. 14, 2017 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved MVASI™ (bevacizumab-awwb) for all eligible indications of the reference product, Avastin® (bevacizumab).  MVASI is the first anti-cancer biosimilar, as well as the first bevacizumab biosimilar, approved by the FDA."
,,,FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer,2017-09-14 18:54:00 +0000,https://finance.yahoo.com/news/fda-approves-amgen-allergans-mvasi-185400720.html?.tsrc=rss,"THOUSAND OAKS, Calif., Sept. 14, 2017 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved MVASI™ (bevacizumab-awwb) for all eligible indications of the reference product, Avastin® (bevacizumab).  MVASI is the first anti-cancer biosimilar, as well as the first bevacizumab biosimilar, approved by the FDA."
,,,AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs,2017-09-14 17:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vAsStPu0JIY/astrazeneca-sells-remaining-rights-to-its-anaesthetics-drugs-cm845851,AstraZeneca plc AZN announced that it has entered into an agreement to dispose theremaining rights to its anaesthetics medicines to Aspen Global Incorporated AGI the Mauritian subsidiary of the Aspen Group for an upfront consideration of 555 million We remind investors that
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs,2017-09-14 17:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vAsStPu0JIY/astrazeneca-sells-remaining-rights-to-its-anaesthetics-drugs-cm845851,AstraZeneca plc AZN announced that it has entered into an agreement to dispose theremaining rights to its anaesthetics medicines to Aspen Global Incorporated AGI the Mauritian subsidiary of the Aspen Group for an upfront consideration of 555 million We remind investors that
AGN,AGN:US,BBG000FH8PX5,These party drugs could become the answer for clinically ...,2017-09-14 15:22:00 +0000,https://finance.yahoo.com/video/party-drugs-could-become-answer-152200362.html?.tsrc=rss,At least 30-percent of depressed patients don't respond to any of the current drugs on the market. Scientists are hopeful these party drugs may help.
,,,These party drugs could become the answer for clinically ...,2017-09-14 15:22:00 +0000,https://finance.yahoo.com/video/party-drugs-could-become-answer-152200362.html?.tsrc=rss,At least 30-percent of depressed patients don't respond to any of the current drugs on the market. Scientists are hopeful these party drugs may help.
,,,AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs,2017-09-14 15:12:03 +0000,https://finance.yahoo.com/news/astrazeneca-sells-remaining-rights-anaesthetics-151203661.html?.tsrc=rss,AstraZeneca (AZN) recently sold its remaining rights to its anaesthetics medicines to Aspen Group for an upfront consideration of $555 million.
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs,2017-09-14 15:12:03 +0000,https://finance.yahoo.com/news/astrazeneca-sells-remaining-rights-anaesthetics-151203661.html?.tsrc=rss,AstraZeneca (AZN) recently sold its remaining rights to its anaesthetics medicines to Aspen Group for an upfront consideration of $555 million.
,,,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-14 12:02:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120217372.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-14 12:02:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120217372.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,TransCelerate BioPharma Adds Novartis; Elects Amgen's Elliott Levy As Chair,2017-09-14 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3FWBXWVs0cg/transcelerate-biopharma-adds-novartis-elects-amgens-elliott-levy-as-chair-20170914-00379,TransCelerate BioPharma Adds Novartis; Elects Amgen's Elliott Levy As Chair
AGN,AGN:US,BBG000FH8PX5,TransCelerate BioPharma Adds Novartis; Elects Amgen's Elliott Levy As Chair,2017-09-14 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3FWBXWVs0cg/transcelerate-biopharma-adds-novartis-elects-amgens-elliott-levy-as-chair-20170914-00379,TransCelerate BioPharma Adds Novartis; Elects Amgen's Elliott Levy As Chair
,,,"&quot;Fast Money&quot; final trades: TGT, TMO and more",2017-09-13 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-tgt-215900672.html?.tsrc=rss,"The “Fast Money” traders share their final trades for the day including Target, Equifax, Allergan and Thermo Fisher Scientific."
AGN,AGN:US,BBG000FH8PX5,"&quot;Fast Money&quot; final trades: TGT, TMO and more",2017-09-13 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-tgt-215900672.html?.tsrc=rss,"The “Fast Money” traders share their final trades for the day including Target, Equifax, Allergan and Thermo Fisher Scientific."
AGN,AGN:US,BBG000FH8PX5,Why pharma companies are scared of Bernie’s Medicare for All plan,2017-09-13 20:41:01 +0000,http://finance.yahoo.com/r/0006c786-8c37-3498-a5bf-5a8a9c69e39c/medicare-for-all-bernie-sanders-universal-health-care-bill-has-pharma-nervous?utm_source=YPL&yptr=yahoo&.tsrc=rss,"The idea of universal health-care in the US has traditionally been an elusive one, a far reach in a nation that relies on private insurance companies to buttress its health system. But debate around the issue has gained energy since US senator Bernie Sanders made it the centerpiece of his unsuccessful bid for the White…"
,,,Why pharma companies are scared of Bernie’s Medicare for All plan,2017-09-13 20:41:01 +0000,http://finance.yahoo.com/r/0006c786-8c37-3498-a5bf-5a8a9c69e39c/medicare-for-all-bernie-sanders-universal-health-care-bill-has-pharma-nervous?utm_source=YPL&yptr=yahoo&.tsrc=rss,"The idea of universal health-care in the US has traditionally been an elusive one, a far reach in a nation that relies on private insurance companies to buttress its health system. But debate around the issue has gained energy since US senator Bernie Sanders made it the centerpiece of his unsuccessful bid for the White…"
,,,"XLV, PFE, MDT, AGN: Large Inflows Detected at ETF",2017-09-13 16:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R2xdk-V17YQ/xlv-pfe-mdt-agn-large-inflows-detected-at-etf-cm845174,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 316 7 million dollar inflow that s a 1 8 increase week over week
AGN,AGN:US,BBG000FH8PX5,"XLV, PFE, MDT, AGN: Large Inflows Detected at ETF",2017-09-13 16:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R2xdk-V17YQ/xlv-pfe-mdt-agn-large-inflows-detected-at-etf-cm845174,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 316 7 million dollar inflow that s a 1 8 increase week over week
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-13 12:03:35 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120335069.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-13 12:03:35 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120335069.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,"Early movers: DIS, JWN, AAL, AGN, CNC, TEX, MU, MNK & more",2017-09-13 11:43:57 +0000,http://finance.yahoo.com/r/0f617996-1599-31a4-b7ef-5ccc7b182f83/104707085?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104707085&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
AGN,AGN:US,BBG000FH8PX5,"Early movers: DIS, JWN, AAL, AGN, CNC, TEX, MU, MNK & more",2017-09-13 11:43:57 +0000,http://finance.yahoo.com/r/0f617996-1599-31a4-b7ef-5ccc7b182f83/104707085?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104707085&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
,,,Tech entity has tribal patent deal similar to Allergan's,2017-09-12 22:16:26 +0000,https://finance.yahoo.com/news/tech-entity-tribal-patent-deal-221626162.html?.tsrc=rss,"The Native American tribe that agreed to  hold patents for the drug company Allergan Plc in an attempt to  shield them from U.S. administrative review is also doing so for  a technology firm.  According to U.S. Patent and Trademark Office records, SRC  Labs LLC on Aug. 2 transferred around 40 patents to the St.  Regis Mohawk Tribe.  Allergan announced on Friday it had reached a deal to  transfer several patents relating to the dry-eye medication  Restasis to the tribe in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,Tech entity has tribal patent deal similar to Allergan's,2017-09-12 22:16:26 +0000,https://finance.yahoo.com/news/tech-entity-tribal-patent-deal-221626162.html?.tsrc=rss,"The Native American tribe that agreed to  hold patents for the drug company Allergan Plc in an attempt to  shield them from U.S. administrative review is also doing so for  a technology firm.  According to U.S. Patent and Trademark Office records, SRC  Labs LLC on Aug. 2 transferred around 40 patents to the St.  Regis Mohawk Tribe.  Allergan announced on Friday it had reached a deal to  transfer several patents relating to the dry-eye medication  Restasis to the tribe in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,Mylan says Allergan misusing tribal sovereignty in patent dispute,2017-09-12 21:15:31 +0000,https://finance.yahoo.com/news/mylan-says-allergan-misusing-tribal-211531064.html?.tsrc=rss,"Generic drugmaker Mylan NV  alleged in a court filing that rival Allergan Plc  is trying to take advantage of Native American  sovereignty to shield its patent for the blockbuster dry-eye  treatment Restasis.  In Federal District Court in Marshall, Texas, on Monday,  Mylan said Allergan is ""attempting to misuse Native American  sovereignty to shield invalid patents from cancellation."" It  said it would vigorously oppose Allergan's attempt to protect a  drug from patent challenges by transferring its rights to a  Native American tribe.  Allergan said last week that it plans to transfer the rights  to Restasis to the Saint Regis Mohawk Tribe, and that it  believes patents for the drug would no longer be subject to  review by the U.S. Patent Trial and Appeal Board."
,,,Mylan says Allergan misusing tribal sovereignty in patent dispute,2017-09-12 21:15:31 +0000,https://finance.yahoo.com/news/mylan-says-allergan-misusing-tribal-211531064.html?.tsrc=rss,"Generic drugmaker Mylan NV  alleged in a court filing that rival Allergan Plc  is trying to take advantage of Native American  sovereignty to shield its patent for the blockbuster dry-eye  treatment Restasis.  In Federal District Court in Marshall, Texas, on Monday,  Mylan said Allergan is ""attempting to misuse Native American  sovereignty to shield invalid patents from cancellation."" It  said it would vigorously oppose Allergan's attempt to protect a  drug from patent challenges by transferring its rights to a  Native American tribe.  Allergan said last week that it plans to transfer the rights  to Restasis to the Saint Regis Mohawk Tribe, and that it  believes patents for the drug would no longer be subject to  review by the U.S. Patent Trial and Appeal Board."
AGN,AGN:US,BBG000FH8PX5,Allergan Launches New Brilliant Distinctions® Patient Loyalty Program,2017-09-12 20:05:00 +0000,https://finance.yahoo.com/news/allergan-launches-brilliant-distinctions-patient-200500598.html?.tsrc=rss,"DUBLIN, Sept. 12, 2017 /PRNewswire/ -- Today, Allergan plc (AGN) announced that the Company is launching the next generation of its groundbreaking U.S.-based Brilliant Distinctions® program.  In addition, Brilliant Distinctions® is also expanding to include the latest addition to the Allergan aesthetic portfolio, CoolScuplting®, in the body treatments category.  In the facial aesthetics category, the program provides savings to patients for loyalty and frequency of treatments and products, such as BOTOX® Cosmetic (onabotulinumtoxinA), the JUVÉDERM® Collection of Fillers, the SkinMedica® cosmetic skincare line, and Latisse® (bimatoprost ophthalmic solution) 0.03%."
,,,Allergan Launches New Brilliant Distinctions® Patient Loyalty Program,2017-09-12 20:05:00 +0000,https://finance.yahoo.com/news/allergan-launches-brilliant-distinctions-patient-200500598.html?.tsrc=rss,"DUBLIN, Sept. 12, 2017 /PRNewswire/ -- Today, Allergan plc (AGN) announced that the Company is launching the next generation of its groundbreaking U.S.-based Brilliant Distinctions® program.  In addition, Brilliant Distinctions® is also expanding to include the latest addition to the Allergan aesthetic portfolio, CoolScuplting®, in the body treatments category.  In the facial aesthetics category, the program provides savings to patients for loyalty and frequency of treatments and products, such as BOTOX® Cosmetic (onabotulinumtoxinA), the JUVÉDERM® Collection of Fillers, the SkinMedica® cosmetic skincare line, and Latisse® (bimatoprost ophthalmic solution) 0.03%."
,,,Allergan Protects Shareholders With Sovereign Immunity Deal,2017-09-12 14:36:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3q4pr5MRO5Y/allergan-protects-shareholders-with-sovereign-immunity-deal-cm844174,By Financial Freedom Institute ByFinancial Freedom Institute Allergan plc AGN may have just delivered a badly needed death blow to the inter partes patent review process AGN transferred all of its Orange Book patents for Cyclosporine Ophthalmic Emulsion 0
AGN,AGN:US,BBG000FH8PX5,Allergan Protects Shareholders With Sovereign Immunity Deal,2017-09-12 14:36:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3q4pr5MRO5Y/allergan-protects-shareholders-with-sovereign-immunity-deal-cm844174,By Financial Freedom Institute ByFinancial Freedom Institute Allergan plc AGN may have just delivered a badly needed death blow to the inter partes patent review process AGN transferred all of its Orange Book patents for Cyclosporine Ophthalmic Emulsion 0
,,,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-12 12:02:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120224627.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-12 12:02:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120224627.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,U.S. tribal patent deal could have big impact on generic drug market,2017-09-12 02:12:49 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-021249480.html?.tsrc=rss,"Allergan said on Friday it had transferred patents on its blockbuster dry eye medicine Restasis to the St. Regis Mohawk Tribe, which will exclusively license the patents back to the company in exchange for ongoing payments.  The deal takes advantage of the fact that the tribe is treated as a sovereign nation immune to civil lawsuits."
AGN,AGN:US,BBG000FH8PX5,U.S. tribal patent deal could have big impact on generic drug market,2017-09-12 02:12:49 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-021249480.html?.tsrc=rss,"Allergan said on Friday it had transferred patents on its blockbuster dry eye medicine Restasis to the St. Regis Mohawk Tribe, which will exclusively license the patents back to the company in exchange for ongoing payments.  The deal takes advantage of the fact that the tribe is treated as a sovereign nation immune to civil lawsuits."
,,,Irma to Bring Droves to Aisles of Home Depot; Teva Reveals Savior CEO - ICYMI,2017-09-11 23:56:00 +0000,http://finance.yahoo.com/r/1501b5cd-ff88-395e-a89a-783b29b24e1d/irma-to-bring-droves-to-aisles-of-home-depot-teva-reveals-savior-ceo-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Monday, September 11."
AGN,AGN:US,BBG000FH8PX5,Irma to Bring Droves to Aisles of Home Depot; Teva Reveals Savior CEO - ICYMI,2017-09-11 23:56:00 +0000,http://finance.yahoo.com/r/1501b5cd-ff88-395e-a89a-783b29b24e1d/irma-to-bring-droves-to-aisles-of-home-depot-teva-reveals-savior-ceo-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Monday, September 11."
AGN,AGN:US,BBG000FH8PX5,Cramer's lightning round: Allergan's in a torturous situa...,2017-09-11 23:27:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-allergans-torturous-232700347.html?.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name."
,,,Cramer's lightning round: Allergan's in a torturous situa...,2017-09-11 23:27:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-allergans-torturous-232700347.html?.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name."
,,,U.S. tribal patent deal could have big impact on generic drug market,2017-09-11 23:22:16 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-232216817.html?.tsrc=rss,"Allergan said on Friday it had transferred patents on its blockbuster dry eye medicine Restasis to the St. Regis Mohawk Tribe, which will exclusively license the patents back to the company in exchange for ongoing payments.  The deal takes advantage of the fact that the tribe is treated as a sovereign nation immune to civil lawsuits."
AGN,AGN:US,BBG000FH8PX5,U.S. tribal patent deal could have big impact on generic drug market,2017-09-11 23:22:16 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-232216817.html?.tsrc=rss,"Allergan said on Friday it had transferred patents on its blockbuster dry eye medicine Restasis to the St. Regis Mohawk Tribe, which will exclusively license the patents back to the company in exchange for ongoing payments.  The deal takes advantage of the fact that the tribe is treated as a sovereign nation immune to civil lawsuits."
AGN,AGN:US,BBG000FH8PX5,Cramer&apos;s lightning round: Allergan&apos;s in a torturous situation,2017-09-11 22:51:21 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-allergan-225121553.html?.tsrc=rss,"Jim Cramer rattles off his take on callers&apos; favorite stocks, including one hurting pharmaceutical name."
AGN,AGN:US,BBG000FH8PX5,Cramer's lightning round: Allergan's in a torturous situation,2017-09-11 22:51:21 +0000,http://finance.yahoo.com/r/0d65c537-1f00-30e4-bdf6-9c4f59605d16/104702462?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104702462&yptr=yahoo&.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name."
,,,Cramer&apos;s lightning round: Allergan&apos;s in a torturous situation,2017-09-11 22:51:21 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-allergan-225121553.html?.tsrc=rss,"Jim Cramer rattles off his take on callers&apos; favorite stocks, including one hurting pharmaceutical name."
,,,Cramer's lightning round: Allergan's in a torturous situation,2017-09-11 22:51:21 +0000,http://finance.yahoo.com/r/0d65c537-1f00-30e4-bdf6-9c4f59605d16/104702462?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104702462&yptr=yahoo&.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name."
,,,U.S. tribal patent deal could have big impact on generic drug market,2017-09-11 22:22:45 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-222245400.html?.tsrc=rss,"A groundbreaking deal between Allergan  Plc and a Native American tribe to shield the company's  patents in administrative proceedings could also be used be to  protect them from challenges in federal court, legal experts  said, potentially dealing a blow to generic competition.  Allergan said on Friday it had transferred patents on its  blockbuster dry eye medicine Restasis to the St. Regis Mohawk  Tribe, which will exclusively license the patents back to the  company in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,U.S. tribal patent deal could have big impact on generic drug market,2017-09-11 22:22:45 +0000,https://finance.yahoo.com/news/u-tribal-patent-deal-could-222245400.html?.tsrc=rss,"A groundbreaking deal between Allergan  Plc and a Native American tribe to shield the company's  patents in administrative proceedings could also be used be to  protect them from challenges in federal court, legal experts  said, potentially dealing a blow to generic competition.  Allergan said on Friday it had transferred patents on its  blockbuster dry eye medicine Restasis to the St. Regis Mohawk  Tribe, which will exclusively license the patents back to the  company in exchange for ongoing payments."
AGN,AGN:US,BBG000FH8PX5,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 18:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Od2xZxsBFFc/why-did-teva-pharmaceuticals-stock-soar-today-cm843915,Shares of Teva Pharmaceuticals TEVA opened more than 15 higher on Monday after the struggling drugmaker picked H Lundbeck HLUYY chief Kare Schultz to fill its long vacant CEO role Schultz who has been at the helm of H Lundbeck since May 2015 is set to take over at Teva a generics
,,,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 18:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Od2xZxsBFFc/why-did-teva-pharmaceuticals-stock-soar-today-cm843915,Shares of Teva Pharmaceuticals TEVA opened more than 15 higher on Monday after the struggling drugmaker picked H Lundbeck HLUYY chief Kare Schultz to fill its long vacant CEO role Schultz who has been at the helm of H Lundbeck since May 2015 is set to take over at Teva a generics
AGN,AGN:US,BBG000FH8PX5,Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 16:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-KhpcxG0fo/heres-why-allergan-stock-might-be-an-incredible-bargain-after-dropping-99-in-august-cm843806,What happened Despite a stronger than expected second quarter earnings report Allergan s NYSE AGN two month long rally came to an abrupt halt in August with the stock losing 9 9 of its value according to data from S amp P Global Market Intelligence The
,,,Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 16:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-KhpcxG0fo/heres-why-allergan-stock-might-be-an-incredible-bargain-after-dropping-99-in-august-cm843806,What happened Despite a stronger than expected second quarter earnings report Allergan s NYSE AGN two month long rally came to an abrupt halt in August with the stock losing 9 9 of its value according to data from S amp P Global Market Intelligence The
,,,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 15:59:03 +0000,https://finance.yahoo.com/news/why-did-teva-pharmaceuticals-stock-155903197.html?.tsrc=rss,Shares of Teva Pharmaceuticals (TEVA) opened more than 15% higher on Monday after the struggling drugmaker picked H. Lundbeck (HLUYY) chief Kare Schultz to fill its long-vacant CEO role.
AGN,AGN:US,BBG000FH8PX5,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 15:59:03 +0000,https://finance.yahoo.com/news/why-did-teva-pharmaceuticals-stock-155903197.html?.tsrc=rss,Shares of Teva Pharmaceuticals (TEVA) opened more than 15% higher on Monday after the struggling drugmaker picked H. Lundbeck (HLUYY) chief Kare Schultz to fill its long-vacant CEO role.
,,,Here&apos;s Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 15:00:00 +0000,http://finance.yahoo.com/r/0b9c515c-4b97-3ac1-bbed-4e355977a68b/heres-why-allergan-stock-might-be-an-incredible-ba.aspx?yptr=yahoo&.tsrc=rss,"Allergan&apos;s stock fell in sympathy with Teva Pharmaceutical Industries in August, but it may now be a bargain as a result."
AGN,AGN:US,BBG000FH8PX5,Here&apos;s Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 15:00:00 +0000,http://finance.yahoo.com/r/0b9c515c-4b97-3ac1-bbed-4e355977a68b/heres-why-allergan-stock-might-be-an-incredible-ba.aspx?yptr=yahoo&.tsrc=rss,"Allergan&apos;s stock fell in sympathy with Teva Pharmaceutical Industries in August, but it may now be a bargain as a result."
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-11 14:07:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140723089.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,See what the IHS Markit Score report has to say about Allergan plc.,2017-09-11 14:07:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140723089.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
,,,Sovereign Immunity and Public Hangings,2017-09-11 13:26:33 +0000,http://finance.yahoo.com/r/b896309b-ea76-38e9-8d31-3142b7492414/sovereign-immunity-and-public-hangings?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Also Mifid II research costs, Juicero and political correctness, bitcoin in China and unicorn worries."
AGN,AGN:US,BBG000FH8PX5,Sovereign Immunity and Public Hangings,2017-09-11 13:26:33 +0000,http://finance.yahoo.com/r/b896309b-ea76-38e9-8d31-3142b7492414/sovereign-immunity-and-public-hangings?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Also Mifid II research costs, Juicero and political correctness, bitcoin in China and unicorn worries."
,,,"The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts",2017-09-11 13:21:00 +0000,https://finance.yahoo.com/news/allergan-foundation-donate-150-000-132100482.html?.tsrc=rss,"DUBLIN, Sept. 11, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that The Allergan Foundation will donate $150,000 to help victims of Hurricane Irma.  The Allergan Foundation is also donating $50,000 to relief efforts across the Caribbean, which was also devastated by the hurricane.  ""Allergan and our 18,000 colleagues offer our thoughts and prayers to the millions of people whose lives are being devastated by Hurricane Irma."
AGN,AGN:US,BBG000FH8PX5,"The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts",2017-09-11 13:21:00 +0000,https://finance.yahoo.com/news/allergan-foundation-donate-150-000-132100482.html?.tsrc=rss,"DUBLIN, Sept. 11, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that The Allergan Foundation will donate $150,000 to help victims of Hurricane Irma.  The Allergan Foundation is also donating $50,000 to relief efforts across the Caribbean, which was also devastated by the hurricane.  ""Allergan and our 18,000 colleagues offer our thoughts and prayers to the millions of people whose lives are being devastated by Hurricane Irma."
AGN,AGN:US,BBG000FH8PX5,Allergan's Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 12:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83hKfVQuGsY/allergans-patent-loophole-could-be-a-huge-gift-for-pfizer-cm843496,The tribe has spoken On Friday Allergan NYSE AGN announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry eye disease drug Restatis Both parties should win from the deal The tribe will receive millions of dollars upfront and in annual
,,,Allergan's Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 12:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83hKfVQuGsY/allergans-patent-loophole-could-be-a-huge-gift-for-pfizer-cm843496,The tribe has spoken On Friday Allergan NYSE AGN announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry eye disease drug Restatis Both parties should win from the deal The tribe will receive millions of dollars upfront and in annual
AGN,AGN:US,BBG000FH8PX5,Allergan Patent Deal Isn't Just Unusual. It's Ugly.,2017-09-11 11:25:07 +0000,http://finance.yahoo.com/r/ff48addf-4d63-3268-b6be-6a3cc3e0f264/allergan-patent-deal-isn-t-just-unusual-it-s-ugly?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Transferring a drug patent to a tribe to hold onto a monopoly may be legal, but that doesn't mean it's right."
,,,Allergan Patent Deal Isn't Just Unusual. It's Ugly.,2017-09-11 11:25:07 +0000,http://finance.yahoo.com/r/ff48addf-4d63-3268-b6be-6a3cc3e0f264/allergan-patent-deal-isn-t-just-unusual-it-s-ugly?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Transferring a drug patent to a tribe to hold onto a monopoly may be legal, but that doesn't mean it's right."
,,,Allergan&apos;s Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 11:17:00 +0000,http://finance.yahoo.com/r/d5dee9dc-458d-389f-b62a-a3853497559d/allergans-patent-loophole-could-be-a-huge-gift-for.aspx?yptr=yahoo&.tsrc=rss,An announcement from Allergan of a novel way to defend against patent challenges could be just what Pfizer needs.
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 11:17:00 +0000,http://finance.yahoo.com/r/d5dee9dc-458d-389f-b62a-a3853497559d/allergans-patent-loophole-could-be-a-huge-gift-for.aspx?yptr=yahoo&.tsrc=rss,An announcement from Allergan of a novel way to defend against patent challenges could be just what Pfizer needs.
,,,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BM1mBJiGts/3-reasons-to-buy-allergan-plc-stock-right-now-cm843382,Allergan NYSE AGN is one of the most underappreciated big pharma stocks on the market right now That s the thought that occurred to me as I listened to Brent Saunders Allergan s CEO speak at the Wells Fargo Healthcare Conference on Thursday One thing s for sure
AGN,AGN:US,BBG000FH8PX5,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BM1mBJiGts/3-reasons-to-buy-allergan-plc-stock-right-now-cm843382,Allergan NYSE AGN is one of the most underappreciated big pharma stocks on the market right now That s the thought that occurred to me as I listened to Brent Saunders Allergan s CEO speak at the Wells Fargo Healthcare Conference on Thursday One thing s for sure
,,,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 12:33:00 +0000,http://finance.yahoo.com/r/12971c33-53fb-314c-93d0-a9192da9f594/3-reasons-to-buy-allergan-plc-stock-right-now.aspx?yptr=yahoo&.tsrc=rss,"This big pharma stock might not be on investors&apos; radar screens, but it should be."
AGN,AGN:US,BBG000FH8PX5,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 12:33:00 +0000,http://finance.yahoo.com/r/12971c33-53fb-314c-93d0-a9192da9f594/3-reasons-to-buy-allergan-plc-stock-right-now.aspx?yptr=yahoo&.tsrc=rss,"This big pharma stock might not be on investors&apos; radar screens, but it should be."
AGN,AGN:US,BBG000FH8PX5,The Media Is the Message; Allergan Gets Jiggy: Doug Kass' Views,2017-09-10 05:00:00 +0000,http://finance.yahoo.com/r/7f419a08-b886-3789-9a9d-0ca698a8a0de/the-media-is-the-message-allergan-gets-jiggy-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on Comcast, Apple, Disney and a few other companies."
,,,The Media Is the Message; Allergan Gets Jiggy: Doug Kass' Views,2017-09-10 05:00:00 +0000,http://finance.yahoo.com/r/7f419a08-b886-3789-9a9d-0ca698a8a0de/the-media-is-the-message-allergan-gets-jiggy-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on Comcast, Apple, Disney and a few other companies."
,,,Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress,2017-09-09 07:00:00 +0000,https://finance.yahoo.com/news/amgen-allergan-present-phase-3-070000545.html?.tsrc=rss,"Results from the neoadjuvant efficacy phase of the study, including pathologic complete response assessed both by local investigators and also by independent pathology review, were presented today during a poster discussion at the European Society for Medical Oncology (ESMO) 2017 Congress.  Efficacy, safety and immunogenicity data support ABP 980 as a trastuzumab biosimilar and add to the totality of evidence currently under review by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)."
AGN,AGN:US,BBG000FH8PX5,Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress,2017-09-09 07:00:00 +0000,https://finance.yahoo.com/news/amgen-allergan-present-phase-3-070000545.html?.tsrc=rss,"Results from the neoadjuvant efficacy phase of the study, including pathologic complete response assessed both by local investigators and also by independent pathology review, were presented today during a poster discussion at the European Society for Medical Oncology (ESMO) 2017 Congress.  Efficacy, safety and immunogenicity data support ABP 980 as a trastuzumab biosimilar and add to the totality of evidence currently under review by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)."
,,,Casinos Aren’t Enough as Native Tribe Makes Deal on Drug Patents,2017-09-09 04:01:00 +0000,https://finance.yahoo.com/news/casinos-aren-t-enough-native-040100622.html?.tsrc=rss,"For one Native American tribe, the money’s not in the casino anymore. Patents are the future."
AGN,AGN:US,BBG000FH8PX5,Casinos Aren’t Enough as Native Tribe Makes Deal on Drug Patents,2017-09-09 04:01:00 +0000,https://finance.yahoo.com/news/casinos-aren-t-enough-native-040100622.html?.tsrc=rss,"For one Native American tribe, the money’s not in the casino anymore. Patents are the future."
,,,Casinos Aren't Enough as Native Tribe Makes Deal on Drug Patents,2017-09-09 04:01:00 +0000,http://finance.yahoo.com/r/cf2aa607-8fe3-3d0f-ae9f-deff42e798d4/casinos-aren-t-enough-as-native-tribe-makes-deal-on-drug-patents?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"For one Native American tribe, the money’s not in the casino anymore. Patents are the future."
AGN,AGN:US,BBG000FH8PX5,Casinos Aren't Enough as Native Tribe Makes Deal on Drug Patents,2017-09-09 04:01:00 +0000,http://finance.yahoo.com/r/cf2aa607-8fe3-3d0f-ae9f-deff42e798d4/casinos-aren-t-enough-as-native-tribe-makes-deal-on-drug-patents?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"For one Native American tribe, the money’s not in the casino anymore. Patents are the future."
,,,[$$] Allergan Partners With Indian Tribe to Protect Drug Patents,2017-09-09 03:43:45 +0000,http://finance.yahoo.com/r/f8d74b5b-8133-313c-a2e6-e5efb64fb43e/allergan-partners-with-indian-tribe-to-protect-drug-patents-1504892222?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"To protect a top-selling drug from generic competition, Allergan PLC has sold the drug’s patents to an Indian tribe in upstate New York to block rivals from challenging the patents at the U.S. Patent and ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan Partners With Indian Tribe to Protect Drug Patents,2017-09-09 03:43:45 +0000,http://finance.yahoo.com/r/f8d74b5b-8133-313c-a2e6-e5efb64fb43e/allergan-partners-with-indian-tribe-to-protect-drug-patents-1504892222?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"To protect a top-selling drug from generic competition, Allergan PLC has sold the drug’s patents to an Indian tribe in upstate New York to block rivals from challenging the patents at the U.S. Patent and ..."
,,,Allergan Shares Rise on Novel Patent Pact for Restasis,2017-09-08 21:14:00 +0000,http://finance.yahoo.com/r/c07ba1f0-5148-3137-aeb0-ce2f969f674c/allergan-shares-rise-on-novel-patent-pact-for-restasis.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The drugmaker unveiled an agreement that transfers patents for Restasis, Allergan's longstanding dry eye medication, to the Saint Regis Mohawk Tribe, which claims immunity from patent challenges."
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Rise on Novel Patent Pact for Restasis,2017-09-08 21:14:00 +0000,http://finance.yahoo.com/r/c07ba1f0-5148-3137-aeb0-ce2f969f674c/allergan-shares-rise-on-novel-patent-pact-for-restasis.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The drugmaker unveiled an agreement that transfers patents for Restasis, Allergan's longstanding dry eye medication, to the Saint Regis Mohawk Tribe, which claims immunity from patent challenges."
,,,[$$] Allergan Partners With Indian Tribe to Protect Drug Patents,2017-09-08 20:29:47 +0000,http://finance.yahoo.com/r/f8d74b5b-8133-313c-a2e6-e5efb64fb43e/allergan-partners-with-indian-tribe-to-protect-drug-patents-1504892222?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"To protect a top-selling drug from generic competition, Allergan PLC has sold the drug’s patents to an Indian tribe in upstate New York to block rivals from challenging the patents at the U.S. Patent and ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan Partners With Indian Tribe to Protect Drug Patents,2017-09-08 20:29:47 +0000,http://finance.yahoo.com/r/f8d74b5b-8133-313c-a2e6-e5efb64fb43e/allergan-partners-with-indian-tribe-to-protect-drug-patents-1504892222?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"To protect a top-selling drug from generic competition, Allergan PLC has sold the drug’s patents to an Indian tribe in upstate New York to block rivals from challenging the patents at the U.S. Patent and ..."
AGN,AGN:US,BBG000FH8PX5,Allergan pays Mohawk Tribe to protect patents from challenges,2017-09-08 19:32:47 +0000,https://finance.yahoo.com/news/allergan-pays-mohawk-tribe-protect-193247356.html?.tsrc=rss,"Allergan Plc will transfer to the  Saint Regis Mohawk Tribe the rights to its blockbuster Restasis  dry-eye treatment, the drugmaker said on Friday, in an unusual  deal to protect it from patent challenges.  The tribe, which has sovereign immunity from such  challenges, will receive a one-time payment of $13.75 million  and annual royalties of around $15 million under the arrangement  proposed by the Saint Regis, Allergan said in a statement.  Sales of Restasis, which totaled over $1.5 billion last  year, account for about 15 percent of Allergan's profits,  according to AllianceBernstein."
,,,Allergan pays Mohawk Tribe to protect patents from challenges,2017-09-08 19:32:47 +0000,https://finance.yahoo.com/news/allergan-pays-mohawk-tribe-protect-193247356.html?.tsrc=rss,"Allergan Plc will transfer to the  Saint Regis Mohawk Tribe the rights to its blockbuster Restasis  dry-eye treatment, the drugmaker said on Friday, in an unusual  deal to protect it from patent challenges.  The tribe, which has sovereign immunity from such  challenges, will receive a one-time payment of $13.75 million  and annual royalties of around $15 million under the arrangement  proposed by the Saint Regis, Allergan said in a statement.  Sales of Restasis, which totaled over $1.5 billion last  year, account for about 15 percent of Allergan's profits,  according to AllianceBernstein."
AGN,AGN:US,BBG000FH8PX5,Forget casinos: This Native American tribe is doing business in pharma patents,2017-09-08 19:29:11 +0000,https://finance.yahoo.com/news/forget-casinos-native-american-tribe-181358823.html?.tsrc=rss,"Allergan transferred all the patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license."
,,,Forget casinos: This Native American tribe is doing business in pharma patents,2017-09-08 19:29:11 +0000,https://finance.yahoo.com/news/forget-casinos-native-american-tribe-181358823.html?.tsrc=rss,"Allergan transferred all the patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license."
AGN,AGN:US,BBG000FH8PX5,Allergan has made an unorthodox agreement with an American Indian tribe to fend off competition for its key product,2017-09-08 19:09:30 +0000,http://finance.yahoo.com/r/7ff5dfd1-d5ac-369b-8ae1-13819e7c2f66/Story.aspx?guid=7227DFFC-94C0-11E7-ABA2-C43A401C9AD2&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"This is “extremely important” for the pharmaceutical industry to track, and other companies may try to follow in Allergan’s footsteps, a Wall Street analyst said."
,,,Allergan has made an unorthodox agreement with an American Indian tribe to fend off competition for its key product,2017-09-08 19:09:30 +0000,http://finance.yahoo.com/r/7ff5dfd1-d5ac-369b-8ae1-13819e7c2f66/Story.aspx?guid=7227DFFC-94C0-11E7-ABA2-C43A401C9AD2&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"This is “extremely important” for the pharmaceutical industry to track, and other companies may try to follow in Allergan’s footsteps, a Wall Street analyst said."
,,,Allergan pays Mohawk Tribe to protect patents from challenges,2017-09-08 18:45:39 +0000,https://finance.yahoo.com/news/allergan-pays-mohawk-tribe-protect-184539352.html?.tsrc=rss,"Allergan Plc will transfer to the  Saint Regis Mohawk Tribe rights to its blockbuster Restasis  dry-eye treatment, the drugmaker said on Friday, in an unusual  deal to protect it from patent challenges.  The tribe, which has sovereign immunity from such  challenges, will receive a one-time payment of $13.75 million  and annual royalties of around $15 million under the arrangement  proposed by the St. Regis, Allergan said in a statement.  Sales of Restasis, which totaled over $1.5 billion last  year, account for about 15 percent of Allergan's profits,  according to AllianceBernstein."
AGN,AGN:US,BBG000FH8PX5,Allergan pays Mohawk Tribe to protect patents from challenges,2017-09-08 18:45:39 +0000,https://finance.yahoo.com/news/allergan-pays-mohawk-tribe-protect-184539352.html?.tsrc=rss,"Allergan Plc will transfer to the  Saint Regis Mohawk Tribe rights to its blockbuster Restasis  dry-eye treatment, the drugmaker said on Friday, in an unusual  deal to protect it from patent challenges.  The tribe, which has sovereign immunity from such  challenges, will receive a one-time payment of $13.75 million  and annual royalties of around $15 million under the arrangement  proposed by the St. Regis, Allergan said in a statement.  Sales of Restasis, which totaled over $1.5 billion last  year, account for about 15 percent of Allergan's profits,  according to AllianceBernstein."
,,,Forget casinos: This Native American tribe is doing business in pharma patents,2017-09-08 18:13:58 +0000,http://finance.yahoo.com/r/c6c96e9f-0e81-344f-914e-973b61b229e9/104698859?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104698859&yptr=yahoo&.tsrc=rss,"Allergan transferred all the patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license."
AGN,AGN:US,BBG000FH8PX5,Forget casinos: This Native American tribe is doing business in pharma patents,2017-09-08 18:13:58 +0000,http://finance.yahoo.com/r/c6c96e9f-0e81-344f-914e-973b61b229e9/104698859?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104698859&yptr=yahoo&.tsrc=rss,"Allergan transferred all the patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license."
AGN,AGN:US,BBG000FH8PX5,Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product,2017-09-08 18:08:06 +0000,http://finance.yahoo.com/r/a82e4724-f63d-32fd-9fa1-dcc4212d56f2/Story.aspx?guid=345E3178-0B67-4E0A-ABDD-D3A83B0A90AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan PLC shares rose 1.8% in heavy Friday afternoon trade on news of an unorthodox agreement the company has made with the Saint Regis Mohawk Tribe that could protect patents on a key Allergan dry ...
,,,Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product,2017-09-08 18:08:06 +0000,http://finance.yahoo.com/r/a82e4724-f63d-32fd-9fa1-dcc4212d56f2/Story.aspx?guid=345E3178-0B67-4E0A-ABDD-D3A83B0A90AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Allergan PLC shares rose 1.8% in heavy Friday afternoon trade on news of an unorthodox agreement the company has made with the Saint Regis Mohawk Tribe that could protect patents on a key Allergan dry ...
,,,Allergan reaches agreement regarding RESTASIS patents,2017-09-08 17:43:00 +0000,https://finance.yahoo.com/video/allergan-reaches-agreement-regarding-restasis-174300736.html?.tsrc=rss,CNBC's Meg Tirrell reports on shares of Allergan popping on reaching an agreement with eye drug RESTASIS patents.
AGN,AGN:US,BBG000FH8PX5,Allergan reaches agreement regarding RESTASIS patents,2017-09-08 17:43:00 +0000,https://finance.yahoo.com/video/allergan-reaches-agreement-regarding-restasis-174300736.html?.tsrc=rss,CNBC's Meg Tirrell reports on shares of Allergan popping on reaching an agreement with eye drug RESTASIS patents.
,,,"A Native American Tribe, a Drugmaker and an Unusual Patent Plan",2017-09-08 16:53:11 +0000,http://finance.yahoo.com/r/080bb7b6-54da-310a-95c7-b828b3287010/allergan-makes-deal-with-native-american-tribe-over-drug-patents?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Allergan Plc has found an unusual way to shield one of its blockbuster drugs from generic competition.
AGN,AGN:US,BBG000FH8PX5,"A Native American Tribe, a Drugmaker and an Unusual Patent Plan",2017-09-08 16:53:11 +0000,http://finance.yahoo.com/r/080bb7b6-54da-310a-95c7-b828b3287010/allergan-makes-deal-with-native-american-tribe-over-drug-patents?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Allergan Plc has found an unusual way to shield one of its blockbuster drugs from generic competition.
,,,Allergan and Saint Regis Mohawk Tribe Announce Agreements Regarding RESTASIS® Patents,2017-09-08 16:34:00 +0000,https://finance.yahoo.com/news/allergan-saint-regis-mohawk-tribe-163400437.html?.tsrc=rss,"DUBLIN, Sept. 8, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and the Saint Regis Mohawk Tribe today announced that the Tribe now owns all Orange Book-listed patents for RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%, and that Allergan has been granted exclusive licenses in the patents related to the product."
AGN,AGN:US,BBG000FH8PX5,Allergan and Saint Regis Mohawk Tribe Announce Agreements Regarding RESTASIS® Patents,2017-09-08 16:34:00 +0000,https://finance.yahoo.com/news/allergan-saint-regis-mohawk-tribe-163400437.html?.tsrc=rss,"DUBLIN, Sept. 8, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and the Saint Regis Mohawk Tribe today announced that the Tribe now owns all Orange Book-listed patents for RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%, and that Allergan has been granted exclusive licenses in the patents related to the product."
,,,"[$$] Merck Tops JNJ, Allergan",2017-09-08 15:07:00 +0000,http://finance.yahoo.com/r/69a4afa3-b32e-3cff-9a3c-6fb5d073cc65/merck-tops-jnj-allergan-1504883229?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  As we wrap up the third quarter, we anticipate the focus for the rest of the year will continue to be macro questions/pressures and a limited number of fundamental catalysts that could change sentiment on the U.S. pharmaceuticals sector as a whole.  Positive product news may provide opportunities for upside, although we believe this may be balanced out by fewer impactful pipeline readouts in the latter part of 2017 and continued debates around drug pricing.  As we approach the fourth quarter, while Gilead Sciences’ (GILD) recent acquisition of Kite Pharma’s (KITE) has improved investor sentiment on the broader biopharma space, we note most of our large-cap companies seem to be waiting for further clarity around tax reform before announcing meaningful deals."
AGN,AGN:US,BBG000FH8PX5,"[$$] Merck Tops JNJ, Allergan",2017-09-08 15:07:00 +0000,http://finance.yahoo.com/r/69a4afa3-b32e-3cff-9a3c-6fb5d073cc65/merck-tops-jnj-allergan-1504883229?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  As we wrap up the third quarter, we anticipate the focus for the rest of the year will continue to be macro questions/pressures and a limited number of fundamental catalysts that could change sentiment on the U.S. pharmaceuticals sector as a whole.  Positive product news may provide opportunities for upside, although we believe this may be balanced out by fewer impactful pipeline readouts in the latter part of 2017 and continued debates around drug pricing.  As we approach the fourth quarter, while Gilead Sciences’ (GILD) recent acquisition of Kite Pharma’s (KITE) has improved investor sentiment on the broader biopharma space, we note most of our large-cap companies seem to be waiting for further clarity around tax reform before announcing meaningful deals."
,,,Allergan Reveals Agreements Regarding RESTASIS Patents,2017-09-08 13:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q8TBk32RflU/allergan-reveals-agreements-regarding-restasis-patents-20170908-00667,Allergan Reveals Agreements Regarding RESTASIS Patents
AGN,AGN:US,BBG000FH8PX5,Allergan Reveals Agreements Regarding RESTASIS Patents,2017-09-08 13:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q8TBk32RflU/allergan-reveals-agreements-regarding-restasis-patents-20170908-00667,Allergan Reveals Agreements Regarding RESTASIS Patents
AGN,AGN:US,BBG000FH8PX5,Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow's Feet With BOTOX® Cosmetic (onabotulinumtoxinA)1,2017-09-08 12:01:00 +0000,https://finance.yahoo.com/news/pro-football-hall-famer-deion-120100193.html?.tsrc=rss,"DUBLIN, Sept. 8, 2017 /PRNewswire/ -- Allergan plc, (AGN), a leading global pharmaceutical company, announced today that NFL analyst and philanthropist, Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, will serve as a brand ambassador for BOTOX® Cosmetic."
,,,Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow's Feet With BOTOX® Cosmetic (onabotulinumtoxinA)1,2017-09-08 12:01:00 +0000,https://finance.yahoo.com/news/pro-football-hall-famer-deion-120100193.html?.tsrc=rss,"DUBLIN, Sept. 8, 2017 /PRNewswire/ -- Allergan plc, (AGN), a leading global pharmaceutical company, announced today that NFL analyst and philanthropist, Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, will serve as a brand ambassador for BOTOX® Cosmetic."
,,,"Noteworthy Thursday Option Activity: AGN, NVDA, BNFT",2017-09-07 20:51:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L9upaAXKb-0/noteworthy-thursday-option-activity-agn-nvda-bnft-cm842545,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 8 188 contracts has been traded thus far today a contract volume which is representative of approximately 818 800
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Thursday Option Activity: AGN, NVDA, BNFT",2017-09-07 20:51:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L9upaAXKb-0/noteworthy-thursday-option-activity-agn-nvda-bnft-cm842545,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 8 188 contracts has been traded thus far today a contract volume which is representative of approximately 818 800
,,,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 15:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRa9UBr0-KY/aerie-initiates-phase-iii-study-for-ophthalmic-drug-roclatan-cm842311,Aerie Pharmaceuticals Inc AERI announced the initiation of phase III study Mercury 3 in Europe for its pipeline candidate Roclatan 0 02 0 005 Roclatan is a once daily quadruple action fixed dose combination of Rhopressa and Pfizer s PFE Xalatan iis being evaluated to lower
AGN,AGN:US,BBG000FH8PX5,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 15:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRa9UBr0-KY/aerie-initiates-phase-iii-study-for-ophthalmic-drug-roclatan-cm842311,Aerie Pharmaceuticals Inc AERI announced the initiation of phase III study Mercury 3 in Europe for its pipeline candidate Roclatan 0 02 0 005 Roclatan is a once daily quadruple action fixed dose combination of Rhopressa and Pfizer s PFE Xalatan iis being evaluated to lower
AGN,AGN:US,BBG000FH8PX5,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 13:41:01 +0000,https://finance.yahoo.com/news/aerie-initiates-phase-iii-study-134101098.html?.tsrc=rss,"Aerie Pharmaceuticals, (AERI) announced that it has commenced phase III study -Mercury 3 in Europe for its pipeline candidate Roclatan 0.02%/0.005%."
,,,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 13:41:01 +0000,https://finance.yahoo.com/news/aerie-initiates-phase-iii-study-134101098.html?.tsrc=rss,"Aerie Pharmaceuticals, (AERI) announced that it has commenced phase III study -Mercury 3 in Europe for its pipeline candidate Roclatan 0.02%/0.005%."
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc :AGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017",2017-09-07 12:45:32 +0000,http://finance.yahoo.com/r/5a6ef87b-73de-3ac8-88cb-8ebba041f2e4/allergan-plc-agn-us-earnings-analysis-q2-2017-by-the-numbers-september-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Allergan Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Allergan Plc – Daiichi Sankyo Company, Limited, Valeant Pharmaceuticals International Inc, Endo International Plc and UCB S.A. (DSKYF-US, VRX-US, ENDP-US and UCBJF-US) that have also reported for this period. ... Read more
<b>(Read more...)</b>"
,,,"Allergan Plc :AGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017",2017-09-07 12:45:32 +0000,http://finance.yahoo.com/r/5a6ef87b-73de-3ac8-88cb-8ebba041f2e4/allergan-plc-agn-us-earnings-analysis-q2-2017-by-the-numbers-september-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Allergan Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Allergan Plc – Daiichi Sankyo Company, Limited, Valeant Pharmaceuticals International Inc, Endo International Plc and UCB S.A. (DSKYF-US, VRX-US, ENDP-US and UCBJF-US) that have also reported for this period. ... Read more
<b>(Read more...)</b>"
,,,Watertown’s Lyndra strikes Alzheimer’s pact with Allergan worth up to $105M,2017-09-07 11:20:10 +0000,http://finance.yahoo.com/r/0a7beb81-64ff-37f7-8909-17ff9f4bfa0c/watertown-s-lyndra-strikes-alzheimer-s-pact-with.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Since being launched in 2015, Watertown-based Lyndra has been on the hunt for Big Pharma partners who may be interested in using its technology, which is designed to make pills last longer with fewer side effects.  On Thursday, the 35-employee company unveiled its first such deal — an agreement with drug giant Allergan (AGN) that could be worth up to $105 million.  Under the pact, the companies will collaborate to develop once-weekly formulations of Allergan’s drugs for Alzheimer’s disease."
AGN,AGN:US,BBG000FH8PX5,Watertown’s Lyndra strikes Alzheimer’s pact with Allergan worth up to $105M,2017-09-07 11:20:10 +0000,http://finance.yahoo.com/r/0a7beb81-64ff-37f7-8909-17ff9f4bfa0c/watertown-s-lyndra-strikes-alzheimer-s-pact-with.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Since being launched in 2015, Watertown-based Lyndra has been on the hunt for Big Pharma partners who may be interested in using its technology, which is designed to make pills last longer with fewer side effects.  On Thursday, the 35-employee company unveiled its first such deal — an agreement with drug giant Allergan (AGN) that could be worth up to $105 million.  Under the pact, the companies will collaborate to develop once-weekly formulations of Allergan’s drugs for Alzheimer’s disease."
,,,Allergan To Present At The 2017 Wells Fargo Conference; Webcast At 12:00 PM ET,2017-09-07 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sKgPDGtj_dw/allergan-to-present-at-the-2017-wells-fargo-conference-webcast-at-1200-pm-et-20170907-01025,Allergan To Present At The 2017 Wells Fargo Conference; Webcast At 12:00 PM ET
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At The 2017 Wells Fargo Conference; Webcast At 12:00 PM ET,2017-09-07 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sKgPDGtj_dw/allergan-to-present-at-the-2017-wells-fargo-conference-webcast-at-1200-pm-et-20170907-01025,Allergan To Present At The 2017 Wells Fargo Conference; Webcast At 12:00 PM ET
,,,Is It The Right Time To Buy Allergan plc (AGN)?,2017-09-06 14:56:09 +0000,https://finance.yahoo.com/news/time-buy-allergan-plc-agn-145609712.html?.tsrc=rss,Let’s talk about the popular Allergan plc (NYSE:AGN). The company’s shares received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
AGN,AGN:US,BBG000FH8PX5,Is It The Right Time To Buy Allergan plc (AGN)?,2017-09-06 14:56:09 +0000,https://finance.yahoo.com/news/time-buy-allergan-plc-agn-145609712.html?.tsrc=rss,Let’s talk about the popular Allergan plc (NYSE:AGN). The company’s shares received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data on Chronic Migraine at the International Headache Congress in Vancouver,2017-09-06 11:35:00 +0000,https://finance.yahoo.com/news/allergan-present-data-chronic-migraine-113500610.html?.tsrc=rss,"DUBLIN , Sept. 6, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that data on Chronic Migraine and the Company's Chronic Migraine treatment will be featured in 11 presentations at the upcoming ..."
,,,Allergan to Present New Data on Chronic Migraine at the International Headache Congress in Vancouver,2017-09-06 11:35:00 +0000,https://finance.yahoo.com/news/allergan-present-data-chronic-migraine-113500610.html?.tsrc=rss,"DUBLIN , Sept. 6, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that data on Chronic Migraine and the Company's Chronic Migraine treatment will be featured in 11 presentations at the upcoming ..."
AGN,AGN:US,BBG000FH8PX5,Why Mallinckrodt Got Crushed,2017-09-05 20:51:00 +0000,http://finance.yahoo.com/r/535698df-4533-3417-a18e-18a77afa2bdf/why-mallinckrodt-got-crushed-1504644691?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was a down day for the stock market.  The selloff by the Dow Industrials notwithstanding, Mallinckrodt (MNK) got manhandled after losing its bid to block Praxair (PX)  from marketing a generic version of  the respiratory treatment Inomax.  The court ruled invalidated Mallinckrodt’s patents, and sent the stock plunging more than 12.2% to end the day at $36.12 a share."
,,,Why Mallinckrodt Got Crushed,2017-09-05 20:51:00 +0000,http://finance.yahoo.com/r/535698df-4533-3417-a18e-18a77afa2bdf/why-mallinckrodt-got-crushed-1504644691?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was a down day for the stock market.  The selloff by the Dow Industrials notwithstanding, Mallinckrodt (MNK) got manhandled after losing its bid to block Praxair (PX)  from marketing a generic version of  the respiratory treatment Inomax.  The court ruled invalidated Mallinckrodt’s patents, and sent the stock plunging more than 12.2% to end the day at $36.12 a share."
,,,Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound?,2017-09-04 14:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBKz6KSLmQg/allergan-agn-down-83-since-earnings-report-can-it-rebound-cm840743,About a month has gone by since the last earnings report for Allergan PLC AGN Shares have lost about 8 3 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound?,2017-09-04 14:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBKz6KSLmQg/allergan-agn-down-83-since-earnings-report-can-it-rebound-cm840743,About a month has gone by since the last earnings report for Allergan PLC AGN Shares have lost about 8 3 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
,,,Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound?,2017-09-04 12:45:12 +0000,https://finance.yahoo.com/news/allergan-agn-down-8-3-124512403.html?.tsrc=rss,Allergan (AGN) reported earnings about a month ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound?,2017-09-04 12:45:12 +0000,https://finance.yahoo.com/news/allergan-agn-down-8-3-124512403.html?.tsrc=rss,Allergan (AGN) reported earnings about a month ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
,,,Cramer's biggest investing mistakes,2017-09-01 23:09:00 +0000,https://finance.yahoo.com/video/cramers-biggest-investing-mistakes-230900720.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
AGN,AGN:US,BBG000FH8PX5,Cramer's biggest investing mistakes,2017-09-01 23:09:00 +0000,https://finance.yahoo.com/video/cramers-biggest-investing-mistakes-230900720.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
AGN,AGN:US,BBG000FH8PX5,Cramer admits his biggest investing mistakes,2017-09-01 22:58:00 +0000,https://finance.yahoo.com/video/cramer-admits-biggest-investing-mistakes-225800259.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
,,,Cramer admits his biggest investing mistakes,2017-09-01 22:58:00 +0000,https://finance.yahoo.com/video/cramer-admits-biggest-investing-mistakes-225800259.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
,,,Cramer admits his biggest investing mistakes,2017-09-01 22:44:40 +0000,https://finance.yahoo.com/news/cramer-admits-biggest-investing-mistakes-224440271.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
AGN,AGN:US,BBG000FH8PX5,Cramer admits his biggest investing mistakes,2017-09-01 22:44:40 +0000,http://finance.yahoo.com/r/169a94ee-2548-3688-8678-002ac142da63/104686099?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104686099&yptr=yahoo&.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
AGN,AGN:US,BBG000FH8PX5,Cramer admits his biggest investing mistakes,2017-09-01 22:44:40 +0000,https://finance.yahoo.com/news/cramer-admits-biggest-investing-mistakes-224440271.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
,,,"Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update",2017-09-01 13:54:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O-ksqXE2hTc/pharma-stock-roundup-novartis-car-t-drug-gets-fda-nod-lilly-gives-baricitinib-update-cm840130,It was a historic week not just for Novartis NVS but also for the medical community and patients with the FDA giving its nod to the first gene therapy in the United States Novartis Kymriah This marks the beginning of a new era for the treatment of cancer and other serious and life
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update",2017-09-01 13:54:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O-ksqXE2hTc/pharma-stock-roundup-novartis-car-t-drug-gets-fda-nod-lilly-gives-baricitinib-update-cm840130,It was a historic week not just for Novartis NVS but also for the medical community and patients with the FDA giving its nod to the first gene therapy in the United States Novartis Kymriah This marks the beginning of a new era for the treatment of cancer and other serious and life
,,,"Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update",2017-09-01 11:57:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-novartis-car-115711976.html?.tsrc=rss,"It was a landmark week for the pharmaceutical sector and the medical community with the FDA approving Novartis&apos; (NVS) Kymriah, the first CAR-T cell treatment to be approved in the United States."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update",2017-09-01 11:57:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-novartis-car-115711976.html?.tsrc=rss,"It was a landmark week for the pharmaceutical sector and the medical community with the FDA approving Novartis&apos; (NVS) Kymriah, the first CAR-T cell treatment to be approved in the United States."
,,,Apricus Biosciences Issues Update On Vitaros NDA Resubmission - Quick Facts,2017-08-31 07:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ktmjQna7QY/apricus-biosciences-issues-update-on-vitaros-nda-resubmission--quick-facts-20170831-00349,Apricus Biosciences Issues Update On Vitaros NDA Resubmission - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Apricus Biosciences Issues Update On Vitaros NDA Resubmission - Quick Facts,2017-08-31 07:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ktmjQna7QY/apricus-biosciences-issues-update-on-vitaros-nda-resubmission--quick-facts-20170831-00349,Apricus Biosciences Issues Update On Vitaros NDA Resubmission - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Oversold Conditions For Allergan (AGN),2017-08-30 17:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TPIEe7ykjEk/oversold-conditions-for-allergan-agn-cm839304,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
,,,Oversold Conditions For Allergan (AGN),2017-08-30 17:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TPIEe7ykjEk/oversold-conditions-for-allergan-agn-cm839304,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
,,,Gilead-Kite: A New Transformative Deal For Biotech,2017-08-30 14:01:00 +0000,http://finance.yahoo.com/r/b2abb760-fa69-3761-beac-10be92400511/gilead-kite-a-new-transformative-deal-and-maybe-the-new-future-of-healthcare-deals?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The Gilead deal couldn’t have been timed better to help activate M&A activity and continue to spur a biotech bull market. It is, however, a reminder that mega-mergers are a distant memory."
AGN,AGN:US,BBG000FH8PX5,Gilead-Kite: A New Transformative Deal For Biotech,2017-08-30 14:01:00 +0000,http://finance.yahoo.com/r/b2abb760-fa69-3761-beac-10be92400511/gilead-kite-a-new-transformative-deal-and-maybe-the-new-future-of-healthcare-deals?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The Gilead deal couldn’t have been timed better to help activate M&A activity and continue to spur a biotech bull market. It is, however, a reminder that mega-mergers are a distant memory."
AGN,AGN:US,BBG000FH8PX5,"David Tepper Reduces General Motors, Allergan Positions, Exits Pfizer",2017-08-29 16:48:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MHkoDdFYvk/david-tepper-reduces-general-motors-allergan-positions-exits-pfizer-cm838706,Appaloosa Management founder David Tepper Trades Portfolio sold shares of the following stocks during the second quarter Appaloosa Management founderDavid Tepper Trades Portfolio sold shares of the following stocks during the second quarter Tepper reduced his holding
,,,"David Tepper Reduces General Motors, Allergan Positions, Exits Pfizer",2017-08-29 16:48:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MHkoDdFYvk/david-tepper-reduces-general-motors-allergan-positions-exits-pfizer-cm838706,Appaloosa Management founder David Tepper Trades Portfolio sold shares of the following stocks during the second quarter Appaloosa Management founderDavid Tepper Trades Portfolio sold shares of the following stocks during the second quarter Tepper reduced his holding
AGN,AGN:US,BBG000FH8PX5,Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic,2017-08-29 14:23:55 +0000,https://finance.yahoo.com/news/battered-teva-pharmaceutical-industries-ltd-142355186.html?.tsrc=rss,"All is not well for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Teva bought Allergan’s generic drug business for $40.5 billion, which put severe pressure on its balance sheet.  One year ago, Teva had nearly $7 billion in cash and just $10.9 billion in debt."
,,,Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic,2017-08-29 14:23:55 +0000,https://finance.yahoo.com/news/battered-teva-pharmaceutical-industries-ltd-142355186.html?.tsrc=rss,"All is not well for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Teva bought Allergan’s generic drug business for $40.5 billion, which put severe pressure on its balance sheet.  One year ago, Teva had nearly $7 billion in cash and just $10.9 billion in debt."
,,,"ALLERGAN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-29 02:50:00 +0000,https://finance.yahoo.com/news/allergan-24-hour-deadline-alert-025000223.html?.tsrc=rss,"ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until August 29, 2017 to file lead plaintiff applications in a securities class action lawsuit against Allergan, Inc."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-29 02:50:00 +0000,https://finance.yahoo.com/news/allergan-24-hour-deadline-alert-025000223.html?.tsrc=rss,"ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until August 29, 2017 to file lead plaintiff applications in a securities class action lawsuit against Allergan, Inc."
,,,Allergan Announces Settlement of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with Famy Care,2017-08-28 20:15:00 +0000,https://finance.yahoo.com/news/allergan-announces-settlement-restasis-cyclosporine-201500751.html?.tsrc=rss,"-- Agreement Provides Dismissal of Litigation and Termination of Pending IPR Petitions -- DUBLIN , Aug. 28, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and its ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Settlement of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with Famy Care,2017-08-28 20:15:00 +0000,https://finance.yahoo.com/news/allergan-announces-settlement-restasis-cyclosporine-201500751.html?.tsrc=rss,"-- Agreement Provides Dismissal of Litigation and Termination of Pending IPR Petitions -- DUBLIN , Aug. 28, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and its ..."
AGN,AGN:US,BBG000FH8PX5,"The Allergan Foundation to Donate $100,000 to Support Hurricane Harvey Relief Efforts",2017-08-28 12:00:00 +0000,https://finance.yahoo.com/news/allergan-foundation-donate-100-000-120000887.html?.tsrc=rss,"""Allergan's 18,000 colleagues extend our thoughts and prayers to the people of Texas and the Gulf Coast who have been affected by the catastrophic winds and rain associated with Hurricane Harvey.  We are eager to help and support the work of the American Red Cross in their direct relief efforts,"" said Brent Saunders, Chairman and CEO of Allergan and Chairman of The Allergan Foundation.  Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world."
,,,"The Allergan Foundation to Donate $100,000 to Support Hurricane Harvey Relief Efforts",2017-08-28 12:00:00 +0000,https://finance.yahoo.com/news/allergan-foundation-donate-100-000-120000887.html?.tsrc=rss,"""Allergan's 18,000 colleagues extend our thoughts and prayers to the people of Texas and the Gulf Coast who have been affected by the catastrophic winds and rain associated with Hurricane Harvey.  We are eager to help and support the work of the American Red Cross in their direct relief efforts,"" said Brent Saunders, Chairman and CEO of Allergan and Chairman of The Allergan Foundation.  Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN)",2017-08-26 02:50:00 +0000,https://finance.yahoo.com/news/allergan-96-hour-deadline-alert-025000291.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 29, 2017 to file lead plaintiff applications in a securities class action lawsuit against Allergan, Inc."
,,,"ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN)",2017-08-26 02:50:00 +0000,https://finance.yahoo.com/news/allergan-96-hour-deadline-alert-025000291.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 29, 2017 to file lead plaintiff applications in a securities class action lawsuit against Allergan, Inc."
,,,Allergan to Present at the 2017 Morgan Stanley Global Healthcare Conference,2017-08-25 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-2017-morgan-stanley-120000972.html?.tsrc=rss,"DUBLIN, Aug. 25, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Maria Teresa Hilado and Chief Research and Development Officer David Nicholson will present at the 2017 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, NY.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors.  Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the 2017 Morgan Stanley Global Healthcare Conference,2017-08-25 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-2017-morgan-stanley-120000972.html?.tsrc=rss,"DUBLIN, Aug. 25, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Maria Teresa Hilado and Chief Research and Development Officer David Nicholson will present at the 2017 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, NY.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors.  Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,3 Top Healthcare Stocks to Buy Now,2017-08-25 03:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7MZ2L1ouyNw/3-top-healthcare-stocks-to-buy-now-cm836905,It s been a good year for healthcare stocks in general but a handful of quality companies haven t been swept upward with the rest of the sector Allergan plc NYSE AGN 160 and CVS Health Corp NYSE CVS are both poised to continue churning out profits and dividends for
,,,3 Top Healthcare Stocks to Buy Now,2017-08-25 03:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7MZ2L1ouyNw/3-top-healthcare-stocks-to-buy-now-cm836905,It s been a good year for healthcare stocks in general but a handful of quality companies haven t been swept upward with the rest of the sector Allergan plc NYSE AGN 160 and CVS Health Corp NYSE CVS are both poised to continue churning out profits and dividends for
AGN,AGN:US,BBG000FH8PX5,3 Top Healthcare Stocks to Buy Now,2017-08-25 02:03:00 +0000,http://finance.yahoo.com/r/eac8eed3-4bdc-3f94-b3e0-f092ee5b3815/3-top-healthcare-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,This year&apos;s healthcare rally hasn&apos;t swept these quality stocks along with the rest of the sector. At least not yet.
,,,3 Top Healthcare Stocks to Buy Now,2017-08-25 02:03:00 +0000,http://finance.yahoo.com/r/eac8eed3-4bdc-3f94-b3e0-f092ee5b3815/3-top-healthcare-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,This year&apos;s healthcare rally hasn&apos;t swept these quality stocks along with the rest of the sector. At least not yet.
,,,"Noteworthy ETF Inflows: VUG, BMY, NVDA, AGN",2017-08-23 19:39:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lp3t7cb3Q8Q/noteworthy-etf-inflows-vug-bmy-nvda-agn-cm836160,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 48 8 million dollar inflow that s a 0 2 increase week over week in outstanding units
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Inflows: VUG, BMY, NVDA, AGN",2017-08-23 19:39:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lp3t7cb3Q8Q/noteworthy-etf-inflows-vug-bmy-nvda-agn-cm836160,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 48 8 million dollar inflow that s a 0 2 increase week over week in outstanding units
,,,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins",2017-08-23 13:42:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8GxZmTpRSuk/the-zacks-analyst-blog-highlights-allergan-ecolab-exelon-glaxosmithkline-and-rockwell-collins-cm835892,For Immediate Release Chicago IL August 23 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins",2017-08-23 13:42:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8GxZmTpRSuk/the-zacks-analyst-blog-highlights-allergan-ecolab-exelon-glaxosmithkline-and-rockwell-collins-cm835892,For Immediate Release Chicago IL August 23 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
,,,Key Developments for Allergan in 2Q17,2017-08-23 13:07:03 +0000,http://finance.yahoo.com/r/4218f96d-aa02-3a03-87ef-cc660c3ad5eb/key-developments-for-allergan-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) is a leading pharmaceuticals company involved with pharmaceuticals, over-the-counter products, eye care, and aesthetics products."
AGN,AGN:US,BBG000FH8PX5,Key Developments for Allergan in 2Q17,2017-08-23 13:07:03 +0000,http://finance.yahoo.com/r/4218f96d-aa02-3a03-87ef-cc660c3ad5eb/key-developments-for-allergan-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) is a leading pharmaceuticals company involved with pharmaceuticals, over-the-counter products, eye care, and aesthetics products."
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins",2017-08-23 12:31:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-allergan-123112454.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins"
,,,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins",2017-08-23 12:31:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-allergan-123112454.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins"
AGN,AGN:US,BBG000FH8PX5,"Allergan Teams Up With Comedian Vanessa Bayer and OB/GYN Jessica Shepherd, M.D., M.B.A, to Debut the Know Your Birth Control Campaign",2017-08-23 12:30:00 +0000,https://finance.yahoo.com/news/allergan-teams-comedian-vanessa-bayer-123000507.html?.tsrc=rss,"""We are committed to women's health and believe it is important to provide a resource about birth control in a fresh and approachable way to address the misinformation that still exists,"" said Jim Maffezzoli, Vice President, Women's Healthcare, Allergan."
,,,"Allergan Teams Up With Comedian Vanessa Bayer and OB/GYN Jessica Shepherd, M.D., M.B.A, to Debut the Know Your Birth Control Campaign",2017-08-23 12:30:00 +0000,https://finance.yahoo.com/news/allergan-teams-comedian-vanessa-bayer-123000507.html?.tsrc=rss,"""We are committed to women's health and believe it is important to provide a resource about birth control in a fresh and approachable way to address the misinformation that still exists,"" said Jim Maffezzoli, Vice President, Women's Healthcare, Allergan."
AGN,AGN:US,BBG000FH8PX5,How Allergan’s International Segment Performed in 2Q17,2017-08-23 11:37:09 +0000,http://finance.yahoo.com/r/c09cbf72-70b9-3692-b2d7-35fb6772ed1b/how-allergans-international-segment-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan’s (AGN) international business includes total revenues from the sales of branded products as well as aesthetics products outside the US markets.
,,,How Allergan’s International Segment Performed in 2Q17,2017-08-23 11:37:09 +0000,http://finance.yahoo.com/r/c09cbf72-70b9-3692-b2d7-35fb6772ed1b/how-allergans-international-segment-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan’s (AGN) international business includes total revenues from the sales of branded products as well as aesthetics products outside the US markets.
,,,"ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-23 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-claimsfiler-reminds-025000288.html?.tsrc=rss,"NEW ORLEANS, Aug. 22, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 29, 2017 to file lead plaintiff applications in a securities class action ..."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-23 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-claimsfiler-reminds-025000288.html?.tsrc=rss,"NEW ORLEANS, Aug. 22, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 29, 2017 to file lead plaintiff applications in a securities class action ..."
,,,"Top Analyst Reports for Allergan, Ecolab & Exelon",2017-08-22 21:15:09 +0000,https://finance.yahoo.com/news/top-analyst-reports-allergan-ecolab-211509289.html?.tsrc=rss,"Top Analyst Reports for Allergan, Ecolab & Exelon"
AGN,AGN:US,BBG000FH8PX5,"Top Analyst Reports for Allergan, Ecolab & Exelon",2017-08-22 21:15:09 +0000,https://finance.yahoo.com/news/top-analyst-reports-allergan-ecolab-211509289.html?.tsrc=rss,"Top Analyst Reports for Allergan, Ecolab & Exelon"
AGN,AGN:US,BBG000FH8PX5,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN",2017-08-22 17:25:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-172500385.html?.tsrc=rss,"NEW YORK , Aug. 22, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Allergan, Inc. (NYSE: ..."
AGN,AGN:US,BBG000FH8PX5,How Did Allergan’s US General Medicines Segment Perform in 2Q17?,2017-08-22 14:36:52 +0000,http://finance.yahoo.com/r/5245b18f-0e3a-34f1-8256-d1346ace4394/how-did-allergans-us-general-medicines-segment-perform-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The US General Medicines segment reported revenues of $1.43 billion in 2Q17, a 1.5% decline as compared to $1.45 billion in 2Q16."
AGN,AGN:US,BBG000FH8PX5,How Allergan’s Segments Contributed to Overall Revenues,2017-08-22 11:37:40 +0000,http://finance.yahoo.com/r/ef40d8eb-e19d-3af4-abd3-77eefcacb823/how-allergans-segments-contributed-to-overall-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The US Specialized therapeutics business includes products from various therapeutic areas including eye care, medical aesthetics including skin care, facial aesthetics, plastic surgery and other products, ..."
,,,Will Conatus Key Candidate Emricasan Drive Long-Term Growth?,2017-08-21 23:37:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KeErzVeGmP4/will-conatus-key-candidate-emricasan-drive-long-term-growth-cm835019,On Aug 11 2017 we issued an updated report on Conatus Pharmaceuticals Inc CNAT Conatus s shares have significantly underperformed the industry so far this year having lost 4 9 as against the industry s 17 5 increase With no approved product in Conatus s portfolio at the
AGN,AGN:US,BBG000FH8PX5,Will Conatus Key Candidate Emricasan Drive Long-Term Growth?,2017-08-21 23:37:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KeErzVeGmP4/will-conatus-key-candidate-emricasan-drive-long-term-growth-cm835019,On Aug 11 2017 we issued an updated report on Conatus Pharmaceuticals Inc CNAT Conatus s shares have significantly underperformed the industry so far this year having lost 4 9 as against the industry s 17 5 increase With no approved product in Conatus s portfolio at the
AGN,AGN:US,BBG000FH8PX5,What Drove Allergan’s Revenues in 2Q17?,2017-08-21 21:05:58 +0000,http://finance.yahoo.com/r/2ecb4fe0-ef2d-365c-b0c3-18ea826d2668/what-drove-allergans-revenues-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Various factors like the strong performance of key brands and the acquisition of LifeCell and other brands contributed to Allergan’s (AGN) revenue growth in 2Q17.
AGN,AGN:US,BBG000FH8PX5,What’s Allergan’s Valuation after 2Q17 Earnings?,2017-08-21 19:11:26 +0000,http://finance.yahoo.com/r/276eff57-8f68-3ddf-8ae1-4f339b403897/whats-allergans-valuation-after-2q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan reported an 8.8% increase in its 2Q17 revenues to $4.0 billion as compared to $3.7 billion in 2Q16.
AGN,AGN:US,BBG000FH8PX5,What Are Appaloosa Management’s Largest Holdings?,2017-08-21 19:05:57 +0000,http://finance.yahoo.com/r/f4154d02-12ba-3b52-998d-0dbe2ba1278b/look-teppers-appaloosa-managements-largest-holdings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN), Alphabet (GOOG), Alibaba Group Holding (BABA), Micron Technology (MU), and Williams Partners (WPZ) are the top five holdings of David Tepper’s firm, Appaloosa Management."
AGN,AGN:US,BBG000FH8PX5,10 Companies with the Biggest 2016 Share Buybacks,2017-08-21 13:04:59 +0000,https://finance.yahoo.com/news/10-companies-biggest-2016-share-130459232.html?.tsrc=rss,Companies included on the S&P 500 index bought back more than $500 billion in stock last year and have bought back more than $4 trillion in shares since 2008.
AGN,AGN:US,BBG000FH8PX5,This Stock Could Be the Tesla of Healthcare,2017-08-20 19:37:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AZ070ir6vHs/this-stock-could-be-the-tesla-of-healthcare-cm834416,Some farsighted or just plain lucky investors bought shares of Tesla Motors NASDAQ TSLA early on They took a huge risk but that risk paid off Tesla stock is up nearly 1 400 since the company went public in 2010 Stocks like Tesla are a pretty rare species And they re
,,,This Stock Could Be the Tesla of Healthcare,2017-08-20 19:37:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AZ070ir6vHs/this-stock-could-be-the-tesla-of-healthcare-cm834416,Some farsighted or just plain lucky investors bought shares of Tesla Motors NASDAQ TSLA early on They took a huge risk but that risk paid off Tesla stock is up nearly 1 400 since the company went public in 2010 Stocks like Tesla are a pretty rare species And they re
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-19 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-025000004.html?.tsrc=rss,"NEW ORLEANS, Aug. 18, 2017-- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 29, 2017 to file lead plaintiff ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc – Value Analysis (NYSE:AGN) : August 18, 2017",2017-08-18 23:10:15 +0000,http://finance.yahoo.com/r/6b0cea44-51bc-39ca-a84d-9246c01e4487/allergan-plc-value-analysis-nyseagn-august-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Allergan Plc a score of 28. Our analysis is based on comparing Allergan Plc with the following peers – Mylan N.V., Zoetis, Inc. Class A, Merck & Co., Inc. and Abbott Laboratories (MYL-US, ZTS-US, MRK-US and ABT-US). Investment Outlook Allergan Plc has a fundamental score of 28 ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Cramer’s Exec Cut: The huge millennial influence on moder...,2017-08-18 23:09:00 +0000,https://finance.yahoo.com/video/cramer-exec-cut-huge-millennial-230900866.html?.tsrc=rss,Jim Cramer spoke with top CEOs throughout the summer months to find out how much influence the millennial generation has had on business.
AGN,AGN:US,BBG000FH8PX5,"Notable Friday Option Activity: AGN, UAA, HES",2017-08-18 18:37:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OzNRtjNuwWc/notable-friday-option-activity-agn-uaa-hes-cm834082,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 13 714 contracts has been traded thus far today a contract volume which is representative of approximately 1 4
,,,"Notable Friday Option Activity: AGN, UAA, HES",2017-08-18 18:37:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OzNRtjNuwWc/notable-friday-option-activity-agn-uaa-hes-cm834082,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 13 714 contracts has been traded thus far today a contract volume which is representative of approximately 1 4
AGN,AGN:US,BBG000FH8PX5,Shire Files Marketing Application for Lifitegrast in Europe,2017-08-16 23:37:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f_KnvLd1ZNs/shire-files-marketing-application-for-lifitegrast-in-europe-cm833067,Shire plc SHPG announced that it has submitted a Marketing Authorization Application MAA for lifitegrast for the treatment of dry eye disease in Europe In fact the application has been validated by the UK as the Reference Member State involved in the Decentralized Procedure DCP
,,,Shire Files Marketing Application for Lifitegrast in Europe,2017-08-16 23:37:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f_KnvLd1ZNs/shire-files-marketing-application-for-lifitegrast-in-europe-cm833067,Shire plc SHPG announced that it has submitted a Marketing Authorization Application MAA for lifitegrast for the treatment of dry eye disease in Europe In fact the application has been validated by the UK as the Reference Member State involved in the Decentralized Procedure DCP
AGN,AGN:US,BBG000FH8PX5,Shire Files Marketing Application for Lifitegrast in Europe,2017-08-16 21:18:09 +0000,https://finance.yahoo.com/news/shire-files-marketing-application-lifitegrast-211809670.html?.tsrc=rss,Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.
AGN,AGN:US,BBG000FH8PX5,"Black, Jewish Goldman Sachs executive sues firm for discr...",2017-08-16 21:16:00 +0000,https://finance.yahoo.com/video/black-jewish-goldman-sachs-executive-211600641.html?.tsrc=rss,"Goldman VP Rebecca Allen spent years trying to land Allergan's CEO, Brent Saunders, as a private wealth management client, her suit says."
AGN,AGN:US,BBG000FH8PX5,"Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices",2017-08-16 19:03:00 +0000,http://finance.yahoo.com/r/b6817ee8-0262-3c07-ba34-44ad27fe1f82/black-jewish-goldman-executive-sues-firm-over-discriminatory-practices.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A Goldman spokesman said that the firm believes the case is 'without merit' and that they will 'vigorously contest it.'
AGN,AGN:US,BBG000FH8PX5,"Black, Jewish Goldman Sachs exec sues firm for discrimination over Allergan CEO client bid",2017-08-16 18:17:06 +0000,https://finance.yahoo.com/news/black-jewish-goldman-sachs-exec-181706695.html?.tsrc=rss,The complaint also blasts Goldman for having few blacks in leadership positions.
AGN,AGN:US,BBG000FH8PX5,"Black, Jewish Goldman Sachs exec sues firm for discrimination over Allergan CEO client bid",2017-08-16 18:17:06 +0000,http://finance.yahoo.com/r/675f6a4c-ebf5-3c77-819e-41eb4bda5244/104656451?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104656451&yptr=yahoo&.tsrc=rss,The complaint also blasts Goldman for having few blacks in leadership positions.
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the 2017 Wells Fargo Healthcare Conference,2017-08-16 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-2017-wells-fargo-120000880.html?.tsrc=rss,"DUBLIN, Aug. 16, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2017 Wells Fargo Healthcare Conference in Boston, Massachusetts.  The presentation will begin at 12:00 p.m. Eastern Time on Thursday, September 7, 2017.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-16 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-claimsfiler-reminds-025000519.html?.tsrc=rss,"NEW ORLEANS , Aug. 15, 2017 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 29, 2017 to file lead plaintiff applications in a securities ..."
AGN,AGN:US,BBG000FH8PX5,Are Amgen's New Drugs Doing Well Enough to Drive Sales?,2017-08-15 15:43:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J8IoSwR2b5Y/are-amgens-new-drugs-doing-well-enough-to-drive-sales-cm832237,We issued an updated research report on Amgen Inc AMGN on Aug 14 The leading biotech beat estimates on both earnings amp sales in the second quarter the results of which were announced on Jul 25 While Amgen slightly tightened the sales guidance it raised the earnings outlook backed by
,,,Are Amgen's New Drugs Doing Well Enough to Drive Sales?,2017-08-15 15:43:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J8IoSwR2b5Y/are-amgens-new-drugs-doing-well-enough-to-drive-sales-cm832237,We issued an updated research report on Amgen Inc AMGN on Aug 14 The leading biotech beat estimates on both earnings amp sales in the second quarter the results of which were announced on Jul 25 While Amgen slightly tightened the sales guidance it raised the earnings outlook backed by
AGN,AGN:US,BBG000FH8PX5,"[$$] Merck, Allergan, Lilly: Top Pharma Picks",2017-08-15 15:18:00 +0000,http://finance.yahoo.com/r/09002060-25c1-36c0-9b27-ae054c4ca643/merck-allergan-lilly-top-pharma-picks-1502810319?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  With second-quarter earnings behind us and a couple weeks until important medical meetings kick off, we expect (and hope for!) two quieter weeks in pharmaceuticals, until things ramp up again with European Society of Cardiology (ESC) at the end of this month and then European Society for Medical Oncology (ESMO) in mid-September.  Merck (MRK) remains our top pick with ESMO, KN-189 data upcoming.  ESMO will be a relatively quieter meeting for Merck this year from a data perspective but we expect continued discussion around the potential uses of Keytruda while awaiting the topline data from the confirmatory KEYNOTE-189 study in the September/October timeframe, which we expect to be positive."
,,,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for August 16, 2017",2017-08-15 13:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LnzwhS6BoE/allergan-plc-agn-ex-dividend-date-scheduled-for-august-16-2017-cm832073,Allergan plc AGN will begin trading ex dividend on August 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on September 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
AGN,AGN:US,BBG000FH8PX5,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for August 16, 2017",2017-08-15 13:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LnzwhS6BoE/allergan-plc-agn-ex-dividend-date-scheduled-for-august-16-2017-cm832073,Allergan plc AGN will begin trading ex dividend on August 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on September 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
AGN,AGN:US,BBG000FH8PX5,Pfizer’s Declining-Revenue Products in 2Q17,2017-08-15 11:36:43 +0000,http://finance.yahoo.com/r/6a6eb8be-826d-366f-89b1-e22fdcc5e854/pfizers-declining-revenue-products-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,We discussed the products that contribute to the growth of Pfizer’s (PFE) revenues in 2Q17. Let's now take a look at the products that have impacted revenue growth in 2Q17.
AGN,AGN:US,BBG000FH8PX5,Shire applies for European approval of potential blockbuster eye drop,2017-08-15 10:00:10 +0000,http://finance.yahoo.com/r/041aecb9-9515-3f04-8cf0-b2cad1ad6649/shire-applies-for-european-approval-of-potential.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"One of the state’s biggest biotech employers, Shire plc, has applied for European approval for its potential blockbuster eye drop to treat dry eye disease, sold by the name of Xiidra in the U.S.  The drug, a twice-a-day eye drop that goes by the generic name of lifitegrast, was approved in the U.S. in August 2016.  It’s touted as the “first and only” drug in the world to treat the signs and symptoms of dry eye disease, and competes head-to-head with Restasis, a similarly-priced drug sold by Allergan plc (AGN) that’s approved to increase tear production due to inflammation."
AGN,AGN:US,BBG000FH8PX5,Big-name U.S. hedge funds shed healthcare stocks during the rally in Q2,2017-08-14 19:42:44 +0000,https://finance.yahoo.com/news/big-name-u-hedge-funds-164646394.html?.tsrc=rss,"Several big-name hedge fund  investors trimmed their stakes in healthcare companies in the  second quarter as the sector led the broad U.S. stock market  higher, rallying amid a Republican effort to repeal and replace  President Obama's signature healthcare law.  Jana Partners sold all of its shares in nine healthcare  companies, ranging from small-cap biotech company Acadia  Pharmaceuticals Inc to health information company WebMD  Health Corp to insurer Aetna Inc, according to  quarterly filings released Monday."
AGN,AGN:US,BBG000FH8PX5,"IWD, SLB, USB, AGN: Large Outflows Detected at ETF",2017-08-14 16:34:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_w7qhKgQYRU/iwd-slb-usb-agn-large-outflows-detected-at-etf-cm831718,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF Symbol IWD where we have detected an approximate 426 5 million dollar outflow that s a 1 2 decrease week over week
,,,"IWD, SLB, USB, AGN: Large Outflows Detected at ETF",2017-08-14 16:34:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_w7qhKgQYRU/iwd-slb-usb-agn-large-outflows-detected-at-etf-cm831718,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF Symbol IWD where we have detected an approximate 426 5 million dollar outflow that s a 1 2 decrease week over week
AGN,AGN:US,BBG000FH8PX5,"Ex-Dividend Reminder: Bio-Techne, Allergan and Park National",2017-08-14 15:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/soDIX7LC6oY/ex-dividend-reminder-bio-techne-allergan-and-park-national-cm831656,Looking at the universe of stocks we cover at Dividend Channel on 8 16 17 Bio Techne Corp Symbol TECH Allergan PLC Symbol AGN and Park National Corp Symbol PRK will all trade ex dividend for their respective upcoming dividends Bio Techne Corp will pay its quarterly dividend
,,,"Ex-Dividend Reminder: Bio-Techne, Allergan and Park National",2017-08-14 15:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/soDIX7LC6oY/ex-dividend-reminder-bio-techne-allergan-and-park-national-cm831656,Looking at the universe of stocks we cover at Dividend Channel on 8 16 17 Bio Techne Corp Symbol TECH Allergan PLC Symbol AGN and Park National Corp Symbol PRK will all trade ex dividend for their respective upcoming dividends Bio Techne Corp will pay its quarterly dividend
AGN,AGN:US,BBG000FH8PX5,Jim Cramer Says Allergan Shares Are 'Just Too Cheap',2017-08-14 13:38:00 +0000,http://finance.yahoo.com/r/a2df6c4c-ef58-32fc-ae75-3ca7335e9106/jim-cramer-says-allergan-shares-are-just-too-cheap.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stockpicker may boost his charitable trust's AGN stake.
AGN,AGN:US,BBG000FH8PX5,Why Jim Cramer Likes Allergan,2017-08-14 13:11:00 +0000,http://finance.yahoo.com/r/2d63fcc1-e071-3781-89ab-4d7d2275484b/why-jim-cramer-likes-allergan.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,He says the stock is 'just too cheap' to pass up.
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-08-14 12:03:10 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120310189.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,"Seth Klarman Buys Synchrony Financial, Antero Resources Corp, Qorvo Inc, Sells Innoviva Inc, ...",2017-08-12 17:34:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TRWPIftn0Wc/seth-klarman-buys-synchrony-financial-antero-resources-corp-qorvo-inc-sells-innoviva-inc-cm831349,Seth Klarman New Purchases CAR SRC SRUN Added Positions SYF AR QRVO ESRX CAH FWP PRTK Reduced Positions LNG CACC BATRK Sold Out INVA MCK SRUNU LVNTA SYT ABC New Purchases CAR SRC SRUN New Purchases
AGN,AGN:US,BBG000FH8PX5,Edited Transcript of AGN earnings conference call or presentation 3-Aug-17 12:30pm GMT,2017-08-12 14:31:02 +0000,https://finance.yahoo.com/news/edited-transcript-agn-earnings-conference-201448968.html?.tsrc=rss,Q2 2017 Allergan plc Earnings Call
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-08-12 12:02:45 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120245178.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN)",2017-08-12 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-025000504.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 29, 2017 to file lead plaintiff applications in a securities class action lawsuit against Allergan, Inc."
AGN,AGN:US,BBG000FH8PX5,[$$] Drug industry faces 'tidal wave' of litigation over opioid crisis,2017-08-11 15:38:03 +0000,"http://finance.yahoo.com/r/ae33356e-0923-3caf-b4b7-ebf23af9ed6e/36e93cee-7e39-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Companies that make or distribute opioid painkillers are facing a ""tidal wave"" of litigation as US officials seek to raise funds to fight the country's addiction epidemic and punish those they ..."
AGN,AGN:US,BBG000FH8PX5,Look Under The Hood: MOAT Has 11% Upside,2017-08-11 14:37:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SBqGgQJ8BSo/look-under-the-hood-moat-has-11-upside-cm830859,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
AGN,AGN:US,BBG000FH8PX5,More than half of women who got an abortion last year were using contraception,2017-08-11 14:27:52 +0000,http://finance.yahoo.com/r/3a61f8b0-fb11-33bf-809d-37354e3a40cd/Story.aspx?guid=2EFB0DFE-76C9-11E7-AFDF-0F22D3C10305&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Contraception like condoms, birth control pills and IUDs usually work, but they don’t always work."
AGN,AGN:US,BBG000FH8PX5,See what the IHS Markit Score report has to say about Allergan plc.,2017-08-11 12:03:58 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120358702.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AGN,AGN:US,BBG000FH8PX5,Company Spotlight: Adamas Pharma,2017-08-11 06:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d3hSFHmSjyo/company-spotlight-adamas-pharma-20170811-00169,Company Spotlight: Adamas Pharma
,,,Company Spotlight: Adamas Pharma,2017-08-11 06:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d3hSFHmSjyo/company-spotlight-adamas-pharma-20170811-00169,Company Spotlight: Adamas Pharma
AGN,AGN:US,BBG000FH8PX5,"AGN: Rosen Law Firm Reminds Allergan, Inc. Investors of Important Deadline in Class Action – AGN",2017-08-11 00:30:00 +0000,https://finance.yahoo.com/news/agn-rosen-law-firm-reminds-003000438.html?.tsrc=rss,"NEW YORK, Aug. 10, 2017-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan, Inc. from February 25, 2014 through April 21, 2014, inclusive of the important ..."
AGN,AGN:US,BBG000FH8PX5,Allergan's Preferred Series A Shares Cross 6.5% Yield Mark,2017-08-10 19:37:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eHsVlSjF5ZQ/allergans-preferred-series-a-shares-cross-65-yield-mark-cm830460,In trading on Thursday shares of Allergan PLC s 5 500 Mandatory Convertible Preferred Shares Series A Symbol AGN PRA were yielding above the 6 5 mark based on its quarterly dividend annualized to 55 00 with shares changing hands as low as 842 44 on the day As of last close AGN PRA
AGN,AGN:US,BBG000FH8PX5,Here's Why Synergy Pharmaceuticals Inc. Is Falling Today,2017-08-10 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcqjUOSw7Wc/heres-why-synergy-pharmaceuticals-inc-is-falling-today-cm830301,What happened After posting a much higher loss than Wall Street expected shares of Synergy Pharmaceuticals NASDAQ SGYP a commercial stage biopharma focused on diseases of the gastrointestinal system fell as much as 13 in early morning trading on Thursday before they started
AGN,AGN:US,BBG000FH8PX5,"Aegon Turns To Profit In Q2 On Gains, Higher Sales; To Resume Dividends",2017-08-10 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RlU6o06GHc0/aegon-turns-to-profit-in-q2-on-gains-higher-sales-to-resume-dividends-20170810-00059,"Aegon Turns To Profit In Q2 On Gains, Higher Sales; To Resume Dividends"
,,,"Aegon Turns To Profit In Q2 On Gains, Higher Sales; To Resume Dividends",2017-08-10 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RlU6o06GHc0/aegon-turns-to-profit-in-q2-on-gains-higher-sales-to-resume-dividends-20170810-00059,"Aegon Turns To Profit In Q2 On Gains, Higher Sales; To Resume Dividends"
AGN,AGN:US,BBG000FH8PX5,"Teva Plunges to 10-Year Low, Credit Rating in Jeopardy",2017-08-09 23:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S6-RxKPsHN0/teva-plunges-to-10-year-low-credit-rating-in-jeopardy-cm829875,Shares of Teva Pharmaceuticals TEVA a favorite for investors chasing large dividend yields fell more than 4 4 and hit a 10 year intraday low on Wednesday Just says after the company reported sluggish Q2 earnings investors are continuing to ditch the stock amid reports that Teva
AGN,AGN:US,BBG000FH8PX5,"Teva Plunges to 10-Year Low, Credit Rating in Jeopardy",2017-08-09 21:21:09 +0000,https://finance.yahoo.com/news/teva-plunges-10-low-credit-212109342.html?.tsrc=rss,"Shares of Teva Pharmaceuticals (TEVA), a favorite for investors chasing large dividend yields, fell more than 4.4%--and hit a 10-year intraday low--on Wednesday."
AGN,AGN:US,BBG000FH8PX5,"Allergan Mandatory Convertible Preferred Shares, Series A About To Put More Money In Your Pocket",2017-08-09 18:36:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4EirsqwJbSE/allergan-mandatory-convertible-preferred-shares-series-a-about-to-put-more-money-in-your-pocket-cm829656,On 8 11 17 Allergan PLC s 5 500 Mandatory Convertible Preferred Shares Series A Symbol AGN PRA will trade ex dividend for its quarterly dividend of 13 75 payable on 9 1 17 As a percentage of AGN PRA s recent share price of 862 06 this dividend works out to approximately 1 60 so
AGN,AGN:US,BBG000FH8PX5,Drugmaker Teva looks to sell Medis business to help cut debt,2017-08-09 14:02:05 +0000,https://finance.yahoo.com/news/drugmaker-teva-looks-sell-medis-140205661.html?.tsrc=rss,"Teva Pharmaceutical Industries  , the world's largest generic drugmaker, said on  Wednesday it was looking for a buyer for its Medis business as  it sells assets to pare down its debt burden.  Teva, which last week reported a drop in  second-quarter results and cut its outlook and dividend,  acquired Iceland-based Medis as part of its acquisition of  Actavis last year.  ""Teva is looking at every opportunity to focus our business  and streamline operations, processes and structure,"" Teva said  in an emailed statement to Reuters."
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-09 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-025000843.html?.tsrc=rss,"NEW ORLEANS , Aug. 8, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have until ..."
AGN,AGN:US,BBG000FH8PX5,Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?,2017-08-08 20:37:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T0buUMNrdkI/synergy-pharmaceuticals-inc-tanked-142-in-july-but-why-cm829006,What happened Synergy Pharmaceuticals NASDAQ SGYP a commercial stage biopharma focused on gastrointestinal diseases fell more than 14 in July according to data from S amp P Global Market Intelligence However there wasn t any news released during the month that
AGN,AGN:US,BBG000FH8PX5,"As Drug Overdoses Hit Record High, Trump Offers Little on Opioid Policy",2017-08-08 17:59:21 +0000,https://finance.yahoo.com/news/cdc-reports-record-high-rate-175921883.html?.tsrc=rss,More than 60% of overdose deaths in 2015 were related to opioid drugs.
AGN,AGN:US,BBG000FH8PX5,"Eos Focused Equity Management, L.P. Buys Univar Inc, Natus Medical Inc, General Electric Co, ...",2017-08-08 14:34:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gDLfdsL41mI/eos-focused-equity-management-lp-buys-univar-inc-natus-medical-inc-general-electric-co-cm828732,Eos Focused Equity Management L P New Purchases UNVR BABY GE SYF SMHI IPXL Added Positions ARNC CKH LILAK POST CAG SEE VVV Reduced Positions NWL NUVA CHTR LMNX CHUBK PJT DHR BIVV APD BCO Sold Out PK TGI BAX KLXI HLT New
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 8, 2017",2017-08-08 13:16:32 +0000,http://finance.yahoo.com/r/9ffe8ea8-3e9a-3c9b-8ce3-cbe2bf6ae8d0/allergan-plc-breached-its-50-day-moving-average-in-a-bearish-manner-agn-us-august-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Allergan's Brent Saunders Is Charging Into Medical Aesthetics. Should Others Follow?,2017-08-08 12:04:00 +0000,http://finance.yahoo.com/r/e79cb7d6-dea1-3d4b-97f4-04cbee41a992/allergans-brent-saunders-is-charging-into-medical-aesthetics-should-others-follow?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Allergan is not abandoning R&D in major diseases. Rather, it has 35% of its portfolio in relatively low-risk, lower cost R&D that can sustain its investments in far more challenging therapeutic areas."
AGN,AGN:US,BBG000FH8PX5,Allergan: Cramer's Top Takeaways,2017-08-08 10:39:00 +0000,http://finance.yahoo.com/r/c10e442e-a70d-3777-b518-d66885b86f7e/allergan-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Brent Saunders, chairman and CEO of Allergan, tells Jim Cramer he's bullish on new treatments for depression."
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: More millennials and men turn to aesthetic ...,2017-08-07 23:24:00 +0000,https://finance.yahoo.com/video/allergan-ceo-more-millennials-men-232400160.html?.tsrc=rss,Jim Cramer sat down with Allergan CEO Brent Saunders to hear how the 'selfie generation' is turning to aesthetic enhancements.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: This tech stock was one of the greatest bar...,2017-08-07 23:01:00 +0000,https://finance.yahoo.com/video/cramer-remix-tech-stock-one-230100375.html?.tsrc=rss,Jim Cramer puts the market into perspective and reveals the high-flying tech company that was cheaper than many investors had thought.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: This tech stock was one of the greatest bargains of all time,2017-08-07 22:59:53 +0000,https://finance.yahoo.com/news/cramer-remix-tech-stock-one-225953441.html?.tsrc=rss,Jim Cramer puts the market into perspective and reveals the high-flying tech company that was cheaper than many investors had thought.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: This tech stock was one of the greatest bargains of all time,2017-08-07 22:59:53 +0000,http://finance.yahoo.com/r/ce917246-ed07-371c-8568-038e7282bbf0/104637125?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104637125&yptr=yahoo&.tsrc=rss,Jim Cramer puts the market into perspective and reveals the high-flying tech company that was cheaper than many investors had thought.
AGN,AGN:US,BBG000FH8PX5,Allergan CEO sees more millennials and men turning to aes...,2017-08-07 22:40:00 +0000,https://finance.yahoo.com/video/allergan-ceo-sees-more-millennials-224000657.html?.tsrc=rss,Jim Cramer sat down with Allergan CEO Brent Saunders to hear how the 'selfie generation' is turning to aesthetic enhancements.
AGN,AGN:US,BBG000FH8PX5,Allergan CEO sees more millennials and men turning to aesthetic medical treatments,2017-08-07 22:22:20 +0000,https://finance.yahoo.com/news/allergan-ceo-sees-more-millennials-222220212.html?.tsrc=rss,Jim Cramer sat down with Allergan CEO Brent Saunders to hear how the &apos;selfie generation&apos; is turning to aesthetic enhancements.
AGN,AGN:US,BBG000FH8PX5,Allergan CEO sees more millennials and men turning to aesthetic medical treatments,2017-08-07 22:22:20 +0000,http://finance.yahoo.com/r/b9b6003f-49ab-31d9-9e9a-7725186f852a/104637382?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104637382&yptr=yahoo&.tsrc=rss,Jim Cramer sat down with Allergan CEO Brent Saunders to hear how the 'selfie generation' is turning to aesthetic enhancements.
AGN,AGN:US,BBG000FH8PX5,Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire,2017-08-07 16:13:00 +0000,http://finance.yahoo.com/r/a2dfd6c8-1eeb-3ac3-8204-45395e18e9b5/pfizer-s-poor-earnings-feed-the-allergan-tie-up-fire.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,All eyes are on Pfizer in the months ahead.
AGN,AGN:US,BBG000FH8PX5,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 15:55:01 +0000,https://finance.yahoo.com/news/every-generation-drug-people-dealing-155501149.html?.tsrc=rss,"The state of Ohio sues pharmaceutical companies for pushing painkillers. Missouri cops carry opioid antidotes in their cars. Judges everywhere play doctor, forcing abusers to choose between anti-addiction ..."
AGN,AGN:US,BBG000FH8PX5,FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years,2017-08-07 12:00:00 +0000,https://finance.yahoo.com/news/fda-approves-medicines360s-snda-liletta-120000892.html?.tsrc=rss,"DUBLIN AND SAN FRANCISCO, Aug. 7, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines, announced that the U.S. Food and Drug Administration (FDA) approved Medicines360's Supplemental New Drug Application (sNDA) to extend the duration of use of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg for the prevention of pregnancy for up to four years.  ""The newly approved indication for LILETTA is an important milestone in our work to make this IUD available to women, in partnership with Allergan,"" said Jessica Grossman, M.D., CEO of Medicines360."
AGN,AGN:US,BBG000FH8PX5,Corporate News Blog - Mallinckrodt to Acquire InfaCare Pharmaceutical and its Developmental Product Stannsoporfin,2017-08-07 11:00:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-mallinckrodt-acquire-110000683.html?.tsrc=rss,"Research Desk Line-up: Allergan Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 7, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Mallinckrodt ..."
AGN,AGN:US,BBG000FH8PX5,Validea Joseph Piotroski Strategy Daily Upgrade Report - 8/5/2017,2017-08-05 12:59:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bfpvsCK7NgA/validea-joseph-piotroski-strategy-daily-upgrade-report-852017-cm827673,The following are today s upgrades for Validea s Book Market Investor model based on the published strategy of Joseph Piotroski This value quant strategy screens for high book to market stocks and then separates out financially sound firms by looking at a host of improving financial criteria
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-05 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-claimsfiler-reminds-025000165.html?.tsrc=rss,"NEW ORLEANS, Aug. 04, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 29, 2017 to file lead plaintiff applications in a securities class action ..."
AGN,AGN:US,BBG000FH8PX5,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, It’s a Guillotine",2017-08-04 19:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hNtbTvkoEXk/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-not-a-falling-knife-its-a-guillotine-cm827499,InvestorPlace Stock Market News Stock Advice amp Trading Tips Fundamentally I am not here to argue for value in Teva Pharmaceutical Industries Ltd ADR NYSE TEVA It is expensive on a fundamental basis Furthermore it s facing operational challenges and competition
AGN,AGN:US,BBG000FH8PX5,Analysts Still Like Allergan,2017-08-04 18:12:49 +0000,https://finance.yahoo.com/news/analysts-still-allergan-181249687.html?.tsrc=rss,"Following Allergan plc Ordinary Shares (NYSE: AGN ) second-quarter results , UBS still likes the company. Analyst Marc Goodman said, despite the beat-and-raise quarter, investors are skeptical concerning ..."
AGN,AGN:US,BBG000FH8PX5,"Teva Q2 Earnings Lag, '17 View & Dividend Cut, Stock Slumps",2017-08-04 16:05:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DlQMZMjR9Ms/teva-q2-earnings-lag-17-view-dividend-cut-stock-slumps-cm827296,Teva Pharmaceutical Industries Limited TEVA reported second quarter 2017 earnings of 99 cents per share including equity compensation expenses which missed the Zacks Consensus Estimate of 1 06 per share by 6 6 The year ago adjusted earnings were 1 22 per share Revenues of 5 69
AGN,AGN:US,BBG000FH8PX5,"Ironwood (IRWD) Q2 Loss Widens, Revenues Miss, Stock Up",2017-08-04 16:03:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yZKQWNaHvdw/ironwood-irwd-q2-loss-widens-revenues-miss-stock-up-cm827222,Ironwood Pharmaceuticals Inc IRWD reported second quarter 2017 adjusted loss of 28 cents per share wider than both the Zacks Consensus Estimate of a loss of 23 cents and the year ago loss of 16 cents Total revenue collaborative revenue in the quarter amounted to 65 1 million up 19
AGN,AGN:US,BBG000FH8PX5,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, It’s a Guillotine",2017-08-04 14:40:55 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-144055959.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
AGN,AGN:US,BBG000FH8PX5,"Ironwood (IRWD) Q2 Loss Widens, Revenues Miss, Stock Up",2017-08-04 14:20:02 +0000,https://finance.yahoo.com/news/ironwood-irwd-q2-loss-widens-142002948.html?.tsrc=rss,"Ironwood Pharmaceuticals&apos; (IRWD) second-quarter results were dismal, missing sales and earnings estimates."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals",2017-08-04 14:02:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ORWtwFM3l7Q/pharma-stock-roundup-mixed-2q-results-from-pfizer-bristol-myers-announces-io-deals-cm827183,This week companies like Pfizer PFE Allergan AGN and Teva TEVA reported second quarter results While Pfizer reported a mixed quarter Allergan topped expectations Teva however had a tough quarter Meanwhile Bristol Myers BMY announced immune oncology IO focused deals including
AGN,AGN:US,BBG000FH8PX5,Lilly's acute migraine drug succeeds in late-stage study,2017-08-04 13:43:57 +0000,https://finance.yahoo.com/news/lillys-acute-migraine-drug-succeeds-111827565.html?.tsrc=rss,"Drugmaker Eli Lilly and Co said on  Friday its acute migraine drug lasmiditan succeeded in a key  late-stage study, setting the stage for U.S. regulatory  approval.  About 40 million Americans suffer from migraine - intense  headaches characterized by throbbing pain and sensitivity to  light and nausea.  The size of the migraine market is expected to balloon to  more than $10 billion in 2025 from $3 billion in 2015 in the  United States and other developed countries, healthcare research  firm Decision Resources Group said last year."
AGN,AGN:US,BBG000FH8PX5,Allergan reports 2Q loss,2017-08-04 06:28:35 +0000,https://finance.yahoo.com/news/allergan-reports-2q-loss-120241966.html?.tsrc=rss,"On a per-share basis, the Dublin-based company said it had a loss of $2.37. Earnings, adjusted for one-time gains and costs, came to $4.02 per share. The results surpassed Wall Street expectations. The ..."
AGN,AGN:US,BBG000FH8PX5,Dow Stretches Record-Making Streak Into Day Seven With Small Gains,2017-08-04 00:00:00 +0000,http://finance.yahoo.com/r/19f83143-55d6-3acd-a365-598ed2befbc1/dow-stretches-record-making-streak-into-day-seven-with-small-gains.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are mixed Thursday.
AGN,AGN:US,BBG000FH8PX5,Cramer: This Bull Will Gore You Without a Thought,2017-08-03 23:01:00 +0000,http://finance.yahoo.com/r/0a3618ed-eb1b-3f2c-8dbe-f2d2eda8d1ad/cramer-bull-will-gore-you-without-thought?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Remain vigilant about companies and disciplined about your buys.
AGN,AGN:US,BBG000FH8PX5,Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone,2017-08-03 20:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GmUb1OO_gqU/heres-why-teva-pharmaceutical-industries-ltd-adr-is-sinking-like-a-stone-cm826768,What happened In response to reporting rough second quarter results shares of Teva Pharmaceutical Industries NYSE TEVA a leading provider of generic drugs dropped 24 as of 1 15 p m EDT on Thursday So what Here s a review of the key takeaways from the company
AGN,AGN:US,BBG000FH8PX5,"Why Allergan Is Stagnant Despite Beating Views, Raising Outlook",2017-08-03 20:00:49 +0000,http://finance.yahoo.com/r/04fe7aba-05e9-307a-9900-d342088dac82/allergan-boosts-2017-outlook-after-beating-q2-forecasts?src=A00220&yptr=yahoo&.tsrc=rss,Allergan on Thursday reported adjusted income of $4.02 per share on revenue of $4.01 billion. Analysts had called for adjusted earnings of $3.95 a share on $3.95 billion in sales.
AGN,AGN:US,BBG000FH8PX5,Allergan Posts Better-Than-Expected Second Quarter Earnings,2017-08-03 19:16:00 +0000,http://finance.yahoo.com/r/bfd65695-bbbd-3f18-97f7-2f16cb81c356/allergan-stock-falls-on-second-quarter-earnings-miss.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Allergan reports a narrower-than-expected per-share loss as products were hindered by patent exclusivity.
AGN,AGN:US,BBG000FH8PX5,Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back,2017-08-03 19:15:00 +0000,http://finance.yahoo.com/r/e3956f72-2ac3-3e2c-8b10-fbd0d456df9f/allergan-just-can-t-break-through-despite-a-ton-of-positive-catalysts-at-its-back.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Allergan's earnings weren't sterling, but with the fourth quarter conventionally standing as their strongest, here's what investors can look forward to."
AGN,AGN:US,BBG000FH8PX5,Here&apos;s Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone,2017-08-03 18:35:00 +0000,http://finance.yahoo.com/r/3142e620-ea78-312f-a47a-b29b8d77030f/heres-why-teva-pharmaceuticals-industries-ltd-adr.aspx?yptr=yahoo&.tsrc=rss,Shares plunge after the company reports dreadful second-quarter results and slashes its dividend payment.
AGN,AGN:US,BBG000FH8PX5,2 factors driving the generics market: Wells Fargo Securi...,2017-08-03 18:09:00 +0000,https://finance.yahoo.com/video/2-factors-driving-generics-market-180900847.html?.tsrc=rss,"David Maris, Wells Fargo Securities, discusses the outlook for generic drug companies in the pharmaceutical sector."
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down",2017-08-03 17:02:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TbIf27IsIbQ/allergan-agn-q2-earnings-sales-top-restasis-sales-down-cm826643,Allergan plc s AGN second quarter 2017 earnings came in at 4 02 per share beating the Zacks Consensus Estimate of 3 95 by 1 8 Earnings rose 20 year over year driven by higher revenues and operating profits Revenues came in at 4 01 billion up 8 8 from the year ago period and beat
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter,2017-08-03 17:01:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LqEO3NSL3hc/teva-pharmaceutical-industries-ltd-slashes-full-year-outlook-after-disappointing-second-quarter-cm826591,Buying the Actavis Generics business from Allergan NYSE AGN made the difference for Teva Pharmaceutical Industries Ltd NYSE TEVA when it reported first quarter results in May That deal boosted Teva s revenue and earnings Teva announced its second quarter results
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q2 Earnings & Sales; Shares Down,2017-08-03 16:06:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kbPLL91tFxE/allergan-agn-beats-q2-earnings-sales-shares-down-cm826566,Dublin Ireland based Allergan plc AGN is engaged in the development manufacturing marketing sale and distribution of branded pharmaceuticals and select over the counter products Allergan has been actively pursuing deals to expand its portfolio especially its branded products offering
AGN,AGN:US,BBG000FH8PX5,"PFF, AGN, HSBC, DB: ETF Inflow Alert",2017-08-03 16:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gyPIg5M08LQ/pff-agn-hsbc-db-etf-inflow-alert-cm826482,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 62 6 million dollar inflow that s a 0 3 increase week over week
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down",2017-08-03 14:50:02 +0000,https://finance.yahoo.com/news/allergan-agn-q2-earnings-sales-145002505.html?.tsrc=rss,Allergan plc (AGN) beat estimates for both earnings and sales in Q2. The company raised its 2017 outlook. Shares were down slightly in pre-market trading.
AGN,AGN:US,BBG000FH8PX5,"Dow Tries to Hold in the Green, but Rest of Market Slides",2017-08-03 14:15:00 +0000,http://finance.yahoo.com/r/5ad454e3-7dc6-3e94-982f-cb615adc57f7/stock-market-hits-pause-after-dow-s-string-of-record-highs.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are mixed Thursday.
AGN,AGN:US,BBG000FH8PX5,Three Large Cap Pharma Picks That Can Outperform This Year,2017-08-03 13:59:00 +0000,http://finance.yahoo.com/r/68c61681-2905-37d1-9c43-12263f22d83a/three-large-cap-pharma-picks-that-can-outperform-this-year-1501768796?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Most large cap U.S. pharmaceuticals companies have already reported second quarter earnings by this point, which means that the focus for the remainder of the year will continue to be macro questions and pressures amid a limited number of catalysts capable of changing sentiment on the sector.  Divan writes that positive product news could provide upside for stocks, but this could be offset by fewer important pipeline readouts and the ongoing debate about drug pricing.  As we move through the back half of the year, Divan argues that sentiment should improve in the sector if significant reforms focusing on drug pricing appear to remain rather low-priority in Washington."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q2 Earnings & Sales; Shares Down,2017-08-03 13:37:01 +0000,https://finance.yahoo.com/news/allergan-agn-beats-q2-earnings-133701281.html?.tsrc=rss,"Allergan plc (AGN) beat expectations for both earnings and sales in the second quarter. However, shares declined in pre-market trading."
AGN,AGN:US,BBG000FH8PX5,Botox-maker Allergan's quarterly profit beats estimates,2017-08-03 12:39:18 +0000,https://finance.yahoo.com/news/botox-maker-allergans-quarterly-profit-123918624.html?.tsrc=rss,"Botox-maker Allergan Plc reported a better-than-expected quarterly profit, helped by strength in its medical aesthetics unit, prompting the drugmaker to raise its full-year revenue forecast. The company ..."
AGN,AGN:US,BBG000FH8PX5,"Wall Street set to open flat after Dow breaks 22,000; jobless claims in focus",2017-08-03 12:35:25 +0000,http://finance.yahoo.com/r/db9be9b1-a26d-37cd-b779-a4e30606eb3f/104629344?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104629344&yptr=yahoo&.tsrc=rss,"U.S. stock index futures pointed to a lower open on Thursday after the Dow Jones broke the 22,000 milestone for the first time ever."
AGN,AGN:US,BBG000FH8PX5,"Wall Street set to open flat after Dow breaks 22,000; jobless claims in focus",2017-08-03 12:35:25 +0000,https://finance.yahoo.com/news/wall-street-set-open-flat-123525362.html?.tsrc=rss,"U.S. stock index futures pointed to a lower open on Thursday after the Dow Jones broke the 22,000 milestone for the first time ever."
AGN,AGN:US,BBG000FH8PX5,"Allergan reports Q2 profit, revenue beats",2017-08-03 12:28:14 +0000,http://finance.yahoo.com/r/6ad94812-5ff9-3b5f-9ce9-c6d1413a2c89/Story.aspx?guid=074263A7-2653-4704-9129-A465A475ECBD&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC reported second-quarter profit and revenue beats early Thursday. The company said it had a loss of $795.5 million, or a loss of $2.37 per share, wider than a loss of $571.3 million, or a loss ..."
AGN,AGN:US,BBG000FH8PX5,Botox-maker Allergan quarterly revenue rises 9 pct,2017-08-03 12:10:26 +0000,https://finance.yahoo.com/news/botox-maker-allergan-quarterly-revenue-121026806.html?.tsrc=rss,"Drugmaker Allergan Plc posted a 9 percent rise in quarterly revenue, helped by strength in its medical aesthetics unit. Net loss attributable to ordinary shareholders widened to $795.5 million, or $2.37 ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion,2017-08-03 11:51:00 +0000,https://finance.yahoo.com/news/allergan-reports-continued-strong-execution-115100875.html?.tsrc=rss,- Q2 2017 GAAP Continuing Operations Loss Per Share of $2.35 ; Q2 Non-GAAP Performance Net Income Per Share of $4.02 - - Q2 2017 GAAP Operating Loss from Continuing Operations of $902.4 Million ; Q2 Non-GAAP ...
AGN,AGN:US,BBG000FH8PX5,"Teva Stares Into Abyss as It Slashes Forecast, Dividends",2017-08-03 10:51:42 +0000,http://finance.yahoo.com/r/2dcc4e7a-cc66-36c2-8724-88e7e26ba9b3/israel-s-teva-cuts-profit-forecast-again-pares-dividend-payment?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd., which has been without a permanent CEO for six months, revealed the full extent of the challenges facing its next leader by announcing more job cuts, a retreat from ..."
AGN,AGN:US,BBG000FH8PX5,"Earnings Reaction History: Allergan Inc, 66.7% Follow-Through Indicator, 3.0% Sensitive",2017-08-03 10:34:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AOORHzKIjrE/earnings-reaction-history-allergan-inc-667-follow-through-indicator-30-sensitive-cm826221,Expected Earnings Release 08 03 2017 PremarketExpected Earnings Release 08 03 2017 Premarket Avg Extended Hours Dollar Volume 20 023 773Avg Extended Hours Dollar Volume 20 023 773 Allergan Inc AGN is due to issue its quarterly earnings report in the upcoming extended hours
AGN,AGN:US,BBG000FH8PX5,Investor Network: Allergan plc to Host Earnings Call,2017-08-03 10:15:00 +0000,https://finance.yahoo.com/news/investor-network-allergan-plc-host-101500093.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Allergan plc (NYSE: AGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 8:30 AM Eastern Time. ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17",2017-08-03 08:31:00 +0000,,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17"
AGN,AGN:US,BBG000FH8PX5,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17",2017-08-03 08:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IMxFQ11uyO0/allergan-q2-attributable-net-loss--widens-lifts-revenue-guidance-for-fy17-20170803-01024,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17"
,,,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17",2017-08-03 08:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IMxFQ11uyO0/allergan-q2-attributable-net-loss--widens-lifts-revenue-guidance-for-fy17-20170803-01024,"Allergan Q2 Attributable Net Loss  Widens, Lifts Revenue Guidance For FY17"
,,,Allergan  Inc. Reports 3% Rise In Q2 Profit,2017-08-03 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JWEGKwFgWE4/allergan--inc-reports-3-rise-in-q2-profit-20170803-00920,Allergan  Inc. Reports 3% Rise In Q2 Profit
AGN,AGN:US,BBG000FH8PX5,Allergan  Inc. Reports 3% Rise In Q2 Profit,2017-08-03 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0lt29c42684/allergan--inc-reports-3%25-rise-in-q2-profit-20170803-00920,Allergan  Inc. Reports 3% Rise In Q2 Profit
AGN,AGN:US,BBG000FH8PX5,Allergan  Inc. Reports 3% Rise In Q2 Profit,2017-08-03 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JWEGKwFgWE4/allergan--inc-reports-3-rise-in-q2-profit-20170803-00920,Allergan  Inc. Reports 3% Rise In Q2 Profit
AGN,AGN:US,BBG000FH8PX5,Allergan Q2 17 Earnings Conference Call At 8:30 AM ET,2017-08-03 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6PrfHeMNhEo/allergan-q2-17-earnings-conference-call-at-830-am-et-20170803-00735,Allergan Q2 17 Earnings Conference Call At 8:30 AM ET
,,,Allergan Q2 17 Earnings Conference Call At 8:30 AM ET,2017-08-03 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6PrfHeMNhEo/allergan-q2-17-earnings-conference-call-at-830-am-et-20170803-00735,Allergan Q2 17 Earnings Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,5 Stocks that are Earnings All-Stars,2017-08-02 22:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6xdJVYNcThk/5-stocks-that-are-earnings-all-stars-cm826097,This week is one of the busiest of the entire earnings season Over 1300 companies are expected to report this week But not all companies are created equal Some have a history of beating the consensus nearly every quarter In spite of what people think it s not easy to beat nearly
AGN,AGN:US,BBG000FH8PX5,5 Stocks that are Earnings All-Stars,2017-08-02 21:02:09 +0000,https://finance.yahoo.com/news/5-stocks-earnings-stars-210209417.html?.tsrc=rss,"These companies have perfect, or near perfect, earnings surprise records over the last 5 years."
AGN,AGN:US,BBG000FH8PX5,"Close Update: Dow Hits Sixth Straight Record High as 22,000 Breached",2017-08-02 20:54:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l_4MuMDFucg/close-update-dow-hits-sixth-straight-record-high-as-22000-breached-cm826064,For a sixth straight day the Dow Jones Industrial Average ended at a record high with the index crossing 22 000 for the first time ever as Apple AAPL lifted the blue chip index But the tech giant s rally couldn t do as much for the other benchmarks For a sixth straight day the Dow
AGN,AGN:US,BBG000FH8PX5,"Pre-Market Earnings Report for August 3, 2017 :  AGN, DUK, EPD, AET, SHPG, REGN, BDX, BCE, CTSH, ICE, ENB, CNQ",2017-08-02 20:13:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjzLqh2wJxg/pre-market-earnings-report-for-august-3-2017-agn-duk-epd-aet-shpg-regn-bdx-bce-ctsh-ice-enb-cnq-cm826059,The following companies are expected to report earnings prior to market open on 08 03 2017 Visit our Earnings Calendar for a full list of expected earnings releases Allergan plc AGN is reporting for the quarter ending June 30 2017 The medical company
AGN,AGN:US,BBG000FH8PX5,"Daily Dividend Report: AAPL, AGN, SYK, KMB, SMG, D",2017-08-02 16:57:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pbHQk07nFi0/daily-dividend-report-aapl-agn-syk-kmb-smg-d-cm825824,Apple has declared a cash dividend of 0 63 per share of the Company s common stock The dividend is payable on August 17 2017 to shareholders of record as of the close of business on August 14 2017 Allergan AGN announced the record and payment dates for a cash dividend of 0 70
AGN,AGN:US,BBG000FH8PX5,Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2,2017-08-02 16:00:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rV6wVStSKyA/aerie-aeri-reports-narrower-than-expected-loss-in-q2-cm825758,Aerie Pharmaceuticals Inc AERI posted second quarter 2017 loss of 82 cents per share including stock based compensation narrower than the Zacks Consensus Estimate of a loss of 84 cents and the year ago loss of 87 cents Being a development stage company Aerie has not generated
AGN,AGN:US,BBG000FH8PX5,Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2,2017-08-02 14:10:02 +0000,https://finance.yahoo.com/news/aerie-aeri-reports-narrower-expected-141002793.html?.tsrc=rss,"Aerie Pharmaceuticals, Inc.&apos;s (AERI) narrower-than-expected loss in the second quarter was encouraging."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Third Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share,2017-08-02 12:00:00 +0000,https://finance.yahoo.com/news/allergan-announces-third-quarter-2017-120000205.html?.tsrc=rss,"-- Dividend to be Paid on September 15, 2017 -- DUBLIN , Aug. 2, 2017 /PRNewswire/ -- Allergan plc (NYSE:AGN) today announced the record and payment dates for a cash dividend of $0.70 per ordinary share ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Shareholder Alert by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-08-02 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-025000456.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 29, 2017 to file lead plaintiff applications in a securities ..."
AGN,AGN:US,BBG000FH8PX5,Hedge Funds' Favorite Health Care Stocks Reporting Earnings This Week,2017-08-01 23:31:07 +0000,https://finance.yahoo.com/news/hedge-funds-favorite-health-care-233107141.html?.tsrc=rss,The global health care industry continues growth streak
AGN,AGN:US,BBG000FH8PX5,"David Carlson Buys First Republic Bank, United Rentals Inc, Applied Materials Inc, Sells ...",2017-08-01 18:54:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AsMLbeWAhH8/david-carlson-buys-first-republic-bank-united-rentals-inc-applied-materials-inc-sells-cm825235,David Carlson New Purchases FRC AVGO AZO Added Positions URI AMAT ALXN CRM MSFT SCHW LBTYK Reduced Positions AMZN LOW ABT INTU V PYPL SIRI COO VRTX AAPL Sold Out QCOM ADP New Purchases FRC AVGO AZO
AGN,AGN:US,BBG000FH8PX5,[$$] Pfizer Waiting for Cues on Tax Reform to Pursue Deals,2017-08-01 17:19:20 +0000,http://finance.yahoo.com/r/18bd490e-865e-3eae-a212-8aada86343ed/pfizer-sales-miss-expectations-on-increased-competition-1501586549?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Pfizer, reporting a drop in second-quarter sales, says it wants to wait to see what happens with tax reform in Washington before deciding on any big mergers or acquisitions"
AGN,AGN:US,BBG000FH8PX5,"Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out",2017-07-31 20:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/li-AiVxSQu4/pfizer-inc-pfe-stock-isnt-the-sexiest-but-its-worth-checking-out-cm824577,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE isn t the sexiest stock in the market but that doesn t mean investors shouldn t be interested PFE stock is up more than 2 in 2017 but down nearly 10 over the past year Now may be as good
AGN,AGN:US,BBG000FH8PX5,3 Dividend Stocks That Outperform the Big Techs,2017-07-31 18:30:00 +0000,http://finance.yahoo.com/r/0f5a7c42-0cf4-37c7-9096-3a7ac326600f/3-dividend-stocks-outperform-big-techs?partner=YahooSA&yptr=yahoo&.tsrc=rss,Blossoming Returns: 3 stocks with future dividend growth are outperforming the tech-heavy Nasdaq 100
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) to Report Q2 Earnings: What's in the Cards?,2017-07-31 16:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GRMxqv27mGg/allergan-agn-to-report-q2-earnings-whats-in-the-cards-cm824328,Allergan plc AGN will be reporting second quarter 2017 earnings on Aug 3 before the market opens Last quarter the company delivered a positive earnings surprise of 0 90 Allergan s share price is up 20 5 this year so far outperforming the 0 4 increase witnessed by the
AGN,AGN:US,BBG000FH8PX5,"Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out",2017-07-31 16:20:38 +0000,https://finance.yahoo.com/news/pfizer-inc-pfe-stock-isn-162038282.html?.tsrc=rss,"Pfizer Inc. (NYSE:PFE) isn’t the sexiest stock in the market, but that doesn’t mean investors shouldn’t be interested.  PFE stock is up more than 2% in 2017, but down nearly 10% over the past year.  Pfizer is probably best known for Viagra, but it’s got other brands, too, such as Eliquis, Lipitor and Celebrex, among others."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) to Report Q2 Earnings: What&apos;s in the Cards?,2017-07-31 14:48:02 +0000,https://finance.yahoo.com/news/allergan-agn-report-q2-earnings-144802846.html?.tsrc=rss,"While Allergan plc&apos;s (AGN) Q2 sales are likely to be driven by new as well as established products and international growth, earnings will likely be driven by sales growth and cost control."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Q2 Earnings Results from Merck, Lilly, Bristol-Myers & More",2017-07-31 13:58:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6oRUXJ7Xm1g/pharma-stock-roundup-q2-earnings-results-from-merck-lilly-bristol-myers-more-cm824039,Last week several pharma majors reported second quarter results Meanwhile important study data was released by Merck MRK and AstraZeneca AZN Recap of the Week s Most Important Stories A Look at Q2 Earnings Results Big pharma companies like Merck Lilly LLY Glaxo
AGN,AGN:US,BBG000FH8PX5,Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration,2017-07-31 13:00:00 +0000,https://finance.yahoo.com/news/amgen-allergan-submit-biosimilar-biologics-130000027.html?.tsrc=rss,"THOUSAND OAKS, Calif., July 31, 2017 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 980, a biosimilar candidate to Herceptin® (trastuzumab).  Amgen and Allergan are collaborating on four oncology biosimilar medicines, including ABP 980 which is the second to be submitted for FDA approval."
AGN,AGN:US,BBG000FH8PX5,Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA,2017-07-31 09:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCRmCGdjAgc/amgen-and-allergan-submit-biosimilar-bla-for-abp-980-to-fda-20170731-00787,Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA
,,,Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA,2017-07-31 09:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCRmCGdjAgc/amgen-and-allergan-submit-biosimilar-bla-for-abp-980-to-fda-20170731-00787,Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN)",2017-07-29 02:50:00 +0000,https://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-025000732.html?.tsrc=rss,"NEW ORLEANS, July 28, 2017-- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 29, 2017 to file lead plaintiff ..."
AGN,AGN:US,BBG000FH8PX5,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. – AGN",2017-07-29 01:24:16 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-012416785.html?.tsrc=rss,"NEW YORK, July 28, 2017-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Allergan, Inc. from February 25, ..."
AGN,AGN:US,BBG000FH8PX5,"U.S. Senator expands opioid probe to distributors, drugmakers",2017-07-27 19:38:25 +0000,https://finance.yahoo.com/news/u-senator-expands-opioid-probe-190757511.html?.tsrc=rss,"U.S. Democratic Senator Claire McCaskill  on Thursday expanded an investigation into the causes of the  opioid crisis plaguing the country, seeking information from  four more drugmakers and three drug distributors.  The investigation comes at a time when lawmakers and  regulators take steps to combat the epidemic of opioid  addiction, with 91 Americans dying everyday as a result of  overdose, according to the U.S. Centers for Disease Control and  Prevention.  McCaskill requested for documents and information from  opioid manufacturers Mallinckrodt Plc, Endo  International Plc, Teva Pharmaceutical and  Allergan Plc."
AGN,AGN:US,BBG000FH8PX5,[$$] McCaskill Expands Probe Into Opioid Addiction Crisis,2017-07-27 14:05:12 +0000,http://finance.yahoo.com/r/b330179a-d776-31ab-bd9d-6f10414362c5/senator-expands-probe-into-opioid-addiction-crisis-1501158600?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Sen. Claire McCaskill asked four more drug companies and three distributors to provide documents and explain steps they have taken to stop prescription painkillers from being diverted to the black market....
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Inflows: PFF, AGN, HSBC, DB",2017-07-26 15:59:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LcO0PHZ7Q3M/noteworthy-etf-inflows-pff-agn-hsbc-db-cm821678,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 137 2 million dollar inflow that s a 0 7 increase week over week
AGN,AGN:US,BBG000FH8PX5,These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now,2017-07-26 13:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X04rQfJPW80/these-2-pharma-giants-may-be-on-pfizers-ma-radar-right-now-cm821381,Despite overcoming a whopping 23 billion in branded patent expirations over the course of 2011 to 2016 and returning to growth on an operational basis Wall Street thinks Pfizer NYSE PFE still has a lot more to work to do The basic issue is that Pfizer is barreling toward
AGN,AGN:US,BBG000FH8PX5,"Notable Tuesday Option Activity: MU, WMT, AGN",2017-07-25 17:01:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--stU3eHnU4/notable-tuesday-option-activity-mu-wmt-agn-cm820994,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Micron Technology Inc Symbol MU where a total of 126 425 contracts have traded so far representing approximately 12 6 million underlying shares That amounts to about 42 4 of MU
AGN,AGN:US,BBG000FH8PX5,"Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN",2017-07-24 21:22:00 +0000,https://finance.yahoo.com/news/pawar-law-group-announces-filing-212200261.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 24, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Allergan, Inc. (NYSE: AGN) investors who purchased Allergan stock between February 25, 2014 ..."
AGN,AGN:US,BBG000FH8PX5,"Trump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says",2017-07-22 14:00:00 +0000,http://finance.yahoo.com/r/5c4f7af8-a319-3de6-91fc-39b583e1d1ae/trump-could-still-unleash-an-attack-on-amazon-real-soon-doug-kass-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's the call.
AGN,AGN:US,BBG000FH8PX5,S&P 500 Analyst Moves: AGN,2017-07-19 17:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b1URGVMOULA/sp-500-analyst-moves-agn-cm818174,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Allergan AGN is now the 90 analyst pick moving up by 1 spot This rank is formed by averaging the analyst opinions for each component from each broker
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Inflows: PFF, AGN, HSBC, DB",2017-07-18 16:05:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h8vgY8r0QQM/noteworthy-etf-inflows-pff-agn-hsbc-db-cm817536,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 171 8 million dollar inflow that s a 0 9 increase week over week
AGN,AGN:US,BBG000FH8PX5,Paratek Antibiotic Candidate's Phase III Data Favorable,2017-07-18 14:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/97Tm-JpNaHI/paratek-antibiotic-candidates-phase-iii-data-favorable-cm817469,Paratek Pharmaceuticals Inc PRTK announced positive results from a phase III study OASIS 2 comparing its antibiotic candidate omadacycline to Pfizer Inc s PFE Zyvox for the treatment of acute bacterial skin and skin structure infections ABSSSI The study met the key primary and
AGN,AGN:US,BBG000FH8PX5,"Intermede Investment Partners Ltd Buys Oracle Corp, CME Group Inc, Wells Fargo, Sells Fidelity ...",2017-07-18 12:03:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pxzt6SJuOZQ/intermede-investment-partners-ltd-buys-oracle-corp-cme-group-inc-wells-fargo-sells-fidelity-cm817299,Intermede Investment Partners Ltd New Purchases ORCL Added Positions CME WFC AGN TJX SCHW ECL Reduced Positions GOOG ANSS BABA Sold Out FIS CHKP New Purchases ORCL New Purchases ORCL Added Positions CME
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Monday Option Activity: VHC, AGN, BIIB",2017-07-17 20:48:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V7Jv8djLPiM/noteworthy-monday-option-activity-vhc-agn-biib-cm817130,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in VirnetX Holding Corp Symbol VHC where a total volume of 1 970 contracts has been traded thus far today a contract volume which is representative of approximately 197
AGN,AGN:US,BBG000FH8PX5,Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod,2017-07-17 16:46:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YtVzMUfzqQw/mylans-biosimilar-herceptin-gets-fda-advisory-committee-nod-cm816954,Mylan N V MYL and partner Biocon Ltd announced that the FDA Oncologic Drugs Advisory Committee ODAC unanimously recommended approval of its biosimilarversion of Roche s RHHBY breast cancer drug Herceptin trastuzumab In fact the FDA s ODAC voted 16 to 0 in favor of biosimilar
AGN,AGN:US,BBG000FH8PX5,Valeant Unloads Yet Another Unit,2017-07-17 15:30:00 +0000,http://finance.yahoo.com/r/341b0be9-5e6f-31eb-be40-2fa9c3ae61c7/valeant-pharmaceuticals-the-fire-sale-continues-1500305414?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund.  The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018.  The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load."
AGN,AGN:US,BBG000FH8PX5,Inside Allergan’s International Business,2017-07-17 14:37:52 +0000,http://finance.yahoo.com/r/2529749b-5374-3344-ab02-204ee7f1b047/inside-allergans-international-business?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan's International segment reported revenues of $737.3 million for 1Q17, which was 9.5% higher than the $673.3 million it reported in 1Q16."
AGN,AGN:US,BBG000FH8PX5,How Allergan’s US General Medicines Segment Performed,2017-07-17 13:06:47 +0000,http://finance.yahoo.com/r/9d346ecb-290d-30a6-a0d2-6cfa12267f9e/how-allergans-us-general-medicines-segment-performed?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The US General Medicines segment reported revenues of $1.35 billion in 1Q17, which marked a 7.4% decline from its $1.45 billion in 1Q16."
AGN,AGN:US,BBG000FH8PX5,How Allergan’s US Specialized Therapeutics Segment Performed,2017-07-17 11:37:28 +0000,http://finance.yahoo.com/r/fb3b4e7e-b138-3fa4-8854-74b0fb23c9b3/how-allergans-us-specialized-therapeutics-segment-performed?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan’s (AGN) US Specialized Therapeutics segment includes branded products from a range of therapeutic areas.
AGN,AGN:US,BBG000FH8PX5,Behind Allergan’s Business Segments and Revenues,2017-07-14 14:37:44 +0000,http://finance.yahoo.com/r/b8409c6e-f373-352f-9106-5f6264a12f14/behind-allergans-business-segments-and-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan's (AGN) business has undergone several changes over the past few years due to acquisitions and divestitures.
AGN,AGN:US,BBG000FH8PX5,Understanding Allergan’s Revenue Stream for 2017,2017-07-14 13:09:13 +0000,http://finance.yahoo.com/r/ed484376-0010-31e3-b5c8-aa9d2b8dede0/understanding-allergans-revenue-stream-for-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan's revenues are driven by the strong performance of products under its key brands as well as the inclusion of revenues from LifeCell and other acquisitions.
AGN,AGN:US,BBG000FH8PX5,What Allergan’s Valuation as of July 13 Tells Us,2017-07-14 11:40:11 +0000,http://finance.yahoo.com/r/96c0385a-c5b0-39cc-9bbf-5a5641d2578f/what-allergans-valuation-as-of-july-13-tells-us?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"For 2Q17, Wall Street analysts estimate AGN's EPS (earnings per share) to come in at $3.93, which would be a 17.5% growth over 2Q16."
AGN,AGN:US,BBG000FH8PX5,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%",2017-07-14 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7aTL7pt1MeE/fda-panel-backs-2-biosimilars-aldr-abuzz-mdxg-q2-revenue-grows-33-20170714-00061,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%"
,,,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%",2017-07-14 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7aTL7pt1MeE/fda-panel-backs-2-biosimilars-aldr-abuzz-mdxg-q2-revenue-grows-33-20170714-00061,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%"
AGN,AGN:US,BBG000FH8PX5,Cramer: Mea culpa! This stock's action is why I say small...,2017-07-13 22:59:00 +0000,https://finance.yahoo.com/video/cramer-mea-culpa-stocks-action-225900388.html?.tsrc=rss,"Jim Cramer admits he was too eager about the stock of Alder BioPharmaceuticals, which just took a huge hit."
AGN,AGN:US,BBG000FH8PX5,Inside Allergan’s Developments in 2Q17,2017-07-13 21:33:58 +0000,http://finance.yahoo.com/r/c2a41bf5-03e9-382f-a7df-7bf0e36a56e5/inside-allergans-developments-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) is a US-based pharmaceuticals company that deals in over-the-counter products, eye care products, and aesthetics products."
AGN,AGN:US,BBG000FH8PX5,Allergan Lends Support to Broaden Uterine Fibroid Awareness Month,2017-07-13 13:00:00 +0000,https://finance.yahoo.com/news/allergan-lends-support-broaden-uterine-130000110.html?.tsrc=rss,"DUBLIN, July 13, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced its support of the White Dress Project and its efforts to expand uterine fibroid education and awareness.   Allergan's Women's Health franchise is providing a donation to help the organization push for Uterine Fibroid Awareness Month to be observed nationally.  Currently, only New York, Florida, and Georgia have passed resolutions marking July as Uterine Fibroid Awareness Month.[i] Led by The White Dress Project, efforts are underway to expand Fibroid Awareness throughout the U.S., with the ultimate goal of having it become a national observance.  Uterine fibroids are abnormal growths that develop in or on a woman's uterus."
AGN,AGN:US,BBG000FH8PX5,"Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab)",2017-07-13 12:00:00 +0000,https://finance.yahoo.com/news/amgen-allergan-discuss-data-supporting-120000429.html?.tsrc=rss,"THOUSAND OAKS, Calif., July 13, 2017 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced that the Companies will discuss data supporting the ABP 215 Biologics License Application (BLA) with the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA).  ABP 215 is a biosimilar candidate to Avastin® (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.  ""Amgen has worked diligently to apply our more than 35 years of experience in biotechnology to the development of biosimilars,"" said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen."
AGN,AGN:US,BBG000FH8PX5,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track",2017-07-13 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hzBiyLUIVzY/nvs-gets-thumbs-up-two-biosimilar-candidates-to-face-fda-panel-vktx-on-track-20170713-00059,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track"
,,,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track",2017-07-13 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hzBiyLUIVzY/nvs-gets-thumbs-up-two-biosimilar-candidates-to-face-fda-panel-vktx-on-track-20170713-00059,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track"
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Positive New Data on Irritable Bowl Drug,2017-07-11 22:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nD2EhBsyE_8/allergan-reports-positive-new-data-on-irritable-bowl-drug-cm814761,Allergan plc AGN has announced encouraging results from a pooled analysis of two phase III studies evaluating the efficacy and safety of its marketed drug Viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea IBS D Notably the drug is
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Positive New Data on Irritable Bowl Drug,2017-07-11 20:29:08 +0000,https://finance.yahoo.com/news/allergan-reports-positive-data-irritable-202908454.html?.tsrc=rss,"Allergan plc (AGN) has announced positive data from a pooled analysis of two phase III studies, evaluating its marketed drug Viberzi (eluxadoline) for treatment of adults suffering from irritable bowel syndrome with diarrhea (IBS-D)."
AGN,AGN:US,BBG000FH8PX5,"As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals",2017-07-11 19:12:00 +0000,https://finance.yahoo.com/news/treasury-moves-bring-back-inversions-182800622.html?.tsrc=rss,The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.
AGN,AGN:US,BBG000FH8PX5,"PFF, AGN, HSBC, DB: ETF Inflow Alert",2017-07-11 16:44:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8AWp97Ol6w/pff-agn-hsbc-db-etf-inflow-alert-cm814492,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 91 6 million dollar inflow that s a 0 5 increase week over week
AGN,AGN:US,BBG000FH8PX5,See America Furthers The Fight Against Preventable Blindness With #EyePic Campaign,2017-07-11 12:07:00 +0000,https://finance.yahoo.com/news/see-america-furthers-fight-against-120700987.html?.tsrc=rss,"DUBLIN, July 11, 2017 /PRNewswire/ -- Allergan plc (AGN), a global leader in eye care for nearly 70 years, today unveiled #EyePic, an exciting new online awareness campaign as part of the See America initiative to fight preventable blindness and visual impairment in the United States.  #EyePic will use the power of social media to broaden awareness of preventable blindness, promote discussion around eye health and ultimately encourage all Americans to visit their eye doctors for comprehensive eye exams."
AGN,AGN:US,BBG000FH8PX5,A Look at Allergan’s Performance in 2Q17,2017-07-11 11:36:41 +0000,http://finance.yahoo.com/r/e38f1c69-4348-35e8-a54c-8bcb98fde9f1/a-look-at-allergans-performance-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Headquartered in Dublin, Ireland, Allergan (AGN) is a leading pharmaceutical company focused on generic and specialty pharmaceutical products. The company has divided its business into three segments: ..."
AGN,AGN:US,BBG000FH8PX5,Lilly Gets Favorable Ruling in Alimta Patent Lawsuit in UK,2017-07-10 15:52:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xMu7Cfg6emk/lilly-gets-favorable-ruling-in-alimta-patent-lawsuit-in-uk-cm813829,Eli Lilly and Company LLY announced that it has received favorable ruling from the UK Supreme Court in a patent lawsuit against generic drugmaker Actavis related to its key cancer drug Alimta pemetrexed disodium Per the court s verdict alternative salt forms of Alimta launched by
AGN,AGN:US,BBG000FH8PX5,InPlay from Briefing.com,2017-07-10 14:55:49 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
AGN,AGN:US,BBG000FH8PX5,"Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® (Eluxadoline) to Treat the Symptoms Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D), Abdominal Pain and Diarrhea",2017-07-10 14:30:00 +0000,https://finance.yahoo.com/news/allergan-reports-data-reinforcing-effectiveness-143000727.html?.tsrc=rss,"-- Viberzi® proven safe and effective in patients who reported inadequate response to prior loperamide use1 -- DUBLIN , July 10, 2017 /PRNewswire/ -- Allergan plc (NYSE:AGN) announced additional results ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Celgene Offer Solid Biotech Value",2017-07-07 20:30:00 +0000,http://finance.yahoo.com/r/e77058be-dfbe-3b99-8202-ade00f74ba9a/allergan-celgene-offer-solid-biotech-value.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The two giants likely won't be home runs, but they remain stalwarts in the biotech space."
AGN,AGN:US,BBG000FH8PX5,"AGN NOTICE: Rosen Law Firm Reminds Allergan, Inc. Investors of Important Deadline in Class Action",2017-07-07 20:19:00 +0000,https://finance.yahoo.com/news/agn-notice-rosen-law-firm-201900005.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan, Inc. from February 25, 2014 through April 21, 2014, inclusive of the important August 29, 2017 lead plaintiff deadline in the class action."
AGN,AGN:US,BBG000FH8PX5,US Pharmaceuticals: Mergers and Acquisitions in 2Q17,2017-07-07 19:51:29 +0000,http://finance.yahoo.com/r/505fca13-53fe-3d01-b2b9-0d49cda317d3/us-pharmaceuticals-mergers-and-acquisitions-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The US pharmaceutical sector comprises different setups pertaining to the development, manufacturing, production, and marketing of drugs. Let's look at its performance in 2Q17."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Celgene Offer Solid Biotech Value",2017-07-07 17:30:00 +0000,http://finance.yahoo.com/r/cb6173c0-a7ea-3616-80a8-bd1c39cbb882/allergan-celgene-offer-solid-biotech-value?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The two giants likely won't be home runs, but they remain stalwarts in the biotech space."
AGN,AGN:US,BBG000FH8PX5,UK Supreme Court rules in Eli Lilly's favor in drug dispute,2017-07-07 14:05:04 +0000,https://finance.yahoo.com/news/uk-supreme-court-rules-eli-140504719.html?.tsrc=rss,Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drug-maker Actavis over Lilly's Alimta cancer treatment. The court announced Friday that Actavis products ...
AGN,AGN:US,BBG000FH8PX5,UK Supreme Court rules in Eli Lilly's favor in drug dispute,2017-07-07 14:05:04 +0000,http://finance.yahoo.com/r/b2e2f91a-1dc3-36b7-8dd2-a2681d9d875c/uk-supreme-court-rules-eli-140504719.html?.tsrc=rss,LONDON (AP) — Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drug-maker Actavis over Lilly's Alimta cancer treatment.
AGN,AGN:US,BBG000FH8PX5,UK Supreme Court Rules in Lilly's Favor: Actavis Infringed on European Vitamins Patents,2017-07-07 14:02:00 +0000,http://finance.yahoo.com/r/6872f3a3-e7ea-3509-8478-c762ce22ce53/uk-supreme-court-rules-in-lilly-s-favor-actavis-infringed-on-european-vitamins-patents.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Lilly sued Actavis, saying its generic product would still infringe on Lilly's vitamin regimens regardless of any dilution."
AGN,AGN:US,BBG000FH8PX5,Eli Lilly Wins Cancer Drug Patent Case at U.K. Supreme Court,2017-07-07 11:33:13 +0000,http://finance.yahoo.com/r/cfcee8f9-7c34-3e2e-8419-df4602922dd7/elli-lilly-wins-cancer-drug-patent-case-at-u-k-supreme-court-j4ts8kkj?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&trackingId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Eli Lilly & Co. won a patent dispute with Actavis at the U.K.’s top court, marking a victory in a long-running legal campaign to defend its third best-selling drug, Alimta, from rival products."
AGN,AGN:US,BBG000FH8PX5,10 Attractively Valued Stocks With Competitive Edge,2017-07-05 23:14:00 +0000,http://finance.yahoo.com/r/f215b011-ac2b-39f0-bed9-09f15bf082bb/several-attractively-valued-stocks-with-competitive-advantages?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Market's continued resilience and advance make stock picking more difficult
AGN,AGN:US,BBG000FH8PX5,How To YieldBoost Allergan To 4.3% Using Options,2017-07-05 17:46:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rDFQHgxe90w/how-to-yieldboost-allergan-to-43-using-options-cm811954,Shareholders of Allergan PLC Symbol AGN looking to boost their income beyond the stock s 1 1 annualized dividend yield can sell the January 2019 covered call at the 290 strike and collect the premium based on the 12 10 bid which annualizes to an additional 3 2 rate of return against
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan, Inc. (AGN) & Lead Plaintiff Deadline: August 29, 2017",2017-07-05 14:10:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141000681.html?.tsrc=rss,"NEW YORK , July 5, 2017 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Allergan, Inc. (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Long-Term Performance of Hedge Funds’ Popular Picks,2017-07-03 15:55:32 +0000,http://finance.yahoo.com/r/51f4ab4f-9bcc-37ba-8f7c-67a58e8b7f5c/long-term-performance-of-hedge-funds-popular-picks-588657?yptr=yahoo&.tsrc=rss,"Despite the recent years of poor performance, hedge funds are still great at picking stocks, as they always have been. Because most hedge funds operate with hundreds of millions of dollars, they can afford to employ resources that are not available to other investors. Moreover, because they usually invest high amounts of money in a […]"
AGN,AGN:US,BBG000FH8PX5,Alkermes Presents Phase III Data on Schizophrenia Candidate,2017-07-03 15:49:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WIXkp83thro/alkermes-presents-phase-iii-data-on-schizophrenia-candidate-cm811221,Alkermes plc ALKS announced positive preliminary top line results from a phase III study ENLIGHTEN 1 evaluating its schizophrenia candidate ALKS 3831 It is a supportive study in the broad clinical development program ENLIGTHEN on ALKS 3831 We note that ALKS 3831 is a once daily
AGN,AGN:US,BBG000FH8PX5,Finding Value in Biotech?,2017-07-03 14:14:00 +0000,http://finance.yahoo.com/r/d634d985-bc32-34a9-a642-02f4d895aef6/finding-value-in-biotech-1499091291?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Biotech stocks are often considered among the faster-growing stocks in the market. But a number of them--Amgen (AMGN) Biogen (BIIB), and Gilead Sciences (GILD), for instance--are part of the Russell 1000 ..."
AGN,AGN:US,BBG000FH8PX5,Allergan to Report Second Quarter 2017 Earnings and Host Conference Call and Webcast,2017-07-03 11:30:00 +0000,https://finance.yahoo.com/news/allergan-report-second-quarter-2017-113000445.html?.tsrc=rss,"DUBLIN, July 3, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced it intends to release second quarter 2017 financial results on Thursday, August 3, 2017, prior to the open of U.S. Financial Markets.  Allergan will host a conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 3, 2017 to discuss its financial results.  The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 65876037."
AGN,AGN:US,BBG000FH8PX5,Looking At The Long-Term Performance of Hedge Funds’ Popular Picks from 2015,2017-07-01 17:43:42 +0000,http://finance.yahoo.com/r/f28e8208-0693-3f12-91c4-dc169f3e1c1a/looking-at-the-long-term-performance-of-hedge-funds-popular-picks-from-2015-588385?yptr=yahoo&.tsrc=rss,"If you want to have a glimpse at how expert investors play the stock market, you can do so by looking at the long-term performance of hedge funds’ popular picks from 2015. Hedge funds may be right or wrong in the short term about a particular stock or sector. Predicting short term share price action […]"
AGN,AGN:US,BBG000FH8PX5,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc.",2017-07-01 01:03:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-010300648.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of investors that sold the call options, purchased the put options and/or sold equity forward contracts of Allergan, Inc."
AGN,AGN:US,BBG000FH8PX5,Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing,2017-06-30 21:21:00 +0000,http://finance.yahoo.com/r/44702e48-5608-3539-8250-b85c16f8c386/pharma-firms-hit-with-lawsuit-from-oklahoma-ag-over-opioid-marketing.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and ""waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Oklahoma Sues Opioid Painkiller Makers,2017-06-30 21:18:47 +0000,http://finance.yahoo.com/r/10e3f37a-4737-3974-abd2-fff895f6be19/oklahoma-sues-opioid-painkiller-makers-1498848561?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Oklahoma became the latest state to file a lawsuit against opioid painkiller makers, alleging they caused widespread addiction by misrepresenting the benefits and addictive risks of their drugs."
AGN,AGN:US,BBG000FH8PX5,Oklahoma sues opioid drugmakers; New Hampshire presses epidemic probe,2017-06-30 19:21:55 +0000,https://finance.yahoo.com/news/oklahoma-sues-opioid-drugmakers-hampshire-192155748.html?.tsrc=rss,"OKLAHOMA CITY/BOSTON, June 30 (Reuters) - Oklahoma on Friday  joined growing litigation over claims drugmakers misrepresented  the risks of opioid painkillers, as New Hampshire cleared a  hurdle in its own probe of the role played by companies in the  national addiction epidemic.  Oklahoma Attorney General Mike Hunter filed a lawsuit in  Cleveland County District Court against Purdue Pharma LP,  Johnson & Johnson, Allergan Plc and units of  Teva Pharmaceutical Industries Ltd."
AGN,AGN:US,BBG000FH8PX5,"Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Allergan, Inc. During the Period February 25, 2014 Through April 21, 2014, Inclusive",2017-06-30 19:15:00 +0000,https://finance.yahoo.com/news/securities-class-action-filed-behalf-191500918.html?.tsrc=rss,"Entwistle & Cappucci LLP and Susman Godfrey L.L.P. today announced that they have filed a securities class action lawsuit on behalf of persons or entities that traded certain derivative securities of Allergan, Inc."
AGN,AGN:US,BBG000FH8PX5,Could This Biotech Be Headed For A Deal After CEO Takes Reins?,2017-06-29 20:21:53 +0000,http://finance.yahoo.com/r/99c5c0ae-4e54-3876-818f-728876325b93/could-this-biotech-be-headed-for-a-deal-after-ceo-takes-reins?src=A00220&yptr=yahoo&.tsrc=rss,Sarepta stock popped on speculation it could be on the auction block after hiring a new merger-savvy chief executive.
AGN,AGN:US,BBG000FH8PX5,Sarepta Appoints Ex-Allergan Executive as CEO and President,2017-06-29 17:06:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jytjtyU3rYU/sarepta-appoints-ex-allergan-executive-as-ceo-and-president-cm810094,Sarepta Therapeutics Inc 160 SRPT announced the appointment of Douglas S Ingram as the new chief executive officer CEO He will also serve as the company s president and will also be a member of the board of directors Ingram has a cumulative experience of more than 20 years as
AGN,AGN:US,BBG000FH8PX5,Sarepta Appoints Ex-Allergan Executive as CEO and President,2017-06-29 14:25:02 +0000,https://finance.yahoo.com/news/sarepta-appoints-ex-allergan-executive-142502918.html?.tsrc=rss,"Sarepta Therapeutics, Inc. (SRPT) announced the appointment of Douglas S. Ingram as the new chief executive officer (CEO)."
AGN,AGN:US,BBG000FH8PX5,Sarepta: A New CEO Goes a Long Way?,2017-06-29 14:12:00 +0000,http://finance.yahoo.com/r/11448022-ea75-3e14-aa2c-eaf23089cb98/sarepta-a-new-ceo-goes-a-long-way-1498745538?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Sarepta Therapeutics (SRPT) last night announced that it had appointed Douglas Ingram as its new CEO. Leerink's Joseph Schwartz and Dae Gon Ha applaud the choice for Sarepta's new CEO: Following Dr. Ed ...
AGN,AGN:US,BBG000FH8PX5,[$$] Sarepta Taps Chase Pharmaceuticals Chief as Next CEO,2017-06-28 22:37:52 +0000,http://finance.yahoo.com/r/8b4f5ecc-94ee-34af-bb44-4669c3b7b238/sarepta-taps-chase-pharmaceuticals-chief-as-next-ceo-1498687839?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Biopharmaceutical developer Sarepta Therapeutics Inc. named a company outsider as its new chief executive, tapping Douglas Ingram to lead the firm."
AGN,AGN:US,BBG000FH8PX5,Sarepta appoints former Allergan executive Douglas Ingram as CEO,2017-06-28 21:14:17 +0000,https://finance.yahoo.com/news/sarepta-appoints-former-allergan-executive-211417848.html?.tsrc=rss,"Sarepta Therapeutics Inc said on Wednesday it appointed Douglas Ingram as president and chief executive officer. Ingram, who previously held a senior executive position in Allergan Plc, will also be a ..."
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Inflow Detected - VHT, GILD, LLY, AGN",2017-06-28 16:05:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rE-tqn3HXLI/notable-etf-inflow-detected-vht-gild-lly-agn-cm809432,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Health Care ETF Symbol VHT where we have detected an approximate 67 1 million dollar inflow that s a 1 0 increase week over week in outstanding
AGN,AGN:US,BBG000FH8PX5,Healthcare: ACA Repeal Efforts Unlikely to Yield Major Legislative Changes,2017-06-28 11:00:00 +0000,http://finance.yahoo.com/r/faf5f7c5-63e5-3d78-8f14-b21b6254c4f4/article.aspx?id=812158&SR=Yahoo&yptr=yahoo&.tsrc=rss,"While the Republican-led Congress continues the push to repeal the Affordable Care Act, we still see challenges in passing any new legislation."
AGN,AGN:US,BBG000FH8PX5,"Valeant: Out of the Frying Pan, Into the Fire",2017-06-27 18:02:00 +0000,http://finance.yahoo.com/r/f21aaf46-59a6-384d-9213-77b33b3d2a43/valeant-out-of-the-frying-pan-into-the-fire-1498586566?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) spiked yesterday on speculation regarding a possible debt-to-equity swap by the troubled drug maker.  Wells Fargo analyst David Maris weighed in on the notion today, arguing that even if a swap does happen, it does not repair poor business trends or the increasingly unlikelihood that Valeant can deliver the strong earnings growth promised by consensus forecasts.  As Maris writes: Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross structure risk."
AGN,AGN:US,BBG000FH8PX5,"John Paulson Buys T-Mobile US Inc, DISH Network Corp, Mead Johnson Nutrition Co, Sells Teva ...",2017-06-27 17:50:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bs7Z9rS0m-o/john-paulson-buys-t-mobile-us-inc-dish-network-corp-mead-johnson-nutrition-co-sells-teva-cm808988,John Paulson New Purchases TMUS DISH BKD ARNC PANW XENT FGL WBMD AMZN Z Added Positions MJN NXPI ALXN TWX FDX STE SD GSK ESPR PFE Reduced Positions TEVA STAY AGN MYL SHPG MNK AIG AEM BIIB GOOG Sold Out BEAV VMW HPE
AGN,AGN:US,BBG000FH8PX5,Bill Ackman's Big Triumph Becomes His Big Problem,2017-06-27 13:51:44 +0000,http://finance.yahoo.com/r/226aaabc-8f7e-3179-b051-79558c80f759/bill-ackman-s-big-triumph-becomes-his-big-problem?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,One of the activist investor's greatest deals is under legal attack. There's no easy way out.
AGN,AGN:US,BBG000FH8PX5,"Allergan Introduces REFRESH OPTIVE® MEGA-3 Enhanced with Flaxseed Oil, Latest Innovation in the REFRESH® Portfolio",2017-06-27 12:00:00 +0000,https://finance.yahoo.com/news/allergan-introduces-refresh-optive-mega-120000007.html?.tsrc=rss,"New Offering from REFRESH®, Number One Doctor Recommended Brand of Artificial Tears(1), Restores Lipid Layer While Bringing Hydration to All Three Layers of Tear Film Damaged by Dry Eye DUBLIN , June 27, ..."
AGN,AGN:US,BBG000FH8PX5,"Dillard's Is One of the Best Long-Term Investments in Retail, Doug Kass Says",2017-06-26 23:54:00 +0000,http://finance.yahoo.com/r/51933b8a-ce98-3bde-b54e-dbc0213d9fb9/more-allergan-profit-adding-dillard-s-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on his Allergan profit and discussing adding Dillard's to his list.
AGN,AGN:US,BBG000FH8PX5,Valeant Pharma: A Debt Swap?,2017-06-26 18:17:00 +0000,http://finance.yahoo.com/r/776a7947-bc63-3e80-9dcb-7c540131cbc6/valeant-pharma-a-debt-swap-1498501031?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Why are shares of Valeant Pharmaceuticals International (VRX) rising and does the market have it right?  According to Evercore ISI analyst Umer Raffat, anytime the market receives a signal of some sort that the embattled drug maker has value beyond its pile of debt, the stock price rises and short sellers cover their positions.  Today, a 7.8% spike in Valeant’s share price is linked to speculation that a debt-to-equity swap could be on the horizon, Raffat says."
AGN,AGN:US,BBG000FH8PX5,Allergan Continues to Focus on Acquisitions and Branded Unit,2017-06-26 15:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BVusu62u1nc/allergan-continues-to-focus-on-acquisitions-and-branded-unit-cm808129,We issued an updated research report on Allergan plc AGN on Jun 23 Acquisitions form an integral part of Allergan s expansion strategy Allergan is reshaping its portfolio through strategic acquisitions With the Allergan Inc acquisition the company finds itself among the top 10
AGN,AGN:US,BBG000FH8PX5,Allergan Continues to Focus on Acquisitions and Branded Unit,2017-06-26 13:15:01 +0000,https://finance.yahoo.com/news/allergan-continues-focus-acquisitions-branded-131501124.html?.tsrc=rss,We issued an updated research report on Allergan plc (AGN) on Jun 23.
AGN,AGN:US,BBG000FH8PX5,"Top Stock Reports for Oracle, Allergan & Abbott",2017-06-23 19:49:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z0besSxmumY/top-stock-reports-for-oracle-allergan-abbott-cm807616,Friday June 23 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 12 major stocks including Oracle ORCL Allergan AGN and Abbott ABT These research reports have been hand picked from
AGN,AGN:US,BBG000FH8PX5,"Top Stock Reports for Oracle, Allergan & Abbott",2017-06-23 17:32:05 +0000,https://finance.yahoo.com/news/top-stock-reports-oracle-allergan-173205132.html?.tsrc=rss,"Top Stock Reports for Oracle, Allergan & Abbott"
AGN,AGN:US,BBG000FH8PX5,7 Healthcare Stocks to Buy Now,2017-06-21 22:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCltdn2YVU4/7-healthcare-stocks-to-buy-now-cm806577,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the benefit of perfect hindsight the middle of 2015 represented a high tide in healthcare investing Source Shutterstock While the sector overall has recovered this year the Health Care SPDR ETF NYSEARCA
AGN,AGN:US,BBG000FH8PX5,"Notable Wednesday Option Activity: LZB, AGN, UPS",2017-06-21 21:21:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yytBIDIqgNI/notable-wednesday-option-activity-lzb-agn-ups-cm806533,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in La Z Boy Inc Symbol LZB where a total volume of 2 395 contracts has been traded thus far today a contract volume which is representative of approximately 239 500
AGN,AGN:US,BBG000FH8PX5,Todd Hagopian's Top 2 Mental Health Biotech Stocks,2017-06-21 18:23:00 +0000,http://finance.yahoo.com/r/a0693153-b04e-303a-8b3c-6df5f684131e/todd-hagopians-top-2-mental-health-biotech-stocks?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The mental health biotech sub-sector includes companies developing drugs for ADHD, depression, bipolar disorder, schizophrenia, migraines, alzheimer's, and other central nervous system conditions. Due to growing public awareness, Todd Hagopian believes these stocks are reaching a tipping point."
AGN,AGN:US,BBG000FH8PX5,"Cramer: If There's No Reason for a Rally, Then Something's Wrong",2017-06-20 23:01:00 +0000,http://finance.yahoo.com/r/5a9efd59-acfc-330f-aa93-c489be2b3d2f/cramer-if-theres-no-reason-rally-then-somethings-wrong?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,I think caution is warranted if we rally again like this.
AGN,AGN:US,BBG000FH8PX5,5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017,2017-06-20 17:20:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6fp94kE4gxM/5-reasons-why-you-should-invest-in-astrazeneca-azn-in-2017-cm805755,London based pharma giant AstraZeneca plc AZN has a strong product portfolio and is one of the key players in the global cardiovascular market AstraZeneca carries a Zacks Rank 2 Buy You can see the complete list of today s Zacks 1 Rank Strong Buy stocks here Here we
AGN,AGN:US,BBG000FH8PX5,"VUG, MMM, UNP, AGN: Large Inflows Detected at ETF",2017-06-20 16:23:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X5Ys2WqqkdA/vug-mmm-unp-agn-large-inflows-detected-at-etf-cm805703,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 80 8 million dollar inflow that s a 0 3 increase week over week in outstanding units
AGN,AGN:US,BBG000FH8PX5,Key Updates on Eli Lilly’s Jardiance,2017-06-20 11:36:03 +0000,http://finance.yahoo.com/r/a6af4747-6c18-3513-b08f-9bd9ae422538/key-updates-on-eli-lillys-jardiance?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Jardiance (empagliflozin) is a part of the Boehringer Ingelheim and Eli Lilly’s (LLY) diabetes alliance.
AGN,AGN:US,BBG000FH8PX5,Novartis eye drug works with fewer injections than rivals,2017-06-20 11:11:22 +0000,https://finance.yahoo.com/news/novartis-eye-drug-works-fewer-111122285.html?.tsrc=rss,"A drug developed by Novartis  to treat vision loss in people over 65 does not need to  be injected as frequently as a rival medicine from Regeneron  to be effective, clinical trials showed on Tuesday.  Novartis said the trials showed its RTH258 drug would reduce  the injection burden for patients with neovascular age-related  macular degeneration (nAMD), the leading cause of vision loss  for over 65s in North America, Europe, Australia and Asia.  Novartis shares climbed 1.4 percent by 1041 GMT,  outperforming the Stoxx European health care sector index  , with analysts saying the trial results gave RTH258 a  competitive advantage over rival treatments."
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 22:19:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Itsgu_jwGQI/valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-healed-by-paulsons-presence-cm805395,InvestorPlace Stock Market News Stock Advice amp Trading Tips It remains to be seen if John Paulson s presence on the board of directors of Valeant Pharmaceuticals Intl Inc NYSE VRX will make a positive difference for the beleaguered company But as far as owners of VRX
AGN,AGN:US,BBG000FH8PX5,Allergan Is Putting the Bull Back in Charge,2017-06-19 18:39:00 +0000,http://finance.yahoo.com/r/9ea68712-a2be-3cb7-b4bd-fdedc006f627/allergan-putting-bull-back-charge?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Prices have rallied since late May.
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 17:47:28 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-174728345.html?.tsrc=rss,"It remains to be seen if John Paulson’s presence on the board of directors of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will make a positive difference for the beleaguered company.  John Paulson is the chief of hedge fund Paulson & Co., which rose to infamy after making a (very) correct bearish call on the U.S. housing market in 2007."
AGN,AGN:US,BBG000FH8PX5,Could Legalized Marijuana Be Making Big Pharma Nervous?,2017-06-18 18:03:00 +0000,http://finance.yahoo.com/r/9371d718-9d4e-3fc3-bce7-f5da1d89c431/could-legalized-marijuana-be-making-big-pharma-ner.aspx?yptr=yahoo&.tsrc=rss,"A new report says that drugmakers could lose billions of dollars per year if marijuana is legalized throughout the U.S. Should Pfizer, Allergan, and others be nervous?"
AGN,AGN:US,BBG000FH8PX5,5 Things Allergan's Management Just Said That You Need to Know,2017-06-15 21:08:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ACAHHnd2j-U/5-things-allergans-management-just-said-that-you-need-to-know-cm804068,What s going on with Allergan NYSE AGN these days Three of the drugmaker s executive team had the opportunity to address that question when they spoke at the Goldman Sachs healthcare conference on Wednesday Allergan CEO Brent Saunders CFO Tessa Hilado and chief
AGN,AGN:US,BBG000FH8PX5,5 Things Allergan&apos;s Management Just Said That You Need to Know,2017-06-15 19:42:00 +0000,http://finance.yahoo.com/r/57b2fb3f-df5f-38b5-af68-2a229f18066c/5-things-allergans-management-just-said-that-you-n.aspx?yptr=yahoo&.tsrc=rss,Allergan executives hint at what&apos;s in store for the drugmaker at the Goldman Sachs healthcare conference.
AGN,AGN:US,BBG000FH8PX5,Allergan CEO on the battle over drug pricing,2017-06-15 17:38:00 +0000,https://finance.yahoo.com/video/allergan-ceo-battle-over-drug-173800939.html?.tsrc=rss,"CNBC's Meg Tirrell talks to Brent Saunders, Allergan CEO, about an executive order on possibly lowering drug prices live from the Heartland Health Summit."
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : June 15, 2017",2017-06-15 12:13:37 +0000,http://finance.yahoo.com/r/209537b7-9a03-3078-b127-0c017b373412/allergan-plc-breached-its-50-day-moving-average-in-a-bullish-manner-agn-us-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Opioid Stocks Feel the Pressure of FDA Measures,2017-06-11 18:27:00 +0000,http://finance.yahoo.com/r/4c7bb277-eae6-3d97-b692-e7273b96a4f0/opioid-stocks-threatened-fda-steps-endp-depo-insy?partner=YahooSA&yptr=yahoo&.tsrc=rss,Recent FDA measures to curb the alarming U.S. opioid epidemic is hurting some drug stocks.
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Inflows: PFF, AGN, HSBC, TMUS",2017-06-09 16:29:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WYucXNHCHrs/noteworthy-etf-inflows-pff-agn-hsbc-tmus-cm801283,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 58 3 million dollar inflow that s a 0 3 increase week over week
AGN,AGN:US,BBG000FH8PX5,"New migraine drugs have promise — and a $8,500 price tag",2017-06-09 16:02:31 +0000,http://finance.yahoo.com/r/6e35c1d6-15ea-384a-8124-ffdec256b78b/Story.aspx?guid=3955D604-4C89-11E7-8F25-FFB46009C8A4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,They’re the first drugs developed for migraine in a long time. But migraine patients worry they won’t be able to access them.
AGN,AGN:US,BBG000FH8PX5,"New migraine drugs have promise — and a $8,500 price tag",2017-06-09 16:02:31 +0000,https://finance.yahoo.com/news/migraine-drugs-promise-8-500-160231070.html?.tsrc=rss,They’re the first drugs developed for migraine in a long time. But migraine patients worry they won’t be able to access them.
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals: Bigger is Better,2017-06-08 16:54:00 +0000,http://finance.yahoo.com/r/bb6a5329-da8b-3dda-bf72-98a69c5a3a95/valeant-pharmaceuticals-bigger-is-better-1496940850?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) has sold its iNova division for $930 million.  Valeant plans to throw the cash from the sale at its debt load, bringing the company within $500 million of it goal of $5 billion in debt reduction by February 2018.  Gary Nacham at BMO Capital Markets was pleased to see Valeant “finally execute” on the deal and applauded the company’s aggressive debt reduction strategy.” Still, he notes the sale “does not move the needle on VRX’s net leverage, which remains at a very high 7.8x,” so assets sales “will need to continue and at some point will probably need to be of a much greater magnitude.” Meanwhile, he notes that the deal highlights some challenges for Valeant in executing these asset sales."
AGN,AGN:US,BBG000FH8PX5,"Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit",2017-06-08 16:31:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/covPxIfOiKs/allergan-to-buy-keller-funnel-boost-plastic-surgery-unit-cm800676,Allergan plc AGN announced a deal to acquire privately held medical device company Keller Medical Inc which makes Keller Funnel for an undisclosed amount These novel plastic funnels are used in breast augmentation or reconstruction procedures They are designed to improve breast
AGN,AGN:US,BBG000FH8PX5,"Wallace Weitz Sells Avon Products, Berkshire Hathaway, Fossil",2017-06-08 16:26:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RManDzKAai4/wallace-weitz-sells-avon-products-berkshire-hathaway-fossil-cm800712,Wallace Weitz Trades Portfolio manages a portfolio composed of 81 stocks with a total value of 2 383 billion During the first quarter the guru sold shares in the following stocks Wallace Weitz Trades Portfolio manages a portfolio composed of 81 stocks with a total value
AGN,AGN:US,BBG000FH8PX5,"Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit",2017-06-08 14:05:02 +0000,https://finance.yahoo.com/news/allergan-buy-keller-funnel-boost-140502718.html?.tsrc=rss,"Allergan plc (AGN) announced a deal to acquire privately held medical device company Keller Medical, Inc, which makes Keller Funnel, for an undisclosed amount."
AGN,AGN:US,BBG000FH8PX5,"ABBV Hits A High Note, AGN Opens Wallet, TEVA's HALO Does An Encore",2017-06-08 03:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7pOA0o3GXxI/abbv-hits-a-high-note-agn-opens-wallet-tevas-halo-does-an-encore-20170608-00112,"ABBV Hits A High Note, AGN Opens Wallet, TEVA's HALO Does An Encore"
AGN,AGN:US,BBG000FH8PX5,Alkermes Gets FDA Nod for Two Month Dose of Aristada,2017-06-07 17:28:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JHabs3M7qXc/alkermes-gets-fda-nod-for-two-month-dose-of-aristada-cm800154,Alkermes plc ALKS announced that the FDA has approved two month Aristada aripiprazole lauroxil extended release injectable suspension for the treatment of schizophrenia The new two month dose is expected to be available in mid June Alkermes share price increased 6 1 year to
AGN,AGN:US,BBG000FH8PX5,Alkermes Gets FDA Nod for Two Month Dose of Aristada,2017-06-07 14:54:02 +0000,https://finance.yahoo.com/news/alkermes-gets-fda-nod-two-145402838.html?.tsrc=rss,Alkermes plc (ALKS) announced that the FDA has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.
AGN,AGN:US,BBG000FH8PX5,"Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab",2017-06-07 13:00:00 +0000,https://finance.yahoo.com/news/amgen-allergan-announce-fda-advisory-130000349.html?.tsrc=rss,"THOUSAND OAKS, Calif., June 7, 2017 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data supporting the Biologics License Application (BLA) for ABP 215, a biosimilar candidate to Avastin® (bevacizumab), on July 13, 2017.  ""Amgen has a long and proud heritage in oncology, and we are committed to providing physicians and patients a range of high quality therapeutic options,"" said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.  The Committee will review analytical, pharmacokinetic and clinical data from studies involving ABP 215, including results from a Phase 3 study in patients with non-squamous non-small cell lung cancer (NSCLC)."
AGN,AGN:US,BBG000FH8PX5,Allergan to buy medical device company and breast surgery funnel-maker Keller Medical Inc.,2017-06-07 12:43:21 +0000,http://finance.yahoo.com/r/2f2cb8e8-6b2c-3505-9c15-c0caae546abf/Story.aspx?guid=B75A06E5-C620-4B83-95F0-ED67F5DE4B36&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Allergan PLC said early Wednesday that it plans to buy privately-held medical device company Keller Medical Inc., which developed a funnel used during breast surgery procedures. The Keller Funnel, which ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan to Acquire Keller Medical, Inc., Adding Keller Funnel® to Company's Leading Plastic Surgery Portfolio",2017-06-07 12:30:00 +0000,https://finance.yahoo.com/news/allergan-acquire-keller-medical-inc-123000962.html?.tsrc=rss,"DUBLIN, June 7, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, today announced that Allergan's wholly-owned subsidiary, Allergan Sales LLC agreed to acquire Keller Medical, Inc., a privately held medical device company and developer of the Keller Funnel®.  The Keller Funnel is a cone-shaped, lubricated plastic funnel that reduces surgeon and patient contact during breast augmentation or reconstruction procedures.  Keller Medical launched the original Keller Funnel® in 2009 and the Keller Funnel® 2 in 2014, and hundreds of thousands of funnels have been used in breast augmentation or reconstruction procedures to date globally."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston,2017-06-07 11:31:00 +0000,https://finance.yahoo.com/news/allergan-present-data-chronic-migraine-113100513.html?.tsrc=rss,"DUBLIN, June 7, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that data on Chronic Migraine and the Company's Chronic Migraine treatment will be featured in eight presentations at the upcoming ..."
AGN,AGN:US,BBG000FH8PX5,Amgen: FDA Committee To Review Data Supporting BLA For ABP 215 - Quick Facts,2017-06-07 09:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Tj1P7KbTCo/amgen-fda-committee-to-review-data-supporting-bla-for-abp-215--quick-facts-20170607-00684,Amgen: FDA Committee To Review Data Supporting BLA For ABP 215 - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Goldman Reveals Top Stocks Owned By Hedge Funds This Year,2017-06-05 18:01:00 +0000,http://finance.yahoo.com/r/3a4124e3-8c24-3b27-af44-ccd7c8655064/goldman-reveals-top-stocks-owned-hedge-funds-year-agn-mjn?partner=YahooSA&yptr=yahoo&.tsrc=rss,The list of VIP names are solidly beating the rest of the market in performance.
AGN,AGN:US,BBG000FH8PX5,Is Ironwood's Growth About to Slow?,2017-06-05 15:04:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/doAJjTW9OPc/is-ironwoods-growth-about-to-slow-cm798639,Ironwood Pharmaceuticals NASDAQ IRWD shares are nudging up against 52 week highs because of optimism surrounding Linzess a drug used in treating chronic idiopathic constipation CIC and irritable bowel syndrome associated with constipation IBS C Linzess sales have grown
AGN,AGN:US,BBG000FH8PX5,Is Ironwood&apos;s Growth About to Slow?,2017-06-05 13:01:00 +0000,http://finance.yahoo.com/r/ecf14ce9-240a-3d38-8891-2124434fcdc3/is-ironwoods-growth-about-to-slow.aspx?yptr=yahoo&.tsrc=rss,New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
AGN,AGN:US,BBG000FH8PX5,Featured Company News - Mylan Launches Two New Generic Drugs: Generic Reclast® Injection and Generic Azilect® Tablets,2017-06-05 12:15:00 +0000,https://finance.yahoo.com/news/featured-company-news-mylan-launches-121500145.html?.tsrc=rss,"Research Desk Line-up: Allergan Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 5, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for pharmaceutical ..."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the Goldman Sachs Global Healthcare Conference,2017-06-02 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-goldman-sachs-global-120000924.html?.tsrc=rss,"DUBLIN, June 2, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the Goldman Sachs 38th Annual Global Healthcare Conference in Rancho Palos Verdes, California.  The presentation will begin at 10:40 a.m. Pacific Time (1:40 p.m. Eastern Time), on Wednesday, June 14, 2017.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,State Sues Big Pharma For Opioid Carnage,2017-06-02 06:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YV9Ux8kb_uU/state-sues-big-pharma-for-opioid-carnage-20170602-00169,State Sues Big Pharma For Opioid Carnage
AGN,AGN:US,BBG000FH8PX5,Bullish Two Hundred Day Moving Average Cross - AGN,2017-06-01 21:32:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uvQhA-MOvVo/bullish-two-hundred-day-moving-average-cross-agn-cm797686,In trading on Thursday shares of Allergan PLC Symbol AGN crossed above their 200 day moving average of 226 86 changing hands as high as 227 24 per share Allergan PLC shares are currently trading up about 1 5 on the day The chart below shows the one year performance of AGN shares
AGN,AGN:US,BBG000FH8PX5,PRESS DIGEST - Wall Street Journal - June 1,2017-06-01 05:06:36 +0000,https://finance.yahoo.com/news/press-digest-wall-street-journal-050636492.html?.tsrc=rss,The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - U.S. President Donald Trump said he would make an announcement ...
AGN,AGN:US,BBG000FH8PX5,How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover,2017-05-31 22:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPvHKLuZacc/how-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-recover-cm797145,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been an awful awful run for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA And the lousy performance in TEVA stock is showing no signs of giving up this week Source Open Grid Scheduler
AGN,AGN:US,BBG000FH8PX5,Ohio attorney general sues 5 drugmakers over opiate crisis,2017-05-31 19:08:59 +0000,https://finance.yahoo.com/news/ohio-attorney-general-sues-5-161145499.html?.tsrc=rss,"The Ohio attorney general sued five drugmakers on Wednesday, accusing the companies of perpetrating the state's addictions epidemic by intentionally misleading patients about the dangers of painkillers ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Ohio sues drugmakers over US opioid addiction crisis,2017-05-31 18:43:05 +0000,"http://finance.yahoo.com/r/29795244-17b2-3645-8795-603437747006/24027d0e-4629-11e7-8d27-59b4dd6296b8,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Ohio's attorney-general has become the latest US official to sue drugmakers for their alleged role in fuelling the country's painkiller addiction crisis, opening a new front in the legal battle to force ..."
AGN,AGN:US,BBG000FH8PX5,Ohio Going After Drug Makers for Fueling Opioid Crisis,2017-05-31 18:33:00 +0000,http://finance.yahoo.com/r/3b8e14f6-3bc4-3dba-ae80-86a269295560/ohio-going-after-drug-makers-for-fueling-opioid-crisis.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Ohio Attorney General Mike DeWine claims the companies weren't honest with doctors about the risks associated with the painkillers.
AGN,AGN:US,BBG000FH8PX5,The Buyback Decline and Five Stocks that Stack Up,2017-05-31 18:30:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jfzCKZcq1zY/the-buyback-decline-and-five-stocks-that-stack-up-cm796985,On page seven of the Berkshire Hathaway 2016 annual report billionaire CEO Warren Buffett offers his opinion on share buybacks My suggestion Before even discussing repurchases a CEO and his or her Board should stand join hands and in unison declare What is smart at one price is stupid
AGN,AGN:US,BBG000FH8PX5,Leon Cooperman Bets On These 19 Stocks,2017-05-31 17:33:00 +0000,http://finance.yahoo.com/r/acdf6573-49d3-3757-9df2-ca81afda3083/leon-cooperman?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Leon Cooperman shared his Top 19 stock picks. Did your favorite investment make the list?
AGN,AGN:US,BBG000FH8PX5,"Johnson and Johnson, other drug companies accused of viol...",2017-05-31 16:10:00 +0000,https://finance.yahoo.com/video/johnson-johnson-other-drug-companies-161000339.html?.tsrc=rss,CNBC's Meg Tirrell reports on the drug companies being sued by the Ohio attorney general for Medicaid fraud.
AGN,AGN:US,BBG000FH8PX5,Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans,2017-05-31 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-data-anti-infectives-120000848.html?.tsrc=rss,"DUBLIN, May 31, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced new data from its anti-fectives portfolio will be featured in 16 presentations at the upcoming American Society for Microbiology ..."
AGN,AGN:US,BBG000FH8PX5,Key Moves by Billionaire David Tepper's Appaloosa Mgmt in Q1: 13F Filings,2017-05-30 16:18:00 +0000,http://finance.yahoo.com/r/3b3aef71-b455-324d-ba71-ce008dd0cff1/key-moves-billionaire-david-teppers-appaloosa-mgmt-q1-13f-filings-agn-etp?partner=YahooSA&yptr=yahoo&.tsrc=rss,The hot-shot billionaire investor grew his assets under management by about half a billion dollars in Q1.
AGN,AGN:US,BBG000FH8PX5,Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1,2017-05-30 16:13:00 +0000,http://finance.yahoo.com/r/bba6c52e-a921-3fcb-b56a-45520f8fbfbb/paulson-co-hedge-fund-cuts-back-health-care-q1-agn-shpg?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Paulson & Co. reduced its number of holdings in Q1, lightening its positions in several health care companies."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Closing of Public Offering of Senior Notes to Refinance Existing Debt,2017-05-26 11:00:00 +0000,https://finance.yahoo.com/news/allergan-announces-closing-public-offering-110000426.html?.tsrc=rss,"DUBLIN, May 26, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has closed an offering of €2.7 billion aggregate principal amount of senior unsecured notes (the ""Notes"") ..."
AGN,AGN:US,BBG000FH8PX5,Aerie's Ophthalmic Candidate Positive in Registration Trial,2017-05-25 20:32:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2HJ6r5hLjoI/aeries-ophthalmic-candidate-positive-in-registration-trial-cm794820,Aerie Pharmaceuticals Inc AERI announced positive primary efficacy results of the 90 day phase III registration trial Mercury 2 for its pipeline candidate Roclatan We note that Aerie has outperformed the Zacks classified Medical Drugs industry in the last 12 months The stock
AGN,AGN:US,BBG000FH8PX5,Aerie&apos;s Ophthalmic Candidate Positive in Registration Trial,2017-05-25 18:13:06 +0000,https://finance.yahoo.com/news/aerie-apos-ophthalmic-candidate-positive-181306598.html?.tsrc=rss,"Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan."
AGN,AGN:US,BBG000FH8PX5,TrumpCare isn't moving health care stocks because it won't pass: NYSE trader,2017-05-25 18:01:28 +0000,https://finance.yahoo.com/video/trumpcare-isnt-moving-health-care-180128765.html?.tsrc=rss,"Alan Valdes, director of floor operations for Silverbear, joins Alexis Christoforous from the New York Stock Exchange to discuss the outlook for health care stocks after the CBO scored the latest healthcare bill from President Trump and the Republicans."
AGN,AGN:US,BBG000FH8PX5,Getting Struck Twice: Acquisitions & Spinouts In Biotech,2017-05-25 11:55:00 +0000,http://finance.yahoo.com/r/3fcc16e5-984d-3844-ab1e-bd229d08ebd4/getting-struck-twice-acquisitions-spinouts-in-biotech?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Biotech M&A deals are often driven by the buyer's interest in the lead asset in the biotech's portfolio. In order to capture the full value, spin-outs of the secondary assets following an acquisition can be solution. Several recent examples hare explored."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Pricing of Tender Offers by Certain Subsidiaries,2017-05-24 20:30:00 +0000,https://finance.yahoo.com/news/allergan-announces-pricing-tender-offers-203000721.html?.tsrc=rss,"DUBLIN, May 24, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the consideration payable in connection with the previously announced tender offers commenced by its wholly owned subsidiaries ..."
AGN,AGN:US,BBG000FH8PX5,"Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna",2017-05-24 15:31:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZnF0ZIAgoY/edward-owens-buys-abbott-labs-sells-allergan-amgen-aetna-cm793947,Edward Owens has managed the Vanguard Health Care Fund Trades Portfolio since its inception in May 1984 It invests primarily in health care companies Edward Owens has managed theVanguard Health Care Fund Trades Portfolio since its inception in May 1984 It invests primarily
AGN,AGN:US,BBG000FH8PX5,Shark Bites: Focus on the 'Little Picture',2017-05-24 15:19:00 +0000,http://finance.yahoo.com/r/2d8c20cc-0bca-31cb-b101-7be36c39682f/shark-bites-focus-little-picture?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's what I'm trading today amid the 'flat with a positive tone' action.
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries,2017-05-24 12:00:00 +0000,https://finance.yahoo.com/news/allergan-announces-early-tender-results-120000613.html?.tsrc=rss,"DUBLIN, May 24, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the early tender results for the previously announced tender offers commenced by its wholly owned subsidiaries Allergan Funding ..."
AGN,AGN:US,BBG000FH8PX5,"Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%",2017-05-23 22:09:00 +0000,https://finance.yahoo.com/news/kristin-chenoweth-kicks-off-less-220900366.html?.tsrc=rss,"DUBLIN, May 23, 2017 /PRNewswire/ -- Allergan plc, (AGN), a leading global pharmaceutical company, announced that Emmy® and Tony® award-winning actress and singer, Kristin Chenoweth will kick off the ""Less Red, More You"" campaign today at an exclusive event in New York City.  ""As a performer who is constantly on stage or in front of the camera, it's important that I take care of my skin, but unfortunately, persistent facial redness from rosacea is something I've struggled with every day for years,"" said Chenoweth."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt,2017-05-23 21:30:00 +0000,https://finance.yahoo.com/news/allergan-announces-pricing-public-offering-213000648.html?.tsrc=rss,"DUBLIN, May 23, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has priced an offering of €2.7 billion aggregate principal amount of senior unsecured notes (the ""Notes"") ..."
AGN,AGN:US,BBG000FH8PX5,The biggest CEO pay raises and pay cuts of 2016,2017-05-23 19:01:52 +0000,https://finance.yahoo.com/news/biggest-ceo-pay-raises-pay-103525025.html?.tsrc=rss,"Here are the three CEOs who got the biggest pay raises last year, and the deepest pay cuts, as calculated by The Associated Press and Equilar, an executive data firm. ___ Top raises: ___ 1. Hock Tan Broadcom ..."
AGN,AGN:US,BBG000FH8PX5,The biggest CEO pay raises and pay cuts of 2016,2017-05-23 18:33:33 +0000,http://finance.yahoo.com/r/2ebb3c6a-6291-3c64-ae9e-e5bc4ba82307/biggest-ceo-pay-raises-pay-103525025.html?.tsrc=rss,"Here are the three CEOs who got the biggest pay raises last year, and the deepest pay cuts, as calculated by The Associated Press and Equilar, an executive data firm."
AGN,AGN:US,BBG000FH8PX5,Has Allergan's Pullback Run Its Course?,2017-05-23 17:26:00 +0000,http://finance.yahoo.com/r/ffa17bf4-002d-3e75-a8fc-09d9f82e8ca8/has-allergans-pullback-run-its-course?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,We make our case.
AGN,AGN:US,BBG000FH8PX5,Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's euro notes; stable outlook,2017-05-23 14:51:09 +0000,http://finance.yahoo.com/r/d29bcec6-83da-3dc9-8a96-fa93b1569a2d/viewresearchdoc.aspx?docid=PR_367129&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170523_PR_367129&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's assigns Baa3 to Allergan's euro notes; stable outlook. Global Credit Research- 23 May 2017. New York, May 23, 2017-- Moody's Investors Service assigned a Baa3 rating to the new euro-denominated ..."
AGN,AGN:US,BBG000FH8PX5,These Big Drug Stocks May Cure the Trump Blues,2017-05-23 10:00:00 +0000,http://finance.yahoo.com/r/ad6e33fd-3aef-3631-9290-e28ffb47ad85/these-big-drug-stocks-may-cure-trump-blues-mrk-lly?partner=YahooSA&yptr=yahoo&.tsrc=rss,Certain pharma stocks have significant upside potential.
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt,2017-05-23 07:53:00 +0000,https://finance.yahoo.com/news/allergan-announces-commencement-proposed-public-075300657.html?.tsrc=rss,"DUBLIN, May 23, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it is commencing an offering of senior unsecured notes (the ""Notes"") in multiple tranches in a registered public offering, subject to market and other conditions.  The Notes will be issued by its indirect wholly-owned subsidiary, Allergan Funding SCS (f.k.a.  Actavis Funding SCS), and guaranteed by its indirect subsidiaries Warner Chilcott Limited, Allergan Capital S.à r.l."
AGN,AGN:US,BBG000FH8PX5,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 14:14:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iIrH_ODdBGw/3-drug-stocks-billionaire-money-managers-dumped-big-time-in-the-first-quarter-cm792533,Monday May 15 was an important day for Wall Street and investors It was the last day for money managers with more than 100 million in assets under management to file 13F paperwork with the Securities and Exchange Commission that in effect discloses their portfolio holding as of
AGN,AGN:US,BBG000FH8PX5,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 12:27:00 +0000,http://finance.yahoo.com/r/3c080f35-6f74-3b88-b068-e8990e4b124f/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?yptr=yahoo&.tsrc=rss,Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
AGN,AGN:US,BBG000FH8PX5,European stocks edge higher as U.S. political commotion subsides,2017-05-22 09:28:37 +0000,https://finance.yahoo.com/news/european-stocks-edge-higher-u-092837269.html?.tsrc=rss,"European stocks are logging modest gains Monday, beginning the week with a merger agreement in the chemicals industry and with relative calm on the political front, troubles from which last week pulled ..."
AGN,AGN:US,BBG000FH8PX5,Aegon To Divest Majority Of Its US Run-off Businesses - Quick Facts,2017-05-22 02:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gSo3vNRgmdg/aegon-to-divest-majority-of-its-us-runoff-businesses--quick-facts-20170522-00060,Aegon To Divest Majority Of Its US Run-off Businesses - Quick Facts
AGN,AGN:US,BBG000FH8PX5,"John Paulson Sells VMware, Hewlett Packard, Several Other Holdings",2017-05-20 17:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dhoa6c2rkCk/john-paulson-sells-vmware-hewlett-packard-several-other-holdings-cm792291,John Paulson Trades Portfolio manages a portfolio composed of 97 stocks that is valued at 7 5 billion During the first quarter the guru sold shares of the following stocks John Paulson Trades Portfolio manages a portfolio composed of 97 stocks that is valued at 7 5
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals: Intrigued…Really?,2017-05-19 17:33:00 +0000,http://finance.yahoo.com/r/316c21e1-5aae-3e85-badb-ab90d5856099/valeant-pharmaceuticals-intriguedreally-1495215191?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This very blog has offered up no shortage of opinions on shares Valeant Pharmaceuticals International (VRX)...some good, some bad and some still undecided.  Quoting from Gilbert’s recent note, StreetInsider reported: We have been cautious/skeptical on VRX for a very long time, and uncertainties around the growth potential and durability of key franchises, the potential cost of past sins, and the heavy debt load have kept us at Hold."
AGN,AGN:US,BBG000FH8PX5,Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab,2017-05-19 16:12:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hllJAarGf7Y/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab-cm791923,Amgen Inc AMGN recently announced the submission of a biologics license application BLA to the FDA for its pipeline candidate erenumab AMG 334 for the prevention of migraine Shares of Amgen have outperformed the Zacks classified Medical Biomed Genetics industry so far this year
AGN,AGN:US,BBG000FH8PX5,Valeant (VRX) Decides to Extend Stay on Xifaxan&apos;s ANDA,2017-05-19 13:48:01 +0000,https://finance.yahoo.com/news/valeant-vrx-decides-extend-stay-134801886.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva&apos;s ANDA for a generic version of Xifaxan 550 mg tablets."
AGN,AGN:US,BBG000FH8PX5,"SPY, TWX, AGN, CHTR: Large Outflows Detected at ETF",2017-05-18 16:14:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4CQmMPvQD9E/spy-twx-agn-chtr-large-outflows-detected-at-etf-cm791299,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P 500 ETF Symbol SPY where we have detected an approximate 84 0 million dollar outflow that s a 0 04 decrease week over week from 961 432 116
AGN,AGN:US,BBG000FH8PX5,AbbVie Down on Humira Patent Loss: Is More Damage in Store?,2017-05-18 15:17:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kDN-ycLwNNU/abbvie-down-on-humira-patent-loss-is-more-damage-in-store-cm791201,AbbVie Inc s ABBV shares declined more than 2 on Wednesday after it lost a lawsuit related to a patent protecting its key rheumatoid arthritis drug Humira to small biotech Coherus BioSciences Inc CHRS So far this year AbbVie s share price has increased 4 4 comparing unfavorably
AGN,AGN:US,BBG000FH8PX5,A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks,2017-05-18 13:15:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-wkOeSsJRYM/a-doomed-trump-presidency-would-be-a-terrifying-development-for-pharmaceutical-stocks-cm791065,Controversy has clouded the brief presidency of Donald Trump especially after he fired FBI Director James Comey If for some reason Trump doesn t finish out his term in office pharmaceutical stocks could get walloped going forward The long and short of it is that the
AGN,AGN:US,BBG000FH8PX5,"Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss",2017-05-17 16:16:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lb4a6h2AmYk/cardiome-crme-q1-loss-wider-than-expected-sales-miss-cm790616,Cardiome Pharma Corp CRME reported loss of 20 cents per share in first quarter of 2017 Reported loss is wider than both the Zacks Consensus Estimate of a loss of 15 cents and year ago loss of 9 cents The wider loss can primarily be attributed to a decrease in revenues and an increase
AGN,AGN:US,BBG000FH8PX5,Allergan's Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 16:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koJKe6prTjw/allergans-irritable-bowel-drug-viberzi-approved-in-canada-cm790612,Allergan plc AGN announced that Health Canada has approved Viberzi eluxadoline for the treatment of adults suffering with irritable bowel syndrome with diarrhea IBS D The drug is marketed in the U S and Europe as a twice daily oral treatment A look at the company s share price
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 14:01:02 +0000,https://finance.yahoo.com/news/allergan-apos-irritable-bowel-drug-140102069.html?.tsrc=rss,Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
AGN,AGN:US,BBG000FH8PX5,"Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss",2017-05-17 13:59:01 +0000,https://finance.yahoo.com/news/cardiome-crme-q1-loss-wider-135901072.html?.tsrc=rss,Cardiome Pharma Corp. (CRME) reported loss of 20 cents per share in first quarter of 2017. Reported loss is wider than both the Zacks Consensus Estimate of a loss of 15 cents and year-ago loss of 9 cents.
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At BOA Merrill Lynch Conference; Webcast At 2:20 PM ET,2017-05-17 13:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LzySgRe9MqU/allergan-to-present-at-boa-merrill-lynch-conference-webcast-at-220-pm-et-20170517-00915,Allergan To Present At BOA Merrill Lynch Conference; Webcast At 2:20 PM ET
AGN,AGN:US,BBG000FH8PX5,"Vanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, ...",2017-05-17 13:14:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bX4cvX8yJQg/vanguard-health-care-fund-buys-abbott-laboratories-tesaro-inc-teva-pharmaceutical-industries-cm790414,Vanguard Health Care Fund New Purchases TSRO CNC PTHN HUM Added Positions ABT REGN TEVA BMY IONS CTEC GEN EVHC APN ACHC Reduced Positions INCY AGN AMGN AET MRK Q UNH HCA MDT BSX Sold Out STJ INOV BIVV New Purchases
AGN,AGN:US,BBG000FH8PX5,Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan,2017-05-17 11:20:20 +0000,http://finance.yahoo.com/r/9eac0c66-b455-3450-9d0c-0f13d3d2558b/Story.aspx?guid=6A82CA7B-57D9-411B-9253-5C14AEE3E750&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Salix Pharmaceuticals Inc. and its parent Valeant Pharmaceuticals International Inc. and Actavis Laboratories Inc., at Actavis' request, have agreed to stay outstanding litigation regarding Actavis' application ..."
AGN,AGN:US,BBG000FH8PX5,Aerie's (AERI) Rhopressa NDA Sufficient for FDA Review,2017-05-17 00:15:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZRwzhXEv7Y4/aeries-aeri-rhopressa-nda-sufficient-for-fda-review-cm790285,Aerie Pharmaceuticals Inc AERI announced that it has received notification from the FDA about the completion of the initial 60 day review of the new drug application NDA for Rhopressa The FDA determined that the application is sufficiently complete and can undergo a substantive
AGN,AGN:US,BBG000FH8PX5,Is Editas Facing a New Reality in CRISPR Land?,2017-05-16 17:40:32 +0000,https://finance.yahoo.com/news/editas-facing-reality-crispr-land-174032071.html?.tsrc=rss,"Big opportunities in emerging health care companies often come with very bumpy rides. There is also the risk, of course, that there are no assurances that the potential promise and upside will come true ..."
AGN,AGN:US,BBG000FH8PX5,Cramer: Carl Icahn Was Right to Sell Apple at $95,2017-05-16 16:30:00 +0000,http://finance.yahoo.com/r/74b4dc76-fec7-3020-ad46-c9c2cf0bbef7/cramer-carl-icahn-was-right-sell-apple-95?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"What's right for a hedge fund manager sitting on a big gain, isn't necessarily right for you."
AGN,AGN:US,BBG000FH8PX5,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 16:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTg-U2W4p0o/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka-cm789994,Teva Pharmaceutical Industries Ltd TEVA announced the launch of a generic version of Valeant Pharmaceuticals International Inc s VRX diabetes drug Glumetza in the U S The drug will be available in 500 mg and 1000 mg tablets Teva s shares have underperformed the Zacks
AGN,AGN:US,BBG000FH8PX5,"Wallace Weitz Buys Dollar Tree Inc, Guidewire Software Inc, Compass Minerals International Inc, ...",2017-05-16 14:14:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gdo0PmpS2UE/wallace-weitz-buys-dollar-tree-inc-guidewire-software-inc-compass-minerals-international-inc-cm789840,Wallace Weitz New Purchases DLTR DFIN Added Positions GWRE CMP WAIR NCMI AMT TMO PX MUSA BUD ZOES Reduced Positions AGN LSXMK FOXA FOSL BRK B AVP LBRDK RWT LBTYK ALSN Sold Out TDG MSI IWV CMG USB New Purchases
AGN,AGN:US,BBG000FH8PX5,"Biotech Movers: Akebia, Editas, Novavax",2017-05-16 13:34:00 +0000,http://finance.yahoo.com/r/82fe9ccd-f5da-39bd-b43d-51ab8e1a33d9/biotech-movers-akebia-editas-novavax.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Akebia Therapeutics, Editas Medicine and Novavax were among the biotech movers in premarket trading on Tuesday."
AGN,AGN:US,BBG000FH8PX5,Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications,2017-05-16 11:45:00 +0000,https://finance.yahoo.com/news/allergans-eyepowerment-campaign-releases-survey-114500406.html?.tsrc=rss,"DUBLIN, May 16, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced the results of a new online eye language survey of 1,019 adult Americans that found approximately half of respondents (53 percent) say the eyes are the first facial feature they notice about another person.  Research shows the eyes provide a powerful form of nonverbal communication about who we are and what we feel.1 To help interpret our eye language, Allergan has partnered with Patti Wood, a body language expert with more than 25 years of experience.  The ""A Look at Eye Language"" online survey was conducted by Kelton Global on behalf of Allergan in support of the brand's Eyepowerment campaign to raise awareness for Chronic Dry Eye disease."
AGN,AGN:US,BBG000FH8PX5,VIBERZI™ Now Approved in Canada for patients with irritable bowel syndrome with diarrhea (IBS-D),2017-05-16 11:00:00 +0000,https://finance.yahoo.com/news/viberzi-now-approved-canada-patients-110000418.html?.tsrc=rss,"– First in class treatment offers patients significant relief from multiple symptoms of IBS-D, including abdominal pain, diarrhea, urgency and bloating i – MARKHAM, ON, May 16, 2017 /CNW/ - Allergan Inc. ..."
AGN,AGN:US,BBG000FH8PX5,Several top fund managers trim Allergan stakes in first quarter,2017-05-16 00:41:00 +0000,https://finance.yahoo.com/news/several-top-fund-managers-trim-000804384.html?.tsrc=rss,"Six closely watched investors sliced their stakes in Allergan Plc (AGN.N) during the first quarter, recent regulatory disclosures show, cutting what had been one of the years' best performing health stocks that has stumbled in recent days.  Billionaire investor Carl Icahn sold out of the pharmaceutical giant entirely, while Farallon Capital Management LLC, David Tepper's Appaloosa LP and Seth Klarman's Baupost Group LLC were among those trimming their stakes by as much as 32 percent, according to regulatory filings."
AGN,AGN:US,BBG000FH8PX5,John Paulson Takes A Shine To Telecom,2017-05-15 21:59:10 +0000,http://finance.yahoo.com/r/36dda89a-f3e7-3c3c-b3df-b2bef394c4e3/paulson0515?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson bought new positions in telecommunications operators T-Mobile US Inc. and Dish Network Corp. in the first quarter, according to securities filings Monday."
AGN,AGN:US,BBG000FH8PX5,"Carl Icahn Adds New Stake In Conduent, Exits Allergan And Nuance Communications",2017-05-15 21:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m9pbocBrK6k/carl-icahn-adds-new-stake-in-conduent-exits-allergan-and-nuance-communications-20170515-01609,"Carl Icahn Adds New Stake In Conduent, Exits Allergan And Nuance Communications"
AGN,AGN:US,BBG000FH8PX5,"ETFs with exposure to Allergan Plc : May 15, 2017",2017-05-15 19:12:00 +0000,http://finance.yahoo.com/r/cba4deb4-63b5-31ff-b992-c572dae5aa36/etfs-with-exposure-to-allergan-plc-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Allergan Plc Here are 5 ETFs with the largest exposure to AGN-US. Comparing the performance and risk of Allergan Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Allergan Becomes Oversold (AGN),2017-05-15 17:16:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0m-0P20Dses/allergan-becomes-oversold-agn-cm789343,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
AGN,AGN:US,BBG000FH8PX5,13-F Reveals Tepper's Big Bet on Bank of America,2017-05-15 13:28:00 +0000,http://finance.yahoo.com/r/0666b6d4-8b92-377d-9901-ba1a89924012/13f-reveals-teppers-big-bet-bank-america-bac-cbs?partner=YahooSA&yptr=yahoo&.tsrc=rss,Tepper's Appaloosa Management invested more than $200 million in Bank of America during the first quarter of the year.
AGN,AGN:US,BBG000FH8PX5,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for May 16, 2017",2017-05-15 13:17:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4a9O088xn94/allergan-plc-agn-ex-dividend-date-scheduled-for-may-16-2017-cm789113,Allergan plc AGN will begin trading ex dividend on May 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on June 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment At the current stock price of 230
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the Bernstein Strategic Decisions Conference,2017-05-15 12:00:00 +0000,https://finance.yahoo.com/news/allergan-present-bernstein-strategic-decisions-120000175.html?.tsrc=rss,"DUBLIN, May 15, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 33rd Annual Strategic Decisions Conference in New York, New York.  The presentation will begin at 9:00 a.m. ET on Wednesday, May 31, 2017.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,Still an Allergan Fan; Oil Vey!: Doug Kass' Views,2017-05-15 05:00:00 +0000,http://finance.yahoo.com/r/03f6dce7-51ab-364a-977e-c9860584d3bd/still-an-allergan-fan-oil-vey-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Allergan and oil.
AGN,AGN:US,BBG000FH8PX5,Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT,2017-05-14 15:26:12 +0000,https://finance.yahoo.com/news/edited-transcript-agn-earnings-conference-192048292.html?.tsrc=rss,Q1 2017 Allergan plc Earnings Call
AGN,AGN:US,BBG000FH8PX5,"David Tepper Buys Bank of America Corporation, General Motors Co, Southwest Airlines Co, Sells ...",2017-05-13 17:14:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/91j_-5dVxZ8/david-tepper-buys-bank-of-america-corporation-general-motors-co-southwest-airlines-co-sells-cm788935,David Tepper New Purchases BAC GM CBS UNH SYMC CHTR NUE TMO AKS SNAP Added Positions LUV MU BSX YHOO MT CNC KMI RF SUM WPZ Reduced Positions AGN TEVA PFE ALL MYL HCA AMLP FB MCK AAPL Sold Out CFG QCOM TPX CMA AAL JCP
AGN,AGN:US,BBG000FH8PX5,Earnings Are Still Calling the Tune: Cramer's 'Mad Money' Recap (Friday 5/12/17),2017-05-13 00:10:00 +0000,http://finance.yahoo.com/r/59fb3196-e096-3835-b43a-8e447ac12f86/earnings-are-still-calling-the-tune-cramer-s-mad-money-recap-friday-5-12-17.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Jim Cramer lays out next week's game plan: Tech stocks look strong, but same-store sales are sinking retail."
AGN,AGN:US,BBG000FH8PX5,High-profile Snap stakeholders revealed in filings,2017-05-12 22:20:10 +0000,https://finance.yahoo.com/news/high-profile-snap-stakeholders-revealed-222010853.html?.tsrc=rss,"NEW YORK/BOSTON, May 12 (Reuters) - Some of the biggest U.S.  mutual and hedge funds, including Daniel Loeb's Third Point and  Daniel Och's Och-Ziff Capital Management, owned stakes  in Snap Inc, parent of the wildly popular Snapchat  messaging app, at the end of March, regulatory filings on Friday  showed.  The filings provide the first definitive snapshot on who  bought Snap shares when it went public in early March, in the  biggest initial public offering for a U.S. tech company since  Facebook Inc's 2012 debut.  While the shares quickly rose after the IPO, they plunged  this week after Snap reported a $2.2 billion first-quarter loss."
AGN,AGN:US,BBG000FH8PX5,13-F Alert: Starboard Dumps Macy's; Appaloosa and Baupost Lighten up on Allergan,2017-05-12 22:03:00 +0000,http://finance.yahoo.com/r/25a59e90-29e4-3b6b-9145-c8655bf94329/13-f-alert-starboard-dumped-macys-appaloosa-and-baupost-lighten-up-on-allergan-1494626646?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Starboard Value, Appaloosa Management, and Baupost Group submitted March-end holdings to the Securities and Exchange Commission.  Starboard dumped its 1% stake in   Macy's (M), which was probably a good call considering its stock took a near 20% hit in the past week.  Appaloosa cut its stake in  Allergan (AGN) by 30%."
AGN,AGN:US,BBG000FH8PX5,Tepper's Appaloosa Trims Bets on Pharmaceuticals,2017-05-12 21:19:38 +0000,http://finance.yahoo.com/r/2dc2a4a8-b255-34e8-8134-364a112f6695/appaloosa0512?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,David Tepper's Appaloosa Management trimmed its wagers on pharmaceutical companies in the first quarter and sold out of retailer J.C. Penney.
AGN,AGN:US,BBG000FH8PX5,Court Battle May Be Responsible For Drugmaker&apos;s 40% Spike,2017-05-12 20:08:36 +0000,http://finance.yahoo.com/r/a8fdca56-4ae2-3ac3-aff0-2739347aafdb/is-a-court-battle-responsible-for-spiking-this-drugmakers-stock?src=A00220&yptr=yahoo&.tsrc=rss,Valeant stock has gained 40% since Monday after a Delaware judge sided with the company on two patent issues related to antibiotic Xifaxan.
AGN,AGN:US,BBG000FH8PX5,"Top Picks For The Rest Of 2017, Courtesy Of UBS",2017-05-12 19:25:19 +0000,https://finance.yahoo.com/news/top-picks-rest-2017-courtesy-192519912.html?.tsrc=rss,"For many, it is hard to believe, but the halfway point of 2017 is inching closer, and quickly. Analysts at UBS released a mid-year report card with its top six picks for the bottom half of 2017 from six ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc :AGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017",2017-05-12 15:38:26 +0000,http://finance.yahoo.com/r/a8641e32-6e1c-3a00-a857-4190d253be85/allergan-plc-agn-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Allergan Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Allergan Plc – Mylan N.V., Zoetis, Inc. Class A, Incyte Corporation and Abbott Laboratories (MYL-US, ZTS-US, INCY-US and ABT-US) that have also reported for this period. Highlights Summary numbers: ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,"Ex-Dividend Reminder: Allergan, Zions Bancorporation and Southside Bancshares",2017-05-12 14:26:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K2T2GoNtKCA/ex-dividend-reminder-allergan-zions-bancorporation-and-southside-bancshares-cm788412,Looking at the universe of stocks we cover at Dividend Channel on 5 16 17 Allergan PLC Symbol AGN Zions Bancorporation Symbol ZION and Southside Bancshares Inc Symbol SBSI will all trade ex dividend for their respective upcoming dividends Allergan PLC will pay its
AGN,AGN:US,BBG000FH8PX5,"Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls",2017-05-12 14:07:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aS3gg3JZRig/teva-teva-q1-earnings-in-line-sales-lag-as-copaxone-falls-cm788375,Teva Pharmaceutical Industries Ltd TEVA reported first quarter 2017 earnings of 1 03 per share including equity compensation expenses which was in line with the Zacks Consensus Estimate The year ago adjusted earnings were 1 18 per share Revenues of 5 63 billion missed the
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study",2017-05-12 12:49:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-teva-124912888.html?.tsrc=rss,"While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs."
AGN,AGN:US,BBG000FH8PX5,"3 Big Stock Charts for Thursday: Allergan plc Ordinary Shares (AGN), Cummins Inc. (CMI) and Michaels Companies Inc (MIK)",2017-05-11 21:03:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caQ024lqTwU/3-big-stock-charts-for-thursday-allergan-plc-ordinary-shares-agn-cummins-inc-cmi-and-michaels-companies-inc-mik-cm788196,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market is stumbling around a bit after earnings from Macy s Inc NYSE M and other retailers have traders in the profit taking mood Today s three big stock charts takes a look at Allergan
AGN,AGN:US,BBG000FH8PX5,"Hologic Topples On &apos;Blip&apos; In Breast Health, Body-Sculpting Unit",2017-05-11 20:07:45 +0000,http://finance.yahoo.com/r/e80377c8-e7ed-3dbd-a182-3b74164d890a/hologic-topples-on-blip-in-breast-health-body-sculpting-unit?src=A00220&yptr=yahoo&.tsrc=rss,Hologic stock toppled to a nearly three-week low Thursday after the firm reported lagging breast-screening revenue and noted &quot;significant disruption&quot; in its Cynosure unit.
AGN,AGN:US,BBG000FH8PX5,Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher,2017-05-11 17:03:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vNxHPIh_dWQ/actavis-generics-acquisition-drives-teva-pharmaceutical-industries-ltd-first-quarter-sales-higher-cm787956,A boost from the acquisition of Actavis Generics from Allergan NYSE AGN made the difference for Teva Pharmaceutical Industries Ltd NYSE TEVA when the company reported its results for the fourth quarter of 2016 The addition of Actavis Generics drove Teva s revenue
AGN,AGN:US,BBG000FH8PX5,"Impax (IPXL) Q1 Earnings Miss, Stock Up on Cost Savings Plan",2017-05-11 17:02:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mn7iLm49NFs/impax-ipxl-q1-earnings-miss-stock-up-on-cost-savings-plan-cm787960,Impax Laboratories Inc 160 IPXL posted first quarter 2017 adjusted earnings of 11 cents per share missing the Zacks Consensus Estimate of 12 cents Earnings were down 74 4 from 43 cents in the year ago period due to lower revenues and higher costs Total revenue decreased 18 2 year
AGN,AGN:US,BBG000FH8PX5,Understanding Allergan’s Valuation after the 1Q17 Results,2017-05-11 14:36:45 +0000,http://finance.yahoo.com/r/dc4cab83-951d-3a6c-b058-0a1fb1c9c1d6/understanding-allergans-valuation-after-the-1q17-results?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On May 10, 2017, Allergan (AGN) was trading at a forward PE multiple of ~14.1x, as compared to the industry average of 11.9x."
AGN,AGN:US,BBG000FH8PX5,"Final Trades: Valeant, Allergan and more",2017-05-11 13:59:00 +0000,http://finance.yahoo.com/video/final-trades-valeant-allergan-more-135900904.html?.tsrc=rss,"The &quot;Fast Money&quot; traders share their final trades of the day including Valeant, Foot Locker, Nabors and Allergan."
AGN,AGN:US,BBG000FH8PX5,What Happened to Allergan’s International Segment in 1Q17?,2017-05-11 13:08:00 +0000,http://finance.yahoo.com/r/f3f47751-7956-3d6d-8bd2-fcff42b7ef69/what-happened-to-allergans-international-segment-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, total revenues from Allergan's International segment reached $737.3 million, as compared to $673.3 million in 1Q16."
AGN,AGN:US,BBG000FH8PX5,Today's Research Reports on Stocks to Watch: Allergan and Celgene,2017-05-11 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000515.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Botox maker Allergan suffered a loss on Wednesday, the day after the multi-national pharmaceutical company released its first quarter earnings that beat estimates. ..."
AGN,AGN:US,BBG000FH8PX5,Behind Allergan’s US General Medicines Segment in 1Q17,2017-05-11 11:37:27 +0000,http://finance.yahoo.com/r/17da457f-3905-3b8f-a416-378861646ecc/behind-allergans-us-general-medicines-segment-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, revenues from Allergan's US General Medicine segment fell 7.4% to $1.35 billion, as compared to $1.45 billion in 1Q16."
AGN,AGN:US,BBG000FH8PX5,"Should You Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock? 3 Pros, 3 Cons",2017-05-11 06:00:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Vy_mukU0dM/should-you-buy-teva-pharmaceutical-industries-ltd-adr-teva-stock-3-pros-3-cons-cm787616,InvestorPlace Stock Market News Stock Advice amp Trading Tips You would be forgiven for thinking Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has profoundly bad luck It seems everything that could go wrong for the company 160 pretty much has over the past year
AGN,AGN:US,BBG000FH8PX5,Asian stocks mostly higher in quiet trading; oil prices gain,2017-05-11 04:19:25 +0000,http://finance.yahoo.com/r/d4060824-b2b5-3a98-b270-8bd8e8cef628/us-stocks-mixed-weak-earnings-higher-oil-prices-141800432--finance.html?.tsrc=rss,"SEOUL, South Korea (AP) — Asian stocks were moderately higher on Thursday with few data reports to move the markets. Investors are watching tax reform developments in the U.S. after President Donald Trump's firing of FBI chief James Comey. Oil prices extended gains."
AGN,AGN:US,BBG000FH8PX5,Asian stocks mostly higher in quiet trading; oil prices gain,2017-05-11 04:19:13 +0000,http://finance.yahoo.com/news/us-stocks-mixed-weak-earnings-higher-oil-prices-141800432--finance.html?.tsrc=rss,Asian stocks were moderately higher on Thursday with few data reports to move the markets. Investors are watching tax reform developments in the U.S. after President Donald Trump's firing of FBI chief ...
AGN,AGN:US,BBG000FH8PX5,Aegon Q1 Net Income Rises; Total Sales Up 11% - Quick Facts,2017-05-11 01:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ct7mQPo5Ba0/aegon-q1-net-income-rises-total-sales-up-11--quick-facts-20170511-00075,Aegon Q1 Net Income Rises; Total Sales Up 11% - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Behind Allergan’s US Specialized Therapeutics Segment in 1Q17,2017-05-10 22:05:46 +0000,http://finance.yahoo.com/r/6495d4df-0986-316a-8f4e-362aca536f64/behind-allergans-us-specialized-therapeutics-segment-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Allergan's US Specialized Therapeutics segment revenues rose 14.1% to $1.48 billion, as compared to $1.30 billion in 1Q16."
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance,2017-05-10 22:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O_L6WypJKGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-has-a-chance-cm787544,InvestorPlace Stock Market News Stock Advice amp Trading Tips The year for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has certainly been awful with the shares off about 14 Yet last year was even worse TEVA stock plunged from 56 44 to 31 15 Source Open
AGN,AGN:US,BBG000FH8PX5,4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning,2017-05-10 20:52:00 +0000,http://finance.yahoo.com/r/32142eed-40ef-341c-a5e3-f4bc101bc863/4-pressing-questions-we-want-answered-when-teva-ph.aspx?yptr=yahoo&.tsrc=rss,"From Copaxone&apos;s patents to its $35.8 billion in debt, shareholders have questions and we want answers."
AGN,AGN:US,BBG000FH8PX5,"Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents",2017-05-10 20:45:17 +0000,http://finance.yahoo.com/r/597df2ae-1f9e-3aba-a842-f25fcc9c5ca1/hologic-smashes-fiscal-q2-sales-views-beats-on-profit-by-4-cents?src=A00220&yptr=yahoo&.tsrc=rss,"Hologic crushed Wall Street&apos;s fiscal second-quarter revenue and profit expectations late Wednesday, led by double-digit growth."
AGN,AGN:US,BBG000FH8PX5,Inside Allergan’s 1Q17 Results: Revenue Streams,2017-05-10 20:24:20 +0000,http://finance.yahoo.com/r/06794fa0-3546-3f4b-b17d-1f08e77ce024/inside-allergans-1q17-results-revenue-streams?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) released its 1Q17 earnings on May 9, 2017, reporting a growth of 5.1% and revenues of ~$3.6 billion, as compared to $3.4 billion in 1Q16."
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall St mixed after Trump fires FBI head; Nasdaq hits record high,2017-05-10 20:17:37 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-mixed-201737537.html?.tsrc=rss,"U.S. stocks were mixed on Wednesday as  investors digested President Donald Trump's abrupt dismissal of  his FBI chief as well as corporate earnings from Walt Disney and  Nvidia.  The Dow Jones industrial average lost ground, while the  Nasdaq closed at a record high."
AGN,AGN:US,BBG000FH8PX5,"Allergan Starts 'Pivotal' 2017 With a Beat, Plus Jim Cramer's Take",2017-05-10 19:28:00 +0000,http://finance.yahoo.com/r/fd7f886f-c38b-3c85-9bb1-5e72434d3bf3/allergan.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Allergan shares had risen $2.55, or 1.05%, in premarket trading to $244.50."
AGN,AGN:US,BBG000FH8PX5,Biotech And Pharma Industry And Stock News,2017-05-10 19:02:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall Street mixed after Trump fires FBI head,2017-05-10 18:17:17 +0000,http://finance.yahoo.com/news/us-stocks-wall-street-mixed-181717430.html?.tsrc=rss,U.S. stocks wavered on Wednesday as  investors digested a batch of weak corporate earnings and  President Donald Trump's dismissal of his FBI chief.  Trump said he fired Federal Bureau of Investigation Director  James Comey over his handling of an email scandal involving  then-Democratic presidential nominee Hillary Clinton.
AGN,AGN:US,BBG000FH8PX5,Allergan Looking Shaky After So-So Quarter,2017-05-10 18:05:00 +0000,http://finance.yahoo.com/r/a10ce00d-cfd0-3caf-8939-1e2d7496085a/allergan-looking-shaky-after-soso-quarter?partner=YahooSA&yptr=yahoo&.tsrc=rss,Allergan's modest quarterly results aren't likely to help the company.
AGN,AGN:US,BBG000FH8PX5,"US STOCKS-Tepid earnings, Comey sacking weigh on Wall St",2017-05-10 17:00:15 +0000,http://finance.yahoo.com/news/us-stocks-tepid-earnings-comey-170015186.html?.tsrc=rss,"U.S. stocks struggled for direction on  Wednesday as investors weighed a batch of weak corporate  earnings and a shock move by President Donald Trump to fire his  FBI chief.  Trump said he fired FBI Director James Comey, who had been  leading an investigation into his 2016 presidential campaign's  possible collusion with Russia, over his handling of an email  scandal involving then-Democratic presidential nominee Hillary  Clinton."
AGN,AGN:US,BBG000FH8PX5,"S&P 500 Movers: PCLN, NVDA",2017-05-10 16:03:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vkFVowo3dDM/sp-500-movers-pcln-nvda-cm787209,In early trading on Wednesday shares of NVIDIA NVDA topped the list of the day s best performing components of the S amp P 500 index trading up 13 3 Year to date NVIDIA registers a 9 2 gain And the worst performing S amp P 500 component thus far on the day is Priceline
AGN,AGN:US,BBG000FH8PX5,"IYY, AGN, ABT, MDLZ: Large Outflows Detected at ETF",2017-05-10 16:02:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q_SbBQlo0DI/iyy-agn-abt-mdlz-large-outflows-detected-at-etf-cm787200,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Dow Jones U S ETF Symbol IYY where we have detected an approximate 30 0 million dollar outflow that s a 2 7 decrease week over week from 9 300 000
AGN,AGN:US,BBG000FH8PX5,"Jim Cramer Discusses Disney, Yelp, Nvidia, Allergan, Abercrombie, Macy's and Kohl's",2017-05-10 15:59:00 +0000,http://finance.yahoo.com/r/b0987a81-e8a2-3745-bbc2-66e55d60e4a0/jim-cramer-discusses-disney-yelp-nvidia-allergan-abercrombie-macy-s-and-kohl-s.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,"TheStreet's Jim Cramer discusses Wednesday's trending stocks including Disney, Yelp, Nvidia, Allergan, Abercrombie & Fitch, Macy's and Kohl's."
AGN,AGN:US,BBG000FH8PX5,"US STOCKS-Wall St weighed down by weak earnings, Comey sacking",2017-05-10 15:25:27 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-weighed-152527112.html?.tsrc=rss,"U.S. stocks slipped on Wednesday, weighed  down by a string of weak corporate earnings, while investors  turned cautious after President Donald Trump fired his FBI  chief.  Trump said he fired FBI Director James Comey, who had been  leading an investigation into his 2016 presidential campaign's  possible collusion with Russia, over his handling of an email  scandal involving then-Democratic presidential nominee Hillary  Clinton."
AGN,AGN:US,BBG000FH8PX5,Jim Cramer on Allergan: There Are So Many Sellers Off the Goldman Downgrade,2017-05-10 15:03:00 +0000,http://finance.yahoo.com/r/df43369f-a8e4-34c6-bdbc-b3db038417f9/jim-cramer-on-allergan-there-are-so-many-sellers-off-the-goldman-downgrade.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,"TheStreet's Jim Cramer said Goldman Sachs' downgrade of Allergan was not ""thoughtful"" in terms of the company's fundamentals."
AGN,AGN:US,BBG000FH8PX5,Cramer: 5 Timeless Rules When a Stock Breaks Down,2017-05-10 15:01:00 +0000,http://finance.yahoo.com/r/4415a4a4-6ed3-3b39-b7b3-2e2579d8b581/cramer-5-timeless-rules-when-stock-breaks-down?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,What to do on the day a stock craters.
AGN,AGN:US,BBG000FH8PX5,"Allergan Stock Falls on Declining U.S. Medicine Revenue, Goldman Downgrade",2017-05-10 14:04:00 +0000,http://finance.yahoo.com/r/815ae2fe-c0e5-3ddc-b7f6-e014d80fcee9/allergan-stock-falls-on-downgrade-at-goldman.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Goldman Sachs downgraded Allergan stock saying the pharmaceutical firm lacks a short-term catalyst.
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : May 10, 2017",2017-05-10 12:52:41 +0000,http://finance.yahoo.com/r/c9b2af14-14ce-3b14-bc76-3983dd47eb77/allergan-plc-breached-its-50-day-moving-average-in-a-bearish-manner-agn-us-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT,2017-05-10 12:41:03 +0000,http://finance.yahoo.com/news/edited-transcript-agn-earnings-conference-192048292.html?.tsrc=rss,Q1 2017 Allergan plc Earnings Call
AGN,AGN:US,BBG000FH8PX5,Allergan: Cramer's Top Takeaways,2017-05-10 10:32:00 +0000,http://finance.yahoo.com/r/cef7a087-6ffe-3489-b696-5a8b0240e188/allergan-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Brent Saunders, chairman, president and CEO of Allergan, tells Jim Cramer about strong growth in aesthetic products."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Proposed Public Offering of Senior Notes to Refinance Existing Debt,2017-05-10 07:00:00 +0000,http://finance.yahoo.com/news/allergan-announces-proposed-public-offering-070000396.html?.tsrc=rss,"DUBLIN, May 10, 2017 /PRNewswire/ -- Allergan plc (AGN) (""Allergan"" or the ""Company"") today announced that, subject to market and other conditions, the Company expects to commence an offering of euro-denominated senior unsecured notes in multiple tranches in the coming weeks.  The notes, which are expected to have maturities of up to 12 years, will be issued in a registered public offering by Allergan's indirect subsidiary, Allergan Funding SCS (f.k.a.  Actavis Funding SCS), and guaranteed by its indirect subsidiaries Warner Chilcott Limited, Allergan Capital S.à r.l."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Tender Offers by Certain Subsidiaries,2017-05-10 07:00:00 +0000,http://finance.yahoo.com/news/allergan-announces-tender-offers-certain-070000614.html?.tsrc=rss,"DUBLIN, May 10, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its indirectly wholly owned subsidiaries Allergan Funding SCS, Allergan Finance LLC, Forest Laboratories, LLC and Allergan, ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Thin Is In as Allergan Dodges Generics Bullet,2017-05-10 05:08:16 +0000,http://finance.yahoo.com/r/5b802f8d-fcaf-375d-9393-3ec44a7c8404/thin-is-in-as-allergan-dodges-generics-bullet-1494343340?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"A series of acquisitions helped turn Allergan into a pharmaceuticals giant, but shareholders should be most grateful for the well-timed sale of its generics unit."
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Where the money leaving retail stocks could...,2017-05-09 23:11:00 +0000,http://finance.yahoo.com/video/cramer-remix-where-money-leaving-231100918.html?.tsrc=rss,Jim Cramer pointed to consumer spending on vacations and travel as a possible pull from retail purchases.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Where the money leaving retail stocks could be headed,2017-05-09 22:59:46 +0000,http://finance.yahoo.com/news/cramer-remix-where-money-leaving-225946819.html?.tsrc=rss,Jim Cramer pointed to consumer spending on vacations and travel as a possible pull from retail purchases.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Where the money leaving retail stocks could be headed,2017-05-09 22:59:46 +0000,http://finance.yahoo.com/r/bd3952a8-d7eb-3cc2-a7ef-605e6f1ada60/104457752?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104457752&yptr=yahoo&.tsrc=rss,Jim Cramer pointed to consumer spending on vacations and travel as a possible pull from retail purchases.
AGN,AGN:US,BBG000FH8PX5,Allergan Says It Continues to Look at Stepping-Stone Deals,2017-05-09 21:42:00 +0000,http://finance.yahoo.com/r/f0decf72-7afe-3de6-a72a-f81856c57483/allergan-says-it-continues-to-look-at-stepping-stone-deals.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"On an earnings call Tuesday, Allergan CEO Brent Saunders discusses recent deals and says the company continues to look at stepping-stone transactions."
AGN,AGN:US,BBG000FH8PX5,"Allergan Earnings Top Estimates On Aesthetic, Eye Care Products",2017-05-09 20:11:10 +0000,http://finance.yahoo.com/r/7c6a1d79-de2b-3fbf-8ff9-bb01674b9561/allergan-reports-first-quarter-earnings-before-the-open?src=A00220&yptr=yahoo&.tsrc=rss,Allergan reported better-than-expected first-quarter earnings and revenue early Tuesday.
AGN,AGN:US,BBG000FH8PX5,"Allergan Mandatory Convertible Preferred Shares, Series A Goes Ex-Dividend Soon",2017-05-09 19:03:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hLcpSwgfdjc/allergan-mandatory-convertible-preferred-shares-series-a-goes-ex-dividend-soon-cm786715,On 5 11 17 Allergan PLC s 5 500 Mandatory Convertible Preferred Shares Series A Symbol AGN PRA will trade ex dividend for its quarterly dividend of 13 75 payable on 6 1 17 As a percentage of AGN PRA s recent share price of 857 85 this dividend works out to approximately 1 60 so
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View",2017-05-09 17:03:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hayuIi7TSS4/allergan-agn-beats-q1-earnings-estimates-ups-2017-view-cm786622,Allergan plc s AGN first quarter 2017 earnings came in at 3 35 per share beating the Zacks Consensus Estimate of 3 32 by 0 9 Earnings rose 12 year over year Revenues came in at 3 57 billion up 5 1 from the year ago period and beat the Zacks Consensus Estimate of 3
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Tuesday Option Activity: AGN, EA, BCRX",2017-05-09 17:01:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r6pkeX_d-aI/noteworthy-tuesday-option-activity-agn-ea-bcrx-cm786601,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 13 412 contracts has been traded thus far today a contract volume which is representative of approximately 1 3
AGN,AGN:US,BBG000FH8PX5,Allergan posts loss as it writes down Teva holdings,2017-05-09 17:01:03 +0000,http://finance.yahoo.com/news/allergans-quarterly-revenue-rises-5-111343709.html?.tsrc=rss,"Allergan sold its generics business Actavis to Teva in August 2016 for $33 billion in cash and 100 million shares of the Israeli generic drugmaker, worth around $5.3 billion at the time.  Under the terms of the deal, Allergan agreed to hold on to the shares for at least one year.  Teva has struggled since then, and the company's chief executive stepped down in February after sharp criticism for a string of costly acquisitions and delayed drug launches."
AGN,AGN:US,BBG000FH8PX5,"Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss",2017-05-09 16:06:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XwcOUXODK2w/ironwood-irwd-q1-loss-wider-than-expected-sales-miss-cm786547,Ironwood Pharmaceuticals Inc IRWD reported first quarter 2017 adjusted loss of 33 cents per share significantly wider than both the Zacks Consensus Estimate of a loss of 19 cents and the year ago loss of 8 cents Total revenue collaborative revenues in the quarter amounted to 52
AGN,AGN:US,BBG000FH8PX5,[$$] Thin Is In as Allergan Dodges Generics Bullet,2017-05-09 15:38:14 +0000,http://finance.yahoo.com/r/5b802f8d-fcaf-375d-9393-3ec44a7c8404/thin-is-in-as-allergan-dodges-generics-bullet-1494343340?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"A series of acquisitions helped turn Allergan into a pharmaceuticals giant, but shareholders should be most grateful for the well-timed sale of its generics unit."
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View",2017-05-09 14:26:02 +0000,http://finance.yahoo.com/news/allergan-agn-beats-q1-earnings-142602636.html?.tsrc=rss,"Allergan plc&apos;s (AGN) first-quarter 2017 earnings came in at $3.35 per share, beating the Zacks Consensus Estimate of $3.32 by 0.9%."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q1 Earnings & Sales; Ups 2017 View,2017-05-09 14:05:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QdUy1GhXgM8/allergan-agn-beats-q1-earnings-sales-ups-2017-view-cm786463,Dublin Ireland based Allergan plc AGN is engaged in the development manufacturing marketing sale and distribution of branded pharmaceuticals and select over the counter products Allergan has been actively pursuing deals to expand its portfolio especially its branded products offering
AGN,AGN:US,BBG000FH8PX5,"Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss",2017-05-09 13:46:01 +0000,http://finance.yahoo.com/news/ironwood-irwd-q1-loss-wider-134601209.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. (IRWD) reported first-quarter 2017 adjusted loss of 33 cents per share, significantly wider than both the Zacks Consensus Estimate of a loss of 19 cents and the year-ago loss of 8 cents."
AGN,AGN:US,BBG000FH8PX5,"Allergan tops Street 1Q forecasts, deal fuels guidance hike",2017-05-09 13:04:28 +0000,http://finance.yahoo.com/news/allergan-reports-1q-loss-111450801.html?.tsrc=rss,"Allergan lost $2.57 billion in the first quarter on higher research and development charges and other costs, but results beat expectations and the maker of Botox increased its 2017 forecast. The drugmaker ..."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q1 Earnings & Sales; Ups 2017 View,2017-05-09 12:23:12 +0000,http://finance.yahoo.com/news/allergan-agn-beats-q1-earnings-122312230.html?.tsrc=rss,Allergan???s first-quarter earnings of $3.35 per share were above our consensus estimate of $3.32 per share.
AGN,AGN:US,BBG000FH8PX5,"Early movers: VRX, AGN, W, ODP, PRTY, VZ, WFC, UAL, P & more",2017-05-09 12:02:46 +0000,http://finance.yahoo.com/r/5609e33c-1651-39f8-8f52-109ffe484d55/104456976?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104456976&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
AGN,AGN:US,BBG000FH8PX5,"Early movers: VRX, AGN, W, ODP, PRTY, VZ, WFC, UAL, P & more",2017-05-09 12:02:46 +0000,http://finance.yahoo.com/news/early-movers-vrx-agn-w-120246815.html?.tsrc=rss,These are the stocks posting the largest moves before the bell.
AGN,AGN:US,BBG000FH8PX5,Medicines360 and Allergan Present Four-Year Multi-Center Pivotal Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the 2017 ACOG Meeting,2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/medicines360-allergan-present-four-multi-120000607.html?.tsrc=rss,"DUBLIN and SAN FRANCISCO, May 9, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines, presented four-year data from their ongoing multi-center U.S.-based pivotal trial of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the American College of Obstetricians and Gynecologists (ACOG) annual clinical and scientific meeting.  LILETTA is an intrauterine system (IUS), approved for the prevention of pregnancy for up to three years.  Women aged 36–45 years received the IUS for safety evaluation only."
AGN,AGN:US,BBG000FH8PX5,"UPDATE: Allergan tops earnings estimates on strength of Botox, eye care products",2017-05-09 11:50:39 +0000,http://finance.yahoo.com/r/b301ed39-7f40-390e-bde9-dceab6cafd4d/Story.aspx?guid=F89619E9-F484-41D4-82C2-768DCEF0F8A3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Botox-maker Allergan Plc said Tuesday it had a GAAP operating loss from continuing operations of $906 million, or $7.85 a share, in the first quarter, after a loss of $171.5 million, or 41 cents a share, ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan tops earnings estimates on strength of Botox, eye care products",2017-05-09 11:20:04 +0000,http://finance.yahoo.com/news/allergan-tops-earnings-estimates-strength-112004531.html?.tsrc=rss,"Botox-maker Allergan Plc said Tuesday it had a GAAP operating loss from continuing operations of $906 million, or $7.85 a share, in the first quarter, after a loss of $171.5 million, or 41 cents a share, ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion,2017-05-09 11:00:00 +0000,http://finance.yahoo.com/news/allergan-reports-solid-start-2017-110000984.html?.tsrc=rss,"DUBLIN, May 9, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its first quarter 2017 continuing operations performance. First Quarter 2017 Continuing Operations  (unaudited; $ in millions, ..."
AGN,AGN:US,BBG000FH8PX5,"Market Recon: Worryingly, the Indices Seem to Be Almost Resting at Lofty Levels",2017-05-09 10:43:00 +0000,http://finance.yahoo.com/r/0ab80846-6ad8-31a1-9946-b9d3a5712db3/market-recon-worryingly-the-indices-seem-to-be-almost-resting-at-lofty-levels.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A mishap in northern Asia would be an awful catalyst even to ponder. But a less apocalyptic one would be oil.
AGN,AGN:US,BBG000FH8PX5,"Earnings Reaction History: Allergan Inc, 66.7% Follow-Through Indicator, 2.9% Sensitive",2017-05-09 10:40:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mb4Rhe7ihjQ/earnings-reaction-history-allergan-inc-667-follow-through-indicator-29-sensitive-cm786299,Expected Earnings Release 05 09 2017 PremarketExpected Earnings Release 05 09 2017 Premarket Avg Extended Hours Dollar Volume 20 915 517Avg Extended Hours Dollar Volume 20 915 517 Allergan Inc AGN is due to issue its quarterly earnings report in the upcoming extended hours
AGN,AGN:US,BBG000FH8PX5,Allergan Q1 17 Earnings Conference Call At 8:30 AM ET,2017-05-09 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/An11YovTAZ0/allergan-q1-17-earnings-conference-call-at-830-am-et-20170509-00471,Allergan Q1 17 Earnings Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,Allergan Raises 2017 Guidance To Reflect Contribution From ZELTIQ - Quick Facts,2017-05-09 07:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pOSf61tcTaY/allergan-raises-2017-guidance-to-reflect-contribution-from-zeltiq--quick-facts-20170509-00432,Allergan Raises 2017 Guidance To Reflect Contribution From ZELTIQ - Quick Facts
AGN,AGN:US,BBG000FH8PX5,The Top Earnings Charts to Start the Week,2017-05-09 00:00:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2TqubzJlYt4/the-top-earnings-charts-to-start-the-week-cm786220,The earnings party isn t over yet While most of the S amp P 500 has reported there are still hundreds of companies expected to report earnings this week including many mid and small cap companies Also on tap are the retailers which has been one of the most maligned industries Will they
AGN,AGN:US,BBG000FH8PX5,4 Stocks In Buy Range Ahead Of Earnings Reports: Investing Action Plan,2017-05-08 21:05:30 +0000,http://finance.yahoo.com/r/6fc378f4-2d4d-3bf9-ab92-096f5c1d1d3e/4-stocks-in-buy-range-ahead-of-earnings-reports-investing-action-plan?src=A00220&yptr=yahoo&.tsrc=rss,"There are some hot, lesser-known stocks that are still in buy zones, such as Microchip Technology and Electronic Arts, which report quarterly results tomorrow."
AGN,AGN:US,BBG000FH8PX5,Allergan&apos;s Q1 Sales Expected To Slip As Jazz Pharma Outperforms,2017-05-08 20:28:32 +0000,http://finance.yahoo.com/r/6f1e841d-3f4d-3ef4-82c6-6f5c4bbd28f8/allergans-q1-sales-expected-to-slip-as-jazz-pharma-outperforms?src=A00220&yptr=yahoo&.tsrc=rss,"Allergan and Jazz are expected Tuesday to report growing first-quarter profits, but Allergan is likely to see sales decline for the first time in nine periods."
AGN,AGN:US,BBG000FH8PX5,"Pre-Market Earnings Report for May 9, 2017 :  AGN, DUK, AON, SRE, XRAY, HSIC, TDG, ARMK, QVCA, SEE, SLW, AER",2017-05-08 20:19:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W5GX7Qv25I8/pre-market-earnings-report-for-may-9-2017-agn-duk-aon-sre-xray-hsic-tdg-armk-qvca-see-slw-aer-cm786163,The following companies are expected to report earnings prior to market open on 05 09 2017 Visit our Earnings Calendar for a full list of expected earnings releases Allergan plc AGN is reporting for the quarter ending March 31 2017 The medical company
AGN,AGN:US,BBG000FH8PX5,M&A Talks May Take Center Stage in Allergan's 1Q Earnings Call,2017-05-08 20:00:00 +0000,http://finance.yahoo.com/r/3ae832b5-d779-3907-af52-c63dacf0e93f/m-amp-a-talks-may-take-centerstage-in-allergan-s-1q-earnings-call.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pfizer CEO Ian Read last week was forced to field questions about M&A and there's a good chance Allergan won't be any different.
AGN,AGN:US,BBG000FH8PX5,"Allergan Must Show Mergers, Drug Pipeline Can Make Up For Lost Sales",2017-05-08 19:21:00 +0000,http://finance.yahoo.com/r/5809cb88-0c48-3dd8-9184-7f489652e00a/allergan-must-show-mergers-drug-pipeline-can-make-up-for-lost-sales.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Analysts estimate total revenue will fall 6.9% to $3.53 billion in the quarter due to the loss of patent exclusivity on some drugs and divestitures of major business lines.
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside,2017-05-08 18:01:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJxZConnWDc/teva-pharmaceutical-industries-ltd-adr-teva-stock-has-25-upside-cm786031,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors who are looking for a beaten down pharma stock should consider Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet nearly 40 160 over the past year including
AGN,AGN:US,BBG000FH8PX5,Allergan: Analysts’ Ratings and Recommendations,2017-05-08 17:05:53 +0000,http://finance.yahoo.com/r/054061a5-7964-3da2-a757-f7a86c107820/allergan-analysts-ratings-recommendations?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan’s stock price rose nearly 16.4% in the last 12 months. Estimates show that the stock has the potential to return ~11.7% over the next 12 months.
AGN,AGN:US,BBG000FH8PX5,Analyzing Allergan’s 1Q17 Revenue Estimates,2017-05-08 15:26:37 +0000,http://finance.yahoo.com/r/0e6042fb-475a-31c0-8d8f-5c0121aacbe1/analyzing-allergans-1q17-revenue-estimates?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Analysts estimate Allergan's (AGN) revenues at $3.53 billion for 1Q17—a 6.9% fall compared to 1Q17. Various factors will impact growth during 1Q17.
AGN,AGN:US,BBG000FH8PX5,Allergan’s 1Q17 Earnings: Analysts’ Estimates,2017-05-08 15:26:30 +0000,http://finance.yahoo.com/r/cf5304d0-8fcb-3337-9810-d2d1b64697e7/allergans-1q17-earnings-analysts-estimates?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) is set to release its 1Q17 earnings on May 9, 2017. Analysts’ estimates show EPS at $3.30 on revenues of $3.53 billion for 1Q17."
AGN,AGN:US,BBG000FH8PX5,Earnings Preview: What To Expect From Allergan On Tuesday,2017-05-07 15:06:00 +0000,http://finance.yahoo.com/r/234b62ee-1886-3704-8d50-96ff79ef102f/earnings-preview-what-to-expect-from-allergan-on-tuesday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Allergan is expected to earn $3.32/share on $3.53 billion in revenue. Meanwhile, the so-called Whisper number is $3.36"
AGN,AGN:US,BBG000FH8PX5,"Daily Dividend Report: MAR, AGN, UPS, DUK, COP, ITW, COF, DAL, EFX",2017-05-05 20:25:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqBvVGtBKt0/daily-dividend-report-mar-agn-ups-duk-cop-itw-cof-dal-efx-cm785220,Marriott International MAR declared a quarterly cash dividend of 33 cents per share of common stock which represents a 10 percent increase over the previous quarterly dividend amount of 30 cents per share The dividend is payable on June 30 2017 to shareholders of record as of May 19
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Second Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share,2017-05-05 12:00:00 +0000,http://finance.yahoo.com/news/allergan-announces-second-quarter-2017-120000969.html?.tsrc=rss,"DUBLIN, May 5, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it is proceeding with its previously initiated cash dividend of $0.70 per ordinary share for the second quarter of 2017.  Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.  Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care."
AGN,AGN:US,BBG000FH8PX5,Here&apos;s Why Paratek Pharmaceuticals Rose as Much as 16.1% Today,2017-05-04 21:05:00 +0000,http://finance.yahoo.com/r/6d33c469-2a75-3666-aec0-23a9adf56ec0/heres-why-paratek-pharmaceuticals-rose-as-much-as.aspx?yptr=yahoo&.tsrc=rss,The company announced first-quarter 2017 earnings and provided a clinical update.
AGN,AGN:US,BBG000FH8PX5,Vanguard Sector Funds,2017-05-04 19:13:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ttRCI5xeuQ/vanguard-sector-funds-cm784531,InvestorPlace Stock Market News Stock Advice amp Trading Tips The list of Vanguard sector funds is relatively short but each of the funds provide focused 160 coverage to specialty areas of the market at a low cost to investors Sector funds can be smart additions to
AGN,AGN:US,BBG000FH8PX5,What's in the Cards for Allergan (AGN) this Earnings Season?,2017-05-04 16:14:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ICPAHbW5lzE/whats-in-the-cards-for-allergan-agn-this-earnings-season-cm784196,Allergan plc AGN will report first quarter 2017 earnings on May 9 before the market opens Last quarter the company delivered a positive earnings surprise of 2 90 Allergan s share price is up 16 1 this year so far outperforming the 1 decline witnessed by the Zacks
AGN,AGN:US,BBG000FH8PX5,What&apos;s in the Cards for Allergan (AGN) this Earnings Season?,2017-05-04 14:34:02 +0000,http://finance.yahoo.com/news/apos-cards-allergan-agn-earnings-143402890.html?.tsrc=rss,"Allergan plc (AGN) will be reporting first-quarter 2017 earnings result on May 9, before the market opens."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference,2017-05-04 12:00:00 +0000,http://finance.yahoo.com/news/allergan-present-bank-america-merrill-120000520.html?.tsrc=rss,"DUBLIN, May 4, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders and Chief Research & Development Officer David Nicholson will participate in a fireside chat at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada.  The fireside chat will begin at 11:20 a.m. PT (2:20 p.m. ET) on Wednesday, May 17, 2017.  The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego,2017-05-04 11:30:00 +0000,http://finance.yahoo.com/news/allergan-present-data-2017-american-113000060.html?.tsrc=rss,"DUBLIN, May 4, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company in women's healthcare, will present new data from its women's healthcare portfolio, at the annual American ..."
AGN,AGN:US,BBG000FH8PX5,"Aerie (AERI) Posts Wider-Than-Expected Q1 Loss, Expenses Up",2017-05-03 20:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_0qDJwaJURY/aerie-aeri-posts-wider-than-expected-q1-loss-expenses-up-cm783562,Aerie Pharmaceuticals Inc AERI posted first quarter 2017 loss of 76 cents per share including stock based compensation wider than the Zacks Consensus Estimate of a loss of 74 cents but narrower than the year ago loss of 85 cents Being a development stage company Aerie has not
AGN,AGN:US,BBG000FH8PX5,"IVE, KO, AGN, MDLZ: Large Outflows Detected at ETF",2017-05-02 16:26:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k591ZZ9HpLs/ive-ko-agn-mdlz-large-outflows-detected-at-etf-cm782724,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Value ETF Symbol IVE where we have detected an approximate 26 0 million dollar outflow that s a 0 2 decrease week over week
AGN,AGN:US,BBG000FH8PX5,"Spot Trading L.L.C Buys Walt Disney Co, Johnson & Johnson, Mastercard, Sells SPDR S&P ...",2017-05-02 15:26:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AZ8OVZ3o4o4/spot-trading-llc-buys-walt-disney-co-johnson-johnson-mastercard-sells-spdr-sp-cm782737,Spot Trading L L C New Purchases DIS MA MRK CL ILMN TER GEL LOW PNRA YUM Added Positions JNJ XLV BX BIDU FMC HSBC BIIB NRZ MCHP UBNT Reduced Positions XOP BAC APC MRO SBUX DVN GILD GLD BMY ULTA Sold Out EOG AGN PFE OXY
AGN,AGN:US,BBG000FH8PX5,Allergan Solidifies Strong Footprint at ARVO 2017 with Several Data Presentations,2017-05-02 11:30:00 +0000,http://finance.yahoo.com/news/allergan-solidifies-strong-footprint-arvo-113000602.html?.tsrc=rss,"DUBLIN, May 2, 2017 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today that  23 Allergan-supported abstracts were selected for poster presentations at the ..."
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Monday Option Activity: EGHT, AGN, DUK",2017-05-01 21:27:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kXDgdkJxg3o/noteworthy-monday-option-activity-eght-agn-duk-cm782311,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in 8x8 Inc Symbol EGHT where a total volume of 2 726 contracts has been traded thus far today a contract volume which is representative of approximately 272 600
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc – Value Analysis (NYSE:AGN) : May 1, 2017",2017-05-01 20:45:01 +0000,http://finance.yahoo.com/r/e5de4a93-cfb4-3b0f-bf0a-6ce7dcd5074a/allergan-plc-value-analysis-nyseagn-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Allergan Plc a score of 13. Our analysis is based on comparing Allergan Plc with the following peers – Mylan N.V., Zoetis, Inc. Class A, Incyte Corporation and Abbott Laboratories (MYL-US, ZTS-US, INCY-US and ABT-US). Investment Outlook Allergan Plc has a fundamental score of 13 and has ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Allergan Is Ready to Turn Higher,2017-05-01 18:43:00 +0000,http://finance.yahoo.com/r/55634f9e-687a-39f8-9e7c-af6870f55a9d/allergan-ready-turn-higher?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The stock is emerging from a one-year base pattern.
AGN,AGN:US,BBG000FH8PX5,MKM: Health care could buck the 'sell in May' trend,2017-05-01 16:37:00 +0000,http://finance.yahoo.com/video/mkm-health-care-could-buck-163700418.html?.tsrc=rss,"Jonathan Krinsky, MKM Partners chief market technician, takes a look at how investors should approach the health care sector in May. The &quot;FMHR&quot; traders weigh in."
AGN,AGN:US,BBG000FH8PX5,"Allergan to Present New and Updated Linzess®, Viberzi®, Relamorelin, Linaclotide Delayed Release, and Cenicriviroc Data at Digestive Disease Week® 2017",2017-05-01 11:30:00 +0000,http://finance.yahoo.com/news/allergan-present-updated-linzess-viberzi-113000862.html?.tsrc=rss,"DUBLIN, May 1, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the company and its collaborators will present clinical and preclinical data for Linzess ® (linaclotide) and linaclotide ..."
AGN,AGN:US,BBG000FH8PX5,"Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing",2017-04-28 15:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7sjk3w74PY/teva-pharmaceutical-is-looking-to-deal-and-thats-a-good-thing-cm781093,The tables have turned pretty quickly for Israeli based branded and generic drug developer Teva Pharmaceutical Industries NYSE TEVA In July 2015 shares of the company were trading north of 72 an all time high Today Teva s stock is struggling to hang onto the 30 mark which
AGN,AGN:US,BBG000FH8PX5,Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition,2017-04-28 12:30:00 +0000,http://finance.yahoo.com/news/allergan-successfully-completes-zeltiq-aesthetics-123000089.html?.tsrc=rss,"DUBLIN, April 28, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced it has successfully completed the acquisition of ZELTIQ® Aesthetics, Inc., a medical technology company behind a proprietary controlled-cooling fat reducing treatment, CoolSculpting®.  Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash.  ZELTIQ® stockholders approved the transaction during its stockholder meeting held on April 27, 2017."
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : April 28, 2017",2017-04-28 12:22:36 +0000,http://finance.yahoo.com/r/5d043ca1-f803-3a5b-8dd0-372835e6b751/allergan-plc-breached-its-50-day-moving-average-in-a-bullish-manner-agn-us-april-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Jerome Dodson Comments on Allergan,2017-04-27 12:25:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I5J9rRVENes/jerome-dodson-comments-on-allergan-cm780079,NYSE AGN Jerome Dodson Trades Portfolio Premium Members This article first appeared on GuruFocus This article first appeared
AGN,AGN:US,BBG000FH8PX5,Teva Confirms CFO Is Leaving,2017-04-26 17:12:00 +0000,http://finance.yahoo.com/r/f39508d2-e559-3781-b081-a4a9e580ee9a/teva-confirms-cfo-is-leaving.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Eyal Desheh became the Israel-based drugmaker's CFO in 2008.
AGN,AGN:US,BBG000FH8PX5,"Intermede Investment Partners Ltd Buys Rockwell Collins, S&P Global, Biogen, Sells B/E ...",2017-04-26 09:02:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D9IMWaiUlo4/intermede-investment-partners-ltd-buys-rockwell-collins-sp-global-biogen-sells-be-cm779197,Intermede Investment Partners Ltd New Purchases COL SPGI Added Positions BIIB MDT TSM FB MA CMCSA GOOG AGN BABA ALLE Reduced Positions CHKP HDS SCHW LBTYA CME Sold Out BEAV COO ACN VWR BIVV New Purchases COL SPGI
AGN,AGN:US,BBG000FH8PX5,PBF Energy Set to Join S&P MidCap 400; Apollo Commercial Real Estate Finance and Waddell & Reed Financial to Join S&P SmallCap 600,2017-04-25 21:58:00 +0000,http://finance.yahoo.com/news/pbf-energy-set-join-p-215800371.html?.tsrc=rss,"NEW YORK, April 25, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open on Friday, April 28: PBF Energy ..."
AGN,AGN:US,BBG000FH8PX5,"Jerome Dodson Keeps Buying McKesson, Axalta, Pentair",2017-04-25 20:47:30 +0000,http://finance.yahoo.com/news/jerome-dodson-keeps-buying-mckesson-204730341.html?.tsrc=rss,Stocks the fund bought in the last 2 quarters
AGN,AGN:US,BBG000FH8PX5,"Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales",2017-04-25 20:07:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7OImiOnjrq0/novartis-tops-q1-earnings-cosentyx-entresto-boost-sales-cm779012,Novartis AG NVS reported first quarter 2017 core earnings of 1 13 per share beating the Zacks Consensus Estimate of 1 10 but it was lower than the year ago figure of 1 17 Novartis AG Price and EPS Surprise Novartis AG Price and EPS
AGN,AGN:US,BBG000FH8PX5,Gilead Sciences: NASH Bridges…To What?,2017-04-25 17:39:00 +0000,http://finance.yahoo.com/r/dc3b1a36-c7c2-39a6-abf9-3ae49378855d/gilead-sciences-nash-bridges-to-what?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"As investors contemplate what Gilead Sciences (GILD) may or may not say when it reports earnings next week, others are already looking for that elusive ingredient that could push its shares higher again. ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production",2017-04-25 11:31:00 +0000,http://finance.yahoo.com/news/allergan-granted-marketing-authorization-fda-113100882.html?.tsrc=rss,"DUBLIN, April 25, 2017 /PRNewswire/ -- Allergan plc, (NYSE: AGN) today announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear ™ Intranasal ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Marketing Authorization For TrueTear - Quick Facts,2017-04-25 07:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xeEkF5Zb538/allergan-announces-marketing-authorization-for-truetear--quick-facts-20170425-00560,Allergan Announces Marketing Authorization For TrueTear - Quick Facts
AGN,AGN:US,BBG000FH8PX5,NASH: The next untapped pharma market gives investors many options,2017-04-24 17:52:43 +0000,http://finance.yahoo.com/news/nash-next-untapped-pharma-market-175243627.html?.tsrc=rss,"Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver ..."
AGN,AGN:US,BBG000FH8PX5,Trump Executive Order Could Revive Allergan-Pfizer Merger,2017-04-24 17:10:00 +0000,http://finance.yahoo.com/news/trump-executive-order-could-revive-200300049.html?.tsrc=rss,The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
AGN,AGN:US,BBG000FH8PX5,3 Healthcare Bargain Stocks You Can Buy Right Now,2017-04-24 13:42:00 +0000,http://finance.yahoo.com/r/9ce0c003-8946-330b-8e0f-3dd31c5c5922/3-healthcare-bargain-stocks-you-can-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,"Allergan, Express Scripts, and Vertex stocks look attractive in a generally overpriced market."
AGN,AGN:US,BBG000FH8PX5,Novartis’s 1Q17 Estimates for Sandoz,2017-04-24 11:38:09 +0000,http://finance.yahoo.com/r/f6c97ebc-3cc3-38a1-8ff2-1f837d537551/novartiss-1q17-estimates-for-sandoz?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Sandoz's revenues are expected to rise in 1Q17 following an increased demand for biopharmaceuticals such as biosimilars and Glatopa.
AGN,AGN:US,BBG000FH8PX5,NASH: The next untapped pharma market gives investors many options,2017-04-24 11:00:00 +0000,http://finance.yahoo.com/news/nash-next-untapped-pharma-market-110000335.html?.tsrc=rss,"Large drugmakers with piles of cash are  on the hunt for promising medicines being developed by small  companies to treat NASH, a progressive fatty liver disease  poised to become the leading cause of liver transplants by 2020.  With intense competition and pricing pressure eroding sales  of medicines for diabetes, rheumatoid arthritis and other  lucrative disease categories, and an already crowded field for  developmental cancer drugs, big pharma sees NASH as an enormous  new market for future profit that will accelerate a wave of deal  making.  Bristol-Myers Squibb also confirmed it is looking  for additional assets to enhance its internally-developed NASH  drugs."
AGN,AGN:US,BBG000FH8PX5,NASH: The next untapped pharma market gives investors many options,2017-04-24 05:00:00 +0000,http://finance.yahoo.com/news/nash-next-untapped-pharma-market-050000478.html?.tsrc=rss,"Large drugmakers with piles of cash are  on the hunt for promising medicines being developed by small  companies to treat NASH, a progressive fatty liver disease  poised to become the leading cause of liver transplants by 2020.  With intense competition and pricing pressure eroding sales  of medicines for diabetes, rheumatoid arthritis and other  lucrative disease categories, and an already crowded field for  developmental cancer drugs, big pharma sees NASH as an enormous  new market for future profit that will accelerate a wave of deal  making.  Bristol-Myers Squibb also confirmed it is looking  for additional assets to enhance its internally-developed NASH  drugs."
AGN,AGN:US,BBG000FH8PX5,Should Gilead Sciences Be Worried About Allergan?,2017-04-23 17:02:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jcp6nZILkeA/should-gilead-sciences-be-worried-about-allergan-cm777591,The next hepatitis C That s what another liver disease non alcoholic steatohepatitis NASH has been called The global market for NASH drugs could be 40 billion annually and there are no approved treatments for the disease Gilead Sciences NASDAQ GILD is sorely in need
AGN,AGN:US,BBG000FH8PX5,Should Gilead Sciences Be Worried About Allergan?,2017-04-23 15:41:00 +0000,http://finance.yahoo.com/r/f0f16d25-7a72-3578-815e-3522eec1cb2b/should-gilead-sciences-be-worried-about-allergan.aspx?yptr=yahoo&.tsrc=rss,Gilead Sciences might want to pay attention to Allergan&apos;s aggressive expansion of its NASH program.
AGN,AGN:US,BBG000FH8PX5,Charlie Munger: Loading Up on Leverage,2017-04-21 19:28:23 +0000,http://finance.yahoo.com/news/charlie-munger-loading-leverage-192823837.html?.tsrc=rss,Guru isn’t afraid to use gearing to boost returns
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL",2017-04-21 13:05:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lhqx_1cDwZE/pharma-stock-roundup-jj-slips-on-mixed-q1-lilly-hit-by-fda-crl-cm776874,Johnson amp Johnson JNJ kicked off the first quarter earnings season for the pharma sector this week Meanwhile Lilly LLY was also in the news with the company receiving a complete response letter CRL for its experimental rheumatoid arthritis RA treatment baricitinib Recap of
AGN,AGN:US,BBG000FH8PX5,"Top Analyst Upgrades and Downgrades: Costco, Domino’s Pizza, Fortinet, Verizon, Yum Brands and More",2017-04-21 13:00:53 +0000,http://finance.yahoo.com/news/top-analyst-upgrades-downgrades-costco-130053667.html?.tsrc=rss,"After a huge Thursday in which the markets soared, the futures traded flat to modestly higher Friday morning. With earnings still coming in hot and heavy, many on Wall Street are encouraged by the overall ..."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL",2017-04-21 11:12:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-j-j-111211147.html?.tsrc=rss,Key highlights from the pharma sector include J&J&apos;s (JNJ) first quarter results and a CRL for Lilly&apos;s RA drug.
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston",2017-04-20 20:15:00 +0000,http://finance.yahoo.com/news/allergan-announces-13-presentations-chronic-201500347.html?.tsrc=rss,"DUBLIN, April 20, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has 13 presentations at the upcoming 69th American Academy of Neurology ..."
AGN,AGN:US,BBG000FH8PX5,Chapel Hill company partners with Allergan,2017-04-20 18:15:10 +0000,http://finance.yahoo.com/r/b4133c2e-2e52-34ac-8372-8676feb59e71/chapel-hill-company-partners-with-allergan.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"On the heels of two collaborations with Bristol-Myers Squibb announced in November , Chapel Hill-based clinical data company TARGET PharmaSolutions has partnered with pharmaceutical giant Allergan.  Allergan will collaborate with the company on its TARGET-NASH study, focused on patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH)."
AGN,AGN:US,BBG000FH8PX5,Allergan Partners with TARGET PharmaSolutions to Advance NASH Research,2017-04-20 13:00:00 +0000,http://finance.yahoo.com/news/allergan-partners-target-pharmasolutions-advance-130000400.html?.tsrc=rss,"DUBLIN, April 20, 2017 /PRNewswire/ -- Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real ..."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Collaborates with Novartis to Treat NASH,2017-04-19 16:06:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RL6L7YsGvEA/allergan-agn-collaborates-with-novartis-to-treat-nash-cm775828,Allergan plc AGN entered into a collaboration with Novartis AG NVS to conduct a phase IIb study to evaluate a combination of its drug cenicriviroc CVC and Novartis lead Fxr agonist to treat non alcoholic steatohepatitis NASH A look at Allergan s year to date share price movement shows
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Collaborates with Novartis to Treat NASH,2017-04-19 14:11:02 +0000,http://finance.yahoo.com/news/allergan-agn-collaborates-novartis-treat-141102929.html?.tsrc=rss,Allergan plc (AGN) entered into a collaboration with Novartis AG (NVS) to conduct a phase IIb study to evaluate a combination of its drug cenicriviroc (cvc) and Novartis lead Fxr agonist to treat non-alcoholic steatohepatitis
AGN,AGN:US,BBG000FH8PX5,[$$] Investors bet on Incyte drug success,2017-04-19 11:00:08 +0000,"http://finance.yahoo.com/r/d5bdbc9b-45f6-3207-b5c4-634e5064750d/c71b04d6-23c2-11e7-a34a-538b4cb30025,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The huge escalator running through the headquarters of Incyte, the US biotech company, harks backs to the building's former life as a department store. Where smartly dressed shop assistants once sold ladieswear ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Argentum settle patent dispute over eye drug Restasis",2017-04-18 20:51:48 +0000,http://finance.yahoo.com/news/allergan-argentum-settle-patent-dispute-205148709.html?.tsrc=rss,"U.S. generic drug company Argentum  Pharmaceuticals LLC said on Tuesday it had reached an agreement  with Allergan Plc that settles a patent dispute over the  generic version of Allergan's eye drug, Restasis.  The agreement gives Argentum the right to sell the copycat  version of Restasis before the patents covering the drug expire,  Argentum said.  It did not disclose when it would launch the  generic product."
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Tuesday Option Activity: GILD, AGN, BA",2017-04-18 20:04:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vM-bMiidE6I/noteworthy-tuesday-option-activity-gild-agn-ba-cm775455,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Gilead Sciences Inc Symbol GILD where a total of 33 309 contracts have traded so far representing approximately 3 3 million underlying shares That amounts to about 47 9 of GILD
AGN,AGN:US,BBG000FH8PX5,Did Pharma & Biotech M&As Pick Pace in Q1?,2017-04-18 15:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4LF2gJ117OU/did-pharma-biotech-mas-pick-pace-in-q1-cm775180,2016 was not exactly a great year for pharma and biotech stocks with the sector facing a lot of criticism for rising drug prices The year also marked a slowdown in M amp A mergers and acquisitions activity in this sector representing a stark contrast to both 2014 and 2015 which saw several
AGN,AGN:US,BBG000FH8PX5,European Markets Dropped After Britain Calls For Snap Elections,2017-04-18 11:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wpovWK6t_C4/european-markets-dropped-after-britain-calls-for-snap-elections-20170418-00968,European Markets Dropped After Britain Calls For Snap Elections
AGN,AGN:US,BBG000FH8PX5,European Shares Retreat As Geopolitical Worries Mount,2017-04-18 06:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/86SnE22EqPg/european-shares-retreat-as-geopolitical-worries-mount-20170418-00206,European Shares Retreat As Geopolitical Worries Mount
AGN,AGN:US,BBG000FH8PX5,Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration,2017-04-18 05:15:00 +0000,http://finance.yahoo.com/news/allergan-expands-leading-research-development-051500371.html?.tsrc=rss,"DUBLIN, April 18, 2017 /PRNewswire/ -- Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan's cenicriviroc (CVC) and Novartis' lead FXR agonist for the treatment of non-alcoholic steatohepatitis (NASH).  The Phase 2b study will assess the safety, efficacy and tolerability of this multi-therapy treatment approach for NASH.  The financial details of this transaction are not disclosed.  ""Our clinical collaboration with Novartis brings together our collective scientific and development expertise in NASH to focus on multi-therapy treatment, which is expected to be the most likely approach based on the multi-factorial aspects of this disease,"" said David Nicholson, Chief Research & Development Officer, Allergan."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Novartis In Clinical Trial Deal To Treat NASH - Quick Facts",2017-04-18 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mz2kyXO8qcw/allergan-novartis-in-clinical-trial-deal-to-treat-nash--quick-facts-20170418-00034,"Allergan, Novartis In Clinical Trial Deal To Treat NASH - Quick Facts"
AGN,AGN:US,BBG000FH8PX5,Novartis Collaborates With Allergan On NASH - Quick Facts,2017-04-18 01:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VweJpN7-bvE/novartis-collaborates-with-allergan-on-nash--quick-facts-20170418-00032,Novartis Collaborates With Allergan On NASH - Quick Facts
AGN,AGN:US,BBG000FH8PX5,A Healthcare Pick That's Moderately Shielded From Upheaval,2017-04-17 10:33:02 +0000,http://finance.yahoo.com/video/healthcare-pick-thats-moderately-shielded-103302202.html?.tsrc=rss,We think Allergan is well positioned with a strong pipeline of specialty drugs and attractively undervalued today.
AGN,AGN:US,BBG000FH8PX5,Why Charlie Munger Hates Value Investing,2017-04-14 14:53:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZbhFyMXsQzI/why-charlie-munger-hates-value-investing-cm774232,When Charlie Munger Trades Portfolio came to Berkshire Hathaway NYSE BRK A NYSE BRK B in the late 60s Warren Buffett Trades Portfolio was still running the business and investing how his teacher Benjamin Graham had taught him to by buying a selection of cigar butt
AGN,AGN:US,BBG000FH8PX5,Why Charlie Munger Hates Value Investing,2017-04-13 19:40:25 +0000,http://finance.yahoo.com/news/why-charlie-munger-hates-value-194025435.html?.tsrc=rss,Guru prefers high-quality businesses
AGN,AGN:US,BBG000FH8PX5,Aerie Reports Positive Data on Ophthalmic Drug Rhopressa,2017-04-13 13:58:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h2rWdBvCVSY/aerie-reports-positive-data-on-ophthalmic-drug-rhopressa-cm773673,Aerie Pharmaceuticals Inc AERI reported encouraging six month top line safety and efficacy results from the phase III trial ROCKET 4 on lead product candidate Rhopressa We note that Aerie is evaluating Rhopressa a novel once daily eye drop for its ability to lower intraocular
AGN,AGN:US,BBG000FH8PX5,Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5),2017-04-13 13:00:00 +0000,http://finance.yahoo.com/news/allergan-ironwood-launch-campaign-designed-130000496.html?.tsrc=rss,"DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ -- Allergan plc (AGN) and Ironwood Pharmaceuticals Inc. (IRWD), in partnership with the American Gastroenterological Association (AGA), initiated a campaign about the importance of bowel health in recognition of Irritable Bowel Syndrome (IBS) Awareness Month, at the Vital Signs of Bowel Health Summit, which took place yesterday in New York City."
AGN,AGN:US,BBG000FH8PX5,"VOO, BMY, GILD, AGN: Large Inflows Detected at ETF",2017-04-12 16:56:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e0YtG5ww43E/voo-bmy-gild-agn-large-inflows-detected-at-etf-cm773342,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard S amp P 500 ETF Symbol VOO where we have detected an approximate 71 5 million dollar inflow that s a 0 1 increase week over week in outstanding
AGN,AGN:US,BBG000FH8PX5,The Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17),2017-04-12 10:03:00 +0000,http://finance.yahoo.com/r/6aff05f8-aa6d-35f3-8387-01fb8dffa05f/the-real-trump-trade-may-be-gold-cramer-s-mad-money-recap-tuesday-4-11-17.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Political negatives keep popping up, forcing us to rethink the Trump trade, says Jim Cramer."
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Why a slew of IPOs might not be a good thin...,2017-04-11 23:12:00 +0000,http://finance.yahoo.com/video/cramer-remix-why-slew-ipos-231200851.html?.tsrc=rss,Jim Cramer analyzed the market’s newest stocks and looked ahead to future IPOs.
AGN,AGN:US,BBG000FH8PX5,Cramer's charts show these biotechs ignoring their 'polit...,2017-04-11 22:53:00 +0000,http://finance.yahoo.com/video/cramers-charts-show-biotechs-ignoring-225300315.html?.tsrc=rss,Jim Cramer looks to Bob Lang's charts to reveal major biotech names that are rallying despite Washington's drug pricing controversy.
AGN,AGN:US,BBG000FH8PX5,"Allergan Launches Frames of Mind, Encouraging People Living with Migraine to Share Common Experiences Through Art",2017-04-11 11:30:00 +0000,http://finance.yahoo.com/news/allergan-launches-frames-mind-encouraging-113000374.html?.tsrc=rss,"DUBLIN, April 11, 2017 /PRNewswire/ -- Allergan plc (AGN) today unveiled Frames of Mind, an interactive campaign to promote awareness of the impact that migraine can have on patients' everyday lives.  People living with this often debilitating condition are encouraged to submit original artwork depicting how the symptoms of migraine personally affect them."
AGN,AGN:US,BBG000FH8PX5,Valeant: It's Not a Game of Chess – Part IV,2017-04-10 15:53:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkNBWXEf4DM/valeant-its-not-a-game-of-chess-part-iv-cm772197,The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its acquisition criteria The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its
AGN,AGN:US,BBG000FH8PX5,How Did Allergan Perform in 1Q17?,2017-04-10 14:36:53 +0000,http://finance.yahoo.com/r/9650d091-d2f2-315c-8cbc-1a39416bb662/how-did-allergan-perform-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan’s stock price rose ~7.7% in 1Q17. On April 6, 2017, the stock had risen 13.2% year-to-date (or YTD)."
AGN,AGN:US,BBG000FH8PX5,Allergan Receives 2017 ENERGY STAR® Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency,2017-04-10 13:00:00 +0000,http://finance.yahoo.com/news/allergan-receives-2017-energy-star-130000075.html?.tsrc=rss,"DUBLIN, April 10, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has been named a 2017 ENERGY STAR Partner of the Year – Sustained Excellence Award winner. The Company has been recognized ..."
AGN,AGN:US,BBG000FH8PX5,Takeaways and Observations; Play a Tesla Tune: Doug Kass' Views,2017-04-10 05:00:00 +0000,http://finance.yahoo.com/r/2e9c8705-b2ff-326d-8e8d-4f4396f2c2e6/takeaways-and-observations-play-a-tesla-tune-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Tesla and the second quarter.
AGN,AGN:US,BBG000FH8PX5,Valeant: It's Not a Game of Chess - Part IV,2017-04-09 19:55:45 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-195545208.html?.tsrc=rss,A case study of the company's rise and fall
AGN,AGN:US,BBG000FH8PX5,"Berson & Corrado Investment Advisors, LLC Buys Colony NorthStar, Uniti Group, Qualcomm, ...",2017-04-08 18:53:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4O79GQ9uflE/berson-corrado-investment-advisors-llc-buys-colony-northstar-uniti-group-qualcomm-cm771788,Berson Corrado Investment Advisors LLC New Purchases CLNS UNIT QCOM KRA TK TEVA BLCM NEP M PEGI Added Positions ENZ XLK BAC FLY STWD AMBC HEDJ MIC IMMY EFA Reduced Positions BA GLW PBI CLMT TGP TNK AGN ACHC INCY V
AGN,AGN:US,BBG000FH8PX5,Allergan is still hopeful about using Botox to treat depression,2017-04-08 15:30:01 +0000,http://finance.yahoo.com/r/7a9c95bd-379a-3d2a-acc2-4f1e4fa7b67d/Story.aspx?guid=56D79A5C-1BB8-11E7-AE82-A1C914D9F1E4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The drugmaker will keep testing the cosmetic surgery treatment despite mixed mid-stage trial results.
AGN,AGN:US,BBG000FH8PX5,3 Stocks the Smartest Investors Are Buying Right Now,2017-04-07 15:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gDKl6JE-irU/3-stocks-the-smartest-investors-are-buying-right-now-cm771393,Keeping tabs on the quarterly activity of elite billionaire investors like George Soros and David Tepper can be a good way to drum up worthwhile investing ideas However everyday investors should never buy a stock simply because a so called super investor added it to their
AGN,AGN:US,BBG000FH8PX5,Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk,2017-04-07 15:00:00 +0000,http://finance.yahoo.com/news/allergan-teams-media-mogul-wendy-150000972.html?.tsrc=rss,"DUBLIN, April 7, 2017 /PRNewswire/ -- Allergan plc (AGN), a global pharmaceutical company and leader in developing best-in-class treatment options for patients, has partnered with the American Gastroenterological Association (AGA), to announce the launch of Toilet TalkSM in celebration of IBS Awareness Month. Toilet TalkSM is a component of a larger corporate initiative to drive awareness for Irritable Bowel Syndrome with diarrhea (IBS-D).  The campaign is intended to reduce the stigma associated with talking about bowel health, and ultimately to empower patients to proactively discuss their bowel function with their healthcare professional.  ""By elevating and normalizing conversations around bowel health, Allergan and the AGA believe Toilet TalkSM will empower patients to feel more comfortable and confident when speaking with their healthcare professional,"" said Aimee Lenar, Vice President, Gastroenterology."
AGN,AGN:US,BBG000FH8PX5,5 Drug Stocks for Your Portfolio this World Health Day,2017-04-07 14:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CYrtPf03ucM/5-drug-stocks-for-your-portfolio-this-world-health-day-cm771289,World Health Day is celebrated on Apr 7 every year to mark the anniversary of the founding of the World Health Organization WHO Every year the focus is on a specific health topic of concern with the goal being to raise awareness and address the issue This World Health Day the focus is
AGN,AGN:US,BBG000FH8PX5,3 Stocks the Smartest Investors Are Buying Right Now,2017-04-07 14:24:00 +0000,http://finance.yahoo.com/r/f8d2caec-706b-32ce-8f13-fdae79425bb9/3-stocks-the-smartest-investors-are-buying-right-n.aspx?yptr=yahoo&.tsrc=rss,These three stocks have attracted some of brightest investors in the world.
AGN,AGN:US,BBG000FH8PX5,5 Drug Stocks for Your Portfolio this World Health Day,2017-04-07 12:47:12 +0000,http://finance.yahoo.com/news/5-drug-stocks-portfolio-world-124712654.html?.tsrc=rss,"With ""Depression: let&apos;s talk"" being this year&apos;s World Health Day campaign slogan, here&apos;s a look at 5 companies developing treatments for various types of depression."
AGN,AGN:US,BBG000FH8PX5,Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy,2017-04-06 20:15:00 +0000,http://finance.yahoo.com/news/allergan-names-daphne-karydas-senior-201500950.html?.tsrc=rss,"DUBLIN, April 6, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.  In this role, Ms. Karydas will lead the Company's engagement with the investment community, and will work with the Company's Executive Leadership Team to develop and execute the Company's long-term business strategy.  Ms. Karydas will report to Tessa Hilado, Chief Financial Officer of Allergan."
AGN,AGN:US,BBG000FH8PX5,Paratek (PRTK) Stock Continues to Rise on Positive Results,2017-04-06 17:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Cj_WY4oBKw/paratek-prtk-stock-continues-to-rise-on-positive-results-cm770913,Paratek Pharmaceuticals Inc s PRTK shares are up more than 22 since it announced positive results from a phase III study of its lead pipeline candidate omadacycline for the treatment of patients with community acquired bacterial pneumonia CABP The study compared omadacycline a
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Presents Mixed Depression Data on Botox,2017-04-06 17:53:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/elMXlAN1JVg/allergan-agn-presents-mixed-depression-data-on-botox-cm770907,Allergan plc AGN announced mixed top line data from a mid stage study evaluating its key drug Botox for the treatment of major depressive disorder MDD Allergan s share price is up 13 2 this year so far while the Zacks classified Medical Generics Drug industry declined 3 4 Botox
AGN,AGN:US,BBG000FH8PX5,Allergan Guilty of Wishful Botox Thinking,2017-04-06 17:35:53 +0000,http://finance.yahoo.com/r/626c3862-b5b8-3764-85b4-6141790c96bf/allergan-botox-depression-trial-data-wishful-thinking?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pushing iffy Phase 2 trial data into Phase 3 is a common recipe for failure.
AGN,AGN:US,BBG000FH8PX5,"Acorda (ACOR) to Reduce Workforce, Focus on Product Pipeline",2017-04-06 15:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6FzIEtVW7vg/acorda-acor-to-reduce-workforce-focus-on-product-pipeline-cm770742,Acorda Therapeutics Inc ACOR recently announced plans to reduce its workforce by approximately 20 The workforce reduction which is expected to be completed in Apr 2017 is part of the company s strategy to significantly lower its operating expenses The company expects this move
AGN,AGN:US,BBG000FH8PX5,Allergan's Botox Studied as Depression Treatment,2017-04-06 15:30:00 +0000,http://finance.yahoo.com/r/c5b10917-8b51-39c0-bcee-2b057f08fcb6/allergans-botox-studied-depression-treatment-agn?partner=YahooSA&yptr=yahoo&.tsrc=rss,Allergan's blockbuster wrinkle treatment Botox will proceed to Phase 3 testing to treat depression.
AGN,AGN:US,BBG000FH8PX5,[$$] Investors question Allergan move to test Botox for depression,2017-04-06 15:29:45 +0000,"http://finance.yahoo.com/r/874719d1-0b17-3269-8a11-af6989f1ab1c/d8bc4204-1acb-11e7-bcac-6d03d067f81f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","A decision by Allergan to conduct a large clinical trial to determine whether its wrinkle smoother Botox can treat depression has left analysts and investors puzzled, after the drugmaker published mixed ..."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Presents Mixed Depression Data on Botox,2017-04-06 15:18:03 +0000,http://finance.yahoo.com/news/allergan-agn-presents-mixed-depression-151803604.html?.tsrc=rss,Allergan plc (AGN) announced mixed top-line data from a mid-stage study evaluating its key drug Botox for the treatment of major depressive disorder (MDD).
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : April 6, 2017",2017-04-06 12:31:02 +0000,http://finance.yahoo.com/r/180204dc-89c6-3457-9c71-f48b22e36ff3/allergan-plc-breached-its-50-day-moving-average-in-a-bearish-manner-agn-us-april-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
AGN,AGN:US,BBG000FH8PX5,Novartis Licenses ECF843 Eye Drops From Lubris,2017-04-06 12:22:00 +0000,http://finance.yahoo.com/r/b3857712-1f3d-33bc-bbfb-c37a25f890ac/novartis-licenses-ecf843-eye-drops-lubris-nvs?partner=YahooSA&yptr=yahoo&.tsrc=rss,Novartis licensed ECF843 eye drops outside Europe from Lubris LLC.
AGN,AGN:US,BBG000FH8PX5,Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction,2017-04-06 12:00:00 +0000,http://finance.yahoo.com/news/allergan-zeltiq-announce-expiration-hart-120000861.html?.tsrc=rss,"DUBLIN and PLEASANTON, Calif., April 6, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, and ZELTIQ® Aesthetics, Inc. (ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the ""HSR Act"") has expired with respect to Allergan's proposed acquisition of ZELTIQ.  On February 13, 2017, Allergan and ZELTIQ entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ.  Following the announcement of the transaction, each of Allergan and ZELTIQ filed a Notification and Report Form pursuant to the HSR Act with the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission."
AGN,AGN:US,BBG000FH8PX5,Allergan to move Botox into late-stage testing for depression,2017-04-05 21:30:27 +0000,http://finance.yahoo.com/news/allergan-move-botox-stage-testing-213027397.html?.tsrc=rss,"Allergan plc said on Wednesday  that its Botox blockbuster wrinkle treatment just missed  achieving a significant improvement in treating depression in a  mid-stage trial, but it found the data encouraging enough to  move into larger Phase III testing.  Allergan said results from the trial on the lower of two  tested doses compared with placebo were close to what has been  seen with more traditional antidepressants on the market and  consistent with what had been reported from earlier, smaller  Botox depression trials conducted by independent researchers.  ""We are encouraged by these data and the potential impact on  adults with major depressive disorder,"" Allergan research chief  David Nicholson said in a statement."
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX® (onabotulinumtoxinA) for the Treatment of Major Depressive Disorder (MDD),2017-04-05 20:30:00 +0000,http://finance.yahoo.com/news/allergan-reports-topline-phase-ii-203000719.html?.tsrc=rss,"DUBLIN, April 5, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced topline data from a Phase II study with Major Depressive Disorder (MDD). The study ..."
AGN,AGN:US,BBG000FH8PX5,Allergan To Test Botox For Depression Despite Mixed Results,2017-04-05 20:18:00 +0000,http://finance.yahoo.com/r/fa8b53cf-3c6f-37d5-8227-fa5b98cefe25/allergan-to-test-botox-for-depression-despite-mixed-results?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"A test of Botox in depression yields mixed results, but the drug maker says it is confident enough to move on to the next step."
AGN,AGN:US,BBG000FH8PX5,Strategy To YieldBoost Allergan To 3.7% Using Options,2017-04-05 16:53:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Vv51N7DP4c/strategy-to-yieldboost-allergan-to-37-using-options-cm770226,Shareholders of Allergan PLC Symbol AGN looking to boost their income beyond the stock s 0 3 annualized dividend yield can sell the January 2019 covered call at the 290 strike and collect the premium based on the 14 45 bid which annualizes to an additional 3 4 rate of return against
AGN,AGN:US,BBG000FH8PX5,Calamos Investments Announces Monthly Dividends,2017-04-05 12:23:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ArWs65MvkcA/calamos-investments-announces-monthly-dividends-cm769990,Calamos Investments has announced monthly dividends for its six closed end funds with an ex dividend date of April 7 Below are details on each of the funds and their forward dividend yields Calamos Investments has announced monthly dividends for its six closed end funds with an ex dividend date
AGN,AGN:US,BBG000FH8PX5,Allergan to Report First Quarter 2017 Earnings and Host Conference Call and Webcast,2017-04-05 12:00:00 +0000,http://finance.yahoo.com/news/allergan-report-first-quarter-2017-120000240.html?.tsrc=rss,"DUBLIN, April 5, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it intends to release first quarter 2017 financial results on Tuesday, May 9, 2017, prior to the open of U.S. Financial Markets.  Allergan will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, May 9, 2017 to discuss its financial results.  The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 65877868."
AGN,AGN:US,BBG000FH8PX5,Why Is  Allergan (AGN) Down 2.2% Since the Last Earnings Report?,2017-04-05 08:23:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fj-yufjaNN0/why-is-allergan-agn-down-22-since-the-last-earnings-report-cm769950,It has been about a month since the last earnings report for Allergan PLC AGN Shares have lost about 2 2 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
AGN,AGN:US,BBG000FH8PX5,Teva's Austedo Gets FDA Nod for Huntington Disease Treatment,2017-04-04 16:26:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WlIGGR2Brwk/tevas-austedo-gets-fda-nod-for-huntington-disease-treatment-cm769624,Teva Pharmaceutical Industries Ltd TEVA recently announced that the FDA has approved its investigational drug Austedo deutetrabenazine tablets previously referred to as SD 809 for the treatment of chorea associated with Huntington disease HD We note that Austedo became part
AGN,AGN:US,BBG000FH8PX5,Why Paratek Pharmaceuticals Inc Is Soaring,2017-04-04 16:25:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J2erbkPp5RU/why-paratek-pharmaceuticals-inc-is-soaring-cm769579,What happened After reporting data from a pivotal Phase 3 trial shares of Paratek Pharmaceuticals NASDAQ PRTK a small cap biotech company focused on next generation antibiotics rose by 30 as of 11 10 a m EDT on Tuesday Image source Getty Images
AGN,AGN:US,BBG000FH8PX5,iShares U.S. Preferred Stock ETF Experiences Big Inflow,2017-04-04 16:24:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gWkezYVL2LU/ishares-us-preferred-stock-etf-experiences-big-inflow-cm769607,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Preferred Stock ETF Symbol PFF where we have detected an approximate 46 5 million dollar inflow that s a 0 3 increase week over week
AGN,AGN:US,BBG000FH8PX5,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Risky,2017-04-03 18:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4def1eYGQQE/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-risky-cm769213,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock is down 40 over the past year and down more than 50 since August 2015 Admittedly the past year and a half hasn t been great
AGN,AGN:US,BBG000FH8PX5,"Acorda's (ACOR) MS Drug Patents Invalidated, Shares Plunge",2017-04-03 15:40:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IXaeHaZgOXk/acordas-acor-ms-drug-patents-invalidated-shares-plunge-cm769055,Acorda Therapeutics Inc s ACOR shares were down almost 21 5 after the U S District Court for the District of Delaware invalidated four patents of its key multiple sclerosis drug Ampyra thereby making way for generic versions of the drug The company is likely to appeal the ruling
AGN,AGN:US,BBG000FH8PX5,Exploring Eli Lilly’s Oncology Franchise in 2016,2017-03-31 14:36:14 +0000,http://marketrealist.com/2017/03/exploring-eli-lillys-oncology-franchise-in-2016/?utm_source=yahoo&utm_medium=feed,Exploring Eli Lilly’s Oncology Franchise in 2016
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: FDA Nod for SNY, Roche Drugs, Generic Advair Relief for GSK?",2017-03-31 13:02:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GW7LpQPRrEM/pharma-stock-roundup-fda-nod-for-sny-roche-drugs-generic-advair-relief-for-gsk-cm768132,Key highlights this week include FDA approval of two highly awaited drugs Sanofi SNY and Regeneron s Dupixent and Roche s RHHBY Ocrevus Both drugs have blockbuster potential Meanwhile Mylan MYL got a complete response letter CRL from the FDA for its generic version of Glaxo s
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: FDA Nod for SNY, Roche Drugs, Generic Advair Relief for GSK?",2017-03-31 11:21:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-fda-nod-112111194.html,"Pharma Stock Roundup: FDA Nod for SNY, Roche Drugs, Generic Advair Relief for GSK?"
AGN,AGN:US,BBG000FH8PX5,Healthcare: Stock-Picking Increasingly Important as Valuations Rise,2017-03-31 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=797902&SR=Yahoo,Healthcare: Stock-Picking Increasingly Important as Valuations Rise
AGN,AGN:US,BBG000FH8PX5,Why Equal Weighted Mutual Funds Scoring Over Index Funds,2017-03-30 17:59:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jhMjnJeuuA4/why-equal-weighted-mutual-funds-scoring-over-index-funds-cm767869,Index funds that invest in different small mid and large cap companies in the same proportion are specifically known as equal weight index funds Investing in equal weight funds helps in reducing single stock risk and simultaneously generates attractive returns Investors interested in
AGN,AGN:US,BBG000FH8PX5,"Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ...",2017-03-30 12:58:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KTPQjHCq6I4/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund-sells-cm767596,Saba Capital Management L P New Purchases AGN AOD ESD GLQ GLV OMF TSLA HYG HTZ THS Added Positions FSD GLO CYH DEX VRX ERC USA GNW RVT AGC Reduced Positions BGX MCR EVG PPT MMT FAX EDD HIO CIF MTG Sold Out DSU EMD
AGN,AGN:US,BBG000FH8PX5,Bill Ackman apologizes for $4 billion Valeant mistake (finally),2017-03-30 11:27:37 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0732EF64-1533-11E7-BCC7-456FC1EDA05D&siteid=yhoof2,Bill Ackman apologizes for $4 billion Valeant mistake (finally)
AGN,AGN:US,BBG000FH8PX5,Fast Money Madness: Nvidia vs. Allergan,2017-03-29 21:40:00 +0000,http://finance.yahoo.com/video/fast-money-madness-nvidia-vs-214000271.html,Fast Money Madness: Nvidia vs. Allergan
AGN,AGN:US,BBG000FH8PX5,Here's the Bill Ackman apology Wall Street's been waiting for,2017-03-29 19:47:18 +0000,http://finance.yahoo.com/news/heres-bill-ackman-apology-wall-194718706.html,Here's the Bill Ackman apology Wall Street's been waiting for
AGN,AGN:US,BBG000FH8PX5,Market Outlook: Lofty Valuations Call for Careful Stock-Picking,2017-03-29 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=799671&SR=Yahoo,Market Outlook: Lofty Valuations Call for Careful Stock-Picking
AGN,AGN:US,BBG000FH8PX5,Did This Beauty Giant Just Solve The Acne Challenge?,2017-03-28 20:30:54 +0000,http://www.investors.com/news/technology/did-this-beauty-giant-just-solve-the-acne-challenge/?src=A00220A,Did This Beauty Giant Just Solve The Acne Challenge?
AGN,AGN:US,BBG000FH8PX5,2016’s Top Earning Hedge Fund Managers And Their Favorite Stocks,2017-03-28 20:09:16 +0000,http://www.insidermonkey.com/blog/2016s-top-earning-hedge-fund-managers-and-their-favorite-stocks-569712/,2016’s Top Earning Hedge Fund Managers And Their Favorite Stocks
AGN,AGN:US,BBG000FH8PX5,Allergan Acne Candidate Meets Endpoints in Phase III Studies,2017-03-28 17:59:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZcgY9SP6U28/allergan-acne-candidate-meets-endpoints-in-phase-iii-studies-cm766765,Allergan plc AGN in collaboration with Paratek Pharmaceuticals Inc PRTK has announced positive results from two phase III studies on sarecycline The companies are developing sarecycline for the treatment of moderate to severe acne The companies said the studies met their 12 week
AGN,AGN:US,BBG000FH8PX5,Allergan Acne Candidate Meets Endpoints in Phase III Studies,2017-03-28 15:47:03 +0000,http://finance.yahoo.com/news/allergan-acne-candidate-meets-endpoints-154703561.html,Allergan Acne Candidate Meets Endpoints in Phase III Studies
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Allergan and Paratek's Acne Drug Reported Positive Results,2017-03-28 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-allergan-parateks-acne-121500213.html,"[Accesswire] - Upcoming AWS Coverage on Patheon Post-Earnings Results LONDON, UK / ACCESSWIRE / March 28, 2017 / Active Wall St. blog coverage looks at the headline from Allergan PLC (NYSE: AGN ) and Paratek Pharmaceuticals, ..."
AGN,AGN:US,BBG000FH8PX5,"FDA Nod For TSRO, DÃ©jÃ  Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz",2017-03-28 04:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pzEgcbmaO5Y/fda-nod-for-tsro-d%C3%A3j%C3%A3%C2%A0-vu-for-arql-fomx-plunges-on-trial-data-selb-abuzz-20170328-00134,"FDA Nod For TSRO, DÃ©jÃ  Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz"
AGN,AGN:US,BBG000FH8PX5,Why Impax Labs Soared 37.3% Today,2017-03-27 23:58:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rYvXtZXrIRc/why-impax-labs-soared-373-today-cm766257,What happened After the company reported it has hired Allergan s NYSE AGN former executive chairman as its new president and CEO investors sent shares in Impax Laboratories NASDAQ IPXL 160 surging 37 3 today So what Impax Labs shareholders have
AGN,AGN:US,BBG000FH8PX5,Risk-Reward With Teva Pharmaceutical,2017-03-27 23:00:15 +0000,http://finance.yahoo.com/news/risk-reward-teva-pharmaceutical-230015395.html,Risk-Reward With Teva Pharmaceutical
AGN,AGN:US,BBG000FH8PX5,Why Impax Labs Soared 37.3% Today,2017-03-27 22:00:00 +0000,https://www.fool.com/investing/2017/03/27/why-impax-labs-soared-373-today.aspx,Why Impax Labs Soared 37.3% Today
AGN,AGN:US,BBG000FH8PX5,Health care showdown: Allergan vs. Valeant,2017-03-27 21:46:00 +0000,http://finance.yahoo.com/video/health-care-showdown-allergan-vs-214600737.html,Health care showdown: Allergan vs. Valeant
AGN,AGN:US,BBG000FH8PX5,"DuPont, Impax Labs gain, G-III Apparel slides",2017-03-27 21:05:49 +0000,http://finance.yahoo.com/news/dupont-impax-labs-gain-g-210549528.html,"DuPont, Impax Labs gain, G-III Apparel slides"
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 03/27/2017: PRTK,AGN,APOP,FOMX",2017-03-27 20:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hgj2-pM9qAE/health-care-sector-update-for-03272017-prtkagnapopfomx-cm766168,Top Health Care StocksTop Health Care Stocks JNJ 0 25 JNJ 0 25 PFE 0 68 PFE 0 68 MRK 0 01 MRK 0 01 ABT 0 24 ABT 0 24 AMGN 0 65 AMGN 0 65 Health care stocks were finishing ahead of most other industry sectors today with the NYSE Health Care Index rising over 0 5 while shares
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 03/27/2017: IPXL,APOP,FOMX",2017-03-27 18:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dDQXkQW388E/health-care-sector-update-for-03272017-ipxlapopfomx-cm766080,Top Health Care StocksTop Health Care Stocks JNJ 0 28 JNJ 0 28 PFE 0 59 PFE 0 59 MRK 0 06 MRK 0 06 ABT 0 05 ABT 0 05 AMGN 0 25 AMGN 0 25 Health care stocks were moderately higher Monday with the NYSE Health Care Index rising about 0 5 while shares of health care companies in
AGN,AGN:US,BBG000FH8PX5,Has Allergan's Pullback Ended?,2017-03-27 17:20:00 +0000,https://www.thestreet.com/story/14060820/1/has-allergan-s-pullback-ended.html?puc=yahoo&cm_ven=YAHOO,Has Allergan's Pullback Ended?
AGN,AGN:US,BBG000FH8PX5,"MOAT, LABD: Big ETF Outflows",2017-03-27 17:00:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zAPvNcnS1Jo/moat-labd-big-etf-outflows-cm765972,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Morningstar Wide Moat ETF MOAT where 3 300 000 units were destroyed or a 10 8 decrease week over week Among the largest underlying components of
AGN,AGN:US,BBG000FH8PX5,Why Moat Indexes Outperformed Others in February,2017-03-27 16:41:07 +0000,http://marketrealist.com/2017/03/led-moat-indices-outperformance-february/?utm_source=yahoo&utm_medium=feed,Why Moat Indexes Outperformed Others in February
AGN,AGN:US,BBG000FH8PX5,"Allergan, Paratek’s Acne Drug Succeeds in Phase 3",2017-03-27 15:34:00 +0000,http://www.investopedia.com/news/allergan-parateks-acne-drug-succeeds-phase-3-agnprtk/?partner=YahooSA,"Allergan, Paratek’s Acne Drug Succeeds in Phase 3"
AGN,AGN:US,BBG000FH8PX5,Paratek eyes FDA filing as acne drug clears late-stage trials,2017-03-27 15:20:12 +0000,http://www.bizjournals.com/boston/news/2017/03/27/paratek-eyes-fda-filing-as-acne-drug-clears-late.html?ana=yahoo,Paratek eyes FDA filing as acne drug clears late-stage trials
AGN,AGN:US,BBG000FH8PX5,Foamix Acne Drug Fails Late-Stage Study,2017-03-27 15:20:00 +0000,http://www.investopedia.com/news/foamix-acne-drug-fails-latestage-study-fomx/?partner=YahooSA,Foamix Acne Drug Fails Late-Stage Study
AGN,AGN:US,BBG000FH8PX5,Skincare Makers Lead Biotech Movers,2017-03-27 13:28:00 +0000,https://www.thestreet.com/story/14060313/1/skincare-makers-lead-biotech-movers.html?puc=yahoo&cm_ven=YAHOO,Skincare Makers Lead Biotech Movers
AGN,AGN:US,BBG000FH8PX5,"Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment",2017-03-27 11:48:59 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=34F036D0-7A3F-42DB-838E-D05F689B6517&siteid=yhoof2,"Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment"
AGN,AGN:US,BBG000FH8PX5,Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne,2017-03-27 11:31:00 +0000,http://finance.yahoo.com/news/allergan-paratek-announce-positive-results-113100706.html,"[PR Newswire] - DUBLIN and BOSTON, March 27, 2017 /PRNewswire/ -- Allergan plc, (AGN), a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced that two (2) Phase 3 trials of sarecycline for the treatment of moderate to severe acne met their 12 week primary efficacy endpoints. Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with anti-inflammatory properties for the potential treatment of moderate to severe acne in the community setting. Based on these data, Allergan plans to file a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) in the second half of this year."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Paratek Report Positive Results From Two Phase 3 Trials Of Sarecycline",2017-03-27 07:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-D0fIXVNOA8/allergan-paratek-report-positive-results-from-two-phase-3-trials-of-sarecycline-20170327-00343,"Allergan, Paratek Report Positive Results From Two Phase 3 Trials Of Sarecycline"
AGN,AGN:US,BBG000FH8PX5,3 Great Stocks to Buy in a Market Pullback,2017-03-26 16:59:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x1bQ6JcMEI8/3-great-stocks-to-buy-in-a-market-pullback-cm765678,Is a stock market pullback on the way Maybe And even if not now it s inevitable that the market will take a breather at some point in the future Smart investors will be ready to take advantage of a market pullback whenever it comes and offers discount prices on great stocks
AGN,AGN:US,BBG000FH8PX5,3 Great Stocks to Buy in a Market Pullback,2017-03-26 15:01:00 +0000,https://www.fool.com/investing/2017/03/26/3-great-stocks-to-buy-in-a-market-pullback.aspx,3 Great Stocks to Buy in a Market Pullback
AGN,AGN:US,BBG000FH8PX5,Can Anyone Challenge Allergan In Medical-Aesthetics Market?,2017-03-24 18:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6bTYoH1ZxgA/can-anyone-challenge-allergan-in-medical-aesthetics-market-cm765346,Fat freezing ear pinning breast augmenting Allergan AGN isn t making expansion in the medical aesthetics market easy for rivals like Hologic HOLX Johnson amp Johnson JNJ and Valeant Pharmaceuticals VRX analysts say Since
AGN,AGN:US,BBG000FH8PX5,Can Anyone Challenge Allergan In Medical-Aesthetics Market?,2017-03-24 18:00:35 +0000,http://www.investors.com/research/industry-snapshot/allergan-hoovers-aesthetics-market-can-hologic-play/?src=A00220A,Can Anyone Challenge Allergan In Medical-Aesthetics Market?
AGN,AGN:US,BBG000FH8PX5,Teva Pharma Denies Rumors of Global Workforce Reduction,2017-03-24 17:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMw8s-wHGuo/teva-pharma-denies-rumors-of-global-workforce-reduction-cm765298,According to recent reports Teva Pharmaceutical Industries Ltd TEVA is likely lay off almost 11 of its global workforce to cut costs and improve growth prospects The news which was first reported by Israeli newspaper Calcalist mentioned that the company may cut 6 000 jobs or about
AGN,AGN:US,BBG000FH8PX5,Amgen's (AMGN) Humira Biosimilar Receives Approval in EU,2017-03-24 17:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RE6mr8HZp-8/amgens-amgn-humira-biosimilar-receives-approval-in-eu-cm765282,Amgen Inc AMGN announced that its biosimilar version of AbbVie Inc s ABBV rheumatoid arthritis RA drug Humira has been approved by the European Commission EC The approval grants marketing rights in 28 member countries of the European Union EU under a unified label of Amgevita
AGN,AGN:US,BBG000FH8PX5,"Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ...",2017-03-24 12:58:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QXl64b6IFvE/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund-sells-cm765103,Saba Capital Management L P New Purchases AGN AOD ESD GLQ GLV OMF TSLA HYG HTZ THS Added Positions FSD GLO CYH DEX VRX ERC USA GNW RVT AGC Reduced Positions BGX MCR EVG PPT MMT FAX EDD HIO CIF MTG Sold Out DSU EMD
AGN,AGN:US,BBG000FH8PX5,"After Trump rally, equity investors move into healthcare, retailers",2017-03-24 05:00:00 +0000,http://finance.yahoo.com/news/trump-rally-equity-investors-move-050000714.html,"[Reuters] - High U.S. share prices are pushing Lipper Award-winning equity fund managers into the shares of beaten-down healthcare companies, retailers and emerging-market stocks that they say offer a greater chance for outsized gains. Fund managers from Poplar Forest, Parnassus Investments and Brandes Investment Partners are among the 2017 Lipper Award winners who are concerned about the high valuation of the benchmark S&P 500 index. With a forward price-to-earnings ratio above 18, the index is at the high end of its historical range."
AGN,AGN:US,BBG000FH8PX5,The Most Attractive Value Stock There Is?,2017-03-23 22:31:48 +0000,http://finance.yahoo.com/news/most-attractive-value-stock-223148265.html,The Most Attractive Value Stock There Is?
AGN,AGN:US,BBG000FH8PX5,Allergan's Restasis Now Available in Multidose Bottle in U.S.,2017-03-23 17:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1c-jRUmNJKo/allergans-restasis-now-available-in-multidose-bottle-in-us-cm764765,Allergan plc AGN recently announced that its marketed drug Restasis cyclosporine ophthalmic emulsion 0 05 is now available in multidose bottles in the U S It is the first and only prescription medication approved by the FDA to help patients with a type of chronic dry eye Restasis
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Stock Rising in '17: What's Working in its Favor?,2017-03-23 17:00:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4C9ACmbhKXE/astrazeneca-stock-rising-in-17-whats-working-in-its-favor-cm764754,Shares of London based pharma giant AstraZeneca plc AZN have risen 13 4 this year so far while the Zacks classified Large Cap Pharma industry increased 6 4 This comes after a decline of almost 20 in 2016 AstraZeneca has a strong product portfolio and is one of the key players
AGN,AGN:US,BBG000FH8PX5,Insys Therapeutics' Syndros Gets Final DEA Rule,2017-03-23 15:24:00 +0000,http://www.investopedia.com/news/insys-therapeutics-syndros-gets-final-dea-rule-insy/?partner=YahooSA,Insys Therapeutics' Syndros Gets Final DEA Rule
AGN,AGN:US,BBG000FH8PX5,Allergan's Restasis Now Available in Multidose Bottle in U.S.,2017-03-23 14:19:02 +0000,http://finance.yahoo.com/news/allergans-restasis-now-available-multidose-141902480.html,Allergan's Restasis Now Available in Multidose Bottle in U.S.
AGN,AGN:US,BBG000FH8PX5,Buyback ETF Steady As Repurchases Decline,2017-03-23 13:20:55 +0000,http://finance.yahoo.com/news/buyback-etf-steady-repurchases-decline-132055914.html,Buyback ETF Steady As Repurchases Decline
AGN,AGN:US,BBG000FH8PX5,The Supreme Court could fundamentally change America's broken patent system,2017-03-23 12:59:40 +0000,http://finance.yahoo.com/news/tc-heartland-v-kraft-foods-125940843.html,The Supreme Court could fundamentally change America's broken patent system
AGN,AGN:US,BBG000FH8PX5,Companies Spend Less on Share Buybacks for Second Year in 2016,2017-03-22 22:45:06 +0000,http://finance.yahoo.com/news/corporate-share-repurchases-decline-2nd-224458257.html,Companies Spend Less on Share Buybacks for Second Year in 2016
AGN,AGN:US,BBG000FH8PX5,"Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500",2017-03-22 20:35:01 +0000,http://www.investors.com/news/technology/allergan-apple-lead-stock-buybacks-in-q4-healthcare-leads-sp-500/?src=A00220A,"Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500"
AGN,AGN:US,BBG000FH8PX5,Allergan Stock Reacts Well In Downtrodden Sector,2017-03-22 18:52:00 +0000,http://www.investopedia.com/news/allergan-acts-well-poor-sector-agn/?partner=YahooSA,Allergan Stock Reacts Well In Downtrodden Sector
AGN,AGN:US,BBG000FH8PX5,​Latest Editas research pact could be worth up to $1 billion,2017-03-22 14:30:13 +0000,http://www.bizjournals.com/boston/news/2017/03/22/latest-editas-research-pact-could-be-worth-up-to.html?ana=yahoo,​Latest Editas research pact could be worth up to $1 billion
AGN,AGN:US,BBG000FH8PX5,7:32 am Allergan announces the availability of RESTASIS MULTIDOSE; the first and only prescription medication FDA-approved to help patients with a type of Chronic Dry Eye make more of their own tears,2017-03-22 11:32:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#agn,7:32 am Allergan announces the availability of RESTASIS MULTIDOSE; the first and only prescription medication FDA-approved to help patients with a type of Chronic Dry Eye make more of their own tears
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle,2017-03-22 11:31:00 +0000,http://finance.yahoo.com/news/allergan-announces-availability-restasis-multidose-113100645.html,"[PR Newswire] - DUBLIN, March 22, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the availability of RESTASIS MULTIDOSE™, which is the same preservative-free RESTASIS® formulation, but now offered in a ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Availability Of RESTASIS MULTIDOSE 0.05%,2017-03-22 07:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R1v_MfQkJO0/allergan-reports-availability-of-restasis-multidose-005-20170322-00301,Allergan Reports Availability Of RESTASIS MULTIDOSE 0.05%
AGN,AGN:US,BBG000FH8PX5,David Tepper Takes Big Risks for Big Rewards,2017-03-21 21:35:40 +0000,http://finance.yahoo.com/news/david-tepper-takes-big-risks-213540165.html,David Tepper Takes Big Risks for Big Rewards
AGN,AGN:US,BBG000FH8PX5,FDA Links Breast Implants To A Rare Form Of Cancer,2017-03-21 21:26:30 +0000,http://finance.yahoo.com/news/fda-links-breast-implants-rare-212630366.html,FDA Links Breast Implants To A Rare Form Of Cancer
AGN,AGN:US,BBG000FH8PX5,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 21:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s3huNu9biqI/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod-cm763764,Allergan plc AGN announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21 The approval was based on the data from a U S pivotal clinical trial It showed that 59 of patients under test
AGN,AGN:US,BBG000FH8PX5,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 18:58:06 +0000,http://finance.yahoo.com/news/allergans-dermal-filler-wrinkle-correction-185806943.html,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
AGN,AGN:US,BBG000FH8PX5,Editas Get A Vetr Upgrade To Strong Buy,2017-03-20 20:51:44 +0000,http://finance.yahoo.com/news/editas-vetr-upgrade-strong-buy-205144827.html,Editas Get A Vetr Upgrade To Strong Buy
AGN,AGN:US,BBG000FH8PX5,Allergan Is Setting Up Nicely for a Possible Move,2017-03-20 17:53:00 +0000,http://www.investopedia.com/news/allergan-sets-nicely-agn/?partner=YahooSA,Allergan Is Setting Up Nicely for a Possible Move
AGN,AGN:US,BBG000FH8PX5,Look Under The Hood: BBH Has 12% Upside,2017-03-20 15:07:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lm6cnY1F0oc/look-under-the-hood-bbh-has-12-upside-cm762798,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
AGN,AGN:US,BBG000FH8PX5,JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21,2017-03-20 11:31:00 +0000,http://finance.yahoo.com/news/juv-derm-vollure-xc-approved-113100212.html,"[PR Newswire] - ""The FDA approval of JUVÉDERM VOLLURE™ XC demonstrates Allergan's imperative to develop next-generation HA fillers designed to meet different patient needs,"" said David Nicholson, Chief Research and Development Officer at Allergan."
AGN,AGN:US,BBG000FH8PX5,Allergan Says FDA Approves JUVÃ‰DERM VOLLURE XC,2017-03-20 07:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h0xt9lji7LE/allergan-says-fda-approves-juv%C3%A3derm-vollure-xc-20170320-00298,Allergan Says FDA Approves JUVÃ‰DERM VOLLURE XC
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded",2017-03-17 15:10:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u6MmFoP6Hs4/pharma-stock-roundup-astrazenecas-lynparza-impresses-in-study-merck-drug-label-expanded-cm762140,Key updates this week include label expansion for Merck s MRK cancer drug Keytruda and AstraZeneca s AZN data on its PARP inhibitor Recap of the Week s Most Important Stories Merck s Keytruda Label Expanded The FDA expanded the label of Merck s anti PD 1 treatment Keytruda
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded",2017-03-17 13:27:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-astrazenecas-lynparza-132701103.html,"Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded"
AGN,AGN:US,BBG000FH8PX5,"Camber Capital Management LLC Buys Allergan PLC, Myriad Genetics, Vertex Pharmaceuticals, Sells ...",2017-03-17 11:05:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oyy1s9Bn6Ss/camber-capital-management-llc-buys-allergan-plc-myriad-genetics-vertex-pharmaceuticals-sells-cm762022,Camber Capital Management LLC New Purchases AGN MYGN VRTX LIVN BIIB ABT ATHN CNC BIOL Added Positions NKTR TEVA GILD BKD ELGX MYL ALKS Reduced Positions CSII ARNA UAM ENDP NVTA Sold Out MDCO CYH VRX PTCT PLX New Purchases
AGN,AGN:US,BBG000FH8PX5,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?",2017-03-16 19:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/16/valeant-yes-ackmans-a-loser-but-how-much-did-short-sellers-make/?mod=yahoobarrons&ru=yahoo,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?"
AGN,AGN:US,BBG000FH8PX5,"Court allows Allergan shareholders to go after Ackman, Valeant as a class",2017-03-16 16:35:16 +0000,http://www.bizjournals.com/newyork/news/2017/03/16/court-allows-allergan-shareholders-to-go-after.html?ana=yahoo,"Court allows Allergan shareholders to go after Ackman, Valeant as a class"
AGN,AGN:US,BBG000FH8PX5,"VLUE, F, ADM, AGN: ETF Inflow Alert",2017-03-16 16:06:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gjV8oe1bV-8/vlue-f-adm-agn-etf-inflow-alert-cm761659,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Edge MSCI USA Value Factor ETF Symbol VLUE where we have detected an approximate 103 9 million dollar inflow that s a 4 0 increase week over week
AGN,AGN:US,BBG000FH8PX5,When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17),2017-03-16 10:11:00 +0000,https://www.thestreet.com/story/14046075/1/when-very-predictable-is-highly-profitable-cramer-s-mad-money-recap-wednesday-3-15-17.html?puc=yahoo&cm_ven=YAHOO,When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) and Editas Tie Up to Treat Eye Diseases,2017-03-16 00:06:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8o0hQ8WPew/allergan-agn-and-editas-tie-up-to-treat-eye-diseases-cm761430,Allergan plc AGN and Editas Medicine Inc EDIT entered into a strategic research and development agreement According to the agreement Allergan will receive exclusive access and the option to license up to five of Editas Medicine s genome editing ocular programs including its
AGN,AGN:US,BBG000FH8PX5,How to maneuver CEO buybacks,2017-03-15 23:15:00 +0000,http://finance.yahoo.com/video/maneuver-ceo-buybacks-231500654.html,How to maneuver CEO buybacks
AGN,AGN:US,BBG000FH8PX5,Cramer on how investors should maneuver CEO buybacks,2017-03-15 22:53:00 +0000,http://finance.yahoo.com/video/cramer-investors-maneuver-ceo-buybacks-225300050.html,Cramer on how investors should maneuver CEO buybacks
AGN,AGN:US,BBG000FH8PX5,Cramer on how investors should maneuver amid CEO buybacks,2017-03-15 22:35:50 +0000,http://www.cnbc.com/id/104343585?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104343585,Cramer on how investors should maneuver amid CEO buybacks
AGN,AGN:US,BBG000FH8PX5,"Notable Wednesday Option Activity: AGN, NKE, KMX",2017-03-15 22:05:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LTa2EzBpirg/notable-wednesday-option-activity-agn-nke-kmx-cm761372,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 13 682 contracts has been traded thus far today a contract volume which is representative of approximately 1 4
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) and Editas Tie Up to Treat Eye Diseases,2017-03-15 21:46:09 +0000,http://finance.yahoo.com/news/allergan-agn-editas-tie-treat-214609411.html,Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
AGN,AGN:US,BBG000FH8PX5,David Tepper on Allergan: Does It Look Cheap?,2017-03-15 14:37:17 +0000,http://marketrealist.com/2017/03/david-tepper-allergan-looks-fairly-cheap/?utm_source=yahoo&utm_medium=feed,David Tepper on Allergan: Does It Look Cheap?
AGN,AGN:US,BBG000FH8PX5,"FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win",2017-03-15 02:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_R_lR9-8ejw/fda-panel-snubs-endp-watch-out-for-tcon-mrks-keytruda-scores-another-win-20170315-00045,"FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win"
AGN,AGN:US,BBG000FH8PX5,Here's Why Editas Medicine Gained as Much as 17.2% Today,2017-03-14 23:07:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nu0u9ozo8lM/heres-why-editas-medicine-gained-as-much-as-172-today-cm760819,What happened Shares of gene editing pioneer Editas Medicine NASDAQ EDIT rose over 17 today before settling near gains of 5 in the last hour of trading after the company announced a strategic research and development collaboration with Allergan NYSE AGN The pair
AGN,AGN:US,BBG000FH8PX5,Here's Why Editas Medicine Gained as Much as 17.2% Today,2017-03-14 21:24:00 +0000,http://www.fool.com/investing/2017/03/14/heres-why-editas-medicine-gained-as-much-as-172-to.aspx,Here's Why Editas Medicine Gained as Much as 17.2% Today
AGN,AGN:US,BBG000FH8PX5,Allergan plc and Editas Medicine Inc Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases Call scheduled for 4:30 pm ET today,2017-03-14 20:30:00 +0000,http://biz.yahoo.com/cc/5/156115.html,Allergan plc and Editas Medicine Inc Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases Call scheduled for 4:30 pm ET today
AGN,AGN:US,BBG000FH8PX5,Common explains why he's fighting against a blindness epidemic most people don't know about,2017-03-14 20:19:36 +0000,http://finance.yahoo.com/news/common-explains-why-hes-fighting-201936246.html,Common explains why he's fighting against a blindness epidemic most people don't know about
AGN,AGN:US,BBG000FH8PX5,"Pfizer Unveils Zavicefta Antibiotic in Germany, UK",2017-03-14 19:05:00 +0000,http://www.investopedia.com/news/pfizer-launches-zavicefta-germany-and-uk-pfe/?partner=YahooSA,"Pfizer Unveils Zavicefta Antibiotic in Germany, UK"
AGN,AGN:US,BBG000FH8PX5,Ackman's winners & losers,2017-03-14 18:03:00 +0000,http://finance.yahoo.com/video/ackmans-winners-losers-180300887.html,Ackman's winners & losers
AGN,AGN:US,BBG000FH8PX5,Bill Ackman Is Done Losing Money on Valeant,2017-03-14 17:48:35 +0000,https://www.bloomberg.com/view/articles/2017-03-14/bill-ackman-is-done-losing-money-on-valeant?cmpid=yhoo.headline,Bill Ackman Is Done Losing Money on Valeant
AGN,AGN:US,BBG000FH8PX5,Ackman's minus touch,2017-03-14 17:12:00 +0000,http://finance.yahoo.com/video/ackmans-minus-touch-171200271.html,Ackman's minus touch
AGN,AGN:US,BBG000FH8PX5,"CRISPR Could Change The World, But Right Now $90 Million Is Enough",2017-03-14 15:25:00 +0000,http://www.forbes.com/sites/matthewherper/2017/03/14/crispr-could-change-the-world-but-right-now-90-million-is-enough/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"CRISPR Could Change The World, But Right Now $90 Million Is Enough"
AGN,AGN:US,BBG000FH8PX5,"Allergan, Editas In Gene-Editing Eye Disease Pact",2017-03-14 15:15:00 +0000,http://www.investopedia.com/news/allergan-editas-ink-eye-disease-pact-agnedit/?partner=YahooSA,"Allergan, Editas In Gene-Editing Eye Disease Pact"
AGN,AGN:US,BBG000FH8PX5,"Allergan, Editas Sign Gene-Editing Pact for Rare Eye Diseases",2017-03-14 13:59:00 +0000,https://www.thestreet.com/story/14042266/1/allergan-editas-sign-gene-editing-pact-for-rare-eye-diseases.html?puc=yahoo&cm_ven=YAHOO,"Allergan, Editas Sign Gene-Editing Pact for Rare Eye Diseases"
AGN,AGN:US,BBG000FH8PX5,New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior,2017-03-14 13:17:00 +0000,http://finance.yahoo.com/news/survey-reveals-impact-double-chin-131700210.html,"[PR Newswire] - DUBLIN, March 14, 2017 /PRNewswire/ -- Results of a recent survey commissioned by Allergan plc to better understand the personal impact of submental fullness as well as how others perceive individuals with submental fullness were revealed at the American Academy of Dermatology (AAD) Meeting in Orlando, FL."
AGN,AGN:US,BBG000FH8PX5,Award Winning Actor And Hip-Hop Artist Common Joins Allergan's See America(SM) Initiative To Further The Fight Against Preventable Blindness,2017-03-14 13:10:00 +0000,http://finance.yahoo.com/news/award-winning-actor-hip-hop-131000335.html,"[PR Newswire] - DUBLIN, March 14, 2017 /PRNewswire/ -- See America, Allergan's initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to ""stand in the way of darkness"". ""I'm proud to join Allergan in the fight against preventable blindness,"" said Common. Common's involvement echoes the mission of Allergan's See America initiative by raising awareness to make sure that each and every one of us makes the time to prioritize our vision."
AGN,AGN:US,BBG000FH8PX5,Editas bags $90M in gene editing R&D pact with Allergan,2017-03-14 13:00:11 +0000,http://www.bizjournals.com/boston/news/2017/03/14/editas-bags-90m-in-gene-editing-r-d-pact-with.html?ana=yahoo,Editas bags $90M in gene editing R&D pact with Allergan
AGN,AGN:US,BBG000FH8PX5,Editas Medicine surges 8% on $90 million Allergan research and development deal,2017-03-14 12:35:30 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=882BFBDB-85DA-40D5-9840-3A8B8D8548FB&siteid=yhoof2,Editas Medicine surges 8% on $90 million Allergan research and development deal
AGN,AGN:US,BBG000FH8PX5,Allergan signs deal with Editas for gene-editing-based eye treatments,2017-03-14 12:22:53 +0000,http://finance.yahoo.com/news/allergan-signs-deal-editas-gene-122253976.html,Allergan signs deal with Editas for gene-editing-based eye treatments
AGN,AGN:US,BBG000FH8PX5,Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases,2017-03-14 12:00:00 +0000,http://finance.yahoo.com/news/allergan-editas-medicine-enter-strategic-120000080.html,[GlobeNewswire] - –Brings Together Eye Care and CRISPR Innovators to Develop Transformative Medicines for Patients–. –Provides Allergan Exclusive Access to Multiple Editas Medicine Ocular Programs Based on its Unparalleled ...
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals Tanks on Ackman Exit Reports (VRX),2017-03-14 11:05:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRg2aSKbEyA/valeant-pharmaceuticals-tanks-on-ackman-exit-reports-vrx-cm760317,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is down 9 in Monday s early after market trade amid reports that billionaire hedge fund manager Bill Ackman has called it quits If true it ends a two year
AGN,AGN:US,BBG000FH8PX5,Editas Medicine Inc. (EDIT) Is Up Sharply After Allergan Alliance,2017-03-14 09:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qHIF5hWwzKs/editas-medicine-inc-edit-is-up-sharply-after-allergan-alliance-20170314-00726,Editas Medicine Inc. (EDIT) Is Up Sharply After Allergan Alliance
AGN,AGN:US,BBG000FH8PX5,Allergan To Receive Option To License Editas Medicine's Ocular Programs,2017-03-14 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wtkLWDATIXo/allergan-to-receive-option-to-license-editas-medicines-ocular-programs-20170314-00483,Allergan To Receive Option To License Editas Medicine's Ocular Programs
AGN,AGN:US,BBG000FH8PX5,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts,2017-03-14 05:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHfY4XAaqVA/pfizer-launches-zavicefta-in-the-uk--germany--quick-facts-20170314-00149,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts
AGN,AGN:US,BBG000FH8PX5,[$$] William Ackman’s Pershing Square Sold Stake in Valeant,2017-03-14 04:02:04 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
AGN,AGN:US,BBG000FH8PX5,[$$] Pershing Square Sold Stake in Valeant,2017-03-14 01:59:47 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?mod=yahoo_hs,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
AGN,AGN:US,BBG000FH8PX5,Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug,2017-03-13 22:25:33 +0000,http://www.insidermonkey.com/blog/food-and-drug-administration-accepts-allergan-plc-agn-vraylar-for-review-as-a-supplemental-drug-565976/,Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug
AGN,AGN:US,BBG000FH8PX5,"Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma",2017-03-13 20:25:43 +0000,http://www.investors.com/news/technology/lilly-merck-allergan-top-analysts-view-for-2017-pharma/?src=A00220A,"Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma"
AGN,AGN:US,BBG000FH8PX5,"Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise",2017-03-13 16:10:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/boqI3w0tzrY/acordas-four-ampyra-patents-upheld-by-ptab-shares-rise-cm760019,Acorda Therapeutics Inc s ACOR shares gained almost 7 after the U S Patent and Trademark Office USPTO Patent Trials and Appeal Board PTAB upheld four patents of its key growth driver Ampyra Acorda holds five Orange Book listed patents for Ampyra that run until 2027 The
AGN,AGN:US,BBG000FH8PX5,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks,2017-03-13 15:18:39 +0000,http://www.insidermonkey.com/blog/billionaire-david-tepper-makes-huge-investments-in-these-4-drug-stocks-565903/,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks
AGN,AGN:US,BBG000FH8PX5,"Synergy Pharmaceuticals: Approval, Now What?",2017-03-13 14:08:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCKVQ4IYkds/synergy-pharmaceuticals-approval-now-what-cm759912,Shares of Synergy Pharmaceuticals NASDAQ SGYP 160 are up more than 100 from their 2016 lows and the company finally received FDA approval of its drug Trulance plecanatide in January of this year However since the drug s approval the stock has traded down over 20 due to
AGN,AGN:US,BBG000FH8PX5,"Aerie Resubmits Rhopressa NDA, Roclatan Gains Traction",2017-03-13 14:07:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zDIHBZ1JcQI/aerie-resubmits-rhopressa-nda-roclatan-gains-traction-cm759899,We issued an updated research report on Aerie Pharmaceuticals Inc AERI on Mar 10 2016 Aerie Pharmaceuticals is a development stage company focused on the development and commercialization of eye disease therapies including glaucoma and other eye diseases Aerie s two lead
AGN,AGN:US,BBG000FH8PX5,"Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise",2017-03-13 13:40:01 +0000,http://finance.yahoo.com/news/acordas-four-ampyra-patents-upheld-134001478.html,"Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise"
AGN,AGN:US,BBG000FH8PX5,"Allergan, Schlumberger, Caterpillar: Doug Kass' Views",2017-03-13 05:00:00 +0000,https://www.thestreet.com/story/14037751/1/allergan-schlumberger-caterpillar-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Allergan, Schlumberger, Caterpillar: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,"Huge Real Estate and Health Care Trades Highlight Insider Selling: Regency Centers, Allegan, UnitedHealthcare, Wyndham and More",2017-03-11 14:55:24 +0000,http://finance.yahoo.com/news/huge-real-estate-health-care-145524005.html,"Huge Real Estate and Health Care Trades Highlight Insider Selling: Regency Centers, Allegan, UnitedHealthcare, Wyndham and More"
AGN,AGN:US,BBG000FH8PX5,"After Hours Most Active for Mar 10, 2017 :  DISH, GE, LLTC, FNB, INTC, QQQ, GM, AGN, V, BAC, ABCO, AMGN",2017-03-11 00:19:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83902fNQHxc/after-hours-most-active-for-mar-10-2017-dish-ge-lltc-fnb-intc-qqq-gm-agn-v-bac-abco-amgn-cm759312,The NASDAQ 100 After Hours Indicator is up 2 to 5 386 1 The total After hours volume is currently 52 885 789 shares traded The following are the most active stocks for the after hours session DISH Network Corporation DISH is 0 05 at 62 00 with 11 936 033
AGN,AGN:US,BBG000FH8PX5,Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?,2017-03-11 00:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4uO1D6aJgvA/why-amgen-amgn-stock-rallied-after-q4-earnings-release-cm759531,Biotech major Amgen Inc s AMGN shares have risen12 1 since it reported better than expected fourth quarter results on Feb 2 The increase also compares favorably with the 6 3 rise registered by the Zacks classified Biomed Genetics industry in the period Q4
AGN,AGN:US,BBG000FH8PX5,Trump nominates FDA head with deep ties to drug companies,2017-03-10 22:57:57 +0000,http://finance.yahoo.com/news/trump-poised-tap-scott-gottlieb-175321839.html,"[Reuters] - U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the U.S. Food and Drug Administration, a White House official said on Friday. If confirmed by the Senate, Gottlieb would be in charge of implementing Trump's plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco."
AGN,AGN:US,BBG000FH8PX5,Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?,2017-03-10 15:28:03 +0000,http://finance.yahoo.com/news/why-amgen-amgn-stock-rallied-152803937.html,Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?
AGN,AGN:US,BBG000FH8PX5,Allergan plc Question if a Feminist Can Love Fillers?,2017-03-09 19:00:00 +0000,http://finance.yahoo.com/news/allergan-plc-feminist-love-fillers-190000903.html,"[PR Newswire] - Allergan plc (AGN), a leading global pharmaceutical company and maker of Juvéderm® facial fillers, reveals the outcome of a heated debate tackling the view that women who enhance the way they look, can be seen as frivolous, or even anti-feminist. The debate, hosted by Cosmetic Executive Women and supported by Allergan, explored new research into women's attitudes towards the quest for beauty and youth. The panellists were Polly Vernon (author of Hot Feminist), Bryony Gordon (author of Mad Girl), journalist Sarah Vine and leading Aesthetic Practitioner, Alison Telfer."
AGN,AGN:US,BBG000FH8PX5,Allergan's (AGN) Vraylar sNDA Accepted for Review by FDA,2017-03-09 18:13:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uRLan_AeZeU/allergans-agn-vraylar-snda-accepted-for-review-by-fda-cm758648,Allergan plc AGN announced that its supplemental New Drug Application sNDA for its schizophrenia capsules Vraylar has been accepted for review by the FDA Allergan is looking to get Vraylar s label expanded to include new data which supports the drug s use as a maintenance
AGN,AGN:US,BBG000FH8PX5,Allergan's (AGN) Vraylar sNDA Accepted for Review by FDA,2017-03-09 15:55:03 +0000,http://finance.yahoo.com/news/allergans-agn-vraylar-snda-accepted-155503245.html,Allergan's (AGN) Vraylar sNDA Accepted for Review by FDA
AGN,AGN:US,BBG000FH8PX5,"Aerie (AERI) Q4 Loss Widens, Rhopressa NDA Resubmitted",2017-03-08 22:13:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mudvyGdh2h4/aerie-aeri-q4-loss-widens-rhopressa-nda-resubmitted-cm758135,Aerie Pharmaceuticals Inc AERI posted fourth quarter 2016 loss of 87 cents per share including stock based compensation wider than both the Zacks Consensus Estimate of a loss of 65 cents and the year ago loss of 76 cents Being a development stage company Aerie has not generated
AGN,AGN:US,BBG000FH8PX5,Battered Biotech Teva Is a Smart Contrarian Buy Now,2017-03-08 21:13:00 +0000,https://www.thestreet.com/story/14033238/1/battered-biotech-teva-is-a-smart-contrarian-buy-now.html?puc=yahoo&cm_ven=YAHOO,Battered Biotech Teva Is a Smart Contrarian Buy Now
AGN,AGN:US,BBG000FH8PX5,"David Tepper Discusses Allergan Investment, Market Valuation",2017-03-08 21:08:29 +0000,http://finance.yahoo.com/news/david-tepper-discusses-allergan-investment-210829925.html,"David Tepper Discusses Allergan Investment, Market Valuation"
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is a Good Spec Buy,2017-03-08 20:12:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zwr74n8XdAc/teva-pharmaceutical-industries-ltd-adr-teva-is-a-good-spec-buy-cm758096,InvestorPlace Stock Market News Stock Advice amp Trading Tips Lately InvestorPlace writers have been busy pounding the table for the stock of Teva Pharmaceutical Industries Ltd ADR NYSE TEVA Source Open Grid Scheduler Modified Teva is based in Israel
AGN,AGN:US,BBG000FH8PX5,The Tepper blitz on The Halftime Report,2017-03-08 18:52:00 +0000,http://finance.yahoo.com/video/tepper-blitz-halftime-report-185200631.html,The Tepper blitz on The Halftime Report
AGN,AGN:US,BBG000FH8PX5,Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs,2017-03-08 17:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eMS5F9JVygY/trump-tweet-on-drug-pricing-hits-biotech-and-pharma-etfs-cm757946,The pharma and biotech industry has been hit badly by concerns over high drug prices in the past few years The initial panic was triggered in September 2015 when the Democratic presidential candidate Hillary Clinton tweeted about price gouging and laid out a proposal for combating
AGN,AGN:US,BBG000FH8PX5,Hedge Fund Guru Tepper Bullish on Allergan,2017-03-08 14:27:00 +0000,http://www.investopedia.com/news/hedge-fund-guru-tepper-bullish-allergan-agn/?partner=YahooSA,Hedge Fund Guru Tepper Bullish on Allergan
AGN,AGN:US,BBG000FH8PX5,"Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ...",2017-03-08 14:12:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uTcERPlvSI4/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund-sells-cm757772,Saba Capital Management L P New Purchases AGN AOD ESD GLQ GLV OMF TSLA HYG HTZ THS Added Positions FSD GLO CYH DEX VRX ERC USA GNW RVT AGC Reduced Positions BGX MCR EVG PPT MMT FAX EDD HIO CIF MTG Sold Out DSU EMD
AGN,AGN:US,BBG000FH8PX5,FDA Accepts Supplemental New Drug Application (sNDA) For VRAYLAR (cariprazine),2017-03-08 13:00:00 +0000,http://finance.yahoo.com/news/fda-accepts-supplemental-drug-application-130000842.html,"[PR Newswire] - DUBLIN, Ireland, March 8, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing ..."
AGN,AGN:US,BBG000FH8PX5,David Tepper's big bet in pharma,2017-03-08 12:50:00 +0000,http://finance.yahoo.com/video/david-teppers-big-bet-pharma-125000611.html,David Tepper's big bet in pharma
AGN,AGN:US,BBG000FH8PX5,Are Hedge Funds Turning Bearish on Healthcare Stocks?,2017-03-08 12:25:02 +0000,http://www.insidermonkey.com/blog/are-hedge-funds-turning-bearish-on-healthcare-stocks-562997/,Are Hedge Funds Turning Bearish on Healthcare Stocks?
AGN,AGN:US,BBG000FH8PX5,Logitech: Cramer's Top Takeaways,2017-03-08 11:24:00 +0000,https://www.thestreet.com/story/14031271/1/logitech-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Logitech: Cramer's Top Takeaways
AGN,AGN:US,BBG000FH8PX5,Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17),2017-03-08 11:15:00 +0000,https://www.thestreet.com/story/14031243/1/trump-s-tweet-creates-opportunity-in-pharma-cramer-s-mad-money-recap-tuesday-2-7-17.html?puc=yahoo&cm_ven=YAHOO,Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Raymond James Conference; Webcast At 8:40 AM ET,2017-03-08 07:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VLilEYadiRk/allergan-to-present-at-raymond-james-conference-webcast-at-840-am-et-20170308-00356,Allergan To Present At Raymond James Conference; Webcast At 8:40 AM ET
AGN,AGN:US,BBG000FH8PX5,3 Drug Stocks Hit by Trump’s Call for Lower Prices,2017-03-08 00:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZP9Qle-HkaA/3-drug-stocks-hit-by-trumps-call-for-lower-prices-cm757633,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are pulling back again on Tuesday pushing the Dow Jones Industrial Average down in what could be the first back to back decline since January Source Shutterstock The tape is heavy as political risk
AGN,AGN:US,BBG000FH8PX5,Fred's adds three industry veterans to board,2017-03-07 20:30:17 +0000,http://www.bizjournals.com/memphis/news/2017/03/07/freds-adds-three-industry-veterans-to-board.html?ana=yahoo,Fred's adds three industry veterans to board
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Inflow Detected - IYH, GILD, AGN, BIIB",2017-03-07 18:13:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tqBCjGfqaII/notable-etf-inflow-detected-iyh-gild-agn-biib-cm757346,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 71 2 million dollar inflow that s a 3 9 increase week over week in
AGN,AGN:US,BBG000FH8PX5,"Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan",2017-03-07 17:38:00 +0000,http://finance.yahoo.com/news/pharma-biotech-stocks-fall-trump-173800221.html,"Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan"
AGN,AGN:US,BBG000FH8PX5,"Jeff Auxier Invests in Gilead, Wells Fargo, Apple",2017-03-07 16:12:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cfnHDFXuHVY/jeff-auxier-invests-in-gilead-wells-fargo-apple-cm757277,Jeff Auxier Trades Portfolio is the manager of Auxier Focus Fund He manages a portfolio composed of 152 stocks with a total value of 460 million In the fourth and third quarters of 2016 the guru bought shares in the following stocks Jeff Auxier Trades Portfolio is the
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Cowen & Co. Health Care Conference; Webcast At 8:40 AM ET,2017-03-07 07:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BIIJCQ1gz3k/allergan-to-present-at-cowen--co-health-care-conference-webcast-at-840-am-et-20170307-00425,Allergan To Present At Cowen & Co. Health Care Conference; Webcast At 8:40 AM ET
AGN,AGN:US,BBG000FH8PX5,"Jeff Auxier Invests in Gilead, Wells Fargo, Apple",2017-03-06 19:35:20 +0000,http://finance.yahoo.com/news/jeff-auxier-invests-gilead-wells-193520954.html,"Jeff Auxier Invests in Gilead, Wells Fargo, Apple"
AGN,AGN:US,BBG000FH8PX5,Billionaires Love These 3 Healthcare Stocks,2017-03-05 14:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3mTE-MRVL7o/billionaires-love-these-3-healthcare-stocks-cm756355,Follow the money And when there s a lot of money follow especially closely Billionaire investors are putting plenty of money into healthcare stocks these days For the most part however they don t tend to agree on exactly which healthcare stocks to buy Allergan NYSE
AGN,AGN:US,BBG000FH8PX5,Billionaires Love These 3 Healthcare Stocks,2017-03-05 12:22:00 +0000,http://www.fool.com/investing/2017/03/05/billionaires-love-these-3-healthcare-stocks.aspx,Billionaires Love These 3 Healthcare Stocks
AGN,AGN:US,BBG000FH8PX5,Icahn's (Potential) Move Into Biotech,2017-03-05 00:25:01 +0000,http://finance.yahoo.com/news/icahns-potential-move-biotech-002501246.html,Icahn's (Potential) Move Into Biotech
AGN,AGN:US,BBG000FH8PX5,FDA approves first drug to limit frequent waking to urinate,2017-03-04 00:13:07 +0000,http://finance.yahoo.com/news/fda-approves-first-drug-limit-frequent-waking-urinate-225537750--finance.html,FDA approves first drug to limit frequent waking to urinate
AGN,AGN:US,BBG000FH8PX5,FDA approves first drug to limit frequent waking to urinate,2017-03-04 00:12:59 +0000,http://sg.finance.yahoo.com/news/fda-approves-first-drug-limit-225527159.html,FDA approves first drug to limit frequent waking to urinate
AGN,AGN:US,BBG000FH8PX5,"Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL",2017-03-03 21:05:00 +0000,http://finance.yahoo.com/news/allergan-presents-data-21-abstracts-210500953.html,"[PR Newswire] - DUBLIN, March 3, 2017 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 21 Allergan-supported abstracts, a record high for the brand, ..."
AGN,AGN:US,BBG000FH8PX5,Jerome Dodson Adds to 9 Positions in 4th Quarter,2017-03-02 19:11:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BW92BGHMM8/jerome-dodson-adds-to-9-positions-in-4th-quarter-cm755576,Jerome Dodson Trades Portfolio Allergan PLCAllergan PLC AGN Vanguard Health Care Fund McKesson Corp McKesson Corp MCK Progressive Corp Progressive Corp PGR Gilead Sciences Inc Gilead Sciences Inc GILD KLA Tencor Corp KLA Tencor Corp KLAC Alliance Data Systems Corp Alliance Data Systems
AGN,AGN:US,BBG000FH8PX5,The Best Dividend Investors Are Preparing For Higher Interest Rates,2017-03-02 19:11:00 +0000,http://www.forbes.com/sites/kenkam/2017/03/02/the-best-dividend-investors-are-preparing-for-higher-interest-rates/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,The Best Dividend Investors Are Preparing For Higher Interest Rates
AGN,AGN:US,BBG000FH8PX5,ALLERGAN PLC Financials,2017-03-02 18:04:14 +0000,http://finance.yahoo.com/q/is?s=agn,ALLERGAN PLC Financials
AGN,AGN:US,BBG000FH8PX5,"Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ...",2017-03-02 17:12:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x-xYP2dBg3k/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund-sells-cm755502,Saba Capital Management L P New Purchases AGN AOD ESD GLQ GLV OMF TSLA HYG HTZ THS Added Positions FSD GLO CYH DEX VRX ERC USA GNW RVT AGC Reduced Positions BGX MCR EVG PPT MMT FAX EDD HIO CIF MTG Sold Out DSU EMD
AGN,AGN:US,BBG000FH8PX5,The eyes have it in Allergan's new ad campaign from FCB Chicago,2017-03-02 14:59:45 +0000,http://www.bizjournals.com/chicago/news/2017/02/27/the-eyes-have-it-in-allergans-new-ad-campaign-from.html?ana=yahoo,The eyes have it in Allergan's new ad campaign from FCB Chicago
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at the Barclays Global Healthcare Conference,2017-03-02 13:00:00 +0000,http://finance.yahoo.com/news/allergan-present-barclays-global-healthcare-130000916.html,"[PR Newswire] - DUBLIN, March 2, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will begin at 10:15 a.m. ET on Tuesday, March 14, 2017. The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Investors are too negative about fast-growi...,2017-03-01 23:58:00 +0000,http://finance.yahoo.com/video/cramer-remix-investors-too-negative-235800308.html,Cramer Remix: Investors are too negative about fast-growi...
AGN,AGN:US,BBG000FH8PX5,Could pharma sector roar even higher? Cramer checks the c...,2017-03-01 23:47:00 +0000,http://finance.yahoo.com/video/could-pharma-sector-roar-even-234700293.html,Could pharma sector roar even higher? Cramer checks the c...
AGN,AGN:US,BBG000FH8PX5,Cramer’s charts uncover 4 pharma stocks ready to explode ...,2017-03-01 23:42:00 +0000,http://finance.yahoo.com/video/cramer-charts-uncover-4-pharma-234200165.html,Cramer’s charts uncover 4 pharma stocks ready to explode ...
AGN,AGN:US,BBG000FH8PX5,Cramer’s charts uncover 4 pharma stocks ready to explode higher,2017-03-01 23:36:07 +0000,http://www.cnbc.com/id/104313689?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104313689,Cramer’s charts uncover 4 pharma stocks ready to explode higher
AGN,AGN:US,BBG000FH8PX5,Jerome Dodson Adds to 9 Positions in 4th Quarter,2017-03-01 23:08:37 +0000,http://finance.yahoo.com/news/jerome-dodson-adds-9-positions-230837617.html,Jerome Dodson Adds to 9 Positions in 4th Quarter
AGN,AGN:US,BBG000FH8PX5,Analyzing Pfizer’s Estimates for the Future,2017-03-01 12:35:47 +0000,http://marketrealist.com/2017/02/analyzing-pfizers-estimates-for-the-future/?utm_source=yahoo&utm_medium=feed,Analyzing Pfizer’s Estimates for the Future
AGN,AGN:US,BBG000FH8PX5,Big Money Still Long Valeant,2017-02-28 16:24:09 +0000,http://finance.yahoo.com/news/big-money-still-long-valeant-151230773.html,Big Money Still Long Valeant
AGN,AGN:US,BBG000FH8PX5,"Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ...",2017-02-28 13:49:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Npenh1t-WAg/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund-sells-cm754005,Saba Capital Management L P New Purchases AGN AOD ESD GLQ GLV OMF TSLA HYG HTZ THS Added Positions FSD GLO CYH DEX VRX ERC USA GNW RVT AGC Reduced Positions BGX MCR EVG PPT MMT FAX EDD HIO CIF MTG Sold Out DSU EMD
AGN,AGN:US,BBG000FH8PX5,"Drugmakers pledge restraint, but prices will still soar",2017-02-27 22:12:26 +0000,http://finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004283.html,"Drugmakers pledge restraint, but prices will still soar"
AGN,AGN:US,BBG000FH8PX5,"Drugmakers pledge restraint, but prices will still soar",2017-02-27 22:12:21 +0000,http://sg.finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004727.html,"Drugmakers pledge restraint, but prices will still soar"
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceuticals Industries Ltd (ADR) (TEVA): Be Cautious and Earn a Double-Digit Return,2017-02-27 21:50:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XOk2MfPqu4Y/teva-pharmaceuticals-industries-ltd-adr-teva-be-cautious-and-earn-a-double-digit-return-cm753860,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s little doubt 2016 was a downer for Teva Pharmaceuticals Industries Ltd ADR NYSE TEVA shareholders Nevertheless there s reason to believe 2017 could be time to forgive and forget or at least give
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Raymond James 38th Annual Institutional Investors Conference,2017-02-27 21:30:00 +0000,http://finance.yahoo.com/news/allergan-present-raymond-james-38th-213000060.html,"[PR Newswire] - DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Bill Meury, Allergan's Chief Commercial Officer, will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at www.allergan.com/investors. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Cowen and Company 37th Annual Health Care Conference,2017-02-27 21:30:00 +0000,http://finance.yahoo.com/news/allergan-present-cowen-company-37th-213000266.html,"[PR Newswire] - DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, today announced that Allergan Chairman and CEO Brent Saunders will present at the Cowen and Company 37th Annual Health Care Conference in Boston, MA. The presentation will begin at 8:40 a.m. ET on Tuesday, March 7th, 2017 at the Boston Marriott Copley Place. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at www.allergan.com/investors."
AGN,AGN:US,BBG000FH8PX5,Jim Cramer Is Passing on Valeant Ahead of Earnings,2017-02-27 18:23:00 +0000,https://www.thestreet.com/story/14017469/1/jim-cramer-is-passing-on-valeant-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer Is Passing on Valeant Ahead of Earnings
AGN,AGN:US,BBG000FH8PX5,Johnson & Johnson reveals 3.5% net hike in drug pricing l...,2017-02-27 17:48:00 +0000,http://finance.yahoo.com/video/johnson-johnson-reveals-3-5-174800715.html,Johnson & Johnson reveals 3.5% net hike in drug pricing l...
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP",2017-02-27 16:53:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bOR0Y_zOANY/the-zacks-analyst-blog-highlights-ibm-allergan-chubb-dish-network-and-hp-cm753629,For Immediate Release Chicago IL February 27 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP",2017-02-27 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-ibm-143002594.html,"The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP"
AGN,AGN:US,BBG000FH8PX5,Eli Lilly & Co.’s Oncology Franchise,2017-02-27 14:06:54 +0000,http://marketrealist.com/2017/02/eli-lilly-co-s-oncology-franchise/?utm_source=yahoo&utm_medium=feed,Eli Lilly & Co.’s Oncology Franchise
AGN,AGN:US,BBG000FH8PX5,"Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan",2017-02-27 13:00:00 +0000,http://finance.yahoo.com/news/lisa-defrancesco-vice-president-investor-130000477.html,"[PR Newswire] - DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Lisa DeFrancesco, Vice President of Investor Relations, has decided to leave Allergan to pursue other professional opportunities. ""After nearly 8 years of leading the Investor Relations function during the transformation of our Company from Watson, a U.S. focused generics company, to Actavis, a leading global generics company to Allergan, a leading branded growth pharma company, I have decided that now is the right time to pursue other career opportunities,"" said DeFrancesco."
AGN,AGN:US,BBG000FH8PX5,Allergan's New Eyepowerment™ Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action,2017-02-27 12:30:00 +0000,http://finance.yahoo.com/news/allergans-eyepowerment-campaign-urges-33-123000157.html,"[PR Newswire] - DUBLIN, Feb. 27, 2017 /PRNewswire/ -- ""Before we had our voice, we had our eyes,"" is the powerful opening message from Allergan's new campaign to raise awareness for Chronic Dry Eye. The campaign, titled ""Eyepowerment,"" aims to empower individuals who may be struggling with symptoms of Chronic Dry Eye to talk to their doctor. Research shows emotions are read in one another's eyes, but redness, itching and watering eyes – all common symptoms of Chronic Dry Eye – may unintentionally send the wrong message."
AGN,AGN:US,BBG000FH8PX5,Drugmakers Eye $35B Market Amid Obesity Crisis,2017-02-27 11:00:00 +0000,http://www.investopedia.com/news/drugmakers-eye-35b-market-amid-obesity-crisis-agn-shpg/?partner=YahooSA,Drugmakers Eye $35B Market Amid Obesity Crisis
AGN,AGN:US,BBG000FH8PX5,"Facing Criticism, Drug Makers Keep Lid On Price Increases",2017-02-27 06:51:36 +0000,https://www.wsj.com/articles/facing-criticism-drug-makers-keep-lid-on-price-increases-1488157893?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President ..."
AGN,AGN:US,BBG000FH8PX5,Drug Companies Keep Lid on Price Increases,2017-02-27 01:03:02 +0000,http://online.wsj.com/article/SB22580892754490123402004582619611883364468.html?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Facing mounting criticism about prices, drug companies put some limits on their increases this year."
AGN,AGN:US,BBG000FH8PX5,Insider Q&A: Allergan CEO on impact of limiting price hikes,2017-02-26 17:28:25 +0000,http://finance.yahoo.com/news/insider-q-allergan-ceo-impact-120117391.html,Insider Q&A: Allergan CEO on impact of limiting price hikes
AGN,AGN:US,BBG000FH8PX5,Insider Q&A: Allergan CEO on impact of limiting price hikes,2017-02-26 17:28:16 +0000,http://sg.finance.yahoo.com/news/insider-q-allergan-ceo-impact-120117843.html,Insider Q&A: Allergan CEO on impact of limiting price hikes
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 10-K, Annual Report",2017-02-24 22:13:24 +0000,http://biz.yahoo.com/e/170224/agn10-k.html,"ALLERGAN PLC Files SEC form 10-K, Annual Report"
AGN,AGN:US,BBG000FH8PX5,NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017,2017-02-24 18:21:00 +0000,http://www.forbes.com/sites/kenkam/2017/02/24/nash-is-todd-hagopians-top-biotech-sub-sector-for-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for February 24, 2017",2017-02-24 15:58:03 +0000,http://finance.yahoo.com/news/top-research-reports-february-24-155803227.html,"Top Research Reports for February 24, 2017"
AGN,AGN:US,BBG000FH8PX5,Eli Lilly & Co.’s Revenues in 4Q16,2017-02-23 22:15:55 +0000,http://marketrealist.com/2017/02/eli-lilly-co-s-revenues-in-4q16/?utm_source=yahoo&utm_medium=feed,Eli Lilly & Co.’s Revenues in 4Q16
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap,2017-02-23 17:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJWUEwQ_m9A/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-crazy-cheap-cm752236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA desperately needed some good news heading into its fourth quarter earnings report TEVA stock hit its lowest level in over a decade the week before after its
AGN,AGN:US,BBG000FH8PX5,Seeking Alpha Interviews: Bret Jensen On Promising Drugs And Acquisition Targets,2017-02-23 15:51:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YJer37_PmcE/seeking-alpha-interviews-bret-jensen-on-promising-drugs-and-acquisition-targets-cm752029,By Bret Jensen ByBret Jensen In the fifth episode of Seeking Alpha Interviews Lilamax s Jane King sits down with Bret Jensen to discuss regulatory changes merger activity and drug development affecting action in the biotech sector In the fifth episode of Seeking Alpha Interviews Lilamax
AGN,AGN:US,BBG000FH8PX5,Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs,2017-02-23 14:41:41 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=36F4B57F-5849-4E08-845D-2F2FC46FBBB7&siteid=yhoof2,Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs
AGN,AGN:US,BBG000FH8PX5,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 24, 2017",2017-02-23 14:20:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WPG3whOyNpQ/allergan-plc-agn-ex-dividend-date-scheduled-for-february-24-2017-cm751848,Allergan plc AGN will begin trading ex dividend on February 24 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on March 28 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This represents an 1300
AGN,AGN:US,BBG000FH8PX5,Allergan CEO Pushes for Trump to Lead Drug Price Discussions,2017-02-23 02:14:15 +0000,https://www.bloomberg.com/news/articles/2017-02-23/allergan-ceo-pushes-for-trump-to-lead-drug-price-restraint-talks?cmpid=yhoo.headline,Allergan CEO Pushes for Trump to Lead Drug Price Discussions
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Wednesday Option Activity: AGN, TXRH, TSRA",2017-02-22 21:49:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5hy-RCb90qM/noteworthy-wednesday-option-activity-agn-txrh-tsra-cm751625,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 18 578 contracts has been traded thus far today a contract volume which is representative of approximately 1 9
AGN,AGN:US,BBG000FH8PX5,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top,2017-02-22 17:52:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5gz4Ub_VeTU/ironwood-irwd-q4-loss-narrower-than-expected-sales-top-cm751417,Ironwood Pharmaceuticals Inc IRWD reported an adjusted loss of 12 cents per share in the fourth quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 23 cents but slightly wider than the year ago loss of 11 cents Total revenue collaborative revenues in the
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Outflow Detected - PJP, MDCO, AGN, PBH",2017-02-22 17:52:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HcGA2CcVH0M/notable-etf-outflow-detected-pjp-mdco-agn-pbh-cm751422,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Pharmaceuticals Portfolio Symbol PJP where we have detected an approximate 18 3 million dollar outflow that s a 2 1 decrease week over
AGN,AGN:US,BBG000FH8PX5,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top,2017-02-22 15:34:03 +0000,http://finance.yahoo.com/news/ironwood-irwd-q4-loss-narrower-153403228.html,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
AGN,AGN:US,BBG000FH8PX5,Allergan to Sponsor Alzheimer's Foundation of America '15th Anniversary National Educating America' Tour,2017-02-22 13:01:00 +0000,http://finance.yahoo.com/news/allergan-sponsor-alzheimers-foundation-america-130100060.html,"[PR Newswire] - DUBLIN, Feb. 22, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, is proud to be a Gold sponsor of the Alzheimer's Foundation of America's (AFA) ""15th Anniversary National Educating America Tour."" This tour commemorates AFA's15 years of educating individuals about Alzheimer's and the availability of services and programs. The tour will include AFA's free Concepts in Care Educational Conferences, free memory screenings and displays of the AFA Quilt to Remember. ""We are excited to be a Gold sponsor of the 15th Anniversary Educating America Tour,"" said Will Kane, senior vice president marketing, U.S. General Medicine at Allergan."
AGN,AGN:US,BBG000FH8PX5,Where Are the Best Buying Opportunities in Stocks Right Now?,2017-02-22 03:06:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MhG5Ub9OamE/where-are-the-best-buying-opportunities-in-stocks-right-now-cm751007,1 30 Joseph Stilwell Investing in the small banking community 6 30 David Tepper s Holdings Buying into the pharmaceutical industry 11 40 George Soro s Holdings Starting new positions in energy 14 25 Kevin and Tracey go in
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Looks Strong,2017-02-21 19:07:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcv7XuqV3Qg/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-looks-strong-cm750819,InvestorPlace Stock Market News Stock Advice amp Trading Tips I m a big fan of Israeli stocks First and foremost Israelis are essentially the world s most educated people You can t progress as a society unless rationality and science reigns and they have it in droves I also love
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 16:11:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_C1tak9H14/the-zacks-analyst-blog-highlights-merck-valeant-pharmaceuticals-international-allergan-astrazeneca-and-johnson-johnson-cm750634,For Immediate Release Chicago IL February 21 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
AGN,AGN:US,BBG000FH8PX5,"Medtronic Earnings Rebound in Third Quarter, Shares Climb",2017-02-21 15:58:00 +0000,https://www.thestreet.com/story/14009548/1/medtronic-earnings-rebound-in-third-quarter-shares-climb.html?puc=yahoo&cm_ven=YAHOO,"Medtronic Earnings Rebound in Third Quarter, Shares Climb"
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-143002469.html,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson"
AGN,AGN:US,BBG000FH8PX5,[$$] Big pharma bets billions on 'silent' liver disease,2017-02-21 05:01:04 +0000,"http://www.ft.com/cms/s/e6ab5da6-f3c9-11e6-8758-6876151821a6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Big pharma thinks it has spotted its next big opportunity - an untreatable silent killer that affects millions of people. In recent months, large drugmakers including Allergan, Gilead and Novartis have ..."
AGN,AGN:US,BBG000FH8PX5,Collapse of Kraft-Unilever tie-up extends run of failed mega-deals,2017-02-20 19:45:22 +0000,http://sg.finance.yahoo.com/news/collapse-kraft-unilever-tie-extends-194522763.html,Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
AGN,AGN:US,BBG000FH8PX5,Riddle Me This; Bendable Market: Best of Kass,2017-02-18 02:00:00 +0000,https://www.thestreet.com/story/14007408/1/riddle-me-this-bendable-market-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Riddle Me This; Bendable Market: Best of Kass
AGN,AGN:US,BBG000FH8PX5,"Stull, Stull & Brody is Investigating Claims on Behalf of Allergan’s (NYSE:AGN) 401(k) Plan",2017-02-17 22:15:00 +0000,http://finance.yahoo.com/news/stull-stull-brody-investigating-claims-221500428.html,"[GlobeNewswire] - NEW YORK, Feb. 17, 2017-- Stull, Stull & Brody today announced that a securities fraud complaint and an ERISA Action have been filed and that it has commenced an investigation relating to the 401 defined ..."
AGN,AGN:US,BBG000FH8PX5,Deals of the Week: Valentine Couplings and Breakups,2017-02-17 21:22:00 +0000,https://www.thestreet.com/story/14007214/1/deals-of-the-week-valentine-couplings-and-breakups.html?puc=yahoo&cm_ven=YAHOO,Deals of the Week: Valentine Couplings and Breakups
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ",2017-02-17 13:57:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YaFi7BW-HOE/pharma-stock-roundup-mercks-alzheimers-study-halted-allergan-to-buy-zeltiq-cm749492,Although companies like Teva Read more Teva Tops on Q4 Earnings Maintains 2017 Guidance and Shire reported fourth quarter results this week focus remained primarily on Merck s MRK announcement regarding its Alzheimer s disease candidate Recap of the Week s Most Important
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ",2017-02-17 12:21:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mercks-alzheimers-122112453.html,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ"
AGN,AGN:US,BBG000FH8PX5,Aegon Turns To Profit In Q4; Sales Down - Quick Facts,2017-02-17 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bc7qdLlybrk/aegon-turns-to-profit-in-q4-sales-down--quick-facts-20170217-00042,Aegon Turns To Profit In Q4; Sales Down - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 23:55:26 +0000,http://www.fool.com/investing/2017/02/16/why-this-billionaire-just-shelled-out-11-billion-o.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
AGN,AGN:US,BBG000FH8PX5,Stress boom to boost drug sales?,2017-02-16 22:38:00 +0000,http://finance.yahoo.com/video/stress-boom-boost-drug-sales-223800695.html,Stress boom to boost drug sales?
AGN,AGN:US,BBG000FH8PX5,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 21:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cLW2Vs0vmNU/why-this-billionaire-just-shelled-out-11-billion-on-4-drug-stocks-cm749190,A billion here a billion there and pretty soon you re talking about real money It s debatable who first uttered that phrase What isn t debatable though is that David Tepper and Appaloosa Management are accustomed to throwing around plenty of real money The multi billion
AGN,AGN:US,BBG000FH8PX5,"Jefferies Group LLC Buys SPDR Select Sector Fund - Financial, Valvoline, Lions Gate ...",2017-02-16 17:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mjSe_8RrbTI/jefferies-group-llc-buys-spdr-select-sector-fund-financial-valvoline-lions-gate-cm749068,Jefferies Group LLC New Purchases VVV LGF A LGF B NTNX RIO XOG CERN VXX ASH DXJ Added Positions XLF RDS A DAL FB TSLA YHOO BAC MCD MDT XLV Reduced Positions PG SRPT PAA SPY TAP GLD AGN BIIB CHTR TWX Sold Out JNK XOP
AGN,AGN:US,BBG000FH8PX5,David Tepper Invests Heavily in Pharma in 4th Quarter,2017-02-16 17:06:55 +0000,http://finance.yahoo.com/news/david-tepper-invests-heavily-pharma-170655363.html,David Tepper Invests Heavily in Pharma in 4th Quarter
AGN,AGN:US,BBG000FH8PX5,Allergan's Roll-Up Is Not Breaking Even (SEC Letter Response),2017-02-16 16:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjVip28BQj8/allergans-roll-up-is-not-breaking-even-sec-letter-response-cm748857,By SigmaCap BySigmaCap On February 13 The Wall Street Journal broke news of a recent letter from the SEC to Allergan AGN highlighting its concerns about AGN s non GAAP earnings practices This letter corroborates my concerns about AGN s approach In its earnings AGN excludes
AGN,AGN:US,BBG000FH8PX5,"Samlyn Capital, Llc Buys TD Ameritrade Holding, American Express Co, Comerica, Sells Aramark, ...",2017-02-16 16:53:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BQcK_5YqYkQ/samlyn-capital-llc-buys-td-ameritrade-holding-american-express-co-comerica-sells-aramark-cm749021,Samlyn Capital Llc TD Ameritrade New Purchases AMTD AXP CMA CMCSA TJX MET KHC PVTB KEY DG Added Positions STZ UHS CI AMGN HUM DKS PTC AGN CVS WMT Reduced Positions ARMK BIIB LH AAP FL DVMT AMZN ST XL AVGO Sold Out K
AGN,AGN:US,BBG000FH8PX5,5 Ways Allergan Can Keep Up Momentum,2017-02-15 20:03:00 +0000,https://www.thestreet.com/story/14003652/1/5-nbsp-ways-allergan-can-keep-up-momentum.html?puc=yahoo&cm_ven=YAHOO,5 Ways Allergan Can Keep Up Momentum
AGN,AGN:US,BBG000FH8PX5,Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016,2017-02-15 19:54:00 +0000,http://www.investopedia.com/news/teppers-appaloosa-fund-continues-bet-drug-companies-q4-2016-pfe-myl/?partner=YahooSA,Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016
AGN,AGN:US,BBG000FH8PX5,"Private Capital Buys OceanFirst Financial, Valeant Pharmaceuticals International, Caesarstone, ...",2017-02-15 19:53:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d1xpKsUl3Uw/private-capital-buys-oceanfirst-financial-valeant-pharmaceuticals-international-caesarstone-cm748517,Private Capital New Purchases CSTE FNWB CSWI Added Positions OCFC AGN VRX FOGO Reduced Positions INTL APEI CAB ALR TROX MENT KKR VC SPTN RELY Sold Out ASNA AJRD BRKL New Purchases CSTE FNWB CSWI
AGN,AGN:US,BBG000FH8PX5,Tepper's Appaloosa triples stake in Allergan,2017-02-15 19:18:00 +0000,http://finance.yahoo.com/video/teppers-appaloosa-triples-stake-allergan-191800406.html,Tepper's Appaloosa triples stake in Allergan
AGN,AGN:US,BBG000FH8PX5,"Billionaire Dan Loeb’s Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN)",2017-02-15 18:24:39 +0000,http://www.insidermonkey.com/blog/billionaire-dan-loebs-biggest-q4-moves-include-bank-buying-spree-selling-allergan-agn-550025/,"Billionaire Dan Loeb’s Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN)"
AGN,AGN:US,BBG000FH8PX5,"Wallace Weitz Buys Visa, Thermo Fisher Scientific, Liberty Expedia Holdings, Sells Express ...",2017-02-15 12:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/piLSga_h2ZI/wallace-weitz-buys-visa-thermo-fisher-scientific-liberty-expedia-holdings-sells-express-cm748074,Wallace Weitz New Purchases TMO LEXEA CVS LGF B LGF A IWV VTI VEA FIS CRM Added Positions V AMZN ORCL LILAK AGN LBTYK LH FOX PX MUSA Reduced Positions BRK B LSXMK WFC FOXA NCMI TXN CFX RWT LVNTA FWONK Sold Out ESRX MCK
AGN,AGN:US,BBG000FH8PX5,Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika,2017-02-15 12:00:00 +0000,http://finance.yahoo.com/news/medicines360-allergan-announce-partnership-health-120000527.html,"[PR Newswire] - SAN FRANCISCO and DUBLIN, Feb. 15, 2017 /PRNewswire/ -- Medicines360, a nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines, and Allergan plc (AGN), a leading global pharmaceutical company, today announced a partnership with 340B-eligible health centers and other safety net providers in Puerto Rico and Florida, both areas where there is local transmission of the Zika virus, to make available their hormonal contraceptive, LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg. LILETTA is an IUS, intrauterine system (otherwise known as an intrauterine device or IUD), that is approved for the prevention of pregnancy for up to three years. Research has shown that pregnant women infected with the Zika virus are at risk of giving birth to infants born with microcephaly -- a birth defect caused by the exposure to the Zika virus where a baby's head is smaller than expected when compared to babies of the same sex and age."
AGN,AGN:US,BBG000FH8PX5,"Walleye Trading LLC Buys Apple, Plains All American Pipeline LP, Micron Technology, Sells ...",2017-02-15 11:17:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RRTYqm90Q70/walleye-trading-llc-buys-apple-plains-all-american-pipeline-lp-micron-technology-sells-cm748058,Walleye Trading LLC New Purchases MU PANW PFE SYF XLE COL MENT ABX BEN STJ Added Positions AAPL PAA RAI MPC AMZN CAG CMI XOM AER IBN Reduced Positions AGN MON TAP SEAS TEVA GLD QQQ SYMC TWO XPO Sold Out LNKD EWW AVGTF
AGN,AGN:US,BBG000FH8PX5,What the Smart Money's buying,2017-02-14 22:52:00 +0000,http://finance.yahoo.com/video/smart-moneys-buying-225200199.html,What the Smart Money's buying
AGN,AGN:US,BBG000FH8PX5,David Tepper Increases Wagers on Drug Companies,2017-02-14 22:32:36 +0000,http://blogs.wsj.com/moneybeat/2017/02/14/david-tepper-increases-wagers-on-drug-companies/?mod=yahoo_hs,David Tepper Increases Wagers on Drug Companies
AGN,AGN:US,BBG000FH8PX5,"Bets on financials, pharma power U.S. hedge funds' strong start to year",2017-02-14 22:22:27 +0000,http://finance.yahoo.com/news/bets-financials-pharma-power-u-222227789.html,"[Reuters] - Several big-name U.S. hedge fund investors in the fourth quarter moved significant parts of their portfolios into financial and pharmaceutical stocks that are expected to benefit under the Trump administration, helping to power the sector to its best January performance in four years. Omega Advisors, run by Leon Cooperman and Steven Einhorn, increased its stake in insurance broker Fidelity & Guaranty Life by 343 percent compared with the quarter before, and added a new position in regional bank Renasant Corp, according to securities filings released Tuesday. Both companies are up 16 percent or more since President Donald Trump's surprising November election victory, compared with a 9.6 percent gain in the broad Standard & Poor's 500."
AGN,AGN:US,BBG000FH8PX5,David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks,2017-02-14 22:19:13 +0000,http://finance.yahoo.com/news/david-teppers-appaloosa-just-dropped-221913843.html,David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks
AGN,AGN:US,BBG000FH8PX5,Appaloosa Management snaps up Allergan shares in 4th quarter,2017-02-14 21:54:01 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C8345F02-33E3-4B3B-8CCD-FEC107064E4F&siteid=yhoof2,Appaloosa Management snaps up Allergan shares in 4th quarter
AGN,AGN:US,BBG000FH8PX5,"Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil",2017-02-14 21:09:19 +0000,http://www.investors.com/news/technology/hologic-trails-allergan-paying-1-65-billion-for-body-sculptor-cynosure/,"Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil"
AGN,AGN:US,BBG000FH8PX5,"Sachem Head's Ferguson to exit Autodesk board, fund gains -letter",2017-02-14 20:37:29 +0000,http://finance.yahoo.com/news/sachem-heads-ferguson-exit-autodesk-203729969.html,"Sachem Head's Ferguson to exit Autodesk board, fund gains -letter"
AGN,AGN:US,BBG000FH8PX5,"Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma",2017-02-14 19:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJ_I01rqGzI/daniel-loeb-picks-up-rate-sensitive-financials-drops-pharma-cm747848,Daniel Loeb Trades Portfolio s weighting in financial services expanded to 14 4 from 6 3 in the fourth quarter as he bought shares of three big banks and nixed several positions in health care Daniel Loeb Trades Portfolio s weighting in financial services expanded to 14
AGN,AGN:US,BBG000FH8PX5,"ETFs with exposure to Allergan Plc : February 14, 2017",2017-02-14 19:13:02 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-allergan-plc-february-14-2017/,"ETFs with exposure to Allergan Plc : February 14, 2017"
AGN,AGN:US,BBG000FH8PX5,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance",2017-02-14 15:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZYais-jvJ_I/teva-teva-tops-on-q4-earnings-maintains-2017-guidance-cm747557,Teva Pharmaceutical Industries Ltd TEVA reported fourth quarter 2016 earnings of 1 34 per share including equity compensation expenses which beat the Zacks Consensus Estimate of 1 28 Excluding stock based compensation expenses earnings were 1 38 per share up 7 8 year over
AGN,AGN:US,BBG000FH8PX5,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan,2017-02-14 14:45:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-144500824.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 14, 2017 / Promises of a ""phenomenal"" tax plan by President Trump continued to push markets to new record highs on Monday. The Dow Jones industrial Average ..."
AGN,AGN:US,BBG000FH8PX5,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit",2017-02-14 14:24:00 +0000,https://www.thestreet.com/story/14001319/1/valeant-pershing-square-will-split-legal-costs-on-allergan-lawsuit.html?puc=yahoo&cm_ven=YAHOO,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit"
AGN,AGN:US,BBG000FH8PX5,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance",2017-02-14 13:20:01 +0000,http://finance.yahoo.com/news/teva-teva-tops-q4-earnings-132001714.html,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance"
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence in the Body Contouring Business,2017-02-14 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-allergan-acquires-zeltiq-131500305.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / February 14, 2017 / Active Wall St. blog coverage looks at the headline from Allergan PLC ( NYSE: AGN ) and ZELTIQ Aesthetics, Inc. ( NASDAQ: ZLTQ ). Allergan announced on February ..."
AGN,AGN:US,BBG000FH8PX5,Botox-maker Allergan is betting that zapping your fat is worth $4 billion,2017-02-14 12:07:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6A13A57C-F1F9-11E6-9546-7567D09D9D1E&siteid=yhoof2,Botox-maker Allergan is betting that zapping your fat is worth $4 billion
AGN,AGN:US,BBG000FH8PX5,New Relic: Cramer's Top Takeaways,2017-02-14 11:26:00 +0000,https://www.thestreet.com/story/14000502/1/new-relic-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,New Relic: Cramer's Top Takeaways
AGN,AGN:US,BBG000FH8PX5,Asian shares fall back as investors await comments by Yellen,2017-02-14 04:48:58 +0000,http://sg.finance.yahoo.com/news/global-stocks-continue-rise-us-151946996.html,Asian shares fall back as investors await comments by Yellen
AGN,AGN:US,BBG000FH8PX5,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%",2017-02-14 00:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l5TdQo_Mv8A/allergan-to-acquire-zeltiq-in-247-billion-deal-zeltiq-shares-pop-13-cm747335,Pharmaceutical giant Allergan AGN announced on Monday they will acquire ZELTIQ Aesthetics ZLTQ in a 2 47 billion deal Allergan expects the deal to close in the latter half of 2017 ZELTIQ a medical technology company focuses on commercializing their proprietary controlled cooling
AGN,AGN:US,BBG000FH8PX5,"Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today",2017-02-13 23:18:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ucvw2yIgTH4/why-chemours-zeltiq-aesthetics-and-vale-jumped-today-cm747323,The stock market maintained its rally on Monday as investors continued to look ahead to more forward momentum from the federal government in its efforts to make Wall Street friendly financial and regulatory reforms The Dow Jones Industrials surged to another all time high and
AGN,AGN:US,BBG000FH8PX5,Allergan Paying Nearly $2.5 Billion for ZELTIQ,2017-02-13 22:57:03 +0000,http://www.investopedia.com/stock-analysis/021317/allergan-paying-nearly-25-billion-zeltiq.aspx?partner=YahooSA,Allergan Paying Nearly $2.5 Billion for ZELTIQ
AGN,AGN:US,BBG000FH8PX5,"Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma",2017-02-13 22:30:40 +0000,http://finance.yahoo.com/news/daniel-loeb-drops-pharma-picks-223040541.html,"Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma"
AGN,AGN:US,BBG000FH8PX5,Allergan Plc -- Moody's: Allergan's ZELTIQ acquisition credit negative on high pricetag,2017-02-13 22:18:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362112&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170213_PR_362112,Allergan Plc -- Moody's: Allergan's ZELTIQ acquisition credit negative on high pricetag
AGN,AGN:US,BBG000FH8PX5,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%",2017-02-13 22:11:10 +0000,http://finance.yahoo.com/news/allergan-acquire-zeltiq-2-47-221110797.html,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%"
AGN,AGN:US,BBG000FH8PX5,"Gainers & Losers Of The Day: ZSAN, PLSE, XOMA, SAGE, CBIO...",2017-02-13 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kp9aiqfn-V0/gainers--losers-of-the-day-zsan-plse-xoma-sage-cbio-20170213-01457,"Gainers & Losers Of The Day: ZSAN, PLSE, XOMA, SAGE, CBIO..."
AGN,AGN:US,BBG000FH8PX5,"Zeltiq, US Steel and Chemours rise; Hain Celestial plunges",2017-02-13 21:51:49 +0000,http://finance.yahoo.com/news/zeltiq-us-steel-chemours-rise-215149578.html,"Zeltiq, US Steel and Chemours rise; Hain Celestial plunges"
AGN,AGN:US,BBG000FH8PX5,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion,2017-02-13 21:40:31 +0000,http://in.finance.yahoo.com/news/allergan-buy-fat-fighter-zeltiq-183332894.html,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
AGN,AGN:US,BBG000FH8PX5,"Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today",2017-02-13 21:40:00 +0000,http://www.fool.com/investing/2017/02/13/why-chemours-zeltiq-aesthetics-and-vale-jumped-tod.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today"
AGN,AGN:US,BBG000FH8PX5,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln,2017-02-13 21:34:03 +0000,http://finance.yahoo.com/news/allergan-buy-fat-fighter-zeltiq-172316414.html,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln
AGN,AGN:US,BBG000FH8PX5,Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Following Acquisition News,2017-02-13 21:19:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Af9mHymCRIo/mid-afternoon-market-update-dow-rises-150-points-zeltiq-aesthetics-shares-surge-following-acquisition-news-cm747281,Toward the end of trading Monday the Dow traded up 0 76 percent to 20 423 25 while the NASDAQ gained 0 57 percent to 5 766 58 The S amp P also rose gaining 0 56 percent to 2 329 09 Leading and Lagging Sectors Basic materials shares climbed by 1 29 percent in trading on
AGN,AGN:US,BBG000FH8PX5,Zeltiq Aesthetics Inc (ZLTQ) Stock Soars on$2.5B Allergan (AGN) Deal,2017-02-13 21:18:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PcRZaGCydzc/zeltiq-aesthetics-inc-zltq-stock-soars-on25b-allergan-agn-deal-cm747298,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Zeltiq Aesthetics Inc NASDAQ ZLTQ stock was up on Monday following news that 160 Allergan plc Ordinary Shares NYSE AGN will acquire
AGN,AGN:US,BBG000FH8PX5,Allergan To Buy Fat-Freezing Zeltiq For $2.5 Bil; Zeltiq Hits Record High,2017-02-13 21:05:02 +0000,http://www.investors.com/news/technology/allergan-to-buy-fat-freezing-zeltiq-for-2-5b-zeltiq-hits-record-high/,Allergan To Buy Fat-Freezing Zeltiq For $2.5 Bil; Zeltiq Hits Record High
AGN,AGN:US,BBG000FH8PX5,STOCKS HIT ALL-TIME HIGHS: Here's what you need to know,2017-02-13 21:00:22 +0000,http://finance.yahoo.com/news/stocks-hit-time-highs-heres-210022075.html,STOCKS HIT ALL-TIME HIGHS: Here's what you need to know
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires Zeltiq Aesthetics for $2.48 Billion,2017-02-13 19:24:00 +0000,http://www.investopedia.com/news/allergan-acquires-zeltiq-aesthetics-248-billion/?partner=YahooSA,Allergan Acquires Zeltiq Aesthetics for $2.48 Billion
AGN,AGN:US,BBG000FH8PX5,Why Zeltiq Aesthetics Stock Is Surging Higher Today,2017-02-13 19:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tqlbZ76sWgs/why-zeltiq-aesthetics-stock-is-surging-higher-today-cm747210,What happened Shares of Zeltiq Aesthetics NASDAQ ZLTQ a medical technology company gained as much as 13 a s of 12 40 p m EST on Monday Zeltiq s stock rose in response to the news that Botox maker Allergan NYSE AGN has agreed to buy the company in an all cash
AGN,AGN:US,BBG000FH8PX5,"How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More",2017-02-13 18:26:00 +0000,https://www.thestreet.com/story/13999935/1/how-to-trade-monday-s-most-active-stocks-bofa-vale-zeltiq-teva-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More"
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires ZELTIQ For $2.47 Billion,2017-02-13 18:15:00 +0000,http://www.investopedia.com/news/allergan-acquires-zeltiq-agn-zltq/?partner=YahooSA,Allergan Acquires ZELTIQ For $2.47 Billion
AGN,AGN:US,BBG000FH8PX5,Why Zeltiq Aesthetics Stock Is Surging Higher Today,2017-02-13 17:56:54 +0000,http://www.fool.com/investing/2017/02/13/why-zeltiq-aesthetics-stock-is-surging-higher-toda.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Zeltiq Aesthetics Stock Is Surging Higher Today
AGN,AGN:US,BBG000FH8PX5,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion,2017-02-13 17:29:54 +0000,http://sg.finance.yahoo.com/news/allergan-agrees-buy-zeltiq-2-131302476.html,Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
AGN,AGN:US,BBG000FH8PX5,Markets Climb Amid Solid Q4 Earnings,2017-02-13 17:17:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LAJ5ggLOhRk/markets-climb-amid-solid-q4-earnings-cm747070,Monday February 13 2017 Q4 earnings season even performed better than analysts had hoped for Of course we re not completely through the entire cycle retailers have yet to report en masse and we see industry leaders like Cisco CSCO Pepsi PEP and AIG AIG on the docket for this
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics,2017-02-13 17:12:00 +0000,http://www.thestreet.com/video/13999917/allergan-shares-surge-after-announcing-acquisition-of-zeltiq-aesthetics.html?puc=yahoov&cm_ven=YAHOOV,Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan agrees to buy fat-freezing company for $2.47bn,2017-02-13 16:21:43 +0000,"http://www.ft.com/cms/s/05813044-f202-11e6-95ee-f14e55513608,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Allergan said it would pay $2.47bn in cash to acquire the maker of machines that freeze and remove fat cells, as the drugmaker best known for its Botox wrinkle treatment expands its offering for plastic ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq,2017-02-13 16:11:00 +0000,https://www.thestreet.com/story/13999813/1/allergan-in-2-5b-deal-for-body-sculptor-zeltiq.html?puc=yahoo&cm_ven=YAHOO,Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
AGN,AGN:US,BBG000FH8PX5,"Stocks Trade Above Record Closes, Apple Nears All-Time High",2017-02-13 16:00:00 +0000,https://www.thestreet.com/story/13999624/1/stocks-trade-above-record-closes-as-positive-vibes-over-tax-reform-linger.html?puc=yahoo&cm_ven=YAHOO,"Stocks Trade Above Record Closes, Apple Nears All-Time High"
AGN,AGN:US,BBG000FH8PX5,UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln,2017-02-13 15:53:15 +0000,http://finance.yahoo.com/news/allergan-buy-zeltiq-aesthetics-2-133017587.html,UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln
AGN,AGN:US,BBG000FH8PX5,Teva seeks CEO with pharma background to lead recovery efforts,2017-02-13 15:31:50 +0000,http://finance.yahoo.com/news/teva-pharma-quarterly-profit-revenue-125153890.html,"[Reuters] - Teva Pharmaceutical Industries is seeking a new chief executive with deep drug industry experience, the Israel-based company said on Monday as it looks to restore confidence after a series of missteps and the departure of CEO Erez Vigodman. Teva, the world's biggest generic drug maker, was left without a permanent chief last week after Vigodman, an industry outsider, stepped down following a string of costly acquisitions and delayed drug launches which sent its shares to their lowest in more than 10 years. ""We are here to fix what is not working, we will leave no stone unturned,"" interim CEO Yitzhak Peterburg said on Monday after the company reported higher than expected fourth-quarter earnings."
AGN,AGN:US,BBG000FH8PX5,Markets Right Now: US indexes open at record highs,2017-02-13 14:40:51 +0000,http://sg.finance.yahoo.com/news/markets-now-us-indexes-open-144051097.html,Markets Right Now: US indexes open at record highs
AGN,AGN:US,BBG000FH8PX5,"Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters",2017-02-13 14:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/13/morning-movers-verizon-falls-teva-jumps-hain-celestial-craters/?mod=yahoobarrons&ru=yahoo,"Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters"
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders - ZLTQ",2017-02-13 14:34:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-143400203.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 13, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ) stock ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion,2017-02-13 14:32:48 +0000,https://www.wsj.com/articles/allergan-to-buy-fat-treatment-maker-zeltiq-for-2-3-billion-1486993396?mod=yahoo_hs,[$$] Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion
AGN,AGN:US,BBG000FH8PX5,"Verizon unlimited data is back, Burger King parent Restaurant Brands boosts profit, Allergan buys fat treatment company",2017-02-13 14:31:00 +0000,http://finance.yahoo.com/news/verizon-unlimited-data-is-back-burger-king-parent-restaurant-brands-boosts-profit-allergan-buys-fat-treatment-company-143100934.html,"Verizon unlimited data is back, Burger King parent Restaurant Brands boosts profit, Allergan buys fat treatment company"
AGN,AGN:US,BBG000FH8PX5,Allergan to spend $2.48 B on CoolSculpting provider Zeltiq,2017-02-13 13:51:53 +0000,http://sg.finance.yahoo.com/news/allergan-spend-2-48-b-135153366.html,Allergan to spend $2.48 B on CoolSculpting provider Zeltiq
AGN,AGN:US,BBG000FH8PX5,Allergan to acquire body contouring company Zeltiq Aesthetics for $2.5 billion,2017-02-13 13:15:01 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F1FB3785-5B65-4E1F-B5F4-9B7CEF8B0556&siteid=yhoof2,Allergan to acquire body contouring company Zeltiq Aesthetics for $2.5 billion
AGN,AGN:US,BBG000FH8PX5,Allergan is buying a fat-freezing company for $2.5 billion,2017-02-13 13:12:57 +0000,http://finance.yahoo.com/news/allergan-buying-fat-freezing-company-131257389.html,Allergan is buying a fat-freezing company for $2.5 billion
AGN,AGN:US,BBG000FH8PX5,Allergan agrees to buy Zeltiq for about $2.48 bln,2017-02-13 13:08:29 +0000,http://finance.yahoo.com/news/allergan-agrees-buy-zeltiq-2-130829971.html,Allergan agrees to buy Zeltiq for about $2.48 bln
AGN,AGN:US,BBG000FH8PX5,"Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion",2017-02-13 13:00:00 +0000,http://finance.yahoo.com/news/allergan-acquire-zeltiq-best-class-130000562.html,"[PR Newswire] - DUBLIN and PLEASANTON, Calif., Feb. 13, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, and ZELTIQ® Aesthetics, Inc. (ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary adjustments. The acquisition of ZELTIQ is immediately accretive and enhances Allergan's global medical aesthetics portfolio with the addition of ZELTIQ's flagship CoolSculpting® System, the sales leader in the fast-growing cash pay body contouring segment of medical aesthetics."
AGN,AGN:US,BBG000FH8PX5,Teva Pharma quarterly profit and revenue beat expectations,2017-02-13 12:54:01 +0000,http://sg.finance.yahoo.com/news/teva-pharma-fourth-quarter-profit-121328169.html,Teva Pharma quarterly profit and revenue beat expectations
AGN,AGN:US,BBG000FH8PX5,"Early movers: AAPL, DD, TEVA, QSR, FDC, HAS, JCP & more",2017-02-13 12:45:04 +0000,http://www.cnbc.com/id/104278275?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104278275,"Early movers: AAPL, DD, TEVA, QSR, FDC, HAS, JCP & more"
AGN,AGN:US,BBG000FH8PX5,[$$] SEC Letter to Allergan Hints at Additional non-GAAP Guidance,2017-02-13 10:00:06 +0000,https://www.wsj.com/articles/sec-letter-to-allergan-hints-at-additional-non-gaap-guidance-1486980000?mod=yahoo_hs,[$$] SEC Letter to Allergan Hints at Additional non-GAAP Guidance
AGN,AGN:US,BBG000FH8PX5,Allergan To Acquire ZELTIQ For $2.475 Bln - Quick Facts,2017-02-13 08:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFsnxQJrExs/allergan-to-acquire-zeltiq-for-2475-bln--quick-facts-20170213-00510,Allergan To Acquire ZELTIQ For $2.475 Bln - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Drugmaker Stada confirms takeover bid from two companies,2017-02-12 21:57:53 +0000,http://uk.finance.yahoo.com/news/drugmaker-stada-confirms-takeover-bid-215753072.html,Drugmaker Stada confirms takeover bid from two companies
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?,2017-02-11 00:17:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RrWtt2xIKGc/teva-pharmaceutical-industries-ltd-adr-teva-stock-will-the-slump-end-cm746621,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Value investors are familiar with pain They endure pain when the stock hits a low then falls some more The markets are hammering 160 Teva Pharmaceutical Industries Ltd ADR NYSE TEVA because it
AGN,AGN:US,BBG000FH8PX5,Cramer's Exec Cut: Why GE isn’t worried about Trump’s tra...,2017-02-11 00:11:00 +0000,http://finance.yahoo.com/video/cramers-exec-cut-why-ge-001100220.html,Cramer's Exec Cut: Why GE isn’t worried about Trump’s tra...
AGN,AGN:US,BBG000FH8PX5,Cramer: Why Are People Dumping Such Good Stocks?,2017-02-11 00:01:00 +0000,http://realmoney.thestreet.com/articles/02/10/2017/cramer-why-are-people-dumping-such-good-stocks?puc=yahoo&cm_ven=YAHOO,Cramer: Why Are People Dumping Such Good Stocks?
AGN,AGN:US,BBG000FH8PX5,"Dan Loeb took new stakes in J.P. Morgan, B. of A. and dumped Allergan",2017-02-10 22:02:47 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E27170B0-1499-4DBC-8710-3801270AB3F9&siteid=yhoof2,"Dan Loeb took new stakes in J.P. Morgan, B. of A. and dumped Allergan"
AGN,AGN:US,BBG000FH8PX5,Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split,2017-02-10 17:16:38 +0000,http://www.investors.com/news/technology/intercept-bounds-to-3-month-high-on-nash-trial-edits-analysts-split/,Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc :AGN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017",2017-02-10 17:02:23 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-agn-us-earnings-analysis-2016-by-the-numbers-february-10-2017/,"Allergan Plc :AGN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017"
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi",2017-02-10 14:20:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UTFQRQy9O5I/pharma-stock-roundup-allergan-gsk-top-4q-earnings-praluent-breather-for-sanofi-cm746062,Major pharma companies like Allergan AGN and GlaxoSmithKline GSK reported better than expected fourth quarter results this week Meanwhile French pharma giant Sanofi SNY got a breather in the PCSK9 inhibitor patent infringement lawsuit with a court allowing the company to continue selling
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi",2017-02-10 11:44:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-allergan-gsk-114411776.html,"Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi"
AGN,AGN:US,BBG000FH8PX5,"Ex-Div Reminder for Allergan Mandatory Convertible Preferred Shares, Series A",2017-02-09 21:19:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Dn1iYVgpBo/ex-div-reminder-for-allergan-mandatory-convertible-preferred-shares-series-a-cm745820,On 2 13 17 Allergan PLC s 5 500 Mandatory Convertible Preferred Shares Series A Symbol AGN PRA will trade ex dividend for its quarterly dividend of 13 75 payable on 3 1 17 As a percentage of AGN PRA s recent share price of 868 94 this dividend works out to approximately 1 58 so
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at The Leerink Partners 6th Annual Global Healthcare Conference,2017-02-09 21:15:00 +0000,http://finance.yahoo.com/news/allergan-present-leerink-partners-6th-211500831.html,"[PR Newswire] - DUBLIN, Feb. 9, 2017 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that David Nicholson, Allergan's Chief R&D Officer will deliver a presentation at the Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15th, 2016 at 1:30 p.m. ET in New York, New York. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: http://wsw.com/webcast/leerink28/agn. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,Cramer: Here's the Reason for Allergan's Remarkable Run,2017-02-09 17:45:00 +0000,https://www.thestreet.com/story/13996883/1/cramer-here-s-the-reason-for-allergan-s-remarkable-run.html?puc=yahoo&cm_ven=YAHOO,Cramer: Here's the Reason for Allergan's Remarkable Run
AGN,AGN:US,BBG000FH8PX5,"Company News for February 09, 2017",2017-02-09 17:21:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q9WRmPO_kvQ/company-news-for-february-09-2017-cm745611,Shares of Allergan plc AGN increased 3 7 after posting fourth quarter earnings of 3 90 per share beating the Zacks Consensus Estimate of 3 79 Cognizant Technology Solutions Corporation s CTSH shares advanced 5 after reporting fourth quarter earnings of 0 87 per
AGN,AGN:US,BBG000FH8PX5,AASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan,2017-02-09 17:00:00 +0000,http://finance.yahoo.com/news/aasld-foundations-liver-disease-research-170000051.html,"[PR Newswire] - ALEXANDRIA, Va. and DUBLIN, Feb. 9, 2017 /PRNewswire/ -- The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest private supporter of hepatology research in the United States, today announced a significant donation from Allergan to support the AASLD Foundation's research and education initiatives. With this donation, Allergan joins the AASLD Foundation's Founder's Society, the premier donor recognition circle established to honor the generosity and commitment of companies who partner with AASLD Foundation to ensure more resources for liver disease research and advanced hepatology training. AASLD Foundation's Founder's Society companies have each made commitments of $2 million or more to support AASLD Foundation's mission to invest in innovative hepatology research and in the people who study and treat liver disease."
AGN,AGN:US,BBG000FH8PX5,"Company News for February 09, 2017",2017-02-09 15:10:03 +0000,http://finance.yahoo.com/news/company-news-february-09-2017-151003447.html,"Company News for February 09, 2017"
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc :AGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017",2017-02-09 14:40:53 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-agn-us-earnings-analysis-q4-2016-by-the-numbers-february-9-2017/,"Allergan Plc :AGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017"
AGN,AGN:US,BBG000FH8PX5,Today's Research Reports on Gilead Sciences and Allergan Post Earnings,2017-02-09 14:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-gilead-sciences-143000829.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 9, 2017 / U.S. markets tumbled out the gates Wednesday as falling yields pressured financial stocks lower. The Dow Jones Industrial Average hit a low of 20,015.33 before ..."
AGN,AGN:US,BBG000FH8PX5,Allergan: Cramer's Top Takeaways,2017-02-09 11:23:00 +0000,https://www.thestreet.com/story/13995497/1/allergan-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Allergan: Cramer's Top Takeaways
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: Why you would be an idiot to sell Disney,2017-02-09 00:34:01 +0000,http://www.cnbc.com/id/104269576?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104269576,Cramer Remix: Why you would be an idiot to sell Disney
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: The reason you would be an idiot to sell Di...,2017-02-09 00:18:00 +0000,http://finance.yahoo.com/video/cramer-remix-reason-idiot-sell-001800619.html,Cramer Remix: The reason you would be an idiot to sell Di...
AGN,AGN:US,BBG000FH8PX5,US STOCKS-S&P 500 ekes out gain while banks drag on Dow,2017-02-08 21:26:15 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-ekes-212615596.html,"[Reuters - UK Focus] - The S&P 500 ended slightly higher on Wednesday as investors digested mixed earnings reports, while the Dow Jones Industrial Average slipped as bank stocks weighed. The Nasdaq gained moderately to close at a record high for a second straight day, lifted by big tech names such as Facebook (Swiss: FB-USD.SW - news) and Apple (NasdaqGS: AAPL - news) ."
AGN,AGN:US,BBG000FH8PX5,"Allergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance",2017-02-08 21:21:27 +0000,http://www.investors.com/news/technology/allergan-leads-drug-stocks-on-view-crushing-q4-2016-2017-guidance/,"Allergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance"
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Wednesday Option Activity: GOOGL, NFLX, AGN",2017-02-08 21:19:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BySsJlk4VTU/noteworthy-wednesday-option-activity-googl-nflx-agn-cm745133,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Alphabet Inc Symbol GOOGL where a total of 24 217 contracts have traded so far representing approximately 2 4 million underlying shares That amounts to about 130 6 of GOOGL s
AGN,AGN:US,BBG000FH8PX5,What's Next For Allergan? How About More Acquisitions and a Dividend!,2017-02-08 21:01:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/08/whats-next-for-allergan-how-about-more-acquisitions-and-a-dividend/?mod=yahoobarrons&ru=yahoo,What's Next For Allergan? How About More Acquisitions and a Dividend!
AGN,AGN:US,BBG000FH8PX5,Allergan PLC (AGN) Launches Campaign To Fight Preventable Blindness In America,2017-02-08 20:17:47 +0000,http://www.insidermonkey.com/blog/allergan-plc-agn-launches-campaign-to-fight-preventable-blindness-in-america-535394/,Allergan PLC (AGN) Launches Campaign To Fight Preventable Blindness In America
AGN,AGN:US,BBG000FH8PX5,US STOCKS-S&P 500 inches up while banks drag on Dow,2017-02-08 20:10:07 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-inches-201007751.html,"[Reuters - UK Focus] - The S&P 500 edged higher on Wednesday as investors digested mixed earnings reports, while the Dow Jones Industrial Average moved lower as bank stocks weighed. Allergan shares rose 4.3 percent after the drugmaker's fourth-quarter profit and revenue topped estimates."
AGN,AGN:US,BBG000FH8PX5,Edited Transcript of AGN earnings conference call or presentation 8-Feb-17 1:30pm GMT,2017-02-08 20:09:06 +0000,http://finance.yahoo.com/news/edited-transcript-agn-earnings-conference-200906825.html,Edited Transcript of AGN earnings conference call or presentation 8-Feb-17 1:30pm GMT
AGN,AGN:US,BBG000FH8PX5,Allergan's Fourth-Quarter Comments Should Comfort Investors,2017-02-08 17:29:00 +0000,https://www.thestreet.com/story/13994397/1/why-allergan-s-fourth-quarter-comments-should-comfort-investors.html?puc=yahoo&cm_ven=YAHOO,Allergan's Fourth-Quarter Comments Should Comfort Investors
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat,2017-02-08 17:22:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a64GforZF5Y/allergan-agn-tops-q4-earnings-2017-sales-view-upbeat-cm744964,Allergan plc s AGN fourth quarter 2016 earnings came in at 3 90 per share beating the Zacks Consensus Estimate of 3 79 by 2 9 Earnings also soared 16 1 year over year and 17 5 sequentially on the back of strong revenues FindTheCompany Graphiq Revenues came in
AGN,AGN:US,BBG000FH8PX5,"Allergan says U.S. tax reform unlikely in 2017, sees strong year",2017-02-08 17:17:47 +0000,http://finance.yahoo.com/news/allergan-revenue-7-percent-botox-121749145.html,"Allergan says U.S. tax reform unlikely in 2017, sees strong year"
AGN,AGN:US,BBG000FH8PX5,Botox Smooths Out Allergan Top and Bottom Line,2017-02-08 16:39:00 +0000,http://www.investopedia.com/news/allergan-shares-gain-following-results-agn/?partner=YahooSA,Botox Smooths Out Allergan Top and Bottom Line
AGN,AGN:US,BBG000FH8PX5,"Stocks Turn Mixed as Oil Prices Rebound, Disney Jumps",2017-02-08 16:28:00 +0000,https://www.thestreet.com/story/13994548/1/stocks-trade-lower-as-falling-oil-prices-pressure-energy-shares.html?puc=yahoo&cm_ven=YAHOO,"Stocks Turn Mixed as Oil Prices Rebound, Disney Jumps"
AGN,AGN:US,BBG000FH8PX5,"[$$] Allergan Results Boosted by New, Established Drugs",2017-02-08 16:09:54 +0000,https://www.wsj.com/articles/allergan-results-boosted-by-new-established-drugs-1486567814?mod=yahoo_hs,"[$$] Allergan Results Boosted by New, Established Drugs"
AGN,AGN:US,BBG000FH8PX5,Allergan Tops Revenue Forecast -- Plus Jim Cramer's Comments,2017-02-08 15:39:00 +0000,https://www.thestreet.com/story/13994076/1/allergan-tops-fourth-quarter-revenue-forecast-sees-2017-sales-modestly-above-forecasts.html?puc=yahoo&cm_ven=YAHOO,Allergan Tops Revenue Forecast -- Plus Jim Cramer's Comments
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q4 Earnings & Sales; Shares Up,2017-02-08 15:21:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9a3LHi-D_jE/allergan-agn-beats-q4-earnings-sales-shares-up-cm744855,Dublin Ireland based Allergan plc AGN is engaged in the development manufacturing marketing sale and distribution of branded pharmaceuticals and select over the counter products Allergan has been actively pursuing deals to expand its portfolio especially its branded products offering
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat,2017-02-08 14:57:02 +0000,http://finance.yahoo.com/news/allergan-agn-tops-q4-earnings-145702292.html,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat
AGN,AGN:US,BBG000FH8PX5,Cramer's Stop Trading: AGN,2017-02-08 14:54:00 +0000,http://finance.yahoo.com/video/cramers-stop-trading-agn-145400124.html,Cramer's Stop Trading: AGN
AGN,AGN:US,BBG000FH8PX5,Stocks Turn Defensive As Supply Pressures Build on Energy Sector,2017-02-08 14:37:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zvna1CD3cr8/stocks-turn-defensive-as-supply-pressures-build-on-energy-sector-cm744759,Stocks were expected to open slightly lower on Wednesday as Wall Street keeps a cautious eye on the energy complex and remaining fourth quarter earnings for direction Stocks were expected to open slightly lower on Wednesday as Wall Street keeps a cautious eye on the energy complex and
AGN,AGN:US,BBG000FH8PX5,Market Recon: The Direction of Oil Has Been Somewhat Shocking,2017-02-08 14:12:00 +0000,https://www.thestreet.com/story/13994165/1/market-recon-the-real-range-bound-trade-has-been-oil.html?puc=yahoo&cm_ven=YAHOO,Market Recon: The Direction of Oil Has Been Somewhat Shocking
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Beats Q4 Earnings & Sales; Shares Up,2017-02-08 14:05:02 +0000,http://finance.yahoo.com/news/allergan-agn-beats-q4-earnings-140502196.html,Allergan (AGN) Beats Q4 Earnings & Sales; Shares Up
AGN,AGN:US,BBG000FH8PX5,Allergan plc Earnings Call scheduled for 8:30 am ET today,2017-02-08 13:30:00 +0000,http://biz.yahoo.com/cc/9/155019.html,Allergan plc Earnings Call scheduled for 8:30 am ET today
AGN,AGN:US,BBG000FH8PX5,"Allergan beats profit estimates, forecasts upbeat 2017",2017-02-08 12:58:22 +0000,http://finance.yahoo.com/news/allergan-beats-profit-estimates-forecasts-125822909.html,"Allergan beats profit estimates, forecasts upbeat 2017"
AGN,AGN:US,BBG000FH8PX5,"US futures point to muted open as traders eye earnings, oil",2017-02-08 12:53:41 +0000,http://www.cnbc.com/id/104268654?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104268654,"US futures point to muted open as traders eye earnings, oil"
AGN,AGN:US,BBG000FH8PX5,Allergan reports 4Q loss,2017-02-08 12:21:35 +0000,http://sg.finance.yahoo.com/news/allergan-reports-4q-loss-122135001.html,Allergan reports 4Q loss
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-08 12:16:37 +0000,http://biz.yahoo.com/e/170208/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
AGN,AGN:US,BBG000FH8PX5,Allergan revenue up 7 pct as Botox offsets drop in older drug sales,2017-02-08 12:14:58 +0000,http://finance.yahoo.com/news/allergan-revenue-7-pct-botox-121458647.html,Allergan revenue up 7 pct as Botox offsets drop in older drug sales
AGN,AGN:US,BBG000FH8PX5,Allergan's stock rallies after adjusted profit and sales beat expectations,2017-02-08 12:14:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F7890881-900A-4386-8C83-0DDE5580054F&siteid=yhoof2,Allergan's stock rallies after adjusted profit and sales beat expectations
AGN,AGN:US,BBG000FH8PX5,Q4 2016 Allergan plc Earnings Release - Before Market Open,2017-02-08 12:07:07 +0000,http://biz.yahoo.com/research/earncal/20170208.html?t=agn,Q4 2016 Allergan plc Earnings Release - Before Market Open
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016,2017-02-08 12:00:00 +0000,http://finance.yahoo.com/news/allergan-reports-strong-2016-finish-120000700.html,"[PR Newswire] - DUBLIN, Feb. 8, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its fourth quarter and full year 2016 continuing operations performance. Fourth Quarter and Full-Year 2016 Continuing Operations ..."
AGN,AGN:US,BBG000FH8PX5,"Earnings Reaction History: Allergan Inc, 62.5% Follow-Through Indicator, 2.5% Sensitive",2017-02-08 11:57:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6n-VmReW4wg/earnings-reaction-history-allergan-inc-625-follow-through-indicator-25-sensitive-cm744640,Expected Earnings Release 02 08 2017 PremarketExpected Earnings Release 02 08 2017 Premarket Avg Extended Hours Dollar Volume 20 183 484Avg Extended Hours Dollar Volume 20 183 484 Allergan Inc AGN is due to issue its quarterly earnings report in the upcoming extended hours
AGN,AGN:US,BBG000FH8PX5,"Driven by Botox, Allergan’s 2017 expected to be a standout",2017-02-08 10:21:49 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9782D332-EC79-11E6-B809-340265B14C97&siteid=yhoof2,"Driven by Botox, Allergan’s 2017 expected to be a standout"
AGN,AGN:US,BBG000FH8PX5,Allergan Q4 16 Earnings Conference Call At 8:30 AM ET,2017-02-08 07:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uiODYpsT5HY/allergan-q4-16-earnings-conference-call-at-830-am-et-20170208-00474,Allergan Q4 16 Earnings Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,"Pre-Market Earnings Report for February 8, 2017 :  AGN, TWX, EXC, CTSH, HUM, SNY, ALK, ITUB, GT, BR, VOYA, JEC",2017-02-07 21:17:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z94WwZ9yZRY/pre-market-earnings-report-for-february-8-2017-agn-twx-exc-ctsh-hum-sny-alk-itub-gt-br-voya-jec-cm744501,The following companies are expected to report earnings prior to market open on 02 08 2017 Visit our Earnings Calendar for a full list of expected earnings releases Allergan plc AGN is reporting for the quarter ending December 31 2016 The medical company
AGN,AGN:US,BBG000FH8PX5,5 Stocks to Watch that Report Earnings Tomorrow,2017-02-07 20:54:35 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-that-report-earnings-tomorrow-205442354.html,5 Stocks to Watch that Report Earnings Tomorrow
AGN,AGN:US,BBG000FH8PX5,Are Allergan Shares Making a 2016 Comeback?,2017-02-07 20:10:00 +0000,http://www.investopedia.com/news/previewing-agn-results-agn/?partner=YahooSA,Are Allergan Shares Making a 2016 Comeback?
AGN,AGN:US,BBG000FH8PX5,Allergan Followers Optimistic Ahead of Wednesday's Fourth-Quarter Report,2017-02-07 17:22:00 +0000,https://www.thestreet.com/story/13993072/1/allergan-followers-optimistic-ahead-of-wednesday-s-fourth-quarter-report.html?puc=yahoo&cm_ven=YAHOO,Allergan Followers Optimistic Ahead of Wednesday's Fourth-Quarter Report
AGN,AGN:US,BBG000FH8PX5,What to Expect From Major Companies Reporting Earnings on Wednesday,2017-02-07 16:50:59 +0000,http://finance.yahoo.com/news/expect-major-companies-reporting-earnings-165059762.html,What to Expect From Major Companies Reporting Earnings on Wednesday
AGN,AGN:US,BBG000FH8PX5,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More",2017-02-07 16:23:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPEt0dlJZec/drug-stock-q4-earnings-to-watch-on-feb-8-agn-gsk-more-cm744195,We are in the thick of the Q4 reporting cycle with quarterly numbers of several companies already on board Growth is likely to be the highest in two years Total earnings may even set a new quarterly record Approximately 275 S amp P 500 members representing 55 of the index s total
AGN,AGN:US,BBG000FH8PX5,[$$] Biotech chiefs from 160 groups attack Trump travel ban,2017-02-07 15:01:45 +0000,"http://www.ft.com/cms/s/13b62f88-ed3f-11e6-930f-061b01e23655,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Chief executives from more than 160 biotech companies have joined the growing chorus of business leaders criticising President Trump's immigration ban, writing an open letter to express their ""deep ..."
AGN,AGN:US,BBG000FH8PX5,Faber Report: Pharma fumbles,2017-02-07 14:43:00 +0000,http://finance.yahoo.com/video/faber-report-pharma-fumbles-144300386.html,Faber Report: Pharma fumbles
AGN,AGN:US,BBG000FH8PX5,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More",2017-02-07 14:06:02 +0000,http://finance.yahoo.com/news/drug-stock-q4-earnings-watch-140602999.html,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More"
AGN,AGN:US,BBG000FH8PX5,"Allergan Launches See America(SM), a Bold Initiative Furthering the Fight Against Preventable Blindness",2017-02-07 12:55:00 +0000,http://finance.yahoo.com/news/allergan-launches-see-america-sm-125500535.html,"[PR Newswire] - DUBLIN, Feb. 7, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a global leader in eye care for nearly 70 years, announces a bold commitment to fight preventable blindness in the United States with a new initiative—See America. Through See America, Allergan sets out to make vision health a priority for all Americans, increase awareness of the diseases that can cause preventable blindness and, critically, help improve access to vision care for those who need it most. The launch follows the release of a major report published in September 2016 by the National Academies of Sciences, Engineering, and Medicine (NASEM), declaring eye health a public health imperative."
AGN,AGN:US,BBG000FH8PX5,Allergan pledges to battle blindness with 'See America' initiative,2017-02-07 06:15:06 +0000,http://www.bizjournals.com/newyork/news/2017/02/07/allergan-pledges-to-battle-blindness-with-see.html?ana=yahoo,Allergan pledges to battle blindness with 'See America' initiative
AGN,AGN:US,BBG000FH8PX5,Thomson Reuters (TRI) Q4 Earnings: What Awaits the Stock?,2017-02-07 00:16:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dtjY5Pl13DQ/thomson-reuters-tri-q4-earnings-what-awaits-the-stock-cm743896,Thomson Reuters Corporation TRI is slated to report fourth quarter 2016 results before the market opens on Feb 9 In the previous quarter the company s earnings surpassed the Zacks Consensus Estimate by 6 cents Notably in the trailing four quarters the company surpassed the Zacks
AGN,AGN:US,BBG000FH8PX5,Bullish and Bearish Reversals for the Week,2017-02-06 17:00:00 +0000,http://realmoney.thestreet.com/articles/02/06/2017/bullish-and-bearish-reversals-week?puc=yahoo&cm_ven=YAHOO,Bullish and Bearish Reversals for the Week
AGN,AGN:US,BBG000FH8PX5,Why Earnings Season Could Be Great for Allergan (AGN),2017-02-06 16:22:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HJwp_56l8kI/why-earnings-season-could-be-great-for-allergan-agn-cm743614,Investors are always looking for stocks that are poised to beat at earnings season and Allergan plc AGN may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Allergan is seeing favorable earnings
AGN,AGN:US,BBG000FH8PX5,Why Earnings Season Could Be Great for Allergan (AGN),2017-02-06 13:48:01 +0000,http://finance.yahoo.com/news/why-earnings-season-could-great-134801398.html,Why Earnings Season Could Be Great for Allergan (AGN)
AGN,AGN:US,BBG000FH8PX5,"California Sues Teva, Allergan for Allegedly Blocking Generic Competition to Lidoderm",2017-02-04 02:32:00 +0000,https://www.thestreet.com/story/13990224/1/california-sues-teva-allergan-for-allegedly-blocking-generic-competition-to-lidoderm.html?puc=yahoo&cm_ven=YAHOO,"California Sues Teva, Allergan for Allegedly Blocking Generic Competition to Lidoderm"
AGN,AGN:US,BBG000FH8PX5,Cramer's game plan: Trump's CEO meeting shouldn't leave investors worried ahead of these earnings,2017-02-03 23:17:16 +0000,http://www.cnbc.com/id/104257976?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104257976,Cramer's game plan: Trump's CEO meeting shouldn't leave investors worried ahead of these earnings
AGN,AGN:US,BBG000FH8PX5,Health Care Sector Update for 02/03/2017: AGN,2017-02-03 15:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mqQwuLcgkhM/health-care-sector-update-for-02032017-agn-cm742834,Top Health care stocks Top Health care stocks JNJ 0 4 JNJ 0 4 PFE 1 0 PFE 1 0 ABT 0 2 ABT 0 2 MRK 0 02 MRK 0 02 AMGN 3 4 AMGN 3 4 Health care shares were mainly higher in pre market trade Friday Health care shares were mainly higher in pre market trade Friday
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling",2017-02-03 13:33:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3s3hs5m8cow/pharma-stock-roundup-pfizer-merck-lly-report-results-teva-hit-by-copaxone-ruling-cm742674,Major pharma companies like Pfizer PFE Merck MRK and Lilly LLY reported fourth quarter results this week Meanwhile Teva TEVA was hit by an unfavorable ruling in the Copaxone patent infringement lawsuit Recap of the Week s Most Important Stories A Look at Earnings
AGN,AGN:US,BBG000FH8PX5,Allergan Declares First Quarterly Cash Dividend of $0.70 Per Ordinary Share,2017-02-03 12:45:00 +0000,http://finance.yahoo.com/news/allergan-declares-first-quarterly-cash-124500808.html,"[PR Newswire] - DUBLIN, Feb. 3, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that its Board of Directors is proceeding with its previously announced cash dividend of $0.70 per ordinary share for the first quarter of 2017. ""Allergan's first dividend highlights our continued confidence in our long-term business strategy, profitability and strong cash flows, while reinforcing our commitment to maximizing shareholder returns. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,Allergan Provides Board and Annual Shareholder Meeting Updates,2017-02-03 12:30:00 +0000,http://finance.yahoo.com/news/allergan-provides-board-annual-shareholder-123000424.html,"[PR Newswire] - DUBLIN, Feb. 3, 2017 /PRNewswire/ -- Allergan plc (AGN) today provided an update on its Board of Directors and set the record date and the meeting date for its 2017 Annual General Meeting of Shareholders. Allergan's Board of Directors elected Adriane M. Brown as a new director. The Company had previously announced that Brown would join the Board beginning in February 2017."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Board Changes - Quick Facts,2017-02-03 07:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mN9C_YuJt08/allergan-announces-board-changes--quick-facts-20170203-00340,Allergan Announces Board Changes - Quick Facts
AGN,AGN:US,BBG000FH8PX5,The Trump Effect Sends Allergan's Shares Higher,2017-02-02 19:51:00 +0000,http://www.investopedia.com/news/allergan-shares-break-out-surge-higher-agn/?partner=YahooSA,The Trump Effect Sends Allergan's Shares Higher
AGN,AGN:US,BBG000FH8PX5,Sanofi Genzyme head weighs in on drug price debate,2017-02-02 18:00:08 +0000,http://www.bizjournals.com/boston/news/2017/02/02/sanofi-genzyme-head-weighs-in-on-drug-price-debate.html?ana=yahoo,Sanofi Genzyme head weighs in on drug price debate
AGN,AGN:US,BBG000FH8PX5,Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary,2017-02-02 17:45:29 +0000,http://finance.yahoo.com/news/daniel-loebs-third-point-hedge-171819691.html,Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary
AGN,AGN:US,BBG000FH8PX5,"Health Care Strengthened, Energy Sector Impacted the S&P 500",2017-02-02 13:40:10 +0000,http://marketrealist.com/2017/02/health-care-continues-strengthen-energy-sector-weighs-sp-500/?utm_source=yahoo&utm_medium=feed,"Health Care Strengthened, Energy Sector Impacted the S&P 500"
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Q4 Earnings: What's in Store for the Stock?,2017-02-02 13:34:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z0lNC851xb8/allergan-agn-q4-earnings-whats-in-store-for-the-stock-cm741983,Allergan plc AGN will be reporting fourth quarter 2016 earnings on Feb 8 before the market opens Last quarter the company delivered a negative earnings surprise of 7 00 Allergan s share price was up 9 1 this year so far while the Zacks classified Medical Generics Drug industry
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Q4 Earnings: What's in Store for the Stock?,2017-02-02 11:46:11 +0000,http://finance.yahoo.com/news/allergan-agn-q4-earnings-whats-114611154.html,Allergan (AGN) Q4 Earnings: What's in Store for the Stock?
AGN,AGN:US,BBG000FH8PX5,Why Synergy Pharmaceuticals Shares Fell 14.6% Today,2017-02-02 00:31:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hfE61LYRJJ4/why-synergy-pharmaceuticals-shares-fell-146-today-cm741916,IMAGE SOURCE GETTY IMAGES What happened Synergy Pharmaceuticals NASDAQ SGYP 160 announced a 125 million stock offering yesterday and shares slipped 14 6 today after the company announced it s pricing the offering at 6 15 per share So what
AGN,AGN:US,BBG000FH8PX5,Allergan Breaks Above 200-Day Moving Average - Bullish for AGN,2017-02-01 22:31:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7msXq6YqPbA/allergan-breaks-above-200-day-moving-average-bullish-for-agn-cm741850,In trading on Wednesday shares of Allergan PLC Symbol AGN crossed above their 200 day moving average of 225 79 changing hands as high as 227 69 per share Allergan PLC shares are currently trading up about 4 on the day The chart below shows the one year performance of AGN shares
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Outflows: IHE, AGN, MYL, ARIA",2017-02-01 17:32:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3dJXCrbde14/noteworthy-etf-outflows-ihe-agn-myl-aria-cm741641,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Pharmaceuticals ETF Symbol IHE where we have detected an approximate 21 3 million dollar outflow that s a 2 9 decrease week over week
AGN,AGN:US,BBG000FH8PX5,Drug Stocks Rally on Trump Meet with Pharma Bigwigs,2017-02-01 13:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QhqKQpny0z4/drug-stocks-rally-on-trump-meet-with-pharma-bigwigs-cm741361,Pharma and biotech shares rallied yesterday following a meeting between President Donald Trump and industry leaders including CEOs of companies like Merck amp Co Inc MRK Johnson amp Johnson JNJ Novartis AG NVS Celgene Corporation CELG Eli Lilly and Company LLY and Amgen
AGN,AGN:US,BBG000FH8PX5,Acelity Completes Sale of LifeCell to Allergan,2017-02-01 13:03:00 +0000,http://uk.finance.yahoo.com/news/acelity-completes-sale-lifecell-allergan-130300277.html,Acelity Completes Sale of LifeCell to Allergan
AGN,AGN:US,BBG000FH8PX5,Allergan Looks Poised to Rally More -- Plus Jim Cramer's View,2017-02-01 13:01:00 +0000,https://www.thestreet.com/story/13973931/1/allergan-looks-poised-to-rally-more-plus-jim-cramer-s-view.html?puc=yahoo&cm_ven=YAHOO,Allergan Looks Poised to Rally More -- Plus Jim Cramer's View
AGN,AGN:US,BBG000FH8PX5,Allergan Successfully Completes LifeCell Acquisition,2017-02-01 13:00:00 +0000,http://finance.yahoo.com/news/allergan-successfully-completes-lifecell-acquisition-130000868.html,"[PR Newswire] - DUBLIN, Feb. 1, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that it has successfully completed the acquisition of LifeCell Corporation, a ..."
AGN,AGN:US,BBG000FH8PX5,"Pfizer swings to 4Q profit after rough year, hikes 2017 view",2017-01-31 22:08:51 +0000,http://sg.finance.yahoo.com/news/pfizer-misses-4q-profit-forecasts-115244544.html,"Pfizer swings to 4Q profit after rough year, hikes 2017 view"
AGN,AGN:US,BBG000FH8PX5,"Blume Capital Management, Inc. Buys TEVA, KMI, VOD, Sells VCSH, PCLN, TWX",2017-01-31 20:31:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mz2D4VxBllw/blume-capital-management-inc-buys-teva-kmi-vod-sells-vcsh-pcln-twx-cm741121,Blume Capital Management Inc New Purchases TEVA SCHG WFCPRL SCHV SCHM PRF SCHA VO SPG ABT Added Positions KMI AGN CMCSA VOD DIS WFC IBB AR MMM EPD Reduced Positions VCSH PCLN TWX QCOM COST MSFT JNJ COF GOOG GILD
AGN,AGN:US,BBG000FH8PX5,Klain: Pharma will be net winner in exchange with Trump a...,2017-01-31 18:06:00 +0000,http://finance.yahoo.com/video/klain-pharma-net-winner-exchange-180600309.html,Klain: Pharma will be net winner in exchange with Trump a...
AGN,AGN:US,BBG000FH8PX5,All The Bad News For Teva (TEVA) Is Now Priced In,2017-01-31 18:05:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tiW11Y3LK00/all-the-bad-news-for-teva-teva-is-now-priced-in-cm741016,"Most of us have, at some time in our lives, experienced a sequence of events when it seems that nothing can go right. Bad news piles on bad news and we seem to go through a run of making bad decisions, albeit for all the right reasons.  Corporations, as Mitt Romney once famously reminded us, are people too, and it"
AGN,AGN:US,BBG000FH8PX5,Teva Is Losing Credibility,2017-01-31 16:48:46 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-31/teva-copaxone-patent-ruling-debt-situation-gets-scary?cmpid=yhoo.headline,Teva Is Losing Credibility
AGN,AGN:US,BBG000FH8PX5,"Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence",2017-01-31 14:45:00 +0000,https://www.thestreet.com/story/13970376/1/unlike-silicon-valley-biopharma-s-top-execs-react-to-trump-migration-ban-with-cowed-silence.html?puc=yahoo&cm_ven=YAHOO,"Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence"
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Avycaz Label to Include New Phase III Data,2017-01-31 14:36:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CZknADxbpIw/allergan-agn-avycaz-label-to-include-new-phase-iii-data-cm740656,Allergan plc AGN announced that its supplemental new drug application sNDA for antibiotic Avycaz ceftazidime and avibactam ex U S trade name Zavicefta has been approved by the FDA Allergan is looking to include new data from two phase III trials RECAPTURE and REPRISE in the drug
AGN,AGN:US,BBG000FH8PX5,Pfizer swings to a 4Q profit after rough year,2017-01-31 13:25:05 +0000,http://finance.yahoo.com/news/pfizer-misses-4q-profit-forecasts-115244063.html,Pfizer swings to a 4Q profit after rough year
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Avycaz Label to Include New Phase III Data,2017-01-31 12:15:12 +0000,http://finance.yahoo.com/news/allergan-agn-avycaz-label-phase-121512658.html,Allergan (AGN) Avycaz Label to Include New Phase III Data
AGN,AGN:US,BBG000FH8PX5,Amgen Wins Favorable CHMP Opinion for Humira Biosimilar,2017-01-30 14:35:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fEbG7xxDhU0/amgen-wins-favorable-chmp-opinion-for-humira-biosimilar-cm739985,Amgen Inc AMGN announced that the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP has rendered a positive opinion on the company s marketing authorization application MAA for ABP 501 a biosimilar version of AbbVie Inc s ABBV best selling drug
AGN,AGN:US,BBG000FH8PX5,Ironwood/Astellas Report Positive Phase III Data on Linzess,2017-01-30 14:35:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RuwpfeswvHQ/ironwoodastellas-report-positive-phase-iii-data-on-linzess-cm739983,Ironwood Pharmaceuticals Inc IRWD and partner Astellas Pharma Inc reported positive top line data from a phase III study on Linzess EU trade name Constella in adults with chronic constipation CC A look at Ironwood s share price movement over the past one year shows that the
AGN,AGN:US,BBG000FH8PX5,Trump travel ban stirs faint corporate outcry beyond Silicon Valley,2017-01-30 13:57:51 +0000,http://sg.finance.yahoo.com/news/trump-travel-ban-stirs-faint-070651355.html,Trump travel ban stirs faint corporate outcry beyond Silicon Valley
AGN,AGN:US,BBG000FH8PX5,"FDA Approves Allergan's sNDA for AVYCAZ® (ceftazidime and avibactam) to include new Phase III data in Patients with Complicated Urinary Tract Infections (cUTI), Including Pyelonephritis",2017-01-30 12:59:00 +0000,http://finance.yahoo.com/news/fda-approves-allergans-snda-avycaz-125900639.html,"[PR Newswire] - DUBLIN, Jan. 30, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental ..."
AGN,AGN:US,BBG000FH8PX5,Amgen Wins Favorable CHMP Opinion for Humira Biosimilar,2017-01-30 12:34:12 +0000,http://finance.yahoo.com/news/amgen-wins-favorable-chmp-opinion-123412462.html,Amgen Wins Favorable CHMP Opinion for Humira Biosimilar
AGN,AGN:US,BBG000FH8PX5,Allergan: FDA Approves SNDA For AVYCAZ To Include Phase III Data - Quick Facts,2017-01-30 08:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AScm0lbd1LU/allergan-fda-approves-snda-for-avycaz-to-include-phase-iii-data--quick-facts-20170130-00403,Allergan: FDA Approves SNDA For AVYCAZ To Include Phase III Data - Quick Facts
AGN,AGN:US,BBG000FH8PX5,"Allergan, Starbucks, Citigroup: Doug Kass' Views",2017-01-30 06:00:00 +0000,https://www.thestreet.com/story/13970375/1/allergan-starbucks-citigroup-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Allergan, Starbucks, Citigroup: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,Trump travel ban stirs faint corporate outcry beyond Silicon Valley,2017-01-30 05:35:42 +0000,http://sg.finance.yahoo.com/news/trump-travel-ban-stirs-faint-050456120.html,Trump travel ban stirs faint corporate outcry beyond Silicon Valley
AGN,AGN:US,BBG000FH8PX5,Trump travel ban stirs faint corporate outcry beyond Silicon Valley,2017-01-30 05:01:00 +0000,http://finance.yahoo.com/news/trump-travel-ban-stirs-faint-050100994.html,Trump travel ban stirs faint corporate outcry beyond Silicon Valley
AGN,AGN:US,BBG000FH8PX5,Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees,2017-01-29 23:43:00 +0000,https://www.thestreet.com/story/13964281/1/drugmakers-plan-big-deals-in-2017-and-banks-will-collect-big-fees.html?puc=yahoo&cm_ven=YAHOO,Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees
AGN,AGN:US,BBG000FH8PX5,Cramer's lightning round: A stock in the crosshairs of President Trump,2017-01-28 00:36:56 +0000,http://www.cnbc.com/id/104246141?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104246141,Cramer's lightning round: A stock in the crosshairs of President Trump
AGN,AGN:US,BBG000FH8PX5,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose,2017-01-27 16:36:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K3EBVP1WRgM/ironwood-allergan-linzess-gets-fda-approval-in-lower-dose-cm739395,Ironwood Pharmaceuticals Inc IRWD and partner Allergan plc AGN announced that the FDA has approved a lower dose strength of Linzess linaclotide 72 mcg for the treatment of adult patients with chronic idiopathic constipation CIC The lower dose is expected to be available in the U
AGN,AGN:US,BBG000FH8PX5,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose,2017-01-27 14:19:02 +0000,http://finance.yahoo.com/news/ironwood-allergan-linzess-gets-fda-141902446.html,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose
AGN,AGN:US,BBG000FH8PX5,5 Cheap Stocks to Buy From Merrill Lynch’s Focus List for a Very Expensive Market,2017-01-27 13:40:25 +0000,http://finance.yahoo.com/news/5-cheap-stocks-buy-merrill-134025199.html,5 Cheap Stocks to Buy From Merrill Lynch’s Focus List for a Very Expensive Market
AGN,AGN:US,BBG000FH8PX5,Weitz Funds Comments on Allergan,2017-01-26 22:06:00 +0000,http://finance.yahoo.com/news/weitz-funds-comments-allergan-220600199.html,Weitz Funds Comments on Allergan
AGN,AGN:US,BBG000FH8PX5,Weitz Investment Management's Value Fund 4th Quarter Commentary,2017-01-26 18:00:43 +0000,http://finance.yahoo.com/news/weitz-investment-managements-value-fund-180043415.html,[Gurufocus] - Review of quarter and holdings
AGN,AGN:US,BBG000FH8PX5,What to Expect from Eli Lilly’s Oncology Franchise in 4Q16,2017-01-26 15:36:17 +0000,http://marketrealist.com/2017/01/what-to-expect-from-eli-lillys-oncology-franchise-in-4q16/?utm_source=yahoo&utm_medium=feed,What to Expect from Eli Lilly’s Oncology Franchise in 4Q16
AGN,AGN:US,BBG000FH8PX5,U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation,2017-01-26 12:01:00 +0000,http://finance.yahoo.com/news/u-food-drug-administration-approves-120100169.html,"[PR Newswire] - CAMBRIDGE, Mass. and DUBLIN, Jan. 26, 2017 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. (IRWD) and Allergan plc (AGN) announced today that the U.S. Food and Drug Administration (FDA) has approved a 72 mcg dose of LINZESS® (linaclotide) for the treatment of chronic idiopathic constipation (CIC) in adult patients. The newly approved dose will provide physicians with dosing flexibility based on individual presentation or tolerability, in treating the large and heterogenous population of adult CIC patients. LINZESS is now FDA-approved in three dosage strengths: 290 mcg for adult patients with irritable bowel syndrome with constipation (IBS-C), and 145 mcg and a new 72 mcg for the treatment of adults with CIC."
AGN,AGN:US,BBG000FH8PX5,"Ironwood, Allergan: FDA Approves 72mcg Dose Of Linzess For Adult CIC Patients",2017-01-26 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H5gyNoqcC-Y/ironwood-allergan-fda-approves-72mcg-dose-of-linzess-for-adult-cic-patients-20170126-00653,"Ironwood, Allergan: FDA Approves 72mcg Dose Of Linzess For Adult CIC Patients"
AGN,AGN:US,BBG000FH8PX5,Biotech Stocks Facing FDA Decision In February,2017-01-26 04:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181,Biotech Stocks Facing FDA Decision In February
AGN,AGN:US,BBG000FH8PX5,Growing insurance consortium eyes industry-wide blockchain,2017-01-25 16:24:09 +0000,http://uk.finance.yahoo.com/news/growing-insurance-consortium-eyes-industry-162409100.html,"[Reuters - UK Focus] - A consortium set up to explore the use of blockchain technology in the insurance industry plans to announce several new members in the coming weeks, and by 2018 could create an organisation to manage contracts and claims, an executive involved told Reuters. Proponents of blockchain - the database technology that underpins bitcoin - believe it could transform the insurance industry through a shared, transparent record of information, allowing for data transfers in seconds and streamlining communications and transactions. The Blockchain Insurance Initiative (B3i) was created by the world's two largest reinsurers, Munich Re and Swiss Re along with insurers Aegon, Allianz and Zurich."
AGN,AGN:US,BBG000FH8PX5,Behind Amgen’s Plans to Expand in Neuroscience in 2017,2017-01-25 14:07:50 +0000,http://marketrealist.com/2017/01/amgen-plans-expand-presence-neuroscience-segment-2017/?utm_source=yahoo&utm_medium=feed,Behind Amgen’s Plans to Expand in Neuroscience in 2017
AGN,AGN:US,BBG000FH8PX5,Can Amgen’s Romosozumab Strengthen Its Bone Health in 2017?,2017-01-25 12:37:50 +0000,http://marketrealist.com/2017/01/romosozumab-expected-strengthen-amgens-bone-health-franchise-2017/?utm_source=yahoo&utm_medium=feed,Can Amgen’s Romosozumab Strengthen Its Bone Health in 2017?
AGN,AGN:US,BBG000FH8PX5,"After hours buzz: CREE, STX, AGN & more",2017-01-24 22:44:08 +0000,http://www.cnbc.com/id/104238232?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104238232,"[at CNBC] - Check out Tuesday's after hours buzz: CREE, STX, CXO & more"
AGN,AGN:US,BBG000FH8PX5,"IWV, MA, AGN, CL: ETF Outflow Alert",2017-01-24 17:32:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Q1ZsWk3hj4/iwv-ma-agn-cl-etf-outflow-alert-cm737412,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 3000 ETF Symbol IWV where we have detected an approximate 53 8 million dollar outflow that s a 0 7 decrease week over week from 53 350 000
AGN,AGN:US,BBG000FH8PX5,Theravance's Infection Drug Vibativ Positive in TOUR Study,2017-01-24 16:34:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uVToTbc8y3c/theravances-infection-drug-vibativ-positive-in-tour-study-cm737307,Theravance Biopharma Inc TBPH recently released positive interim data from the ongoing TOUR Telavancin Observational Use Registry study evaluating how Vibativ telavancin is used to treat patients with bacteremia or infective endocarditis IE We note that Vibativ is the only
AGN,AGN:US,BBG000FH8PX5,UPDATE 1-Synergy wins U.S. approval for constipation drug (Jan 19),2017-01-24 16:23:19 +0000,http://finance.yahoo.com/news/1-synergy-wins-u-approval-162319240.html,"[Reuters] - The U.S. Food and Drug Administration said on Thursday it had approved Synergy Pharmaceuticals Inc's drug to treat chronic idiopathic constipation (CIC). CIC, which affects 14 percent of the global population, is a type of gastrointestinal disorder where individuals have difficult and infrequent bowel movements. Trulance met the main goals of two late-stage studies in December on irritable bowel syndrome patients with constipation (IBS-C)."
AGN,AGN:US,BBG000FH8PX5,U.S. FTC reaches pay-for-delay settlement with Endo,2017-01-23 21:49:42 +0000,http://finance.yahoo.com/news/u-ftc-reaches-pay-delay-214942894.html,[Reuters] - Endo International Plc said on Monday it had reached a proposed settlement with U.S. anti-trust regulators under which it will not pay rivals to delay the introduction of generic competitors to its medications. The Federal Trade Commission had alleged Endo paid Impax Laboratories Inc to delay the introduction of a generic version of its painkiller Opana ER. The agency also alleged Endo paid Watson Laboratories Inc to delay introduction of a generic version of its Lidoderm pain treatment.
AGN,AGN:US,BBG000FH8PX5,"Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed",2017-01-23 21:27:03 +0000,http://www.investors.com/news/technology/endo-resolves-ftc-antitrust-suit-but-allergan-hanging-stocks-split/,"Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed"
AGN,AGN:US,BBG000FH8PX5,Allergan Stock is Still Struggling Amid FTC Ruling,2017-01-23 19:49:00 +0000,http://www.investopedia.com/news/pricing-continues-plague-allergan-agn-teva/?partner=YahooSA,Allergan Stock is Still Struggling Amid FTC Ruling
AGN,AGN:US,BBG000FH8PX5,"FTC settles pay-for-delay lawsuit, files two related complaints",2017-01-23 19:42:58 +0000,http://finance.yahoo.com/news/ftc-settles-pay-delay-lawsuit-194258547.html,"[Reuters] - The U.S. Federal Trade Commission said on Monday it had settled allegations that Endo Pharmaceuticals violated antitrust law when it agreed to pay rivals Watson Laboratories and Impax to delay introducing generic versions of two painkillers. The FTC filed charges against Watson, and Allergan Plc , accusing it of breaking the law by reaching an agreement with Endo to block a generic competitor for the local anesthetic Lidoderm. The FTC also filed an administrative complaint against Impax, saying it reached an illegal agreement with Endo in 2010 to prevent Impax from marketing a generic copy of Endo's painkiller Opana ER."
AGN,AGN:US,BBG000FH8PX5,The FTC is suing 2 drug companies for obstructing generic competition,2017-01-23 19:02:00 +0000,http://finance.yahoo.com/news/ftc-suing-2-drug-companies-190200555.html,The FTC is suing 2 drug companies for obstructing generic competition
AGN,AGN:US,BBG000FH8PX5,"Why Cynosure, Inc. Is Rising Today",2017-01-23 18:33:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kLxaZZV8JHI/why-cynosure-inc-is-rising-today-cm736863,Image source Getty Images What happened Shares of Cynosure NASDAQ CYNO a laser maker whose products are used in aesthetic and medical procedures rose by double digits in early morning trading on Monday in response to a report that suggests the company is looking
AGN,AGN:US,BBG000FH8PX5,"Why Cynosure, Inc. Is Rising Today",2017-01-23 16:59:28 +0000,http://www.fool.com/investing/2017/01/23/why-cynosure-is-rising-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Cynosure, Inc. Is Rising Today"
AGN,AGN:US,BBG000FH8PX5,Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open,2017-01-23 14:01:00 +0000,https://www.thestreet.com/story/13961840/1/laser-maker-cynosure-leads-biotech-movers-ahead-of-market-open.html?puc=yahoo&cm_ven=YAHOO,Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
AGN,AGN:US,BBG000FH8PX5,Allergan Continues Commitment to Future of Headache Medicine with Educational Grants for Young Neurologists and Research Scientists,2017-01-23 13:01:00 +0000,http://finance.yahoo.com/news/allergan-continues-commitment-future-headache-130100325.html,"[PR Newswire] - DUBLIN, Jan. 23, 2017 /PRNewswire/ -- Allergan plc, (AGN), a leading global pharmaceutical company, today announced its continued support of the International Headache Academy (IHA). Designed to inspire a long-term commitment to Headache Medicine in young neurologists and research scientists, IHA offers a three-day, intensive overview on research and treatment options. This is the fourth year that Allergan has been the sole sponsor since the inception of IHA in North America in 2013, and iHEAD in Europe in 2014."
AGN,AGN:US,BBG000FH8PX5,"Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See Red Flags",2017-01-23 11:00:00 +0000,https://www.thestreet.com/story/13960573/1/biotech-school-when-cellceutix-ceo-rants-about-criminal-short-smart-investors-see-red-flags.html?puc=yahoo&cm_ven=YAHOO,"Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See Red Flags"
AGN,AGN:US,BBG000FH8PX5,How Will Pfizer Inc. Fare Under President Trump?,2017-01-21 18:37:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PmaqHXlKRWo/how-will-pfizer-inc-fare-under-president-trump-cm736369,President Trump could shake up the pharmaceutical world If he delivers on his promises it means that Pfizer NYSE PFE one of the biggest of the big pharma companies is in for some significant changes How might Pfizer fare in a Trump Administration
AGN,AGN:US,BBG000FH8PX5,Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?,2017-01-20 21:37:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/su_u7lvh8KE/novartis-nvs-q4-earnings-stock-likely-to-disappoint-cm736208,Swiss pharmaceutical company Novartis AG NVS is scheduled to report fourth quarter and full year 2016 results on Jan 25 A look at Novartis share price movement in the last 12 months shows that the stock has underperformed the Zacks classified Large Cap
AGN,AGN:US,BBG000FH8PX5,Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?,2017-01-20 19:52:07 +0000,http://finance.yahoo.com/news/novartis-nvs-q4-earnings-stock-195207259.html,Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
AGN,AGN:US,BBG000FH8PX5,Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon,2017-01-20 16:53:00 +0000,https://www.thestreet.com/story/13960735/1/jim-cramer-is-not-a-fan-of-retail-in-the-age-of-amazon.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon
AGN,AGN:US,BBG000FH8PX5,Synergy Pharmaceuticals Secures Approval for Linzess Competitor,2017-01-20 15:37:00 +0000,https://www.thestreet.com/story/13960531/1/synergy-pharmaceuticals-secures-approval-for-linzess-competitor.html?puc=yahoo&cm_ven=YAHOO,Synergy Pharmaceuticals Secures Approval for Linzess Competitor
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.,2017-01-20 14:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3JPA-JFTW8A/allergan-agn-rhofade-cream-for-rosacea-approved-in-us-cm735952,Allergan plc AGN announced that the FDA has approved Rhofade oxymetazoline hydrochloride cream for topical treatment of persistent facial erythema redness associated with rosacea in adults Rhofade will be available commercially from May 2017 in the U S Allergan claims that Rhofade
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.,2017-01-20 13:17:01 +0000,http://finance.yahoo.com/news/allergan-agn-rhofade-cream-rosacea-131701258.html,Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
AGN,AGN:US,BBG000FH8PX5,"ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC",2017-01-20 02:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5V4t5bWZVv0/admp-waiting-to-see-if-3rd-time-is-charm-fda-nod-for-sgyp-be-all-ears-for-otic-20170120-00071,"ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC"
AGN,AGN:US,BBG000FH8PX5,Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico,2017-01-19 16:55:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ItIOBKL1xCs/apricus-apri-stock-gains-on-vitaros-approval-in-mexico-cm735441,Shares of Apricus Biosciences Inc APRI surged almost 90 after the company announced that its topical cream Vitaros was approved in Mexico for the treatment of patients with erectile dysfunction However a look at Apricus price movement in the past one year shows that the company
AGN,AGN:US,BBG000FH8PX5,Should Value Investors Choose Allergan (AGN)?,2017-01-19 16:49:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iyppgFKx_mk/should-value-investors-choose-allergan-agn-cm735415,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
AGN,AGN:US,BBG000FH8PX5,Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?,2017-01-19 15:42:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FBxpCbvYNfY/vertex-pharma-vrtx-q4-earnings-stock-likely-to-beat-cm735337,We expect biotech company Vertex Pharmaceuticals Inc VRTX to beat expectations when it reports fourth quarter 2016 and full year earnings results on Jan 25 after the market closes Vertex s share price lost 14 9 in the past one year comparing unfavorably with the 12 9 decline
AGN,AGN:US,BBG000FH8PX5,Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?,2017-01-19 15:41:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-IICdyRleIM/biogen-biib-q4-earnings-whats-in-store-for-the-stock-cm735329,Biogen Inc BIIB a well known name in the multiple sclerosis MS market will be reporting fourth quarter 2016 and full year earnings on Jan 26 before the market opens Last quarter the company delivered a positive earnings surprise of 4 01 Biogen s shares rose 5 3 in the past one
AGN,AGN:US,BBG000FH8PX5,Bull-Bear Battle Coming to a Head for Allergan,2017-01-19 14:35:00 +0000,http://www.investopedia.com/news/fda-approves-allergan-rosacea-drug-agn/?partner=YahooSA,Bull-Bear Battle Coming to a Head for Allergan
AGN,AGN:US,BBG000FH8PX5,Should Value Investors Choose Allergan (AGN)?,2017-01-19 14:30:02 +0000,http://finance.yahoo.com/news/value-investors-choose-allergan-agn-143002694.html,Should Value Investors Choose Allergan (AGN)?
AGN,AGN:US,BBG000FH8PX5,Allergan says the FDA has approved its cream for facial redness,2017-01-19 13:07:26 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B434D6D2-60B8-4B1F-B56A-79E7C2EBC298&siteid=yhoof2,Allergan says the FDA has approved its cream for facial redness
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults",2017-01-19 12:59:00 +0000,http://finance.yahoo.com/news/allergan-announces-fda-approval-rhofade-125900548.html,"[PR Newswire] - DUBLIN, Jan. 19, 2017 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today the approval of RHOFADE™ cream by the U.S. Food and Drug Administration (FDA) for ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces FDA Approval Of RHOFADE Cream,2017-01-19 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LBb7MQiaHpg/allergan-announces-fda-approval-of-rhofade-cream-20170119-00580,Allergan Announces FDA Approval Of RHOFADE Cream
AGN,AGN:US,BBG000FH8PX5,"DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA",2017-01-19 03:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MGyqv56qtxs/derm-delights-with-a-hattrick-shot-in-the-arm-for-apri-fda-nod-for-teva-20170119-00163,"DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA"
AGN,AGN:US,BBG000FH8PX5,Allergan's Uterine Fibroids Candidate Positive in Phase III,2017-01-18 23:37:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WPeqP17ncI/allergans-uterine-fibroids-candidate-positive-in-phase-iii-cm735124,Allergan Plc AGN and European specialty pharma company Gedeon Richter reported encouraging results from a phase III study on their pipeline candidate ulipristal acetate a selective progesterone receptor modulator SPRM in women with abnormal bleeding due to uterine fibroids 160 Venus
AGN,AGN:US,BBG000FH8PX5,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids,2017-01-18 21:27:43 +0000,http://blogs.wsj.com/moneybeat/2017/01/18/dealpolitik-sec-tilts-playing-field-against-targets-of-hostile-bids/?mod=yahoo_hs,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids
AGN,AGN:US,BBG000FH8PX5,Allergan's Uterine Fibroids Candidate Positive in Phase III,2017-01-18 21:22:09 +0000,http://finance.yahoo.com/news/allergans-uterine-fibroids-candidate-positive-212209474.html,Allergan's Uterine Fibroids Candidate Positive in Phase III
AGN,AGN:US,BBG000FH8PX5,"Aviance Capital Partners, LLC Buys Exxon Mobil Corp, iShares Intermediate Credit Bond, Equifax ...",2017-01-18 15:36:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/11LN5R2qTLk/aviance-capital-partners-llc-buys-exxon-mobil-corp-ishares-intermediate-credit-bond-equifax-cm734781,Aviance Capital Partners LLC New Purchases CSJ APC CSCO JLL RHI BAC PDCO CAH NDAQ WWW Added Positions XOM CIU EFX MUB LOW SCHW JMF STZ MTH PSEC Reduced Positions CI AGG GILD NKE BABA PFE JAZZ CELG TMO AGN Sold Out MGM
AGN,AGN:US,BBG000FH8PX5,"Intermede Investment Partners Ltd Buys Wells Fargo & Co, Facebook Inc, Amgen Inc, Sells B/E ...",2017-01-18 13:36:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-EqLogSxzzU/intermede-investment-partners-ltd-buys-wells-fargo-co-facebook-inc-amgen-inc-sells-be-cm734604,Intermede Investment Partners Ltd New Purchases WFC FB Added Positions AMGN AGN TSM ALLE Reduced Positions BEAV VWR HDS GOOG DLTR ANSS BIIB CMCSA MA BABA Sold Out CMG New Purchases WFC FB New Purchases WFC
AGN,AGN:US,BBG000FH8PX5,"Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions",2017-01-18 12:25:00 +0000,https://www.thestreet.com/story/13954895/1/allergan-rebounding-with-strong-product-pipeline-smart-acquisitions.html?puc=yahoo&cm_ven=YAHOO,"Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions"
AGN,AGN:US,BBG000FH8PX5,PRESS DIGEST- Wall Street Journal - Jan 18,2017-01-18 05:30:22 +0000,http://finance.yahoo.com/news/press-digest-wall-street-journal-053022976.html,[Reuters] - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - President Barack Obama shortened Chelsea Manning's 35-year ...
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan Admits to Disclosure Violations During Valeant Bid,2017-01-17 22:49:55 +0000,http://www.wsj.com/articles/allergan-admits-to-disclosure-violations-during-valeant-bid-1484693391?mod=yahoo_hs,[$$] Allergan Admits to Disclosure Violations During Valeant Bid
AGN,AGN:US,BBG000FH8PX5,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks,2017-01-17 21:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uamSiJLhw6E/allergan-to-pay-15-mln-fine-for-disclosure-failures-during-merger-talks-20170117-01757,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks
AGN,AGN:US,BBG000FH8PX5,5 Trump-Proof Pharma Dividend Stocks to Buy,2017-01-17 16:38:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C0k6xbz5rvs/5-trump-proof-pharma-dividend-stocks-to-buy-cm734299,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Donald Trump needed just 20 minutes to knock 24 6 billion in value from the nine biggest Big Pharma companies That was the statistic bandied about recently when the president elect at
AGN,AGN:US,BBG000FH8PX5,AGN Falls Despite Positive Trial Results,2017-01-17 15:33:00 +0000,http://www.investopedia.com/news/allergan-solid-trial-results-stock-down-agn/?partner=YahooSA,AGN Falls Despite Positive Trial Results
AGN,AGN:US,BBG000FH8PX5,Wall Street To Start On Nervous Note,2017-01-17 07:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kxd_vLY1I1w/wall-street-to-start-on-nervous-note-20170117-00377,Wall Street To Start On Nervous Note
AGN,AGN:US,BBG000FH8PX5,Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids,2017-01-17 07:01:00 +0000,http://finance.yahoo.com/news/allergan-gedeon-richter-announce-positive-070100970.html,"[PR Newswire] - DUBLIN and BUDAPEST, Hungary, Jan. 17, 2017 /PRNewswire/ -- Allergan Plc (AGN) and Gedeon Richter Plc. today announced positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women with abnormal bleeding due to uterine fibroids. A new drug application filing for ulipristal acetate is planned for the second half of 2017. ""We are pleased with the favorable results of Venus II supporting the efficacy and safety profile of ulipristal acetate as shown in our Venus I trial,"" said David Nicholson, Chief Research and Development Officer, Allergan."
AGN,AGN:US,BBG000FH8PX5,"Allergan, Schlumberger, IBM: Doug Kass' Views",2017-01-16 06:00:00 +0000,https://www.thestreet.com/story/13954487/1/allergan-schlumberger-ibm-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Allergan, Schlumberger, IBM: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,Jobless Claims and Trimming GLD: Best of Kass,2017-01-14 10:59:00 +0000,https://www.thestreet.com/story/13954218/1/jobless-claims-and-trimming-gld-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Jobless Claims and Trimming GLD: Best of Kass
AGN,AGN:US,BBG000FH8PX5,Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit,2017-01-13 14:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VzUn73dxtJE/lilly-wins-appeal-against-teva-in-alimta-patent-lawsuit-cm733160,Eli Lilly and Company LLY announced that it has received a favorable ruling in a lawsuit against generic drugmaker Teva Pharmaceutical Industries Limited TEVA related to the infringement of a vitamin regimen patent for its cancer drug Alimta by the U S Court of Appeals for the Federal
AGN,AGN:US,BBG000FH8PX5,Pharma company executives debate drug pricing increases,2017-01-12 19:45:48 +0000,http://finance.yahoo.com/news/pharma-company-executives-debate-drug-194548006.html,Pharma company executives debate drug pricing increases
AGN,AGN:US,BBG000FH8PX5,Lawsuit accuses Shire of monopolizing market for ADHD drug,2017-01-12 19:00:08 +0000,http://www.bizjournals.com/boston/news/2017/01/12/lawsuit-accuses-shire-of-monopolizing-market-for.html?ana=yahoo,Lawsuit accuses Shire of monopolizing market for ADHD drug
AGN,AGN:US,BBG000FH8PX5,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again,2017-01-12 13:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zeRYgq2tqVE/deja-vu-for-drug-stocks-as-trump-slams-drug-pricing-again-cm732558,It was déjà vu for the healthcare sector with pharma and biotech stocks once again being hit by President elect Donald Trump s comments regarding drug pricing Although drug stocks had rallied following Trump s surprise win in November reflecting relief that the price controls that Hillary
AGN,AGN:US,BBG000FH8PX5,Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast,2017-01-12 13:00:00 +0000,http://finance.yahoo.com/news/allergan-report-fourth-quarter-full-130000397.html,"[PR Newswire] - DUBLIN, Jan. 12, 2017 /PRNewswire/ -- Allergan plc (AGN) today announced that it intends to release fourth quarter and full year 2016 financial results on Wednesday, February 8, 2017, prior to the open of U.S. financial markets. The Company will also provide revenue and certain additional financial metrics guidance for full year 2017. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time on Wednesday, February 8, 2017 to discuss its financial results."
AGN,AGN:US,BBG000FH8PX5,Cramer: Trump Doesn't Seem to Care About the Trump Rally,2017-01-12 00:01:00 +0000,http://realmoney.thestreet.com/articles/01/11/2017/cramer-trump-doesnt-seem-care-about-trump-rally?puc=yahoo&cm_ven=YAHOO,Cramer: Trump Doesn't Seem to Care About the Trump Rally
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Wednesday Option Activity: AGN, SWKS, WBA",2017-01-11 21:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nqemoY-mZkA/noteworthy-wednesday-option-activity-agn-swks-wba-cm732437,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Allergan PLC Symbol AGN where a total volume of 19 856 contracts has been traded thus far today a contract volume which is representative of approximately 2 0
AGN,AGN:US,BBG000FH8PX5,Correction: Drug Prices-Johnson & Johnson story,2017-01-11 21:16:35 +0000,http://sg.finance.yahoo.com/news/johnson-johnson-reveal-average-drug-180849527.html,Correction: Drug Prices-Johnson & Johnson story
AGN,AGN:US,BBG000FH8PX5,Trump's Comments Are Big Pharma's Nightmare,2017-01-11 18:26:00 +0000,http://www.forbes.com/sites/matthewherper/2017/01/11/trumps-comments-are-big-pharmas-nightmare/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Trump's Comments Are Big Pharma's Nightmare
AGN,AGN:US,BBG000FH8PX5,Stocks Recover But Pharma Still Down After Trump's Threats,2017-01-11 17:31:00 +0000,http://www.forbes.com/sites/jaysomaney/2017/01/11/trump-says-pharma-getting-away-with-murder-stocks-take-a-hit/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Stocks Recover But Pharma Still Down After Trump's Threats
AGN,AGN:US,BBG000FH8PX5,"Berson & Corrado Investment Advisors, LLC Buys Communications Sales & Leasing Inc, ...",2017-01-11 14:50:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QfoGe3xibc4/berson-corrado-investment-advisors-llc-buys-communications-sales-leasing-inc-cm732084,Berson Corrado Investment Advisors LLC New Purchases MIC CBS FLY NEE CTL GAIN HEDJ HMLP KNOP HSY Added Positions CSAL T PBI TGP TOO BAC AGN CLMT SPY EFA Reduced Positions SCHX XLK TNK STWD GILD BA SGEN GLW AMBC NEWM
AGN,AGN:US,BBG000FH8PX5,Allergan Shifts Strategy to Focus on Growth,2017-01-11 13:36:00 +0000,http://www.thestreet.com/video/13950090/allergan-shifts-strategy-to-focus-on-growth.html?puc=yahoov&cm_ven=YAHOOV,Allergan Shifts Strategy to Focus on Growth
AGN,AGN:US,BBG000FH8PX5,Allergan Hints It Is Ready to Make a Splash for More Near-term Growth,2017-01-11 01:01:00 +0000,https://www.thestreet.com/story/13947754/1/allergan-to-veer-toward-accretive-m-amp-a.html?puc=yahoo&cm_ven=YAHOO,Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
AGN,AGN:US,BBG000FH8PX5,Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation,2017-01-10 21:51:30 +0000,http://www.investors.com/news/technology/celgene-ceo-drug-pricing-debate-hinges-on-incentives-for-innovation/,Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
AGN,AGN:US,BBG000FH8PX5,5 Manufacturing Stocks With 25% Upside Potential,2017-01-10 21:06:04 +0000,http://finance.yahoo.com/news/5-manufacturing-stocks-25-upside-210604017.html,5 Manufacturing Stocks With 25% Upside Potential
AGN,AGN:US,BBG000FH8PX5,Todd Hagopian's Top Biotech Takeover Targets For 2017,2017-01-10 17:59:00 +0000,http://www.forbes.com/sites/kenkam/2017/01/10/todd-hagopians-top-biotech-takeover-targets-for-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Todd Hagopian's Top Biotech Takeover Targets For 2017
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: Seeing constructive movement by entire indu...,2017-01-10 17:45:00 +0000,http://finance.yahoo.com/video/allergan-ceo-seeing-constructive-movement-174500878.html,Allergan CEO: Seeing constructive movement by entire indu...
AGN,AGN:US,BBG000FH8PX5,"Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes",2017-01-10 15:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VLhdzyt46RY/biotech-resolutions-more-innovation-better-execution-and-fewer-price-hikes-cm731583,Pushback on pricing and high profile pipeline disappointments last year means that battered biopharma companies have a lot of work to do to restore investors confidence in 2017 In 2016 the Nasdaq Biotechnology ETF tumbled 21 following revelations of sky high drug price
AGN,AGN:US,BBG000FH8PX5,"Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes",2017-01-10 14:09:11 +0000,http://www.fool.com/investing/2017/01/10/biotech-resolutions-more-innovation-better-executi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes"
AGN,AGN:US,BBG000FH8PX5,AGN Makes Two Small Deals,2017-01-09 20:47:00 +0000,http://www.investopedia.com/news/agn-stock-preparing-battle-agn/?partner=YahooSA,AGN Makes Two Small Deals
AGN,AGN:US,BBG000FH8PX5,Allergan wants to buy a Cambridge biotech founded by ex-Genzyme CEO,2017-01-09 20:05:06 +0000,http://www.bizjournals.com/boston/news/2017/01/09/allergan-wants-to-buy-a-cambridge-biotech-founded.html?ana=yahoo,Allergan wants to buy a Cambridge biotech founded by ex-Genzyme CEO
AGN,AGN:US,BBG000FH8PX5,[video]Allergan Continues Down 'Stepping Stone' Path With Two Deals,2017-01-09 16:13:00 +0000,https://www.thestreet.com/story/13946937/1/allergan-continues-down-quot-stepping-stone-quot-path-with-two-deals.html?puc=yahoo&cm_ven=YAHOO,[video]Allergan Continues Down 'Stepping Stone' Path With Two Deals
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At J.P. Morgan Conference;	Webcast At 6:00 PM ET,2017-01-09 15:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XuytuMq3C6U/allergan-to-present-at-jp-morgan-conferencewebcast-at-600-pm-et-20170109-00877,Allergan To Present At J.P. Morgan Conference;	Webcast At 6:00 PM ET
AGN,AGN:US,BBG000FH8PX5,Teva Falls on Disappointing 2017 Sales & Earnings Guidance,2017-01-09 14:53:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3B3GGPYOZl4/teva-falls-on-disappointing-2017-sales-earnings-guidance-cm730924,Teva Pharmaceutical Industries Ltd TEVA provided a weaker than expected sales and earnings guidance for 2017 seeing that its blockbuster multiple sclerosis drug Copaxone is reeling under competitive pressures Following the announcement shares of the Israeli generic pharmaceuticals
AGN,AGN:US,BBG000FH8PX5,Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit,2017-01-09 14:52:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pp9f7lZbji0/impax-ipxl-applies-for-generic-aubagio-sanofi-files-lawsuit-cm730897,Impax Laboratories Inc IPXL announced that it has filed an Abbreviated New Drug application ANDA with the FDA for a generic version of Sanofi s Aubagio teriflunomide tablets 14 mg Aubagio has been approved for the treatment of relapsing forms of multiple sclerosis MS Impax s
AGN,AGN:US,BBG000FH8PX5,Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds,2017-01-09 13:30:00 +0000,http://finance.yahoo.com/news/allergan-enters-parkinsons-disease-option-133000332.html,"[PR Newswire] - DUBLIN and CAMBRIDGE, Mass., Jan. 9, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and Lysosomal Therapeutics (LTI) today announced that Allergan has purchased an exclusive option right to acquire LTI. LTI is focused on innovative small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. LTI-291, LTI's lead program, aims to stimulate the activity of glucocerebrosidase (GCase) in the brain. Importantly, approximately 5 to 10 percent of patients with Parkinson's disease (PD) have mutations of the GBA1 gene,[i] and it is well documented that these patients have a more rapid progression of Parkinson's disease."
AGN,AGN:US,BBG000FH8PX5,Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs,2017-01-09 13:00:00 +0000,http://finance.yahoo.com/news/allergan-enters-licensing-agreement-assembly-130000565.html,"[GlobeNewswire] - --Expands Allergan’ s Innovative GI Pipeline with ABI-M201 and ABI-M301, Preclinical Compounds Targeting Ulcerative Colitis and Crohn’ s Disease, as well as Future Compounds for Irritable Bowel Syndrome--. ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Purchases Option Right To Acquire Lysosomal Therapeutics - Quick Facts,2017-01-09 08:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6IbH8AYGOao/allergan-purchases-option-right-to-acquire-lysosomal-therapeutics--quick-facts-20170109-00525,Allergan Purchases Option Right To Acquire Lysosomal Therapeutics - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Futures Pointing To Mixed Open On Wall Street - U.S. Commentary,2017-01-09 08:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zV3WwJU8-j4/futures-pointing-to-mixed-open-on-wall-street--us-commentary-20170109-00526,Futures Pointing To Mixed Open On Wall Street - U.S. Commentary
AGN,AGN:US,BBG000FH8PX5,"Allergan, Google, Oaktree Capital: Doug Kass' Views",2017-01-09 06:00:00 +0000,https://www.thestreet.com/story/13946000/1/allergan-google-oaktree-capital-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Allergan, Google, Oaktree Capital: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017,2017-01-07 20:03:00 +0000,https://www.thestreet.com/story/13940033/1/allergan-hikes-prices-on-several-drugs-but-adheres-to-social-contract.html?puc=yahoo&cm_ven=YAHOO,These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
AGN,AGN:US,BBG000FH8PX5,Craft a Strategy From Retail's Wreckage: Best of Kass,2017-01-07 02:00:00 +0000,https://www.thestreet.com/story/13945738/1/craft-a-strategy-from-retail-s-wreckage-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Craft a Strategy From Retail's Wreckage: Best of Kass
AGN,AGN:US,BBG000FH8PX5,"Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)",2017-01-07 01:09:00 +0000,https://www.thestreet.com/story/13945604/1/health-care-banks-lead-game-strategy-for-next-week-cramer-s-mad-money-recap-friday-1-6-17.html?puc=yahoo&cm_ven=YAHOO,"Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)"
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers",2017-01-06 21:22:26 +0000,http://biz.yahoo.com/e/170106/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers"
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway?,2017-01-06 20:26:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/06/teva-pharmaceutical-what-the-heck-does-focused-on-execution-mean-anyway/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway?
AGN,AGN:US,BBG000FH8PX5,Allergan CEO on the Hot Seat: Here's What He Had to Say,2017-01-06 18:48:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1GDO3c2bwuA/allergan-ceo-on-the-hot-seat-heres-what-he-had-to-say-cm730511,It s not easy being a CEO on the hot seat at a conference when your company s stock is down nearly 30 over the last 12 months Allergan NYSE AGN CEO Brent Saunders experienced that first hand at the Goldman Sachs Healthcare CEOs Unscripted event on Thursday Here s what
AGN,AGN:US,BBG000FH8PX5,Allergan CEO on the Hot Seat: Here's What He Had to Say,2017-01-06 18:26:07 +0000,http://www.fool.com/investing/2017/01/06/allergan-ceo-on-the-hot-seat-heres-what-he-had-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Allergan CEO on the Hot Seat: Here's What He Had to Say
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View",2017-01-06 14:41:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CVGADu1vf3U/pharma-stock-roundup-pcsk9-inhibitor-praluent-in-news-allergans-preliminary-2017-view-cm730250,French pharma giant Sanofi SNY and partner Regeneron were hit by a court injunction blocking the sale of their PCSK9 inhibitor Praluent in the U S Meanwhile Allergan AGN provided a preliminary look at its expectations for 2017 Recap of the Week s Most Important Stories Sanofi
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View",2017-01-06 12:24:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pcsk9-inhibitor-122412444.html,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View"
AGN,AGN:US,BBG000FH8PX5,Allergan Pops On 2017 Guidance; Can It Survive Alzheimer's Rivalries?,2017-01-05 21:01:13 +0000,http://www.investors.com/news/technology/allergan-pops-on-2017-guidance-can-it-survive-alzheimers-rivalries/,Allergan Pops On 2017 Guidance; Can It Survive Alzheimer's Rivalries?
AGN,AGN:US,BBG000FH8PX5,"Allergan: No More ""Aspirational"" Financial Guidance",2017-01-05 20:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/05/allergan-no-more-aspirational-financial-guidance/?mod=yahoobarrons&ru=yahoo,"Allergan: No More ""Aspirational"" Financial Guidance"
AGN,AGN:US,BBG000FH8PX5,Cooperman's best ideas: 14 stock picks,2017-01-05 17:52:00 +0000,http://finance.yahoo.com/video/coopermans-best-ideas-14-stock-175200302.html,Cooperman's best ideas: 14 stock picks
AGN,AGN:US,BBG000FH8PX5,Allergan Is Playing Its Cards Close To The Vest,2017-01-05 16:19:00 +0000,http://www.investopedia.com/news/allergan-playing-it-conservative-agn/?partner=YahooSA,Allergan Is Playing Its Cards Close To The Vest
AGN,AGN:US,BBG000FH8PX5,Saunders Paints Realistic Outlook for Allergan in 2017,2017-01-05 15:07:00 +0000,https://www.thestreet.com/story/13943733/1/saunders-paints-realistic-outlook-for-allergan-in-2017.html?puc=yahoo&cm_ven=YAHOO,Saunders Paints Realistic Outlook for Allergan in 2017
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.,2017-01-05 14:40:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ELsMwwpvu2c/allergan-agn-liletta-snda-accepted-for-review-in-the-us-cm729783,Allergan plc AGN and partner Medicines360 a nonprofit global women s health pharmaceutical company announced that the FDA has accepted a supplemental New Drug Application sNDA for its marketed intrauterine system IUS Liletta The companies are looking to update Liletta s label to
AGN,AGN:US,BBG000FH8PX5,"Allergan issues 2017 guidance, expects double-digit EPS growth",2017-01-05 13:57:34 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4DDAAEC5-C36C-432B-9709-A946ADDFD034&siteid=yhoof2,"Allergan issues 2017 guidance, expects double-digit EPS growth"
AGN,AGN:US,BBG000FH8PX5,How Trump-related uncertainty is bringing out the health-care stock bears,2017-01-05 13:29:15 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F9EE0888-D2BC-11E6-BCD6-E2A1A77CE9A2&siteid=yhoof2,How Trump-related uncertainty is bringing out the health-care stock bears
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.,2017-01-05 13:16:01 +0000,http://finance.yahoo.com/news/allergan-agn-liletta-snda-accepted-131601849.html,Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
AGN,AGN:US,BBG000FH8PX5,Allergan expects mid-single digit 2017 revenue growth,2017-01-05 12:52:21 +0000,http://finance.yahoo.com/news/allergan-expects-mid-single-digit-125221671.html,Allergan expects mid-single digit 2017 revenue growth
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook,2017-01-05 12:44:06 +0000,http://www.publicnow.com/view/2A4E8FCFDF0B7B48A0FEEDE07C0F115C55887F16,"[at noodls] - DUBLIN, Jan. 5, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced that Brent Saunders, Allergan's Chairman and CEO, will participate in a fireside chat at ..."
AGN,AGN:US,BBG000FH8PX5,What Pharma and Healthcare Investors Should Watch For at JPM Next Week,2017-01-05 11:45:00 +0000,https://www.thestreet.com/story/13942732/1/what-pharma-and-healthcare-investors-should-watch-for-at-jpm-next-week.html?puc=yahoo&cm_ven=YAHOO,What Pharma and Healthcare Investors Should Watch For at JPM Next Week
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Goldman Sachs Conference; Webcast At 10:15 AM ET,2017-01-05 09:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jRXqX98Q_ak/allergan-to-present-at-goldman-sachs-conference-webcast-at-1015-am-et-20170105-00660,Allergan To Present At Goldman Sachs Conference; Webcast At 10:15 AM ET
AGN,AGN:US,BBG000FH8PX5,Allergan Plc (AGN) Explodes After FDA Approval Of Natrelle Inspira,2017-01-04 16:14:32 +0000,http://www.insidermonkey.com/blog/allergan-plc-agn-explodes-after-fda-approval-of-natrelle-inspira-514558/,Allergan Plc (AGN) Explodes After FDA Approval Of Natrelle Inspira
AGN,AGN:US,BBG000FH8PX5,Allergan Natrelle Inspira Breast Implants Approved in the U.S.,2017-01-04 15:42:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LhgA7PybhqE/allergan-natrelle-inspira-breast-implants-approved-in-the-us-cm729219,Allergan plc AGN announced that the FDA has approved Natrelle Inspira SoftTouch a new medium firmness gel or cohesive implant option for breast reconstruction augmentation or revision surgery Note that Natrelle Inspira is the only line of breast implants with three levels of cohesive
AGN,AGN:US,BBG000FH8PX5,"Teva: Good Value, Questionable Management?",2017-01-04 14:36:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BROb7sU_3vQ/teva-good-value-questionable-management-cm729155,One of the few sectors that has the potential to offer returns in our opinion is the pharmaceutical sector Political claims sent pharma stocks into tailspin Both Hillary Clinton and President elect Donald Trump repeatedly campaigned that they wanted to lower drug prices It is difficult
AGN,AGN:US,BBG000FH8PX5,FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg,2017-01-04 13:33:19 +0000,http://www.publicnow.com/view/76005266ED5C194B76D7FCE62960AB8A1438B753,"[at noodls] - DUBLIN and SAN FRANCISCO, Jan. 4, 2017 /PRNewswire/ -- Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, and Medicines360, a nonprofit global women's health pharmaceutical company, today ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Natrelle Inspira Breast Implants Approved in the U.S.,2017-01-04 13:33:01 +0000,http://finance.yahoo.com/news/allergan-natrelle-inspira-breast-implants-133301485.html,Allergan Natrelle Inspira Breast Implants Approved in the U.S.
AGN,AGN:US,BBG000FH8PX5,FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg,2017-01-04 12:35:00 +0000,http://finance.yahoo.com/news/fda-accepts-filing-supplemental-drug-123500913.html,"[PR Newswire] - The supplement currently being reviewed by FDA includes additional efficacy and safety data from an ongoing U.S.-based Phase 3 hormonal IUD trial, ACCESS IUS (A Comprehensive Contraceptive Efficacy & Safety Study of an IUS), with 1,751 women receiving LILETTA. LILETTA® was first approved in February 2015 with a two-handed inserter and received additional FDA approval in January 2016 for a new single-handed inserter."
AGN,AGN:US,BBG000FH8PX5,Allergan: FDA Accepts For Filing SNDA For Liletta,2017-01-04 07:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hv8FDnqHoUs/allergan-fda-accepts-for-filing-snda-for-liletta-20170104-00269,Allergan: FDA Accepts For Filing SNDA For Liletta
AGN,AGN:US,BBG000FH8PX5,"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal",2017-01-04 01:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EQUoX5n_LN8/agrx-fails-to-secure-investor-confidence-itek-hit-hard-cbay-rises-on-kowa-deal-20170104-00025,"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal"
AGN,AGN:US,BBG000FH8PX5,"Abraham, Fruchter & Twersky, LLP Files Securities Class Action Lawsuit Against Allergan PLC (NYSE: AGN)",2017-01-04 00:20:18 +0000,http://finance.yahoo.com/news/abraham-fruchter-twersky-llp-files-002018758.html,"[Marketwired] - Abraham, Fruchter & Twersky, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York against Allergan plc and certain of its current or former officers. ..."
AGN,AGN:US,BBG000FH8PX5,"After Hours Most Active for Jan 3, 2017 :  CNDT, S, XRX, AGN, T, ODP, AAPL, TSNU, QQQ, EBAY, NVDA, MSFT",2017-01-03 21:56:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mtr1V1U93RY/after-hours-most-active-for-jan-3-2017-cndt-s-xrx-agn-t-odp-aapl-tsnu-qqq-ebay-nvda-msft-cm728957,The NASDAQ 100 After Hours Indicator is down 1 17 to 4 910 16 The total After hours volume is currently 21 758 453 shares traded The following are the most active stocks for the after hours session Conduent Incorporated CNDT is 0 13 at 13 85 with 11 510 345
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at 35th Annual J.P. Morgan Healthcare Conference,2017-01-03 21:15:00 +0000,http://finance.yahoo.com/news/allergan-present-35th-annual-j-211500638.html,"[PR Newswire] - DUBLIN, Jan. 3, 2017 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's Chairman and CEO, will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9th, 2017 at 3:00 p.m. PT (6:00 p.m. ET) at the Westin St. Francis in San Francisco, CA. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22477. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,"New year, new drug prices",2017-01-03 19:42:00 +0000,http://finance.yahoo.com/video/drug-prices-194200228.html,"New year, new drug prices"
AGN,AGN:US,BBG000FH8PX5,"Allergan Drug Price Hikes Are in Effect, Though Increases Are Modest",2017-01-03 17:32:00 +0000,http://www.thestreet.com/video/13940496/allergan-drug-price-hikes-are-in-effect-though-increases-are-modest.html?puc=yahoov&cm_ven=YAHOOV,"Allergan Drug Price Hikes Are in Effect, Though Increases Are Modest"
AGN,AGN:US,BBG000FH8PX5,Allergan Continues 2017 Where It Left Off In 2016,2017-01-03 16:01:00 +0000,http://www.investopedia.com/news/allergan-stock-kicks-new-year-4-agn/?partner=YahooSA,Allergan Continues 2017 Where It Left Off In 2016
AGN,AGN:US,BBG000FH8PX5,EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN,2017-01-03 15:31:00 +0000,http://finance.yahoo.com/news/equity-rosen-law-firm-announces-153100186.html,"[PR Newswire] - NEW YORK, Jan. 3, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Allergan plc (NYSE- ..."
AGN,AGN:US,BBG000FH8PX5,Allergan took its pricing pledge last fall about as literally as it gets,2017-01-03 14:48:17 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C34CBCEA-D1B6-11E6-AEBA-2C03F27C1C77&siteid=yhoof2,Allergan took its pricing pledge last fall about as literally as it gets
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 01/03/2017: AGN, ITEK, JNJ, PFE, ABT, MRK, AMGN",2017-01-03 14:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sb1mzHFP7K4/health-care-sector-update-for-01032017-agn-itek-jnj-pfe-abt-mrk-amgn-cm728543,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 5 PFE 0 5 ABT 2 2 ABT 2 2 MRK 0 03 MRK 0 03 AMGN 0 6 AMGN 0 6 Health care shares were mostly higher in pre market trade Tuesday Health care shares were mostly higher in pre market trade Tuesday In
AGN,AGN:US,BBG000FH8PX5,Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants,2017-01-03 13:03:09 +0000,http://www.publicnow.com/view/E17B27DAFD9926D3C936D2456FB7351DD1748E4B,"[at noodls] - DUBLIN, Jan. 3, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA SoftTouch breast ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants,2017-01-03 12:35:00 +0000,http://finance.yahoo.com/news/allergan-announces-fda-approval-natrelle-123500784.html,"[PR Newswire] - DUBLIN, Jan. 3, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA ® SoftTouch breast ..."
AGN,AGN:US,BBG000FH8PX5,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses In Excess of $100,000 of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017",2017-01-02 15:25:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-152500349.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 2, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,"Starbucks, Allergan, Amazon: Doug Kass' Views",2017-01-02 06:00:00 +0000,https://www.thestreet.com/story/13939432/1/starbucks-allergan-amazon-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Starbucks, Allergan, Amazon: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Friday Option Activity: HLF, AGN, DIS",2016-12-30 21:58:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Saz06Xwkfw/noteworthy-friday-option-activity-hlf-agn-dis-cm728122,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Herbalife Ltd Symbol HLF where a total volume of 4 596 contracts has been traded thus far today a contract volume which is representative of approximately 459 600
AGN,AGN:US,BBG000FH8PX5,Cempra (CEMP) Gets CRL from FDA for Pneumonia Candidate,2016-12-30 16:59:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ChJ8Ymutd-k/cempra-cemp-gets-crl-from-fda-for-pneumonia-candidate-cm727941,Shares of Cempra Inc CEMP plunged 57 3 after the company announced that it received a Complete Response Letter CRL from the FDA relating to the company s new drug applications NDAs for oral and intravenous formulation of candidate solithromycin Cempra s share price has lost 91 6
AGN,AGN:US,BBG000FH8PX5,"Company News for December 30, 2016",2016-12-30 16:56:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/snuDL7ypk4U/company-news-for-december-30-2016-cm727914,160 160 160 Raytheon Company s RTN shares gained 1 1 after receiving a 304 million Tomahawk missile contract from the U S Navy 160 160 160 Shares of Sears Holdings Corporation SHLD jumped 10 after announcing that it received a secured standby letter of
AGN,AGN:US,BBG000FH8PX5,3 Sleeper Biotechs That Could Bounce Back Strong in 2017,2016-12-30 16:15:37 +0000,http://finance.yahoo.com/news/3-sleeper-biotechs-could-bounce-161537373.html,3 Sleeper Biotechs That Could Bounce Back Strong in 2017
AGN,AGN:US,BBG000FH8PX5,Apple and Microsoft: Moving Opposite on Share Buybacks?,2016-12-30 16:02:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4mU1oB-BeDA/apple-and-microsoft-moving-opposite-on-share-buybacks-cm727844,Apple Inc AAPL and Microsoft Corp MSFT pioneers of two completely different eco systems iOS and Windows are apparently moving in opposite directions regarding share buybacks as well Per latest data from S amp P Dow Jones Indices S amp P DJI Apple s spending on share
AGN,AGN:US,BBG000FH8PX5,4 Biotech Stocks with Bright Prospects in 2017,2016-12-30 15:31:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BGi-iwi1xt0/4-biotech-stocks-with-bright-prospects-in-2017-cm727700,Biotech a happening but highly volatile sector again found itself in rough waters this year due to the drug pricing issue This is evident from the 20 8 decline witnessed by the NASDAQ Biotechnology Index in the year to date period Besides strained balance sheets and macroeconomic woes are
AGN,AGN:US,BBG000FH8PX5,GPM Reminds Investors of the January 3 Deadline in the Class Action Lawsuit Against Allergan PLC,2016-12-30 15:30:00 +0000,http://finance.yahoo.com/news/gpm-reminds-investors-january-3-153000321.html,"[Business Wire] - Glancy Prongay & Murray LLP reminds investors of the January 3, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Allergan PLC securities between February 25, 2014 and November 3, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,Apple and Microsoft: Moving Opposite on Share Buybacks?,2016-12-30 13:58:01 +0000,http://finance.yahoo.com/news/apple-microsoft-moving-opposite-share-135801558.html,Apple and Microsoft: Moving Opposite on Share Buybacks?
AGN,AGN:US,BBG000FH8PX5,Brent Saunders's New Model Will Be Tested in 2017,2016-12-30 13:00:11 +0000,http://www.bloomberg.com/gadfly/articles/2016-12-30/brent-saunders-allergan-model-faces-2017-test?cmpid=yhoo.headline,Brent Saunders's New Model Will Be Tested in 2017
AGN,AGN:US,BBG000FH8PX5,Analyzing Merck’s General Medicine and Women’s Health Segment,2016-12-30 12:35:58 +0000,http://marketrealist.com/2016/12/merck-may-witness-decline-general-medicine-womens-health-segment-revenues-2017/?utm_source=yahoo&utm_medium=feed,Analyzing Merck’s General Medicine and Women’s Health Segment
AGN,AGN:US,BBG000FH8PX5,Is Allergan plc Ordinary Shares (AGN) Snapping Out of It?,2016-12-29 21:58:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eSVZiU597ss/is-allergan-plc-ordinary-shares-agn-snapping-out-of-it-cm727653,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The chart of Allergan plc Ordinary Shares NYSE AGN has been turning heads recently It has been in a long term downtrend since August 2015 but with the stock forming a
AGN,AGN:US,BBG000FH8PX5,Bulls Are Pushing Allergan Shares Higher,2016-12-29 21:19:00 +0000,http://www.investopedia.com/news/bulls-have-taken-control-agn-now-agn/?partner=YahooSA,Bulls Are Pushing Allergan Shares Higher
AGN,AGN:US,BBG000FH8PX5,"DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) & Lead Plaintiff Deadline: January 3, 2017",2016-12-29 15:10:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-151000122.html,"[GlobeNewswire] - NEW YORK, Dec. 29, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC and/or Actavis plc and certain of ..."
AGN,AGN:US,BBG000FH8PX5,Healthcare: What Does a Trump Administration Mean for Healthcare Stocks?,2016-12-29 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=784804&SR=Yahoo,Healthcare: What Does a Trump Administration Mean for Healthcare Stocks?
AGN,AGN:US,BBG000FH8PX5,January 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Allergan PLC Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm,2016-12-28 20:42:00 +0000,http://finance.yahoo.com/news/january-3-deadline-alert-law-204200931.html,"[Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming January 3, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Allergan PLC securities between February 25, 2014 and November 3, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,"DEADLINE ALERT: Brower Piven Reminds Investors Of The January 3, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Allergan plc To Contact The Firm - AGN",2016-12-28 20:05:47 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-200547981.html,"[GlobeNewswire] - STEVENSON, Md., Dec. 28, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
AGN,AGN:US,BBG000FH8PX5,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016,2016-12-28 14:06:36 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-gastro-intestinal-segment-continues-report-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016
AGN,AGN:US,BBG000FH8PX5,Biotech plays for the new year,2016-12-28 11:52:00 +0000,http://finance.yahoo.com/video/biotech-plays-115200673.html,Biotech plays for the new year
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline",2016-12-27 19:13:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-191300533.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 27, 2016 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allergan plc (""Allergan"" or the ""Company"") (NYSE: ..."
AGN,AGN:US,BBG000FH8PX5,"Stock Market News for December 27, 2016",2016-12-27 17:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MaTwsn2mxUU/stock-market-news-for-december-27-2016-cm726524,Major U S benchmarks ended the last trading session ahead of Christmas holiday on a positive note as investors continued to cheer Trump s promises Encouraging economic data also played a vital role in boosting stocks on Friday While healthcare sector emerged as the biggest gainer decline
AGN,AGN:US,BBG000FH8PX5,Shares of Allergan Showing Positive Momentum,2016-12-27 16:53:00 +0000,http://www.investopedia.com/news/allergan-stock-showing-signs-life-agn/?partner=YahooSA,Shares of Allergan Showing Positive Momentum
AGN,AGN:US,BBG000FH8PX5,Biotech Poised for Rebound,2016-12-27 16:00:00 +0000,http://realmoney.thestreet.com/articles/12/27/2016/biotech-poised-rebound?puc=yahoo&cm_ven=YAHOO,Biotech Poised for Rebound
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017",2016-12-27 15:02:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150200230.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline – AGN,2016-12-26 14:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-140000596.html,"[GlobeNewswire] - NEW YORK, Dec. 26, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc and certain of its officers. The class action, filed in United States District Court, Southern ..."
AGN,AGN:US,BBG000FH8PX5,5 Struggling Stocks That Will Turn Around in 2017,2016-12-26 13:56:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zEKqQbRbKh4/5-struggling-stocks-that-will-turn-around-in-2017-cm726054,Fueled by a late year surge Standard amp Poor s 500 stock index has returned 13 2 so far in 2016 But the factors that have boosted stocks since Election Day hopes for corporate tax cuts less regulation and a revival of animal spirits among consumers and businesses haven t
AGN,AGN:US,BBG000FH8PX5,Asian stocks lower in light trading after Christmas,2016-12-26 03:05:33 +0000,http://finance.yahoo.com/news/asian-stocks-lower-light-trading-christmas-030524366--finance.html,Asian stocks lower in light trading after Christmas
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN ALERT: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action Filed by Firm - AGN",2016-12-23 21:48:57 +0000,http://finance.yahoo.com/news/allergan-alert-investors-losses-excess-214857000.html,"[GlobeNewswire] - NEW YORK, Dec. 23, 2016-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc and/or Actavis plc between February 25, 2014 and November 3, 2016, both ..."
AGN,AGN:US,BBG000FH8PX5,US stocks inch higher in slow pre-holiday trading,2016-12-23 21:37:52 +0000,http://sg.finance.yahoo.com/news/us-stocks-move-slightly-higher-151503704.html,US stocks inch higher in slow pre-holiday trading
AGN,AGN:US,BBG000FH8PX5,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse,2016-12-23 21:04:28 +0000,http://www.investors.com/news/technology/allergan-outlook-improves-on-good-trial-for-colon-drug-credit-suisse/,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
AGN,AGN:US,BBG000FH8PX5,Allergan Is Gaining Traction -- Plus Jim Cramer's Take,2016-12-23 19:52:00 +0000,https://www.thestreet.com/story/13936552/1/allergan-is-gaining-traction-plus-jim-cramer-s-take.html?puc=yahoo&cm_ven=YAHOO,Allergan Is Gaining Traction -- Plus Jim Cramer's Take
AGN,AGN:US,BBG000FH8PX5,Why Synergy Pharmaceuticals Is Jumping 10% Today,2016-12-23 17:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCGdRp-ekB4/why-synergy-pharmaceuticals-is-jumping-10-today-cm725780,IMAGE SOURCE GETTY IMAGES What happened After announcing 160 positive results in phase 3 trials evaluating 160 plecanatide for the treatment of irritable bowel syndrome with constipation IBS C shares in Synergy Pharmaceuticals NASDAQ SGYP 160 rallied 10
AGN,AGN:US,BBG000FH8PX5,US stock indexes slip again in slow pre-holiday trading,2016-12-23 17:00:33 +0000,http://finance.yahoo.com/news/us-stocks-move-slightly-higher-151503465.html,US stock indexes slip again in slow pre-holiday trading
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Inflows: XLV, UNH, ABBV, AGN",2016-12-23 16:59:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YSNgU875gao/noteworthy-etf-inflows-xlv-unh-abbv-agn-cm725723,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 120 6 million dollar inflow that s a 0 9 increase week over week
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: FedEx, Verizon, Morgan Stanley, Caterpillar and Allergan",2016-12-23 16:58:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vdeow7owHec/the-zacks-analyst-blog-highlights-fedex-verizon-morgan-stanley-caterpillar-and-allergan-cm725720,For Immediate Release Chicago IL December 23 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
AGN,AGN:US,BBG000FH8PX5,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data",2016-12-23 16:01:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uemYRp_wn8k/ironwood-allergan-report-positive-linzess-ibs-c-study-data-cm725670,Ironwood Pharmaceuticals Inc IRWD and Allergan plc AGN announced encouraging top line data from a phase IIb study on the colonic release 1 CR1 formulation of Linzess linaclotide for the treatment of adult patients suffering from irritable bowel syndrome with constipation IBS C In
AGN,AGN:US,BBG000FH8PX5,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data",2016-12-23 13:35:01 +0000,http://finance.yahoo.com/news/ironwood-allergan-report-positive-linzess-133501794.html,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data"
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe",2016-12-23 12:58:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gu5pZXFat3c/pharma-stock-roundup-jj-back-in-talks-with-actelion-teva-settles-corruption-probe-cm725508,Several tuck in deals and licensing agreements were announced this week while healthcare giant Johnson amp Johnson JNJ is back in exclusive talks with Actelion regarding a possible deal Recap of the Week s Most Important Stories J amp J In Where Does that Leave Sanofi in
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe",2016-12-23 10:48:10 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-j-j-104810335.html,"Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe"
AGN,AGN:US,BBG000FH8PX5,Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients,2016-12-22 20:38:04 +0000,http://www.publicnow.com/view/DFAF2AABE654BA1558449EE66F54D68D943E37E0,"[at noodls] - DUBLIN, Dec. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) Board of Directors issued the following statement on the Company's Social Contract with Patients: Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO ..."
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for FedEx, Verizon & Morgan Stanley",2016-12-22 18:33:06 +0000,http://finance.yahoo.com/news/top-research-reports-fedex-verizon-183306705.html,"Top Research Reports for FedEx, Verizon & Morgan Stanley"
AGN,AGN:US,BBG000FH8PX5,Cambridge's Ironwood reports positive data on constipation drug,2016-12-22 16:20:09 +0000,http://www.bizjournals.com/boston/news/2016/12/22/cambridges-ironwood-reports-positive-data-on.html?ana=yahoo,Cambridge's Ironwood reports positive data on constipation drug
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017",2016-12-22 15:08:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150800039.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 22, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Ironwood Shares Eye 3.5-Yr High; Joint Trial With Allergan Shows Reduced Abdominal Pain,2016-12-22 12:57:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8nInu_T6VY0/ironwood-shares-eye-35-yr-high-joint-trial-with-allergan-shows-reduced-abdominal-pain-cm724938,Ironwood Pharmaceuticals IRWD shares were higher over 6 in recent pre market trade as it and Allergan AGN said a phase 2b clinical trial showed irritable bowel syndrome patients treated with its linaclotide colonic release 1 300 mcg saw a 56 2 improvement in abdominal pain relative
AGN,AGN:US,BBG000FH8PX5,Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS,2016-12-22 12:52:17 +0000,http://www.publicnow.com/view/BAB42BECBE6732751D74E1299D0AAB33A4DD8424,"[at noodls] - December 22, 2016 Data also support potential for broad opportunity to treat additional GI indications associated with abdominal pain Companies separately announced Phase IIb data with linaclotide colonic ..."
AGN,AGN:US,BBG000FH8PX5,Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C,2016-12-22 12:52:17 +0000,http://www.publicnow.com/view/4D7AFCEF9C24EDE266C25B440DC3B8DB56A6FD4A,"[at noodls] - December 22, 2016 Abdominal pain improved 56% with CR1 300 mcg relative to placebo in this trial Companies separately announced Phase IIb data with linaclotide colonic release-2 (CR2) supporting investigation ..."
AGN,AGN:US,BBG000FH8PX5,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C",2016-12-22 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OeqqyC9ZBqA/ironwood-allergan-report-topline-phase-iib-data-for-linaclotide-cr1-in-ibsc-20161222-00161,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C"
AGN,AGN:US,BBG000FH8PX5,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2",2016-12-22 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yy-7qdBp5Qs/ironwood-allergan-report-topline-phase-iib-data-for-linaclotide-cr2-20161222-00158,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2"
AGN,AGN:US,BBG000FH8PX5,3 Stocks That Could Get Pounded by Tax Loss Selling,2016-12-21 21:56:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PgMD04mWNwA/3-stocks-that-could-get-pounded-by-tax-loss-selling-cm724800,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips This year has been a pretty good one for most stock investors Unfortunately for stocks that have lagged the market in 2016 tis the season for tax loss selling Source Pictures of Money via
AGN,AGN:US,BBG000FH8PX5,Allergan: Why LifeCell Deal is a 'Christmas Miracle!',2016-12-21 18:06:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/21/allergan-why-lifecell-deal-is-a-christmas-miracle/?mod=yahoobarrons&ru=yahoo,Allergan: Why LifeCell Deal is a 'Christmas Miracle!'
AGN,AGN:US,BBG000FH8PX5,Allergan's a Bargain That Could Pop 20%,2016-12-21 16:39:00 +0000,http://realmoney.thestreet.com/articles/12/21/2016/allergans-bargain-could-pop-20?puc=yahoo&cm_ven=YAHOO,Allergan's a Bargain That Could Pop 20%
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite,2016-12-21 14:59:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzdaDHK4aVQ/allergan-to-buy-lifecell-to-boost-regenerative-medicine-suite-cm724428,Allergan plc AGN announced that it has signed a definitive agreement to acquire LifeCell the regenerative medicine unit of Texas based privately held company Acelity for 2 9 billion in cash Allergan s share price was up 1 3 in the past one month outperforming the 0 6 increase for the
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy LifeCell For $2.9 Billion,2016-12-21 14:56:00 +0000,http://www.investopedia.com/news/allergan-buy-lifecell-29-billion-agn/?partner=YahooSA,Allergan to Buy LifeCell For $2.9 Billion
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite,2016-12-21 13:16:01 +0000,http://finance.yahoo.com/news/allergan-buy-lifecell-boost-regenerative-131601069.html,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference,2016-12-21 12:30:00 +0000,http://finance.yahoo.com/news/allergan-present-goldman-sachs-healthcare-123000310.html,"[PR Newswire] - DUBLIN, Dec. 21, 2016 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's Chairman and CEO, will participate in a fireside chat at the Goldman Sachs Healthcare CEO's Unscripted event on Thursday, January 5th, 2017 at 10:15 a.m. ET at the InterContinental Hotel in Boston, MA. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: https://cc.talkpoint.com/gold006/010517a_as/?entity=5_YOLTTUX. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date",2016-12-20 23:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nKXhi36iXl0/akba-inks-blockbuster-deal-agn-on-buying-spree-tsro-gets-fda-date-20161220-01025,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date"
AGN,AGN:US,BBG000FH8PX5,San Antonio biotech firm sells unit for $2.9 billion,2016-12-20 20:45:06 +0000,http://www.bizjournals.com/sanantonio/news/2016/12/20/san-antonio-biotech-firm-sells-unit-for-2-9.html?ana=yahoo,San Antonio biotech firm sells unit for $2.9 billion
AGN,AGN:US,BBG000FH8PX5,Allergan to buy Acelity's tissue unit LifeCell for $2.9 bln,2016-12-20 17:43:36 +0000,http://in.finance.yahoo.com/news/allergan-buy-acelitys-tissue-unit-174336267.html,Allergan to buy Acelity's tissue unit LifeCell for $2.9 bln
AGN,AGN:US,BBG000FH8PX5,Why Biogen's new CEO stands to gain from an acquisition,2016-12-20 17:15:06 +0000,http://www.bizjournals.com/boston/news/2016/12/20/why-biogens-new-ceo-stands-to-gain-from-an.html?ana=yahoo,Why Biogen's new CEO stands to gain from an acquisition
AGN,AGN:US,BBG000FH8PX5,Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion,2016-12-20 15:32:55 +0000,http://finance.yahoo.com/news/allergan-buy-acelitys-unit-lifecell-144652775.html,Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion
AGN,AGN:US,BBG000FH8PX5,Allergan to buy Acelity's tissue unit LifeCell for $2.9 bln,2016-12-20 15:30:20 +0000,http://finance.yahoo.com/news/allergan-buy-acelitys-tissue-unit-153020954.html,Allergan to buy Acelity's tissue unit LifeCell for $2.9 bln
AGN,AGN:US,BBG000FH8PX5,Allergan shares slump 1.4% after $2.9 bln cash deal for Acelity's regenerative medicine company,2016-12-20 15:23:31 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=32EC4C76-5352-45DE-B480-48633128A587&siteid=yhoof2,Allergan shares slump 1.4% after $2.9 bln cash deal for Acelity's regenerative medicine company
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion,2016-12-20 15:12:15 +0000,http://www.publicnow.com/view/2925A37D7F2CB34B161BE61CFFDEEB611315B9DB,"[at noodls] - DUBLIN, Dec. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, and Acelity today announced that they have entered into a definitive agreement under which Allergan ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Takes Biggest Step Yet in 'Stepping Stone' Strategy, Signs $2.9 Billion Breast Cancer Deal",2016-12-20 15:06:00 +0000,https://www.thestreet.com/story/13932739/1/allergan-takes-biggest-step-yet-in-stepping-stone-strategy-signs-2-9-billion-breast-cancer-deal.html?puc=yahoo&cm_ven=YAHOO,"Allergan Takes Biggest Step Yet in 'Stepping Stone' Strategy, Signs $2.9 Billion Breast Cancer Deal"
AGN,AGN:US,BBG000FH8PX5,Botox-maker Allergan just picked up a regenerative medicine company for $2.9 billion,2016-12-20 14:55:24 +0000,http://finance.yahoo.com/news/botox-maker-allergan-just-picked-145524799.html,Botox-maker Allergan just picked up a regenerative medicine company for $2.9 billion
AGN,AGN:US,BBG000FH8PX5,Allergan to buy Acelity's unit LifeCell for $2.9 bln,2016-12-20 14:43:38 +0000,http://finance.yahoo.com/news/allergan-buy-acelitys-unit-lifecell-144338165.html,Allergan to buy Acelity's unit LifeCell for $2.9 bln
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-20 14:30:09 +0000,http://biz.yahoo.com/e/161220/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AGN,AGN:US,BBG000FH8PX5,Acelity to Sell LifeCell Business Unit to Allergan,2016-12-20 14:30:00 +0000,http://au.finance.yahoo.com/news/acelity-sell-lifecell-business-unit-143000926.html,"[Business Wire] - SAN ANTONIO--(BUSINESSWIRE)-- Acelity L.P. today announced a definitive agreement with Allergan for the acquisition of Acelity’s LifeCell business unit for $2.9 billion in cash. Upon completion of the transaction, LifeCell’s industry-leading regenerative medicine and reconstructive surgery portfolio will be combined with Allergan’s leading portfolio of medical aesthetics and breast implants and tissue expanders, enhancing the potential for continued long-term growth of the LifeCell portfolio."
AGN,AGN:US,BBG000FH8PX5,"Biogen Names Commercial Officer as New CEO, Shares Fall",2016-12-20 13:59:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/low-NExMo6M/biogen-names-commercial-officer-as-new-ceo-shares-fall-cm723820,Biogen Inc BIIB has appointed its present chief commercial officer CCO Michel Vounatsos as the new chief executive officer CEO effective Jan 6 2017 Vounatsos who also holds the position of executive vice president at Biogen will replace George A Scangos In July Scangos
AGN,AGN:US,BBG000FH8PX5,Billionaire Activist Paul Singer Is Terrible At Investing In These Stocks,2016-12-20 12:42:29 +0000,http://www.insidermonkey.com/blog/billionaire-activist-paul-singer-is-terrible-at-investing-in-these-stocks-512205/,Billionaire Activist Paul Singer Is Terrible At Investing In These Stocks
AGN,AGN:US,BBG000FH8PX5,Allergan To Acquire LifeCell Corp Of Acelity For $2.9 Bln In Cash,2016-12-20 10:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwk9SxQDWgA/allergan-to-acquire-lifecell-corp-of-acelity-for-29-bln-in-cash-20161220-00553,Allergan To Acquire LifeCell Corp Of Acelity For $2.9 Bln In Cash
AGN,AGN:US,BBG000FH8PX5,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks,2016-12-19 21:16:15 +0000,http://www.investors.com/news/technology/supernus-pharmaceuticls-breaks-out-on-up-day-for-biotech-stocks/,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks
AGN,AGN:US,BBG000FH8PX5,"The Worst Stocks Of 2016: First Solar, Allergan, TripAdvisor",2016-12-19 19:41:00 +0000,http://www.forbes.com/sites/laurengensler/2016/12/19/worst-stocks-2016/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"The Worst Stocks Of 2016: First Solar, Allergan, TripAdvisor"
AGN,AGN:US,BBG000FH8PX5,"Salpeter Gitkin, LLP Informing Investors of Allergan plc of Securities Class Action Lawsuits",2016-12-19 16:57:00 +0000,http://finance.yahoo.com/news/salpeter-gitkin-llp-informing-investors-165700739.html,"[PR Newswire] - FORT LAUDERDALE, Fla., Dec. 19, 2016 /PRNewswire/ -- Attorney Advertising -- the law firm of Salpeter Gitkin, LLP is informing investors and shareholders of Allergan plc (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017",2016-12-19 15:06:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150600647.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 19, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Could Be Poised for a Powerful Reversal -- Plus Jim Cramer's Take,2016-12-19 12:50:00 +0000,https://www.thestreet.com/story/13930160/1/allergan-shares-could-be-poised-for-a-powerful-reversal-plus-jim-cramer-s-take.html?puc=yahoo&cm_ven=YAHOO,Allergan Shares Could Be Poised for a Powerful Reversal -- Plus Jim Cramer's Take
AGN,AGN:US,BBG000FH8PX5,[$$] Big pharma braces for further bruising publicity over drug prices,2016-12-18 06:00:52 +0000,"http://www.ft.com/cms/s/ca1f7748-c2bf-11e6-9bca-2b93a6856354,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Pharmaceutical executives are steeling themselves for 2017 to be another year defined by public outcry over the price of drugs, even as some investors bask in Donald Trump's election victory. The issue ..."
AGN,AGN:US,BBG000FH8PX5,Why You Should Avoid These Stock Picks of Billionaire John Paulson,2016-12-18 03:18:53 +0000,http://www.insidermonkey.com/blog/why-you-should-avoid-these-stock-picks-of-billionaire-john-paulson-511583/,Why You Should Avoid These Stock Picks of Billionaire John Paulson
AGN,AGN:US,BBG000FH8PX5,Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?,2016-12-17 13:57:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n80Rs3qt6YY/could-these-2-small-biotechs-beat-allergan-and-gilead-sciences-cm722862,Several companies are eyeing the potential 40 billion market in treating nonalcoholic steatohepatitis NASH and Allergan NYSE AGN and Gilead Sciences NASDAQ GILD have multiple NASH pipeline candidates But two small biotechs just might beat both of these big companies in
AGN,AGN:US,BBG000FH8PX5,Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?,2016-12-17 12:35:35 +0000,http://www.fool.com/investing/2016/12/17/could-these-2-small-biotechs-beat-allergan-and-gil.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Allergan plc to Contact the Firm before Lead Plaintiff Deadline",2016-12-17 00:55:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-005500197.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 16, 2016 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allergan plc (""Allergan"" or the ""Company"") (NYSE: ..."
AGN,AGN:US,BBG000FH8PX5,Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga,2016-12-16 21:06:43 +0000,http://www.investors.com/news/technology/mylan-launching-cheaper-epipen-generic-amid-drug-pricing-saga/,Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga
AGN,AGN:US,BBG000FH8PX5,Actavis UK accused of overcharging hydrocortisone drug,2016-12-16 17:10:28 +0000,http://sg.finance.yahoo.com/news/actavis-uk-accused-overcharging-hydrocortisone-165335692.html,Actavis UK accused of overcharging hydrocortisone drug
AGN,AGN:US,BBG000FH8PX5,Actavis UK accused of overcharging hydrocortisone drug,2016-12-16 16:53:38 +0000,http://finance.yahoo.com/news/actavis-uk-accused-overcharging-hydrocortisone-165335548.html,Actavis UK accused of overcharging hydrocortisone drug
AGN,AGN:US,BBG000FH8PX5,Allergan's Stock Price Can't Make Up Its Mind,2016-12-16 16:33:00 +0000,http://www.investopedia.com/news/allergan-continues-trade-undecidedly-agn/?partner=YahooSA,Allergan's Stock Price Can't Make Up Its Mind
AGN,AGN:US,BBG000FH8PX5,"Actavis UK raised drug prices 12,000 percent, watchdog finds",2016-12-16 11:27:30 +0000,http://sg.finance.yahoo.com/news/actavis-uk-raised-drug-prices-083232463.html,"Actavis UK raised drug prices 12,000 percent, watchdog finds"
AGN,AGN:US,BBG000FH8PX5,"Actavis UK raised drug prices 12,000 pct, watchdog finds",2016-12-16 10:28:10 +0000,http://uk.finance.yahoo.com/news/actavis-uk-raised-drug-prices-083021302.html,"[Reuters - UK Focus] - Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday. Higher prices ..."
AGN,AGN:US,BBG000FH8PX5,3 Biggest Risks for Celgene Corporation,2016-12-15 22:57:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QhdjBxoJAEE/3-biggest-risks-for-celgene-corporation-cm722198,There are few stocks that I am as bullish about as Celgene NASDAQ CELG The biotech has enjoyed strong earnings growth thanks to dominance of its blood cancer treatment Revlimid and the tremendous success of autoimmune disease drug Otezla However like any other company
AGN,AGN:US,BBG000FH8PX5,"[$$] Allergan Agrees to $38 Million Settlement Over Marketing, Sales Practices",2016-12-15 21:21:05 +0000,http://www.wsj.com/articles/allergan-agrees-to-38-million-settlement-linked-to-marketing-sales-practices-1481834795?mod=yahoo_hs,"[$$] Allergan Agrees to $38 Million Settlement Over Marketing, Sales Practices"
AGN,AGN:US,BBG000FH8PX5,Allegan announces $38 mln civil settlement with government over subsidiaries' sales and marketing practices,2016-12-15 19:39:45 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0F0EF57D-0308-4F9A-BB60-DD333E01BC1F&siteid=yhoof2,Allegan announces $38 mln civil settlement with government over subsidiaries' sales and marketing practices
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Civil Resolution Concluding Federal Investigation into Forest Sales & Marketing Practices,2016-12-15 19:18:00 +0000,http://finance.yahoo.com/news/allergan-announces-civil-resolution-concluding-191800613.html,"[PR Newswire] - DUBLIN, Dec. 15, 2016 /PRNewswire/ -- Allergan plc (AGN) today announced that its indirect subsidiaries Forest Laboratories, LLC and Forest Pharmaceuticals, Inc. (collectively, ""Forest"") have reached a civil resolution with the federal government, concluding a previously disclosed federal investigation into certain sales and marketing practices involving three Forest products, Bystolic®, Savella® and Namenda®, during the time period January 1, 2008 through December 31, 2011. Under the terms of the settlement agreement, Forest will pay a total of $38,000,000 to the federal government and any Settling States to resolve all civil claims. The settlements will resolve claims stemming from instances in which Forest allegedly lacked adequate controls over payments made to physicians for conducting speaker programs. Forest Laboratories, LLC previously recorded charges for the entire settlement amount in connection with the government's investigation. The agreement will not affect Allergan's ongoing business with any customers, including the government."
AGN,AGN:US,BBG000FH8PX5,"U.S. states sue Mylan, Teva, others for fixing drug prices",2016-12-15 19:06:32 +0000,http://finance.yahoo.com/news/u-states-sue-mylan-teva-164431362.html,"[Reuters] - Two years after high generic drug prices became a public controversy, legal cases are starting to land. Twenty states filed a lawsuit Thursday against Mylan NV , Teva Pharmaceuticals and four other generic drug makers, saying they conspired over steak dinners and ""girls nights out"" on pricing of two common generic drugs, according to a copy of the complaint."
AGN,AGN:US,BBG000FH8PX5,Favorite Healthcare Stocks of Billionaire Seth Klarman’s Baupost Group,2016-12-15 19:01:02 +0000,http://www.insidermonkey.com/blog/favorite-healthcare-stocks-of-billionaire-seth-klarmans-baupost-group-489908/,Favorite Healthcare Stocks of Billionaire Seth Klarman’s Baupost Group
AGN,AGN:US,BBG000FH8PX5,U.S. says Allergan's Forest units to pay $38 mln to settle kickback allegations,2016-12-15 17:20:52 +0000,http://finance.yahoo.com/news/u-says-allergans-forest-units-172052337.html,"[Reuters] - Allergan PLC's Forest Laboratories and Forest Pharmaceuticals units will pay $38 million to settle U.S. charges that it paid physicians to prescribe three medications, the U.S. Justice Department said ..."
AGN,AGN:US,BBG000FH8PX5,A Primer On NASH,2016-12-15 14:47:50 +0000,http://finance.yahoo.com/news/primer-nash-144750419.html,A Primer On NASH
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: Need to shift industry from treatments to cures,2016-12-15 14:11:29 +0000,http://finance.yahoo.com/video/allergan-ceo-shift-industry-treatments-141129642.html,Allergan CEO: Need to shift industry from treatments to cures
AGN,AGN:US,BBG000FH8PX5,Trending: Transportation and Steel Industries Prepare for Trumponomics,2016-12-15 13:00:00 +0000,http://finance.yahoo.com/news/trending-transportation-steel-industries-prepare-130000236.html,Trending: Transportation and Steel Industries Prepare for Trumponomics
AGN,AGN:US,BBG000FH8PX5,"Alan Fournier Exits 4 Positions, Reduces 3 Others",2016-12-14 22:43:26 +0000,http://finance.yahoo.com/news/alan-fournier-exits-4-positions-224326160.html,"Alan Fournier Exits 4 Positions, Reduces 3 Others"
AGN,AGN:US,BBG000FH8PX5,"DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall",2016-12-14 21:22:02 +0000,http://www.investors.com/news/technology/doj-charges-pharma-execs-with-price-fixing-teva-mylan-stocks-topple/,"DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall"
AGN,AGN:US,BBG000FH8PX5,Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Allergan PLC Investors and Encourages Investors to Contact the Firm,2016-12-14 18:59:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-announces-185900183.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Allergan PLC securities between February 25, 2014 and November 3, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,Billionaire David Tepper’s ETF Killer Stock Picks,2016-12-14 14:12:59 +0000,http://www.insidermonkey.com/blog/billionaire-david-teppers-etf-killer-stock-picks-508193/,Billionaire David Tepper’s ETF Killer Stock Picks
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: This group’s out of the penalty box and on ...,2016-12-14 00:00:00 +0000,http://finance.yahoo.com/video/cramer-remix-group-penalty-box-000000862.html,Cramer Remix: This group’s out of the penalty box and on ...
AGN,AGN:US,BBG000FH8PX5,"After Hours Most Active for Dec 13, 2016 :  QQQ, SWN, MSFT, GE, AGN, V, CHK, XRX, CSCO, AAPL, INTC, AAXJ",2016-12-13 21:56:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cci8USJ5MAM/after-hours-most-active-for-dec-13-2016-qqq-swn-msft-ge-agn-v-chk-xrx-csco-aapl-intc-aaxj-cm720995,The NASDAQ 100 After Hours Indicator is up 99 to 4 936 83 The total After hours volume is currently 35 998 926 shares traded The following are the most active stocks for the after hours session PowerShares QQQ Trust Series 1 QQQ is 0 023 at 120 48 with 2 886
AGN,AGN:US,BBG000FH8PX5,Why These Billionaire Seth Klarman’s Stock Picks Deserve Your Attention,2016-12-13 18:50:11 +0000,http://www.insidermonkey.com/blog/why-these-billionaire-seth-klarmans-stock-picks-deserve-your-attention-506289/,Why These Billionaire Seth Klarman’s Stock Picks Deserve Your Attention
AGN,AGN:US,BBG000FH8PX5,"SPYG, SBUX, AGN, NKE: Large Outflows Detected at ETF",2016-12-13 16:59:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q7Sqo8OMIxA/spyg-sbux-agn-nke-large-outflows-detected-at-etf-cm720756,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P 500 Growth ETF Symbol SPYG where we have detected an approximate 31 9 million dollar outflow that s a 4 4 decrease week over week from 6 800
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals: Round and Round and Round We Go,2016-12-13 14:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/13/valeant-pharmaceuticals-round-and-round-and-round-we-go/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Round and Round and Round We Go
AGN,AGN:US,BBG000FH8PX5,Betting Responsibly on Healthcare,2016-12-13 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=781320&SR=Yahoo,Betting Responsibly on Healthcare
AGN,AGN:US,BBG000FH8PX5,Top 10 Holdings of Our Ultimate Stock-Pickers' Index,2016-12-13 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=784462&SR=Yahoo,Top 10 Holdings of Our Ultimate Stock-Pickers' Index
AGN,AGN:US,BBG000FH8PX5,Eli Lilly Offers Discount for Insulin,2016-12-13 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HFgOzuJJZP8/eli-lilly-offers-discount-for-insulin-20161213-00412,Eli Lilly Offers Discount for Insulin
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) & Lead Plaintiff Deadline: January 3, 2017",2016-12-12 15:05:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150500764.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 12, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Lonza Nears Deal to Buy KKR's Capsugel,2016-12-11 19:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yDIS7DLAdt0/lonza-nears-deal-to-buy-kkrs-capsugel-20161211-00064,Lonza Nears Deal to Buy KKR's Capsugel
AGN,AGN:US,BBG000FH8PX5,"PRO Weekly Digest: Revisiting Healthcare Ideas, Plus Some Of Our Top Articles This Week",2016-12-11 11:56:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t6haUSQWVR0/pro-weekly-digest-revisiting-healthcare-ideas-plus-some-of-our-top-articles-this-week-cm719806,By SA PRO Editors BySA PRO Editors Welcome to the latest issue of the PRO Weekly Digest Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users we publish highlights from our PRO coverage as well as feature interviews and other
AGN,AGN:US,BBG000FH8PX5,Will Trump Break With Republicans And Push Major Drug Price Reform?,2016-12-10 14:42:35 +0000,http://www.investors.com/news/technology/will-trump-break-with-republicans-to-champion-against-drug-prices/,Will Trump Break With Republicans And Push Major Drug Price Reform?
AGN,AGN:US,BBG000FH8PX5,Nippon Telegraph & Telephone Corp (ADR) (NTT): Are Hedge Funds Right About This Stock?,2016-12-10 13:25:58 +0000,http://www.insidermonkey.com/blog/nippon-telegraph-telephone-corp-adr-ntt-are-hedge-funds-right-about-this-stock-504849/,Nippon Telegraph & Telephone Corp (ADR) (NTT): Are Hedge Funds Right About This Stock?
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN,2016-12-10 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010000330.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 9, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) and ..."
AGN,AGN:US,BBG000FH8PX5,Record-setting stock streak hits sixth day on broad gains,2016-12-09 21:40:42 +0000,http://sg.finance.yahoo.com/news/health-stocks-rebound-us-indexes-150712805.html,Record-setting stock streak hits sixth day on broad gains
AGN,AGN:US,BBG000FH8PX5,Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents,2016-12-09 21:12:00 +0000,https://www.thestreet.com/story/13921090/1/allergan-unhappy-with-patent-office-decision-to-allow-mylan-challenge-to-restasis-patents.html?puc=yahoo&cm_ven=YAHOO,Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents
AGN,AGN:US,BBG000FH8PX5,Can Trump Solve Pfizer's $80 Billion Problem?,2016-12-09 15:48:57 +0000,http://www.fool.com/investing/2016/12/09/can-trump-solve-pfizers-80-billion-problem.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Can Trump Solve Pfizer's $80 Billion Problem?
AGN,AGN:US,BBG000FH8PX5,Allergan Shares Are Up 4% After Analyst Comments,2016-12-09 15:10:00 +0000,http://www.investopedia.com/news/allergan-jumps-early-trading-agn/?partner=YahooSA,Allergan Shares Are Up 4% After Analyst Comments
AGN,AGN:US,BBG000FH8PX5,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN,2016-12-09 00:07:28 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-000728894.html,"[GlobeNewswire] - NEW YORK, Dec. 08, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Allergan plc and/or Actavis plc ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Says Dissapointed In PTAB's Decision On RESTASIS Patents,2016-12-09 00:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DORB_yJb9Yk/allergan-says-dissapointed-in-ptabs-decision-on-restasis-patents-20161209-00003,Allergan Says Dissapointed In PTAB's Decision On RESTASIS Patents
AGN,AGN:US,BBG000FH8PX5,Health care sector suffers: Time to buy the dip?,2016-12-08 21:18:00 +0000,http://finance.yahoo.com/video/health-care-sector-suffers-time-211800961.html,Health care sector suffers: Time to buy the dip?
AGN,AGN:US,BBG000FH8PX5,Allergan Talks Strategy at Citi Conference,2016-12-08 21:15:00 +0000,http://www.investopedia.com/news/allergan-talks-strategy-citi-conference-agn/?partner=YahooSA,Allergan Talks Strategy at Citi Conference
AGN,AGN:US,BBG000FH8PX5,Allergan Comments on PTAB Decision Regarding Mylan's Petitions for Inter Partes Review (IPR) of RESTASIS® Patents,2016-12-08 20:39:00 +0000,http://finance.yahoo.com/news/allergan-comments-ptab-decision-regarding-203900309.html,"[PR Newswire] - DUBLIN, Dec. 8, 2016 /PRNewswire/ -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, today announced the U.S. Patent & Trademark Office's Patent Trial and Appeal Board (PTAB) granted ..."
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm",2016-12-08 17:07:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-170700450.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 8, 2016 / Khang & Khang LLP (the ""Firm"") announces a class action lawsuit against Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) ..."
AGN,AGN:US,BBG000FH8PX5,The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Allergan PLC Investors and Encourages Investors to Contact the Firm,2016-12-08 15:30:00 +0000,http://finance.yahoo.com/news/law-offices-howard-g-smith-153000932.html,"[Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Allergan PLC securities between February 25, 2014 and November 3, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,Should Biotech Investors Worry About Donald Trump?,2016-12-08 15:01:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kPsuChBg-A8/should-biotech-investors-worry-about-donald-trump-cm718499,The biotech sector got a major wake up call yesterday President elect Donald Trump does not like price increases Biotech stocks which enjoy huge profit margins under current law had jumped 9 the day after Trump s election reflecting relief that the price controls that Hillary Clinton
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Citi Global Conference; Webcast At 11:00 AM ET,2016-12-08 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l5MStizNt60/allergan-to-present-at-citi-global-conference-webcast-at-1100-am-et-20161208-00607,Allergan To Present At Citi Global Conference; Webcast At 11:00 AM ET
AGN,AGN:US,BBG000FH8PX5,"Aegon Accelerates US Restructuring, Expects to Cut 500 Jobs",2016-12-08 08:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hDRWKVkwOPw/aegon-accelerates-us-restructuring-expects-to-cut-500-jobs-20161208-00379,"Aegon Accelerates US Restructuring, Expects to Cut 500 Jobs"
AGN,AGN:US,BBG000FH8PX5,"Aegon NV To Cut 500 Jobs; To Exit Affinity, Direct TV And Direct Mail Channels",2016-12-08 07:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/87_T-04cGwk/aegon-nv-to-cut-500-jobs-to-exit-affinity-direct-tv-and-direct-mail-channels-20161208-00240,"Aegon NV To Cut 500 Jobs; To Exit Affinity, Direct TV And Direct Mail Channels"
AGN,AGN:US,BBG000FH8PX5,Correction to Novo Nordisk Pledges to Limit Price Increases in US for Its Drugs Story on Tuesday,2016-12-08 06:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wu5QwPvw-Oo/correction-to-novo-nordisk-pledges-to-limit-price-increases-in-us-for-its-drugs-story-on-tuesday-20161208-00141,Correction to Novo Nordisk Pledges to Limit Price Increases in US for Its Drugs Story on Tuesday
AGN,AGN:US,BBG000FH8PX5,"DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Allergan plc To Contact The Firm",2016-12-08 03:00:00 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-alerts-030000560.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Allergan plc securities during the period between February 25, 2014 and November 2, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,Trump Warns Investors &quot;I'm Going To Bring Down Drug Prices&quot;,2016-12-07 23:57:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fBuuciNiDss/trump-warns-investors-im-going-to-bring-down-drug-prices-cm718362,Time magazine s Person of the Year President elect Donald Trump just dropped a bomb on biotech and pharmaceutical industry CEO s and investors During an interview with Time Trump suggested that it s a bad bet to bank on him as being friendly to drug companies at least in
AGN,AGN:US,BBG000FH8PX5,"Trump Warns Investors ""I'm Going To Bring Down Drug Prices""",2016-12-07 22:02:07 +0000,http://www.fool.com/investing/2016/12/07/trump-warns-investors-im-going-to-bring-down-drug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Trump Warns Investors ""I'm Going To Bring Down Drug Prices"""
AGN,AGN:US,BBG000FH8PX5,Biotech analyst: Republicans will protect drug companies from Trump,2016-12-07 18:50:00 +0000,http://finance.yahoo.com/news/biotech-analyst-republicans-protect-drug-185000966.html,Biotech analyst: Republicans will protect drug companies from Trump
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s End-Of-Year Switch Of Generics CEO Surprises Investors,2016-12-07 18:36:58 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-tevas-end-of-year-switch-of-generics-ceo-surprises-investors-500807/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s End-Of-Year Switch Of Generics CEO Surprises Investors
AGN,AGN:US,BBG000FH8PX5,S&P 500 Analyst Moves: AGN,2016-12-07 17:57:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vCa87KtwhfM/sp-500-analyst-moves-agn-cm718100,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Allergan AGN is now the 85 analyst pick moving up by 1 spot This rank is formed by averaging the analyst opinions for each component from each broker
AGN,AGN:US,BBG000FH8PX5,Drug pressure deja vu?,2016-12-07 17:07:00 +0000,http://finance.yahoo.com/video/drug-pressure-deja-vu-170700183.html,Drug pressure deja vu?
AGN,AGN:US,BBG000FH8PX5,Don't Expect Allergan To Rebound In 2017,2016-12-07 16:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/07/dont-expect-allergan-to-rebound-in-2017/?mod=yahoobarrons&ru=yahoo,Don't Expect Allergan To Rebound In 2017
AGN,AGN:US,BBG000FH8PX5,Teva Copaxone EU Label to Omit Pregnancy Contraindication,2016-12-07 16:00:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qH8ieVntLC4/teva-copaxone-eu-label-to-omit-pregnancy-contraindication-cm717944,Teva Pharmaceutical Industries Ltd TEVA announced that it has received a positive outcome to remove the pregnancy contraindication from the label of its key drug Copaxone in the EU The latest label update will improve the safety and tolerability profile of the multiple sclerosis drug
AGN,AGN:US,BBG000FH8PX5,Piper Jaffray Negative On Allergan (AGN),2016-12-07 14:56:00 +0000,http://www.investopedia.com/news/allergan-down-negative-analyst-comments-agn/?partner=YahooSA,Piper Jaffray Negative On Allergan (AGN)
AGN,AGN:US,BBG000FH8PX5,TRUMP: 'I’m going to bring down drug prices',2016-12-07 14:18:47 +0000,http://finance.yahoo.com/news/trump-m-going-bring-down-141847678.html,TRUMP: 'I’m going to bring down drug prices'
AGN,AGN:US,BBG000FH8PX5,Teva Copaxone EU Label to Omit Pregnancy Contraindication,2016-12-07 14:05:02 +0000,http://finance.yahoo.com/news/teva-copaxone-eu-label-omit-140502061.html,Teva Copaxone EU Label to Omit Pregnancy Contraindication
AGN,AGN:US,BBG000FH8PX5,3 Beaten-Down Generic Drugmakers to Buy,2016-12-06 21:27:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eme2rex36mo/3-beaten-down-generic-drugmakers-to-buy-cm717611,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Earlier in November some of the largest firms in the generic drugs firm space received subpoenas from the U S Justice Department The Justice Department is alleging that certain generic drugmakers may
AGN,AGN:US,BBG000FH8PX5,Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today,2016-12-06 21:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IYEMPdp1iM8/heres-why-teva-pharmaceuticals-teva-stock-is-down-today-cm717403,Shares of Teva Pharmaceutical Industries TEVA slipped over 5 8 in morning trading Tuesday after the company announced a change in upper level management Teva is replacing the chief executive of its global generics group Siggi Olafsson with Dipankar Bhattacharjee the current chief of
AGN,AGN:US,BBG000FH8PX5,5 Best Large-Caps To Buy According To This Billionaire,2016-12-06 18:20:43 +0000,http://www.insidermonkey.com/blog/5-best-large-caps-to-buy-according-to-this-billionaire-499830/,5 Best Large-Caps To Buy According To This Billionaire
AGN,AGN:US,BBG000FH8PX5,Teva shares plummet after key departure in generics business,2016-12-06 16:11:33 +0000,http://www.cnbc.com/id/104149679?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104149679,Teva shares plummet after key departure in generics business
AGN,AGN:US,BBG000FH8PX5,Novo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs,2016-12-06 15:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wd-tHD63scU/novo-nordisk-pledges-to-limit-price-increases-in-us-for-its-drugs-20161206-00988,Novo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs
AGN,AGN:US,BBG000FH8PX5,Questions Mount at Teva as Generics Head Quits Without Explanation,2016-12-06 15:05:00 +0000,https://www.thestreet.com/story/13915892/1/questions-mount-at-teva-amid-c-suite-change.html?puc=yahoo&cm_ven=YAHOO,Questions Mount at Teva as Generics Head Quits Without Explanation
AGN,AGN:US,BBG000FH8PX5,Allergan's Strength Lies In Its New Products And Robust Pipeline,2016-12-05 17:04:26 +0000,http://finance.yahoo.com/news/allergans-strength-lies-products-robust-170426655.html,Allergan's Strength Lies In Its New Products And Robust Pipeline
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017",2016-12-05 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000242.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 5, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Amgen/Allergan File for EU Approval of Avastin Biosimilar,2016-12-05 14:36:02 +0000,http://finance.yahoo.com/news/amgen-allergan-file-eu-approval-143602758.html,Amgen/Allergan File for EU Approval of Avastin Biosimilar
AGN,AGN:US,BBG000FH8PX5,JP Morgan Positive on Allergan (AGN),2016-12-05 14:15:00 +0000,http://www.investopedia.com/news/allergan-viewed-positively-jp-morgan-agn/?partner=YahooSA,JP Morgan Positive on Allergan (AGN)
AGN,AGN:US,BBG000FH8PX5,"Amgen, Allergan File for Avastin Biosimilar in EU (AGN)",2016-12-05 13:47:00 +0000,http://www.investopedia.com/news/amgen-allergan-seek-eu-ok-avastin-biosimilar-amgn/?partner=YahooSA,"Amgen, Allergan File for Avastin Biosimilar in EU (AGN)"
AGN,AGN:US,BBG000FH8PX5,5 Healthcare Stocks Billionaires Love The Most,2016-12-04 23:05:39 +0000,http://www.insidermonkey.com/blog/5-healthcare-stocks-billionaires-love-the-most-494391/,5 Healthcare Stocks Billionaires Love The Most
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN,2016-12-03 01:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010300295.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 2, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) and ..."
AGN,AGN:US,BBG000FH8PX5,Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts,2016-12-02 21:32:18 +0000,http://www.investors.com/news/technology/shire-loses-ground-to-allergan-in-thanksgiving-week-dry-eye-scripts/,Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
AGN,AGN:US,BBG000FH8PX5,"Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter",2016-12-02 20:49:51 +0000,http://finance.yahoo.com/news/oaktree-reduces-cuts-multiple-positions-204951222.html,"Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter"
AGN,AGN:US,BBG000FH8PX5,Billionaire Investors Are Bullish On These 5 Stocks,2016-12-02 15:59:50 +0000,http://www.insidermonkey.com/blog/billionaire-investors-are-bullish-on-these-5-stocks-493425/,Billionaire Investors Are Bullish On These 5 Stocks
AGN,AGN:US,BBG000FH8PX5,"Allergan & Amgen Looking for Approvals (AGN, AMGN)",2016-12-02 14:53:00 +0000,http://www.investopedia.com/news/allergan-amgen-file-abp-215-agn-amgn/?partner=YahooSA,"Allergan & Amgen Looking for Approvals (AGN, AMGN)"
AGN,AGN:US,BBG000FH8PX5,"Amgen, Allergan apply for European nod for Avastin biosimilar",2016-12-02 14:33:15 +0000,http://finance.yahoo.com/news/amgen-allergan-apply-european-nod-143315960.html,"[Reuters] - Amgen Inc and Allergan Plc said they have submitted an application to the European health regulator seeking approval of their biosimilar version of Roche Holding AG's blockbuster cancer treatment, Avastin. The submission is based on the results of a late-stage study that showed Amgen and Allergan's ABP 215 was as safety and effective as Avastin in patients with the most common form of lung cancer. Avastin is also approved for use by patients with cancer of the colon, kidney, ovarian and breast."
AGN,AGN:US,BBG000FH8PX5,"Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab",2016-12-02 14:00:00 +0000,http://finance.yahoo.com/news/amgen-allergan-submit-biosimilar-marketing-140000270.html,"[PR Newswire] - THOUSAND OAKS, Calif., Dec. 2, 2016 /PRNewswire/ -- Amgen (AMGN) and Allergan plc. (AGN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ABP 215, a biosimilar candidate to Avastin® (bevacizumab). ""The submission of ABP 215 to the EMA is an important milestone as Amgen seeks to expand our oncology portfolio,"" said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen."
AGN,AGN:US,BBG000FH8PX5,"Stock Futures Hold Lower After U.S. Adds 178,000 Jobs",2016-12-02 13:36:00 +0000,https://www.thestreet.com/story/13911403/1/stock-futures-step-back-ahead-of-u-s-jobs-report.html?puc=yahoo&cm_ven=YAHOO,"Stock Futures Hold Lower After U.S. Adds 178,000 Jobs"
AGN,AGN:US,BBG000FH8PX5,The 10 Best Healthcare Stocks to Buy for 2017,2016-12-02 12:54:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tLw6HuwfLDU/the-10-best-healthcare-stocks-to-buy-for-2017-cm716729,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When Donald Trump ended up defeating Hillary Clinton earlier this month in their bid for the U S presidency it wasn t just voters who were thrown for a loop investors were a bit shocked too Most
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2016-12-02 12:45:59 +0000,http://biz.yahoo.com/e/161202/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
AGN,AGN:US,BBG000FH8PX5,Allergan Provides Update on Accelerated Share Repurchase (ASR) Program,2016-12-02 12:30:00 +0000,http://finance.yahoo.com/news/allergan-provides-accelerated-share-repurchase-123000320.html,"[PR Newswire] - DUBLIN, Dec. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today provided additional information on its previously announced Accelerated Share Repurchase (ASR) ..."
AGN,AGN:US,BBG000FH8PX5,Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis treatment,2016-12-02 12:20:38 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=30A10CE3-4520-40FE-89EA-157BDF5F0177&siteid=yhoof2,Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis treatment
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation,2016-12-02 12:00:00 +0000,http://finance.yahoo.com/news/allergan-announces-settlement-delzicol-mesalamine-120000042.html,"[PR Newswire] - DUBLIN, Dec. 2, 2016 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, and its subsidiaries today announced that they, along with Qualicaps Co., Ltd., have reached a settlement regarding their litigation with Zydus Pharmaceuticals (USA) Inc., and Cadila Healthcare Limited relating to United States Patent No. 6,649,180 and Allergan's DELZICOL® (mesalamine) product. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Settlement Of Patent Litigation On DELZICOL,2016-12-02 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BgaYH6lfwDw/allergan-announces-settlement-of-patent-litigation-on-delzicol-20161202-00155,Allergan Announces Settlement Of Patent Litigation On DELZICOL
AGN,AGN:US,BBG000FH8PX5,Pharma execs weigh in on possible changes under Trump,2016-12-01 23:36:25 +0000,http://sg.finance.yahoo.com/news/allergan-ceo-expects-drug-industry-192405801.html,Pharma execs weigh in on possible changes under Trump
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: We're in era of populism & drug industry is...,2016-12-01 22:17:00 +0000,http://finance.yahoo.com/video/allergan-ceo-were-era-populism-221700283.html,Allergan CEO: We're in era of populism & drug industry is...
AGN,AGN:US,BBG000FH8PX5,Allergan CEO expects drug industry to face pricing heat from Trump,2016-12-01 19:22:20 +0000,http://finance.yahoo.com/news/allergan-ceo-expects-drug-industry-192220357.html,"[Reuters] - U.S. President-elect Donald Trump could be more critical of drugmakers and their price increases than the industry expects, Allergan Inc Chief Executive Brent Saunders said on Thursday. Saunders, speaking at the annual Forbes Healthcare Summit in New York, predicted Trump could be a ""more vicious tweeter"" against the drug industry than his former Democratic rival Hillary Clinton had been during the campaign. Clinton's tweets committing to a crackdown on exorbitant price increases weighed heavily on pharmaceutical shares."
AGN,AGN:US,BBG000FH8PX5,The Deal Economy Event Is Live,2016-12-01 15:31:00 +0000,https://www.thestreet.com/story/13910941/1/the-deal-economy-event-is-live.html?puc=yahoo&cm_ven=YAHOO,The Deal Economy Event Is Live
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017",2016-12-01 15:19:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151900762.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 1, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: 'I worry today that pharma has a false sense of relief or security' with Trump presidency,2016-12-01 14:18:50 +0000,http://finance.yahoo.com/news/allergan-ceo-worry-today-pharma-141850122.html,Allergan CEO: 'I worry today that pharma has a false sense of relief or security' with Trump presidency
AGN,AGN:US,BBG000FH8PX5,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report,2016-11-30 22:03:47 +0000,http://www.investors.com/news/technology/valeant-takeda-salix-negotiations-bust-on-10-billion-price-report/,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
AGN,AGN:US,BBG000FH8PX5,"Can Bill Ackman Revive Chipotle Mexican Grill, Inc. (CMG) Stock?",2016-11-30 18:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xoAVMPLVOuc/can-bill-ackman-revive-chipotle-mexican-grill-inc-cmg-stock-cm715893,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The last 12 months haven t been great ones for either Bill Ackman or Chipotle Mexican Grill Inc NYSE CMG In 2015 Ackman s Pershing Square lost 20 of its value As of October it was down
AGN,AGN:US,BBG000FH8PX5,Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock,2016-11-30 17:06:00 +0000,http://www.forbes.com/sites/kenkam/2016/11/30/allergans-ceo-signals-confidence-with-1-million-purchase-of-stock/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock
AGN,AGN:US,BBG000FH8PX5,Allergan Seeks to Reassure Antsy Investors but Will They Buy It?,2016-11-30 16:24:00 +0000,https://www.thestreet.com/story/13909291/1/allergan-seeks-to-reassure-antsy-investors-but-will-they-buy-it.html?puc=yahoo&cm_ven=YAHOO,Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
AGN,AGN:US,BBG000FH8PX5,November Buffett-Munger Bargain Newsletter is Ready for Download,2016-11-30 15:53:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i6Iwl8TjlrE/november-buffett-munger-bargain-newsletter-is-ready-for-download-cm715525,This month s Newsletter is about a company that both Warren Buffet and Charlie Munger Trades Portfolio have invested in Various issues obscure the true earnings power of the business causing the company to trade at less than 6x a conservative estimate of sustainable owner
AGN,AGN:US,BBG000FH8PX5,Steady Rise: Allergan’s International Segment in 3Q16,2016-11-30 13:05:14 +0000,http://marketrealist.com/2016/11/allergans-international-segment-3q16/?utm_source=yahoo&utm_medium=feed,Steady Rise: Allergan’s International Segment in 3Q16
AGN,AGN:US,BBG000FH8PX5,Falling Revenue in Allergan’s US General Medicines Segment,2016-11-29 22:04:05 +0000,http://marketrealist.com/2016/11/allergans-us-general-medicines-segment-3q16/?utm_source=yahoo&utm_medium=feed,Falling Revenue in Allergan’s US General Medicines Segment
AGN,AGN:US,BBG000FH8PX5,"Q3 Shows Hedge Funds Abandoning Healthcare Stocks (AGN, EBAY)",2016-11-29 20:45:00 +0000,http://www.investopedia.com/news/q3-shows-hedge-funds-abandoning-healthcare-stocks-agn-ebay/?partner=YahooSA,"Q3 Shows Hedge Funds Abandoning Healthcare Stocks (AGN, EBAY)"
AGN,AGN:US,BBG000FH8PX5,Pfizer (PFE) Stock Rating Upgraded at Barclays,2016-11-29 19:18:00 +0000,https://www.thestreet.com/story/13908006/1/pfizer-pfe-stock-rating-upgraded-at-barclays.html?puc=yahoo&cm_ven=YAHOO,Pfizer (PFE) Stock Rating Upgraded at Barclays
AGN,AGN:US,BBG000FH8PX5,Understanding Allergan’s 3Q16 Revenue Stream,2016-11-29 18:27:03 +0000,http://marketrealist.com/2016/11/understanding-allergans-3q16-revenue-stream/?utm_source=yahoo&utm_medium=feed,Understanding Allergan’s 3Q16 Revenue Stream
AGN,AGN:US,BBG000FH8PX5,Analyzing Allergan’s Growth Pharma Plans,2016-11-29 18:26:59 +0000,http://marketrealist.com/2016/11/analyzing-allergans-growth-pharma-plans/?utm_source=yahoo&utm_medium=feed,Analyzing Allergan’s Growth Pharma Plans
AGN,AGN:US,BBG000FH8PX5,Allergan’s News: Recent Acquisitions and Divestments,2016-11-29 18:26:50 +0000,http://marketrealist.com/2016/11/allergans-news-recent-acquisitions-divestments/?utm_source=yahoo&utm_medium=feed,Allergan’s News: Recent Acquisitions and Divestments
AGN,AGN:US,BBG000FH8PX5,Allergan’s Valuation Compared to Its Peers,2016-11-29 18:26:47 +0000,http://marketrealist.com/2016/11/allergans-valuation-compared-peers/?utm_source=yahoo&utm_medium=feed,Allergan’s Valuation Compared to Its Peers
AGN,AGN:US,BBG000FH8PX5,Weekly CEO Buys Highlight,2016-11-29 15:55:29 +0000,http://finance.yahoo.com/news/weekly-ceo-buys-highlight-155529196.html,Weekly CEO Buys Highlight
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at 2016 Citi Global Healthcare Conference,2016-11-29 12:30:00 +0000,http://finance.yahoo.com/news/allergan-present-2016-citi-global-123000594.html,"[PR Newswire] - Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day."
AGN,AGN:US,BBG000FH8PX5,"Carl Icahn Nearly Exits Allergan Position in Q3 (AGN, HLF)",2016-11-29 12:00:00 +0000,http://www.investopedia.com/news/carl-icahn-nearly-exits-allergan-position-q3-agn-hlf/?partner=YahooSA,"Carl Icahn Nearly Exits Allergan Position in Q3 (AGN, HLF)"
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for Alphabet, Deere & Bristol-Myers",2016-11-28 23:55:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F1vWyRhFVnE/top-research-reports-for-alphabet-deere-bristol-myers-cm714803,Monday November 28 2016 Today s Research Daily features new research reports on 16 major stocks including Bristol Myers BMY Google GOOGL and Deere DE Bristol Myers shares have underperformed the broader market as well as the large cap pharma group this year though the stock
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for Alphabet, Deere & Bristol-Myers",2016-11-28 20:06:08 +0000,http://finance.yahoo.com/news/top-research-reports-alphabet-deere-200608145.html,"Top Research Reports for Alphabet, Deere & Bristol-Myers"
AGN,AGN:US,BBG000FH8PX5,3 Stocks That Had Billionaires Running for the Exit in Q3,2016-11-28 18:31:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A8DyPw0NoN8/3-stocks-that-had-billionaires-running-for-the-exit-in-q3-cm714582,Image source Getty Images A little more than a week ago the 13F filing deadline with the Securities and Exchange Commission came and passed These filings allow Wall Street and investors to get an under the hood look at what institutional money managers with 100 million or more
AGN,AGN:US,BBG000FH8PX5,5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy,2016-11-28 18:11:26 +0000,http://www.insidermonkey.com/blog/5-healthcare-stocks-hedge-funds-are-dumping-like-crazy-492511/,5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy
AGN,AGN:US,BBG000FH8PX5,3 Stocks That Had Billionaires Running for the Exit in Q3,2016-11-28 17:01:00 +0000,http://www.fool.com/investing/2016/11/28/3-stocks-that-had-billionaires-running-for-the-exi.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Stocks That Had Billionaires Running for the Exit in Q3
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF",2016-11-28 15:32:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jXY0HwZ0e7M/pharma-stock-roundup-lilly-alzheimers-drug-fails-jj-in-acquisition-talks-with-aliof-cm714418,The big news last week was the high profile failure of Lilly s LLY investigational Alzheimer s disease drug solanezumab While the news dented Lilly s shares with the stock touching a 52 week low other companies involved in developing Alzheimer s disease treatments were also not spared
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline",2016-11-28 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000994.html,"[GlobeNewswire] - NEW YORK, Nov. 28, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC and/or Actavis plc and certain of ..."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF",2016-11-28 13:49:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-lilly-alzheimers-134901886.html,"Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF"
AGN,AGN:US,BBG000FH8PX5,Is Nike Inc (NKE) Worthy of Your Portfolio?,2016-11-28 01:25:34 +0000,http://www.insidermonkey.com/blog/is-nike-inc-nke-worthy-of-your-portfolio-490111/,Is Nike Inc (NKE) Worthy of Your Portfolio?
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – AGN",2016-11-27 11:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-110000556.html,"[GlobeNewswire] - STEVENSON, Md., Nov. 27, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline – AGN,2016-11-26 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010000123.html,"[GlobeNewswire] - NEW YORK, Nov. 25, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc and certain of its officers. The class action, filed in United States District Court, Southern ..."
AGN,AGN:US,BBG000FH8PX5,"Ken Fisher Continues to Buy Allergan, HP, Lowe's",2016-11-25 23:21:03 +0000,http://finance.yahoo.com/news/ken-fisher-continues-buy-allergan-232103776.html,"Ken Fisher Continues to Buy Allergan, HP, Lowe's"
AGN,AGN:US,BBG000FH8PX5,"[$$] Clinical Development News, Nov. 21-25",2016-11-25 22:12:41 +0000,http://www.wsj.com/articles/clinical-development-news-nov-21-25-1480111955?mod=yahoo_hs,"[$$] Clinical Development News, Nov. 21-25"
AGN,AGN:US,BBG000FH8PX5,Allergan Could Pay $1 Billion for Chase Pharma,2016-11-25 19:00:00 +0000,http://realmoney.thestreet.com/articles/11/25/2016/allergan-could-pay-1-billion-chase-pharma?puc=yahoo&cm_ven=YAHOO,Allergan Could Pay $1 Billion for Chase Pharma
AGN,AGN:US,BBG000FH8PX5,Hedge Funds Aren’t Crazy About Accenture Plc (ACN) Anymore,2016-11-24 16:28:42 +0000,http://www.insidermonkey.com/blog/hedge-funds-arent-crazy-about-accenture-plc-acn-anymore-491140/,Hedge Funds Aren’t Crazy About Accenture Plc (ACN) Anymore
AGN,AGN:US,BBG000FH8PX5,"Sensex Drops 100 Points As Rupee Hits 9-month Low; Nifty Below 8,000",2016-11-23 23:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jBQMMpfZ1UA/sensex-drops-100-points-as-rupee-hits-9month-low-nifty-below-8000-20161123-00784,"Sensex Drops 100 Points As Rupee Hits 9-month Low; Nifty Below 8,000"
AGN,AGN:US,BBG000FH8PX5,Allergan Makes Yet Another Acquisition,2016-11-23 22:00:08 +0000,http://www.investopedia.com/stock-analysis/112316/allergan-makes-yet-another-acquisition-agn.aspx?partner=YahooSA,Allergan Makes Yet Another Acquisition
AGN,AGN:US,BBG000FH8PX5,Lilly's drug for Alzheimer's fails big trial; shares drop,2016-11-23 21:25:38 +0000,http://sg.finance.yahoo.com/news/lillys-drug-alzheimers-fails-big-190703746.html,Lilly's drug for Alzheimer's fails big trial; shares drop
AGN,AGN:US,BBG000FH8PX5,FDA Approves Allergan's Xen Glaucoma Stent (AGN),2016-11-23 20:50:00 +0000,http://www.investopedia.com/news/allergans-xen-glaucoma-injector-gets-fda-ok-agn/?partner=YahooSA,FDA Approves Allergan's Xen Glaucoma Stent (AGN)
AGN,AGN:US,BBG000FH8PX5,"Should You Avoid Allergan, Inc. (AGN)?",2016-11-23 19:13:22 +0000,http://www.insidermonkey.com/blog/should-you-avoid-allergan-inc-agn-489654/,"Should You Avoid Allergan, Inc. (AGN)?"
AGN,AGN:US,BBG000FH8PX5,Targeted Acquisitions Have Strengthened Teva’s Generic Business,2016-11-23 18:04:21 +0000,http://marketrealist.com/2016/11/targeted-acquisitions-strengthened-teva-pharmaceuticals-generic-business-2016/?utm_source=yahoo&utm_medium=feed,Targeted Acquisitions Have Strengthened Teva’s Generic Business
AGN,AGN:US,BBG000FH8PX5,Allergan Buys Alzheimer's Drug Maker for $125M (AGN),2016-11-23 17:58:00 +0000,http://www.investopedia.com/news/allergan-buys-chase-pharmaceuticals-125m-agn/?partner=YahooSA,Allergan Buys Alzheimer's Drug Maker for $125M (AGN)
AGN,AGN:US,BBG000FH8PX5,[$$] Four traders exit Paulson & Co's London office,2016-11-23 17:10:28 +0000,"http://www.ft.com/cms/s/b2c6a4bc-b190-11e6-9c37-5787335499a0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Four traders at Paulson & Co's London office have left this month as the shrinking New York-based hedge fund continues to downsize. Assets under management at the merger arbitrage fund, run by billionaire ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN",2016-11-23 15:27:00 +0000,http://finance.yahoo.com/news/allergan-plc-investors-losses-excess-152700098.html,"[PR Newswire] - NEW YORK, Nov. 23, 2016 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc (NYSE- AGN) and/or Actavis plc between February 25, 2014 ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Acquires Chase Pharma, Expands CNS Portfolio",2016-11-23 15:07:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZD5XIl7yPc/allergan-acquires-chase-pharma-expands-cns-portfolio-cm713191,Allergan plc AGN announced that it has acquired Chase Pharmaceuticals Corporation a clinical stage biopharmaceutical company that focuses on the development of treatments for Alzheimer s disease As per the terms of the agreement Allergan provided an upfront payment of 125 million and
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017",2016-11-23 15:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150300622.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 23, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Acquires Chase Pharma, Expands CNS Portfolio",2016-11-23 12:59:12 +0000,http://finance.yahoo.com/news/allergan-acquires-chase-pharma-expands-125912339.html,"Allergan Acquires Chase Pharma, Expands CNS Portfolio"
AGN,AGN:US,BBG000FH8PX5,"Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals",2016-11-23 11:00:00 +0000,https://www.thestreet.com/story/13903359/1/jim-cramer-s-top-takeaways-home-depot-corbus-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals"
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease,2016-11-22 22:25:21 +0000,http://www.publicnow.com/view/0BA07CD96FE44259BF984426443945883E1F8DD7,"[at noodls] - DUBLIN, Nov. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has completed the acquisition of Chase Pharmaceuticals Corporation, a clinical-stage ..."
AGN,AGN:US,BBG000FH8PX5,CEO Saunders' Stake Fails to Bolster Allergan,2016-11-22 19:12:00 +0000,https://www.thestreet.com/story/13902982/1/ceo-saunders-stake-fails-to-bolster-allergan.html?puc=yahoo&cm_ven=YAHOO,CEO Saunders' Stake Fails to Bolster Allergan
AGN,AGN:US,BBG000FH8PX5,Is Donald Trump a Blessing or a Curse for Big Pharma?,2016-11-22 17:27:40 +0000,http://www.fool.com/investing/2016/11/22/is-donald-trump-a-blessing-or-a-curse-for-big-phar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Donald Trump a Blessing or a Curse for Big Pharma?
AGN,AGN:US,BBG000FH8PX5,Teva's Leukemia Drug Gets EU Approval in First-Line Setting,2016-11-22 15:22:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fa9RVWjLN1g/tevas-leukemia-drug-gets-eu-approval-in-first-line-setting-cm712595,Teva Pharmaceutical Industries Ltd TEVA announced that the European Commission EC has approved a label expansion of Trisenox Now Trisenox in combination with retinoic acid can be used for the first line treatment of low to intermediate risk Acute Promyelocytic Leukemia APL Trisenox
AGN,AGN:US,BBG000FH8PX5,Allergan's Fibristal Approved in Canada for Label Expansion,2016-11-22 15:22:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xW5ZJPej1cw/allergans-fibristal-approved-in-canada-for-label-expansion-cm712589,Allergan plc AGN announced that it has received approval from Health Canada to expand the label of its drug Fibristal for the long term treatment of signs and symptoms of uterine fibroids Fibristal is already approved for the treatment of signs and symptoms of uterine fibroids However now
AGN,AGN:US,BBG000FH8PX5,"The Chief Executive Officers of These Four Companies Buy Shares, Plus Insider Selling at Sanmina Corp (SANM)",2016-11-22 14:41:22 +0000,http://www.insidermonkey.com/blog/the-chief-executive-officers-of-these-four-companies-buy-shares-plus-insider-selling-at-sanmina-corp-sanm-489506/,"The Chief Executive Officers of These Four Companies Buy Shares, Plus Insider Selling at Sanmina Corp (SANM)"
AGN,AGN:US,BBG000FH8PX5,"Allergan Receives FDA Clearance for the XEN® Gel Stent, a New Surgical Treatment for Refractory Glaucoma",2016-11-22 13:33:16 +0000,http://www.publicnow.com/view/0E55EEE93B9108F87980584D47651E27CB6233A8,"[at noodls] - DUBLIN, Nov. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today the U.S. Food and Drug Administration (FDA) has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent ..."
AGN,AGN:US,BBG000FH8PX5,Allergan's Fibristal Approved in Canada for Label Expansion,2016-11-22 13:16:01 +0000,http://finance.yahoo.com/news/allergans-fibristal-approved-canada-label-131601424.html,Allergan's Fibristal Approved in Canada for Label Expansion
AGN,AGN:US,BBG000FH8PX5,Allergan Gets FDA Clearance For Xen Glaucoma Treatment,2016-11-22 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kv8tbxik61U/allergan-gets-fda-clearance-for-xen-glaucoma-treatment-20161122-00424,Allergan Gets FDA Clearance For Xen Glaucoma Treatment
AGN,AGN:US,BBG000FH8PX5,Should You Follow Ionic Capital Management’s Lead And Cut Exposure To Allergan (AGN) & Three Other Stocks?,2016-11-22 00:45:39 +0000,http://www.insidermonkey.com/blog/should-you-follow-ionic-capital-managements-lead-and-cut-exposure-to-allergan-agn-three-other-stocks-487505/,Should You Follow Ionic Capital Management’s Lead And Cut Exposure To Allergan (AGN) & Three Other Stocks?
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc (AGN) CEO and President Brent L Saunders Bought $992,932 of Shares",2016-11-22 00:15:01 +0000,http://finance.yahoo.com/news/allergan-plc-agn-ceo-president-001501543.html,"Allergan Plc (AGN) CEO and President Brent L Saunders Bought $992,932 of Shares"
AGN,AGN:US,BBG000FH8PX5,Acorda Scrapping Stroke Drug Just 'Small Disappointment': RBC,2016-11-21 21:19:12 +0000,http://www.investors.com/news/technology/acorda-scrapping-stroke-drug-is-small-disappointment-for-cheap-stock/,Acorda Scrapping Stroke Drug Just 'Small Disappointment': RBC
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Expected to Report Robust Revenue in 2016,2016-11-21 18:35:57 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-expected-report-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Expected to Report Robust Revenue in 2016
AGN,AGN:US,BBG000FH8PX5,Spectrum (SPPI) Gets CRL for Bladder Cancer Drug in U.S.,2016-11-21 14:53:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SZQVKL2HDD8/spectrum-sppi-gets-crl-for-bladder-cancer-drug-in-us-cm711821,Spectrum Pharmaceuticals Inc SPPI announced that it has received a Complete Response Letter CRL from the FDA for its New Drug Application NDA for Qapzola apaziquone The company was looking to get Qapzola approved for the immediate intravesical instillation post
AGN,AGN:US,BBG000FH8PX5,Cardinal Health Inc (CAH) Stock Looks Healthy in the Long Term,2016-11-21 13:56:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/it7dq2IFSwo/cardinal-health-inc-cah-stock-looks-healthy-in-the-long-term-cm711794,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When the polls suggested Hillary Clinton would take the election pharmaceutical stocks felt the pressure and Cardinal Health Inc NYSE CAH was no exception Near
AGN,AGN:US,BBG000FH8PX5,"FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment",2016-11-21 13:00:00 +0000,http://finance.yahoo.com/news/fibristal-first-only-medication-indicated-130000772.html,"[CNW Group] - FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment"
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Additional Approval From Health Canada For FIBRISTAL,2016-11-21 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9K5Z3A_iJSg/allergan-reports-additional-approval-from-health-canada-for-fibristal-20161121-00357,Allergan Reports Additional Approval From Health Canada For FIBRISTAL
AGN,AGN:US,BBG000FH8PX5,Weekly Top Insider Buys Highlight for Week of Nov. –8,2016-11-20 22:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qmEo7z6U4B4/weekly-top-insider-buys-highlight-for-week-of-nov-8-cm711721,Largest Insider Buys for Allergan PLC AGN Mondelez International Inc MDLZ Enterprise Products Partners LP EPD and Occidental Petroleum Corp OXY Allergan PLC AGN CFO Maria Teresa Hilado Bought 4 Shares CFO Maria Teresa Hilado bought 4 shares
AGN,AGN:US,BBG000FH8PX5,Sales of Allergan's Older Drugs Dwindle (AGN),2016-11-20 14:00:00 +0000,http://www.investopedia.com/news/allergans-older-drugs-face-new-threats-agn/?partner=YahooSA,Sales of Allergan's Older Drugs Dwindle (AGN)
AGN,AGN:US,BBG000FH8PX5,Weekly Top Insider Buys Highlight for Week of Nov. 18,2016-11-20 01:10:00 +0000,http://finance.yahoo.com/news/weekly-top-insider-buys-highlight-011000902.html,Weekly Top Insider Buys Highlight for Week of Nov. 18
AGN,AGN:US,BBG000FH8PX5,"INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",2016-11-19 04:45:00 +0000,http://finance.yahoo.com/news/investor-alert-brower-piven-encourages-044500793.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Allergan plc securities during the period between February 25, 2014 and November 2, 2016, inclusive ."
AGN,AGN:US,BBG000FH8PX5,No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass,2016-11-19 02:00:00 +0000,https://www.thestreet.com/story/13900102/1/no-to-closed-end-muni-bond-funds-cara-on-a-run-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN,2016-11-19 01:06:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010600082.html,"[PR Newswire] - NEW YORK, Nov. 18, 2016 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08661, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Allergan securities between February 25, 2014 and November 2, 2016, both dates inclusive (the ""Class Period""), seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934. If you are a shareholder who purchased Allergan securities during the Class Period, you have until January 3, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext."
AGN,AGN:US,BBG000FH8PX5,NOTICE TO ALLERGAN CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Allergan Savings and Investment Plan for Possible ERISA Violations,2016-11-18 23:45:00 +0000,http://finance.yahoo.com/news/notice-allergan-current-former-employees-234500558.html,[Business Wire] - Zamansky LLC announces that it has commenced an investigation of Allergan plc on behalf of its current and former employees over the Allergan Savings and Investment Plan for potential violations of the federal Employee Retirement Income Security Act .
AGN,AGN:US,BBG000FH8PX5,"After Hours Most Active for Nov 18, 2016 :  F, BAC, FB, AAPL, RAD, SLQD, AGN, CTL, COWN, NBL, QQQ, AMAT",2016-11-18 21:59:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WGUNx0zrCHI/after-hours-most-active-for-nov-18-2016-f-bac-fb-aapl-rad-slqd-agn-ctl-cown-nbl-qqq-amat-cm711488,The NASDAQ 100 After Hours Indicator is up 1 34 to 4 809 38 The total After hours volume is currently 26 897 130 shares traded The following are the most active stocks for the after hours session Ford Motor Company F is unchanged at 11 76 with 2 317 499 shares
AGN,AGN:US,BBG000FH8PX5,Drugmaker losses pull stocks lower; small-cap surge goes on,2016-11-18 21:42:36 +0000,http://sg.finance.yahoo.com/news/us-stocks-hardly-move-energy-145917790.html,Drugmaker losses pull stocks lower; small-cap surge goes on
AGN,AGN:US,BBG000FH8PX5,Valeant: The Shorts Are Back in Town,2016-11-18 16:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/18/valeant-the-shorts-are-back-in-town/?mod=yahoobarrons&ru=yahoo,Valeant: The Shorts Are Back in Town
AGN,AGN:US,BBG000FH8PX5,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3,2016-11-18 15:51:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3RyrNMN2fdU/3-big-drug-stocks-that-billionaire-money-managers-dumped-in-q3-cm711210,Image source Getty Images It s that time of the quarter again folks the filing of 13Fs with the Securities and Exchange Commission by institutional money managers with more than 100 million under management The release of 13Fs is highly anticipated because it gives Wall Street
AGN,AGN:US,BBG000FH8PX5,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3,2016-11-18 14:03:00 +0000,http://www.fool.com/investing/2016/11/18/3-big-drug-stocks-that-billionaire-money-managers.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal",2016-11-18 13:51:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rzqSEN84ZPw/pharma-stock-roundup-data-presented-at-acr-bristol-myers-inks-immuno-oncology-deal-cm711052,Several companies were present at the annual meeting of the American College of Rheumatology ACR presenting data on approved as well as pipeline candidates Meanwhile Bristol Myers BMY announced an immune oncology deal and also provided updates on some of its cancer treatments Recap of
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal",2016-11-18 11:22:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-data-presented-112211338.html,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal"
AGN,AGN:US,BBG000FH8PX5,13Fs: Nobody Holds A Monopoly On Brainpower,2016-11-17 20:27:00 +0000,http://www.forbes.com/sites/martinsosnoff/2016/11/17/13fs-nobody-holds-a-monopoly-on-brainpower/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,13Fs: Nobody Holds A Monopoly On Brainpower
AGN,AGN:US,BBG000FH8PX5,[$$] Teva Takes a Tumble,2016-11-17 18:15:00 +0000,http://www.barrons.com/articles/teva-takes-a-tumble-1479406538?mod=yahoobarrons&ru=yahoo,[$$] Teva Takes a Tumble
AGN,AGN:US,BBG000FH8PX5,Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study,2016-11-17 17:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SDkDXfPWt00/amgens-migraine-drug-hits-primary-endpoint-in-strive-study-cm710685,Amgen Inc AMGN announced top line data from a phase III study STRIVE which showed that its calcitonin gene related peptide CGRP receptor erenumab significantly reduced monthly migraine days in patients with episodic migraine Erenumab is being evaluated in two phase III studies for
AGN,AGN:US,BBG000FH8PX5,"Top Hedge Funds Buy P&G, Apple, BABA But Shed Healthcare",2016-11-17 17:24:00 +0000,http://blogs.barrons.com/focusonfunds/2016/11/17/top-hedge-funds-buy-pg-apple-baba-but-shed-healthcare/?mod=yahoobarrons&ru=yahoo,"Top Hedge Funds Buy P&G, Apple, BABA But Shed Healthcare"
AGN,AGN:US,BBG000FH8PX5,NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe,2016-11-17 16:00:00 +0000,http://www.bloomberg.com/news/articles/2016-11-17/nypd-union-goes-after-drug-prices-amid-doj-pharma-investigation?cmpid=yhoo.headline,NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe
AGN,AGN:US,BBG000FH8PX5,Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study,2016-11-17 15:14:03 +0000,http://finance.yahoo.com/news/amgens-migraine-drug-hits-primary-151403648.html,Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study
AGN,AGN:US,BBG000FH8PX5,"Carl Icahn Buys More Herbalife (HLF), Hertz (HTZ), Unloads Energy Stocks",2016-11-17 15:07:30 +0000,http://www.insidermonkey.com/blog/carl-icahn-buys-more-herbalife-hlf-hertz-htz-unloads-energy-stocks-488684/,"Carl Icahn Buys More Herbalife (HLF), Hertz (HTZ), Unloads Energy Stocks"
AGN,AGN:US,BBG000FH8PX5,"The Conference Board Leading Economic Index® for Brazil, Together with Fundação Getulio Vargas (TCB/FGV Brazil LEI), Increased",2016-11-17 15:00:00 +0000,http://finance.yahoo.com/news/allergan-acquires-topical-dermatology-company-203000500.html,"[PR Newswire] - NEW YORK, Nov. 17, 2016 /PRNewswire/ -- The Conference Board Leading Economic Index ® for Brazil, together with Fundação Getulio Vargas (TCB/FGV Brazil LEI), increased 0.1 percent in October to 99.9 (2010=100). ..."
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Piper Jaffray 28th Annual Healthcare Conference,2016-11-17 12:30:00 +0000,http://finance.yahoo.com/news/allergan-present-piper-jaffray-28th-123000684.html,"[PR Newswire] - Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day."
AGN,AGN:US,BBG000FH8PX5,"Amgen, Novartis aim for big, crowded migraine market after new drug data",2016-11-17 09:47:15 +0000,http://finance.yahoo.com/news/amgen-novartis-aim-big-crowded-094715360.html,"Amgen, Novartis aim for big, crowded migraine market after new drug data"
AGN,AGN:US,BBG000FH8PX5,John Griffin Gains 3 Positions in 3rd Quarter,2016-11-16 23:13:25 +0000,http://finance.yahoo.com/news/john-griffin-expands-portfolio-3rd-231325585.html,John Griffin Gains 3 Positions in 3rd Quarter
AGN,AGN:US,BBG000FH8PX5,"How This Fund’s Bets on Allergan, Inc. (AGN), Charter Communications, Inc. (CHTR) & Two Other Stocks Pay Off?",2016-11-16 18:27:59 +0000,http://www.insidermonkey.com/blog/how-this-funds-bets-on-allergan-inc-agn-charter-communications-inc-chtr-two-other-stocks-pay-off-485959/,"How This Fund’s Bets on Allergan, Inc. (AGN), Charter Communications, Inc. (CHTR) & Two Other Stocks Pay Off?"
AGN,AGN:US,BBG000FH8PX5,Amgen Files for Avastin Biosimilar; Repatha Data Positive,2016-11-16 15:53:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGc4ehw4k_A/amgen-files-for-avastin-biosimilar-repatha-data-positive-cm710019,Amgen Inc AMGN along with its partner Allergan plc AGN announced the submission of a Biologics License Application BLA to the FDA for its biosimilar version of Roche Holding AG s RHHBY Avastin bevacizumab ABP 215 ABP 215 is the most advanced oncology biosimilar in Amgen
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017",2016-11-16 15:02:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150200153.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 16 , 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Allergan PLC (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings,2016-11-16 14:43:02 +0000,http://finance.yahoo.com/news/6-things-know-tevas-teva-144302626.html,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings
AGN,AGN:US,BBG000FH8PX5,"Amgen Files BLA for Avastin Biosimilar (AMGN, AGN)",2016-11-16 14:02:00 +0000,http://www.investopedia.com/news/amgen-allergan-unveil-avastin-copycat-amgn-agn/?partner=YahooSA,"Amgen Files BLA for Avastin Biosimilar (AMGN, AGN)"
AGN,AGN:US,BBG000FH8PX5,"Teva Pharmaceutical (TEVA) Beats on Q3 Earnings, Cuts View",2016-11-16 13:51:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z1bL4GeFYyI/teva-pharmaceutical-teva-beats-on-q3-earnings-cuts-view-cm709844,Teva Pharmaceutical Industries Ltd TEVA reported third quarter earnings of 1 28 per share including equity compensation expenses which beat the Zacks Consensus Estimate of 1 27 However revenues of 5 6 billion missed the Zacks Consensus Estimate of 5 90 billion On a year over
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improve Patient-Physician Conversations About Irritable Bowel Syndrome with Diarrhea (IBS-D)",2016-11-16 13:18:03 +0000,http://www.publicnow.com/view/A9D5A2E425ACC5C0DDC651E9B8B3C7DF91028EFC,"[at noodls] - DUBLIN, Nov. 16, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced a national partnership with Amy Dixon, world champion paratriathlete and irritable bowel syndrome with diarrhea (IBS-D) patient. ..."
AGN,AGN:US,BBG000FH8PX5,Amgen Files for Avastin Biosimilar; Repatha Data Positive,2016-11-16 13:17:01 +0000,http://finance.yahoo.com/news/amgen-files-avastin-biosimilar-repatha-131701212.html,Amgen Files for Avastin Biosimilar; Repatha Data Positive
AGN,AGN:US,BBG000FH8PX5,Medicines360 and Allergan Announce Study Publication Evaluating Pelvic Infection Risk Following Same-Day Sexually Transmitted Infection Testing and LILETTA (levonorgestrel-releasing intrauterine system) 52 mg Placement,2016-11-16 13:00:00 +0000,http://finance.yahoo.com/news/medicines360-allergan-announce-study-publication-130000344.html,"[PR Newswire] - SAN FRANCISCO and DUBLIN, Nov. 16, 2016 /PRNewswire/ -- Medicines360, a nonprofit global women's health pharmaceutical company, and Allergan, plc (AGN), a leading global pharmaceutical company, today announced the publication of, ""A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement"" in the November, 2016 medical journal, American Journal of Obstetrics & Gynecology. The study evaluated the relationship of chlamydia and gonorrhea screening to pelvic infection for up to 2 years following placement of the LILETTA levonorgestrel intrauterine system (IUS) 52 mg during the ACCESS IUS (A Comprehensive Contraceptive Efficacy and Safety Study of an IUS) clinical trial (study ongoing for 7 years)."
AGN,AGN:US,BBG000FH8PX5,"All Is Well With ACRS, First Avastin Biosimilar In The Works, CLRB Abuzz",2016-11-16 00:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vhyY5TVA16c/all-is-well-with-acrs-first-avastin-biosimilar-in-the-works-clrb-abuzz-20161116-00005,"All Is Well With ACRS, First Avastin Biosimilar In The Works, CLRB Abuzz"
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-11-15 21:37:47 +0000,http://biz.yahoo.com/e/161115/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers"
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 11/15/2016: ABT,STJ,JNJ,JNP,AGN,TSRO",2016-11-15 21:30:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9VQxGMR1JDQ/health-care-sector-update-for-11152016-abtstjjnjjnpagntsro-cm709694,Top Health Care StocksTop Health Care Stocks JNJ 0 35 JNJ 0 35 PFE 0 68 PFE 0 68 MRK 1 54 MRK 1 54 ABT 1 51 ABT 1 51 AMGN 0 29 AMGN 0 29 Health care stocks turned narrowly higher this afternoon reversing prior declines with the NYSE Health Care Index adding about 0 1 while
AGN,AGN:US,BBG000FH8PX5,Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 215 To U.S. Food And Drug Administration,2016-11-15 21:18:24 +0000,http://www.publicnow.com/view/D4ABCEC00232F1E1B83A77DF8B4BC62234209A41,"[at noodls] - THOUSAND OAKS, Calif., Nov. 15, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration ..."
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 11/15/2016: AMRN,JNP,AGN,TSRO",2016-11-15 18:49:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h05FbLcVNd8/health-care-sector-update-for-11152016-amrnjnpagntsro-cm709600,Top Health Care StocksTop Health Care Stocks JNJ 0 61 JNJ 0 61 PFE 1 34 PFE 1 34 MRK 0 77 MRK 0 77 ABT 0 40 ABT 0 40 AMGN 0 29 AMGN 0 29 Health care stocks were narrowly lower this afternoon with the NYSE Health Care Index slipping about 0 3 while shares of health care companies
AGN,AGN:US,BBG000FH8PX5,"S&P 500 Movers: ENDP, AAP",2016-11-15 17:28:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UGTO5ALULGA/sp-500-movers-endp-aap-cm709504,In early trading on Tuesday shares of Advance Auto Parts AAP topped the list of the day s best performing components of the S amp P 500 index trading up 14 3 Year to date Advance Auto Parts registers a 8 5 gain And the worst performing S amp P 500 component thus far on the day
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough,2016-11-15 16:10:47 +0000,http://www.fool.com/investing/2016/11/15/teva-pharmaceutical-industries-ltd-q3-helped-by-ac.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough
AGN,AGN:US,BBG000FH8PX5,Teva trims 2016 outlook on drug launch delays,2016-11-15 15:49:34 +0000,http://sg.finance.yahoo.com/news/teva-pharm-third-quarter-beats-124337588.html,Teva trims 2016 outlook on drug launch delays
AGN,AGN:US,BBG000FH8PX5,[$$] Teva Revenue Rises on Allergan Deal,2016-11-15 14:31:29 +0000,http://www.wsj.com/articles/teva-revenue-rises-on-allergan-deal-but-its-specialty-drugs-saw-pressure-1479215460?mod=yahoo_hs,[$$] Teva Revenue Rises on Allergan Deal
AGN,AGN:US,BBG000FH8PX5,Teva Pharm Q3 beats estimates as acquisition lifts revenue,2016-11-15 12:25:42 +0000,http://finance.yahoo.com/news/teva-pharm-q3-beats-estimates-122542304.html,Teva Pharm Q3 beats estimates as acquisition lifts revenue
AGN,AGN:US,BBG000FH8PX5,Juniper Pharmaceuticals Monetizes U.S. Crinone Royalty Stream with Allergan,2016-11-15 11:08:06 +0000,http://www.publicnow.com/view/8CF4BE32E5464F930835FA3C0F107D1202CBCEE5,"[at noodls] - BOSTON, Nov. 15, 2016 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ('Juniper' or the 'Company'), a women's health therapeutics company, today announced it has entered into an agreement with ..."
AGN,AGN:US,BBG000FH8PX5,Teva Revenue Rises on Allergan Deal -- Update,2016-11-15 09:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ruk-ebBxkUI/teva-revenue-rises-on-allergan-deal--update-20161115-00784,Teva Revenue Rises on Allergan Deal -- Update
AGN,AGN:US,BBG000FH8PX5,Teva Revenue Rises on Allergan Deal,2016-11-15 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oecTvL7-mWg/teva-revenue-rises-on-allergan-deal-20161115-00564,Teva Revenue Rises on Allergan Deal
AGN,AGN:US,BBG000FH8PX5,AstraZeneca's Symbicort Positive in Pediatric Asthma Study,2016-11-15 00:27:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W33ck9svw58/astrazenecas-symbicort-positive-in-pediatric-asthma-study-cm709049,AstraZeneca PLC AZN announced phase III study results for its well known product for asthma Symbicort The study showed that the drug improves lung function in pediatric asthma patients aged six to twelve years Results from CHASE 3 phase III study evaluated Symbicort budesonide
AGN,AGN:US,BBG000FH8PX5,AstraZeneca's Symbicort Positive in Pediatric Asthma Study,2016-11-14 22:41:10 +0000,http://finance.yahoo.com/news/astrazenecas-symbicort-positive-pediatric-asthma-224110777.html,AstraZeneca's Symbicort Positive in Pediatric Asthma Study
AGN,AGN:US,BBG000FH8PX5,Carl Icahn Sells Down Most of Allergan Bet,2016-11-14 21:31:12 +0000,http://blogs.wsj.com/moneybeat/2016/11/14/carl-icahn-sells-down-most-of-allergan-bet/?mod=yahoo_hs,Carl Icahn Sells Down Most of Allergan Bet
AGN,AGN:US,BBG000FH8PX5,5 Stocks to Watch that Report Earnings Tomorrow,2016-11-14 21:30:12 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-that-report-earnings-tomorrow-213021033.html,5 Stocks to Watch that Report Earnings Tomorrow
AGN,AGN:US,BBG000FH8PX5,Could Trump 'Make Drug Development Great Again'?,2016-11-14 21:06:56 +0000,http://www.investors.com/news/technology/could-trump-make-drug-development-great-again-biotechs-see-rally/,Could Trump 'Make Drug Development Great Again'?
AGN,AGN:US,BBG000FH8PX5,5 Reasons to Buy 5 Low P/E Biotech ETFs,2016-11-14 18:29:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m-WpRAqTBCc/5-reasons-to-buy-5-low-pe-biotech-etfs-cm708807,With Trump winning the U S presidential election the biotech and pharma sectors have regained their lost ground Since Clinton who has long been vocal against the price gouging issue in the pharma sector is no more threat to the sector pharma and biotech stocks should get a break
AGN,AGN:US,BBG000FH8PX5,REUTERS SUMMIT-Omega's Einhorn sees Trump's policies boosting stocks,2016-11-14 18:15:47 +0000,http://uk.finance.yahoo.com/news/reuters-summit-omegas-einhorn-sees-174711149.html,REUTERS SUMMIT-Omega's Einhorn sees Trump's policies boosting stocks
AGN,AGN:US,BBG000FH8PX5,Fidelity Healthcare Fund: 5 Things You Should Know,2016-11-14 14:30:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-AguBvxurhg/fidelity-healthcare-fund-5-things-you-should-know-cm708469,Image source Getty Images The Fidelity Select Health Care Fund NASDAQMUTFUND FSPHX is one of the best performing Fidelity mutual funds helped by the strong performance of healthcare stocks and stock selection that puts it among the top healthcare mutual funds on the market
AGN,AGN:US,BBG000FH8PX5,Adriane M. Brown to Join Allergan plc Board of Directors,2016-11-14 13:17:09 +0000,http://www.publicnow.com/view/EE8DE3EBB5EB719E45008EED4F40CCAE00B87D77,"[at noodls] - DUBLIN, Nov. 14, 2016 /PRNewswire/ -- Allergan plc (NYSE:AGN) today announced that Adriane M. Brown will join its board of directors effective February 2017. Ms. Brown is currently President and Chief ..."
AGN,AGN:US,BBG000FH8PX5,3 Drugmakers That Probably Have Lower Tax Rates Than You Do,2016-11-13 14:28:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zWT8LCWdwHg/3-drugmakers-that-probably-have-lower-tax-rates-than-you-do-cm708324,How much did you pay in taxes last year If you paid any taxes at all there s a good chance that your effective tax rate was higher than the tax rates of three huge drugmakers Amgen NASDAQ AMGN Eli Lilly NYSE LLY and Gilead Sciences NASDAQ GILD And one
AGN,AGN:US,BBG000FH8PX5,3 Drugmakers That Probably Have Lower Tax Rates Than You Do,2016-11-13 12:45:29 +0000,http://www.fool.com/investing/2016/11/13/3-drugmakers-that-probably-have-lower-tax-rates-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Drugmakers That Probably Have Lower Tax Rates Than You Do
AGN,AGN:US,BBG000FH8PX5,Weitz Funds Comments on Allergan,2016-11-12 15:27:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5BhYR0qiA40/weitz-funds-comments-on-allergan-cm708253,Allergan NYSE AGN is a global specialty pharmaceutical company focusing on the development manufacturing marketing and distribution of brand name biosimilar and over the counter OTC pharmaceutical products One week after closing the sale of Actavis generics to Teva
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data on BYSTOLIC® (nebivolol) at Annual American Heart Association Meeting (AHA) in New Orleans,2016-11-12 13:00:00 +0000,http://finance.yahoo.com/news/allergan-present-data-bystolic-nebivolol-130000507.html,"[PR Newswire] - DUBLIN, Nov. 12, 2016 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company today announced that data on nebivolol will be presented at the American Heart Association (AHA) Annual Scientific Meeting scheduled November 12-16th, 2016 in New Orleans, Louisiana, at the Ernest N. Morial Convention Center. Nebivolol is approved and marketed in the US as BYSTOLIC for the treatment of hypertension to lower blood pressure."
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm",2016-11-12 00:40:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-004000094.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 11, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Allergan plc (""Allergan"" or the ""Company"") ..."
AGN,AGN:US,BBG000FH8PX5,AGN LOSS ALERT: Rosen Law Firm Reminds Allergan PLC Investors of Important Deadline in Class Action Filed by Firm - AGN,2016-11-11 23:21:00 +0000,http://finance.yahoo.com/news/agn-loss-alert-rosen-law-232100964.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc and/or Actavis plc between February 25, 2014 and November 3, 2016, both dates inclusive of the important January 3, 2017 lead plaintiff deadline in the class action filed by the firm."
AGN,AGN:US,BBG000FH8PX5,3 Biotech Stocks You MUST Buy for Donald Trump’s Presidency,2016-11-11 20:29:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XGKLDkkun44/3-biotech-stocks-you-must-buy-for-donald-trumps-presidency-cm707294,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The biotech industry has been dealt a Trump card Wednesday Now it s your turn to vote and go long in a much more hospitable environment in these three large cap biotech stocks Source Pixelbay
AGN,AGN:US,BBG000FH8PX5,Trouble Developing for Generic Pharma Stocks?,2016-11-11 19:50:39 +0000,http://finance.yahoo.com/tumblr/blog-trouble-developing-for-generic-pharma-stocks-195047922.html,Trouble Developing for Generic Pharma Stocks?
AGN,AGN:US,BBG000FH8PX5,Weitz Funds Comments on Allergan,2016-11-11 17:17:23 +0000,http://finance.yahoo.com/news/weitz-funds-comments-allergan-171723139.html,Weitz Funds Comments on Allergan
AGN,AGN:US,BBG000FH8PX5,Weitz Balanced Fund 3rd Quarter Commentary,2016-11-11 17:09:43 +0000,http://finance.yahoo.com/news/weitz-balanced-fund-3rd-quarter-170943983.html,[Gurufocus] - Overview of quarter and holdings
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm",2016-11-11 17:04:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-170400026.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / November 11, 2016 / Khang & Khang LLP (the ""Firm"") announces a class action lawsuit against Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) ..."
AGN,AGN:US,BBG000FH8PX5,Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep,2016-11-11 14:35:07 +0000,http://247wallst.com/healthcare-business/2016/11/11/top-biotech-and-health-care-stocks-set-to-run-on-huge-republican-sweep/,Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep
AGN,AGN:US,BBG000FH8PX5,Allergan Shows Strong Presence at the AASLD Liver Meeting with Data in Poster Sessions and an Oral Plenary Presentation,2016-11-11 13:01:00 +0000,http://finance.yahoo.com/news/allergan-shows-strong-presence-aasld-130100991.html,"[PR Newswire] - DUBLIN, Nov. 11, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to the research and development of new treatments for gastrointestinal diseases, today ..."
AGN,AGN:US,BBG000FH8PX5,5 Stocks to Watch on Icahn & Paulson's Gain from Trump Win,2016-11-11 00:13:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cq1urjneTuw/5-stocks-to-watch-on-icahn-paulsons-gain-from-trump-win-cm707515,Major U S benchmarks witnessed a remarkable rebound from their pre market losses on Wednesday to log gains of more than 1 after Donald Trump was declared victorious in the Presidential election Trump s pledge of expanding infrastructure spending and promise of reducing corporate taxes played
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline",2016-11-10 22:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-223000518.html,"[PR Newswire] - NEW YORK, Nov. 10, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allergan plc (""Allergan"" or the ""Company"") (AGN) of the January 3, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased Allergan stock or options between February 25, 2014 and November 3, 2016 (the ""Class Period""). The case, Haile, Jr. v. Allergan plc et al, No. 1:16-cv-08661 was filed on November 8, 2016."
AGN,AGN:US,BBG000FH8PX5,Pfizer Spikes On Report It's Mulling $14 Billion Consumer Care Sale,2016-11-10 22:19:33 +0000,http://www.investors.com/news/technology/pfizer-spikes-on-report-its-mulling-14-billion-consumer-care-sale/,Pfizer Spikes On Report It's Mulling $14 Billion Consumer Care Sale
AGN,AGN:US,BBG000FH8PX5,Spa owner who catered to 'Real Housewives' stars pleads guilty over Botox,2016-11-10 21:36:24 +0000,http://finance.yahoo.com/news/spa-owner-catered-real-housewives-213624634.html,"[Reuters] - The owner of a medical spa frequented by stars on Bravo's hit television show ""Real Housewives of Orange County,"" has pleaded guilty to a criminal charge that she purchased Botox with foreign labels, federal prosecutors said Thursday. Bridget ""Gigi"" Goddard, 50, a nurse and the owner of Pure Indulgence Skin Rejuvenation, Inc, in Laguna Niguel, California, pleaded guilty to one felony count of receiving and delivering a misbranded drug, said Eileen Decker, U.S. attorney for the Central District of California. Goddard appeared on the cover of the free ""Orange County Gazette"" magazine in 2009 alongside ""Real Housewives"" stars Lynne Curtin and Jeana Keough."
AGN,AGN:US,BBG000FH8PX5,5 Health Care Stocks Set to Bounce,2016-11-10 20:00:00 +0000,http://realmoney.thestreet.com/articles/11/10/2016/5-health-care-stocks-set-bounce?puc=yahoo&cm_ven=YAHOO,5 Health Care Stocks Set to Bounce
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm",2016-11-10 18:28:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-182800215.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 10, 2016 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Allergan plc (""Allergan"" or the ""Company"") (NYSE: ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Donald Trump's victory provides antidote for US drugmakers,2016-11-10 16:25:55 +0000,"http://www.ft.com/cms/s/3e981008-a6cd-11e6-8b69-02899e8bd9d1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - There were few investors who cheered the election of Donald Trump as much as those who held large positions in pharmaceutical stocks, and his victory has prompted a wave of relief across the sector. Whereas ..."
AGN,AGN:US,BBG000FH8PX5,4 Stocks We're Never Selling,2016-11-10 15:56:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V-BgfjNFF-I/4-stocks-were-never-selling-cm707100,Our contributors say you should put these stocks in your piggy bank and never let them go Image source Getty Images There s a lot of evidence that investors who focus on the long term buying and holding stocks for many years have the best shot at getting the best returns We
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017",2016-11-10 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000497.html,"[GlobeNewswire] - NEW YORK, Nov. 10, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Allergan PLC and/or Actavis plc and certain ..."
AGN,AGN:US,BBG000FH8PX5,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday",2016-11-10 14:56:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nt0jXMlZqJU/why-allergan-horizon-pharma-plc-and-pfizer-all-spiked-wednesday-cm706980,What happened Shares of Allergan NYSE AGN Horizon Pharma plc NASDAQ HZNP and Pfizer NYSE PFE all surged higher yesterday on the news that Donald Trump would become the next president of the United States of America AGN Price
AGN,AGN:US,BBG000FH8PX5,4 Stocks We're Never Selling,2016-11-10 14:14:09 +0000,http://www.fool.com/investing/2016/11/10/4-stocks-were-never-selling.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Stocks We're Never Selling
AGN,AGN:US,BBG000FH8PX5,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday",2016-11-10 13:14:31 +0000,http://www.fool.com/investing/2016/11/10/why-allergan-horizon-pharma-plc-and-pfizer-all-spi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday"
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces Launch of TAYTULLA™ (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule",2016-11-10 13:01:04 +0000,http://www.publicnow.com/view/5FF588BBDC53BC7177ED91D3BB1A4BBEDF1AB5A8,"[at noodls] - DUBLIN, Nov. 10, 2016 /PRNewswire/ -- Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, today announced the availability of TAYTULLA™ (norethindrone acetate and ethinyl estradiol capsules ..."
AGN,AGN:US,BBG000FH8PX5,Q3 2016 Aegon NV Earnings Release - 01:30 am ET,2016-11-10 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20161110.html?t=agn,Q3 2016 Aegon NV Earnings Release - 01:30 am ET
AGN,AGN:US,BBG000FH8PX5,Aegon NV Earnings Call scheduled for 3:00 am ET today,2016-11-10 08:00:00 +0000,http://biz.yahoo.com/cc/2/154902.html,Aegon NV Earnings Call scheduled for 3:00 am ET today
AGN,AGN:US,BBG000FH8PX5,"Aegon Returns to Net Profit in Third Quarter, Shares Up 8%",2016-11-10 03:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/28TTvO01BU0/aegon-returns-to-net-profit-in-third-quarter-shares-up-8-20161110-00145,"Aegon Returns to Net Profit in Third Quarter, Shares Up 8%"
AGN,AGN:US,BBG000FH8PX5,Aegon Turns To Profit In Q3 - Quick Facts,2016-11-10 02:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FzJk6oUumuU/aegon-turns-to-profit-in-q3--quick-facts-20161110-00084,Aegon Turns To Profit In Q3 - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Cramer turns bullish on drug stocks with Trump in the White House,2016-11-09 23:30:06 +0000,http://www.cnbc.com/id/104094621?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104094621,Cramer turns bullish on drug stocks with Trump in the White House
AGN,AGN:US,BBG000FH8PX5,"Cramer and Mohr: Allergan, Apple May Gain from Trump Win",2016-11-09 22:45:00 +0000,http://realmoney.thestreet.com/articles/11/09/2016/cramer-and-mohr-allergan-apple-may-gain-trump-win?puc=yahoo&cm_ven=YAHOO,"Cramer and Mohr: Allergan, Apple May Gain from Trump Win"
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",2016-11-09 22:35:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-223500021.html,"[Business Wire] - Khang & Khang LLP announces a class action lawsuit against Allergan plc and/or Actavis plc. Investors who purchased or otherwise acquired shares between February 25, 2014 and November 3, 2016 inclusive , are encouraged to contact the Firm prior to the January 3, 2017 lead plaintiff motion deadline."
AGN,AGN:US,BBG000FH8PX5,Trump Victory A Step In The Right Direction: Carl Icahn,2016-11-09 21:19:00 +0000,http://www.investopedia.com/news/trump-victory-step-right-direction-carl-icahn-agn-aig/?partner=YahooSA,Trump Victory A Step In The Right Direction: Carl Icahn
AGN,AGN:US,BBG000FH8PX5,Robbins Arroyo LLP: Allergan plc (AGN) Misled Shareholders According to a Recently Filed Class Action,2016-11-09 19:23:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-allergan-plc-192300150.html,[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Allergan plc in the U.S. District Court for the Central District of California.
AGN,AGN:US,BBG000FH8PX5,Drug stocks rip higher after Trump's upset victory signals easing pressure on prices,2016-11-09 17:21:00 +0000,http://finance.yahoo.com/news/drug-company-stocks-soaring-144847328.html,Drug stocks rip higher after Trump's upset victory signals easing pressure on prices
AGN,AGN:US,BBG000FH8PX5,"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm",2016-11-09 17:15:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-171500231.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Allergan plc and/or Actavis plc concerning possible violations of federal securities laws between February 25, 2014 and November 3, 2016 inclusive ."
AGN,AGN:US,BBG000FH8PX5,Teva (TEVA): Can it Keep the Earnings Streak Alive in Q3?,2016-11-09 16:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83DGZSqKNog/teva-teva-can-it-keep-the-earnings-streak-alive-in-q3-cm706520,Teva Pharmaceutical Industries Ltd TEVA will be reporting third quarter 2016 earnings on Nov 15 before market open Last quarter the company delivered a positive earnings surprise of 5 93 The generic drug maker has been consistently beating earnings expectations The company s
AGN,AGN:US,BBG000FH8PX5,INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Allergan plc Investors Concerning Recent Revelations Regarding An Alleged Illegal Conspiracy To Fix Drug Prices,2016-11-09 15:30:00 +0000,http://finance.yahoo.com/news/investor-alert-law-offices-howard-153000246.html,[Business Wire] - Law Offices of Howard G. Smith announces an investigation on behalf of investors of Allergan plc or the “Company”) concerning recent reports that the Company has unlawfully colluded with other pharmaceutical companies to fix generic drug prices.
AGN,AGN:US,BBG000FH8PX5,"Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC",2016-11-09 14:56:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MPshT4BFZf4/drug-stocks-q3-earnings-roster-for-nov-10-avxs-gbt-bpmc-cm706265,The bulk of the Q3 earnings season is over with 423 S amp P 500 members as of Nov 4 accounting for 87 1 of the index s total market capitalization having already reported results according to the latest Earnings Preview While total earnings for these index members were up 3 6 from
AGN,AGN:US,BBG000FH8PX5,Pharma Stocks Gain on U.S. Election Result,2016-11-09 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1S-IrJZIDQ/pharma-stocks-gain-on-us-election-result-20161109-00570,Pharma Stocks Gain on U.S. Election Result
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc – AGN",2016-11-09 03:07:00 +0000,http://finance.yahoo.com/news/allergan-shareholder-alert-former-louisiana-030700338.html,"[GlobeNewswire] - NEW ORLEANS, Nov. 08, 2016-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 3, 2017 to file lead plaintiff ..."
AGN,AGN:US,BBG000FH8PX5,"INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",2016-11-08 23:30:00 +0000,http://finance.yahoo.com/news/investor-alert-goldberg-law-pc-233000146.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc and/or Actavis plc."
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline",2016-11-08 22:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-223000595.html,"[GlobeNewswire] - NEW YORK, Nov. 08, 2016-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allergan plc of the January 3, 2017 deadline to seek the role of lead plaintiff in a federal ..."
AGN,AGN:US,BBG000FH8PX5,Markel's Tom Gayner Buys 4 Stocks During Quarter,2016-11-08 22:07:32 +0000,http://finance.yahoo.com/news/markels-tom-gayner-buys-4-215436684.html,Markel's Tom Gayner Buys 4 Stocks During Quarter
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline – AGN",2016-11-08 21:35:58 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-213558791.html,"[GlobeNewswire] - STEVENSON, Md., Nov. 08, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Mandatory Convertible Preferred Shares, Series A Ex-Dividend Reminder",2016-11-08 21:15:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XdwH6lubk_E/allergan-mandatory-convertible-preferred-shares-series-a-ex-dividend-reminder-cm705801,On 11 10 16 Allergan PLC s 5 500 Mandatory Convertible Preferred Shares Series A Symbol AGN PRA will trade ex dividend for its quarterly dividend of 13 75 payable on 12 1 16 As a percentage of AGN PRA s recent share price of 739 95 this dividend works out to approximately 1 86 so
AGN,AGN:US,BBG000FH8PX5,iShares Global Healthcare ETF Experiences Big Outflow,2016-11-08 19:36:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SzAQiKICFpQ/ishares-global-healthcare-etf-experiences-big-outflow-cm705689,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Global Healthcare ETF Symbol IXJ where we have detected an approximate 136 9 million dollar outflow that s a 9 5 decrease week over week
AGN,AGN:US,BBG000FH8PX5,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses to Contact the Firm,2016-11-08 17:08:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-170800219.html,"[Business Wire] - Khang & Khang LLP announces a class action lawsuit against Allergan plc and/or Actavis plc. Investors who purchased or otherwise acquired shares between February 25, 2014 and November 3, 2016 inclusive , are encouraged to contact the Firm prior to the January 3, 2017 lead plaintiff motion deadline."
AGN,AGN:US,BBG000FH8PX5,Pomerantz Law Firm Announces the Filing of a Class Action against Allergan plc and Certain Officers – AGN,2016-11-08 16:13:07 +0000,http://finance.yahoo.com/news/pomerantz-law-firm-announces-filing-161307220.html,"[GlobeNewswire] - NEW YORK, Nov. 08, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc and certain of its officers. The class action, filed in United States District Court, Southern ..."
AGN,AGN:US,BBG000FH8PX5,"Elliott Management Talks Activism, Korea, and Favorite Stocks",2016-11-08 15:45:43 +0000,http://www.insidermonkey.com/blog/elliott-management-talks-activism-korea-and-favorite-stocks-484389/,"Elliott Management Talks Activism, Korea, and Favorite Stocks"
AGN,AGN:US,BBG000FH8PX5,Is Allergan heading for a rebound?,2016-11-08 14:02:30 +0000,http://finance.yahoo.com/news/allergan-heading-rebound-140230306.html,Is Allergan heading for a rebound?
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Credit Suisse Healthcare Conference; Webcast At 11:00 AM,2016-11-08 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gayrRUf0vGY/allergan-to-present-at-credit-suisse-healthcare-conference-webcast-at-1100-am-20161108-00756,Allergan To Present At Credit Suisse Healthcare Conference; Webcast At 11:00 AM
AGN,AGN:US,BBG000FH8PX5,"Bonuses on Wall Street to Take a Dive (DOW, PFE)",2016-11-08 01:25:00 +0000,http://www.investopedia.com/news/bonuses-wall-street-take-dive-dow-pfe/?partner=YahooSA,"Bonuses on Wall Street to Take a Dive (DOW, PFE)"
AGN,AGN:US,BBG000FH8PX5,1 Reason Behind Allergan's Dreadful October,2016-11-07 22:55:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wh-InCZHWUQ/1-reason-behind-allergans-dreadful-october-cm705295,Image source Getty Images What happened Shares of Botox maker Allergan NYSE AGN shed nearly 14 of their value in October according to data from S amp P Global Market Intelligence AGN data by YCharts The silver lining is
AGN,AGN:US,BBG000FH8PX5,Drugmaker Mylan Slated For Q3 Growth Following Price-Fixing Fracas,2016-11-07 21:05:01 +0000,http://www.investors.com/news/technology/drugmaker-mylan-slated-for-q3-growth-following-price-fixing-fracas/,Drugmaker Mylan Slated For Q3 Growth Following Price-Fixing Fracas
AGN,AGN:US,BBG000FH8PX5,1 Reason Behind Allergan's Dreadful October,2016-11-07 20:53:15 +0000,http://www.fool.com/investing/2016/11/07/1-reason-behind-allergans-dreadful-october.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,1 Reason Behind Allergan's Dreadful October
AGN,AGN:US,BBG000FH8PX5,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses to Contact the Firm,2016-11-07 17:54:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-175400328.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Allergan plc and/or Actavis plc concerning possible violations of federal securities laws between February 25, 2014 and November 3, 2016 inclusive ."
AGN,AGN:US,BBG000FH8PX5,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 17:17:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEFch77D0EY/if-hillary-clinton-wins-these-2-beaten-down-stocks-are-buys-cm705012,With the major market indices dropping in sync leading up to the U S presidential election I think it s safe to say the market isn t pleased with the uncertainty Tuesday s vote is stirring up The flip side of the coin though is that this cliff dive has arguably created some
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure",2016-11-07 16:02:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wGjCdid42RA/pharma-stock-roundup-pfizer-allergan-q3-results-fall-short-insulin-drugmakers-under-pricing-pressure-cm704894,This week key earnings updates came from companies like Pfizer PFE and Allergan AGN while pharma stocks remained under drug pricing pressure with lawmakers questioning the prices of insulin drugs Recap of the Week s Most Important Stories Pfizer Allergan Disappoint in
AGN,AGN:US,BBG000FH8PX5,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 15:37:15 +0000,http://www.fool.com/investing/2016/11/07/if-hillary-clinton-wins-these-2-beaten-down-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys"
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017",2016-11-07 15:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-153000033.html,"[PR Newswire] - NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Allergan PLC (""Allergan"" ..."
AGN,AGN:US,BBG000FH8PX5,Hedge Fund-Mimicking ETF Launched by Goldman Sachs,2016-11-07 13:56:49 +0000,http://www.insidermonkey.com/blog/hedge-fund-mimicking-etf-launched-by-goldman-sachs-485167/,Hedge Fund-Mimicking ETF Launched by Goldman Sachs
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure",2016-11-07 13:39:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pfizer-allergan-133901017.html,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure"
AGN,AGN:US,BBG000FH8PX5,New Global Research Shows Changing Attitude Toward Beauty as Women Seek Confidence Over Youth,2016-11-07 13:30:00 +0000,http://finance.yahoo.com/news/global-research-shows-changing-attitude-133000847.html,[CNW Group] - New Global Research Shows Changing Attitude Toward Beauty as Women Seek Confidence Over Youth
AGN,AGN:US,BBG000FH8PX5,Asanko Gold reports Q3 2016 results,2016-11-07 12:14:10 +0000,http://www.publicnow.com/view/1B6970AB5717C825301A7C064BB3F4227429D809,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Nov. 7, 2016) -Asanko Gold Inc. ('Asanko' or the 'Company') (TSX:AKG)(NYSE MKT:AKG) reports its financial results for the three-month and nine-month period ended ..."
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Reports Q3 2016 Results,2016-11-07 12:04:07 +0000,http://www.publicnow.com/view/416F63A6B0639BC3BBDC0EA389055A077414F57A,"[at noodls] - November 7th, 2016 Vancouver, British Columbia, November 7, 2016 - Asanko Gold Inc. ('Asanko' or the 'Company') (TSX, NYSE MKT: AKG) reports its financial results for the three-month and nine-month period ..."
AGN,AGN:US,BBG000FH8PX5,Buy Europe?,2016-11-07 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=778759&SR=Yahoo,Buy Europe?
AGN,AGN:US,BBG000FH8PX5,Allergan: Trading at a Low Earnings Multiple,2016-11-07 02:48:11 +0000,http://finance.yahoo.com/news/allergan-trading-low-earnings-multiple-024811925.html,Allergan: Trading at a Low Earnings Multiple
AGN,AGN:US,BBG000FH8PX5,Mattress Firm (MFRM) Acquisition Powers 40 North Management to Impressive Q3 Returns,2016-11-05 21:49:31 +0000,http://www.insidermonkey.com/blog/mattress-firm-mfrm-acquisition-powers-40-north-management-to-impressive-q3-returns-485078/,Mattress Firm (MFRM) Acquisition Powers 40 North Management to Impressive Q3 Returns
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Allergan plc and Encourages Investors with Losses to Contact the Firm,2016-11-05 02:52:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-025200991.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc and/or Actavis plc."
AGN,AGN:US,BBG000FH8PX5,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass,2016-11-05 01:00:00 +0000,https://www.thestreet.com/story/13882286/1/friday-wasn-t-bad-amazon-induced-woes-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass
AGN,AGN:US,BBG000FH8PX5,Rosen Law Firm Files Securities Class Action Lawsuit Against Allergan PLC - AGN,2016-11-05 00:54:00 +0000,http://finance.yahoo.com/news/rosen-law-firm-files-securities-005400530.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of the securities of Allergan plc and/or Actavis plc between February 25, 2014 and November 3, 2016, both dates inclusive ."
AGN,AGN:US,BBG000FH8PX5,Digging Into Four Large Caps,2016-11-04 22:46:00 +0000,https://www.thestreet.com/story/13881439/1/digging-into-four-large-caps.html?puc=yahoo&cm_ven=YAHOO,Digging Into Four Large Caps
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 10-Q, Quarterly Report",2016-11-04 21:22:17 +0000,http://biz.yahoo.com/e/161104/agn10-q.html,"ALLERGAN PLC Files SEC form 10-Q, Quarterly Report"
AGN,AGN:US,BBG000FH8PX5,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Allergan plc and Advises Investors with Losses to Contact the Firm,2016-11-04 19:24:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-192400016.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Allergan plc concerning possible violations of federal securities laws."
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Allergan PLC (AGN)",2016-11-04 18:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-183000392.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 4, 2016 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Allergan PLC (""Allergan"") or the ..."
AGN,AGN:US,BBG000FH8PX5,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'",2016-11-04 17:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/04/credit-suisse-allergan-selloff-inappropriate-teva-an-overreaction/?mod=yahoobarrons&ru=yahoo,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'"
AGN,AGN:US,BBG000FH8PX5,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allergan plc - AGN,2016-11-04 17:56:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-175600356.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allergan plc (""Allergan"" or the ""Company"") (NYSE: AGN) (ISIN: IE00BY9D5467). Investors ..."
AGN,AGN:US,BBG000FH8PX5,Skin in the Game: This Dermatology Market Stock Is a Good M&A Bet,2016-11-04 16:43:00 +0000,https://www.thestreet.com/story/13881313/1/skin-in-the-game-this-dermatology-market-stock-is-a-good-m-amp-a-bet.html?puc=yahoo&cm_ven=YAHOO,Skin in the Game: This Dermatology Market Stock Is a Good M&A Bet
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies",2016-11-04 16:26:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9s-8nwy3Pg/the-zacks-analyst-blog-highlights-allergan-gilead-sciences-pfizer-regeneron-pharmaceuticals-and-lion-biotechnologies-cm704183,For Immediate Release Chicago IL November 04 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
AGN,AGN:US,BBG000FH8PX5,"ETF’s with exposure to Allergan Plc : November 4, 2016",2016-11-04 16:25:40 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-allergan-plc-november-4-2016/,"ETF’s with exposure to Allergan Plc : November 4, 2016"
AGN,AGN:US,BBG000FH8PX5,INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Allergan plc and Encourages Investors with Losses to Contact the Firm,2016-11-04 16:16:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-161600279.html,[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Allergan plc concerning possible violations of federal securities laws.
AGN,AGN:US,BBG000FH8PX5,Ironwood (IRWD) Posts Narrower-than-Expected Loss in Q3,2016-11-04 15:12:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/syv0Nw7FiZU/ironwood-irwd-posts-narrower-than-expected-loss-in-q3-cm703958,Ironwood Pharmaceuticals Inc IRWD reported an adjusted loss of 18 cents per share in the third quarter of 2016 narrower than both the Zacks Consensus Estimate of a loss of 23 cents and the year ago loss of 25 cents FindTheCompany Graphiq Total revenue in the
AGN,AGN:US,BBG000FH8PX5,EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Allergan plc - AGN,2016-11-04 15:01:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-150100000.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Allergan plc (NYSE: AGN) ..."
AGN,AGN:US,BBG000FH8PX5,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Allergan plc and Advises Investors with Losses to Contact the Firm,2016-11-04 15:00:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-150000969.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Allergan plc concerning possible violations of federal securities laws."
AGN,AGN:US,BBG000FH8PX5,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More",2016-11-04 14:15:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ybyP7kU5h3I/drug-stocks-earnings-roster-for-nov-7-hznp-acad-more-cm704072,The bulk of the Q3 earnings season is over with 364 S amp P 500 members as of Nov 2 accounting for 72 6 of the index s total market capitalization having already reported results according to the latest Earnings Outlook While total earnings for these index members were up 1 6 from
AGN,AGN:US,BBG000FH8PX5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Allergan PLC (AGN)",2016-11-04 14:15:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141500945.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Allergan PLC (""Allergan"") ..."
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies",2016-11-04 13:46:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-allergan-134601929.html,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies"
AGN,AGN:US,BBG000FH8PX5,Allergan Needs Better Targets,2016-11-04 13:28:51 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-04/allergan-stock-buyback-try-m-a-instead?cmpid=yhoo.headline,Allergan Needs Better Targets
AGN,AGN:US,BBG000FH8PX5,"Trader's Daily Notebook: For a Decline, It Sure Was Smooth",2016-11-04 11:00:00 +0000,http://realmoney.thestreet.com/articles/11/04/2016/traders-daily-notebook-decline-it-sure-was-smooth?puc=yahoo&cm_ven=YAHOO,"Trader's Daily Notebook: For a Decline, It Sure Was Smooth"
AGN,AGN:US,BBG000FH8PX5,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-04 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNbvi-Fa7J0/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-20161104-00162,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
AGN,AGN:US,BBG000FH8PX5,[$$] Generic-Drug Firms Face Possible Collusion Charges,2016-11-04 03:57:43 +0000,http://www.wsj.com/articles/generic-drug-makers-shares-drop-on-report-of-possible-probe-1478209036?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Federal prosecutors, after a lengthy probe, are nearing possible criminal charges for price-collusion in the generic-drug industry, according to a person familiar with the matter."
AGN,AGN:US,BBG000FH8PX5,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark",2016-11-04 03:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBMAZAXetGU/achn-tanks-innls-acts-fail-lci-in-the-crosshair-of-law-once-loses-its-spark-20161104-00065,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark"
AGN,AGN:US,BBG000FH8PX5,Generic Drug Firms Face Possible Collusion Charges -- WSJ,2016-11-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/78-5RUwZImE/generic-drug-firms-face-possible-collusion-charges--wsj-20161104-00491,Generic Drug Firms Face Possible Collusion Charges -- WSJ
AGN,AGN:US,BBG000FH8PX5,IMPORTANT SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Allergan plc and Advises Investors with Losses to Contact the Firm,2016-11-04 02:08:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-goldberg-law-020800482.html,[Business Wire] - Goldberg Law PC announces that it is investigating Allergan plc concerning reports that the Company unlawfully colluded with other companies to fix generic drug prices.
AGN,AGN:US,BBG000FH8PX5,Glancy Prongay & Murray LLP Commences Investigation on Behalf of Allergan PLC Investors Concerning Recent Revelations Regarding an Alleged Illegal Conspiracy to Fix Drug Prices,2016-11-03 23:42:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-234200583.html,[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of Allergan PLC or the “Company”) investors concerning recent reports that the Company has unlawfully colluded with other pharmaceutical companies to fix generic drug prices.
AGN,AGN:US,BBG000FH8PX5,Generics Hit by Report on Pending DOJ Price Fixing Charges,2016-11-03 23:17:00 +0000,https://www.thestreet.com/story/13880923/1/generics-hit-by-report-on-pending-doj-price-fixing-charges.html?puc=yahoo&cm_ven=YAHOO,Generics Hit by Report on Pending DOJ Price Fixing Charges
AGN,AGN:US,BBG000FH8PX5,Cramer: Credibility Is a Precious Market Commodity,2016-11-03 23:01:00 +0000,http://realmoney.thestreet.com/articles/11/03/2016/cramer-credibility-precious-market-commodity?puc=yahoo&cm_ven=YAHOO,Cramer: Credibility Is a Precious Market Commodity
AGN,AGN:US,BBG000FH8PX5,[$$] Generic-Drug Makers' Shares Drop on Report of Possible Probe,2016-11-03 21:59:32 +0000,http://www.wsj.com/articles/generic-drug-makers-shares-drop-on-report-of-possible-probe-1478209036?mod=yahoo_hs,[$$] Generic-Drug Makers' Shares Drop on Report of Possible Probe
AGN,AGN:US,BBG000FH8PX5,"Allergan Initiates Dividend, Boosts Share Buybacks",2016-11-03 21:45:02 +0000,http://www.investopedia.com/stock-analysis/110316/allergan-initiates-dividend-boosts-share-buybacks-agn-teva.aspx?partner=YahooSA,"Allergan Initiates Dividend, Boosts Share Buybacks"
AGN,AGN:US,BBG000FH8PX5,Generic-Drug Firms Face Possible Collusion Charges -- 1st update,2016-11-03 20:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-bOvVSAKTss/genericdrug-firms-face-possible-collusion-charges--1st-update-20161103-01236,Generic-Drug Firms Face Possible Collusion Charges -- 1st update
AGN,AGN:US,BBG000FH8PX5,Generic-Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q_BrV9vSKks/genericdrug-firms-face-possible-collusion-charges-20161103-01241,Generic-Drug Firms Face Possible Collusion Charges
AGN,AGN:US,BBG000FH8PX5,Generic Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kn4Mp2kihCw/generic-drug-firms-face-possible-collusion-charges-20161103-01234,Generic Drug Firms Face Possible Collusion Charges
AGN,AGN:US,BBG000FH8PX5,Generic-Drug Makers'' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdznyXa-NO0/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01155,Generic-Drug Makers'' Shares Drop on Report of Possible Probe
AGN,AGN:US,BBG000FH8PX5,Generic-Drug Makers' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qi3HbUrZ900/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01235,Generic-Drug Makers' Shares Drop on Report of Possible Probe
AGN,AGN:US,BBG000FH8PX5,"Allergan Expands Buyback to $15B, Begins Div (AGN)",2016-11-03 17:40:00 +0000,http://www.investopedia.com/news/allergan-sets-quarterly-div-expands-buyback-agn/?partner=YahooSA,"Allergan Expands Buyback to $15B, Begins Div (AGN)"
AGN,AGN:US,BBG000FH8PX5,Valeant’s Salix Acquisition Saga,2016-11-03 17:03:31 +0000,http://marketrealist.com/2016/11/valeants-salix-acquisition-saga/?utm_source=yahoo&utm_medium=feed,Valeant’s Salix Acquisition Saga
AGN,AGN:US,BBG000FH8PX5,Allergan Cuts Year Forecast: 3Q Below Street (AGN),2016-11-03 16:45:00 +0000,http://www.investopedia.com/news/allergan-3q-below-street-cuts-fy-estimate-agn/?partner=YahooSA,Allergan Cuts Year Forecast: 3Q Below Street (AGN)
AGN,AGN:US,BBG000FH8PX5,"Company News for November 03, 2016",2016-11-03 16:10:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/miMmPoSfj-4/company-news-for-november-03-2016-cm703297,Shares of Gilead Sciences Inc GILD fell 2 1 after reporting third quarter earnings of 2 70 per share missing the Zacks Consensus Estimate of 2 74 Allergan plc s AGN shares slumped 5 4 after posting third quarter earnings per share of 3 32 lower than the Zacks
AGN,AGN:US,BBG000FH8PX5,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg,2016-11-03 15:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a_8Tr5zcdTE/doj-looking-into-possible-price-collusion-in-generic-drug-sector-bloomberg-20161103-02025,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg
AGN,AGN:US,BBG000FH8PX5,Drug Stocks to Watch for Earnings on Nov 4; REGN & More,2016-11-03 15:10:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Z9jy-dH23s/drug-stocks-to-watch-for-earnings-on-nov-4-regn-more-cm703210,The bulk of the Q3 earnings season is over with 364 S amp P 500 members as of Nov 2 accounting for 72 6 of the index s total market capitalization having already reported results according to the latest Earnings Outlook While total earnings for these index members were up 1 6 from
AGN,AGN:US,BBG000FH8PX5,"Company News for November 03, 2016",2016-11-03 14:15:02 +0000,http://finance.yahoo.com/news/company-news-november-03-2016-141502030.html,"Company News for November 03, 2016"
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc :AGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016",2016-11-03 13:17:18 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-agn-us-earnings-analysis-q3-2016-by-the-numbers-november-3-2016/,"Allergan Plc :AGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016"
AGN,AGN:US,BBG000FH8PX5,Asanko Gold to Proceed With Phase 2A Expansion,2016-11-03 11:18:17 +0000,http://www.publicnow.com/view/6BCF70232222A04A31DAD05B9E95B5807D04848E,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Nov. 3, 2016) - Highlights: Environmental Invoice received for mining operations at Esaase and overland conveyor to the existing processing facility, clearing ..."
AGN,AGN:US,BBG000FH8PX5,3 Things You Really Need to Know About Allergan's Q3 Results,2016-11-03 10:23:39 +0000,http://www.fool.com/investing/2016/11/02/3-things-you-really-need-to-know-about-allergans-q.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things You Really Need to Know About Allergan's Q3 Results
AGN,AGN:US,BBG000FH8PX5,3 Things You Really Need to Know About Allergan's Q3 Results,2016-11-02 22:08:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPtftckG-Q8/3-things-you-really-need-to-know-about-allergans-q3-results-cm702857,You might think that nothing has gone right for Allergan plc NYSE AGN this year Its share price has declined over 30 since January as the potential acquisition by Pfizer fell apart However Allergan actually has seen some positive developments in 2016 The
AGN,AGN:US,BBG000FH8PX5,3 Beaten-Down Healthcare Stocks to Buy,2016-11-02 22:07:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/98JH4uilX-c/3-beaten-down-healthcare-stocks-to-buy-cm702843,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips So far this year the S amp P 500 has returned about 3 Surprisingly and uncharacteristically the healthcare sector has fallen 7 which qualifies it as the worst performer this year Source Will
AGN,AGN:US,BBG000FH8PX5,Saunders Takes Responsibility for Allergan's 3Q Hit,2016-11-02 21:10:00 +0000,https://www.thestreet.com/story/13877534/1/saunders-takes-responsibility-for-allergan-s-q3-miss.html?puc=yahoo&cm_ven=YAHOO,Saunders Takes Responsibility for Allergan's 3Q Hit
AGN,AGN:US,BBG000FH8PX5,Four Large Cap Stocks That Appear Ready to Rebound,2016-11-02 20:48:00 +0000,http://www.thestreet.com/video/13877631/four-large-cap-stocks-that-appear-ready-to-rebound.html?puc=yahoov&cm_ven=YAHOOV,Four Large Cap Stocks That Appear Ready to Rebound
AGN,AGN:US,BBG000FH8PX5,"Gilead Cuts Losses On NASH Drug, But Liver Is 'Area Of Opportunity'",2016-11-02 20:28:04 +0000,http://www.investors.com/news/technology/gilead-cuts-losses-on-nash-drug-but-liver-area-of-opportunity/,"Gilead Cuts Losses On NASH Drug, But Liver Is 'Area Of Opportunity'"
AGN,AGN:US,BBG000FH8PX5,US STOCKS-S&P 500 ends down for 7th straight session,2016-11-02 20:27:16 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-ends-202716163.html,US STOCKS-S&P 500 ends down for 7th straight session
AGN,AGN:US,BBG000FH8PX5,Allergan Stock Topples On Q3 Miss; Slashes 2016 Outlook,2016-11-02 20:23:36 +0000,http://www.investors.com/news/technology/allergan-stock-topples-on-q3-miss-slashes-2016-eps-guidane/,Allergan Stock Topples On Q3 Miss; Slashes 2016 Outlook
AGN,AGN:US,BBG000FH8PX5,Which Of The Latest 13F Filers Holds Allergan?,2016-11-02 20:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ze-IihaZ1R4/which-of-the-latest-13f-filers-holds-allergan-cm702752,At Holdings Channel we have reviewed the latest batch of the 27 most recent 13F filings for the 09 30 2016 reporting period and noticed that Allergan PLC Symbol AGN was held by 11 of these funds When hedge fund managers appear to be thinking alike we find it is a good idea to take a
AGN,AGN:US,BBG000FH8PX5,Stocks Hold Lower as Chance for December Rate Hike Increases,2016-11-02 18:40:00 +0000,https://www.thestreet.com/story/13877746/1/stocks-decline-as-crude-oil-falls-to-five-week-low.html?puc=yahoo&cm_ven=YAHOO,Stocks Hold Lower as Chance for December Rate Hike Increases
AGN,AGN:US,BBG000FH8PX5,Scout Daily Update: Allergan PLC (AGN) Misses EPS By A Wide Margin,2016-11-02 18:24:02 +0000,http://www.insidermonkey.com/blog/scout-daily-update-allergan-plc-agn-misses-eps-by-a-wide-margin-484631/,Scout Daily Update: Allergan PLC (AGN) Misses EPS By A Wide Margin
AGN,AGN:US,BBG000FH8PX5,Allergan Falls as Investors Give New Dividend Cold Shoulder,2016-11-02 17:57:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/02/allergan-falls-as-investors-give-new-dividend-cold-shoulder/?mod=yahoobarrons&ru=yahoo,Allergan Falls as Investors Give New Dividend Cold Shoulder
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan misses revenue forecasts as sales of older drugs slump,2016-11-02 17:54:09 +0000,"http://www.ft.com/cms/s/45ec60fa-a11b-11e6-891e-abe238dee8e2,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Allergan, the maker of wrinkle treatment Botox, missed Wall Street revenue forecasts for sales for the second quarter in a row, prompting investors to beat the share price down by more than 4 per cent. ..."
AGN,AGN:US,BBG000FH8PX5,2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG),2016-11-02 17:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mmYJol4ltYc/2-bullish-biotech-trades-to-take-your-mind-off-the-election-biib-celg-cm702607,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips If the market is always right it may finally be time for a different sort of bullish pairs trade in Biogen Inc NASDAQ BIIB and Celgene Corporation NASDAQ
AGN,AGN:US,BBG000FH8PX5,Daniel Loeb Comments on Akarna Therapeutics,2016-11-02 16:38:41 +0000,http://finance.yahoo.com/news/daniel-loeb-comments-akarna-therapeutics-163841154.html,Daniel Loeb Comments on Akarna Therapeutics
AGN,AGN:US,BBG000FH8PX5,Allergan CEO takes blame for big miss on quarterly earnings,2016-11-02 16:07:07 +0000,http://finance.yahoo.com/news/allergan-revenue-rises-4-4-105645402.html,Allergan CEO takes blame for big miss on quarterly earnings
AGN,AGN:US,BBG000FH8PX5,"[$$] Allergan Initiates Dividend, Expands Buyback",2016-11-02 15:59:20 +0000,http://www.wsj.com/articles/allergan-initiates-dividend-and-expands-stock-buyback-as-it-eschews-megadeals-1478089790?mod=yahoo_hs,"[$$] Allergan Initiates Dividend, Expands Buyback"
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback",2016-11-02 15:09:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ghT4RNqEA_o/allergan-agn-lags-q3-earnings-cuts-view-ups-buyback-cm702532,Allergan plc s AGN third quarter 2016 earnings came in at 3 32 per share missing the Zacks Consensus Estimate of 3 57 by 7 Earnings declined 2 6 from the year ago period and almost 1 sequentially FindTheCompany Graphiq Lower revenues and higher research
AGN,AGN:US,BBG000FH8PX5,What Allergan Is Buying and Shedding to Gain a Better Position,2016-11-02 15:05:25 +0000,http://marketrealist.com/2016/11/what-allergan-is-buying-and-shedding-to-gain-a-better-position/?utm_source=yahoo&utm_medium=feed,What Allergan Is Buying and Shedding to Gain a Better Position
AGN,AGN:US,BBG000FH8PX5,Allergan's Namenda Numbers Were 'Disappointment': More Squawk From Jim Cramer,2016-11-02 14:44:00 +0000,https://www.thestreet.com/story/13877510/1/allergan-s-namenda-numbers-were-disappointment-more-squawk-from-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,Allergan's Namenda Numbers Were 'Disappointment': More Squawk From Jim Cramer
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Stock Slides on Q3 Miss, Guidance",2016-11-02 14:15:00 +0000,https://www.thestreet.com/story/13876929/1/allergan-agn-stock-slides-on-q3-miss-guidance.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Slides on Q3 Miss, Guidance"
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Misses Q3 Earnings & Sales; Ups Buyback Plan,2016-11-02 14:11:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2rTBbToTOLQ/allergan-agn-misses-q3-earnings-sales-ups-buyback-plan-cm702439,Dublin Ireland based Allergan plc AGN is engaged in the development manufacturing marketing sale and distribution of branded biosimilar and over the counter pharmaceutical products Allergan has been actively pursuing deals to expand its portfolio especially its branded products
AGN,AGN:US,BBG000FH8PX5,Could Allergan’s Revenues Show Growth in 3Q16?,2016-11-02 14:06:32 +0000,http://marketrealist.com/2016/11/could-allergans-revenues-show-growth-in-3q16/?utm_source=yahoo&utm_medium=feed,Could Allergan’s Revenues Show Growth in 3Q16?
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback",2016-11-02 13:51:01 +0000,http://finance.yahoo.com/news/allergan-agn-lags-q3-earnings-135101886.html,"Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback"
AGN,AGN:US,BBG000FH8PX5,7 Top Stocks to Buy in November,2016-11-02 13:16:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gVeGu-tGjYQ/7-top-stocks-to-buy-in-november-cm702212,IMAGE SOURCE GETTY IMAGES Every month millions of Americans sit down and evaluate their investment portfolios Should some stocks be sold What should be purchased with any excess cash that s available These are important questions and the answers are never easy So if you re
AGN,AGN:US,BBG000FH8PX5,"The Market In 5 Minutes: Alibaba, Brocade And A Game 6",2016-11-02 13:05:35 +0000,http://finance.yahoo.com/news/market-5-minutes-alibaba-brocade-130535168.html,"The Market In 5 Minutes: Alibaba, Brocade And A Game 6"
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Misses Q3 Earnings & Sales; Ups Buyback Plan,2016-11-02 12:42:12 +0000,http://finance.yahoo.com/news/allergan-agn-misses-q3-earnings-124212143.html,Allergan (AGN) Misses Q3 Earnings & Sales; Ups Buyback Plan
AGN,AGN:US,BBG000FH8PX5,"Allergan expands buyback to $15 bln, sets first quarterly div",2016-11-02 12:32:38 +0000,http://finance.yahoo.com/news/allergan-expands-buyback-5-bln-114606720.html,"Allergan expands buyback to $15 bln, sets first quarterly div"
AGN,AGN:US,BBG000FH8PX5,Allergan plc Earnings Call scheduled for 8:30 am ET today,2016-11-02 12:30:00 +0000,http://biz.yahoo.com/cc/1/154221.html,Allergan plc Earnings Call scheduled for 8:30 am ET today
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Allergan Completes the $1.69 Billion Acquisition of NASH Therapy Maker,2016-11-02 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-allergan-completes-1-121500794.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / November 2, 2016 / Active Wall St. blog coverage looks at the headline from Allergan PLC (NYSE: AGN ) as the company announced on November 01st, 2016, that it has successfully ..."
AGN,AGN:US,BBG000FH8PX5,7 Top Stocks to Buy in November,2016-11-02 12:10:46 +0000,http://www.fool.com/investing/2016/11/02/7-top-stocks-to-buy-in-november.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Top Stocks to Buy in November
AGN,AGN:US,BBG000FH8PX5,Through the Eyes of Analysts: Allergan’s 3Q16 Estimates in Focus,2016-11-02 12:07:28 +0000,http://marketrealist.com/2016/11/through-the-eyes-of-analysts-allergans-3q16-estimates-in-focus/?utm_source=yahoo&utm_medium=feed,Through the Eyes of Analysts: Allergan’s 3Q16 Estimates in Focus
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: These drug price increases have to stop,2016-11-02 12:06:57 +0000,http://finance.yahoo.com/video/allergan-ceo-drug-price-increases-120657380.html,Allergan CEO: These drug price increases have to stop
AGN,AGN:US,BBG000FH8PX5,"Earnings Reaction History: Allergan Inc, 57.1% Follow-Through Indicator, 2.0% Sensitive",2016-11-02 11:43:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eavWl7qtsK4/earnings-reaction-history-allergan-inc-571-follow-through-indicator-20-sensitive-cm702204,Expected Earnings Release 11 02 2016 PremarketExpected Earnings Release 11 02 2016 Premarket Avg Extended Hours Dollar Volume 17 925 411Avg Extended Hours Dollar Volume 17 925 411 Allergan Inc AGN is due to issue its quarterly earnings report in the upcoming extended hours
AGN,AGN:US,BBG000FH8PX5,Allergan Misses Earnings Estimates but $10 Billion Buyback Soothes,2016-11-02 11:28:00 +0000,https://www.thestreet.com/story/13876916/1/allergan-misses-earnings-estimates-but-10b-buyback-soothes.html?puc=yahoo&cm_ven=YAHOO,Allergan Misses Earnings Estimates but $10 Billion Buyback Soothes
AGN,AGN:US,BBG000FH8PX5,"Investors Cheer Allergan's Share Buyback Program, Dividend Initiation Despite Q3 Miss",2016-11-02 11:23:30 +0000,http://finance.yahoo.com/news/investors-cheer-allergans-share-buyback-112330082.html,"Investors Cheer Allergan's Share Buyback Program, Dividend Initiation Despite Q3 Miss"
AGN,AGN:US,BBG000FH8PX5,5 Things You Must Know Before the Market Opens Wednesday,2016-11-02 11:22:00 +0000,https://www.thestreet.com/story/13874489/1/5-things-you-must-know-before-the-market-opens-wednesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Wednesday
AGN,AGN:US,BBG000FH8PX5,Q3 2016 Allergan plc Earnings Release - Before Market Open,2016-11-02 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20161102.html?t=agn,Q3 2016 Allergan plc Earnings Release - Before Market Open
AGN,AGN:US,BBG000FH8PX5,Allergan's stock gains as $10 billion ASR and new dividend offsets profit and sales miss,2016-11-02 11:02:15 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4B80DA11-D94E-42DE-96E1-5AFDC606EB8E&siteid=yhoof2,Allergan's stock gains as $10 billion ASR and new dividend offsets profit and sales miss
AGN,AGN:US,BBG000FH8PX5,Allergan misses Street 3Q forecasts,2016-11-02 11:00:16 +0000,http://sg.finance.yahoo.com/news/allergan-misses-street-3q-forecasts-105328477.html,Allergan misses Street 3Q forecasts
AGN,AGN:US,BBG000FH8PX5,"Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend",2016-11-02 10:50:11 +0000,http://www.publicnow.com/view/94C77FC643A3970F7AA0272FA9F0E105B43F3F7D,"[at noodls] - DUBLIN, Nov. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its third quarter 2016 continuing operations performance. ... This is an abstract of the original noodl. To continue reading ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan Announces $10 Billion Accelerated Share Repurchase, Initiation of Cash Dividend in 2017",2016-11-02 10:40:11 +0000,http://www.publicnow.com/view/D9C072D72A31A1FF9A75FADF281752DD19733467,"[at noodls] - DUBLIN, Nov. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has completed its initial $5 billion in share repurchases under its previously announced share repurchase program, ..."
AGN,AGN:US,BBG000FH8PX5,"MARKET SNAPSHOT: S&P 500 Edges Lower, On Track For Seventh Straight Loss",2016-11-02 09:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kCnFXyiP3Hs/market-snapshot-sp-500-edges-lower-on-track-for-seventh-straight-loss-20161102-00293,"MARKET SNAPSHOT: S&P 500 Edges Lower, On Track For Seventh Straight Loss"
AGN,AGN:US,BBG000FH8PX5,U.S. Hot Stocks: Hot Stocks to Watch,2016-11-02 09:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRw69z86RoU/us-hot-stocks-hot-stocks-to-watch-20161102-00276,U.S. Hot Stocks: Hot Stocks to Watch
AGN,AGN:US,BBG000FH8PX5,Allergan Cuts 2016 Cont. Ops. Guidance - Quick Facts,2016-11-02 06:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6G6Cs2_b95E/allergan-cuts-2016-cont-ops-guidance--quick-facts-20161102-01530,Allergan Cuts 2016 Cont. Ops. Guidance - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Allergan  Inc. Bottom Line Retreats 3% In Q3,2016-11-02 06:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5EjqzaDSne0/allergan--inc-bottom-line-retreats-3-in-q3-20161102-01500,Allergan  Inc. Bottom Line Retreats 3% In Q3
AGN,AGN:US,BBG000FH8PX5,Allergan Announces $10 Bln Share Repurchase; Initiates Dividend,2016-11-02 06:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DVK57R0s5g0/allergan-announces-10-bln-share-repurchase-initiates-dividend-20161102-01498,Allergan Announces $10 Bln Share Repurchase; Initiates Dividend
AGN,AGN:US,BBG000FH8PX5,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA",2016-11-02 04:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z38L-536a5M/ptn-surges-on-trial-data-pfe-dumps-cholesterol-drug-watch-out-for-prta-20161102-00006,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA"
AGN,AGN:US,BBG000FH8PX5,Your Two Minute Earnings Preview for Allergan (AGN) Stock,2016-11-01 23:14:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9GSgtyf9WY/your-two-minute-earnings-preview-for-allergan-agn-stock-cm702094,Today s quick video takes a closer look at Allergan AGN stock ahead of its coming earnings report This pharma giant has been under pressure thanks to broad sector woes as the industry is suffering under the weight of a bottom 40 industry rank However AGN has seen decent earnings
AGN,AGN:US,BBG000FH8PX5,Your Two Minute Earnings Preview for Allergan (AGN) Stock,2016-11-01 21:34:09 +0000,http://finance.yahoo.com/news/two-minute-earnings-preview-allergan-213409955.html,Your Two Minute Earnings Preview for Allergan (AGN) Stock
AGN,AGN:US,BBG000FH8PX5,"Amazon Price Target Bumped; Chevron, Twilio Get Analyst Love",2016-11-01 20:25:01 +0000,http://www.investors.com/news/amazon-price-target-bumped-chevron-twilio-get-analyst-love/,"Amazon Price Target Bumped; Chevron, Twilio Get Analyst Love"
AGN,AGN:US,BBG000FH8PX5,T2 Biosystems Announces Collaboration with Allergan to Develop the First Blood-Based Diagnostic Panel to Detect Antimicrobial Resistance,2016-11-01 20:16:10 +0000,http://www.publicnow.com/view/AC8AE9744F36BFC803CF92ADC006E608E328A11D,"[at noodls] - -- T2 Biosystems to develop new panel on T2Dx platform and commercialize worldwide while receiving milestone and other payments - -- Panel to aid in rapid bacterial infection diagnosis, including sepsis; ..."
AGN,AGN:US,BBG000FH8PX5,"Pre-Market Earnings Report for November 2, 2016 :  BABA, AGN, TWX, ADP, ANTM, TRP, SE, SRE, HCN, ZTS, TEL, EL",2016-11-01 20:14:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z5_8zlC3pCo/pre-market-earnings-report-for-november-2-2016-baba-agn-twx-adp-antm-trp-se-sre-hcn-zts-tel-el-cm702017,The following companies are expected to report earnings prior to market open on 11 02 2016 Visit our Earnings Calendar for a full list of expected earnings releases Alibaba Group Holding Limited BABA is reporting for the quarter ending September 30 2016
AGN,AGN:US,BBG000FH8PX5,"Pfizer Ends Cholesterol Drug Development, Lowers EPS Guidance",2016-11-01 20:10:41 +0000,http://www.investors.com/news/technology/pfizer-ends-cholesterol-drug-development-lowers-eps-guidance/,"Pfizer Ends Cholesterol Drug Development, Lowers EPS Guidance"
AGN,AGN:US,BBG000FH8PX5,5 Stocks to Watch Before the Market Opens Tomorrow,2016-11-01 20:10:21 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-201025824.html,5 Stocks to Watch Before the Market Opens Tomorrow
AGN,AGN:US,BBG000FH8PX5,What to Look for When Allergan (AGN) Posts Q3 Earnings,2016-11-01 19:09:00 +0000,https://www.thestreet.com/story/13876006/1/what-to-look-for-when-allergan-agn-posts-q3-earnings.html?puc=yahoo&cm_ven=YAHOO,What to Look for When Allergan (AGN) Posts Q3 Earnings
AGN,AGN:US,BBG000FH8PX5,Jim Cramer -- Allergan Is a Good Company in a Tough Environment,2016-11-01 19:00:00 +0000,https://www.thestreet.com/story/13876008/1/jim-cramer-allergan-is-a-good-company-in-a-tough-environment.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Allergan Is a Good Company in a Tough Environment
AGN,AGN:US,BBG000FH8PX5,Merrimack Pharmaceuticals Inc (MACK) Sees Earnings Boost As FDA Accepts Application For Generic Drug,2016-11-01 18:50:27 +0000,http://www.insidermonkey.com/blog/merrimack-pharmaceuticals-inc-mack-sees-earnings-boost-as-fda-accepts-application-for-generic-drug-484499/,Merrimack Pharmaceuticals Inc (MACK) Sees Earnings Boost As FDA Accepts Application For Generic Drug
AGN,AGN:US,BBG000FH8PX5,AVEO Pharmaceuticals (AVEO) Q3 Earnings: What's in Store?,2016-11-01 18:17:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSig-uYNmV0/aveo-pharmaceuticals-aveo-q3-earnings-whats-in-store-cm701830,AVEO Pharmaceuticals Inc AVEO is expected to report third quarter 2016 results this month The company has an impressive track record for the last four reported quarters While it has beaten estimates on three occasions it met expectations in one with an average positive surprise of 57
AGN,AGN:US,BBG000FH8PX5,Jim Cramer: Allergan a Winner in a Tough Time to Own Drug Stocks,2016-11-01 17:18:00 +0000,http://www.thestreet.com/video/13875600/jim-cramer-allergan-a-winner-in-a-tough-time-to-own-drug-stocks.html?puc=yahoov&cm_ven=YAHOOV,Jim Cramer: Allergan a Winner in a Tough Time to Own Drug Stocks
AGN,AGN:US,BBG000FH8PX5,PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril,2016-11-01 17:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tZc7FXHMDvI/pfe-stock-ignore-pfizer-incs-earnings-miss-at-your-own-peril-cm701879,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When an industry bellwether fails the first question must be is the problem with the industry or the bellwether 160 There are clues in the case of Pfizer Inc NYSE PFE Source Kojach Via
AGN,AGN:US,BBG000FH8PX5,Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?,2016-11-01 14:19:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8yJ_3K-hM3s/jazz-pharma-jazz-q3-earnings-a-disappointment-in-store-cm701576,Jazz Pharmaceuticals plc JAZZ is scheduled to report third quarter 2016 results on Nov 8 after the market closes Last quarter the company had comfortably surpassed expectations with a positive earnings surprise of 5 26 Jazz s track record is quite encouraging with the company
AGN,AGN:US,BBG000FH8PX5,Epizyme (EPZM) Q3 Earnings: What's in Store for the Stock?,2016-11-01 14:17:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KCtlOsKB214/epizyme-epzm-q3-earnings-whats-in-store-for-the-stock-cm701682,Epizyme Inc EPZM is scheduled to report third quarter 2016 results on Nov 3 before the opening bell Last quarter the company recorded a positive earnings surprise of 2 00 Let s see how things are shaping up for this quarter Factors Influencing This Quarter Epizyme is
AGN,AGN:US,BBG000FH8PX5,Why Allergan (AGN) Might Surprise This Earnings Season,2016-11-01 14:17:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yhiE6FKe1Kw/why-allergan-agn-might-surprise-this-earnings-season-cm701679,Investors are always looking for stocks that are poised to beat at earnings season and Allergan AGN 160 may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Allergan is seeing favorable earnings
AGN,AGN:US,BBG000FH8PX5,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More",2016-11-01 13:15:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rxmVtmQScKM/drug-stocks-to-watch-for-earnings-on-nov-2-agn-zts-more-cm701594,The Q3 earnings season moves into the second half of the reporting cycle with results from 291 S amp P 500 members as of Oct 28 accounting for 58 2 of the index s total market capitalization according to the Earnings Preview report While total earnings for these 291 index members were
AGN,AGN:US,BBG000FH8PX5,"Pfizer net plunges 38 pct., misses Street 3Q forecasts",2016-11-01 13:00:27 +0000,http://sg.finance.yahoo.com/news/pfizer-misses-street-3q-forecasts-112325987.html,"Pfizer net plunges 38 pct., misses Street 3Q forecasts"
AGN,AGN:US,BBG000FH8PX5,Why Allergan (AGN) Might Surprise This Earnings Season,2016-11-01 12:56:12 +0000,http://finance.yahoo.com/news/why-allergan-agn-might-surprise-125612572.html,Why Allergan (AGN) Might Surprise This Earnings Season
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Credit Suisse 25th Annual Healthcare Conference,2016-11-01 12:30:00 +0000,http://finance.yahoo.com/news/allergan-present-credit-suisse-25th-123000888.html,"[PR Newswire] - The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: https://cc.talkpoint.com/cred001/110716a_as/?entity=36_NOH6WSI. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development."
AGN,AGN:US,BBG000FH8PX5,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More",2016-11-01 12:20:12 +0000,http://finance.yahoo.com/news/drug-stocks-watch-earnings-nov-122012908.html,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More"
AGN,AGN:US,BBG000FH8PX5,Allergan Successfully Completes Tobira Therapeutics Acquisition,2016-11-01 11:53:40 +0000,http://www.publicnow.com/view/F73009A9A3B52F446F2CD952F97D54524C1E8D02,"[at noodls] - DUBLIN, Nov. 1, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Tobira Therapeutics, Inc. (NASDAQ: ..."
AGN,AGN:US,BBG000FH8PX5,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",2016-11-01 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DyZ3RcP2GjQ/pfizer-cuts-outlook-ends-development-of-cholesterol-drug-20161101-00079,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug"
AGN,AGN:US,BBG000FH8PX5,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 22:15:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iisq-O1OdeA/5-healthcare-stocks-poised-to-trump-q3-earnings-cm701421,The past few months have been pretty rough for the healthcare sector with the drug pricing issue taking the center stage once again This time it was the massive price hike of Mylan N V s MYL severe allergy treatment EpiPen that sparked controversies With no possibility of dying down
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-10-31 21:02:30 +0000,http://biz.yahoo.com/e/161031/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers"
AGN,AGN:US,BBG000FH8PX5,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 19:55:07 +0000,http://finance.yahoo.com/news/5-healthcare-stocks-poised-trump-195507008.html,5 Healthcare Stocks Poised to Trump Q3 Earnings
AGN,AGN:US,BBG000FH8PX5,Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?,2016-10-31 15:18:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HsrTiEy1PL4/nivalis-nvls-q3-earnings-preview-can-the-stock-surprise-cm700957,Nivalis Therapeutics Inc NVLS is expected to report third quarter 2016 results on Nov 7 Last quarter the company posted a negative surprise of 5 77 Let s see how things are shaping up for this announcement Nivalis performance has been disappointing so far Over the four
AGN,AGN:US,BBG000FH8PX5,$40 Billion Opportunity: 3 Biotechs Poised to Dominate,2016-10-31 15:16:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uw0Tdwdxnko/40-billion-opportunity-3-biotechs-poised-to-dominate-cm700969,Nonalcoholic steatohepatitis NASH has been called the next hepatitis C by some Both NASH and hepatitis C are liver diseases and both represent huge markets for drugmakers working on cures While the hepatitis C treatment landscape has filled out over the past few years with
AGN,AGN:US,BBG000FH8PX5,ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?,2016-10-31 14:16:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QrdDpzGVf7Y/acadia-pharma-acad-will-it-disappoint-in-q3-earnings-cm700962,ACADIA Pharmaceuticals Inc ACAD is expected to report third quarter 2016 results on Nov 3 In the four trailing quarters the company has missed estimates thrice bringing the average negative earnings surprise to 15 72 ACADIA PHARMA Price and EPS
AGN,AGN:US,BBG000FH8PX5,$40 Billion Opportunity: 3 Biotechs Poised to Dominate,2016-10-31 14:04:18 +0000,http://www.fool.com/investing/2016/10/31/40-billion-opportunity-3-biotechs-poised-to-domina.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,$40 Billion Opportunity: 3 Biotechs Poised to Dominate
AGN,AGN:US,BBG000FH8PX5,Allergan Needs a Shot of Investor Confidence,2016-10-31 13:18:00 +0000,https://www.thestreet.com/story/13872802/1/allergan-needs-a-shot-of-investor-confidence.html?puc=yahoo&cm_ven=YAHOO,Allergan Needs a Shot of Investor Confidence
AGN,AGN:US,BBG000FH8PX5,Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections,2016-10-29 23:43:02 +0000,http://www.publicnow.com/view/D81368C082C9DA99B375AB03717E5530D8B13A63,"[at noodls] - DUBLIN, Oct. 29, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to research informing the treatment of infectious diseases, presented new data identifying ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Presents Data Highlighting Risk Factors For CRE Infections,2016-10-29 21:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v26QkGOQ4N4/allergan-presents-data-highlighting-risk-factors-for-cre-infections-20161029-00022,Allergan Presents Data Highlighting Risk Factors For CRE Infections
AGN,AGN:US,BBG000FH8PX5,Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections,2016-10-29 12:00:00 +0000,http://finance.yahoo.com/news/data-presented-idweek-highlight-risk-120000894.html,"[PR Newswire] - DUBLIN, Oct. 29, 2016 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company committed to research informing the treatment of infectious diseases, presented new data identifying hospitalized patients with serious infections due to Enterobactericaeae who are at greater risk for having carbapenem-resistant Enterobacteriaceae (CRE) infections. ""The increasing prevalence of difficult-to-treat infections—including those caused by CRE— represents a significant challenge to physicians, as certain Gram-negative bacteria have become resistant to nearly all treatments currently available for patients,"" said David Nicholson, Ph.D, Chief R&D Officer, Allergan."
AGN,AGN:US,BBG000FH8PX5,[$$] Elliott Management Favors Samsung,2016-10-29 04:01:00 +0000,http://www.barrons.com/articles/elliott-management-favors-allergan-hess-samsung-1477715827?mod=yahoobarrons&ru=yahoo,[$$] Elliott Management Favors Samsung
AGN,AGN:US,BBG000FH8PX5,5 Things Amgen Inc.'s Management Wants You to Know,2016-10-28 22:32:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xFiZCBNF3ek/5-things-amgen-incs-management-wants-you-to-know-cm700591,Amgen Inc NASDAQ AMGN reported its third quarter results after the market closed on Thursday Those results looked good overall but the numbers only tell about the past To find out about the biotech s future listen carefully to what management has to say Here are five
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod",2016-10-28 14:34:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_mEm4L1No38/pharma-stock-roundup-bristol-myers-merck-top-estimates-merck-wins-key-fda-nod-cm700213,Third quarter earnings season is in full flow with several large cap pharma companies like Lilly LLY Merck MRK Bristol Myers BMY Novartis and others reporting results this week While companies like Merck and Bristol Myers surpassed expectations others like Lilly fell short Recap
AGN,AGN:US,BBG000FH8PX5,"Allergan Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears",2016-10-28 13:58:04 +0000,http://www.publicnow.com/view/7BE6A7BF3D362247C8720D7739A9345ACAE6A7E5,"[at noodls] - DUBLIN, Oct. 28, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic ..."
AGN,AGN:US,BBG000FH8PX5,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock,2016-10-28 13:44:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WcxrjgQexpI/3-charts-that-show-why-to-buy-acadia-pharmaceuticals-stock-cm700020,Why should an investor consider buying ACADIA Pharmaceuticals NASDAQ ACAD stock Not because the biotech s Nuplazid stormed out of the gate after winning FDA approval in April It didn t There are reasons to buy ACADIA though These three charts show why the biotech stock
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod",2016-10-28 13:25:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-bristol-myers-132501541.html,"Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod"
AGN,AGN:US,BBG000FH8PX5,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock,2016-10-28 12:36:59 +0000,http://www.fool.com/investing/2016/10/28/3-charts-that-show-why-to-buy-acadia-pharmaceutica.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock
AGN,AGN:US,BBG000FH8PX5,"Opioid Makers Targeted in Lawsuits (JNJ, AGN)",2016-10-28 11:00:00 +0000,http://www.investopedia.com/news/opioid-makers-sued-amid-addiction-rise-jnj-agn/?partner=YahooSA,"Opioid Makers Targeted in Lawsuits (JNJ, AGN)"
AGN,AGN:US,BBG000FH8PX5,"'Mad Money' Lightning Round: Shopify's Too High Right Now, Jim Cramer Says",2016-10-28 10:00:00 +0000,https://www.thestreet.com/story/13741647/1/mad-money-lightning-round-shopify-s-too-high-right-now-jim-cramer-says.html?puc=yahoo&cm_ven=YAHOO,"'Mad Money' Lightning Round: Shopify's Too High Right Now, Jim Cramer Says"
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Biotech Firm for $200M (AGN),2016-10-28 06:30:00 +0000,http://www.investopedia.com/news/allergan-buy-gi-drug-maker-200m-agn/?partner=YahooSA,Allergan to Acquire Biotech Firm for $200M (AGN)
AGN,AGN:US,BBG000FH8PX5,Allergan Scoops Up Yet Another Biotech Company,2016-10-27 20:44:00 +0000,https://www.thestreet.com/story/13870974/1/allergan-scoops-up-yet-another-biotech-company.html?puc=yahoo&cm_ven=YAHOO,Allergan Scoops Up Yet Another Biotech Company
AGN,AGN:US,BBG000FH8PX5,"[$$] Unity Biotechnology, in Battle Against Aging, Raises $116M",2016-10-27 18:09:12 +0000,http://www.wsj.com/articles/unity-biotechnology-in-battle-against-aging-raises-116m-1477591201?mod=yahoo_hs,"[$$] Unity Biotechnology, in Battle Against Aging, Raises $116M"
AGN,AGN:US,BBG000FH8PX5,Can Allergan (AGN) Keep the Earnings Streak Alive in Q3?,2016-10-27 17:43:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1-d8lgEeapE/can-allergan-agn-keep-the-earnings-streak-alive-in-q3-cm699587,Allergan plc AGN will be reporting third quarter 2016 earnings on Nov 2 before market open Last quarter the company delivered a positive earnings surprise of 2 13 Allergan s performance has been pretty impressive with consistent positive surprises The average earnings beat over the
AGN,AGN:US,BBG000FH8PX5,Can Allergan (AGN) Keep the Earnings Streak Alive in Q3?,2016-10-27 15:35:03 +0000,http://finance.yahoo.com/news/allergan-agn-keep-earnings-streak-153503141.html,Can Allergan (AGN) Keep the Earnings Streak Alive in Q3?
AGN,AGN:US,BBG000FH8PX5,Allergan to acquire Boston drug company for $200M,2016-10-27 14:41:07 +0000,http://www.bizjournals.com/boston/news/2016/10/27/allergan-to-acquire-boston-drug-company-for-200m.html?ana=yahoo,Allergan to acquire Boston drug company for $200M
AGN,AGN:US,BBG000FH8PX5,$690M done deal: Allergan completes Vitae acquisition,2016-10-27 11:55:12 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/26/allegarn-buys-vitae-three-execs-depart-hatfield.html?ana=yahoo,$690M done deal: Allergan completes Vitae acquisition
AGN,AGN:US,BBG000FH8PX5,"Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC, Expanding Innovative Gastroenterology Pipeline",2016-10-27 11:46:15 +0000,http://www.publicnow.com/view/F14D441AF2D00E00B3377CEB043E21B046BA0C56,"[at noodls] - DUBLIN and BOSTON, Oct. 27, 2016 /PRNewswire/ -- Allergan plc. (NYSE: AGN), a leading global pharmaceutical company and Rhythm Holding Company, LLC, which owns Motus Therapeutics, Inc. a biopharmaceutical ..."
AGN,AGN:US,BBG000FH8PX5,"Allergan To Acquire Motus, To Initiate Phase 3 Trials Of Relamorelin",2016-10-27 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bn8LK4prByA/allergan-to-acquire-motus-to-initiate-phase-3-trials-of-relamorelin-20161027-01842,"Allergan To Acquire Motus, To Initiate Phase 3 Trials Of Relamorelin"
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Changes to Board Leadership,2016-10-26 20:55:10 +0000,http://www.publicnow.com/view/B0E321ADB5913D35F57DFAE221317E6418C1156C,"[at noodls] - DUBLIN, Oct. 26, 2016 /PRNewswire/ -- Allergan plc (NYSE:AGN) today announced changes to leadership roles within its board of directors. Effective today, Brenton L. Saunders has been elected Chairman of ..."
AGN,AGN:US,BBG000FH8PX5,Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman,2016-10-26 20:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4wrasAdpF_Q/allergan-ceo-brent-saunders-succeeds-paul-bisaro-as-chairman-20161026-01342,Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman
AGN,AGN:US,BBG000FH8PX5,Allergan: Brenton Saunders Elected Chairman Of Board,2016-10-26 18:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gCjAOKObswQ/allergan-brenton-saunders-elected-chairman-of-board-20161026-01227,Allergan: Brenton Saunders Elected Chairman Of Board
AGN,AGN:US,BBG000FH8PX5,"VUG, QCOM, AGN, BMY: Large Inflows Detected at ETF",2016-10-26 16:51:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCpATBnPrVg/vug-qcom-agn-bmy-large-inflows-detected-at-etf-cm698650,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 86 0 million dollar inflow that s a 0 4 increase week over week in outstanding units
AGN,AGN:US,BBG000FH8PX5,Hedge Funds Are Cashing Out Of These Stocks As Investors Yank Capital,2016-10-25 14:03:35 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-cashing-out-of-these-stocks-as-investors-yank-capital-483045/,Hedge Funds Are Cashing Out Of These Stocks As Investors Yank Capital
AGN,AGN:US,BBG000FH8PX5,"KYBELLA® (deoxycholic acid) injection 10 mg/mL Puts ""Profiles in Focus"" With Expert Panel And New Direct-To-Consumer Campaign",2016-10-25 12:30:00 +0000,http://finance.yahoo.com/news/kybella-deoxycholic-acid-injection-10-123000953.html,"[PR Newswire] - DUBLIN, Oct. 25, 2016 /PRNewswire/ -- Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or ""double chin.""1 And with social media profile images becoming more important than ever, there is interest in looking one's best."
AGN,AGN:US,BBG000FH8PX5,Allergan Successfully Completes Vitae Tender Offer,2016-10-25 12:01:05 +0000,http://www.publicnow.com/view/0231902470C40C1C34D34FDC09275CD00474B0F5,"[at noodls] - DUBLIN, Oct. 25, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the successful completion of Allergan's tender offer to purchase all outstanding ..."
AGN,AGN:US,BBG000FH8PX5,MoneyBeat: Banner M&A Week Despite Election -- WSJ,2016-10-25 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n_qhHBXibuI/moneybeat-banner-ma-week-despite-election--wsj-20161025-00076,MoneyBeat: Banner M&A Week Despite Election -- WSJ
AGN,AGN:US,BBG000FH8PX5,Why Jim Cramer says the hottest theme on Wall Street is your selfie stick,2016-10-24 22:37:59 +0000,http://www.cnbc.com/id/104044198?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104044198,Why Jim Cramer says the hottest theme on Wall Street is your selfie stick
AGN,AGN:US,BBG000FH8PX5,Cramer says the hottest theme on Wall Street is thanks to...,2016-10-24 22:25:00 +0000,http://finance.yahoo.com/video/cramer-says-hottest-theme-wall-222500575.html,Cramer says the hottest theme on Wall Street is thanks to...
AGN,AGN:US,BBG000FH8PX5,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says",2016-10-24 17:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-stay-far-away-jpmorgan-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says"
AGN,AGN:US,BBG000FH8PX5,Biosimilars May Pose a Threat to Roche’s Herceptin,2016-10-24 15:30:19 +0000,http://marketrealist.com/2016/03/biosimilars-may-pose-threat-roches-herceptin/?utm_source=yahoo&utm_medium=feed,Biosimilars May Pose a Threat to Roche’s Herceptin
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans,2016-10-24 12:31:04 +0000,http://www.publicnow.com/view/3B295EDF4DCB53D83926D5F10E679F4E563578C5,"[at noodls] - DUBLIN, Oct. 24, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to improving outcomes and meeting critical needs in infectious diseases, will present new ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan's Upside: 20%-30%,2016-10-22 04:01:00 +0000,http://www.barrons.com/articles/allergans-upside-20-30-1477111126?mod=yahoobarrons&ru=yahoo,[$$] Allergan's Upside: 20%-30%
AGN,AGN:US,BBG000FH8PX5,"Gilead NASH Drug 'Active And Promising,' But Lagging Intercept",2016-10-21 20:03:20 +0000,http://www.investors.com/news/technology/gileads-nash-drug-is-active-and-promising-but-lagging-intercept/,"Gilead NASH Drug 'Active And Promising,' But Lagging Intercept"
AGN,AGN:US,BBG000FH8PX5,"Invest in Allergan on Weakness, Analysts Say",2016-10-21 15:45:00 +0000,https://www.thestreet.com/story/13862529/1/invest-in-allergan-on-weakness-analysts-say.html?puc=yahoo&cm_ven=YAHOO,"Invest in Allergan on Weakness, Analysts Say"
AGN,AGN:US,BBG000FH8PX5,Allergan's Nocturia Drug Gets FDA Advisory Committee's Nod,2016-10-21 15:25:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wG3EBvwGlpA/allergans-nocturia-drug-gets-fda-advisory-committees-nod-cm696526,Allergan plc AGN and partner Serenity Pharmaceuticals announced that the FDA s Advisory Committee of Bone Reproductive and Urologic Drugs recommended approval for its pipeline candidate SER120 desmopressin nasal spray for the treatment of nocturia Nocturia is a very common
AGN,AGN:US,BBG000FH8PX5,Allergan's Nocturia Drug Gets FDA Advisory Committee's Nod,2016-10-21 14:06:02 +0000,http://finance.yahoo.com/news/allergans-nocturia-drug-gets-fda-140602347.html,Allergan's Nocturia Drug Gets FDA Advisory Committee's Nod
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Another Strong Quarter from J&J, Lilly Cancer Drug Approved",2016-10-21 14:04:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iHEfrrCHCpA/pharma-stock-roundup-another-strong-quarter-from-jj-lilly-cancer-drug-approved-cm696502,Earnings started on a positive note for the pharma sector with industry bellwether Johnson amp Johnson JNJ reporting better than expected results Swiss company Roche RHHBY also reported nine month sales figures this week Recap of the Week s Most Important Stories J amp J
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Another Strong Quarter from J&J, Lilly Cancer Drug Approved",2016-10-21 12:28:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-another-strong-122812176.html,"Pharma Stock Roundup: Another Strong Quarter from J&J, Lilly Cancer Drug Approved"
AGN,AGN:US,BBG000FH8PX5,"Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma",2016-10-21 11:45:12 +0000,http://247wallst.com/healthcare-business/2016/10/21/why-despite-alkermes-success-suicidal-ideation-still-eludes-big-pharma/,"Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma"
AGN,AGN:US,BBG000FH8PX5,FDA Advisory Committee Recommends Approval of SER120 (desmopressin nasal spray),2016-10-20 18:59:07 +0000,http://www.publicnow.com/view/0F00B3C6863489274EB17683DF7C29EA1F543B8E,"[at noodls] - DUBLIN and MILFORD, Pa., Oct. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Serenity Pharmaceuticals, LLC, announced today that the US Food and Drug Administration ..."
AGN,AGN:US,BBG000FH8PX5,Gilead Sciences: 'Far From Compelling',2016-10-20 16:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/20/gilead-sciences-far-from-compelling/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: 'Far From Compelling'
AGN,AGN:US,BBG000FH8PX5,FDA panel backs Allergan's drug for frequent nightly urination,2016-10-19 20:11:23 +0000,http://finance.yahoo.com/news/fda-panel-backs-allergans-drug-201123481.html,"[Reuters] - The benefits associated with Allergan Plc's experimental drug to treat frequent nightly urination outweigh the risks for certain patients, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The FDA is not obliged to follow its advisory panel's recommendations but typically does so."
AGN,AGN:US,BBG000FH8PX5,Allergan and Tobira Therapeutics Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Proposed Acquisition of Tobira,2016-10-19 16:38:08 +0000,http://www.publicnow.com/view/F5565DB8B5A920145A926260B73ADDA78E2B5E3E,"[at noodls] - DUBLIN, and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage ..."
AGN,AGN:US,BBG000FH8PX5,Wellesley clinical trial software startup raises $5M,2016-10-19 15:03:52 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/10/wellesley-clinical-trial-software-startup-raises.html?ana=yahoo,"[at American City Business Journals] - A clinical trials software startup based in Wellesley has raised $5 million in Series A1 financing led by Boston-based Schooner Capital, bringing its total funding raised this year to $7.5 million. 4G Clinical says the money will be used further develop its product, Prancer, the company’s fourth generation Randomization and Trial Supply Management offering, as well as for marketing and general company operations. Co-founder and Chief Technical Officer Ed Tourtellotte created Prancer, as well as the clinical supply forecasting software, tcVisualize."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Brings Juvederm Voluma XC to U.S. Market,2016-10-19 14:50:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w_7WzCU21ns/allergan-agn-brings-juvederm-voluma-xc-to-us-market-cm695256,Allergan plc AGN announced that it has launched Juvéderm Voluma XC in the U S The product is a new addition to the Juvéderm range of fillers for lip augmentation and for correcting perioral rhytids or lipstick lines in adults aged 21 and above In one year of clinical trials the
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Brings Juvederm Voluma XC to U.S. Market,2016-10-19 13:00:01 +0000,http://finance.yahoo.com/news/allergan-agn-brings-juvederm-voluma-130001417.html,Allergan (AGN) Brings Juvederm Voluma XC to U.S. Market
AGN,AGN:US,BBG000FH8PX5,Allergan and Tobira Therapeutics Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Proposed Acquisition of Tobira,2016-10-19 12:28:06 +0000,http://www.publicnow.com/view/44733D61B59F4EBEB3745D65035D1367E87C43D2,"[at noodls] - DUBLIN, and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage ..."
AGN,AGN:US,BBG000FH8PX5,FTC Grants Early Termination Of HSR Waiting Period For Allergan-Tobira Deal,2016-10-19 08:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IcxIxKRgpVs/ftc-grants-early-termination-of-hsr-waiting-period-for-allergantobira-deal-20161019-00291,FTC Grants Early Termination Of HSR Waiting Period For Allergan-Tobira Deal
AGN,AGN:US,BBG000FH8PX5,Options Insight: How to Play Allergan,2016-10-18 20:04:39 +0000,http://finance.yahoo.com/video/options-insight-play-allergan-200439529.html,Options Insight: How to Play Allergan
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Inflow Detected - VUG, BMY, AGN, QCOM",2016-10-18 16:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YUoa-Gr4c_I/notable-etf-inflow-detected-vug-bmy-agn-qcom-cm694829,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 104 6 million dollar inflow that s a 0 5 increase week over week in outstanding
AGN,AGN:US,BBG000FH8PX5,JUVÉDERM VOLBELLA® XC Now Available To Doctors And Patients In The U.S.,2016-10-18 13:23:02 +0000,http://www.publicnow.com/view/DAEBFF4D10D146A65E0B9EAB85DA3E969C5D88F7,"[at noodls] - DUBLIN, Oct. 18, 2016 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today that the latest addition to the JUVÉDERM® collection of fillers, JUVÉDERM VOLBELLA® ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Says JUVÃ‰DERM VOLBELLA XC Now Available In U.S,2016-10-18 09:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B3CN-wJCEBI/allergan-says-juv%C3%A3derm-volbella-xc-now-available-in-us-20161018-00473,Allergan Says JUVÃ‰DERM VOLBELLA XC Now Available In U.S
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Gains Rights to RTGel from UroGen Pharma,2016-10-17 15:44:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QzLGXbWNX1Y/allergan-agn-gains-rights-to-rtgel-from-urogen-pharma-cm694165,Ireland based Allergan plc AGN has gained worldwide rights to RTGel delivery system technology for use with neurotoxins from privately held pharma company UroGen Pharma for an upfront payment of 17 5 million RTGel technology was developed by New York based UroGen to promote ease of
AGN,AGN:US,BBG000FH8PX5,Johnson & Johnson’s Expected Profitability in 3Q16,2016-10-17 15:04:21 +0000,http://marketrealist.com/2016/10/johnson-johnsons-expected-profitability-in-3q16/?utm_source=yahoo&utm_medium=feed,Johnson & Johnson’s Expected Profitability in 3Q16
AGN,AGN:US,BBG000FH8PX5,Allergan's Belkyra Gets Swedish Approval for Double Chin,2016-10-17 14:44:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJi3sB9iMvo/allergans-belkyra-gets-swedish-approval-for-double-chin-cm694040,Allergan plc AGN announced that its prescription medicine Belkyra deoxycholic acid has been granted marketing approval in Sweden for the treatment of moderate to severe fullness under the chin in adults commonly referred to as double chin Belkyra was added to Allergan s portfolio
AGN,AGN:US,BBG000FH8PX5,FDA staff flag concerns about Allergan's urinary drug,2016-10-17 14:35:57 +0000,http://finance.yahoo.com/news/fda-staff-flag-concerns-allergans-143557686.html,"[Reuters] - The proposed dosing for a drug being developed by Allergan Plc to treat frequent urination at night has not been adequately studied in trials, a preliminary review by the U.S. Food and Drug Administration staff concluded. The drug, SER120, is a low-dose nasal version of the commonly used treatment, desmopressin, and is designed to treat adults with nocturia, a disorder where a person wakes up to urinate twice or more at night. Allergan has proposed starting patients with a 0.75 microgram (mcg) dose, and moving up to 1.5 mcg if necessary, but this dosing regimen was not studied in any clinical trials, staff reviewers said on Monday."
AGN,AGN:US,BBG000FH8PX5,"FDA staff flags concerns about Allergan, Serenity Pharma urinary drug",2016-10-17 13:22:49 +0000,http://finance.yahoo.com/news/fda-staff-flags-concerns-allergan-132249482.html,"[Reuters] - The proposed dosing regimen for a frequent nightly urination treatment, developed by Allergan Plc and privately held Serenity Pharmaceuticals, has not been adequately studied in clinical trials, a preliminary review by the U.S. Food and Drug Administration staff concluded. The drug, SER120, is a low-dose nasal version of the commonly used treatment, desmopressin, and is designed to treat adults with nocturia, a urological disorder characterized by frequent urination at night. Allergan has proposed starting patients with a 0.75 microgram (mcg) dose, and moving up to 1.5 mcg if necessary, but this dosing regimen was not studied in any clinical trials, staff reviewers said on Monday."
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Gains Rights to RTGel from UroGen Pharma,2016-10-17 13:14:01 +0000,http://finance.yahoo.com/news/allergan-agn-gains-rights-rtgel-131401585.html,Allergan (AGN) Gains Rights to RTGel from UroGen Pharma
AGN,AGN:US,BBG000FH8PX5,Allergan's Belkyra Gets Swedish Approval for Double Chin,2016-10-17 12:57:12 +0000,http://finance.yahoo.com/news/allergans-belkyra-gets-swedish-approval-125712395.html,Allergan's Belkyra Gets Swedish Approval for Double Chin
AGN,AGN:US,BBG000FH8PX5,Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae,2016-10-17 12:23:02 +0000,http://www.publicnow.com/view/AD2D3EF09D669A9F6355DB3475815CB70FB11726,"[at noodls] - DUBLIN and FORT WASHINGTON, Pa., Oct. 17, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Vitae Pharmaceuticals, Inc. (NASDAQ: VTAE), a clinical-stage biotechnology ..."
AGN,AGN:US,BBG000FH8PX5,This Space Presents a Market Opportunity for Valeant,2016-10-17 12:04:25 +0000,http://marketrealist.com/2016/10/xifaxan-may-witness-strong-growth-trends-hepatic-encephalopathy-segment-2016/?utm_source=yahoo&utm_medium=feed,This Space Presents a Market Opportunity for Valeant
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data Including Ulipristal Acetate at the American Society of Reproductive Medicine (ASRM) Scientific Congress and Expo in Salt Lake City,2016-10-17 12:01:00 +0000,http://finance.yahoo.com/news/allergan-present-data-including-ulipristal-120100672.html,"[PR Newswire] - DUBLIN, Oct. 17, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has two presentations including a late breaking abstract that will be presented ..."
AGN,AGN:US,BBG000FH8PX5,Making Sense of Merger-Arbitrage Funds,2016-10-17 10:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=774331&SR=Yahoo,Making Sense of Merger-Arbitrage Funds
AGN,AGN:US,BBG000FH8PX5,"Allergan, Vitae Pharma Announce Expiration Of HSR Waiting Period - Quick Facts",2016-10-17 08:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A_GSnxFDbgA/allergan-vitae-pharma-announce-expiration-of-hsr-waiting-period--quick-facts-20161017-00362,"Allergan, Vitae Pharma Announce Expiration Of HSR Waiting Period - Quick Facts"
AGN,AGN:US,BBG000FH8PX5,Allergan Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) with Development of IBS CounSEL,2016-10-16 12:23:56 +0000,http://www.publicnow.com/view/E5D2C92B94EBCEF5BDECFDB126210C35152BA8CA,"[at noodls] - DUBLIN, Oct. 16, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today the formation of the IBS CounSEL, a group of multidisciplinary experts dedicated to improving diagnosis and management of ..."
AGN,AGN:US,BBG000FH8PX5,Shire Routs Incumbent Allergan In Booming Dry-Eye Market: RBC,2016-10-14 20:15:43 +0000,http://www.investors.com/news/technology/shire-routs-incumbent-allergan-in-booming-dry-eye-market-rbc/,Shire Routs Incumbent Allergan In Booming Dry-Eye Market: RBC
AGN,AGN:US,BBG000FH8PX5,Allergan Demonstrates Continued Commitment to Irritable Bowel Syndrome with Diarrhea Management with Two Poster Presentations at ACG 2016,2016-10-14 12:20:05 +0000,http://www.publicnow.com/view/747A6C09B5D851AC96B9A6190DFDB4240B42A18C,"[at noodls] - DUBLIN, Oct. 14, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to the research and development of new treatments for gastrointestinal diseases, today ..."
AGN,AGN:US,BBG000FH8PX5,UroGen Pharma Announces Agreement to License RTGel™ for Use with Neurotoxins to Allergan,2016-10-14 11:00:00 +0000,http://finance.yahoo.com/news/urogen-pharma-announces-agreement-license-110000346.html,"[GlobeNewswire] - RAANANA, Israel, Oct. 14, 2016-- UroGen Pharma, a privately-held, clinical-stage biotechnology company, announced today that it has completed an agreement to license worldwide rights to UroGen’ s RTGel ..."
AGN,AGN:US,BBG000FH8PX5,[$$] US modifies plans to crack down on inversions,2016-10-13 23:05:42 +0000,"http://www.ft.com/cms/s/87d30dc4-9190-11e6-a72e-b428cb934b78,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The Obama administration has revised a proposed crackdown on US companies moving overseas to cut their tax bills in an effort to stop other businesses from suffering collateral damage. Jack Lew, the US ..."
AGN,AGN:US,BBG000FH8PX5,Treasury takes its latest step to keep corporate taxes in the US,2016-10-13 21:32:36 +0000,http://www.cnbc.com/id/104017976?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104017976,Treasury takes its latest step to keep corporate taxes in the US
AGN,AGN:US,BBG000FH8PX5,Allergan Gets Priority Review for Avycaz Label Expansion,2016-10-13 20:41:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MJy8Y2ahVOc/allergan-gets-priority-review-for-avycaz-label-expansion-cm693134,Allergan plc AGN announced that its supplemental new drug application for antibiotic Avycaz ceftazidime and avibactam ex U S trade name Zavicefta has been accepted for review by the FDA Allergan is looking to include data from a phase III study in Avycaz s existing label The phase
AGN,AGN:US,BBG000FH8PX5,Allergan to Host Third Quarter 2016 Earnings Conference Call and Webcast,2016-10-13 20:40:02 +0000,http://www.publicnow.com/view/38B9DE8F2876B0512710E4372F2CB6ABFA789DE8,"[at noodls] - DUBLIN, Oct. 13, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it intends to release third quarter 2016 financial results on Wednesday, November 2, 2016, prior to the open of the U.S. ..."
AGN,AGN:US,BBG000FH8PX5,Pfizer Will Likely Overpay For M&A Post-Allergan Breakup Flop: Jeffries,2016-10-13 20:29:13 +0000,http://www.investors.com/news/technology/pfizer-will-likely-overpay-for-ma-post-allergan-breakup-flop-jefferies/,Pfizer Will Likely Overpay For M&A Post-Allergan Breakup Flop: Jeffries
AGN,AGN:US,BBG000FH8PX5,Keep Calm and Focus on What Is Significant,2016-10-13 19:00:00 +0000,http://realmoney.thestreet.com/articles/10/13/2016/keep-calm-and-focus-what-significant?puc=yahoo&cm_ven=YAHOO,Keep Calm and Focus on What Is Significant
AGN,AGN:US,BBG000FH8PX5,Allergan Gets Priority Review for Avycaz Label Expansion,2016-10-13 18:30:06 +0000,http://finance.yahoo.com/news/allergan-gets-priority-review-avycaz-183006860.html,Allergan Gets Priority Review for Avycaz Label Expansion
AGN,AGN:US,BBG000FH8PX5,"ETF’s with exposure to Allergan Plc : October 13, 2016",2016-10-13 13:24:08 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-allergan-plc-october-13-2016/,"ETF’s with exposure to Allergan Plc : October 13, 2016"
AGN,AGN:US,BBG000FH8PX5,Allergan Partners with SonarMD® to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients,2016-10-13 13:01:00 +0000,http://finance.yahoo.com/news/allergan-partners-sonarmd-develop-innovative-130100311.html,"[PR Newswire] - DUBLIN, Oct. 13, 2016 /PRNewswire/ -- Allergan plc (AGN) announced today a collaboration with SonarMD®, a leader in population health management, on the development of clinical decision support (CDS) and patient engagement tools which can be used to facilitate physician identification of patients suffering from Irritable Bowel Syndrome with Diarrhea (IBS-D) in clinical practice and monitor their treatment outcomes. SonarMD has previously applied this technology to support patients with Crohn's Disease, combining the use of clinical metrics derived from CDS tools with patient reported outcomes."
AGN,AGN:US,BBG000FH8PX5,In Depth Review of Gilead Sciences’ NASH Pipeline Opportunities,2016-10-13 12:04:49 +0000,http://marketrealist.com/2016/10/in-depth-review-of-gilead-sciences-nash-pipeline-opportunities/?utm_source=yahoo&utm_medium=feed,In Depth Review of Gilead Sciences’ NASH Pipeline Opportunities
AGN,AGN:US,BBG000FH8PX5,Allergan's BELKYRA® (Deoxycholic Acid) Receives Marketing Authorisation In Sweden For The Treatment Of Moderate To Severe Fullness Under The Chin (Double Chin),2016-10-13 11:20:08 +0000,http://www.publicnow.com/view/30DA155A46FFBB53EC7C7B6057D9F8120164BCDE,"[at noodls] - DUBLIN, Oct. 13, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company, announced that Sweden has received the Marketing Authorisation for BELKYRA® (deoxycholic acid) after ..."
AGN,AGN:US,BBG000FH8PX5,"Asanko Gold Produces 53,986 oz in Q3 2016",2016-10-13 11:10:03 +0000,http://www.publicnow.com/view/555DEFA633C85BBCC189AE9E5683C0EC7CDF6448,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Oct. 13, 2016) - Q3 2016 Highlights: Gold production ahead of plan at 53,986 ounces and gold sales of 54,393 ounces for US$71.3m in gold revenue Mined ore grades ..."
AGN,AGN:US,BBG000FH8PX5,Pfizer Loses UK Appeal Court Patent Case Over Lyrica,2016-10-13 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z4aeQHGA_wU/pfizer-loses-uk-appeal-court-patent-case-over-lyrica-20161013-00287,Pfizer Loses UK Appeal Court Patent Case Over Lyrica
AGN,AGN:US,BBG000FH8PX5,Allergan: BELKYRA Receives Marketing Authorisation In Sweden - Quick Facts,2016-10-13 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HThwRB3ItCc/allergan-belkyra-receives-marketing-authorisation-in-sweden--quick-facts-20161013-00280,Allergan: BELKYRA Receives Marketing Authorisation In Sweden - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Asian stocks fall after disappointing China data,2016-10-13 03:32:11 +0000,http://sg.finance.yahoo.com/news/us-stocks-steady-oil-prices-142730649.html,Asian stocks fall after disappointing China data
AGN,AGN:US,BBG000FH8PX5,[$$] Drugmakers respond to growing need for eye treatments,2016-10-12 22:57:26 +0000,"http://www.ft.com/cms/s/431c9692-65fc-11e6-8310-ecf0bddad227,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Of the five senses, none may be more precious than sight. Yet even as other areas of medicine have advanced rapidly in recent decades, the area of eyecare has been comparatively static, especially when ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Eye research closes in on blockbuster drugs,2016-10-12 22:57:26 +0000,"http://www.ft.com/cms/s/4684b7fe-65fe-11e6-8310-ecf0bddad227,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Most blockbuster medicines, that is to say drugs with sales of $1bn and more a year, fall into three categories: anti-inflammatory wonder drugs that treat everything from arthritis to psoriasis, cancer ..."
AGN,AGN:US,BBG000FH8PX5,Controversy Over Allergan's 500% Premium for Tobira Looks Overdone,2016-10-12 20:15:00 +0000,https://www.thestreet.com/story/13850988/1/controversy-over-allergan-s-500-premium-for-tobira-looks-overdone.html?puc=yahoo&cm_ven=YAHOO,Controversy Over Allergan's 500% Premium for Tobira Looks Overdone
AGN,AGN:US,BBG000FH8PX5,Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD,2016-10-12 18:33:00 +0000,https://www.thestreet.com/story/13849365/1/rebound-may-be-in-store-for-beaten-down-shares-of-therapeuticsmd.html?puc=yahoo&cm_ven=YAHOO,Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD
AGN,AGN:US,BBG000FH8PX5,US stocks steady as oil prices fall; bond yields surge,2016-10-12 14:27:44 +0000,http://finance.yahoo.com/news/us-stocks-steady-oil-prices-fall-bond-yields-142730369--finance.html,US stocks steady as oil prices fall; bond yields surge
AGN,AGN:US,BBG000FH8PX5,Allergan Challenges Intercept With Tobira NASH Drug,2016-10-11 20:18:50 +0000,http://www.investors.com/news/technology/allergan-to-buoy-vs-intercept-on-solid-tobira-nash-drug-mizuho/,Allergan Challenges Intercept With Tobira NASH Drug
AGN,AGN:US,BBG000FH8PX5,"Allergan Launches #ActuallySheCan(SM) Mentorship, Sharing Inspirational Portraits And Interviews Of Women In Entertainment, Sports And Business",2016-10-11 14:01:00 +0000,http://finance.yahoo.com/news/allergan-launches-actuallyshecan-sm-mentorship-140100082.html,"[PR Newswire] - DUBLIN, Oct. 11, 2016 /PRNewswire/ -- ActuallySheCanSM, the female empowerment campaign by Allergan, today unveiled a striking series of portraits shot by celebrated photographers Inez van Lamsweerde and Vinoodh Matadin to announce the launch of #ActuallySheCan Mentorship, providing young women with inspirational advice. Award-winning Inez and Vinoodh have created portraits of actress Chloë Grace Moretz, Olympic gold-medal gymnast Gabby Douglas, actress Gabourey Sidibe, supermodel and entrepreneur Iman, and television host and CEO Amanda de Cadenet, alongside their mentors or mentees – women who have meaningfully impacted their lives or whom they have supported in turn."
AGN,AGN:US,BBG000FH8PX5,FDA Accepts Supplemental New Drug Application (sNDA) for AVYCAZ® (ceftazidime and avibactam),2016-10-11 12:01:00 +0000,http://finance.yahoo.com/news/fda-accepts-supplemental-drug-application-120100842.html,"[PR Newswire] - DUBLIN, Oct. 11, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has accepted for filing the company's ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Files SNDA To Expand AVYCAZ Label - Quick Facts,2016-10-11 08:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bbhkgpDyHlg/allergan-files-snda-to-expand-avycaz-label--quick-facts-20161011-00231,Allergan Files SNDA To Expand AVYCAZ Label - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Nestle appoints new CEO for skin health business,2016-10-11 05:42:32 +0000,http://finance.yahoo.com/news/nestle-appoints-ceo-skin-health-054232499.html,Nestle appoints new CEO for skin health business
AGN,AGN:US,BBG000FH8PX5,"Nestle Names Paul Navarre Nestle Skin Health CEO, Effective Nov. 1 - Quick Facts",2016-10-11 01:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B55s2EFGlL4/nestle-names-paul-navarre-nestle-skin-health-ceo-effective-nov-1--quick-facts-20161011-00059,"Nestle Names Paul Navarre Nestle Skin Health CEO, Effective Nov. 1 - Quick Facts"
AGN,AGN:US,BBG000FH8PX5,"S&P 500’s ‘triangle’ chart pattern warns of a big selloff, analyst says",2016-10-10 20:24:47 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=AE28E0D2-8F1C-11E6-94B4-A9EAC68D0F98&siteid=yhoof2,"S&P 500’s ‘triangle’ chart pattern warns of a big selloff, analyst says"
AGN,AGN:US,BBG000FH8PX5,"Noteworthy Monday Option Activity: HUM, ILMN, AGN",2016-10-10 19:17:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DIlROBlZXwE/noteworthy-monday-option-activity-hum-ilmn-agn-cm691214,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Humana Inc Symbol HUM where a total volume of 10 221 contracts has been traded thus far today a contract volume which is representative of approximately 1 0
AGN,AGN:US,BBG000FH8PX5,"Notable ETF Inflow Detected - VUG, BMY, AGN, CELG",2016-10-10 16:18:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JSGyh8XBM6Q/notable-etf-inflow-detected-vug-bmy-agn-celg-cm691056,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 80 8 million dollar inflow that s a 0 4 increase week over week in outstanding units
AGN,AGN:US,BBG000FH8PX5,Repros' Secondary Hypogonadism Drug under Review in EU,2016-10-10 15:21:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t4tzMfTI8yQ/repros-secondary-hypogonadism-drug-under-review-in-eu-cm691016,Repros Therapeutics Inc RPRX announced that the European Medicines Agency has accepted for review its marketing authorization application for enclomiphene The company is looking to get enclomiphene approved for the treatment of secondary hypogonadism Repros expects to receive day
AGN,AGN:US,BBG000FH8PX5,Repros' Secondary Hypogonadism Drug under Review in EU,2016-10-10 13:20:01 +0000,http://finance.yahoo.com/news/repros-secondary-hypogonadism-drug-under-132001317.html,Repros' Secondary Hypogonadism Drug under Review in EU
AGN,AGN:US,BBG000FH8PX5,Allergan to Showcase Novel and Expanding Eye Care Portfolio with New Data Presentations at the 2016 American Academy of Ophthalmology Annual Meeting in Chicago,2016-10-10 12:05:00 +0000,http://finance.yahoo.com/news/allergan-showcase-novel-expanding-eye-120500956.html,"[PR Newswire] - DUBLIN, Oct. 10, 2016 /PRNewswire/ -- Allergan (NYSE: AGN) today announced that its data will be presented during the 2016 American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, October 14-18. ..."
AGN,AGN:US,BBG000FH8PX5,3 Tax Loopholes Hillary Clinton Wants to Close,2016-10-09 12:43:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TYQHbKiXbMQ/3-tax-loopholes-hillary-clinton-wants-to-close-cm690751,Image source Hillary Clinton for President With about a month left in the 2016 Presidential election campaign Donald Trump and Hillary Clinton have started to hammer home their stances on important policies Few issues inspire more controversy than taxes and the
AGN,AGN:US,BBG000FH8PX5,3 Tax Loopholes Hillary Clinton Wants to Close,2016-10-09 11:05:06 +0000,http://www.fool.com/retirement/2016/10/09/3-tax-loopholes-hillary-clinton-wants-to-close.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Tax Loopholes Hillary Clinton Wants to Close
AGN,AGN:US,BBG000FH8PX5,5 Stock Picks Ahead of World Mental Health Day,2016-10-07 15:46:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NFC9-1yOqfM/5-stock-picks-ahead-of-world-mental-health-day-cm690306,World Mental Health Day is observed every year on Oct 10 this year the theme is psychological first aid which covers both psychological and social support According to information provided by the National Alliance on Mental Illness about one in five adults in the U S or 43 8
AGN,AGN:US,BBG000FH8PX5,5 Stock Picks Ahead of World Mental Health Day,2016-10-07 13:57:01 +0000,http://finance.yahoo.com/news/5-stock-picks-ahead-world-135701600.html,5 Stock Picks Ahead of World Mental Health Day
AGN,AGN:US,BBG000FH8PX5,Allergan and the Dystonia Medical Research Foundation Continue Longstanding Partnership,2016-10-07 12:29:03 +0000,http://www.publicnow.com/view/A6AE2CFCA91740DF6A9C614138ACAB41397D36DB,"[at noodls] - DUBLIN and CHICAGO, Oct. 7, 2016 /PRNewswire/ -- Allergan and the Dystonia Medical Research Foundation (DMRF) are proud to continue their long-standing partnership in support of dystonia patients by conducting ..."
AGN,AGN:US,BBG000FH8PX5,John Paulson's Health Care Stocks Drop Far Below Sector Return,2016-10-06 22:06:03 +0000,http://finance.yahoo.com/news/john-paulsons-health-care-picks-220603846.html,John Paulson's Health Care Stocks Drop Far Below Sector Return
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S",2016-10-06 20:33:34 +0000,http://biz.yahoo.com/e/161006/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S"
AGN,AGN:US,BBG000FH8PX5,"Commit To Purchase Allergan At $155, Earn 3.7% Using Options",2016-10-06 16:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SnIiDA707iI/commit-to-purchase-allergan-at-155-earn-37-using-options-cm689878,Investors eyeing a purchase of Allergan PLC Symbol AGN stock but cautious about paying the going market price of 237 00 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018 put
AGN,AGN:US,BBG000FH8PX5,3 Value Stocks Near 52-Week Lows Worth Buying,2016-10-06 16:45:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UQEGdoBIV08/3-value-stocks-near-52-week-lows-worth-buying-cm689854,Image source Getty Images While many companies shares are rising 160 past their fair values now others are trading at potentially bargain prices The difficulty with bargain shopping though is that you may be understandably hesitant to buy stocks wallowing near their 52 week
AGN,AGN:US,BBG000FH8PX5,Teva to Divest Actavis Generics' UK & Ireland Operations,2016-10-06 15:48:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tE8fkFH2seg/teva-to-divest-actavis-generics-uk-ireland-operations-cm689783,Teva Pharmaceutical Industries Ltd TEVA announced that it has agreed to divest the UK and Ireland assets of Actavis Generics to Accord Healthcare a subsidiary of Intas Pharmaceuticals Ltd subject to a final approval from the European Commission EC The deal has been settled with
AGN,AGN:US,BBG000FH8PX5,Nonalcoholic Steatohepatitis: What's The Market Opportunity And Who Are The Major Players?,2016-10-06 15:45:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9Jh7zq_Hgo/nonalcoholic-steatohepatitis-whats-the-market-opportunity-and-who-are-the-major-players-cm686383,By Slingshot Insights BySlingshot Insights By Killian McKee Slingshot contributor By Killian McKee Slingshot contributorBy Killian McKee Slingshot contributor On September 20th Allergan AGN brought increased investor attention to the NASH market by buying two
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Lilly Inks Animal Health Deal, J&J's Psoriasis Data Looks Good",2016-10-06 14:47:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9ivxzZZw6s/pharma-stock-roundup-lilly-inks-animal-health-deal-jjs-psoriasis-data-looks-good-cm689700,Once again acquisitions and deals were in focus in the pharma sector with Lilly LLY announcing a deal to boost its animal health segment and Allergan AGN and AstraZeneca AZN announcing licensing agreements Meanwhile companies like Johnson amp Johnson JNJ and Novartis NVS presented data
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan steps out of Pfizer ashes with $7bn of deals,2016-10-06 10:10:46 +0000,"http://www.ft.com/cms/s/abeb615e-8b44-11e6-8aa5-f79f5696c731,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Allergan, the drugmaker best known for its Botox wrinkle treatment, has been engaged in a furious bout of dealmaking over the past six months, after attempts to sell the company to Pfizer for $160bn collapsed. ..."
AGN,AGN:US,BBG000FH8PX5,Teva Divests More Assets to Win EC Approval for Allergan Generics Deal,2016-10-05 19:03:00 +0000,https://www.thestreet.com/story/13842947/1/teva-divests-more-assets-to-win-ec-approval-for-allergan-generics-deal.html?puc=yahoo&cm_ven=YAHOO,Teva Divests More Assets to Win EC Approval for Allergan Generics Deal
AGN,AGN:US,BBG000FH8PX5,"Teva to sell Allergan's generics business in UK, Ireland for $769 million",2016-10-05 18:40:01 +0000,http://sg.finance.yahoo.com/news/teva-sell-allergans-generics-business-163832469.html,"Teva to sell Allergan's generics business in UK, Ireland for $769 million"
AGN,AGN:US,BBG000FH8PX5,[$$] Teva Sells Actavis Generics European Assets to Accord Healthcare,2016-10-05 16:29:11 +0000,http://www.wsj.com/articles/teva-sells-actavis-generics-european-assets-to-accord-healthcare-1475684946?mod=yahoo_hs,[$$] Teva Sells Actavis Generics European Assets to Accord Healthcare
AGN,AGN:US,BBG000FH8PX5,"Teva to sell Allergan's generics business in UK, Ireland for $769 mln",2016-10-05 16:04:45 +0000,http://finance.yahoo.com/news/teva-sell-allergans-generics-business-160445195.html,"[Reuters] - Teva Pharmaceutical Industries Ltd said on Wednesday it would sell Allergan Plc's generics business in the UK and Ireland to India's Intas Pharmaceuticals Ltd for 603 million pounds ($769.37 million). The sale was part of Teva's deal with the European Commission to get approval for the acquisition of Allergan's generics business, called Actavis Generics. Teva completed the $40.5-billion acquisition of Allergan's generics business in August."
AGN,AGN:US,BBG000FH8PX5,Biotech Mergers Run the Show: 5 Small-Cap Stocks for Q4,2016-10-05 13:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/REB_8Ifg5zA/biotech-mergers-run-the-show-5-small-cap-stocks-for-q4-cm688679,Healthcare merger and acquisition activity has gathered steam over the past few years A few big mergers in the recent past include that of Pfizer Inc PFE and Wyeth Pfizer and Hospira Novartis AG NVS and Alcon Sanofi SNY and Genzyme Roche Holding AG RHHBY and Genentech and
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Heart Drug Brilinta Fails a Study; Shares Down,2016-10-05 13:46:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bvJAnkS88MQ/astrazeneca-heart-drug-brilinta-fails-a-study-shares-down-cm688949,AstraZeneca PLC AZN announced that its heart medicine Brilinta did not meet the primary endpoint in EUCLID trial for a new indication in peripheral artery disease PAD Shares slipped more than 1 on Tuesday Brilinta 90 mg is presently marketed for the reduction of the rate of
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals",2016-10-05 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-vivus-133001958.html,"The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals"
AGN,AGN:US,BBG000FH8PX5,New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy,2016-10-05 13:28:02 +0000,http://www.publicnow.com/view/E37220AF99C2F5E8C7757488CBDC24C711822BE5,"[at noodls] - MADISON, N.J., Oct. 5, 2016 /PRNewswire/ -- A new study conducted by Econsult Solutions, Inc., a Philadelphia-based economic consulting firm, found that Allergan's current New Jersey operations generated ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Indian drugmaker buys Actavis' UK and Ireland business,2016-10-05 13:22:28 +0000,"http://www.ft.com/cms/s/c1ccac48-8ae1-11e6-8cb7-e7ada1d123b1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Intas, one of India's biggest privately owned drugmakers, will announce a £600m deal to buy Actavis' UK and Ireland business on Thursday, in what is being billed as a vote of confidence in Britain following ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Enters the Attractive NASH Market,2016-10-05 12:04:26 +0000,http://marketrealist.com/2016/09/allergan-enters-the-attractive-nash-market/?utm_source=yahoo&utm_medium=feed,Allergan Enters the Attractive NASH Market
AGN,AGN:US,BBG000FH8PX5,Teva Boosts Generic Business with Allergan Anda Takeover,2016-10-04 23:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r19uRrJGq_0/teva-boosts-generic-business-with-allergan-anda-takeover-cm688847,Teva Pharmaceutical Industries Limited TEVA announced that it has completed the acquisition of Allergan plc s AGN U S generic distribution business Anda Inc Teva entered into a definitive agreement to acquire Anda the 4th largest distributor of generic pharmaceuticals in the U S for
AGN,AGN:US,BBG000FH8PX5,Teva Boosts Generic Business with Allergan Anda Takeover,2016-10-04 21:59:09 +0000,http://finance.yahoo.com/news/teva-boosts-generic-business-allergan-215909803.html,Teva Boosts Generic Business with Allergan Anda Takeover
AGN,AGN:US,BBG000FH8PX5,Understanding Gilead Sciences’ NASH Pipeline,2016-10-04 15:04:40 +0000,http://marketrealist.com/2016/09/understanding-gilead-sciences-nash-pipeline/?utm_source=yahoo&utm_medium=feed,Understanding Gilead Sciences’ NASH Pipeline
AGN,AGN:US,BBG000FH8PX5,5 FDA Decisions to Watch Out for in October 2016,2016-10-04 13:45:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VcF0rpyLWrY/5-fda-decisions-to-watch-out-for-in-october-2016-cm688404,The drug development process is often lengthy and time consuming and involves a lot of funds and resources It could take a drug anything between 10 12 years to be successfully developed and reach the market In such a scenario key pipeline events including data readouts and regulatory updates
AGN,AGN:US,BBG000FH8PX5,Allergan Buys Rights to AstraZeneca's Crohn's Disease Drug,2016-10-04 13:44:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F_kK8wxk81E/allergan-buys-rights-to-astrazenecas-crohns-disease-drug-cm688392,Leading drugmaker Allergan plc AGN announced that it has obtained global rights to develop and commercialize AstraZeneca PLC s AZN experimental drug MEDI2070 to treat Crohn s disease and ulcerative colitis for an upfront payment of 250 million Other than the upfront payment Allergan
AGN,AGN:US,BBG000FH8PX5,Allergan Buys Rights to AstraZeneca's Crohn's Disease Drug,2016-10-04 12:55:12 +0000,http://finance.yahoo.com/news/allergan-buys-rights-astrazenecas-crohns-125512192.html,Allergan Buys Rights to AstraZeneca's Crohn's Disease Drug
AGN,AGN:US,BBG000FH8PX5,Blog Coverage AstraZeneca Enters into an Agreement with Allergan,2016-10-04 12:50:14 +0000,http://news.investornetwork.com/2016/10/04/blog-coverage-astrazeneca-enters-into-an-agreement-with-allergan/?1=1&1475585414,Blog Coverage AstraZeneca Enters into an Agreement with Allergan
AGN,AGN:US,BBG000FH8PX5,5 FDA Decisions to Watch Out for in October 2016,2016-10-04 12:42:12 +0000,http://finance.yahoo.com/news/5-fda-decisions-watch-october-124212646.html,5 FDA Decisions to Watch Out for in October 2016
AGN,AGN:US,BBG000FH8PX5,Financial Services: Berkshire Is Bigger Than Buffett,2016-10-04 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=770495&SR=Yahoo,Financial Services: Berkshire Is Bigger Than Buffett
AGN,AGN:US,BBG000FH8PX5,Allergan Repeatedly Increased Offer For Tobira Before Sealing Deal,2016-10-03 21:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/No6bnc3Ir40/allergan-repeatedly-increased-offer-for-tobira-before-sealing-deal-20161003-01286,Allergan Repeatedly Increased Offer For Tobira Before Sealing Deal
AGN,AGN:US,BBG000FH8PX5,Allergan PLC’s Charm-and-Merger Offensive (AGN),2016-10-03 19:44:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itzx__LEK3E/allergan-plcs-charm-and-merger-offensive-agn-cm688064,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Since losing in his effort to take out Pfizer Inc NYSE PFE in a huge tax inversion deal this past spring Allergan Plc NYSE AGN CEO Brent Saunders has hatched a new strategy with the
AGN,AGN:US,BBG000FH8PX5,"Why Allergan, eBay, Dynavax, KBR, and More Are Trending",2016-10-03 15:33:36 +0000,http://www.insidermonkey.com/blog/why-allergan-ebay-dynavax-kbr-and-more-are-trending-478296/,"Why Allergan, eBay, Dynavax, KBR, and More Are Trending"
AGN,AGN:US,BBG000FH8PX5,$1.5B deal: AstraZeneca licenses experimental Crohn's disease drug to Allergan,2016-10-03 15:05:11 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/03/astrazeneca-allergan-licensing-deal-crohns-disease.html?ana=yahoo,$1.5B deal: AstraZeneca licenses experimental Crohn's disease drug to Allergan
AGN,AGN:US,BBG000FH8PX5,Botox-maker Allergan just struck another billion-dollar deal,2016-10-03 14:45:27 +0000,http://finance.yahoo.com/news/botox-maker-allergan-just-struck-144527016.html,Botox-maker Allergan just struck another billion-dollar deal
AGN,AGN:US,BBG000FH8PX5,Allergan's New Products And Robust R&D Pipeline Support A Positive Long-Term View,2016-10-03 14:31:32 +0000,http://finance.yahoo.com/news/allergans-products-robust-r-d-143132380.html,Allergan's New Products And Robust R&D Pipeline Support A Positive Long-Term View
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to buy bowel disease drug from AstraZeneca,2016-10-03 14:13:17 +0000,"http://www.ft.com/cms/s/1f23f2d2-896d-11e6-8cb7-e7ada1d123b1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Allergan, the drugmaker behind wrinkle treatment Botox, said it would pay up to $1.3bn to its Anglo-Swedish rival AstraZeneca to acquire the rights to an experimental medicine for inflammatory gastrointestinal ..."
AGN,AGN:US,BBG000FH8PX5,6 Best Performing Drug Stocks of September,2016-10-03 12:39:12 +0000,http://finance.yahoo.com/news/6-best-performing-drug-stocks-123912721.html,6 Best Performing Drug Stocks of September
AGN,AGN:US,BBG000FH8PX5,Stock Market Outlook: A Little Too Buoyant?,2016-10-03 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=771403&SR=Yahoo,Stock Market Outlook: A Little Too Buoyant?
AGN,AGN:US,BBG000FH8PX5,"European Stock Markets Rise; Pound Falls on Brexit Countdown, Henderson up on Janus Merger",2016-10-03 08:06:00 +0000,https://www.thestreet.com/story/13838274/1/european-stock-markets-rise-pound-falls-on-brexit-countdown-henderson-up-on-janus-merger.html?puc=yahoo&cm_ven=YAHOO,"European Stock Markets Rise; Pound Falls on Brexit Countdown, Henderson up on Janus Merger"
AGN,AGN:US,BBG000FH8PX5,3 October 2016 MedImmune out-licenses potential medicine for inflammatory diseases to Allergan Corporate Press Release,2016-10-03 06:36:01 +0000,http://www.publicnow.com/view/9F4F6BFCCB7A8B92E2FA56108A890CA884850135,"[at noodls] - 3 October 2016 AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Allergan plc for the global rights to MEDI2070. ..."
AGN,AGN:US,BBG000FH8PX5,Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program,2016-10-03 06:26:01 +0000,http://www.publicnow.com/view/4C3CD498478F2530511FFC49C346C87204C211F3,"[at noodls] - DUBLIN, Oct. 3, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has entered into a licensing agreement with MedImmune, AstraZeneca's global biologics research and development arm, ..."
AGN,AGN:US,BBG000FH8PX5,AstraZeneca licenses inflammatory disease candidate to Allergan,2016-10-03 06:21:43 +0000,http://uk.finance.yahoo.com/news/astrazeneca-licenses-inflammatory-disease-candidate-062143144.html,AstraZeneca licenses inflammatory disease candidate to Allergan
AGN,AGN:US,BBG000FH8PX5,"For Business Leaders, Hacking Attacks Get Personal",2016-10-03 05:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7tZgDUncQlc/for-business-leaders-hacking-attacks-get-personal-20161003-00140,"For Business Leaders, Hacking Attacks Get Personal"
AGN,AGN:US,BBG000FH8PX5,FTSE 100 Hits 16-month High,2016-10-03 05:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCcsqTPJeUQ/ftse-100-hits-16month-high-20161003-00139,FTSE 100 Hits 16-month High
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Licenses Global Rights Of MEDI2070 To Allergan For $250 Mln,2016-10-03 02:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yxk7GYC5SQk/astrazeneca-licenses-global-rights-of-medi2070-to-allergan-for-250-mln-20161003-00057,AstraZeneca Licenses Global Rights Of MEDI2070 To Allergan For $250 Mln
AGN,AGN:US,BBG000FH8PX5,Depomed fends off Allergan's attempt at generic painkiller,2016-09-30 20:39:22 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D1907A83-4DE1-462F-B776-CBE848D1255B&siteid=yhoof2,Depomed fends off Allergan's attempt at generic painkiller
AGN,AGN:US,BBG000FH8PX5,3 Top Healthcare Stocks to Buy Now,2016-09-30 20:22:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6aZIqzIYYEM/3-top-healthcare-stocks-to-buy-now-cm687338,Because of an aging global population an unprecedented amount of innovation and wider access to medical services in the United States the healthcare sector should continue to push higher in the coming years To take advantage of this rising tide investors may want to grab shares
AGN,AGN:US,BBG000FH8PX5,Cempra Gets More Good News,2016-09-30 19:04:52 +0000,http://finance.yahoo.com/tumblr/blog-cempra-gets-more-good-news-190457155.html,Cempra Gets More Good News
AGN,AGN:US,BBG000FH8PX5,3 Top Healthcare Stocks to Buy Now,2016-09-30 18:45:00 +0000,http://www.fool.com/investing/2016/09/30/3-top-healthcare-stocks-to-buy-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Healthcare Stocks to Buy Now
AGN,AGN:US,BBG000FH8PX5,Depomed Gets Favorable Nucynta Patent Decision,2016-09-30 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jDtEg4JZIxI/depomed-gets-favorable-nucynta-patent-decision-20160930-00777,Depomed Gets Favorable Nucynta Patent Decision
AGN,AGN:US,BBG000FH8PX5,Biotech stocks have plenty of catalysts around the corner,2016-09-30 17:28:21 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0681569A-8646-11E6-A751-447CDAF369FF&siteid=yhoof2,Biotech stocks have plenty of catalysts around the corner
AGN,AGN:US,BBG000FH8PX5,Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint,2016-09-30 16:24:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rKvo6B6iSSE/amgen-amgn-migraine-drug-hits-phase-iii-primary-endpoint-cm687174,Amgen Inc AMGN announced positive top line data from a phase III study ARISE on calcitonin gene related peptide CGRP receptor erenumab AMG 334 for the prevention of episodic migraine The multi center randomized 12 week double blind placebo controlled study evaluated the safety
AGN,AGN:US,BBG000FH8PX5,"Allergan Focus on Brands, Biosimilar Products & Acquisitions",2016-09-30 15:25:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h8Oy_QfJCPc/allergan-focus-on-brands-biosimilar-products-acquisitions-cm687112,We issued an updated research report on Allergan plc AGN on Sep 28 Allergan is reshaping its portfolio through acquisitions divestitures Allergan has been pretty active on the acquisition front With the Allergan Inc takeover the company finds itself among the top 10 pharmas
AGN,AGN:US,BBG000FH8PX5,Allergan Generics Has Strengthened Teva’s Research Pipeline,2016-09-30 14:04:24 +0000,http://marketrealist.com/2016/09/acquisition-allergan-generics-strengthened-teva-pharmaceuticals-research-pipeline-2016/?utm_source=yahoo&utm_medium=feed,Allergan Generics Has Strengthened Teva’s Research Pipeline
AGN,AGN:US,BBG000FH8PX5,"Allergan Focus on Brands, Biosimilar Products & Acquisitions",2016-09-30 13:12:01 +0000,http://finance.yahoo.com/news/allergan-focus-brands-biosimilar-products-131201897.html,"Allergan Focus on Brands, Biosimilar Products & Acquisitions"
AGN,AGN:US,BBG000FH8PX5,Teva Has a Targeted Strategy to Expand in Major Growth Markets,2016-09-30 12:04:27 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-developed-targeted-strategy-expanding-major-growth-markets/?utm_source=yahoo&utm_medium=feed,Teva Has a Targeted Strategy to Expand in Major Growth Markets
AGN,AGN:US,BBG000FH8PX5,Asian stocks lower on renewed worries about banking sector,2016-09-30 03:13:40 +0000,http://sg.finance.yahoo.com/news/stocks-off-quiet-start-oil-145515138.html,Asian stocks lower on renewed worries about banking sector
AGN,AGN:US,BBG000FH8PX5,"Dow 30 Stock Roundup: Nike Earnings Impress, Boeing Wins $8B Saudi Order",2016-09-29 16:23:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GD-wWBC4RTQ/dow-30-stock-roundup-nike-earnings-impress-boeing-wins-8b-saudi-order-cm686568,The Dow chalked up gains this week boosted by encouraging consumer related data and OPEC s landmark production control agreement Consumer confidence touched a nine year high leading to significant gains for consumer discretionary stocks on Tuesday Meanwhile the world s largest oil
AGN,AGN:US,BBG000FH8PX5,Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals,2016-09-29 13:50:05 +0000,http://www.publicnow.com/view/A6C672B3D171304CBD3FA2A64B6D42840F48FFB5,"[at noodls] - DUBLIN, Sept. 29, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), today issued the following statement regarding ongoing litigation on patents related to NAMENDA XR® (memantine hydrochloride) extended release ..."
AGN,AGN:US,BBG000FH8PX5,These 3 Stocks Tripled in 12 Months,2016-09-29 12:50:02 +0000,http://www.fool.com/investing/2016/09/28/these-3-stocks-tripled-in-12-months.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Stocks Tripled in 12 Months
AGN,AGN:US,BBG000FH8PX5,Allergan Issues Statement On Namenda XR Patent Litigation - Quick Facts,2016-09-29 09:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uh1FvF8UQm0/allergan-issues-statement-on-namenda-xr-patent-litigation--quick-facts-20160929-00557,Allergan Issues Statement On Namenda XR Patent Litigation - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Nonalcoholic Steatohepatitis (NASH): What's The Market Opportunity And Who Are The Major Players?,2016-09-29 08:21:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qDwPZbB20h4/nonalcoholic-steatohepatitis-nash-whats-the-market-opportunity-and-who-are-the-major-players-cm686378,By Slingshot Insights BySlingshot Insights By Killian McKee Slingshot contributorBy Killian McKee Slingshot contributor On September 20th Allergan AGN brought increased investor attention to the NASH market by buying two treatment developers Tobira Therapeutics Inc 1 7 billion
AGN,AGN:US,BBG000FH8PX5,Biotech Stocks Facing FDA Decision In October,2016-09-29 03:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZnJKegvZeFY/biotech-stocks-facing-fda-decision-in-october-20160929-00092,Biotech Stocks Facing FDA Decision In October
AGN,AGN:US,BBG000FH8PX5,Are Hedge Funds Technically Wrong?,2016-09-28 19:45:00 +0000,http://realmoney.thestreet.com/articles/09/28/2016/are-hedge-funds-technically-wrong?puc=yahoo&cm_ven=YAHOO,Are Hedge Funds Technically Wrong?
AGN,AGN:US,BBG000FH8PX5,These 3 Stocks Tripled in 12 Months,2016-09-28 14:21:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pfv8iW_ohlE/these-3-stocks-tripled-in-12-months-cm685848,Image source Teck Resources The stock market has done well over the past year with most major market benchmarks producing returns in the 10 to 15 range since September 2015 The Dow and S amp P 500 hit new record levels during the summer months and although volatility has
AGN,AGN:US,BBG000FH8PX5,5 Stocks Hedge Funds Hate -- Should You Too?,2016-09-28 13:07:00 +0000,https://www.thestreet.com/story/13754745/1/hedge-funds-hate-these-5-stocks-should-you-too.html?puc=yahoo&cm_ven=YAHOO,5 Stocks Hedge Funds Hate -- Should You Too?
AGN,AGN:US,BBG000FH8PX5,Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy,2016-09-27 17:19:07 +0000,http://www.publicnow.com/view/EE9C6CDB3B44D454607A455405EDF122140AF07E,"[at noodls] - IRVINE, Calif., Sept. 27, 2016 /PRNewswire/ -- A new study conducted by the Orange County Business Council (OCBC) found that Allergan'sCalifornia operations generated a combined annual economic activity ..."
AGN,AGN:US,BBG000FH8PX5,Pfizer (PFE) to Stay Together as a Single Company After All,2016-09-27 16:24:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iSyZA5gjw2w/pfizer-pfe-to-stay-together-as-a-single-company-after-all-cm685345,Drug maker Pfizer Inc PFE has finally decided not to split its two segments Innovative Health IH and Essential Health EH into two publicly traded companies For years the company has been facing pressure from investors and analysts alike to split into two separate companies in
AGN,AGN:US,BBG000FH8PX5,The Drug Price Increase Debate: Separating The Winners From The Losers,2016-09-27 15:23:28 +0000,http://finance.yahoo.com/news/drug-price-increase-debate-separating-152328816.html,The Drug Price Increase Debate: Separating The Winners From The Losers
AGN,AGN:US,BBG000FH8PX5,This Strategy Could Boost Teva’s Growth Prospects Even More,2016-09-27 14:04:36 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-geographic-diversification-strategy-may-boost-growth-prospects-2016/?utm_source=yahoo&utm_medium=feed,This Strategy Could Boost Teva’s Growth Prospects Even More
AGN,AGN:US,BBG000FH8PX5,Allergan to Present New Data at the American Urogynecologic Society Annual Meeting in Denver,2016-09-27 12:05:00 +0000,http://finance.yahoo.com/news/allergan-present-data-american-urogynecologic-120500721.html,"[PR Newswire] - DUBLIN, Sept. 27, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has presentations in overactive bladder and nocturia at the upcoming American ..."
AGN,AGN:US,BBG000FH8PX5,Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger,2016-09-26 20:30:48 +0000,http://www.investors.com/news/technology/unexpected-twist-pfizer-scraps-breakup-following-dead-allergen-merger/,Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger
AGN,AGN:US,BBG000FH8PX5,Drugmaker Pfizer decides not to break up business,2016-09-26 19:12:06 +0000,http://sg.finance.yahoo.com/news/drugmaker-pfizer-decides-not-break-115352233.html,Drugmaker Pfizer decides not to break up business
AGN,AGN:US,BBG000FH8PX5,Read Scraps Pfizer Break-Up as Megadeals Escape Its Grasp,2016-09-26 16:17:00 +0000,https://www.thestreet.com/story/13751876/1/read-scraps-pfizer-break-up-as-megadeals-escape-its-grasp.html?puc=yahoo&cm_ven=YAHOO,Read Scraps Pfizer Break-Up as Megadeals Escape Its Grasp
AGN,AGN:US,BBG000FH8PX5,Drugmaker Pfizer decides not to break up business,2016-09-26 15:35:29 +0000,http://finance.yahoo.com/news/drugmaker-pfizer-decides-not-break-business-115353624--finance.html,Drugmaker Pfizer decides not to break up business
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and Gilead Sciences",2016-09-26 15:24:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cuYL08TEqFA/the-zacks-analyst-blog-highlights-deutsche-bank-apple-therapeutics-allergan-and-gilead-sciences-cm684461,For Immediate Release Chicago IL September 26 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
AGN,AGN:US,BBG000FH8PX5,Allergan Gets FDA Approval for New Line of Breast Implants,2016-09-26 14:23:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2m0GcC2fDe4/allergan-gets-fda-approval-for-new-line-of-breast-implants-cm684381,Allergan plc AGN announced the FDA approval for the Natrelle Inspira Cohesive line of breast implants for breast reconstruction augmentation or revision surgery These implants which combine a high gel fill ratio and Allergan s highly cohesive gel will be available in two versions a
AGN,AGN:US,BBG000FH8PX5,"The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and Gilead Sciences",2016-09-26 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-deutsche-133001339.html,"The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and Gilead Sciences"
AGN,AGN:US,BBG000FH8PX5,Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval,2016-09-26 13:22:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/krEMIMDkzoM/amgens-biosimilar-of-abbvies-humira-gets-fda-approval-cm684356,Amgen Inc AMGN today announced the approval of Amjevita adalimumab atto a biosimilar version to AbbVie Inc s ABBV rheumatoid arthritis RA drug Humira Amjevita has been approved for the same indications that Humira is being used for including rheumatoid arthritis RA
AGN,AGN:US,BBG000FH8PX5,Allergan Gets FDA Approval for New Line of Breast Implants,2016-09-26 12:41:12 +0000,http://finance.yahoo.com/news/allergan-gets-fda-approval-line-124112078.html,Allergan Gets FDA Approval for New Line of Breast Implants
AGN,AGN:US,BBG000FH8PX5,Pfizer decides against splitting into two companies,2016-09-26 10:59:35 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=5F35D862-65A1-4A31-A060-7D0EC8ED1F56&siteid=yhoof2,Pfizer decides against splitting into two companies
AGN,AGN:US,BBG000FH8PX5,Pfizer Won't Pursue a Split of Established and New Medical Lines,2016-09-26 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S-8KpAlvaEs/pfizer-wont-pursue-a-split-of-established-and-new-medical-lines-20160926-00683,Pfizer Won't Pursue a Split of Established and New Medical Lines
AGN,AGN:US,BBG000FH8PX5,Pfizer Throws Out Plan to Split Into Two Companies,2016-09-26 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5guaYSe2st0/pfizer-throws-out-plan-to-split-into-two-companies-20160926-00758,Pfizer Throws Out Plan to Split Into Two Companies
AGN,AGN:US,BBG000FH8PX5,Pfizer Won''t Pursue a Split of Established and New Medical Lines -- Update,2016-09-26 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vorw_GplH_8/pfizer-wont-pursue-a-split-of-established-and-new-medical-lines--update-20160926-00308,Pfizer Won''t Pursue a Split of Established and New Medical Lines -- Update
AGN,AGN:US,BBG000FH8PX5,Pfizer Won't Pursue a Split,2016-09-26 07:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yC_zdbQzCU/pfizer-wont-pursue-a-split-20160926-00272,Pfizer Won't Pursue a Split
AGN,AGN:US,BBG000FH8PX5,"FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE",2016-09-26 01:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmAd31XN2xM/fda-approves-amgns-1st-biosimilar-mrns-on-track-all-ears-for-drrx-ptie-20160926-00017,"FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE"
AGN,AGN:US,BBG000FH8PX5,3 Dirt-Cheap Dividend Stocks You Can Buy Right Now,2016-09-24 13:21:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u9V_MhwUems/3-dirt-cheap-dividend-stocks-you-can-buy-right-now-cm684151,There aren t a whole lot of compelling bargains these days when it comes to income generating stocks but there are a select few flying under the radar at the moment AbbVie NYSE ABBV Gilead Sciences NASDAQ GILD and Teva Pharmaceutical Industries NYSE TEVA
AGN,AGN:US,BBG000FH8PX5,Allergan Announces FDA Approval of NATRELLE INSPIRA® Cohesive Breast Implants,2016-09-23 20:42:01 +0000,http://www.publicnow.com/view/145CA86660D8527B47CEAD8DCE9FF34CC1CBC2D7,"[at noodls] - DUBLIN, Sept. 23, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRACohesive breast ..."
AGN,AGN:US,BBG000FH8PX5,Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract,2016-09-23 20:20:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Okj_skKjTc/dow-30-stock-roundup-microsoft-rewards-shareholders-ge-wins-19b-nuclear-power-contract-cm684014,The Dow experienced a strong week of gains buoyed by the Fed s decision to leave rates unchanged in September Japan s central bank s decision to control the yield curve also provided a flip to stocks Additionally gains arising from developments related to major healthcare deals also
AGN,AGN:US,BBG000FH8PX5,ETFs in Focus on the Nasdaq Rally,2016-09-23 17:21:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rN7UsL9J31U/etfs-in-focus-on-the-nasdaq-rally-cm683888,The tech heavy Nasdaqclosed at an all time record high on Thursday for the second consecutive session as investors continued to cheer the Fed s no rate hike decision Moreover the continuing rally in biotech stocks on merger and acquisition news also gave a significant boost to the index For
AGN,AGN:US,BBG000FH8PX5,ProShares Ultra S&P500 Experiences Big Outflow,2016-09-23 16:20:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pHBcP4Qz9mc/proshares-ultra-sp500-experiences-big-outflow-cm683781,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares Ultra S amp P500 Symbol SSO where we have detected an approximate 28 6 million dollar outflow that s a 1 9 decrease week over week from 21 450
AGN,AGN:US,BBG000FH8PX5,Allergan/Adamas Launch New Dosage Strengths of Namzaric,2016-09-23 15:25:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OkedGGqyYZA/allerganadamas-launch-new-dosage-strengths-of-namzaric-cm683757,Allergan plc AGN and partner Adamas Pharmaceuticals Inc ADMS announced that four new dosage strengths for the new expanded indication of its Alzheimer s drug Namzaric extended release XR capsules are now available throughout U S pharmacies by prescription Namzaric is a once
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO",2016-09-23 14:24:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UDVTQGxu0qM/pharma-stock-roundup-allergan-acquisitions-in-focus-jj-to-buy-abbotts-amo-cm683695,Once again acquisitions and deals were in focus in the pharma sector with Allergan AGN announcing a couple of back to back deals including one worth up to 1 695 billion Meanwhile industry bellwether Johnson amp Johnson JNJ signed an agreement to acquire Abbott s ABT eye care segment
AGN,AGN:US,BBG000FH8PX5,Big trade buys time for gains in Allergan,2016-09-23 14:22:50 +0000,http://finance.yahoo.com/news/big-trade-buys-time-gains-142250782.html,Big trade buys time for gains in Allergan
AGN,AGN:US,BBG000FH8PX5,[$$] US politicians lament inaction over price-gouging drug companies,2016-09-23 13:37:34 +0000,"http://www.ft.com/cms/s/1b773ca8-8124-11e6-8e50-8ec15fb462f4,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The spectacle of pharma executives being hauled over the coals for ""price gouging"" US consumers has become a staple of American politics. This week it was the turn of Mylan chief executive, ..."
AGN,AGN:US,BBG000FH8PX5,Allergan/Adamas Launch New Dosage Strengths of Namzaric,2016-09-23 13:09:01 +0000,http://finance.yahoo.com/news/allergan-adamas-launch-dosage-strengths-130901254.html,Allergan/Adamas Launch New Dosage Strengths of Namzaric
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO",2016-09-23 12:00:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-allergan-acquisitions-120012919.html,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO"
AGN,AGN:US,BBG000FH8PX5,Saluting Biotech M&A: Onward And Upward,2016-09-23 12:00:00 +0000,http://www.forbes.com/sites/brucebooth/2016/09/23/saluting-biotech-ma-onward-and-upward/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Saluting Biotech M&A: Onward And Upward
AGN,AGN:US,BBG000FH8PX5,Allergan's Vitae Buy Could Spark More Interest in Kadmon,2016-09-23 10:25:00 +0000,https://www.thestreet.com/story/13746516/1/allergan-s-vitae-buy-could-spark-more-interest-in-kadmon.html?puc=yahoo&cm_ven=YAHOO,Allergan's Vitae Buy Could Spark More Interest in Kadmon
AGN,AGN:US,BBG000FH8PX5,Traders look for opportunities after Nasdaq hits new all-time high,2016-09-22 22:39:04 +0000,http://www.cnbc.com/id/103962622?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103962622,Traders look for opportunities after Nasdaq hits new all-time high
AGN,AGN:US,BBG000FH8PX5,New highs: What's left to buy?,2016-09-22 21:00:00 +0000,http://finance.yahoo.com/video/highs-whats-left-buy-210000841.html,New highs: What's left to buy?
AGN,AGN:US,BBG000FH8PX5,"Gilead, Allergan Seen Trailing Intercept In Ongoing NASH Battle",2016-09-22 20:35:02 +0000,http://www.investors.com/news/technology/gilead-allergan-seen-trailing-intercept-in-ongoing-nash-battle/,"Gilead, Allergan Seen Trailing Intercept In Ongoing NASH Battle"
AGN,AGN:US,BBG000FH8PX5,Will Gilead Make a Good Fit for Allergan? (GILD),2016-09-22 20:07:00 +0000,http://www.investopedia.com/news/will-gilead-make-good-fit-allergan-gild/?partner=YahooSA,Will Gilead Make a Good Fit for Allergan? (GILD)
AGN,AGN:US,BBG000FH8PX5,5 Biotech Stocks to Watch as Interest in NASH Increases,2016-09-22 15:25:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/01KeIduehic/5-biotech-stocks-to-watch-as-interest-in-nash-increases-cm683161,The market is suddenly abuzz about nonalcoholic steatohepatitis or NASH a common but often silent liver disease Interest in NASH has gone up with Allergan plc AGN announcing a couple of deals targeting this disease area earlier this week The company announced two back to back deals one
AGN,AGN:US,BBG000FH8PX5,Gilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note,2016-09-22 15:20:00 +0000,https://www.thestreet.com/story/13749098/1/gilead-sciences-gild-stock-lower-despite-bullish-gabelli-note.html?puc=yahoo&cm_ven=YAHOO,Gilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note
AGN,AGN:US,BBG000FH8PX5,"[$$] Teva, Allergan Pump Up the Pipelines",2016-09-22 15:17:00 +0000,http://www.barrons.com/articles/teva-allergan-pump-up-the-pipelines-1474557432?mod=yahoobarrons&ru=yahoo,"[$$] Teva, Allergan Pump Up the Pipelines"
AGN,AGN:US,BBG000FH8PX5,Gilead Sciences: A Hidden Asset?,2016-09-22 14:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/22/gilead-sciences-a-hidden-asset/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: A Hidden Asset?
AGN,AGN:US,BBG000FH8PX5,Allergan is Not Going to Buy Gilead,2016-09-22 14:26:50 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-22/allergan-gilead-deal-is-not-happening?cmpid=yhoo.headline,Allergan is Not Going to Buy Gilead
AGN,AGN:US,BBG000FH8PX5,Is Galectin The Next Takeover Target for the Biotech World?,2016-09-22 12:23:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A0rYvgRWPxg/is-galectin-the-next-takeover-target-for-the-biotech-world-cm683019,Shares of Galectin Therapeutics Inc GALT were up almost 36 on Wednesday It is being speculated that Galectin could be the next takeover target in the biotech world after Allergan plc s AGN highly expensive definitive deal to acquire Tobira Therapeutics Inc TBRA was announced on
AGN,AGN:US,BBG000FH8PX5,Allergan and Adamas Announce U.S. Availability of New Dosage Strengths for NAMZARIC® (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease,2016-09-22 12:21:04 +0000,http://www.publicnow.com/view/4174CBE96C8338E8CA4FAD495083B23C4D6B9860,"[at noodls] - DUBLIN and EMERYVILLE, Calif., Sept. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced today that all ..."
AGN,AGN:US,BBG000FH8PX5,"Jim Cramer's Top Takeaways: Flex, Walt Disney, Allergan",2016-09-22 10:00:00 +0000,https://www.thestreet.com/story/13672662/1/jim-cramer-s-top-takeaways-flex-walt-disney-allergan.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Flex, Walt Disney, Allergan"
AGN,AGN:US,BBG000FH8PX5,Is Galectin The Next Takeover Target for the Biotech World?,2016-09-22 09:53:09 +0000,http://finance.yahoo.com/news/galectin-next-takeover-target-biotech-095309244.html,Is Galectin The Next Takeover Target for the Biotech World?
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas: New Dosage Strengths For NAMZARIC Available In US",2016-09-22 08:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aswmMeszXVE/allergan-adamas-new-dosage-strengths-for-namzaric-available-in-us-20160922-00380,"Allergan, Adamas: New Dosage Strengths For NAMZARIC Available In US"
AGN,AGN:US,BBG000FH8PX5,[$$] Big Pharma’s Big Checkbooks Drive Biotech Resurgence,2016-09-22 04:39:25 +0000,http://www.wsj.com/articles/big-pharmas-big-checkbooks-drive-biotech-resurgence-1474485234?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - Big Pharma’s thirst for growth is a biotech investor’s dream.
AGN,AGN:US,BBG000FH8PX5,Cramer Remix: This tech growth story just got better,2016-09-21 23:10:31 +0000,http://www.cnbc.com/id/103958922?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103958922,Cramer Remix: This tech growth story just got better
AGN,AGN:US,BBG000FH8PX5,Allergan CEO says 'the American people deserve to be angr...,2016-09-21 22:25:00 +0000,http://finance.yahoo.com/video/allergan-ceo-says-american-people-222500843.html,Allergan CEO says 'the American people deserve to be angr...
AGN,AGN:US,BBG000FH8PX5,Allergan's Boldness may not be Limited to Tobira Deal,2016-09-21 21:05:00 +0000,https://www.thestreet.com/story/13748129/1/allergan-s-boldness-may-not-be-limited-to-tobira-deal.html?puc=yahoo&cm_ven=YAHOO,Allergan's Boldness may not be Limited to Tobira Deal
AGN,AGN:US,BBG000FH8PX5,Biotech: Why NASH is So Hot Right Now,2016-09-21 19:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/21/biotech-why-nash-is-so-hot-right-now/?mod=yahoobarrons&ru=yahoo,Biotech: Why NASH is So Hot Right Now
AGN,AGN:US,BBG000FH8PX5,[$$] Big Pharma's Big Checkbooks Drive Biotech Resurgence,2016-09-21 19:13:58 +0000,http://www.wsj.com/articles/big-pharmas-big-checkbooks-drive-biotech-resurgence-1474485234?mod=yahoo_hs,[$$] Big Pharma's Big Checkbooks Drive Biotech Resurgence
AGN,AGN:US,BBG000FH8PX5,Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain,2016-09-21 17:22:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/44NjLmzb1bY/biotech-etfs-in-focus-on-tobira-therapeutics-massive-gain-cm682753,Tuesday was quite eventful for the biotech space with Allergan Plc AGN announcing back to back takeover deals within a short span of time The drug maker announced the 1 695 billion acquisition of Tobira Therapeutics TBR A which is into developing therapies for a fatty liver disease
AGN,AGN:US,BBG000FH8PX5,"Moody's: Regulatory, political event risks remain for US drug companies; geographic and product diversity to help mitigate effects",2016-09-21 16:51:02 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_355403&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20160921_PR_355403,"Moody's: Regulatory, political event risks remain for US drug companies; geographic and product diversity to help mitigate effects"
AGN,AGN:US,BBG000FH8PX5,"Stock Market News for September 21, 2016",2016-09-21 16:25:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6tHh0bgiaSs/stock-market-news-for-september-21-2016-cm682704,Benchmarks finished slightly higher on Tuesday ahead of the two day policy meetings of the Fed and Bank of Japan BOJ ending today Inventors eagerly awaited any major policy decisions from the two central banks Moreover gains in healthcare stocks offset declines in energy stocks
AGN,AGN:US,BBG000FH8PX5,Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain,2016-09-21 15:23:03 +0000,http://finance.yahoo.com/news/biotech-etfs-focus-tobira-therapeutics-152303566.html,Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
AGN,AGN:US,BBG000FH8PX5,"Here’s Why Alphabet Inc (GOOG), Vale SA (ADR) (VALE) & Three Other Stocks Are Among Trending Names on Wednesday",2016-09-21 15:04:04 +0000,http://www.insidermonkey.com/blog/heres-why-alphabet-inc-goog-vale-sa-adr-vale-three-other-stocks-are-among-trending-names-on-wednesday-475968/,"Here’s Why Alphabet Inc (GOOG), Vale SA (ADR) (VALE) & Three Other Stocks Are Among Trending Names on Wednesday"
AGN,AGN:US,BBG000FH8PX5,"Gilead Sciences (GILD) Stock Lower, Gabelli: Allergan Could Be Buyer",2016-09-21 14:37:00 +0000,https://www.thestreet.com/story/13747459/1/gilead-sciences-gild-stock-lower-gabelli-allergan-could-be-buyer.html?puc=yahoo&cm_ven=YAHOO,"Gilead Sciences (GILD) Stock Lower, Gabelli: Allergan Could Be Buyer"
AGN,AGN:US,BBG000FH8PX5,Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers',2016-09-21 14:30:34 +0000,http://finance.yahoo.com/news/allergan-going-gilead-gabelli-says-143034293.html,Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
AGN,AGN:US,BBG000FH8PX5,S&P 500 Remains in a Holding Pattern,2016-09-21 14:21:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HAaRZ0F7KHg/sp-500-remains-in-a-holding-pattern-cm682498,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips On Tuesday stocks turned in a flat performance as investors hesitated prior to any immediate changes in Federal Reserve policy unlikely or indications of a hike in rates in December
AGN,AGN:US,BBG000FH8PX5,Allergan Buys 2 Liver Disease-Focused Biopharmas,2016-09-21 13:40:05 +0000,http://www.investopedia.com/stock-analysis/092116/allergan-buys-2-liver-diseasefocused-biopharmas-agn-tbra.aspx?partner=YahooSA,Allergan Buys 2 Liver Disease-Focused Biopharmas
AGN,AGN:US,BBG000FH8PX5,Gilead Sciences: Allergan's Next Target?,2016-09-21 13:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/21/gilead-sciences-allergans-next-target/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: Allergan's Next Target?
AGN,AGN:US,BBG000FH8PX5,Allergan Buys NASH Therapy Maker Tobira at Huge Premium,2016-09-21 13:24:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hCPam6OL-2E/allergan-buys-nash-therapy-maker-tobira-at-huge-premium-cm682451,Allergan plc AGN announced a definitive deal to acquire Tobira Therapeutics Inc TBRA for a total potential consideration of around 1 7 billion Tobira is a clinical stage biotechnology company focused on making drugs to treat non alcoholic steatohepatitis NASH and other liver
AGN,AGN:US,BBG000FH8PX5,"Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug",2016-09-21 12:39:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-tobira-soars-123912296.html,"Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug"
AGN,AGN:US,BBG000FH8PX5,Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma,2016-09-21 11:21:53 +0000,http://finance.yahoo.com/news/allergans-tobira-acquisition-represents-highest-112153149.html,Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Acquire U.K.'s Akarna Therapeutics,2016-09-21 11:10:42 +0000,http://www.wsj.com/articles/allergan-to-acquire-u-k-s-akarna-therapeutics-1474456238?mod=yahoo_hs,[$$] Allergan to Acquire U.K.'s Akarna Therapeutics
AGN,AGN:US,BBG000FH8PX5,Allergan Buys NASH Therapy Maker Tobira at Huge Premium,2016-09-21 10:55:10 +0000,http://finance.yahoo.com/news/allergan-buys-nash-therapy-maker-105510563.html,Allergan Buys NASH Therapy Maker Tobira at Huge Premium
AGN,AGN:US,BBG000FH8PX5,Allergan is paying a stunning 500% premium to buy a clinical-stage biotech,2016-09-21 10:53:15 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=884F1BE8-7F4E-11E6-BFDA-43FAB098C397&siteid=yhoof2,Allergan is paying a stunning 500% premium to buy a clinical-stage biotech
AGN,AGN:US,BBG000FH8PX5,Allergan Acquisition Conference Call At 8:30 AM ET,2016-09-21 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q-AmJDTrscE/allergan-acquisition-conference-call-at-830-am-et-20160921-00215,Allergan Acquisition Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,Allergan Investor Conference Call At 8:30 AM ET,2016-09-21 07:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IMXPrrhOoBo/allergan-investor-conference-call-at-830-am-et-20160921-00176,Allergan Investor Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,Wall Street Set For Strong Start On BOJ Decision; Fed Verdict In Spotlight,2016-09-21 06:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hfNV3mtyXfE/wall-street-set-for-strong-start-on-boj-decision-fed-verdict-in-spotlight-20160921-00135,Wall Street Set For Strong Start On BOJ Decision; Fed Verdict In Spotlight
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal,2016-09-21 04:50:27 +0000,http://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639?ru=yahoo?mod=yahoo_itp,[$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal
AGN,AGN:US,BBG000FH8PX5,"Why DTS Inc. (DTSI), FedEx Corporation (FDX), and Tobira Therapeutics Inc (TBRA) Are 3 of Today’s Best Stocks",2016-09-21 03:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J0uz_Ra6BT8/why-dts-inc-dtsi-fedex-corporation-fdx-and-tobira-therapeutics-inc-tbra-are-3-of-todays-best-stocks-cm682374,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors seemed comfortable with what will come of this week s Federal Reserve and Bank of Japan meetings bidding stocks higher Tuesday Oil rose and Treasury yields fell
AGN,AGN:US,BBG000FH8PX5,"Asian shares mixed as Bank of Japan, Fed mull policy options",2016-09-21 03:06:57 +0000,http://finance.yahoo.com/news/machinery-makers-lead-us-stocks-higher-early-trading-143852443.html,"Asian shares mixed as Bank of Japan, Fed mull policy options"
AGN,AGN:US,BBG000FH8PX5,"Asian shares mixed as Bank of Japan, Fed mull policy options",2016-09-21 03:06:45 +0000,http://sg.finance.yahoo.com/news/machinery-makers-lead-us-stocks-143852457.html,"Asian shares mixed as Bank of Japan, Fed mull policy options"
AGN,AGN:US,BBG000FH8PX5,"MSTX Crashes On EPIC Data, MIRN Ditches MRX34, More Good News From SRPT",2016-09-21 02:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AYXMV9I-zTU/mstx-crashes-on-epic-data-mirn-ditches-mrx34-more-good-news-from-srpt-20160921-00036,"MSTX Crashes On EPIC Data, MIRN Ditches MRX34, More Good News From SRPT"
AGN,AGN:US,BBG000FH8PX5,Why Did Tobira Therapeutics (TBRA) Stock Skyrocket 720% Today?,2016-09-20 23:21:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u5XF1-LqCd0/why-did-tobira-therapeutics-tbra-stock-skyrocket-720-today-cm682351,On Tuesday shares of Tobira Therapeutics Inc TBRA skyrocketed up over 720 in late afternoon trading after the company announced it would be acquired by Allergan AGN in a deal worth up to 1 7 billion Allergan is set to acquire Tobira for an upfront payment of 28 35 per share in cash
AGN,AGN:US,BBG000FH8PX5,Allergan to buy Tobira in push for fatty liver disease drugs,2016-09-20 22:50:03 +0000,http://finance.yahoo.com/news/allergan-buy-tobira-push-nash-122253726.html,Allergan to buy Tobira in push for fatty liver disease drugs
AGN,AGN:US,BBG000FH8PX5,Allergan targets liver disease drugs with Tobira acquisition,2016-09-20 22:45:42 +0000,http://sg.finance.yahoo.com/news/allergan-targets-liver-disease-drugs-141334965.html,Allergan targets liver disease drugs with Tobira acquisition
AGN,AGN:US,BBG000FH8PX5,"Allergan Buys Two Pharmas, CBS Talks Netflix As Market Awaits Fed",2016-09-20 22:26:50 +0000,http://finance.yahoo.com/video/allergan-buys-two-pharmas-cbs-222650582.html,"Allergan Buys Two Pharmas, CBS Talks Netflix As Market Awaits Fed"
AGN,AGN:US,BBG000FH8PX5,"Why DTS, SolarCity, and Tobira Therapeutics Jumped Today",2016-09-20 22:21:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bJtfq_RuKc4/why-dts-solarcity-and-tobira-therapeutics-jumped-today-cm682322,Tuesday was an upbeat day on Wall Street as major market benchmarks climbed a small fraction of a percent despite ongoing nervousness about the future of the U S economy The Federal Reserve began its two day meeting to discuss interest rates but investors seemed as if they d be
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal,2016-09-20 21:58:44 +0000,http://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639?mod=yahoo_hs,[$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal
AGN,AGN:US,BBG000FH8PX5,"Tobira, Royal Caribbean and Marriott rise; Ascena dives",2016-09-20 21:49:38 +0000,http://sg.finance.yahoo.com/news/tobira-royal-caribbean-marriott-rise-214938186.html,"Tobira, Royal Caribbean and Marriott rise; Ascena dives"
AGN,AGN:US,BBG000FH8PX5,Allergan Buys Two Liver Disease Companies in Less Than a Day,2016-09-20 21:28:58 +0000,http://finance.yahoo.com/news/allergan-buys-two-liver-disease-212858903.html,Allergan Buys Two Liver Disease Companies in Less Than a Day
AGN,AGN:US,BBG000FH8PX5,Why Tobira Therapeutics Inc Was an Overnight Octuple,2016-09-20 21:21:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/13Ziq0sWATg/why-tobira-therapeutics-inc-was-an-overnight-octuple-cm682276,Image source Getty Images What happened Tobira Therapeutics NASDAQ TBRA is up more than 700 today after Allergan NYSE AGN announced that the big biotech was purchasing its smaller brethren Minute brethren might be a better description Before today
AGN,AGN:US,BBG000FH8PX5,Business Highlights,2016-09-20 21:17:20 +0000,http://sg.finance.yahoo.com/news/business-highlights-211720637.html,Business Highlights
AGN,AGN:US,BBG000FH8PX5,"Why DTS, SolarCity, and Tobira Therapeutics Jumped Today",2016-09-20 21:13:00 +0000,http://www.fool.com/investing/2016/09/20/why-dts-solarcity-and-tobira-therapeutics-jumped-t.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why DTS, SolarCity, and Tobira Therapeutics Jumped Today"
AGN,AGN:US,BBG000FH8PX5,How Will Allergan (AGN) Stock React to Akarna Therapeutics Deal?,2016-09-20 20:55:00 +0000,https://www.thestreet.com/story/13746560/1/how-will-allergan-agn-stock-react-to-akarna-therapeutics-deal.html?puc=yahoo&cm_ven=YAHOO,How Will Allergan (AGN) Stock React to Akarna Therapeutics Deal?
AGN,AGN:US,BBG000FH8PX5,Why Did Tobira Therapeutics (TBRA) Stock Skyrocket 720% Today?,2016-09-20 20:49:08 +0000,http://finance.yahoo.com/news/why-did-tobira-therapeutics-tbra-204908198.html,Why Did Tobira Therapeutics (TBRA) Stock Skyrocket 720% Today?
AGN,AGN:US,BBG000FH8PX5,Allergan pays $50 mln to buy privately-held Akarna Therapeutics,2016-09-20 20:41:15 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=2DCB023E-9139-4426-AA18-97AD7C78F5A3&siteid=yhoof2,Allergan pays $50 mln to buy privately-held Akarna Therapeutics
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires Akarna Therapeutics Adding to its Strong Development Program and Commitment to Innovation in NASH,2016-09-20 20:38:06 +0000,http://www.publicnow.com/view/0C87AD2B8C9395E51C701F3657018F3A05ABF9C6,"[at noodls] - DUBLIN, Sept. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the Company has acquired Akarna Therapeutics Ltd., a privately held biopharmaceutical ..."
AGN,AGN:US,BBG000FH8PX5,Allergan just acquired two companies in one day,2016-09-20 20:37:40 +0000,http://finance.yahoo.com/news/allergan-just-acquired-two-companies-203740540.html,Allergan just acquired two companies in one day
AGN,AGN:US,BBG000FH8PX5,"US STOCKS-Wall St ends flat with Fed, BOJ up next",2016-09-20 20:23:45 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-ends-202345644.html,"US STOCKS-Wall St ends flat with Fed, BOJ up next"
AGN,AGN:US,BBG000FH8PX5,Akarna Therapeutics Ltd acquired by Allergan plc,2016-09-20 20:23:00 +0000,http://uk.finance.yahoo.com/news/akarna-therapeutics-ltd-acquired-allergan-202300258.html,Akarna Therapeutics Ltd acquired by Allergan plc
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 09/20/2016: AQXP,TBRA,AGN,CYH,APO",2016-09-20 20:21:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9Q4Id2eKno/health-care-sector-update-for-09202016-aqxptbraagncyhapo-cm682263,Top Health Care StocksTop Health Care Stocks JNJ 0 44 JNJ 0 44 PFE 0 73 PFE 0 73 MRK 0 06 MRK 0 06 ABT 1 36 ABT 1 36 AMGN 1 49 AMGN 1 49 Health care stocks rebounded from Monday s losses with the NYSE Health Care Index posting a 0 5 increase while shares of health care companies
AGN,AGN:US,BBG000FH8PX5,Allergan buys second fatty liver-disease company,2016-09-20 20:15:42 +0000,http://finance.yahoo.com/news/allergan-buys-second-fatty-liver-201542960.html,Allergan buys second fatty liver-disease company
AGN,AGN:US,BBG000FH8PX5,[$$] Sarepta jumps after drugs regulator boost,2016-09-20 20:11:39 +0000,"http://www.ft.com/cms/s/6999827a-7f4d-11e6-8e50-8ec15fb462f4,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Wall Street's bull camp on Sarepta Therapeutics grew on Tuesday, a day after the US drugs regulator approved its treatment for a rare and fatal childhood muscle disorder. Sarepta shares climbed 13.9 per ..."
AGN,AGN:US,BBG000FH8PX5,Wall Street Creeps Higher Ahead of Fed Decision,2016-09-20 20:03:00 +0000,https://www.thestreet.com/story/13746415/1/wall-street-creeps-higher-ahead-of-fed-decision.html?puc=yahoo&cm_ven=YAHOO,Wall Street Creeps Higher Ahead of Fed Decision
AGN,AGN:US,BBG000FH8PX5,STOCKS DO NOTHING AHEAD OF THE FED: Here's what you need to know,2016-09-20 20:00:14 +0000,http://finance.yahoo.com/news/stocks-nothing-ahead-fed-heres-200014514.html,STOCKS DO NOTHING AHEAD OF THE FED: Here's what you need to know
AGN,AGN:US,BBG000FH8PX5,Why Tobira Therapeutics Inc Was an Overnight Octuple,2016-09-20 19:58:36 +0000,http://www.fool.com/investing/2016/09/20/why-tobira-therapeutics-inc-was-an-overnight-octup.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Tobira Therapeutics Inc Was an Overnight Octuple
AGN,AGN:US,BBG000FH8PX5,Biotech buyout: The next big liver disease,2016-09-20 19:28:00 +0000,http://finance.yahoo.com/video/biotech-buyout-next-big-liver-192800484.html,Biotech buyout: The next big liver disease
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall St buoyed by healthcare with Fed on deck,2016-09-20 19:02:26 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-buoyed-190226038.html,US STOCKS-Wall St buoyed by healthcare with Fed on deck
AGN,AGN:US,BBG000FH8PX5,Allergan snares Bay Area drug maker for potential $1.7 billion,2016-09-20 18:54:31 +0000,http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/09/allergan-acquires-tobira-agn-tbra.html?ana=yahoo,Allergan snares Bay Area drug maker for potential $1.7 billion
AGN,AGN:US,BBG000FH8PX5,"Stocks Post Modest Gains as Fed Meets, Crude Higher",2016-09-20 18:40:00 +0000,https://www.thestreet.com/story/13746073/1/stocks-move-higher-as-fed-meets-crude-reverses-course.html?puc=yahoo&cm_ven=YAHOO,"Stocks Post Modest Gains as Fed Meets, Crude Higher"
AGN,AGN:US,BBG000FH8PX5,Ariad Shares Rise Amid Speculation of Potential Buyout,2016-09-20 18:32:43 +0000,http://www.bloomberg.com/news/articles/2016-09-20/ariad-shares-rise-amid-speculation-of-buyout-target-potential?cmpid=yhoo.headline,Ariad Shares Rise Amid Speculation of Potential Buyout
AGN,AGN:US,BBG000FH8PX5,Mid-Day Market Update: Tobira Therapeutics Jumps Following Allergan Buyout; HNI Shares Slide,2016-09-20 17:35:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9sr-89rNsNI/mid-day-market-update-tobira-therapeutics-jumps-following-allergan-buyout-hni-shares-slide-cm682188,Midway through trading Tuesday the Dow traded up 0 26 percent to 18 167 66 while the NASDAQ climbed 0 17 percent to 5 243 88 The S amp P also rose gaining 0 17 percent to 2 142 85 Leading and Lagging Sectors On Tuesday healthcare shares gained 0 70 percent Meanwhile top
AGN,AGN:US,BBG000FH8PX5,Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?,2016-09-20 17:21:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a5xFoBTc9cY/allergan-plc-ordinary-shares-what-is-agn-getting-for-its-billion-dollars-cm682112,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s one of those one in a million biotech buyout stories the young unknown company few have even heard of ends up being a diamond in the rough to a giant in the industry The result is a big triple
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 09/20/2016: TXMD,TBRA,AGN,CYH,APO",2016-09-20 17:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IWBq6Dc5MG0/health-care-sector-update-for-09202016-txmdtbraagncyhapo-cm682155,Top Health Care StocksTop Health Care Stocks JNJ 0 22 JNJ 0 22 PFE 0 43 PFE 0 43 MRK 0 02 MRK 0 02 ABT 1 47 ABT 1 47 AMGN 1 38 AMGN 1 38 Health care stocks were recovering from Monday s declines with the NYSE Health Care Index climbing over 0 4 while shares of health care
AGN,AGN:US,BBG000FH8PX5,Allergan's Chart Is Not Persuasive,2016-09-20 15:59:00 +0000,http://realmoney.thestreet.com/articles/09/20/2016/allergans-chart-not-persuasive?puc=yahoo&cm_ven=YAHOO,Allergan's Chart Is Not Persuasive
AGN,AGN:US,BBG000FH8PX5,Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today,2016-09-20 15:46:00 +0000,https://www.thestreet.com/story/13746035/1/here-s-why-conatus-pharmaceuticals-cnat-stock-is-soaring-today.html?puc=yahoo&cm_ven=YAHOO,Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today
AGN,AGN:US,BBG000FH8PX5,"This Stock Has Gained Over 700% Today, Plus the Latest on GoPro, Petrobras and Sinclair",2016-09-20 15:44:04 +0000,http://www.insidermonkey.com/blog/this-stock-has-gained-over-700-today-plus-the-latest-on-gopro-petrobras-and-sinclair-475739/,"This Stock Has Gained Over 700% Today, Plus the Latest on GoPro, Petrobras and Sinclair"
AGN,AGN:US,BBG000FH8PX5,South S.F. liver disease treatment developer fetches up to $1.7B in sale,2016-09-20 15:36:32 +0000,http://www.bizjournals.com/sanjose/news/2016/09/20/south-s-f-liver-disease-treatment-developer.html?ana=yahoo,South S.F. liver disease treatment developer fetches up to $1.7B in sale
AGN,AGN:US,BBG000FH8PX5,Tobira Therapeutics Skyrockets on Allergan Acquisition,2016-09-20 15:25:02 +0000,http://finance.yahoo.com/news/tobira-therapeutics-skyrockets-allergan-acquisition-152502746.html,Tobira Therapeutics Skyrockets on Allergan Acquisition
AGN,AGN:US,BBG000FH8PX5,Stocks Rise as Wall Street Looks to Fed's Decision on Interest Rates,2016-09-20 15:16:00 +0000,https://www.thestreet.com/story/13745666/1/stocks-rise-as-federal-reserve-meeting-begins.html?puc=yahoo&cm_ven=YAHOO,Stocks Rise as Wall Street Looks to Fed's Decision on Interest Rates
AGN,AGN:US,BBG000FH8PX5,More Squawk from Jim Cramer: Allergan (AGN) CEO Saunders 'Really Smart',2016-09-20 14:34:00 +0000,https://www.thestreet.com/story/13745704/1/more-squawk-from-jim-cramer-allergan-agn-ceo-saunders-really-smart.html?puc=yahoo&cm_ven=YAHOO,More Squawk from Jim Cramer: Allergan (AGN) CEO Saunders 'Really Smart'
AGN,AGN:US,BBG000FH8PX5,Allergan pays top dollar for 'stepping stones' from neurology to dermatology,2016-09-20 14:32:34 +0000,http://finance.yahoo.com/news/allergan-pays-top-dollar-stepping-143234754.html,Allergan pays top dollar for 'stepping stones' from neurology to dermatology
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy Tobria in Deal Nearing $1.7 Billion,2016-09-20 14:22:53 +0000,http://finance.yahoo.com/video/allergan-buy-tobria-deal-nearing-142253510.html,Allergan to Buy Tobria in Deal Nearing $1.7 Billion
AGN,AGN:US,BBG000FH8PX5,Tobira Therapeutics (TBRA) Stock Surging After Allergan Deal,2016-09-20 14:22:00 +0000,https://www.thestreet.com/story/13745805/1/tobira-therapeutics-tbra-stock-surging-after-allergan-deal.html?puc=yahoo&cm_ven=YAHOO,Tobira Therapeutics (TBRA) Stock Surging After Allergan Deal
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Financials boost Wall St ahead of Fed meet,2016-09-20 13:58:41 +0000,http://finance.yahoo.com/news/us-stocks-financials-boost-wall-135841165.html,US STOCKS-Financials boost Wall St ahead of Fed meet
AGN,AGN:US,BBG000FH8PX5,Allergan (AGN) Stock Down After Tobira Therapeutics Deal,2016-09-20 13:46:00 +0000,https://www.thestreet.com/story/13745697/1/allergan-agn-stock-down-after-tobira-therapeutics-deal.html?puc=yahoo&cm_ven=YAHOO,Allergan (AGN) Stock Down After Tobira Therapeutics Deal
AGN,AGN:US,BBG000FH8PX5,Applied Genetic Technologies Is an Attractive Acquisition Target for Allergan or Biogen,2016-09-20 13:05:00 +0000,https://www.thestreet.com/story/13744610/1/applied-genetic-technologies-is-an-attractive-acquisition-target-for-allergan-or-biogen.html?puc=yahoo&cm_ven=YAHOO,Applied Genetic Technologies Is an Attractive Acquisition Target for Allergan or Biogen
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH,2016-09-20 12:38:03 +0000,http://www.publicnow.com/view/D9D10E3C72CDAE6C56A3F75178D8F6E54E7642A7,"[at noodls] - DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ --Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage biopharmaceutical ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Agrees to Buy Tobira Therapeutics in $1.7 Billion Deal,2016-09-20 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOeWFYkYlws/allergan-agrees-to-buy-tobira-therapeutics-in-17-billion-deal-20160920-00175,Allergan Agrees to Buy Tobira Therapeutics in $1.7 Billion Deal
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal,2016-09-20 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KICoivIhBEk/allergan-to-buy-tobira-therapeutics-in-17-billion-deal-20160920-00338,Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal
AGN,AGN:US,BBG000FH8PX5,Tobira Therapeutics (TBRA) Has Surged To A New High After Bought By Allergan,2016-09-20 09:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xFXFR8S-1Kg/tobira-therapeutics-tbra-has-surged-to-a-new-high-after-bought-by-allergan-20160920-00173,Tobira Therapeutics (TBRA) Has Surged To A New High After Bought By Allergan
AGN,AGN:US,BBG000FH8PX5,Allergan To Acquire Tobira For Potential Consideration Of Up To $1.695 Bln,2016-09-20 08:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PUT7a4yhkt8/allergan-to-acquire-tobira-for-potential-consideration-of-up-to-1695-bln-20160920-00981,Allergan To Acquire Tobira For Potential Consideration Of Up To $1.695 Bln
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Inch Up as Investors Watch Central Banks,2016-09-20 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jeTlRmh2cbE/us-stocks-inch-up-as-investors-watch-central-banks-20160920-00599,U.S. Stocks Inch Up as Investors Watch Central Banks
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Rise as Investors Watch Central Banks,2016-09-20 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TuJUejT39Q8/us-stocks-rise-as-investors-watch-central-banks-20160920-00228,U.S. Stocks Rise as Investors Watch Central Banks
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc – Value Analysis (NYSE:AGN) : September 19, 2016",2016-09-19 15:08:05 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-value-analysis-nyseagn-september-19-2016/,"Allergan Plc – Value Analysis (NYSE:AGN) : September 19, 2016"
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Announces Encouraging Initial Drill Results From New Exploration Target,2016-09-19 11:18:02 +0000,http://www.publicnow.com/view/412FA593C33F493FC7C7AC34CA449551E190300B,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Sept. 19, 2016) - Highlights: Highly encouraging results from new near-mine exploration target, Akwasiso 10,000 metres of drilling has been completed over 81 ..."
AGN,AGN:US,BBG000FH8PX5,Trump Means Change Equals Major Inflection Point,2016-09-19 10:00:52 +0000,http://finance.yahoo.com/tumblr/blog-trump-means-change-equals-major-inflection-point-100058139.html,Trump Means Change Equals Major Inflection Point
AGN,AGN:US,BBG000FH8PX5,Industry Research Forecasts Wellness Tourism Market To Reach $1018.5 Bln By 2020,2016-09-19 06:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Popxg18oeyc/industry-research-forecasts-wellness-tourism-market-to-reach-10185-bln-by-2020-20160919-00124,Industry Research Forecasts Wellness Tourism Market To Reach $1018.5 Bln By 2020
AGN,AGN:US,BBG000FH8PX5,Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC® Patent Litigation,2016-09-17 09:38:09 +0000,http://www.publicnow.com/view/C9BC07F40386289A4018DE625A87670052F16FEB,"[at noodls] - DUBLIN and EMERYVILLE, Calif., Aug. 31, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company's Innovative Eye Care Pipeline,2016-09-17 09:38:09 +0000,http://www.publicnow.com/view/EF4C1A796DE20666DFCE73FB620D47CCCF082766,"[at noodls] - DUBLIN and ANN ARBOR, Mich., Sept. 6, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Will Bayer's Takeover of Monsanto Be a Bust?,2016-09-17 06:27:00 +0000,http://www.barrons.com/articles/will-bayers-takeover-of-monsanto-be-a-bust-1474093622?mod=yahoobarrons&ru=yahoo,[$$] Will Bayer's Takeover of Monsanto Be a Bust?
AGN,AGN:US,BBG000FH8PX5,"Denver Gold Forum Colorado Springs, CO",2016-09-17 03:28:05 +0000,http://www.publicnow.com/view/3589F9C7D189F625CF9919A4D76897C8B3BFB62E,"[at noodls] - Registration is offered by invitation only to qualified institutional investors, equity research analysts and select members of the financial media. Investment bankers, marketing and IR firms, and corporate ..."
AGN,AGN:US,BBG000FH8PX5,Synergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch,2016-09-16 17:19:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nyllvvauJ5k/synergy-pharmaceuticals-inc-sgyp-buyout-talks-reach-a-fever-pitch-cm680204,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Synergy Pharmaceuticals Inc 160 NASDAQ SGYP is at it again wafting up an impressive 8 to put its year to date chart back in black Since I last wrote
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data",2016-09-16 15:22:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TqdC7YLSoCo/pharma-stock-roundup-acquisitions-deals-pick-up-pace-aerie-up-on-positive-data-cm680517,Acquisitions as well as collaborations are picking up pace with Bayer BAYRY finally signing a merger agreement with Monsanto and Allergan AGN announcing its decision to acquire Vitae Moreover companies like Teva TEVA and Sanofi SNY announced collaborations that involve the use of
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Allergan Boosts its RandD Expenditure and Pours 639m Dollars in the New Merger,2016-09-16 13:19:25 +0000,http://news.investornetwork.com/2016/09/16/blog-coverage-allergan-boosts-its-randd-expenditure-and-pours-639m-dollars-in-the-new-merger/?1=1&1474031965,Blog Coverage Allergan Boosts its RandD Expenditure and Pours 639m Dollars in the New Merger
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Allergan Boosts its R&D Expenditure and Pours $639m in the New Merger,2016-09-16 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-allergan-boosts-r-131500536.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / September 16, 2016 / Active Wall St. blog coverage looks at the headline from Allergan PLC (NYSE: AGN ) as the leading global pharmaceutical firm, declared a definitive agreement ..."
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data",2016-09-16 13:04:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-acquisitions-deals-130401877.html,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data"
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : September 16, 2016",2016-09-16 12:21:18 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-breached-its-50-day-moving-average-in-a-bullish-manner-agn-us-september-16-2016/,"Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : September 16, 2016"
AGN,AGN:US,BBG000FH8PX5,"Company News for September 15, 2016",2016-09-15 16:19:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ghiGFLmPD0/company-news-for-september-15-2016-cm680037,160 160 160 Shares of Monsanto Co MON increased 0 6 after Bayer AG BAYN raised its offer for Monsanto to 128 per share 160 160 160 Shares of Vitae Pharmaceuticals Inc VTAE soared more than 100 after Allergan plc AGN agreed to buy Vitae
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy Vitae Pharma to Boost Dermatology Suite,2016-09-15 14:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DnxO2R4PsbI/allergan-to-buy-vitae-pharma-to-boost-dermatology-suite-cm679902,Allergan plc AGN announced that it has entered into a definitive agreement to acquire privately held Vitae Pharmaceuticals in a bid to enhance its dermatology pipeline Shares of Vitae Pharmaceuticals skyrocketed 157 41 while Allergan s stock gained 1 96 on the news The deal has
AGN,AGN:US,BBG000FH8PX5,"Stock Market News for September 15, 2016",2016-09-15 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-september-15-141002387.html,"Stock Market News for September 15, 2016"
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy Vitae Pharma to Boost Dermatology Suite,2016-09-15 12:08:12 +0000,http://finance.yahoo.com/news/allergan-buy-vitae-pharma-boost-120812374.html,Allergan to Buy Vitae Pharma to Boost Dermatology Suite
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Increases H2 2016 Production Guidance,2016-09-15 11:28:04 +0000,http://www.publicnow.com/view/CAB81E3D1644DDBF0C8D8EF60C3083B89AA3D804,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Sept. 15, 2016) - Highlights: Steady state operations continue with 34,301 ounces produced in July and August 2016 H2 2016 production guidance increased to 100,000 ..."
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Buy Vitae Pharmaceuticals for $639 Million,2016-09-15 04:08:45 +0000,http://www.wsj.com/articles/allergan-to-buy-vitae-pharmaceuticals-for-639-million-1473857881?ru=yahoo?mod=yahoo_itp,[$$] Allergan to Buy Vitae Pharmaceuticals for $639 Million
AGN,AGN:US,BBG000FH8PX5,Asian markets lower after Wall Street decline,2016-09-15 03:37:45 +0000,http://finance.yahoo.com/news/stocks-tick-higher-quiet-start-142108363.html,Asian markets lower after Wall Street decline
AGN,AGN:US,BBG000FH8PX5,"Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz",2016-09-15 02:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKeSj7mxQ1A/data-boosts-aeri-fda-panel-snubs-sppi-dday-for-acrx-today-vtae-abuzz-20160915-00082,"Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz"
AGN,AGN:US,BBG000FH8PX5,What Happened in the Stock Market Today,2016-09-15 00:18:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pp2tH57ryag/what-happened-in-the-stock-market-today-cm679704,Image source Getty Images Stocks had a relatively quiet session on Wednesday After three consecutive days of volatile trading the Dow Jones Industrial Average DJINDICES DJI and the S amp P 500 SNPINDEX GSPC index both fell just slightly Today s stock
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 09/14/2016: SPPI,VTAE,AGN,APPY",2016-09-14 23:34:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tl3QbcwqzfA/health-care-sector-update-for-09142016-sppivtaeagnappy-cm679648,Top Health Care StocksTop Health Care Stocks JNJ 0 09 JNJ 0 09 PFE 0 43 PFE 0 43 MRK 0 16 MRK 0 16 ABT 0 63 ABT 0 63 AMGN 0 43 AMGN 0 43 Health care stocks were slightly lower in late trade with the NYSE Health Care Index declining 0 1 while shares of health care companies in
AGN,AGN:US,BBG000FH8PX5,"Close Update: Stocks Lose Early Gains as Data Deluge Looms, Oil Retreats",2016-09-14 23:34:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZDmdoeOP4mE/close-update-stocks-lose-early-gains-as-data-deluge-looms-oil-retreats-cm679632,Stocks closed mixed on Wednesday with the Dow and S amp P 500 returning early gains but the Nasdaq Composite reversing Tuesday s loss All three benchmark indices retreated from their session highs late in the day as oil extended earlier losses and investors braced for Thursday s deluge
AGN,AGN:US,BBG000FH8PX5,Mid-Afternoon Market Update: Dow Turns Lower; Radiant Logistics Shares Drop Following Q4 Results,2016-09-14 23:19:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5uAodl_0Og0/mid-afternoon-market-update-dow-turns-lower-radiant-logistics-shares-drop-following-q4-results-cm679600,Toward the end of trading Wednesday the Dow traded down 0 16 percent to 18 037 10 while the NASDAQ gained 0 39 percent to 5 175 22 The S amp P also fell dropping 0 06 percent to 2 125 86 Leading and Lagging Sectors Wednesday afternoon technology shares gained 0 60
AGN,AGN:US,BBG000FH8PX5,Vitae Shares Zoom Higher on Sale to Allergan,2016-09-14 21:00:03 +0000,http://www.investopedia.com/stock-analysis/091416/vitae-shares-zoom-higher-sale-allergan-agn-vtae.aspx?partner=YahooSA,Vitae Shares Zoom Higher on Sale to Allergan
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Stock Closed Up on Vitae Deal, Evercore: Acquisition May Be 'Home Run'",2016-09-14 20:50:00 +0000,https://www.thestreet.com/story/13740309/1/allergan-agn-stock-closed-up-on-vitae-deal-evercore-acquisition-may-be-home-run.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Closed Up on Vitae Deal, Evercore: Acquisition May Be 'Home Run'"
AGN,AGN:US,BBG000FH8PX5,"Con Edison and Vitae rise, Ford and Marathon Oil skid",2016-09-14 20:42:57 +0000,http://sg.finance.yahoo.com/news/con-edison-vitae-rise-ford-204257379.html,"Con Edison and Vitae rise, Ford and Marathon Oil skid"
AGN,AGN:US,BBG000FH8PX5,Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal,2016-09-14 19:23:00 +0000,https://www.thestreet.com/story/13735460/1/vitae-pharmaceuticals-vtae-stock-downgraded-on-639-million-allergan-deal.html?puc=yahoo&cm_ven=YAHOO,Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal
AGN,AGN:US,BBG000FH8PX5,Allergan's Dealmaking Continues With Vitae Takeout,2016-09-14 18:56:00 +0000,https://www.thestreet.com/story/13729121/1/allergan-s-dealmaking-continues-with-vitae-takeout.html?puc=yahoo&cm_ven=YAHOO,Allergan's Dealmaking Continues With Vitae Takeout
AGN,AGN:US,BBG000FH8PX5,Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq,2016-09-14 18:40:00 +0000,https://www.thestreet.com/story/13729024/1/stocks-off-highs-but-remain-in-green-as-apple-leads-tech-sector.html?puc=yahoo&cm_ven=YAHOO,Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 09/14/2016: ACST,VTAE,AGN,APPY",2016-09-14 18:05:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QoWnWnCsITk/health-care-sector-update-for-09142016-acstvtaeagnappy-cm679585,Top Health Care StocksTop Health Care Stocks JNJ 0 19 JNJ 0 19 PFE 0 03 PFE 0 03 MRK 0 27 MRK 0 27 ABT 0 23 ABT 0 23 AMGN 0 68 AMGN 0 68 Health care stocks were little changed in recent trade with the NYSE Health Care Index climbing 0 1 while shares of health care companies in
AGN,AGN:US,BBG000FH8PX5,Allergan plc Ordinary Shares (AGN) Up on $639M Buyout of Vitae Pharmaceuticals Inc (VTAE),2016-09-14 17:47:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/56FCBjSfUbA/allergan-plc-ordinary-shares-agn-up-on-639m-buyout-of-vitae-pharmaceuticals-inc-vtae-cm679540,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks 160 are looking to erase their losses over the past month today strongly driven by the buyout of 160 Vitae Pharmaceuticals Inc 160 NASDAQ VTAE by Allergan plc Ordinary Shares
AGN,AGN:US,BBG000FH8PX5,Here's Why Shares of Vitae Pharmaceuticals Inc Are Skyrocketing Today,2016-09-14 17:47:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/78-eIgYTXi4/heres-why-shares-of-vitae-pharmaceuticals-inc-are-skyrocketing-today-cm679531,Image source Getty Images What happened Investors in Vitae Pharmaceuticals NASDAQ VTAE should be smiling from ear to ear today The company s shares are up more than 158 as of 10 30 a m EDT in response to the news that pharma giant Allergan 160 PLC NYSE AGN will
AGN,AGN:US,BBG000FH8PX5,Allergan: A Home Run?,2016-09-14 17:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/14/allergan-a-home-run/?mod=yahoobarrons&ru=yahoo,Allergan: A Home Run?
AGN,AGN:US,BBG000FH8PX5,Mid-Day Market Update: Crude Oil Down Over 2%; Vitae Pharmaceuticals Shares Surge Following Allergan Buyout,2016-09-14 17:35:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QvxKpQC76_Q/mid-day-market-update-crude-oil-down-over-2-vitae-pharmaceuticals-shares-surge-following-allergan-buyout-cm679555,Midway through trading Wednesday the Dow traded up 0 31 percent to 18 122 70 while the NASDAQ gained 0 72 percent to 5 192 17 The S amp P also rose gaining 0 34 percent to 2 134 61 Leading and Lagging Sectors On Wednesday technology shares gained 0 93 percent Meanwhile
AGN,AGN:US,BBG000FH8PX5,Midday Update: Stocks Cautiously Higher as Tech Gains Offset Weak Energy Markets,2016-09-14 17:25:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Awlrcm6fBbc/midday-update-stocks-cautiously-higher-as-tech-gains-offset-weak-energy-markets-cm679551,Stocks are trading conservatively higher Wednesday with gains in the technology sector offsetting losses in the energy complex Bargain hunting after Tuesday s sell off coupled with stability in the bond market has eased jittery investors and is keeping the S amp P 500 above key support at
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Vitae Pharmaceuticals,2016-09-14 17:04:00 +0000,http://www.thestreet.com/video/13729006/allergan-to-acquire-vitae-pharmaceuticals.html?puc=yahoov&cm_ven=YAHOOV,Allergan to Acquire Vitae Pharmaceuticals
AGN,AGN:US,BBG000FH8PX5,[$$] Allergan to Buy Vitae Pharmaceuticals for $639 Million,2016-09-14 16:54:59 +0000,http://www.wsj.com/articles/allergan-to-buy-vitae-pharmaceuticals-for-639-million-1473857881?mod=yahoo_hs,[$$] Allergan to Buy Vitae Pharmaceuticals for $639 Million
AGN,AGN:US,BBG000FH8PX5,Allergan's Vitae Buyout Makes a Statement,2016-09-14 16:06:11 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-14/allergan-vitae-deal-seriously-we-are-not-valeant?cmpid=yhoo.headline,Allergan's Vitae Buyout Makes a Statement
AGN,AGN:US,BBG000FH8PX5,Five Stocks Trading Higher Amid Positive News,2016-09-14 15:55:15 +0000,http://www.insidermonkey.com/blog/five-stocks-trading-higher-amid-positive-news-474607/,Five Stocks Trading Higher Amid Positive News
AGN,AGN:US,BBG000FH8PX5,"Bayer Finally Buys Monsanto, Inflation Vanishes",2016-09-14 15:50:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqlbzhCQh-g/bayer-finally-buys-monsanto-inflation-vanishes-cm679403,Wednesday September 14 2016 It was a long time coming but St Louis based agribusiness giant Monsanto MON has agreed to be purchased by German Big Pharma staple Bayer BAYRY for 66 billion in cash This amounts to 128 per share a 21 premium from Monsanto s closing price Tuesday
AGN,AGN:US,BBG000FH8PX5,Here's Why Shares of Vitae Pharmaceuticals Inc Are Skyrocketing Today,2016-09-14 15:43:22 +0000,http://www.fool.com/investing/2016/09/14/why-vitae-pharmaceuticals-inc-is-skyrocketing-toda.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Shares of Vitae Pharmaceuticals Inc Are Skyrocketing Today
AGN,AGN:US,BBG000FH8PX5,Mid-Morning Market Update: Markets Edge Higher; Bayer To Buy Monsanto For $66B,2016-09-14 15:00:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6DmtObkQgig/mid-morning-market-update-markets-edge-higher-bayer-to-buy-monsanto-for-66b-cm679426,Following the market opening Wednesday the Dow traded up 0 06 percent to 18 078 15 while the NASDAQ gained 0 30 percent to 5 170 53 The S amp P also rose gaining 0 03 percent to 2 127 55 Leading and Lagging Sectors Wednesday morning basic materials shares gained 0 51
AGN,AGN:US,BBG000FH8PX5,"Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates",2016-09-14 14:50:00 +0000,https://www.thestreet.com/story/13728516/1/stocks-slightly-higher-after-volatile-three-days.html?puc=yahoo&cm_ven=YAHOO,"Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates"
AGN,AGN:US,BBG000FH8PX5,Vitae Pharmaceuticals (VTAE) Stock Soars on $639 Million Allergan Deal,2016-09-14 14:37:00 +0000,https://www.thestreet.com/story/13728659/1/vitae-pharmaceuticals-vtae-stock-soars-on-639-million-allergan-deal.html?puc=yahoo&cm_ven=YAHOO,Vitae Pharmaceuticals (VTAE) Stock Soars on $639 Million Allergan Deal
AGN,AGN:US,BBG000FH8PX5,"Bayer Finally Buys Monsanto, Inflation Vanishes",2016-09-14 14:04:02 +0000,http://finance.yahoo.com/news/bayer-finally-buys-monsanto-inflation-140402022.html,"Bayer Finally Buys Monsanto, Inflation Vanishes"
AGN,AGN:US,BBG000FH8PX5,"Stocks to Watch: Vitae Pharmaceuticals, Ford, Monsanto, Herbalife",2016-09-14 13:24:35 +0000,http://blogs.wsj.com/moneybeat/2016/09/14/stocks-to-watch-vitae-pharmaceuticals-ford-monsanto-herbalife/?mod=yahoo_hs,"Stocks to Watch: Vitae Pharmaceuticals, Ford, Monsanto, Herbalife"
AGN,AGN:US,BBG000FH8PX5,"ALLERGAN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-14 13:21:56 +0000,http://biz.yahoo.com/e/160914/agn8-k.html,"ALLERGAN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AGN,AGN:US,BBG000FH8PX5,$639M deal: Allergan to buy Montco biotech firm,2016-09-14 13:15:03 +0000,http://www.bizjournals.com/philadelphia/news/2016/09/14/allergan-buying-vitae-biotech-firm-vtae-agn.html?ana=yahoo,$639M deal: Allergan to buy Montco biotech firm
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions,2016-09-14 13:08:04 +0000,http://www.publicnow.com/view/B83F855B5941AF6429555B9F2AB2690761DD4E48,"[at noodls] - - Acquisition Adds Differentiated Development Programs to Strengthen Allergan's Medical Dermatology Pipeline - - VTP-43742, First-in-Class Oral RORγt Inhibitor for Potential Treatment of Psoriasis, Other ..."
AGN,AGN:US,BBG000FH8PX5,"[video]Allergan (AGN) Stock Higher, Buys Vitae Pharmaceuticals for $639 Million",2016-09-14 12:31:00 +0000,https://www.thestreet.com/story/13728278/1/allergan-agn-stock-higher-buys-vitae-pharmaceuticals-for-639-million.html?puc=yahoo&cm_ven=YAHOO,"[video]Allergan (AGN) Stock Higher, Buys Vitae Pharmaceuticals for $639 Million"
AGN,AGN:US,BBG000FH8PX5,Allergan and Medicines360 Announce Launch of New LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Single-Handed Inserter,2016-09-14 12:28:02 +0000,http://www.publicnow.com/view/27285D478364E62D34C55643E820079354A0ADEA,"[at noodls] - DUBLIN and SAN FRANCISCO, Sept. 14, 2016 /PRNewswire/ -- Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, and Medicines360, a nonprofit global women's health pharmaceutical company, today ..."
AGN,AGN:US,BBG000FH8PX5,Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million,2016-09-14 12:08:26 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F9A44F65-B207-4325-845D-34C08F280F76&siteid=yhoof2,Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million
AGN,AGN:US,BBG000FH8PX5,Allergan to Buy Vitae Pharmaceuticals for $639 Million,2016-09-14 09:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e7s8CNbCObc/allergan-to-buy-vitae-pharmaceuticals-for-639-million-20160914-00567,Allergan to Buy Vitae Pharmaceuticals for $639 Million
AGN,AGN:US,BBG000FH8PX5,Allergan Launches Liletta Single Handed Inserter To Prevent Pregnancy,2016-09-14 08:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjkfNqfU-qM/allergan-launches-liletta-single-handed-inserter-to-prevent-pregnancy-20160914-00438,Allergan Launches Liletta Single Handed Inserter To Prevent Pregnancy
AGN,AGN:US,BBG000FH8PX5,Allergan To Acquire Vitae Pharma In $639 Mln Cash Deal,2016-09-14 08:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RTmdf5BgTPs/allergan-to-acquire-vitae-pharma-in-639-mln-cash-deal-20160914-00395,Allergan To Acquire Vitae Pharma In $639 Mln Cash Deal
AGN,AGN:US,BBG000FH8PX5,Why Allergan Should Start Paying a Dividend,2016-09-13 23:46:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CpoumXdcSQ8/why-allergan-should-start-paying-a-dividend-cm679116,Image source Getty Images Raise your hand if you think big pharma Allergan s NYSE AGN s recent stock performance has been 160 dismal 160 Every hand raised I thought so The company s stock 160 has dropped 24 this year 160 while the S amp P has gained 4 2 And that
AGN,AGN:US,BBG000FH8PX5,"Final Trade: LULU, AGN & more",2016-09-13 21:59:00 +0000,http://finance.yahoo.com/video/final-trade-lulu-agn-more-215900030.html,"Final Trade: LULU, AGN & more"
AGN,AGN:US,BBG000FH8PX5,Why Allergan Should Start Paying a Dividend,2016-09-13 21:47:16 +0000,http://www.fool.com/investing/2016/09/13/why-allergan-should-start-paying-a-dividend.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Allergan Should Start Paying a Dividend
AGN,AGN:US,BBG000FH8PX5,3 Reasons to Buy Teva Right Now,2016-09-13 15:09:00 +0000,https://www.thestreet.com/story/13725950/1/3-reasons-to-buy-teva-right-now.html?puc=yahoo&cm_ven=YAHOO,3 Reasons to Buy Teva Right Now
AGN,AGN:US,BBG000FH8PX5,Allergan Showcases Commitment to Eye Care Innovation with New Data Presentations at the Retina Society 49th Annual Scientific Meeting in San Diego,2016-09-13 12:00:00 +0000,http://finance.yahoo.com/news/allergan-showcases-commitment-eye-care-120000764.html,"[PR Newswire] - DUBLIN, Sept. 13, 2016 /PRNewswire/ -- Allergan (NYSE: AGN) today announced that its data will be presented during the Retina Society 49 th Annual Scientific Meeting in San Diego, CA, September 14-17, ..."
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Morgan Stanley Global Conference; Webcast At 11:45 AM ET,2016-09-13 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4JJY8hlIWjE/allergan-to-present-at-morgan-stanley-global-conference-webcast-at-1145-am-et-20160913-00741,Allergan To Present At Morgan Stanley Global Conference; Webcast At 11:45 AM ET
AGN,AGN:US,BBG000FH8PX5,"IYH, BMY, AGN, CELG: Large Outflows Detected at ETF",2016-09-12 16:32:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CLtDXwDt-so/iyh-bmy-agn-celg-large-outflows-detected-at-etf-cm678026,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 29 7 million dollar outflow that s a 1 5 decrease week over week from 13 250
AGN,AGN:US,BBG000FH8PX5,What’s behind Biogen Buyout Rumors?,2016-09-12 14:04:37 +0000,http://marketrealist.com/2016/09/whats-behind-biogen-buyout-rumors/?utm_source=yahoo&utm_medium=feed,What’s behind Biogen Buyout Rumors?
AGN,AGN:US,BBG000FH8PX5,"Amazon, Costco and Allergan: Doug Kass' Views",2016-09-12 05:00:00 +0000,https://www.thestreet.com/story/13702913/1/amazon-costco-and-allergen-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Amazon, Costco and Allergan: Doug Kass' Views"
AGN,AGN:US,BBG000FH8PX5,Where are the buying opportunities?,2016-09-09 20:21:00 +0000,http://finance.yahoo.com/video/where-buying-opportunities-202100254.html,Where are the buying opportunities?
AGN,AGN:US,BBG000FH8PX5,Pfizer CEO: Clinton's plan to curb high drug prices would be 'very negative for innovation',2016-09-09 14:58:58 +0000,http://finance.yahoo.com/news/pfizer-ceo-clintons-plan-curb-145858531.html,Pfizer CEO: Clinton's plan to curb high drug prices would be 'very negative for innovation'
AGN,AGN:US,BBG000FH8PX5,"Pharma Stock Roundup: Drug Pricing Remains in Focus, Merck Drops Odanacatib",2016-09-09 14:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gg7G3Kk_UQY/pharma-stock-roundup-drug-pricing-remains-in-focus-merck-drops-odanacatib-cm676813,While drug pricing and Mylan MYL remained in the news this week as well companies like Merck MRK Bristol Myers BMY and Novo Nordisk NVO came out with regulatory pipeline updates Recap of the Week s Most Important Stories Mylan now Being Investigated by New York AG Allergan
AGN,AGN:US,BBG000FH8PX5,When Will the Generic Version of Abraxane Be Available?,2016-09-09 12:04:31 +0000,http://marketrealist.com/2016/09/when-will-the-generic-version-of-abraxane-be-available/?utm_source=yahoo&utm_medium=feed,When Will the Generic Version of Abraxane Be Available?
AGN,AGN:US,BBG000FH8PX5,The maker of Botox is now targeting all your bodily flaws,2016-09-09 12:00:56 +0000,http://qz.com/776771/the-maker-of-botox-is-now-targeting-all-your-bodily-flaws/?utm_source=YPL,The maker of Botox is now targeting all your bodily flaws
AGN,AGN:US,BBG000FH8PX5,Drug Pricing Power Transcends Politics,2016-09-09 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=768713&SR=Yahoo,Drug Pricing Power Transcends Politics
AGN,AGN:US,BBG000FH8PX5,[$$] 'Middlemen' under the spotlight in EpiPen furore,2016-09-09 10:00:24 +0000,"http://www.ft.com/cms/s/489f7276-75cc-11e6-b60a-de4532d5ea35,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - When Jamie Hilton visited her local pharmacy to stock up on an injection that might save her son's life, she was hit with a nasty surprise: a bill for more than $600. Ms Hilton has been purchasing EpiPens ..."
AGN,AGN:US,BBG000FH8PX5,Bayer Reportedly Explores Sale Of Dermatology Business,2016-09-08 22:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xvyi7iNhUXs/bayer-reportedly-explores-sale-of-dermatology-business-20160908-01283,Bayer Reportedly Explores Sale Of Dermatology Business
AGN,AGN:US,BBG000FH8PX5,"Pharma industry should self-police drug prices, Allergan CEO says",2016-09-08 21:26:49 +0000,http://www.cnbc.com/id/103926371?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103926371,"Pharma industry should self-police drug prices, Allergan CEO says"
AGN,AGN:US,BBG000FH8PX5,Allergan CEO on Rx prices: Not a problem govt. solves,2016-09-08 20:16:00 +0000,http://finance.yahoo.com/video/allergan-ceo-rx-prices-not-201600507.html,Allergan CEO on Rx prices: Not a problem govt. solves
AGN,AGN:US,BBG000FH8PX5,Bayer exploring sale of dermatology business - Bloomberg,2016-09-08 17:31:19 +0000,http://sg.finance.yahoo.com/news/bayer-exploring-sale-dermatology-business-173119851.html,Bayer exploring sale of dermatology business - Bloomberg
AGN,AGN:US,BBG000FH8PX5,Vistagen Therapeutics Inc. (VTGN) May Hold the Key to Treatment Resistant Depression,2016-09-08 17:23:27 +0000,http://www.insidermonkey.com/blog/vistagen-therapeutics-inc-vtgn-may-hold-the-key-to-treatment-resistant-depression-473053/,Vistagen Therapeutics Inc. (VTGN) May Hold the Key to Treatment Resistant Depression
AGN,AGN:US,BBG000FH8PX5,EpiPen pricing fallout,2016-09-08 17:16:00 +0000,http://finance.yahoo.com/video/epipen-pricing-fallout-171600073.html,EpiPen pricing fallout
AGN,AGN:US,BBG000FH8PX5,"Asanko Gold partners with leading Canadian NGO, CODE to bring its world class literacy and education program to the Ashanti Region of Ghana",2016-09-08 13:49:14 +0000,http://www.publicnow.com/view/8673768DAE3CAD85D16C0AB69F04C1B8687DA4B8,"[at noodls] - September 8th, 2016 Ottawa, September 8, 2016 - Celebrating this 50 Anniversary of UNESCO's International Literacy Day, CODE is pleased to announce a new, six-year partnership with Asanko Gold which will ..."
AGN,AGN:US,BBG000FH8PX5,Multi-Billion Dollar Cancer Treatment & Patient Care Industry Boosting Biotech Sector to New Highs,2016-09-08 12:30:00 +0000,http://finance.yahoo.com/news/multi-billion-dollar-cancer-treatment-123000511.html,[CNW Group] - Multi-Billion Dollar Cancer Treatment & Patient Care Industry Boosting Biotech Sector to New Highs
AGN,AGN:US,BBG000FH8PX5,Allergan To Present At Wells Fargo Conference; Webcast At 10:30 AM ET,2016-09-08 09:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a6zK39xn0Ls/allergan-to-present-at-wells-fargo-conference-webcast-at-1030-am-et-20160908-00659,Allergan To Present At Wells Fargo Conference; Webcast At 10:30 AM ET
AGN,AGN:US,BBG000FH8PX5,Robert Bruce Invests in Allergan in 2nd Quarter,2016-09-07 23:29:08 +0000,http://finance.yahoo.com/news/robert-bruce-invests-allergan-2nd-232826621.html,Robert Bruce Invests in Allergan in 2nd Quarter
AGN,AGN:US,BBG000FH8PX5,GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill,2016-09-07 23:17:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aHRi_zDMMpE/gw-pharmaceuticals-plc-adr-gwph-boards-the-buyout-rumor-mill-cm675939,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips GW Pharmaceuticals PLC ADR 160 NASDAQ GWPH finished 23 higher 160 on seven times its typical volume Wednesday after buyout rumors emerged
AGN,AGN:US,BBG000FH8PX5,Invest Where You Eat: Ackman's Love of Chipotle Burritos,2016-09-07 16:40:59 +0000,http://blogs.wsj.com/moneybeat/2016/09/07/invest-where-you-eat-ackmans-love-of-chipotle-burritos/?mod=yahoo_hs,Invest Where You Eat: Ackman's Love of Chipotle Burritos
AGN,AGN:US,BBG000FH8PX5,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline,2016-09-07 16:20:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Csb7PttCQ-0/allergan-takes-over-retrosense-boosts-eye-care-pipeline-cm675659,Allergan plc AGN has acquired RetroSense Therapeutics a privately held clinical stage biotechnology company which will add the latter s lead gene therapy development program RST 001 to its eye care pipeline RST 001 is being developed for the treatment of the eye disease retinitis
AGN,AGN:US,BBG000FH8PX5,"Burlington Stores, Movado Group, Mylan, Allergan and Valeant highlighted as Zacks Bull and Bear of the Day",2016-09-07 15:21:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RjMKHAOv8Zs/burlington-stores-movado-group-mylan-allergan-and-valeant-highlighted-as-zacks-bull-and-bear-of-the-day-cm675562,For Immediate Release Chicago IL September 07 2016 Zacks Equity Research highlights 160 Burlington Stores Inc BURL as the Bull of the Day and Movado Group Inc MOV as the Bear of the Day In addition Zacks Equity Research provides analysis on Mylan NV
AGN,AGN:US,BBG000FH8PX5,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline,2016-09-07 14:20:02 +0000,http://finance.yahoo.com/news/allergan-takes-over-retrosense-boosts-142002221.html,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline
AGN,AGN:US,BBG000FH8PX5,"Burlington Stores, Movado Group, Mylan, Allergan and Valeant highlighted as Zacks Bull and Bear of the Day",2016-09-07 13:30:01 +0000,http://finance.yahoo.com/news/burlington-stores-movado-group-mylan-133001809.html,"Burlington Stores, Movado Group, Mylan, Allergan and Valeant highlighted as Zacks Bull and Bear of the Day"
AGN,AGN:US,BBG000FH8PX5,4 Stocks We Would Never Sell,2016-09-07 13:19:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LMulCFRBWG0/4-stocks-we-would-never-sell-cm675400,Image source Getty Images You only have to do a very few things right in your life so long as you don t do too many things wrong Warren Buffett He s right more often than not if you simply hold on to a stock over the years through thick and thin you ll likely
AGN,AGN:US,BBG000FH8PX5,4 Stocks We Would Never Sell,2016-09-07 12:06:10 +0000,http://www.fool.com/investing/2016/09/07/4-stocks-we-would-never-sell.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Stocks We Would Never Sell
AGN,AGN:US,BBG000FH8PX5,Medicines360 and Allergan announce publication of levonorgestrel release rates over five years with the LILETTA® 52 mg intrauterine system in 'Contraception',2016-09-07 12:00:00 +0000,http://finance.yahoo.com/news/medicines360-allergan-announce-publication-levonorgestrel-120000967.html,"[PR Newswire] - SAN FRANCISCO and DUBLIN, Sept. 7, 2016 /PRNewswire/ -- Medicines360, a nonprofit global women's health pharmaceutical company, and Allergan, plc (AGN), a leading global pharmaceutical company, today announced the publication of five-year levonorgestrel release rates for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg in the September 2016 issue of the medical journal Contraception. The study evaluated the remaining hormone content in LILETTA systems that had been removed from women at various time points during the first five years of the ongoing seven-year ACCESS IUS (A Comprehensive Contraceptive Efficacy and Safety Study of an IUS) clinical trial, the largest ever IUS clinical trial conducted in the US. The remaining amount of levonorgestrel, the active hormone in LILETTA, was used to calculate the hormone release rate over five years."
AGN,AGN:US,BBG000FH8PX5,"Pharma Round-Up: Mylan's Antitrust Probe, Allergan Limits Drug Price Hikes",2016-09-06 23:16:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PmkRzZfp2wY/pharma-round-up-mylans-antitrust-probe-allergan-limits-drug-price-hikes-cm675253,On Tuesday New York Attorney General Eric Schneiderman opened an investigation into Mylan NV MYL that focuses on the drugmaker s contracts with local school districts to purchase its EpiPens In a statement Schneiderman said No child s life should be put at risk because a parent school
AGN,AGN:US,BBG000FH8PX5,"Pharma Round-Up: Mylan's Antitrust Probe, Allergan Limits Drug Price Hikes",2016-09-06 21:13:09 +0000,http://finance.yahoo.com/news/pharma-round-mylans-antitrust-probe-211309531.html,"Pharma Round-Up: Mylan's Antitrust Probe, Allergan Limits Drug Price Hikes"
AGN,AGN:US,BBG000FH8PX5,"Allergan Buys Into Gene Therapy, Promises To Limit Price Increases",2016-09-06 20:53:38 +0000,http://www.investors.com/news/technology/allergan-buys-into-gene-therapy-promises-to-limit-price-increases/,"Allergan Buys Into Gene Therapy, Promises To Limit Price Increases"
AGN,AGN:US,BBG000FH8PX5,"Allergan vows limited price hikes, says 'outliers' deter research",2016-09-06 20:32:18 +0000,http://sg.finance.yahoo.com/news/allergan-says-outlier-drugmakers-scaring-180726834.html,"Allergan vows limited price hikes, says 'outliers' deter research"
AGN,AGN:US,BBG000FH8PX5,Allergan's CEO wants to be the drug industry's good guy,2016-09-06 19:08:23 +0000,http://finance.yahoo.com/news/allergans-ceo-wants-drug-industrys-190823796.html,Allergan's CEO wants to be the drug industry's good guy
AGN,AGN:US,BBG000FH8PX5,"Allergan Slaps Peers, Self With Pricing Gauntlet",2016-09-06 18:32:27 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-06/allergan-drug-price-promises-throw-down-a-gauntlet?cmpid=yhoo.headline,"Allergan Slaps Peers, Self With Pricing Gauntlet"
AGN,AGN:US,BBG000FH8PX5,Allergan offers a rare pharmaceutical company promise: limits on drug-price increases,2016-09-06 14:59:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7CE4A646-7437-11E6-94C6-EF06C25BC212&siteid=yhoof2,Allergan offers a rare pharmaceutical company promise: limits on drug-price increases
AGN,AGN:US,BBG000FH8PX5,Allergan CEO Lays Out Plan to Buck Trend of Rising Drug Prices,2016-09-06 14:58:50 +0000,http://www.bloomberg.com/news/articles/2016-09-06/allergan-ceo-lays-out-plan-to-buck-trend-of-rising-drug-prices?cmpid=yhoo.headline,Allergan CEO Lays Out Plan to Buck Trend of Rising Drug Prices
AGN,AGN:US,BBG000FH8PX5,"Finally, A Pharma CEO Takes The High Road On Drug Pricing",2016-09-06 14:19:00 +0000,http://www.forbes.com/sites/frankdavid/2016/09/06/allergan/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Finally, A Pharma CEO Takes The High Road On Drug Pricing"
AGN,AGN:US,BBG000FH8PX5,This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders,2016-09-06 14:17:06 +0000,http://finance.yahoo.com/news/pharmaceutical-ceo-just-laid-4-141706982.html,This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders
AGN,AGN:US,BBG000FH8PX5,Allergan CEO: No More Predatory Drug Pricing,2016-09-06 13:20:00 +0000,https://www.thestreet.com/story/13694738/1/allergan-ceo-no-more-predatory-drug-pricing.html?puc=yahoo&cm_ven=YAHOO,Allergan CEO: No More Predatory Drug Pricing
AGN,AGN:US,BBG000FH8PX5,Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company's Innovative Eye Care Pipeline,2016-09-06 13:19:07 +0000,http://www.publicnow.com/view/6948E77BA732B65FF47A9F4DDF16A2C98A088885,"[at noodls] - DUBLIN and ANN ARBOR, Mich., Sept. 6, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company ..."
AGN,AGN:US,BBG000FH8PX5,Allergan acquires assets of RetroSense for $60 million upfront payment,2016-09-06 12:16:22 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=82F54AD8-75D3-4F10-B657-152A14B2B79A&siteid=yhoof2,Allergan acquires assets of RetroSense for $60 million upfront payment
AGN,AGN:US,BBG000FH8PX5,Allergan Buys Gene Therapy Company RetroSense Therapeutics - Quick Facts,2016-09-06 08:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fbdsm_rG7qM/allergan-buys-gene-therapy-company-retrosense-therapeutics--quick-facts-20160906-00491,Allergan Buys Gene Therapy Company RetroSense Therapeutics - Quick Facts
AGN,AGN:US,BBG000FH8PX5,"Aegon CFO Darryl Button To Leave, Effective Dec.1 - Quick Facts",2016-09-06 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NmxgOqIoDh0/aegon-cfo-darryl-button-to-leave-effective-dec1--quick-facts-20160906-00057,"Aegon CFO Darryl Button To Leave, Effective Dec.1 - Quick Facts"
AGN,AGN:US,BBG000FH8PX5,Is Biogen a Worthwhile Buyout Candidate?,2016-09-04 16:05:34 +0000,http://www.fool.com/investing/2016/09/03/is-biogen-a-worthwhile-buyout-candidate.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Biogen a Worthwhile Buyout Candidate?
AGN,AGN:US,BBG000FH8PX5,Is Biogen a Worthwhile Buyout Candidate?,2016-09-03 17:16:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j3y6yjUaNwc/is-biogen-a-worthwhile-buyout-candidate-cm674454,Image source Getty Images Biogen s NASDAQ BIIB shares have been screaming higher over the last few weeks fueled by a better than expected second quarter earnings report 160 and rumors that Allergan NYSE AGN and Merck NYSE MRK are both considering a buyout
AGN,AGN:US,BBG000FH8PX5,Billionaire Leon Cooperman’s Favorite Stock Picks,2016-09-02 18:33:15 +0000,http://www.insidermonkey.com/blog/billionaire-leon-coopermans-favorite-stock-picks-471889/,Billionaire Leon Cooperman’s Favorite Stock Picks
AGN,AGN:US,BBG000FH8PX5,Two Stocks Most at Risk From Clinton's New Drug Plan,2016-09-02 16:34:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/02/two-stocks-most-at-risk-from-clintons-new-drug-plan/?mod=yahoobarrons&ru=yahoo,Two Stocks Most at Risk From Clinton's New Drug Plan
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Outflows: IYH, BMY, AGN, CELG",2016-09-02 16:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nNDWzM9usNk/noteworthy-etf-outflows-iyh-bmy-agn-celg-cm674090,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 60 3 million dollar outflow that s a 2 9 decrease week over week from 13 650
AGN,AGN:US,BBG000FH8PX5,Analyzing Eli Lilly’s Blockbuster Endocrinology Drugs,2016-09-02 12:04:38 +0000,http://marketrealist.com/2016/09/analyzing-eli-lillys-blockbuster-endocrinology-drugs/?utm_source=yahoo&utm_medium=feed,Analyzing Eli Lilly’s Blockbuster Endocrinology Drugs
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas Agree to Settle Namzaric Patent Litigation",2016-09-01 15:31:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yj7l73PclWw/allergan-adamas-agree-to-settle-namzaric-patent-litigation-cm673446,Allergan plc AGN announced that its subsidiaries and Adamas Pharmaceuticals Inc ADMS have entered into a settlement agreement with privately held U S generic drug maker Amneal Pharmaceuticals to resolve the patent infringement litigation related to Namzaric Amneal was looking for
AGN,AGN:US,BBG000FH8PX5,How Are Eli Lilly’s Business Segments Performing?,2016-09-01 15:04:32 +0000,http://marketrealist.com/2016/09/eli-lillys-business-segments-performing/?utm_source=yahoo&utm_medium=feed,How Are Eli Lilly’s Business Segments Performing?
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas Agree to Settle Namzaric Patent Litigation",2016-09-01 14:23:02 +0000,http://finance.yahoo.com/news/allergan-adamas-agree-settle-namzaric-142302183.html,"Allergan, Adamas Agree to Settle Namzaric Patent Litigation"
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at Morgan Stanley Global Healthcare Conference,2016-09-01 11:30:00 +0000,http://finance.yahoo.com/news/allergan-present-morgan-stanley-global-113000778.html,"[PR Newswire] - DUBLIN, Sept. 1, 2016 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's CEO and President, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 11:45 a.m. ET at the Grand Hyatt in New York, NY. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 65+ mid-to-late stage pipeline programs in development."
AGN,AGN:US,BBG000FH8PX5,"David Tepper Exits Facebook, Boosts Allergan",2016-08-31 22:47:39 +0000,http://finance.yahoo.com/news/david-tepper-exits-facebook-boosts-224739483.html,"David Tepper Exits Facebook, Boosts Allergan"
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas settle patent lawsuit with Amneal",2016-08-31 14:10:54 +0000,http://finance.yahoo.com/news/allergan-adamas-settle-patent-lawsuit-141054117.html,"[Reuters] - Allergan Plc said it and Adamas Pharmaceuticals Inc settled a patent infringement lawsuit with Amneal Pharmaceuticals over their Alzheimer's drug. Allergan said its Forest Labs unit and Adamas had filed a lawsuit against privately owned Amneal, which was seeking regulatory approval for generic versions of Namzaric. The drug, which has been licensed to Forest by Adamas, had U.S. sales of $12.8 million for the quarter ended June 30."
AGN,AGN:US,BBG000FH8PX5,How Allergan Changed Its Guidance for Remainder of 2016,2016-08-31 14:04:14 +0000,http://marketrealist.com/2016/08/how-allergan-changed-its-guidance-for-remainder-of-2016/?utm_source=yahoo&utm_medium=feed,How Allergan Changed Its Guidance for Remainder of 2016
AGN,AGN:US,BBG000FH8PX5,Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC® Patent Litigation,2016-08-31 12:53:04 +0000,http://www.publicnow.com/view/9CEC71D4DBBA5BE9EA3923150F25B82784D3F36E,"[at noodls] - DUBLIN and EMERYVILLE, Calif., Aug. 31, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories ..."
AGN,AGN:US,BBG000FH8PX5,5 Health Care Stocks John Paulson Is Betting On in 2016,2016-08-31 12:33:00 +0000,https://www.thestreet.com/story/13285848/1/health-care-stocks-john-paulson-loves.html?puc=yahoo&cm_ven=YAHOO,5 Health Care Stocks John Paulson Is Betting On in 2016
AGN,AGN:US,BBG000FH8PX5,Franchises that Drove Allergan’s International Sales in 2Q,2016-08-31 12:04:19 +0000,http://marketrealist.com/2016/08/franchises-that-drove-allergans-international-sales-in-2q/?utm_source=yahoo&utm_medium=feed,Franchises that Drove Allergan’s International Sales in 2Q
AGN,AGN:US,BBG000FH8PX5,Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC® Patent Litigation,2016-08-31 12:00:00 +0000,http://finance.yahoo.com/news/allergan-adamas-announce-settlement-amneal-120000940.html,"[PR Newswire] - DUBLIN and EMERYVILLE, Calif., Aug. 31, 2016 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals, Inc. (ADMS), have entered into a settlement agreement with Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York, LLC. The settlement relates to a patent infringement litigation brought by Forest and Adamas in response to Amneal's abbreviated new drug application (ANDA) seeking approval to market generic versions of Allergan's NAMZARIC® (memantine and donepezil hydrochlorides) extended-release, a once-daily, fixed-dose combination of memantine hydrochloride (a NMDA receptor antagonist) and donepezil hydrochloride (an acetylcholinesterase inhibitor, AChEI)."
AGN,AGN:US,BBG000FH8PX5,Ultimate Stock-Pickers: Top 10 Buys and Sells,2016-08-31 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=764378&SR=Yahoo,Ultimate Stock-Pickers: Top 10 Buys and Sells
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas Announce Settlement With Amneal On NAMZARIC Patent Litigation",2016-08-31 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4O3bkZeW9wI/allergan-adamas-announce-settlement-with-amneal-on-namzaric-patent-litigation-20160831-00320,"Allergan, Adamas Announce Settlement With Amneal On NAMZARIC Patent Litigation"
AGN,AGN:US,BBG000FH8PX5,"Allergan, Adamas Announce Settlement With Amneal On NAMZARIC Patent Litigation",2016-08-31 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jY4LPXh4q4/allergan-adamas-announce-settlement-with-amneal-on-namzaric-patent-litigation-20160831-00322,"Allergan, Adamas Announce Settlement With Amneal On NAMZARIC Patent Litigation"
AGN,AGN:US,BBG000FH8PX5,U.S. Chamber of Commerce Files Suit Over Anti-Inversion Regs,2016-08-30 16:38:00 +0000,http://www.forbes.com/sites/taxanalysts/2016/08/30/u-s-chamber-of-commerce-files-suit-over-anti-inversion-regs/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,U.S. Chamber of Commerce Files Suit Over Anti-Inversion Regs
AGN,AGN:US,BBG000FH8PX5,Allergan’s US General Medicine Segment Performance in 2Q16,2016-08-30 15:04:32 +0000,http://marketrealist.com/2016/08/allergans-us-general-medicine-segment-performance-in-2q16/?utm_source=yahoo&utm_medium=feed,Allergan’s US General Medicine Segment Performance in 2Q16
AGN,AGN:US,BBG000FH8PX5,Allergan’s US Specialized Therapeutics Key to Future Growth,2016-08-30 14:04:32 +0000,http://marketrealist.com/2016/08/allergans-us-specialized-therapeutics-key-to-future-growth/?utm_source=yahoo&utm_medium=feed,Allergan’s US Specialized Therapeutics Key to Future Growth
AGN,AGN:US,BBG000FH8PX5,Understanding Allergan’s Revenue Stream in 2Q16,2016-08-30 12:04:33 +0000,http://marketrealist.com/2016/08/understanding-allergans-revenue-stream-in-2q16/?utm_source=yahoo&utm_medium=feed,Understanding Allergan’s Revenue Stream in 2Q16
AGN,AGN:US,BBG000FH8PX5,Allergan: An Undervalued Powerhouse,2016-08-30 11:09:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l1OkyBJYFLc/allergan-an-undervalued-powerhouse-cm671557,"Allergan ( AGN ) is one of the largest pharmaceutical powerhouses, operating in many areas including eye care, facial aesthetics, plastic surgery, skin care and neuroscience and urology. Allergan's history is quite interesting as the"
AGN,AGN:US,BBG000FH8PX5,Your Complete Guide to the Generic Drug Industry,2016-08-29 23:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PYxkSVeu3VI/your-complete-guide-to-the-generic-drug-industry-cm671899,"On Monday, embattled drugmaker Mylan NV MYL announced that it will launch a generic version of the EpiPen at a 50% discount to the branded version as the company continues to respond to widespread criticism surrounding the"
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for Apple, Allergan & Occidental Petroleum",2016-08-29 18:12:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cWfRSXLk3U/top-research-reports-for-apple-allergan-occidental-petroleum-cm671776,"Monday, August 29, 2016  Today's Research Daily features 16 fresh analyst reports on major stocks, including Allergan (AGN), Occidental Petroleum (OXY) and Apple (AAPL). These research reports have been hand picked from the roughly 75 research"
AGN,AGN:US,BBG000FH8PX5,S&P 500 Analyst Moves: AGN,2016-08-29 17:07:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ubPuaobBRMg/sp-500-analyst-moves-agn-cm671738,"The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Allergan is now the #75 analyst pick, moving up by"
AGN,AGN:US,BBG000FH8PX5,Mondelez Walks Away After Hershey Spurns Raised Bid,2016-08-29 16:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mwbCskVkyEw/mondelez-walks-away-after-hershey-spurns-raised-bid-20160829-00815,Mondelez Walks Away After Hershey Spurns Raised Bid
AGN,AGN:US,BBG000FH8PX5,Five Healthcare Stocks Hedge Funds Like,2016-08-29 16:53:26 +0000,http://www.insidermonkey.com/blog/five-healthcare-stocks-hedge-funds-like-471117/,Five Healthcare Stocks Hedge Funds Like
AGN,AGN:US,BBG000FH8PX5,A Look at Allergan’s Growth Pharma Model,2016-08-29 15:05:07 +0000,http://marketrealist.com/2016/08/a-look-at-allergans-growth-pharma-model/?utm_source=yahoo&utm_medium=feed,A Look at Allergan’s Growth Pharma Model
AGN,AGN:US,BBG000FH8PX5,"Top Research Reports for Apple, Allergan & Occidental Petroleum",2016-08-29 14:49:02 +0000,http://finance.yahoo.com/news/top-research-reports-apple-allergan-144902960.html,"Top Research Reports for Apple, Allergan & Occidental Petroleum"
AGN,AGN:US,BBG000FH8PX5,How Allergan Is Still Benefiting from Actavis Deal,2016-08-29 14:05:26 +0000,http://marketrealist.com/2016/08/how-allergan-is-still-benefiting-from-actavis-deal/?utm_source=yahoo&utm_medium=feed,How Allergan Is Still Benefiting from Actavis Deal
AGN,AGN:US,BBG000FH8PX5,Is Allergan’s Valuation High Compared to Its Peers?,2016-08-29 12:03:36 +0000,http://marketrealist.com/2016/08/is-allergans-valuation-high-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,Is Allergan’s Valuation High Compared to Its Peers?
AGN,AGN:US,BBG000FH8PX5,Allergan Still Undervalued,2016-08-29 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=767174&SR=Yahoo,Allergan Still Undervalued
AGN,AGN:US,BBG000FH8PX5,Allergan: An Undervalued Powerhouse,2016-08-28 19:01:07 +0000,http://finance.yahoo.com/news/allergan-undervalued-powerhouse-190107007.html,Allergan: An Undervalued Powerhouse
AGN,AGN:US,BBG000FH8PX5,Here Are All The Big Biotech Mergers In 2016,2016-08-27 22:36:10 +0000,http://finance.yahoo.com/news/big-biotech-mergers-2016-223610312.html,Here Are All The Big Biotech Mergers In 2016
AGN,AGN:US,BBG000FH8PX5,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan",2016-08-27 08:17:36 +0000,http://www.insidermonkey.com/blog/billionaire-john-paulsons-favorite-healthcare-stocks-include-the-latest-industry-punching-bag-mylan-470472/,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan"
AGN,AGN:US,BBG000FH8PX5,FTC spells out new concerns over generic drug mergers,2016-08-26 20:49:00 +0000,https://www.thestreet.com/story/13686671/1/ftc-spells-out-new-concerns-over-generic-drug-mergers.html?puc=yahoo&cm_ven=YAHOO,FTC spells out new concerns over generic drug mergers
AGN,AGN:US,BBG000FH8PX5,FTC Details Concerns on Generic Drug Company Mergers,2016-08-26 16:02:00 +0000,https://www.thestreet.com/story/13686819/1/ftc-details-concerns-on-generic-drug-company-mergers.html?puc=yahoo&cm_ven=YAHOO,FTC Details Concerns on Generic Drug Company Mergers
AGN,AGN:US,BBG000FH8PX5,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time,2016-08-26 15:46:45 +0000,http://www.cnbc.com/id/103895913?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103895913,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time
AGN,AGN:US,BBG000FH8PX5,"ETF’s with exposure to Allergan Plc : August 26, 2016",2016-08-26 14:15:39 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-allergan-plc-august-26-2016/,"ETF’s with exposure to Allergan Plc : August 26, 2016"
AGN,AGN:US,BBG000FH8PX5,Elliott Management Added Allergan in 2Q16,2016-08-25 23:04:10 +0000,http://marketrealist.com/2016/08/elliott-management-corp-added-allergan-largest-buys-2q16/?utm_source=yahoo&utm_medium=feed,Elliott Management Added Allergan in 2Q16
AGN,AGN:US,BBG000FH8PX5,Markets Right Now: Health care pulls stocks lower again,2016-08-25 20:09:47 +0000,http://sg.finance.yahoo.com/news/markets-now-stocks-slightly-lower-141955409.html,Markets Right Now: Health care pulls stocks lower again
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical Industries Ltd -- Moody's: Teva's Loss of Two Copaxone Patents is Credit Negative,2016-08-25 18:33:02 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_354148&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20160825_PR_354148,Teva Pharmaceutical Industries Ltd -- Moody's: Teva's Loss of Two Copaxone Patents is Credit Negative
AGN,AGN:US,BBG000FH8PX5,"Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out",2016-08-25 17:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/25/specialty-pharma-never-mind-the-pricing-controversy-fundamentals-will-win-out/?mod=yahoobarrons&ru=yahoo,"Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out"
AGN,AGN:US,BBG000FH8PX5,AstraZeneca’s Recent Product Developments,2016-08-25 15:04:05 +0000,http://marketrealist.com/2016/08/astrazenecas-recent-product-developments/?utm_source=yahoo&utm_medium=feed,AstraZeneca’s Recent Product Developments
AGN,AGN:US,BBG000FH8PX5,"Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3",2016-08-25 13:30:16 +0000,http://www.insidermonkey.com/blog/allergan-humana-biogen-billionaires-favorite-healthcare-stocks-for-q3-470339/,"Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3"
AGN,AGN:US,BBG000FH8PX5,"Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016",2016-08-25 12:06:31 +0000,http://www.capitalcube.com/blog/index.php/allergan-plc-breached-its-50-day-moving-average-in-a-bearish-manner-agn-us-august-25-2016/,"Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016"
AGN,AGN:US,BBG000FH8PX5,Asian shares waver in thin trading after Wall Street decline,2016-08-25 02:58:52 +0000,http://sg.finance.yahoo.com/news/stocks-edge-lower-mining-materials-142723451.html,Asian shares waver in thin trading after Wall Street decline
AGN,AGN:US,BBG000FH8PX5,Which Criteria Best Determine the Success of Mergers?,2016-08-25 00:41:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1oCpLErAors/which-criteria-best-determine-the-success-of-mergers-cm669847,"Throughout the past three months, several mergers, including the $14 billion merger between Pfizer Inc. ( PFE ) and Medivation Inc. ( MDVN ), were announced. In part one of our study , we discussed how the"
AGN,AGN:US,BBG000FH8PX5,"PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business",2016-08-24 22:46:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0ZfP6ogCvA/pfe-azn-pfizer-inc-to-buy-astrazeneca-plc-adrs-antibiotic-business-cm669799,Pfizer Inc. (NYSE  PFE ) has announced that it will be acquiring part of  AstraZeneca plc (ADR)'s (NYSE  AZN ) antibiotic business.
AGN,AGN:US,BBG000FH8PX5,Cempra's Application for Pneumonia Drug Validated in EU,2016-08-24 22:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B2tySEc7D2s/cempras-application-for-pneumonia-drug-validated-in-eu-cm669809,"Cempra, Inc . CEMP announced that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for the oral capsule and intravenous (IV) formulations of pipeline candidate solithromycin, for the treatment of community acquired bacterial"
AGN,AGN:US,BBG000FH8PX5,"Dear Pfizer, Stop Overpaying for Acquisitions!",2016-08-24 21:45:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GOUg-HeNGsg/dear-pfizer-stop-overpaying-for-acquisitions-cm669797,"Image source  Getty Images.  If you've ever taken the time to sit down and listen to one of Pfizer 's(NYSE  PFE) quarterly conference calls or investor day updates, you'll catch many of"
AGN,AGN:US,BBG000FH8PX5,Business Highlights,2016-08-24 21:24:40 +0000,http://sg.finance.yahoo.com/news/business-highlights-212440159.html,Business Highlights
AGN,AGN:US,BBG000FH8PX5,Pfizer on buying spree with AstraZeneca antibiotics deal,2016-08-24 21:11:59 +0000,http://sg.finance.yahoo.com/news/pfizer-buying-spree-astrazeneca-antibiotics-175437812.html,Pfizer on buying spree with AstraZeneca antibiotics deal
AGN,AGN:US,BBG000FH8PX5,Top 5 Shareholders of Allergan (AGN),2016-08-24 16:00:00 +0000,http://www.investopedia.com/articles/insights/082416/top-5-shareholders-allergan-agn.asp?partner=YahooSA,Top 5 Shareholders of Allergan (AGN)
AGN,AGN:US,BBG000FH8PX5,Performance of AstraZeneca’s RI&A Segment in 2Q16,2016-08-24 15:04:05 +0000,http://marketrealist.com/2016/08/performance-astrazenecas-ria-segment-2q16/?utm_source=yahoo&utm_medium=feed,Performance of AstraZeneca’s RI&A Segment in 2Q16
AGN,AGN:US,BBG000FH8PX5,David Einhorn Cashed Out of These 9 Stocks,2016-08-24 14:43:00 +0000,https://www.thestreet.com/story/13464969/1/david-einhorn-cashed-out-of-these-6-stocks.html?puc=yahoo&cm_ven=YAHOO,David Einhorn Cashed Out of These 9 Stocks
AGN,AGN:US,BBG000FH8PX5,Stocks edge lower as mining and materials companies slip,2016-08-24 14:27:23 +0000,http://finance.yahoo.com/news/stocks-edge-lower-mining-materials-142723779.html,Stocks edge lower as mining and materials companies slip
AGN,AGN:US,BBG000FH8PX5,"Apple, McDonald’s, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2",2016-08-24 13:00:22 +0000,http://www.insidermonkey.com/blog/apple-mcdonalds-yahoo-5-stocks-hedge-funds-were-getting-rid-of-during-q2-470315/,"Apple, McDonald’s, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2"
AGN,AGN:US,BBG000FH8PX5,Pfizer Picks Up AstraZeneca's Antibiotics Business,2016-08-24 11:01:00 +0000,https://www.thestreet.com/story/13683495/1/pfizer-picks-up-astrazeneca-s-antibiotics-business.html?puc=yahoo&cm_ven=YAHOO,Pfizer Picks Up AstraZeneca's Antibiotics Business
AGN,AGN:US,BBG000FH8PX5,AstraZeneca Sells Part of its Antibiotics Business to Pfizer,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y7m0aXZPEWg/astrazeneca-sells-part-of-its-antibiotics-business-to-pfizer-20160824-00062,AstraZeneca Sells Part of its Antibiotics Business to Pfizer
AGN,AGN:US,BBG000FH8PX5,Pfizer Buys Part of AstraZeneca's Antibiotics Business,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VzprFIAXXwk/pfizer-buys-part-of-astrazenecas-antibiotics-business-20160824-00076,Pfizer Buys Part of AstraZeneca's Antibiotics Business
AGN,AGN:US,BBG000FH8PX5,Pfizer Buys Part of AstraZeneca''s Antibiotics Business,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjyXaj3rYnY/pfizer-buys-part-of-astrazenecas-antibiotics-business-20160824-00075,Pfizer Buys Part of AstraZeneca''s Antibiotics Business
AGN,AGN:US,BBG000FH8PX5,3 Stocks Billionaires Are Buying,2016-08-24 01:43:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p4x2-mv3tkw/3-stocks-billionaires-are-buying-cm669291,"Image source  The Motley Fool.  Billionaire investors Warren Buffett, George Soros, and Carl Icahn may not be on your speed dial, but you can still find out what stocks they've been buying. That's"
AGN,AGN:US,BBG000FH8PX5,3 Stocks Billionaires Are Buying,2016-08-23 23:41:00 +0000,http://www.fool.com/investing/2016/08/23/3-stocks-billionaires-are-buying.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Stocks Billionaires Are Buying
AGN,AGN:US,BBG000FH8PX5,Blog Coverage Valeant Pharma Appoints New CEO,2016-08-23 13:20:47 +0000,http://news.investornetwork.com/2016/08/23/blog-coverage-valeant-pharma-appoints-new-ceo/?1=1&1471958447,Blog Coverage Valeant Pharma Appoints New CEO
AGN,AGN:US,BBG000FH8PX5,Pfizer Has Had A Busy M&A Year...Or Has It?,2016-08-23 12:58:07 +0000,http://finance.yahoo.com/news/pfizer-had-busy-m-125807635.html,Pfizer Has Had A Busy M&A Year...Or Has It?
AGN,AGN:US,BBG000FH8PX5,13F Filings: Thumbs Up Or Thumbs Down For Gladiators?,2016-08-22 22:32:00 +0000,http://www.forbes.com/sites/martinsosnoff/2016/08/22/13f-filings-thumbs-up-or-thumbs-down-for-gladiators/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,13F Filings: Thumbs Up Or Thumbs Down For Gladiators?
AGN,AGN:US,BBG000FH8PX5,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise",2016-08-22 20:05:36 +0000,http://www.investors.com/news/technology/valeant-stock-up-on-cfo-appointment-as-ma-hopes-rise/,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise"
AGN,AGN:US,BBG000FH8PX5,7 Intriguing Healthcare Growth Stocks In The S&P 500: Part 2,2016-08-22 17:46:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1a_0IgdyM7g/7-intriguing-healthcare-growth-stocks-in-the-sp-500-part-2-cm664304,"By Chuck Carnevale Introduction The S&P 500 index is commonly used as a benchmark that investors use to measure the performance of their individual portfolios against. However, the S&P 500 is comprised of a very diverse group of companies."
AGN,AGN:US,BBG000FH8PX5,[$$] Pfizer makes $14bn bet on cancer drugmaker Medivation,2016-08-22 17:24:11 +0000,"http://www.ft.com/cms/s/2a6693de-687f-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Pfizer unveiled its biggest takeover of a cancer company in its 167-year history on Monday - the $14bn acquisition of Californian biotech Medivation - following a hotly-contested auction of the sought-after ...
AGN,AGN:US,BBG000FH8PX5,Carl Icahn Buys Allergan,2016-08-22 16:48:56 +0000,http://finance.yahoo.com/news/carl-icahn-buys-allergan-164856508.html,Carl Icahn Buys Allergan
AGN,AGN:US,BBG000FH8PX5,"XLV, MDT, ABBV, AGN: ETF Inflow Alert",2016-08-22 16:45:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/afpba-l7Pg8/xlv-mdt-abbv-agn-etf-inflow-alert-cm668490,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the Health Care Select Sector SPDR Fund (Symbol XLV) where we have detected an approximate $52.1 million"
AGN,AGN:US,BBG000FH8PX5,Allergan Makes an Eye-Opening Acquisition,2016-08-22 15:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AQD8b83dmDU/allergan-makes-an-eye-opening-acquisition-cm668466,"Image source  Getty Images.  Global pharmaceutical company Allergan (NYSE  AGN) may have just revealed its plans for the future. On Aug. 11, the company announced its plan to acquire ForSight Vision5, a"
AGN,AGN:US,BBG000FH8PX5,Pfizer spends $14B on Medivation in cancer fight,2016-08-22 15:46:45 +0000,http://sg.finance.yahoo.com/news/pfizer-buying-medivation-deal-valued-110146084.html,Pfizer spends $14B on Medivation in cancer fight
AGN,AGN:US,BBG000FH8PX5,Teva Pharmaceutical: A Successful Bond Financing Program in 2016,2016-08-22 15:04:55 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-managed-complete-successful-bond-financing-program-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical: A Successful Bond Financing Program in 2016
AGN,AGN:US,BBG000FH8PX5,Allergan Makes an Eye-Opening Acquisition,2016-08-22 14:05:00 +0000,http://www.fool.com/investing/2016/08/22/allergan-makes-an-eye-opening-acquisition.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Allergan Makes an Eye-Opening Acquisition
AGN,AGN:US,BBG000FH8PX5,How Did Bristol-Myers Squibb’s Oncology Segment Perform in 2Q16?,2016-08-22 13:06:27 +0000,http://marketrealist.com/2016/08/how-did-bristol-myers-squibbs-oncology-segment-perform-in-2q16/?utm_source=yahoo&utm_medium=feed,How Did Bristol-Myers Squibb’s Oncology Segment Perform in 2Q16?
AGN,AGN:US,BBG000FH8PX5,EU mergers and takeovers (Aug 22),2016-08-22 10:53:14 +0000,http://uk.finance.yahoo.com/news/eu-mergers-takeovers-aug-22-105314377.html,[Reuters - UK Focus] - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- British industrial property developer Segro and Canada's Public ...
AGN,AGN:US,BBG000FH8PX5,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KihbsWcp3RM/pfizer-adds-key-cancer-drug-in-14-billion-biotech-deal-20160822-00298,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal
AGN,AGN:US,BBG000FH8PX5,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oxs4TbrNtn8/pfizer-adds-key-cancer-drug-in-14-billion-biotech-deal-20160822-00297,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal
AGN,AGN:US,BBG000FH8PX5,Pfizer Adds Key Drug for Cancer in $14 Billion Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TAn5fmFfuxI/pfizer-adds-key-drug-for-cancer-in-14-billion-deal-20160822-00434,Pfizer Adds Key Drug for Cancer in $14 Billion Deal
AGN,AGN:US,BBG000FH8PX5,Valeant Names Zoetis Executive as CFO,2016-08-22 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lpz4ut4DILM/valeant-names-zoetis-executive-as-cfo-20160822-00098,Valeant Names Zoetis Executive as CFO
AGN,AGN:US,BBG000FH8PX5,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation,2016-08-22 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9dklLZSptco/pfizer-reportedly-nears-14-bln-deal-to-acquire-medivation-20160822-00012,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation
AGN,AGN:US,BBG000FH8PX5,[$$] Pfizer nears $14bn takeover of Medivation,2016-08-21 22:15:17 +0000,"http://www.ft.com/cms/s/0b556924-67e5-11e6-a0b1-d87a9fea034f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Pfizer is nearing a deal worth about $14bn to acquire California biotechnology company Medivation, beating out a handful of its biggest rivals to win the auction for the sought-after cancer drugmaker. ..."
AGN,AGN:US,BBG000FH8PX5,Pfizer Nears Agreement to Buy Medivation,2016-08-21 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Gi_gLh3HiU/pfizer-nears-agreement-to-buy-medivation-20160821-00050,Pfizer Nears Agreement to Buy Medivation
AGN,AGN:US,BBG000FH8PX5,Valeant Hiring Paul Herendeen as New CFO,2016-08-21 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yeFyLSu3Lus/valeant-hiring-paul-herendeen-as-new-cfo-20160821-00049,Valeant Hiring Paul Herendeen as New CFO
AGN,AGN:US,BBG000FH8PX5,9 Stocks Smart Investors Put Their Money in Last Quarter,2016-08-20 12:34:00 +0000,https://www.thestreet.com/slideshow/13680539/1/9-stocks-smart-investors-put-their-money-in-last-quarter.html?puc=yahoo&cm_ven=YAHOO,9 Stocks Smart Investors Put Their Money in Last Quarter
AGN,AGN:US,BBG000FH8PX5,"Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)",2016-08-19 23:25:00 +0000,http://www.investopedia.com/news/big-selloff-pfizer-amid-merger-collapse-pfe-agn/?partner=YahooSA,"Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)"
AGN,AGN:US,BBG000FH8PX5,Actavis recalls diabetes drugs made by Durham-based Patheon,2016-08-19 20:40:11 +0000,http://www.bizjournals.com/triangle/news/2016/08/19/actavis-allergan-teva-durham-patheon-diabetes-drug.html?ana=yahoo,Actavis recalls diabetes drugs made by Durham-based Patheon
AGN,AGN:US,BBG000FH8PX5,Allergan Upgraded As New Product Launch Could Drive Botox Sales,2016-08-19 20:25:13 +0000,http://www.investors.com/news/technology/allergan-upgraded-as-new-product-launch-could-drive-botox-sales/,Allergan Upgraded As New Product Launch Could Drive Botox Sales
AGN,AGN:US,BBG000FH8PX5,Top stocks for hedge funds,2016-08-19 14:54:00 +0000,http://finance.yahoo.com/video/top-stocks-hedge-funds-145400897.html,Top stocks for hedge funds
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC",2016-08-19 14:33:00 +0000,https://www.thestreet.com/story/13680200/1/allergan-agn-stock-should-outperform-analyst-tells-cnbc.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC"
AGN,AGN:US,BBG000FH8PX5,"Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More",2016-08-19 12:55:15 +0000,http://247wallst.com/investing/2016/08/19/top-analyst-upgrades-and-downgrades-ak-steel-allergan-arcelormittal-symantec-teck-resources-us-steel-emerson-hormel-and-more/,"Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More"
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Stock Rises, Mizuho Upgrades to 'Buy'",2016-08-19 12:32:00 +0000,https://www.thestreet.com/story/13680109/1/allergan-agn-stock-rises-mizuho-upgrades-to-buy.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Rises, Mizuho Upgrades to 'Buy'"
AGN,AGN:US,BBG000FH8PX5,4 Stocks Carl Icahn Is Buying in 2016,2016-08-19 11:57:00 +0000,https://www.thestreet.com/story/13052615/1/3-stocks-carl-icahn-is-buying-in-2015.html?puc=yahoo&cm_ven=YAHOO,4 Stocks Carl Icahn Is Buying in 2016
AGN,AGN:US,BBG000FH8PX5,"Early movers: CXW, HIBB, DE, FL, EL, GPS, AMAT, ROST, VIAB, NKE & more",2016-08-19 11:56:35 +0000,http://www.cnbc.com/id/103880628?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103880628,"Early movers: CXW, HIBB, DE, FL, EL, GPS, AMAT, ROST, VIAB, NKE & more"
AGN,AGN:US,BBG000FH8PX5,These three stocks are working now: Pro,2016-08-19 11:41:00 +0000,http://finance.yahoo.com/video/three-stocks-working-now-pro-114100885.html,These three stocks are working now: Pro
AGN,AGN:US,BBG000FH8PX5,Allergan upgraded by Mizuho,2016-08-19 09:34:07 +0000,http://finance.yahoo.com/q/ud?s=AGN,Allergan upgraded by Mizuho
AGN,AGN:US,BBG000FH8PX5,7 Stocks the Smart Money Loves … Or Hates,2016-08-19 01:46:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUMqruO7DdM/7-stocks-the-smart-money-loves-or-hates-cm667460,"Every quarter, 45 days after the end of each quarter, big institutional money managers are required to disclose the stocks they bought or sold during"
AGN,AGN:US,BBG000FH8PX5,"Hedge Fund Confidence in Stocks Improves in Q2 (CHTR, MS)",2016-08-18 21:35:00 +0000,http://www.investopedia.com/news/hedge-fund-confidence-stocks-improves-q2-chtr-ms/?partner=YahooSA,"Hedge Fund Confidence in Stocks Improves in Q2 (CHTR, MS)"
AGN,AGN:US,BBG000FH8PX5,Allergan to Present at 2016 Wells Fargo Healthcare Conference,2016-08-18 12:00:00 +0000,http://finance.yahoo.com/news/allergan-present-2016-wells-fargo-120000894.html,"[PR Newswire] - DUBLIN, Aug. 18, 2016 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's CEO and President, will present at the 2016 Wells Fargo Healthcare Conference on Thursday, September 8, 2016 at 10:30 a.m. ET at the Westin Waterfront Hotel in Boston, MA. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: https://cc.talkpoint.com/well001/090716a_ae/?entity=47_N33Y4X5. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world."
AGN,AGN:US,BBG000FH8PX5,Billionaire Money Managers Sold off This Stock in the 2nd Quarter,2016-08-17 22:01:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fhDQckwW0oQ/billionaire-money-managers-sold-off-this-stock-in-the-2nd-quarter-cm666652,"Image source  Getty Images.  Ready or not, here come the 13F filings with the Securities and Exchange Commission.  Once every quarter institutional money managers with more than $100 million in qualifying assets"
AGN,AGN:US,BBG000FH8PX5,"Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter",2016-08-17 21:29:41 +0000,http://finance.yahoo.com/news/steve-mandel-buys-shire-axes-212941327.html,"Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter"
AGN,AGN:US,BBG000FH8PX5,"Allergan Features Prominently in Q2 2016 (AGN, PFE)",2016-08-17 21:10:00 +0000,http://www.investopedia.com/news/allergan-features-prominently-q2-2016-agn-pfe/?partner=YahooSA,"Allergan Features Prominently in Q2 2016 (AGN, PFE)"
AGN,AGN:US,BBG000FH8PX5,[$$] Four Picks for a Specialty Pharma Comeback,2016-08-17 20:21:00 +0000,http://www.barrons.com/articles/four-picks-for-a-specialty-pharma-comeback-1471465279?mod=yahoobarrons&ru=yahoo,[$$] Four Picks for a Specialty Pharma Comeback
AGN,AGN:US,BBG000FH8PX5,Big Changes At The Top of Passport Capital’s Portfolio As Yahoo (YHOO) Takes Top Spot,2016-08-17 18:58:18 +0000,http://www.insidermonkey.com/blog/big-changes-at-the-top-of-passport-capitals-portfolio-as-yahoo-yhoo-takes-top-spot-469428/,Big Changes At The Top of Passport Capital’s Portfolio As Yahoo (YHOO) Takes Top Spot
AGN,AGN:US,BBG000FH8PX5,Billionaire Money Managers Sold off This Stock in the 2nd Quarter,2016-08-17 16:03:00 +0000,http://www.fool.com/investing/2016/08/17/billionaire-money-managers-sold-off-this-stock-in.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,Billionaire Money Managers Sold off This Stock in the 2nd Quarter
AGN,AGN:US,BBG000FH8PX5,What Do Analysts Estimate for Merck?,2016-08-17 15:04:25 +0000,http://marketrealist.com/2016/08/what-do-analysts-estimate-for-merck/?utm_source=yahoo&utm_medium=feed,What Do Analysts Estimate for Merck?
AGN,AGN:US,BBG000FH8PX5,Is Valeant’s Xifaxan Resuming Growth?,2016-08-17 13:04:39 +0000,http://marketrealist.com/2016/08/is-valeants-xifaxan-resuming-growth/?utm_source=yahoo&utm_medium=feed,Is Valeant’s Xifaxan Resuming Growth?
AGN,AGN:US,BBG000FH8PX5,"For Value Investors, Arbiter Partners Knows How to Pick 'Em",2016-08-16 18:00:00 +0000,http://realmoney.thestreet.com/articles/08/16/2016/value-investors-arbiter-partners-knows-how-pick-em?puc=yahoo&cm_ven=YAHOO,"For Value Investors, Arbiter Partners Knows How to Pick 'Em"
AGN,AGN:US,BBG000FH8PX5,13F 2Q Wrap: Big Bets on Allergan; Buffett Buys Apple; Soros Sells Gold,2016-08-16 17:13:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/16/13f-2q-wrap-big-bets-on-allergan-buffett-buys-apple-soros-sells-gold/?mod=yahoobarrons&ru=yahoo,13F 2Q Wrap: Big Bets on Allergan; Buffett Buys Apple; Soros Sells Gold
AGN,AGN:US,BBG000FH8PX5,Will Allergan (AGN) Stock Be Helped as Icahn Makes New Bet on Shares?,2016-08-16 14:54:00 +0000,https://www.thestreet.com/story/13676615/1/will-allergan-agn-stock-be-helped-as-icahn-makes-new-bet-on-shares.html?puc=yahoo&cm_ven=YAHOO,Will Allergan (AGN) Stock Be Helped as Icahn Makes New Bet on Shares?
AGN,AGN:US,BBG000FH8PX5,Icahn Bets Big on Allergan; Trims PayPal Stake,2016-08-16 14:25:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/16/icahn-bets-big-on-allergan-trims-paypal-stake/?mod=yahoobarrons&ru=yahoo,Icahn Bets Big on Allergan; Trims PayPal Stake
AGN,AGN:US,BBG000FH8PX5,Credit Suisse Presents Bull And Bear Cases For Allergan,2016-08-16 14:01:06 +0000,http://finance.yahoo.com/news/credit-suisse-presents-bull-bear-140106141.html,Credit Suisse Presents Bull And Bear Cases For Allergan
AGN,AGN:US,BBG000FH8PX5,Icahn makes new bet on Allergan in Q2 -filing,2016-08-16 13:54:42 +0000,http://finance.yahoo.com/news/icahn-makes-bet-allergan-q2-135442811.html,Icahn makes new bet on Allergan in Q2 -filing
AGN,AGN:US,BBG000FH8PX5,"Activist Carl Icahn Takes Stakes in Allergan, Herc Holdings, Slashes PayPal Position",2016-08-16 13:33:23 +0000,http://www.insidermonkey.com/blog/activist-carl-icahn-takes-stakes-in-allergan-herc-holdings-slashes-paypal-position-469232/,"Activist Carl Icahn Takes Stakes in Allergan, Herc Holdings, Slashes PayPal Position"
AGN,AGN:US,BBG000FH8PX5,Allergan Sees Action on 13F Deadline Day,2016-08-15 21:52:00 +0000,http://realmoney.thestreet.com/articles/08/15/2016/allergan-sees-action-13f-deadline-day?puc=yahoo&cm_ven=YAHOO,Allergan Sees Action on 13F Deadline Day
AGN,AGN:US,BBG000FH8PX5,"Icahn makes new bet on Allergan, cuts Hertz in Q2 - filing",2016-08-15 20:39:16 +0000,http://finance.yahoo.com/news/icahn-makes-bet-allergan-cuts-203916237.html,"Icahn makes new bet on Allergan, cuts Hertz in Q2 - filing"
AGN,AGN:US,BBG000FH8PX5,Hedge funds made big changes at drug companies in 2nd qtr -filings,2016-08-15 20:25:30 +0000,http://finance.yahoo.com/news/hedge-funds-made-big-changes-202530271.html,Hedge funds made big changes at drug companies in 2nd qtr -filings
AGN,AGN:US,BBG000FH8PX5,"David Tepper Raises Bet on Allergan, Adds 2 New Positions in Latest Quarter",2016-08-15 20:05:18 +0000,http://finance.yahoo.com/news/david-tepper-raises-bet-allergan-200518605.html,"David Tepper Raises Bet on Allergan, Adds 2 New Positions in Latest Quarter"
AGN,AGN:US,BBG000FH8PX5,Why is Time (TIME) Stock Popping Today?,2016-08-15 19:35:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5zA1Xgcs6tE/why-is-time-time-stock-popping-today-cm665504,"On Monday, shares of magazine publisher Time Inc. TIME are popping, up over 6% in late morning trading after Jana Partners LLC, a New York based hedge fund, announced a new, 5 million share position in the media company."
AGN,AGN:US,BBG000FH8PX5,Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis,2016-08-15 17:05:26 +0000,http://247wallst.com/healthcare-business/2016/08/15/credit-suisse-issues-top-pharma-picks-in-bullbear-upside-analysis/,Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis
AGN,AGN:US,BBG000FH8PX5,Why Allergan is Fine Without Large M&A,2016-08-15 15:29:00 +0000,https://www.thestreet.com/story/13675009/1/why-allergan-is-fine-without-large-m-amp-a.html?puc=yahoo&cm_ven=YAHOO,Why Allergan is Fine Without Large M&A
AGN,AGN:US,BBG000FH8PX5,"Billionaire David Tepper’s Biggest Q2 Moves Involve Western Digital, Facebook & Others",2016-08-15 15:00:57 +0000,http://www.insidermonkey.com/blog/buying-wdc-selling-dal-among-david-teppers-biggest-q2-moves-469022/,"Billionaire David Tepper’s Biggest Q2 Moves Involve Western Digital, Facebook & Others"
AGN,AGN:US,BBG000FH8PX5,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline",2016-08-15 14:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J7m9W9nNbww/allergan-to-buy-forsight-vision5-boost-glaucoma-pipeline-cm665348,"Late last week, Allergan plcAGN announced that it will be acquiring a privately held, clinical stage biotechnology company focused on eye care. ForSight VISION5 will be acquired by Allergan for an upfront payment of $95 million as well as"
AGN,AGN:US,BBG000FH8PX5,Appaloosa's Tepper Boosts Allergan Stake; Exits Delta And Facebook,2016-08-15 13:42:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/15/appaloosas-tepper-boosts-allergan-stake-exits-delta-and-facebook/?mod=yahoobarrons&ru=yahoo,Appaloosa's Tepper Boosts Allergan Stake; Exits Delta And Facebook
AGN,AGN:US,BBG000FH8PX5,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline",2016-08-15 13:13:01 +0000,http://finance.yahoo.com/news/allergan-buy-forsight-vision5-boost-131301835.html,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline"
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Reports Q2 2016 Results,2016-08-15 11:21:06 +0000,http://www.publicnow.com/view/281C264B67E42E558A201418D794774079205445,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Aug. 15, 2016) -Asanko Gold Inc. ('Asanko' or the 'Company') (TSX:AKG)(NYSE MKT:AKG) reports its financial results for the three-month and six-month period ended ..."
AGN,AGN:US,BBG000FH8PX5,Healthcare Growth Stocks in the S&P 500: Part 2,2016-08-13 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ucyzi7AiXv4/healthcare-growth-stocks-in-the-sp-500-part-2-cm664985,"Introduction The S&P 500 index is commonly used as a benchmark that investors use to measure the performance of their individual portfolios against. However, the S&P 500 is comprised of a very diverse group of companies. Just about every"
AGN,AGN:US,BBG000FH8PX5,"Third Point Takes New Stakes in Facebook, Energy Firms",2016-08-12 21:44:58 +0000,http://blogs.wsj.com/moneybeat/2016/08/12/third-point-takes-new-stakes-in-facebook-energy-firms/?mod=yahoo_hs,"Third Point Takes New Stakes in Facebook, Energy Firms"
AGN,AGN:US,BBG000FH8PX5,"David Tepper Goes Big on Allergan, Shies From S&P",2016-08-12 21:01:11 +0000,http://blogs.wsj.com/moneybeat/2016/08/12/david-tepper-goes-big-on-allergan-shies-from-sp/?mod=yahoo_hs,"David Tepper Goes Big on Allergan, Shies From S&P"
AGN,AGN:US,BBG000FH8PX5,Valeant Pharmaceuticals (VRX) Stock: The Philidor Nightmare Isn’t Over,2016-08-12 20:24:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/shAS8OsO3yA/valeant-pharmaceuticals-vrx-stock-the-philidor-nightmare-isnt-over-cm664277,"The U.S. Attorney for the Southern District of New York, which often prosecutes Wall Street cases, has opened an investigation into Valeant Pharmaceuticals Intl Inc (NYSE VRX ). The topic Valeant's"
AGN,AGN:US,BBG000FH8PX5,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD",2016-08-12 01:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W4VOFMRrPOQ/avxs-walks-the-talk-agn-opens-wallet-zika-virus-data-lifts-aemd-20160812-00018,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD"
AGN,AGN:US,BBG000FH8PX5,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD",2016-08-12 01:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xR3cLWnXEIc/avxs-walks-the-talk-agn-opens-wallet-zika-virus-data-lifts-aemd-20160812-00017,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD"
AGN,AGN:US,BBG000FH8PX5,Five Healthcare Stocks Billionaires Are Bullish On,2016-08-11 23:14:23 +0000,http://www.insidermonkey.com/blog/five-healthcare-stocks-billionaires-are-bullish-on-459931/,Five Healthcare Stocks Billionaires Are Bullish On
AGN,AGN:US,BBG000FH8PX5,Healthcare Growth Stocks in the S&P 500: Part 2,2016-08-11 21:41:17 +0000,http://finance.yahoo.com/news/healthcare-growth-stocks-p-500-214117025.html,Healthcare Growth Stocks in the S&P 500: Part 2
AGN,AGN:US,BBG000FH8PX5,"ETF’s with exposure to Allergan Plc : August 11, 2016",2016-08-11 16:27:09 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-allergan-plc-august-11-2016/,"ETF’s with exposure to Allergan Plc : August 11, 2016"
AGN,AGN:US,BBG000FH8PX5,Allergan Bought Itself an Exciting Opportunity in ForSight,2016-08-11 15:30:00 +0000,http://realmoney.thestreet.com/articles/08/11/2016/allergan-bought-itself-exciting-opportunity-forsight?puc=yahoo&cm_ven=YAHOO,Allergan Bought Itself an Exciting Opportunity in ForSight
AGN,AGN:US,BBG000FH8PX5,"Glaucoma Treatment Maker a $95M ""Stepping Stone"" for Allergan",2016-08-11 15:16:00 +0000,https://www.thestreet.com/story/13672836/1/allergan-adds-glaucoma-treatment-maker-for-95m.html?puc=yahoo&cm_ven=YAHOO,"Glaucoma Treatment Maker a $95M ""Stepping Stone"" for Allergan"
AGN,AGN:US,BBG000FH8PX5,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox,2016-08-11 13:31:34 +0000,http://news.investornetwork.com/2016/08/11/post-earnings-coverage-as-allergan-tops-earnings-expectation-bolstered-by-botox/?1=1&1470922294,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox
AGN,AGN:US,BBG000FH8PX5,Allergan agrees to buy private biotech ForSight VISION5 for $95 mln,2016-08-11 12:16:38 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D0758B29-F2DD-4FF6-AB4D-D8A163007CD3&siteid=yhoof2,Allergan agrees to buy private biotech ForSight VISION5 for $95 mln
AGN,AGN:US,BBG000FH8PX5,Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio of Innovative Eye Health Products,2016-08-11 12:11:04 +0000,http://www.publicnow.com/view/67C5A7D1ECB3108B6C46385A3D187ACC85806A3B,"[at noodls] - DUBLIN and MENLO PARK, Calif., Aug. 11, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and ForSight VISION5, a privately held, clinical-stage biotechnology company ..."
AGN,AGN:US,BBG000FH8PX5,Biogen Inc: BIIB Stock Is a Biotech Standout,2016-08-10 21:52:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/41EDlQGg5QQ/biogen-inc-biib-stock-is-a-biotech-standout-cm663695,"There's no question that the biotechnology industry has been under pressure since it peaked in July 2015. However, the  iShares Nasdaq Biotechnology Index (ETF) (NASDAQ"
AGN,AGN:US,BBG000FH8PX5,See Which Of The Latest 13F Filers Holds Allergan,2016-08-10 20:48:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cHPl9Ba9bYA/see-which-of-the-latest-13f-filers-holds-allergan-cm663668,"At Holdings Channel , we have reviewed the latest batch of the 25 most recent 13F filings for the 06 30 2016 reporting period, and noticed that Allergan PLC (Symbol AGN) was held by 11 of these funds. When"
AGN,AGN:US,BBG000FH8PX5,"Dow going to 20,000?",2016-08-10 18:42:00 +0000,http://finance.yahoo.com/video/dow-going-20-000-184200951.html,"Dow going to 20,000?"
AGN,AGN:US,BBG000FH8PX5,"Stock Market News for August 10, 2016",2016-08-10 16:54:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YkY2E8UcFbg/stock-market-news-for-august-10-2016-cm663526,Benchmarks closed narrowly in the green as drop in oil prices and disappointing productivity data offset some of the gains in healthcare and consumer staples stocks. Strong gains in Endo International following encouraging earnings results boosted the healthcare sector.
AGN,AGN:US,BBG000FH8PX5,"Allergan Mandatory Convertible Preferred Shares, Series A About To Put More Money In Your Pocket",2016-08-09 19:32:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G-YMCORfv-Y/allergan-mandatory-convertible-preferred-shares-series-a-about-to-put-more-money-in-your-pocket-cm662729,"On 8 11 16, Allergan PLC's 5.500% Mandatory Convertible Preferred Shares, Series A (Symbol AGN.PRA) will trade ex dividend, for its quarterly dividend of $13.75, payable on 9 1 16. As a percentage of AGN.PRA's recent share price of"
AGN,AGN:US,BBG000FH8PX5,"Stock Market News for August 09, 2016",2016-08-09 16:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZG-8sKAiAGM/stock-market-news-for-august-09-2016-cm662605,"Despite strong crude rally, major benchmarks closed in the red on Monday on the back of declines in healthcare stocks. Declines in healthcare giants like Bristol Myers and Merck offset gains in energy stocks on the back of rising"
AGN,AGN:US,BBG000FH8PX5,"Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks",2016-08-09 03:16:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E-LjSVn79-Y/why-allergan-plc-ordinary-shares-agn-amn-healthcare-services-inc-ahs-and-bristol-myers-squibb-co-bmy-are-3-of-todays-worst-stocks-cm662187,The bulls certainly didn't start the new trading week on the same bullish foot they left last week on. With nothing inspirational to cue another
AGN,AGN:US,BBG000FH8PX5,"Botox Maker Allergan's Revenue Climbs, but Loss More Than Doubles -- WSJ",2016-08-09 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U5oYaEg-IAo/botox-maker-allergans-revenue-climbs-but-loss-more-than-doubles--wsj-20160809-00036,"Botox Maker Allergan's Revenue Climbs, but Loss More Than Doubles -- WSJ"
AGN,AGN:US,BBG000FH8PX5,Allergan reports 2Q loss,2016-08-08 21:45:08 +0000,http://au.finance.yahoo.com/news/allergan-reports-2q-loss-214508160.html,[AAP] - Allergan PLC has reported a loss of $US501.7 million ($A655.86 million) in its second quarter. The Dublin-based company said it had a loss of $US1.44 per share. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $US3.28 per share.
AGN,AGN:US,BBG000FH8PX5,Close Update: Rally Loses Steam as Healthcare Sector Weighs,2016-08-08 21:11:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bMq6H1zJaE4/close-update-rally-loses-steam-as-healthcare-sector-weighs-cm662124,Stocks closed slightly lower on Monday when the rally associated with Friday's July labor market report showed signs of fatigue after the S&P 500 and Nasdaq Composite hit record highs soon after the open. Healthcare stocks bore the brunt
AGN,AGN:US,BBG000FH8PX5,"Mattress Firm, Sotheby's, Horizon Pharma rise",2016-08-08 20:46:03 +0000,http://sg.finance.yahoo.com/news/mattress-firm-sothebys-horizon-pharma-204603539.html,"Mattress Firm, Sotheby's, Horizon Pharma rise"
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall Street takes tiny step back from record highs,2016-08-08 20:25:24 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-street-takes-202524668.html,US STOCKS-Wall Street takes tiny step back from record highs
AGN,AGN:US,BBG000FH8PX5,Markets Right Now: Stocks closing lower on Wall Street,2016-08-08 20:09:33 +0000,http://sg.finance.yahoo.com/news/markets-now-stocks-opening-higher-134348442.html,Markets Right Now: Stocks closing lower on Wall Street
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall Street steps back from record highs,2016-08-08 18:49:04 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-street-steps-184904307.html,US STOCKS-Wall Street steps back from record highs
AGN,AGN:US,BBG000FH8PX5,"Allergan (AGN) Tops Q2 Earnings, Revises '16 Outlook",2016-08-08 18:12:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MDHBxdiRxEk/allergan-agn-tops-q2-earnings-revises-16-outlook-cm661985,"Allergan plc 's AGN second quarter 2016 earnings came in at $3.35 per share, easily surpassing the Zacks Consensus Estimate of $3.28. Though up 12% sequentially, reported earnings were down 8.7% from the year ago period. Allergan Inc. (AGN)"
AGN,AGN:US,BBG000FH8PX5,"S&P 500 Movers: AGN, FCX",2016-08-08 16:16:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPtZz075uCg/sp-500-movers-agn-fcx-cm661856,"In early trading on Monday, shares of Freeport McMoran Copper & Gold ( FCX ) topped the list of the day's best performing components of the S&P 500 index, trading up 3.4%. Year to date, Freeport McMoran Copper &"
AGN,AGN:US,BBG000FH8PX5,"Noteworthy ETF Outflows: OEF, GILD, AGN, CELG",2016-08-08 16:12:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcp1-rs6D9I/noteworthy-etf-outflows-oef-gild-agn-celg-cm661850,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares S&P 100 ETF (Symbol OEF) where we have detected an approximate $28.9 million dollar outflow"
AGN,AGN:US,BBG000FH8PX5,"Allergan Revenue Increases, Though Loss Widens--Update",2016-08-08 14:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y6ocCRVqxMA/allergan-revenue-increases-though-loss-widensupdate-20160808-00757,"Allergan Revenue Increases, Though Loss Widens--Update"
AGN,AGN:US,BBG000FH8PX5,"Health Care Sector Update for 08/08/2016: JNJ, PFE, ABT, MRK, AMGN",2016-08-08 14:28:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s8C1pQmbjRM/health-care-sector-update-for-08082016-jnj-pfe-abt-mrk-amgn-cm661766,"Top Health care stocks AMGN +0.2% ABT 0.4% JNJ 0.6% PFE 1.5% MRK 2.1% Health care shares were mostly lower in pre market trade Monday. In health care stocks news, Allergan ( AGN ) reported Q2 EPS of $3.35"
AGN,AGN:US,BBG000FH8PX5,Allergan reports 2Q loss,2016-08-08 13:53:05 +0000,http://sg.finance.yahoo.com/news/allergan-reports-2q-loss-111749289.html,Allergan reports 2Q loss
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion,2016-08-08 11:28:07 +0000,http://www.publicnow.com/view/E688184A93865052FBFCC01EACA606D8AA7189F3,"[at noodls] - DUBLIN, Aug. 8, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its second quarter 2016 continuing operations performance. ... This is an abstract of the original noodl. To continue reading ..."
AGN,AGN:US,BBG000FH8PX5,Progressing Near-Mine Satellite Targets Towards Production in 2017,2016-08-08 11:28:06 +0000,http://www.publicnow.com/view/14457FF50050B91F05263CE9AF6CD83D40DE71C6,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - Aug. 8, 2016) - Highlights: Currently evaluating three near surface exploration targets within short trucking distance of existing processing plant: Nkran Extension, ..."
AGN,AGN:US,BBG000FH8PX5,Stocks Giving Back Ground In Early Trading - U.S. Commentary,2016-08-08 10:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M9g_1C7xCN8/stocks-giving-back-ground-in-early-trading--us-commentary-20160808-00586,Stocks Giving Back Ground In Early Trading - U.S. Commentary
AGN,AGN:US,BBG000FH8PX5,Allergan Inc. (AGN) Is Losing Ground After Q2 Revenues Disappoint,2016-08-08 09:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s84x29981tI/allergan-inc-agn-is-losing-ground-after-q2-revenues-disappoint-20160808-00551,Allergan Inc. (AGN) Is Losing Ground After Q2 Revenues Disappoint
AGN,AGN:US,BBG000FH8PX5,"Allergan Revenue Increases, Though Loss Widens",2016-08-08 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8l0xeZ_HrgQ/allergan-revenue-increases-though-loss-widens-20160808-00413,"Allergan Revenue Increases, Though Loss Widens"
AGN,AGN:US,BBG000FH8PX5,Allergan Q2 16 Earnings Conference Call At 8:30 AM ET,2016-08-08 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S7MfEdLmXJ0/allergan-q2-16-earnings-conference-call-at-830-am-et-20160808-00116,Allergan Q2 16 Earnings Conference Call At 8:30 AM ET
AGN,AGN:US,BBG000FH8PX5,Allergan  Inc. Bottom Line Drops 8% In Q2,2016-08-08 07:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O8BDFa4zpdU/allergan--inc-bottom-line-drops-8-in-q2-20160808-00191,Allergan  Inc. Bottom Line Drops 8% In Q2
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Down Despite Surge in Energy Sector,2016-08-08 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8oPXTJwJ7vk/us-stocks-down-despite-surge-in-energy-sector-20160808-00796,U.S. Stocks Down Despite Surge in Energy Sector
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Slip But Energy Shares Gain,2016-08-08 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nXQwRFgfor0/us-stocks-slip-but-energy-shares-gain-20160808-00751,U.S. Stocks Slip But Energy Shares Gain
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Slip But Oil Shares Gain,2016-08-08 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fXx3tD_JsZ0/us-stocks-slip-but-oil-shares-gain-20160808-00674,U.S. Stocks Slip But Oil Shares Gain
AGN,AGN:US,BBG000FH8PX5,U.S. Stocks Slip Despite Surge in Energy Sector,2016-08-08 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLIOEmnOGD4/us-stocks-slip-despite-surge-in-energy-sector-20160808-01111,U.S. Stocks Slip Despite Surge in Energy Sector
AGN,AGN:US,BBG000FH8PX5,Allergan and Richter Provide Update on Cariprazine Program,2016-08-05 06:54:05 +0000,http://www.publicnow.com/view/821262E13B04B9265679F149AED5316234679E3D,"[at noodls] - DUBLIN, Ireland and BUDAPEST, Hungary, Aug. 5, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today provided a clinical and regulatory ..."
AGN,AGN:US,BBG000FH8PX5,Business groups sue over new U.S. limit on tax-driven foreign buyouts,2016-08-05 06:41:26 +0000,http://in.finance.yahoo.com/news/business-groups-sue-over-u-064126010.html,Business groups sue over new U.S. limit on tax-driven foreign buyouts
AGN,AGN:US,BBG000FH8PX5,Richter and Allergan Provide Update on Cariprazine Program,2016-08-05 06:14:06 +0000,http://www.publicnow.com/view/03E7AB33DAEBA3CAB28846AE2BB584BEABB49F0D,[at noodls] - ​Cariprazine was approved by the FDA in September 2015 and is marketed as VRAYLAR™ in the US for the treatment of manic or mixed episodes of Bipolar I Disorder and Schizophrenia in adults. ... This is ...
AGN,AGN:US,BBG000FH8PX5,Business Groups Sue Over Inversion Rules -- WSJ,2016-08-05 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vj_rLoAkdVQ/business-groups-sue-over-inversion-rules--wsj-20160805-00034,Business Groups Sue Over Inversion Rules -- WSJ
AGN,AGN:US,BBG000FH8PX5,Allergan Reports Results From MD-72 Adjunctive MDD Trial - Quick Facts,2016-08-05 02:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aSWe2iqoFlU/allergan-reports-results-from-md72-adjunctive-mdd-trial--quick-facts-20160805-00030,Allergan Reports Results From MD-72 Adjunctive MDD Trial - Quick Facts
AGN,AGN:US,BBG000FH8PX5,Teva Pharm eyes more acquisitions after buying Allergan's generics business,2016-08-04 14:40:35 +0000,http://sg.finance.yahoo.com/news/teva-pharma-focus-integrating-allergans-124534771.html,Teva Pharm eyes more acquisitions after buying Allergan's generics business
AGN,AGN:US,BBG000FH8PX5,Biogen not pursuing a sale - source,2016-08-03 18:55:10 +0000,http://in.finance.yahoo.com/news/biogen-not-pursuing-sale-source-185510909.html,Biogen not pursuing a sale - source
AGN,AGN:US,BBG000FH8PX5,Allergan to sell Anda drug distribution business to Teva,2016-08-03 14:07:08 +0000,http://sg.finance.yahoo.com/news/allergan-sell-anda-drug-distribution-140708189.html,Allergan to sell Anda drug distribution business to Teva
AGN,AGN:US,BBG000FH8PX5,Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceuticals,2016-08-03 11:22:02 +0000,http://www.publicnow.com/view/15B33D01136870083CC627AD98B4C5138043119C,"[at noodls] - DUBLIN, Aug. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a global pharmaceutical company, today announced that it has entered into a definitive agreement under which Teva Pharmaceutical Industries ..."
AGN,AGN:US,BBG000FH8PX5,"Biogen draws takeover interest from Merck, Allergan - WSJ",2016-08-02 22:12:44 +0000,http://sg.finance.yahoo.com/news/biogen-draws-takeover-interest-merck-221244544.html,"Biogen draws takeover interest from Merck, Allergan - WSJ"
AGN,AGN:US,BBG000FH8PX5,Teva completes $40 bn purchase of Allergan generics arm,2016-08-02 20:16:54 +0000,http://uk.finance.yahoo.com/news/teva-completes-40-bn-purchase-201654197.html,Teva completes $40 bn purchase of Allergan generics arm
AGN,AGN:US,BBG000FH8PX5,Allergan plc Completes Divestiture of Global Generics Business to Teva Pharmaceuticals,2016-08-02 17:11:03 +0000,http://www.publicnow.com/view/7B1095D385662E9A0A8128D59DE620ED31051ECB,"[at noodls] - DUBLIN, Aug. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries Ltd. ..."
AGN,AGN:US,BBG000FH8PX5,Pfizer beats Street 2Q forecasts despite big drop in profit,2016-08-02 17:02:35 +0000,http://sg.finance.yahoo.com/news/pfizer-beats-street-2q-forecasts-105923276.html,Pfizer beats Street 2Q forecasts despite big drop in profit
AGN,AGN:US,BBG000FH8PX5,"Teva, Allergan win U.S. antitrust approval for generics deal",2016-07-27 21:44:58 +0000,http://sg.finance.yahoo.com/news/teva-purchase-allergan-generics-business-185011607.html,"Teva, Allergan win U.S. antitrust approval for generics deal"
AGN,AGN:US,BBG000FH8PX5,Teva expect to close $40.5B Allergan generic deal next week,2016-07-27 20:31:33 +0000,http://sg.finance.yahoo.com/news/teva-expect-close-40-5b-203133173.html,Teva expect to close $40.5B Allergan generic deal next week
AGN,AGN:US,BBG000FH8PX5,Allergan Receives Positive Opinion For Truberzi® (Eluxadoline) For Treatment Of Irritable Bowel Syndrome With Diarrhoea (IBS-D) In Adults,2016-07-25 16:08:09 +0000,http://www.publicnow.com/view/F0BE0BFA713C4E950F75DF3AB0C5EE53D759C0AB,"[at noodls] - DUBLIN, July 25, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive ..."
AGN,AGN:US,BBG000FH8PX5,Judge refuses to block generic versions of AstraZeneca's Crestor,2016-07-19 23:00:39 +0000,http://sg.finance.yahoo.com/news/judge-refuses-block-generic-versions-230039489.html,Judge refuses to block generic versions of AstraZeneca's Crestor
AGN,AGN:US,BBG000FH8PX5,Allergan to Host Second Quarter 2016 Earnings Conference Call and Webcast,2016-07-12 12:33:06 +0000,http://www.publicnow.com/view/A79036B4022259DB82E58730E966E21CBDD98093,"[at noodls] - DUBLIN, July 12, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it intends to release second quarter 2016 financial results on Monday, August 8, 2016, prior to the open of the U.S. ..."
AGN,AGN:US,BBG000FH8PX5,Shire on a roll as U.S. approves keenly awaited eye drug,2016-07-12 12:19:04 +0000,http://sg.finance.yahoo.com/news/fda-approves-shires-keenly-watched-013647286.html,Shire on a roll as U.S. approves keenly awaited eye drug
AGN,AGN:US,BBG000FH8PX5,FDA approves Shire's keenly-watched eye drug,2016-07-12 01:34:05 +0000,http://uk.finance.yahoo.com/news/fda-approves-shires-keenly-watched-013405832.html,FDA approves Shire's keenly-watched eye drug
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Conference Call Details for Q2 2016 Production Results,2016-07-08 16:21:03 +0000,http://www.publicnow.com/view/A0C13D79E647F3106775DBD75B2A7CBDBB8490DF,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - July 8, 2016) -Asanko Gold Inc. ('Asanko' or the 'Company') (TSX:AKG)(NYSE MKT:AKG) will release its second quarter 2016 production results before the North American ..."
AGN,AGN:US,BBG000FH8PX5,"Annual General Meeting Vancouver, BC",2016-07-08 15:51:02 +0000,http://www.publicnow.com/view/DF88BC2C772731EE50A62ED36748CE34DF32E8F5,"[at noodls] - Annual General Meeting Vancouver, BC The text version of this document is not available at the moment. The original content was posted at original link . Asanko Gold Inc. published this content on 16 June ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Demonstrates a Strong Commitment to America's First Responders Donating Over $1 Million Worth of REFRESH® Eye Drops,2016-07-07 12:21:05 +0000,http://www.publicnow.com/view/A751AB427967FA9D27D32145276EBD4D4C335789,"[at noodls] - DUBLIN, July 7, 2016 /PRNewswire/ -- Allergan plc is pleased to announce that it is leading the effort to alleviate discomfort of dry eye symptoms for America's heroes and has exceeded its goal of donating ..."
AGN,AGN:US,BBG000FH8PX5,Allergan Receives Positive Opinion Through European Decentralised Procedure For BELKYRA® (Deoxycholic Acid) For Patients With Submental Fullness,2016-07-01 12:21:05 +0000,http://www.publicnow.com/view/FA7AD4DA3178A8C37221D7253FD6A89C8847F9F9,"[at noodls] - DUBLIN, July 1, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has received a Positive Opinion from the Swedish Medical Products Agency ..."
AGN,AGN:US,BBG000FH8PX5,Mayne Pharma buys Teva drugs for $US652m,2016-06-28 12:36:14 +0000,http://au.finance.yahoo.com/news/mayne-pharma-buys-teva-drugs-042108818.html,"[AAP] - Mayne Pharma is set to significantly expand its US presence through the $US652 million ($A889 million) acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne said the price excludes transaction costs and an extra investment of $A120 million needed for capital expenditure, technology transfer and working capital. ""The acquisition transforms Mayne Pharma's generic products division into a top 25 player in the US retail generics market, diversifying Mayne Pharma's earnings across a broad range of products, therapeutic areas and technologies,"" Mayne Pharma chief executive Scott Richards said on Tuesday."
AGN,AGN:US,BBG000FH8PX5,Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ® (ceftazidime and avibactam),2016-06-23 12:29:03 +0000,http://www.publicnow.com/view/331CF5FF942D9AAC7DA6161215C7461E7EAF12D5,"[at noodls] - DUBLIN, June 23, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental ..."
AGN,AGN:US,BBG000FH8PX5,"Data Presented at ASM Microbe Highlight In Vitro Antimicrobial Activity of AVYCAZ® (ceftazidime and avibactam) Against Several Species of Enterobacteriaceae Pathogens and Pseudomonas aeruginosa, Including Certain Resistant Strains",2016-06-20 13:09:08 +0000,http://www.publicnow.com/view/D82E8077D496D04BA4FBCD4A5303790803B3FA1D,"[at noodls] - DUBLIN, June 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to developing new treatment options for infectious diseases, today presented new data highlighting ..."
AGN,AGN:US,BBG000FH8PX5,Asanko Gold Results of Annual General Meeting,2016-06-17 12:19:39 +0000,http://www.publicnow.com/view/C15A0BCBA20FBF1318FDD41935C79F88A45C3EE4,"[at noodls] - VANCOUVER, BRITISH COLUMBIA-(Marketwired - June 17, 2016) -Asanko Gold Inc. ('Asanko' or the 'Company') (TSX:AKG)(NYSE MKT:AKG) announced that all the resolutions put to shareholders at the Company's annual ..."
AGN,AGN:US,BBG000FH8PX5,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan",2016-06-11 09:56:38 +0000,http://in.finance.yahoo.com/news/dr-reddys-buy-8-u-081954765.html,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan"
AGN,AGN:US,BBG000FH8PX5,Indivior wins patent ruling on Suboxone Film heroin substitute,2016-06-03 16:38:48 +0000,http://uk.finance.yahoo.com/news/indivior-wins-patent-ruling-suboxone-163848697.html,Indivior wins patent ruling on Suboxone Film heroin substitute
AGN,AGN:US,BBG000FH8PX5,Business Highlights,2016-05-31 21:45:11 +0000,http://sg.finance.yahoo.com/news/business-highlights-214511469.html,Business Highlights
AGN,AGN:US,BBG000FH8PX5,Markets Right Now: Stocks struggle to a mixed close,2016-05-31 20:09:58 +0000,http://sg.finance.yahoo.com/news/markets-now-stocks-open-higher-134008606.html,Markets Right Now: Stocks struggle to a mixed close
AGN,AGN:US,BBG000FH8PX5,Icahn takes 'large' stake in Botox maker Allergan,2016-05-31 19:37:17 +0000,http://uk.finance.yahoo.com/news/icahn-takes-large-stake-botox-193717931.html,Icahn takes 'large' stake in Botox maker Allergan
AGN,AGN:US,BBG000FH8PX5,Carl Icahn says he bought a stake in Botox-maker Allergan,2016-05-31 18:18:57 +0000,http://sg.finance.yahoo.com/news/carl-icahn-says-bought-stake-171803835.html,Carl Icahn says he bought a stake in Botox-maker Allergan
AGN,AGN:US,BBG000FH8PX5,"Pharma sector set for wave of mergers, acquisitions: study",2016-05-30 13:05:26 +0000,http://uk.finance.yahoo.com/news/pharma-sector-set-wave-mergers-130526415.html,"Pharma sector set for wave of mergers, acquisitions: study"
AGN,AGN:US,BBG000FH8PX5,Allergan CEO says company is 'weeks away' from closing Teva deal,2016-05-23 17:49:58 +0000,http://sg.finance.yahoo.com/news/allergan-ceo-says-company-weeks-163359525.html,Allergan CEO says company is 'weeks away' from closing Teva deal
AGN,AGN:US,BBG000FH8PX5,Pfizer buying skin drug maker Anacor for $5.2 billion,2016-05-16 18:54:14 +0000,http://sg.finance.yahoo.com/news/pfizer-buying-anacor-pharmaceuticals-5-112120058.html,Pfizer buying skin drug maker Anacor for $5.2 billion
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Higher health stocks and falling oil leave S&P 500 flat,2016-05-10 15:20:31 +0000,http://uk.finance.yahoo.com/news/us-stocks-higher-health-stocks-152031874.html,US STOCKS-Higher health stocks and falling oil leave S&P 500 flat
AGN,AGN:US,BBG000FH8PX5,"US STOCKS-Wall Street mixed as energy falls, Allergan rallies",2016-05-10 15:20:02 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-street-mixed-152002890.html,"US STOCKS-Wall Street mixed as energy falls, Allergan rallies"
AGN,AGN:US,BBG000FH8PX5,US STOCKS SNAPSHOT-Wall St little changed as health offsets commodities,2016-05-09 20:03:23 +0000,http://uk.finance.yahoo.com/news/us-stocks-snapshot-wall-st-200323442.html,US STOCKS SNAPSHOT-Wall St little changed as health offsets commodities
AGN,AGN:US,BBG000FH8PX5,"Pfizer earnings rise, boosted by Hospira assets",2016-05-03 12:33:10 +0000,http://uk.finance.yahoo.com/news/pfizer-earnings-rise-boosted-hospira-123310683.html,"Pfizer earnings rise, boosted by Hospira assets"
AGN,AGN:US,BBG000FH8PX5,INVESTMENT FOCUS-Investors favour European drug stocks in spite of M&A crackdown,2016-04-08 13:55:38 +0000,http://uk.finance.yahoo.com/news/investment-focus-investors-favour-european-135538897.html,INVESTMENT FOCUS-Investors favour European drug stocks in spite of M&A crackdown
AGN,AGN:US,BBG000FH8PX5,Investors stick with Pfizer CEO after Allergan deal scrapped,2016-04-07 23:20:27 +0000,http://in.finance.yahoo.com/news/investors-stick-pfizer-ceo-allergan-232027481.html,Investors stick with Pfizer CEO after Allergan deal scrapped
AGN,AGN:US,BBG000FH8PX5,Sosei Subsidiary Heptares and Allergan Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders,2016-04-07 05:34:00 +0000,http://uk.finance.yahoo.com/news/sosei-subsidiary-heptares-allergan-announce-053400127.html,Sosei Subsidiary Heptares and Allergan Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders
AGN,AGN:US,BBG000FH8PX5,"US and European stocks gain as oil, pharma shares rally",2016-04-06 21:47:47 +0000,http://uk.finance.yahoo.com/news/us-european-stocks-gain-oil-214747585.html,"US and European stocks gain as oil, pharma shares rally"
AGN,AGN:US,BBG000FH8PX5,US STOCKS-Wall St rises with healthcare; oil rallies,2016-04-06 20:57:11 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rises-205711337.html,US STOCKS-Wall St rises with healthcare; oil rallies
AGN,AGN:US,BBG000FH8PX5,Tax rules that killed Allergan-Pfizer deal may be hard to challenge,2016-04-06 19:54:50 +0000,http://uk.finance.yahoo.com/news/u-business-lobbyist-asks-tax-155150848.html,Tax rules that killed Allergan-Pfizer deal may be hard to challenge
AGN,AGN:US,BBG000FH8PX5,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",2016-04-06 18:20:35 +0000,http://in.finance.yahoo.com/news/pfizer-allergan-scrap-160-bln-105613100.html,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change"
AGN,AGN:US,BBG000FH8PX5,Obama's inversion curbs kill Pfizer's $160 bln Allergan deal,2016-04-06 12:46:21 +0000,http://in.finance.yahoo.com/news/obamas-inversion-curbs-kill-pfizers-062325568.html,Obama's inversion curbs kill Pfizer's $160 bln Allergan deal
AGN,AGN:US,BBG000FH8PX5,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal,2016-04-06 05:51:34 +0000,http://in.finance.yahoo.com/news/obamas-inversion-curbs-kill-pfizers-055134446.html,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
AGN,AGN:US,BBG000FH8PX5,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says",2016-04-06 02:52:07 +0000,http://in.finance.yahoo.com/news/pfizers-allergan-deal-teeters-u-002720378.html,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says"
AGN,AGN:US,BBG000FH8PX5,Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources,2016-03-10 00:04:24 +0000,http://in.finance.yahoo.com/news/exclusive-teva-set-win-eu-000424015.html,Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources
AGN,AGN:US,BBG000FH8PX5,"Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources",2016-03-09 19:38:31 +0000,http://in.finance.yahoo.com/news/exclusive-eu-regulators-set-clear-193831553.html,"Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources"
AGN,AGN:US,BBG000FH8PX5,Pfizer to buy Allergan in $160 billion deal,2015-11-24 03:15:02 +0000,http://in.finance.yahoo.com/news/pfizer-buy-allergan-160-billion-031502366.html,Pfizer to buy Allergan in $160 billion deal
AGN,AGN:US,BBG000FH8PX5,"Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources",2015-11-21 03:59:58 +0000,http://in.finance.yahoo.com/news/exclusive-pfizer-allergan-ceos-agree-035958837.html,"Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources"
AGN,AGN:US,BBG000FH8PX5,Pfizer-Allergan talks accelerate amid new inversion clamp-down,2015-11-19 04:17:22 +0000,http://in.finance.yahoo.com/news/pfizer-allergan-talks-accelerate-amid-041722835.html,Pfizer-Allergan talks accelerate amid new inversion clamp-down
AGN,AGN:US,BBG000FH8PX5,Exclusive: Moelis clinches Pfizer advisory role with help from Eric Cantor - sources,2015-11-16 18:55:31 +0000,http://in.finance.yahoo.com/news/exclusive-moelis-clinches-pfizer-advisory-185531719.html,Exclusive: Moelis clinches Pfizer advisory role with help from Eric Cantor - sources
AGN,AGN:US,BBG000FH8PX5,"Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks",2015-11-02 17:57:51 +0000,http://in.finance.yahoo.com/news/exclusive-guggenheim-jpmorgan-clinch-key-175751460.html,"Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks"
AGN,AGN:US,BBG000FH8PX5,"Pfizer, Allergan drug merger talks raise tax hackles in U.S.",2015-10-29 22:06:34 +0000,http://in.finance.yahoo.com/news/pfizer-allergan-talks-forge-worlds-191510216.html,"Pfizer, Allergan drug merger talks raise tax hackles in U.S."
AGN,AGN:US,BBG000FH8PX5,Pfizer said to be in talks with Allergan to forge $330 bln drugs giant,2015-10-29 09:05:53 +0000,http://in.finance.yahoo.com/news/drugmakers-pfizer-allergan-considering-combination-031229276.html,Pfizer said to be in talks with Allergan to forge $330 bln drugs giant
AGN,AGN:US,BBG000FH8PX5,"Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid",2015-07-27 18:32:04 +0000,http://in.finance.yahoo.com/news/teva-buy-allergan-generic-drug-100202496.html,"Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid"
